data_1bfm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bfm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.459 HD11 ' CB ' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.252 1.187 0 CA-C-O 122.016 0.912 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.5 Cg_endo -56.74 140.3 90.59 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.751 2.301 . . . . 0.0 113.49 171.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.2 -14.11 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.456 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.23 -55.37 3.78 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.653 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.531 ' HG2' ' HG2' ' A' ' 4' ' ' PRO . 15.5 Cg_exo -49.77 -49.59 15.51 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.655 2.237 . . . . 0.0 113.644 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 8' ' ' ILE . 63.0 mt -61.25 -45.74 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.521 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.05 59.23 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.37 -29.44 18.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.475 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD11 ' HG2' ' B' ' 33' ' ' GLU . 27.8 mt -61.5 -57.63 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.309 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.529 HG21 HD13 ' B' ' 44' ' ' ILE . 10.9 mm -61.21 -36.19 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.331 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mttm -62.98 -36.68 84.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.444 170.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.63 -34.02 76.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.753 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.24 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.376 169.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.42 20.61 0.34 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.691 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.21 149.34 33.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.401 166.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.23 -55.17 2.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 111.59 10.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -169.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG13 ' HD2' ' A' ' 25' ' ' ARG . 94.3 t -133.04 132.15 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.384 -169.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.4 p -65.92 157.17 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.351 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.92 -18.56 63.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.428 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.537 ' HA ' HG21 ' A' ' 26' ' ' ILE . 24.2 m-20 -81.0 -34.57 32.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.455 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB3' HD11 ' B' ' 60' ' ' ILE . . . -61.52 -40.36 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.192 166.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.504 ' HD2' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -66.08 -40.51 90.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.333 -177.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.537 HG21 ' HA ' ' A' ' 23' ' ' ASP . 7.3 tt -81.39 -34.88 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.375 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.537 HG23 HG23 ' B' ' 60' ' ' ILE . 84.9 m -63.58 -45.96 88.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.091 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.535 ' HB2' HG12 ' B' ' 60' ' ' ILE . 3.3 tp -60.36 -42.84 96.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.289 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 26' ' ' ILE . . . -61.53 -42.93 99.54 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.268 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -78.62 -27.15 45.43 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.384 -176.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 27' ' ' THR . 23.3 mt -61.42 -73.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 166.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -26.66 65.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.848 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.52 -48.14 14.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.081 -176.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -63.98 -26.41 68.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.017 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.523 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 13.5 ttm -71.92 -43.49 65.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.452 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.456 ' CA ' HD23 ' B' ' 32' ' ' LEU . . . -65.06 -45.33 92.39 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -60.69 -22.16 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.39 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.07 -54.83 5.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.489 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.523 ' HB ' HD13 ' B' ' 28' ' ' LEU . 10.1 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.208 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB3' HD12 ' B' ' 12' ' ' ILE . . . -61.24 -54.24 46.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.309 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.49 ' N ' ' HB3' ' B' ' 15' ' ' ALA . 84.3 p -61.48 -28.17 69.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.393 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.06 -56.37 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.061 165.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -65.18 -4.52 5.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.023 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.529 HD13 ' HB1' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -94.1 -56.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.248 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -62.49 -17.12 58.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.74 167.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 5.1 mp -67.18 -61.03 2.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.112 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.53 -14.21 18.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.462 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . 18.4 ttt-85 -97.41 -23.21 16.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.016 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -36.1 76.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.051 163.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -56.76 8.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 161.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.96 -14.05 21.79 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.358 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 172.47 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.785 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.66 28.81 0.0 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.991 164.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.519 HG21 ' N ' ' A' ' 55' ' ' ILE . 100.0 m 63.45 150.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.407 177.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' HG21 ' A' ' 54' ' ' THR . 9.6 mm -69.73 134.25 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.014 169.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HA ' ' HB1' ' B' ' 24' ' ' ALA . 41.1 mtmt -142.38 175.31 9.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.504 -164.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -63.86 -55.13 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.289 -173.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 3.4 mt-10 -68.5 -16.05 63.75 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.992 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -39.3 69.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.325 172.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.541 HG13 HD12 ' B' ' 28' ' ' LEU . 1.5 mp -62.83 -56.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.501 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 22.1 mt-10 -60.6 -43.22 97.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.877 -161.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HB3' HD22 ' A' ' 46' ' ' LEU . 5.5 tp -61.03 -45.45 94.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.468 167.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.54 -29.09 69.79 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.452 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -86.22 -52.2 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.62 -168.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -18.73 60.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.589 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -76.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.316 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.184 -162.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' B' ' 29' ' ' ALA . 18.9 mt . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.481 0.658 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.458 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 7.9 Cg_endo -48.81 138.09 26.62 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.16 1.907 . . . . 0.0 113.353 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -80.91 -11.33 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.627 -165.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.47 6.54 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.764 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.458 ' CG ' ' HG2' ' B' ' 4' ' ' PRO . 3.7 Cg_endo -58.74 -48.83 13.35 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 122.504 2.136 . . . . 0.0 113.499 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' B' ' 3' ' ' LEU . 26.8 mt -60.89 -21.11 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.321 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.82 -53.55 44.31 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.6 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 10.7 mtp-105 -79.28 -21.56 45.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.372 -172.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.459 HD13 HD13 ' A' ' 3' ' ' LEU . 64.0 mt -61.36 -57.6 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.153 165.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 40' ' ' ALA . 5.6 mt -78.55 -12.93 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.944 -172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtmm -68.47 -40.38 81.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 162.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.35 -32.98 73.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.876 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' B' ' 12' ' ' ILE . . . -57.48 -52.06 66.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.554 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.9 25.61 0.26 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.732 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.536 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -77.94 145.48 36.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.289 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.725 162.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 100.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.423 -163.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.511 HG11 ' HB ' ' A' ' 55' ' ' ILE . 12.7 t -100.91 169.27 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.1 t -117.14 141.52 48.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.393 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -27.48 68.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.332 -167.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -40.12 91.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.464 172.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -63.84 -57.97 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -61.06 -33.25 73.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.388 -167.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mt -82.18 -38.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.449 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.457 HG21 HD13 ' B' ' 31' ' ' ILE . 85.3 m -61.26 -47.07 87.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.541 HD12 HG13 ' A' ' 60' ' ' ILE . 4.4 tp -60.49 -47.83 84.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.382 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.504 ' HA ' HD13 ' B' ' 3' ' ' LEU . . . -61.31 -27.1 68.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.373 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -36.18 40.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.389 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' B' ' 28' ' ' LEU . 4.9 mt -61.14 -72.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.051 172.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.456 HD23 ' CA ' ' A' ' 36' ' ' GLY . 3.0 mp -60.06 -31.99 70.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 -165.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.408 ' HG2' HD11 ' A' ' 11' ' ' ILE . 3.3 tm-20 -76.82 -33.61 57.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.061 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.2 89.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.064 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.64 -43.5 80.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.527 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.61 -40.33 97.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -32.9 71.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.429 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -63.73 -56.88 12.23 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.539 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' A' ' 28' ' ' LEU . 5.0 mt -62.52 -26.38 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.787 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 12' ' ' ILE . . . -61.88 -70.53 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.317 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.9 OUTLIER -62.14 -17.29 57.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.371 -173.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.446 ' HB3' ' CB ' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -73.36 -59.04 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.067 170.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.52 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.8 -14.45 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 62.8 mt -94.3 -54.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.97 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -60.46 -14.88 21.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.373 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' B' ' 43' ' ' ALA . 16.8 mt -75.83 -53.81 7.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.465 169.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.23 -16.43 61.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.27 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -34.57 14.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.373 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.65 -34.26 74.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.12 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.336 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.3 12.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.31 -176.34 2.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.009 -0.595 . . . . 0.0 110.431 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -115.07 -46.29 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.336 -170.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -87.45 117.54 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.42 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' B' ' 59' ' ' ASP . 9.8 mt -78.72 143.55 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.327 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.416 ' N ' HG21 ' B' ' 55' ' ' ILE . 2.1 mtmp? -125.92 177.33 6.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.455 -167.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -21.37 64.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.273 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 30.2 tt0 -69.08 -48.61 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.044 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' B' ' 55' ' ' ILE . 7.6 m-20 -63.51 -37.49 87.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.4 -168.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.537 HG23 HG23 ' A' ' 27' ' ' THR . 1.4 mp -62.7 -39.13 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.777 163.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -62.28 -39.46 93.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -170.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 22.9 mt -84.53 -39.26 19.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.479 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.461 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.49 -49.18 78.59 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.393 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.486 HG12 HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -72.66 -52.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.015 -170.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -60.3 -31.45 70.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . 0.514 ' NH2' HD22 ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.31 -40.36 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.325 178.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 14.8 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.336 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.9 mt . . . . . 0 C--O 1.243 0.739 0 CA-C-O 121.241 0.543 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -46.66 141.34 11.34 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.387 2.058 . . . . 0.0 113.438 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' HB3' ' A' ' 25' ' ' ARG . 42.3 pt -89.83 17.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.975 -167.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.0 -55.98 0.65 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.627 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.05 -54.64 2.12 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.659 2.239 . . . . 0.0 113.575 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.513 ' HA ' HD11 ' A' ' 11' ' ' ILE . 23.8 mt -65.02 -45.25 95.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.361 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.58 62.3 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -88.02 -27.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 8' ' ' ILE . 44.8 mt -62.07 -55.27 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 169.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.524 HG21 HD13 ' B' ' 44' ' ' ILE . 10.0 mm -67.89 -36.21 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.33 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -33.27 72.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.286 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -62.43 -34.66 77.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.824 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.56 -52.35 65.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.435 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.79 23.88 0.35 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.544 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.86 150.57 32.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.436 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -122.55 -75.32 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.033 -167.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -121.92 104.97 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.434 -174.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.44 ' CG2' ' NH2' ' A' ' 25' ' ' ARG . 19.8 t -116.13 150.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.323 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -87.79 148.84 24.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.365 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -60.95 -20.14 61.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.375 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -60.8 -54.73 41.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.441 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' B' ' 56' ' ' LYS . . . -62.22 -42.61 99.47 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.385 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.534 ' HB3' HG23 ' A' ' 5' ' ' ILE . 4.6 mmt85 -61.71 -46.12 91.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.354 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 5' ' ' ILE . 40.3 mm -73.31 -32.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.451 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.529 HG22 ' HB3' ' B' ' 57' ' ' ALA . 97.1 m -60.95 -44.33 97.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.497 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 7.4 tp -83.43 -14.07 53.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.078 -172.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . . . -81.73 -21.76 37.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.407 163.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' GLU . 6.3 tttt -88.57 -31.14 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.37 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.473 HD12 HG23 ' B' ' 60' ' ' ILE . 3.1 mp -61.08 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.658 159.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' B' ' 32' ' ' LEU . 4.3 mm? -59.04 -14.86 10.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.634 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' HG3' HD11 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -71.02 -69.11 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.699 163.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.8 -32.3 71.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.097 -167.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.455 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -66.42 -34.92 79.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.433 166.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.23 -53.96 12.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' B' ' 15' ' ' ALA . 0.0 OUTLIER -64.31 -26.09 68.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.458 173.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 15.0 m-20 -60.89 -62.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.477 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 3.2 mt -62.59 -17.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.583 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -80.78 -69.17 0.62 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.254 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -61.04 -13.57 17.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.459 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -73.2 -63.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.077 166.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -60.93 -11.26 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.556 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.537 HD12 HG21 ' B' ' 12' ' ' ILE . 95.8 mt -93.28 -49.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.803 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -60.28 -33.12 71.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.395 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 43' ' ' ALA . 15.6 mt -60.34 -42.72 96.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.334 166.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -61.23 -54.36 45.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.277 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -68.09 -14.94 63.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.431 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -71.27 -56.54 5.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.219 172.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.34 24.08 0.23 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.909 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD3' ' HG3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 55.21 -162.71 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 O-C-N 122.184 -0.598 . . . . 0.0 111.428 158.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 0.4 OUTLIER 70.23 -81.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.559 -165.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 m -115.45 137.87 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.379 -160.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 44' ' ' ILE . 8.3 mm -94.28 137.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.164 161.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 167.42 23.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.547 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.261 -167.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.1 -42.86 99.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.942 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.8 -45.42 94.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.5 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG21 HD23 ' B' ' 28' ' ' LEU . 37.0 mm -66.86 -47.2 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.401 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.68 -33.89 74.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.23 -53.85 51.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.384 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -61.02 -49.46 77.3 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.328 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -67.37 -53.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.931 -164.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -20.26 66.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.818 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -43.87 98.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.255 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 43.0 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.465 168.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' B' ' 29' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.52 ' HB2' ' HG2' ' B' ' 7' ' ' PRO . 19.3 Cg_endo -62.09 143.37 94.71 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.397 2.064 . . . . 0.0 113.463 164.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.496 HD13 ' NH2' ' B' ' 25' ' ' ARG . 12.2 pt -108.23 -14.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.444 -167.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.0 -54.76 1.51 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.682 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 17.2 Cg_exo -50.23 -46.48 28.49 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.722 2.281 . . . . 0.0 113.617 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.6 -47.61 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.459 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.84 -29.07 71.28 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.552 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -89.19 -19.99 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.332 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.523 HD11 ' HG3' ' A' ' 33' ' ' GLU . 46.1 mm -61.61 -48.39 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.106 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.537 HG21 HD12 ' A' ' 44' ' ' ILE . 4.8 mm -70.22 -39.27 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.711 -174.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.1 OUTLIER -60.44 -43.11 97.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.442 169.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.96 -31.99 72.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.857 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.512 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . . . -58.45 -53.62 56.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.492 169.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.48 20.83 0.61 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.45 119.88 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.272 167.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.94 -61.18 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.057 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 108.83 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.468 167.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' B' ' 17' ' ' ALA . 11.6 t -75.17 114.47 15.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.232 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -60.73 151.59 29.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.409 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 60.2 m-20 -61.59 -19.23 61.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.363 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.528 ' HA ' HG23 ' B' ' 26' ' ' ILE . 2.3 t0 -89.42 -26.08 21.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.32 -175.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -63.78 -47.74 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.251 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.496 ' NH2' HD13 ' B' ' 5' ' ' ILE . 12.6 ptt180 -71.4 -29.14 64.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.402 -169.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.528 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -73.13 -42.21 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.443 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.482 HG21 HG23 ' A' ' 60' ' ' ILE . 67.1 m -60.93 -37.57 82.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.242 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.106 167.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' B' ' 3' ' ' LEU . . . -62.86 -32.57 73.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.27 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -45.14 68.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.587 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' B' ' 28' ' ' LEU . 3.2 mt -61.15 -73.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.211 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.532 ' HB3' HD13 ' A' ' 32' ' ' LEU . 6.5 mp -55.55 -28.51 55.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.32 -167.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.24 -57.8 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.88 -38.2 87.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.986 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 22.1 mmm -72.0 -38.24 69.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.54 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.11 -40.71 95.14 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.388 170.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -58.86 4.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.511 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 4.1 mt -61.51 -31.71 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.339 -173.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 12' ' ' ILE . . . -61.92 -70.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.244 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 16.1 t -62.27 -12.42 20.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.444 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' CZ ' ' B' ' 67' ' ' PHE . 1.2 mp0 -93.84 -48.24 6.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.175 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.55 -10.89 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.378 167.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.524 HD13 HG21 ' A' ' 12' ' ' ILE . 56.7 mt -100.74 -49.15 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.793 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.01 -11.38 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.454 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' B' ' 43' ' ' ALA . 8.1 mt -84.1 -59.52 2.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.422 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.501 ' HB2' HD12 ' B' ' 55' ' ' ILE . . . -60.69 -18.21 52.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.523 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.11 -28.48 20.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.052 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -60.23 -35.7 76.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.174 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.59 17.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.998 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 2.98 44.76 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.762 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 178.71 -163.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.638 -166.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt 76.02 -93.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' B' ' 55' ' ' ILE . 99.7 m -172.08 168.81 5.74 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.824 -0.548 . . . . 0.0 109.955 -160.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' B' ' 47' ' ' ALA . 7.3 mm -114.74 135.41 54.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.903 155.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.535 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -147.22 -177.46 5.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 -165.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 27' ' ' THR . . . -61.74 -15.49 41.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.346 -176.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 1.8 tp10 -100.76 -30.15 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.047 -170.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -36.36 79.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.136 167.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mp -61.39 -64.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.814 162.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -61.08 -22.46 64.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 -163.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.67 -39.67 15.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.458 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.84 -36.17 78.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.355 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.529 HG21 HG12 ' B' ' 39' ' ' ILE 0.274 0.5 OUTLIER -88.15 -45.1 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.876 -166.167 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.38 -27.17 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.53 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.5 95.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.107 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' B' ' 42' ' ' GLU . 18.3 m-85 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 162.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.524 HD22 HD12 ' B' ' 11' ' ' ILE . 2.5 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.267 0.556 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.29 144.31 95.14 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.484 2.123 . . . . 0.0 113.52 164.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.495 HG23 HG12 ' A' ' 26' ' ' ILE . 2.2 pp -107.84 16.54 7.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.879 -169.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.84 -55.87 0.51 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -61.09 -42.49 35.9 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.555 2.17 . . . . 0.0 113.561 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mt -60.63 -35.04 60.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.472 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -46.82 93.46 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.585 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -18.57 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.347 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' HG3' ' B' ' 33' ' ' GLU . 93.6 mt -60.91 -40.22 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.162 163.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.536 HD12 ' HB3' ' B' ' 40' ' ' ALA . 7.8 mt -93.22 -25.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.51 -162.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -64.02 -36.88 85.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.05 -32.97 74.71 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.088 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 12' ' ' ILE . . . -58.02 -52.36 65.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.509 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.7 28.51 0.25 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.978 -1.464 . . . . 0.0 110.713 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' B' ' 44' ' ' ILE . . . -75.18 127.77 33.96 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.531 -175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.22 -25.47 11.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.96 107.71 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.462 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.14 133.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.418 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 p -70.64 157.18 38.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.351 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.64 -33.3 72.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.406 171.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -44.61 96.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.429 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 -52.66 62.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.24 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -79.17 -14.23 59.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.38 -167.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.495 HG12 HG23 ' A' ' 5' ' ' ILE . 37.3 mt -96.81 -32.16 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.4 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.524 HG21 HD11 ' A' ' 31' ' ' ILE . 58.6 m -60.43 -35.4 75.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 168.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.521 ' HB2' HG12 ' B' ' 60' ' ' ILE . 3.5 tp -60.01 -48.44 81.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.294 165.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.0 -29.8 69.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.386 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.57 -40.75 15.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.444 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 27' ' ' THR . 18.4 mt -59.79 -69.37 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.982 171.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' B' ' 32' ' ' LEU . 2.7 tt -59.38 -31.2 69.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.846 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG3' HD12 ' B' ' 11' ' ' ILE . 0.6 OUTLIER -62.05 -53.74 51.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.007 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 58.4 tt0 -64.59 -20.95 66.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.958 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.509 ' HB3' HD22 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -63.06 -44.59 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 160.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' B' ' 32' ' ' LEU . . . -61.28 -51.96 54.74 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.699 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 8.3 ptm180 -61.46 -27.41 68.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.208 -0.496 . . . . 0.0 109.904 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -59.83 -54.44 46.21 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.669 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 28' ' ' LEU . 1.7 mt -62.44 -37.49 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.776 -174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -61.12 -68.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.401 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' HG23 ' A' ' 44' ' ' ILE . 4.7 t -62.52 -31.75 72.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.152 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -53.6 54.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.227 171.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -69.66 -13.25 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.528 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -83.77 -55.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.197 -168.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -76.19 -16.74 59.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.574 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 HD23 ' HD2' ' A' ' 66' ' ' ARG . 11.4 mt -61.3 -45.11 95.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.16 166.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.527 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -79.85 -24.36 41.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.253 -167.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.444 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -79.32 -52.5 8.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.494 178.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.05 66.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -60.71 -55.96 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.178 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 6.95 0.08 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.755 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 54.21 80.05 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.616 0.722 . . . . 0.0 112.182 162.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 -68.36 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.143 165.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.524 HG22 ' HB2' ' B' ' 21' ' ' SER . 6.0 t -138.13 -169.37 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.049 164.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 9.0 mm -100.93 135.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.738 161.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.461 ' N ' ' HB3' ' B' ' 24' ' ' ALA . 3.4 mttt -136.29 159.78 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.527 -164.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.504 ' HA ' HG23 ' B' ' 27' ' ' THR . . . -61.26 -20.42 62.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.307 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.29 -59.23 4.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.979 165.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 1.3 m-20 -66.51 -40.47 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.392 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.467 ' CG2' HD11 ' B' ' 28' ' ' LEU . 16.8 mm -61.93 -56.56 16.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.396 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.6 mt-10 -61.67 -19.48 62.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -64.26 -53.94 41.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.322 167.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 39' ' ' ILE . . . -61.06 -31.35 71.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.353 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 50.2 t -62.45 -67.72 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.6 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -60.52 -12.84 10.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.749 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HD2' HD23 ' A' ' 46' ' ' LEU . 1.1 tpm_? -79.47 -36.95 37.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.14 -170.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.513 ' CZ ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.452 158.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' B' ' 29' ' ' ALA . 17.8 mt . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.474 0.654 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 7.3 Cg_exo -46.33 148.78 3.01 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.612 2.208 . . . . 0.0 113.389 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.536 ' HA ' HG23 ' B' ' 8' ' ' ILE . 1.8 pp -66.89 -10.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.467 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.86 -56.9 0.31 Allowed Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.868 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 6.3 Cg_endo -60.3 -39.96 62.97 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.609 2.206 . . . . 0.0 113.463 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.536 HG23 ' HA ' ' B' ' 5' ' ' ILE . 0.1 OUTLIER -61.72 -55.78 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.829 167.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.05 -17.11 50.9 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.894 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.1 ttm105 -82.06 -37.93 25.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.295 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.527 HD12 ' HG3' ' A' ' 33' ' ' GLU . 64.6 mt -58.31 -50.36 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.9 164.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' A' ' 40' ' ' ALA . 3.6 mm -68.72 -30.18 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.322 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 17.5 mtmt -61.98 -38.45 88.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.181 170.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -61.16 -30.56 70.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.884 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . . . -57.83 -52.04 67.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.508 169.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.38 34.74 0.6 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.59 -164.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.524 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -83.32 149.21 26.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.278 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.05 -25.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.984 169.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -106.21 34.24 3.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.307 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -82.34 138.15 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.253 167.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.524 ' HB2' HG22 ' A' ' 54' ' ' THR . 31.2 t -80.05 152.31 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.386 163.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.2 -15.25 32.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.5 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.538 ' HA ' HG23 ' B' ' 26' ' ' ILE . 9.2 t70 -90.31 -29.3 18.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.389 -171.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -68.28 -44.27 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.207 167.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.464 ' HG3' HG13 ' B' ' 20' ' ' VAL . 1.2 mtt180 -61.82 -43.98 97.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.279 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.1 OUTLIER -62.9 -49.5 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.256 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -62.27 -29.13 70.2 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.949 -170.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 39' ' ' ILE . 3.8 tp -61.82 -42.73 99.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.943 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -64.12 -34.76 78.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.446 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.465 ' HD3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -83.94 -41.51 17.28 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.687 -175.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.503 HG22 HG23 ' A' ' 64' ' ' VAL . 21.8 mt -60.45 -65.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.048 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.53 ' HB3' HD22 ' A' ' 32' ' ' LEU . 5.2 mt -55.81 -23.01 27.65 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.234 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.503 ' HG3' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -61.6 -62.63 1.68 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.663 169.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.35 -20.95 63.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.888 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.5 mmt -66.32 -48.82 69.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.176 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.01 -46.04 95.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.911 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -33.93 74.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.255 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -61.69 2.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.974 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' B' ' 67' ' ' PHE . 3.1 mt -61.14 -41.35 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.241 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 12' ' ' ILE . . . -67.2 -53.44 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.308 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 30.6 t -63.82 -30.36 71.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.53 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.464 ' HB3' ' CB ' ' B' ' 63' ' ' ALA . 1.4 tm-20 -62.03 -62.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.904 170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -60.92 -9.88 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.533 HD13 HG21 ' A' ' 12' ' ' ILE . 39.1 mt -95.07 -48.23 12.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.783 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.05 -16.29 30.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.336 166.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.7 mt -82.84 -46.64 12.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.247 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -80.45 -32.67 37.2 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.367 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -60.4 -35.89 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.268 168.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.39 73.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.18 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 41.26 23.55 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -130.61 -173.76 3.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.405 -167.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -75.04 98.06 3.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.48 -165.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t 60.34 -176.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.952 166.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.517 HD12 HG12 ' B' ' 44' ' ' ILE . 3.3 mt -112.05 142.24 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.428 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -125.11 -176.68 3.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.384 -167.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.3 93.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.289 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -31.43 71.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.256 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 3.1 m-20 -80.22 -36.38 34.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.409 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -64.2 -47.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.607 174.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 7.9 mt-10 -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.138 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' B' ' 46' ' ' LEU . 8.6 tp -64.47 -51.93 60.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.378 171.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.503 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -66.88 -32.95 74.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 41.5 t -61.54 -67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.715 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.59 4.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.772 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -73.97 -39.45 63.7 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.069 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' B' ' 39' ' ' ILE . 12.3 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.493 164.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.5 Cg_endo -46.22 139.13 12.49 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.444 2.096 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.28 -8.26 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.915 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB1' ' CD ' ' A' ' 7' ' ' PRO . . . -69.25 -57.8 6.85 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.663 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.467 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 1.7 Cg_endo -51.87 -60.39 0.79 Allowed 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.615 2.21 . . . . 0.0 113.584 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 26.4 mt -61.02 -49.09 86.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.521 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.05 -22.88 63.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -171.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -82.74 -35.34 26.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.364 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' B' ' 33' ' ' GLU . 62.6 mt -59.69 -58.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.648 166.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.519 HD13 HD22 ' A' ' 28' ' ' LEU . 5.5 mm -61.94 -20.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.063 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 18' ' ' GLU . 3.6 mmmt -74.63 -36.77 62.91 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.299 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.85 -32.76 73.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.821 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' B' ' 44' ' ' ILE . . . -59.1 -53.41 58.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.383 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.51 17.62 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.316 -167.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -66.51 -163.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.678 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 61.6 24.2 14.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.612 -158.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -110.78 22.63 15.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 154.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG21 HD13 ' B' ' 55' ' ' ILE . 14.6 t -117.35 176.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.192 -162.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 16.6 t -125.08 168.37 13.47 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.526 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 65.6 m-20 -61.8 -25.75 67.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.19 -55.96 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.447 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . . . -62.12 -52.73 62.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.329 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.519 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -61.07 -37.37 82.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.263 -168.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.38 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.422 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.46 HG21 ' CD1' ' A' ' 31' ' ' ILE . 82.9 m -61.05 -44.7 97.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.245 -168.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 HD11 ' B' ' 39' ' ' ILE . 4.5 tp -59.79 -45.66 91.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.34 171.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -16.82 44.68 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.494 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 1.3 tptp -101.32 -26.15 13.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.326 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD11 ' HA ' ' A' ' 28' ' ' LEU . 1.6 mp -60.6 -68.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.792 161.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' B' ' 32' ' ' LEU . 3.7 mm? -58.48 -34.72 71.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.743 -168.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.459 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -74.24 -50.2 20.1 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.001 -175.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -61.7 -44.09 97.59 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.952 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.511 ' HA ' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -60.46 -35.16 75.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.574 172.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.37 -49.32 32.69 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -60.3 -14.28 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.417 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.8 -47.13 8.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.52 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.537 HD13 HD12 ' B' ' 32' ' ' LEU . 20.5 mt -60.64 -30.73 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.285 170.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -61.72 -74.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.304 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.94 -18.9 61.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.462 -174.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.22 -61.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.013 167.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.97 -9.96 5.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.587 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HA ' HD13 ' A' ' 55' ' ' ILE . 65.8 mt -94.26 -52.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.946 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -60.32 -10.65 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.487 167.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.498 HD23 ' HB1' ' A' ' 63' ' ' ALA . 3.8 mp -82.96 -47.05 12.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.217 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.19 96.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.355 167.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -54.53 27.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.375 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.48 -28.78 68.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.332 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.07 92.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.317 169.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.66 17.83 2.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -98.77 -167.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.4 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -127.23 -37.05 2.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.398 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.1 m -101.41 149.55 23.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.424 -168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 44' ' ' ILE . 13.9 mm -91.44 137.8 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.365 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.74 175.46 9.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.66 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.227 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.58 -40.47 69.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.111 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -33.67 71.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.399 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.533 HG21 HD12 ' B' ' 28' ' ' LEU . 44.5 mm -61.15 -69.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.29 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -61.66 -12.09 14.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.269 -170.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mt -75.47 -48.93 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.391 168.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HB1' HD23 ' A' ' 46' ' ' LEU . . . -64.24 -35.72 81.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.361 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 25.0 t -66.09 -72.01 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.65 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -59.66 -11.16 4.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -169.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -29.36 14.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.367 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.49 ' CE2' HG12 ' A' ' 39' ' ' ILE . 1.5 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.445 163.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' B' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 2.4 Cg_endo -57.88 163.26 9.65 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.476 2.117 . . . . 0.0 113.509 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 pt -86.21 -25.25 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.4 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.64 -59.88 4.32 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.781 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 1.2 Cg_endo -54.48 -48.72 19.9 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 C-N-CA 122.498 2.132 . . . . 0.0 113.517 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.472 HD13 ' HB2' ' B' ' 3' ' ' LEU . 38.9 mt -61.03 -43.73 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.369 169.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -16.18 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.7 OUTLIER -96.38 -26.76 15.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.359 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -61.27 -56.02 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.325 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.475 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.8 mm -64.04 -36.11 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.168 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.8 OUTLIER -62.68 -36.9 84.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.435 171.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.57 -34.2 76.5 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.777 -1.102 . . . . 0.0 109.817 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -59.26 -53.34 59.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.488 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.58 19.93 0.35 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.806 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.513 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -60.2 120.9 10.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.311 -0.445 . . . . 0.0 110.335 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.27 -74.65 0.34 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.048 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.19 109.25 14.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.407 -169.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.505 HG13 ' HG2' ' B' ' 25' ' ' ARG . 47.5 t -112.14 150.27 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.74 150.04 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.311 169.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.85 -12.97 12.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.357 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -55.35 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.457 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -61.98 -40.69 96.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.304 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.505 ' HG2' HG13 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -61.61 -45.39 94.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.456 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -77.73 -21.56 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.422 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.534 HG23 HD13 ' B' ' 31' ' ' ILE . 88.3 m -72.79 -50.58 23.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.312 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.533 HD12 HG21 ' A' ' 60' ' ' ILE . 3.2 tp -59.19 -37.86 78.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.561 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.09 75.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.32 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -26.42 23.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.43 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.534 HD13 HG23 ' B' ' 27' ' ' THR . 67.5 mt -61.04 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.033 170.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 39' ' ' ILE . 7.2 mp -60.03 -38.34 82.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.715 -170.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.37 -30.09 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.929 -170.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.02 -45.45 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.122 167.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 33.9 mtt -61.43 -42.33 98.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.517 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.07 99.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -170.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.498 ' HG3' HG22 ' A' ' 11' ' ' ILE . 2.4 mtp180 -60.43 -35.35 75.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.552 171.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -77.95 -45.7 23.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.499 -167.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 HD11 HD13 ' A' ' 28' ' ' LEU . 11.9 mt -60.85 -35.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.099 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.501 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -60.65 -59.55 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.341 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.537 ' HA ' HG23 ' B' ' 44' ' ' ILE . 72.0 p -68.79 -24.33 64.39 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.224 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -55.93 26.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.041 165.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -65.82 -13.68 59.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.602 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -87.62 -56.46 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.309 -164.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -72.26 -17.29 61.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.467 172.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' B' ' 43' ' ' ALA . 8.3 mt -60.83 -44.16 97.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.369 167.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -44.02 97.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.362 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -50.99 25.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.43 -171.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -61.54 -34.29 75.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.32 91.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.335 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.1 29.99 5.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -110.46 135.63 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.404 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.88 -42.95 47.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.382 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 7.0 m -111.07 119.8 40.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.399 -168.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 20' ' ' VAL . 79.9 mt -76.74 139.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.291 168.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.424 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 5.5 mtmt -141.8 -170.33 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.463 -169.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.36 73.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.241 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -30.43 69.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.064 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.19 -39.14 19.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.415 -166.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -65.2 -42.19 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.216 162.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.53 -31.15 71.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.977 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.7 -33.27 18.8 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.357 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.54 -42.9 97.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.436 172.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.529 HG21 HG12 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -82.44 -52.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -164.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.28 78.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.799 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.98 -17.93 54.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.9 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.327 173.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.462 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.4 Cg_endo -57.68 162.66 10.21 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.614 2.21 . . . . 0.0 113.545 170.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -84.82 -15.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.526 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -63.42 -58.59 14.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.762 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -59.3 -57.65 0.85 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.595 2.197 . . . . 0.0 113.619 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 27.5 mt -61.71 -43.33 97.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.372 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 25' ' ' ARG . . . -61.74 -41.06 99.56 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.539 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -72.82 -18.47 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.455 -174.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.489 HD12 ' HG2' ' B' ' 33' ' ' GLU . 69.7 mt -77.67 -41.18 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.53 172.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' B' ' 40' ' ' ALA . 7.5 mm -63.99 -43.96 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.149 171.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.8 mttt -62.07 -35.68 79.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.244 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.49 -31.15 71.12 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.845 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.63 -52.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.521 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.1 24.6 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.493 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 20' ' ' VAL . . . -60.91 120.27 9.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.314 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -90.35 -48.02 7.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.189 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.52 90.43 2.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.501 168.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 17' ' ' ALA . 97.8 t -96.41 129.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.126 166.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 p -60.84 146.2 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.546 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -61.16 -21.97 64.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.34 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.14 -27.17 64.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.42 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -78.06 -41.76 34.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.288 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.536 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -60.7 -45.7 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.503 172.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -66.55 -27.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.437 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.473 HG21 HG22 ' B' ' 60' ' ' ILE . 1.3 t -76.5 -33.19 58.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.228 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 31' ' ' ILE . 1.1 mm? -59.9 -39.13 84.34 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.434 170.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.05 98.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.396 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -25.69 24.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.415 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 28' ' ' LEU . 17.4 mt -61.42 -72.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.925 165.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.816 -167.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HG2' ' CD1' ' B' ' 11' ' ' ILE . 9.8 mt-10 -63.29 -55.69 22.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 170.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.77 -32.82 73.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.966 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.446 ' HB3' HD23 ' B' ' 32' ' ' LEU . 3.0 tpp -66.36 -44.83 82.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.414 167.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.24 99.14 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -35.17 75.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.195 -0.503 . . . . 0.0 110.427 169.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -61.42 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.533 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.537 HD11 HG21 ' A' ' 64' ' ' VAL . 8.7 mt -61.79 -31.78 51.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.353 -171.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' B' ' 12' ' ' ILE . . . -66.86 -61.18 2.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.253 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -60.87 -10.52 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.412 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CE1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -81.37 -57.94 3.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.412 169.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -66.01 -5.47 9.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.818 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' A' ' 41' ' ' SER . 77.5 mt -85.95 -65.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.906 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -21.96 64.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.951 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 8.4 mp -60.01 -57.18 13.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.21 158.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.76 99.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.236 -169.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -56.57 13.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.472 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -64.45 -23.7 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.419 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.11 -55.71 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.016 164.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.27 19.67 0.26 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 113.85 -1.523 . . . . 0.0 111.035 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.64 -167.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.358 -0.495 . . . . 0.0 111.012 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 98.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 -164.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.4 m 71.65 117.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.622 165.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.52 ' HB ' HG12 ' B' ' 20' ' ' VAL . 14.6 mt -71.76 147.72 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.614 157.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' N ' HG21 ' A' ' 55' ' ' ILE . 27.9 mttt -141.97 160.63 39.83 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.323 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' B' ' 23' ' ' ASP . . . -61.99 -28.0 69.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -41.02 96.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.977 166.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.268 0.0 OUTLIER -67.6 -40.41 84.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.352 -173.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.528 HG12 ' HB3' ' B' ' 24' ' ' ALA . 45.7 mm -73.14 -36.12 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.288 -169.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -87.48 -17.56 31.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.157 177.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.489 HD21 ' N ' ' A' ' 62' ' ' LEU . 3.8 mm? -72.16 -47.17 52.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.104 164.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.65 94.76 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.063 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 39' ' ' ILE . 23.9 t -61.22 -73.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.616 171.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.85 -11.05 6.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.387 -167.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HD2' HD22 ' A' ' 46' ' ' LEU . 7.4 mtt180 -70.4 -47.58 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.314 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.311 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.531 ' HG ' ' HG3' ' B' ' 33' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.486 0.66 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -50.48 152.86 8.29 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 122.617 2.211 . . . . 0.0 113.622 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.468 ' CG2' HD12 ' B' ' 26' ' ' ILE . 17.4 pt -85.28 -10.61 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.858 -170.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.05 -62.69 1.76 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.781 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.93 -52.3 8.74 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.337 2.025 . . . . 0.0 113.505 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' B' ' 11' ' ' ILE . 26.3 mt -60.26 -38.43 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.461 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.77 95.17 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.622 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.521 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -80.7 -16.52 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.361 -0.42 . . . . 0.0 110.443 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' B' ' 8' ' ' ILE . 17.7 mt -80.15 -39.1 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.772 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.509 HG22 ' NH2' ' B' ' 25' ' ' ARG . 20.1 mm -61.18 -46.99 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.243 168.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 5.7 mtpt -63.65 -36.93 85.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.225 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.4 -30.82 70.79 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.878 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -57.28 -53.4 58.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.681 169.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.06 30.4 0.27 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.707 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -88.44 -175.5 5.0 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 114.763 -0.718 . . . . 0.0 110.296 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.25 -72.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.047 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -99.11 122.01 41.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.354 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.54 HG13 ' HG2' ' B' ' 25' ' ' ARG . 14.0 t -145.52 155.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.303 -166.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.452 ' N ' HG11 ' B' ' 20' ' ' VAL . 46.5 t -93.2 149.51 21.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 167.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.85 -13.07 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.267 167.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . 1.2 m-20 -60.4 -59.64 5.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.529 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.528 ' HB3' HG12 ' A' ' 60' ' ' ILE . . . -63.8 -43.97 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.315 -175.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.54 ' HG2' HG13 ' B' ' 20' ' ' VAL . 5.3 mmt-85 -67.62 -33.32 74.74 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.486 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.468 HD12 ' CG2' ' B' ' 5' ' ' ILE . 26.0 mm -84.25 -19.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.403 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 60' ' ' ILE . 89.5 m -71.77 -48.83 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.426 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 39' ' ' ILE . 4.4 tp -60.53 -46.86 88.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.404 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -61.99 -29.69 70.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.467 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -26.02 15.03 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.319 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.528 HD11 HG23 ' A' ' 60' ' ' ILE . 79.4 mt -60.87 -70.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.961 163.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.32 -27.23 67.17 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.551 -170.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.531 ' HG3' ' HG ' ' B' ' 3' ' ' LEU . 6.5 mt-10 -61.27 -47.2 87.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.203 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.8 -29.24 70.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.005 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.401 ' HA ' ' HE2' ' B' ' 35' ' ' MET . 0.2 OUTLIER -64.52 -49.8 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.427 166.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.0 98.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -32.4 71.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.393 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.47 -58.73 5.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.427 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' B' ' 67' ' ' PHE . 2.9 mt -65.61 -24.88 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.157 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 12' ' ' ILE . . . -64.2 -75.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.312 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.517 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.5 p -61.43 -16.81 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.583 -171.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.491 ' HG3' ' CE1' ' B' ' 67' ' ' PHE . 0.0 OUTLIER -72.45 -59.46 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.082 168.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -60.89 -12.72 11.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.41 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 17' ' ' ALA . 96.6 mt -94.45 -50.34 11.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.724 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.27 -21.37 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.547 168.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -71.61 -46.67 58.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.391 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -45.09 14.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.387 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -61.55 -35.93 79.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.356 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.85 -46.83 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.35 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 29.46 6.91 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 174.04 7.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.343 170.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.18 151.29 48.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.389 -168.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 99.1 m 70.1 127.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.463 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.527 ' HB ' HG23 ' A' ' 20' ' ' VAL . 4.6 mp -87.58 140.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.265 166.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -137.65 -171.25 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 27' ' ' THR . . . -61.13 -16.91 49.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 -166.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 1.3 tm-20 -90.15 -20.73 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.042 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.522 ' HB2' HG22 ' B' ' 55' ' ' ILE . 18.2 m-20 -81.06 -34.08 32.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.389 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.536 HG22 HD21 ' A' ' 28' ' ' LEU . 35.9 mm -60.53 -68.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.348 167.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.426 ' HA ' HG13 ' B' ' 64' ' ' VAL . 41.4 mt-10 -61.38 -15.29 34.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.772 -170.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 11.5 mt -68.31 -50.82 50.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.284 165.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.439 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.49 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -75.52 -56.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.861 -162.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -21.31 59.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.875 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -48.85 79.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.281 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' B' ' 39' ' ' ILE . 4.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.301 164.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.761 0 CA-C-O 121.647 0.737 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 20.4 Cg_endo -60.89 148.1 93.43 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.099 1.866 . . . . 0.0 113.469 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -12.48 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.846 -175.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.14 -56.3 7.25 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.701 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CG ' ' HB2' ' A' ' 4' ' ' PRO . 9.9 Cg_endo -63.22 -51.8 2.49 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.586 2.191 . . . . 0.0 113.542 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HA ' HD11 ' A' ' 11' ' ' ILE . 45.9 mt -60.88 -55.45 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.39 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -30.04 74.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -68.49 -36.33 78.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.397 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 8' ' ' ILE . 23.9 mt -60.63 -40.6 85.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.509 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.518 HG21 HD12 ' B' ' 44' ' ' ILE . 8.8 mm -68.09 -41.03 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.277 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.62 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.275 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -62.25 -35.11 77.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.855 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.75 -53.09 62.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.428 169.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.74 24.99 0.28 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.583 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.87 129.15 40.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.393 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.64 -37.64 6.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.115 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 109.64 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.37 169.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.501 HG23 HD11 ' B' ' 55' ' ' ILE . 17.5 t -107.51 127.69 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.308 169.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.45 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 26.6 t -62.5 146.45 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.352 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -30.28 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.347 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.8 -45.83 92.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.432 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' B' ' 56' ' ' LYS . . . -65.73 -59.06 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.297 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -62.55 -23.72 67.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -82.49 -32.72 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.564 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 m -61.21 -39.36 89.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.397 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD13 ' HB ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -60.79 -45.03 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.135 170.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -61.35 -42.95 99.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.461 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 1.3 ttpm? -76.15 -25.29 55.15 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.224 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.528 HG12 HG12 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -61.82 -50.42 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.402 162.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 ' HG ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -58.63 -36.4 74.03 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.608 -172.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HB2' HD23 ' A' ' 3' ' ' LEU . 22.3 tp10 -81.26 -41.37 22.31 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.978 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -86.34 -18.99 30.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.889 -170.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -44.35 48.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.9 160.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.29 99.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.696 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.38 -35.66 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.023 175.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -49.89 75.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.507 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.521 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 28.2 mt -61.62 -53.03 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.272 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' B' ' 12' ' ' ILE . . . -63.33 -47.83 80.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.28 -167.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.482 ' N ' ' HB3' ' B' ' 15' ' ' ALA . 7.1 t -64.68 -19.93 66.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.156 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -78.67 -50.05 12.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.124 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -71.67 -32.05 67.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.987 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' B' ' 17' ' ' ALA . 65.5 mt -60.58 -44.06 95.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.935 161.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.57 -31.05 70.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.477 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 6.5 mt -80.47 -43.44 20.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.279 -169.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.75 -38.87 86.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.221 165.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 8.0 tpp180 -71.71 -47.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.37 -169.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -34.47 74.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.446 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.72 83.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.242 168.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.61 43.66 5.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -168.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -119.45 160.8 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.334 -168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -93.65 147.37 23.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.393 -177.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' HG2' ' A' ' 53' ' ' LYS . 98.8 m 68.16 128.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.475 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.524 HG23 HG11 ' B' ' 20' ' ' VAL . 41.1 mm -91.61 138.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.375 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -144.3 -171.76 3.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.316 -166.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' B' ' 23' ' ' ASP . . . -74.13 -38.94 63.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.21 -167.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.34 -36.34 79.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.11 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -42.76 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.405 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' B' ' 24' ' ' ALA . 29.2 mm -61.11 -56.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.345 168.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HA ' HG13 ' A' ' 64' ' ' VAL . 7.6 mt-10 -62.06 -22.8 66.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.931 -172.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -52.6 64.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.312 165.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 43' ' ' ALA . . . -60.25 -44.81 94.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.588 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.514 ' HA ' ' CD2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -79.91 -55.52 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.043 -160.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -29.18 68.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.74 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.381 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 11.0 m-85 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.419 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.424 ' CB ' HD13 ' B' ' 8' ' ' ILE . 14.5 mt . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.03 151.9 11.13 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.328 2.019 . . . . 0.0 113.547 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' B' ' 25' ' ' ARG . 1.1 pt -92.42 18.31 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.685 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.04 -58.67 0.59 Allowed Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.673 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.65 -54.57 2.76 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.18 . . . . 0.0 113.496 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' B' ' 3' ' ' LEU . 26.4 mt -67.83 -23.84 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.386 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.11 97.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.444 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -86.9 -14.2 42.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.477 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mt -60.97 -49.57 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 163.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.528 HG22 ' HB3' ' A' ' 40' ' ' ALA . 5.7 mt -92.03 -19.69 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.484 -166.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 9.3 mttm -62.48 -41.63 98.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.459 159.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.62 -33.01 73.18 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.09 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' B' ' 12' ' ' ILE . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.397 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.78 38.35 0.54 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.565 -163.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -79.8 164.09 23.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.767 -0.717 . . . . 0.0 110.26 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -132.0 -39.04 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.78 100.2 2.05 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.345 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -92.53 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.055 160.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.7 t -68.51 171.19 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.2 165.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' B' ' 25' ' ' ARG . 0.5 OUTLIER -60.58 -22.34 63.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.407 172.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 1.8 m-20 -61.17 -61.67 2.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.48 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' A' ' 60' ' ' ILE . . . -62.4 -51.2 68.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.243 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HB2' HG23 ' B' ' 5' ' ' ILE . 1.4 ptm180 -60.89 -48.0 83.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.361 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' B' ' 22' ' ' ASP . 86.0 mt -62.08 -43.59 97.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.457 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.18 -45.84 89.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 -167.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' B' ' 31' ' ' ILE . 1.9 tp -59.51 -33.69 71.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.665 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -61.42 -41.55 97.34 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.311 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 -18.97 19.47 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.331 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' B' ' 28' ' ' LEU . 42.7 mt -60.22 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.891 161.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.541 ' HG ' HD12 ' A' ' 32' ' ' LEU . 1.1 mp -58.49 -25.9 62.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.705 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -56.97 14.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.011 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -30.6 70.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.935 -168.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.434 ' CG ' HD12 ' B' ' 39' ' ' ILE . 3.4 tpp -61.98 -45.08 95.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.297 164.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.51 -41.44 94.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.422 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.41 -57.46 8.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.493 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 28' ' ' LEU . 1.9 mt -62.16 -29.42 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.872 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -62.28 -75.14 0.08 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -62.13 -12.71 21.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.454 -170.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.5 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -88.27 -44.52 10.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.23 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.517 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -66.64 -10.76 49.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.344 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.537 HD12 ' HB1' ' A' ' 17' ' ' ALA . 74.0 mt -95.39 -53.98 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.113 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -60.69 -21.36 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.468 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' B' ' 43' ' ' ALA . 5.9 mt -66.72 -63.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.429 168.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.05 75.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.22 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -38.23 51.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.419 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.63 -35.96 77.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.331 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' B' ' 52' ' ' ARG . . . -60.75 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.301 167.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 52.39 5.96 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -130.22 21.94 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.341 -169.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt 65.31 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.472 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 1.7 m -89.09 140.54 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.366 -167.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 20' ' ' VAL . 3.6 mt -92.83 140.85 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.391 168.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.526 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.61 178.71 5.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.45 -169.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.92 -22.48 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.376 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 4.4 tp10 -71.37 -22.44 61.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.166 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.59 -35.4 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.297 -172.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 28' ' ' LEU . 1.3 mp -64.2 -36.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.487 160.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 1.1 mt-10 -62.06 -46.23 90.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.84 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.42 -50.35 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.525 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.65 -56.61 19.22 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.521 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -64.2 -52.62 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.227 -170.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -60.49 -37.23 80.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.742 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . 0.462 ' HA ' ' HD2' ' B' ' 66' ' ' ARG . 1.4 tpt180 -61.6 -40.57 95.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -171.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 1.2 m-85 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.398 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.474 HD23 HD12 ' B' ' 11' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 8.0 Cg_endo -61.31 144.14 98.41 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.472 2.115 . . . . 0.0 113.525 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.44 HD11 ' NH2' ' A' ' 25' ' ' ARG . 2.5 pp -64.96 -7.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.911 -169.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -81.19 -55.17 0.67 Allowed Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.81 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 3.5 Cg_endo -59.7 -49.8 9.36 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.469 2.112 . . . . 0.0 113.599 176.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 27.8 mt -60.83 -37.77 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.232 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.79 -16.03 44.27 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.564 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 3.8 tpp85 -96.3 -26.66 15.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.501 HG22 ' HG3' ' B' ' 37' ' ' ARG . 8.6 mm -60.28 -54.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.394 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.531 HG21 HD13 ' B' ' 44' ' ' ILE . 8.1 mm -76.73 -35.88 25.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.271 -164.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -65.1 -34.62 78.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.338 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.33 -33.39 74.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.77 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' B' ' 40' ' ' ALA . . . -58.64 -54.18 50.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.461 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.19 30.4 0.31 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.613 -173.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -75.99 147.3 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.727 -0.737 . . . . 0.0 110.344 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HG3' ' NH1' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -171.13 47.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.013 166.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.508 ' NH1' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -164.88 24.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.42 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 24' ' ' ALA . 37.3 t -85.85 119.65 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.31 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB3' ' CG2' ' B' ' 54' ' ' THR . 25.1 p -62.2 164.23 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.297 168.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 11.7 t70 -60.65 -21.89 63.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.535 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -90.04 -31.94 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.448 -168.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -69.39 -44.03 72.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.22 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.99 -21.99 59.78 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.383 -173.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -83.45 -42.81 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.361 178.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.538 HG23 HG23 ' B' ' 60' ' ' ILE . 57.3 m -61.34 -38.49 87.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.447 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 HG23 ' B' ' 39' ' ' ILE . 3.6 tp -62.02 -41.37 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.131 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.58 98.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.354 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 2.4 tppt? -83.32 -29.05 28.62 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.396 -172.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.525 HG23 HG23 ' B' ' 64' ' ' VAL . 45.4 mt -60.53 -66.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.011 165.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.539 HD11 HD22 ' B' ' 32' ' ' LEU . 0.7 OUTLIER -58.15 -32.96 68.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.787 -169.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 1.8 pp20? -82.67 -30.96 28.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.081 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -61.64 -33.92 74.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -55.58 8.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.509 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.442 ' CA ' HD12 ' B' ' 32' ' ' LEU . . . -61.15 -45.11 97.2 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -60.69 -33.92 73.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.419 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.76 -56.78 8.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.481 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.531 ' HB ' HD13 ' B' ' 28' ' ' LEU . 4.5 mt -61.51 -26.1 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.289 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB1' ' CD1' ' B' ' 12' ' ' ILE . . . -61.82 -74.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.211 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.459 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 15.5 t -62.2 -12.88 22.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.351 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -80.55 -57.88 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.07 171.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HA ' HD21 ' A' ' 46' ' ' LEU . . . -60.78 -10.49 5.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.595 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 HD13 HG21 ' B' ' 12' ' ' ILE . 96.9 mt -98.89 -51.42 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.662 -174.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 12.2 ttpt -60.04 -10.58 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.348 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 62' ' ' LEU . 3.8 mp -82.73 -42.6 17.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.246 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.09 77.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.353 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -82.71 -43.93 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.415 -168.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.44 ' N ' ' HD3' ' A' ' 48' ' ' ARG . 7.1 m-70 -61.22 -23.86 65.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.191 168.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.94 -54.34 46.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.082 165.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.12 29.85 0.38 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.532 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.64 99.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.782 -0.709 . . . . 0.0 110.446 169.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.69 -169.08 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.297 168.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -65.22 125.53 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.378 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 44' ' ' ILE . 44.6 mt -62.53 147.8 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.301 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -145.95 164.02 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.509 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.06 64.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.247 -168.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -58.14 9.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.034 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.89 -21.79 65.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.434 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.539 HG23 HG21 ' B' ' 27' ' ' THR . 29.8 mm -72.68 -76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.224 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -62.74 -8.44 6.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.454 -176.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 46' ' ' LEU . 3.4 tt -90.12 -27.56 19.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.586 172.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . . . -81.53 -31.98 32.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.005 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 25.7 t -60.64 -69.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.637 160.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -14.3 19.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.565 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -62.09 -51.12 69.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.358 167.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 54.0 m-85 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.537 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' B' ' 33' ' ' GLU . 2.8 mt . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.325 0.584 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.12 142.63 97.52 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 122.471 2.114 . . . . 0.0 113.558 167.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.433 HG21 HD11 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -67.78 -20.19 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.381 -170.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.35 -62.2 6.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.736 -170.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.07 -50.56 13.52 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.455 2.103 . . . . 0.0 113.623 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' B' ' 29' ' ' ALA . 7.5 mt -62.22 -21.7 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.449 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.86 97.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.624 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -86.44 -15.32 40.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.522 -173.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.474 HD12 HD23 ' A' ' 3' ' ' LEU . 11.1 mm -60.85 -73.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.234 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.535 HG21 ' HB1' ' B' ' 17' ' ' ALA . 8.0 mm -63.27 -20.96 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.936 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -73.51 -36.35 65.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.391 172.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.92 -31.88 72.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.825 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.64 64.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.455 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.96 33.5 0.51 Allowed Glycine 0 CA--C 1.527 0.783 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.607 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' B' ' 12' ' ' ILE . . . -77.45 147.1 36.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.28 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -106.48 -67.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.977 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 112.14 9.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.418 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.461 ' CG2' HD11 ' A' ' 55' ' ' ILE . 80.6 t -103.62 137.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.31 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 54.0 p -61.11 146.55 47.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.427 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.502 ' HA ' ' NH1' ' B' ' 25' ' ' ARG . 2.3 p30 -61.69 -24.4 66.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.412 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.53 ' HA ' HG21 ' B' ' 26' ' ' ILE . 4.9 t0 -84.04 -26.0 29.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.382 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.413 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -62.7 -45.05 94.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.171 168.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.502 ' NH1' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptt-85 -85.88 -13.27 48.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.554 -166.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' B' ' 23' ' ' ASP . 0.1 OUTLIER -84.12 -38.33 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.444 168.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 31' ' ' ILE . 59.4 m -61.33 -43.15 99.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.218 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 39' ' ' ILE . 2.6 tp -60.22 -37.59 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.272 166.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' B' ' 8' ' ' ILE . . . -61.33 -43.04 99.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -26.13 33.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.448 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 27' ' ' THR . 34.7 mt -60.95 -71.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.539 HD22 HD11 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.99 -32.19 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.681 -166.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.529 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.7 pp20? -80.85 -39.68 26.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.175 -170.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.59 -39.23 90.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.007 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 4.8 mtp -61.0 -54.86 39.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.535 168.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . 0.485 ' HA2' HD22 ' A' ' 32' ' ' LEU . . . -61.3 -45.81 95.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -165.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.501 ' HG3' HG22 ' A' ' 11' ' ' ILE . 9.2 mtp-105 -61.21 -32.33 72.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.235 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -49.58 76.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.604 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.537 HG23 HD12 ' A' ' 28' ' ' LEU . 2.8 mt -62.06 -37.17 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.524 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -61.59 -69.0 0.27 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.315 -175.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 p -62.17 -10.27 10.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -93.84 -50.78 5.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.279 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.531 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.72 -10.57 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.376 170.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 12' ' ' ILE . 87.4 mt -101.24 -50.77 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.752 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' B' ' 45' ' ' LYS . 15.3 tptp -60.42 -11.71 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.463 168.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' B' ' 43' ' ' ALA . 6.0 mt -83.97 -54.05 5.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.395 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.462 ' CB ' HD12 ' B' ' 55' ' ' ILE . . . -61.22 -21.15 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.386 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -44.91 15.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.311 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -60.41 -30.51 69.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.398 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.78 76.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.423 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.26 37.6 0.79 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -168.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mtt85 66.05 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.492 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -130.77 -177.65 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.351 167.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 21' ' ' SER . 87.7 m -78.16 130.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.468 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 13.5 mm -69.97 134.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.249 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -139.73 175.51 9.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.527 -171.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -25.37 67.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.279 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -63.59 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.11 169.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.524 ' HA ' HD11 ' B' ' 62' ' ' LEU . 1.0 OUTLIER -61.06 -12.44 11.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.468 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.538 HG23 HG23 ' A' ' 27' ' ' THR . 41.4 mm -88.39 -57.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.178 -177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 9.6 mt-10 -61.48 -16.89 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.177 170.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -67.56 -59.73 3.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.324 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' B' ' 39' ' ' ILE . . . -65.09 -30.77 71.75 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.119 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 31' ' ' ILE . 43.4 t -61.61 -71.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.693 169.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -61.16 -9.17 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.497 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.51 48.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.296 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' B' ' 39' ' ' ILE . 38.1 m-85 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.34 171.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 mt . . . . . 0 C--O 1.242 0.688 0 CA-C-O 121.511 0.672 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.29 148.8 13.62 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.341 2.027 . . . . 0.0 113.285 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.1 pp -93.03 20.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.628 -167.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.53 -59.54 0.31 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.68 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.05 -50.46 14.0 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.493 2.129 . . . . 0.0 113.522 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 12' ' ' ILE . 86.3 mt -69.05 -30.36 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.382 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.04 99.66 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.47 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -78.25 -31.91 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.353 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 HD12 ' CD2' ' B' ' 3' ' ' LEU . 85.5 mt -60.81 -40.05 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.379 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.538 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . 12.1 mt -97.86 -15.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.516 -162.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -38.1 85.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 158.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.85 -33.57 76.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.022 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 12' ' ' ILE . . . -57.85 -52.11 66.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.483 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.0 25.15 0.2 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.772 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -76.09 152.4 36.81 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 114.665 -0.768 . . . . 0.0 110.262 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 -42.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.194 169.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 113.56 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.421 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' B' ' 55' ' ' ILE . 22.4 t -137.3 161.93 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.393 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.8 p -88.42 133.93 33.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.414 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.99 -25.4 68.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.358 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.93 -36.38 79.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.421 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.17 -52.67 61.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.272 169.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -68.82 -18.0 64.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.477 -168.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.25 -37.79 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.44 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.6 m -60.74 -32.29 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.457 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 ' HB2' HG12 ' B' ' 60' ' ' ILE . 10.9 tp -92.03 -33.74 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.024 -171.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . . . -61.02 -41.9 97.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.153 166.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -36.11 83.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.517 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.135 -167.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' B' ' 32' ' ' LEU . 2.8 mp -65.71 -57.61 7.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.507 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HG2' HD11 ' B' ' 11' ' ' ILE . 9.5 tm-20 -61.47 -32.97 72.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.166 -166.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -40.25 95.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.93 170.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt -65.17 -38.02 89.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.581 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.466 ' CA ' HD22 ' B' ' 32' ' ' LEU . . . -76.98 -40.54 25.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -24.41 66.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.165 164.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -60.6 2.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.514 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.529 HD13 HD12 ' B' ' 32' ' ' LEU . 5.0 mt -61.37 -31.73 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.3 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -61.43 -61.36 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.347 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.6 -27.35 68.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.33 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.13 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.011 166.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 46' ' ' LEU . . . -72.28 -12.24 61.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.576 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -85.86 -56.67 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.268 -168.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HD2' ' NH2' ' A' ' 48' ' ' ARG . 20.5 ttpp -66.52 -19.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.457 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 43' ' ' ALA . 3.2 mp -60.88 -44.05 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.294 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.6 -58.83 6.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.401 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.511 ' NH2' ' HD2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -71.07 -28.8 64.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.304 -165.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -60.54 -39.69 88.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.324 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -54.98 39.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.007 164.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.74 32.85 0.31 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.583 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 69.42 -87.89 0.03 OUTLIER 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.769 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt 58.44 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.055 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -157.8 168.47 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.129 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.417 ' HB ' HG21 ' B' ' 20' ' ' VAL . 6.7 mm -82.44 137.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.214 165.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.22 155.87 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.418 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' B' ' 23' ' ' ASP . . . -61.33 -29.2 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.236 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.54 -42.43 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 169.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.03 -43.12 79.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.487 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG13 ' CB ' ' B' ' 24' ' ' ALA . 44.7 mm -61.24 -45.72 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.499 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.74 -28.47 60.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.106 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.08 -43.3 87.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.31 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 39' ' ' ILE . . . -61.49 -41.44 97.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.4 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG22 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -83.81 -55.08 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.143 -169.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -27.61 66.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.839 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -69.8 -36.29 75.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.377 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 3.9 mt . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.47 0.652 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -58.02 144.44 94.59 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.368 2.046 . . . . 0.0 113.509 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.08 -24.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.375 -168.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' B' ' 7' ' ' PRO . . . -64.98 -56.39 21.12 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 6' ' ' ALA . 5.8 Cg_endo -48.37 -53.83 6.2 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 122.507 2.138 . . . . 0.0 113.446 171.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' B' ' 11' ' ' ILE . 36.2 mt -61.1 -33.95 58.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.514 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -29.04 71.17 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.529 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 11.6 mtp-105 -87.88 -28.29 21.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.795 -0.703 . . . . 0.0 110.494 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.528 HD11 ' HG2' ' A' ' 33' ' ' GLU . 65.5 mt -60.9 -53.07 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.419 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 40' ' ' ALA . 7.0 mm -63.87 -37.88 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.259 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 3.1 mtpm? -61.49 -35.78 78.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.265 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.82 -32.43 72.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.794 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 44' ' ' ILE . . . -58.6 -53.58 56.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.506 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.92 21.61 0.29 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.956 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -76.21 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.275 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -167.69 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.048 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -130.8 98.98 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.459 168.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' A' ' 55' ' ' ILE . 58.3 t -106.22 145.21 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.322 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.7 p -70.06 155.99 39.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.321 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.413 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 1.0 OUTLIER -61.89 -32.09 72.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.353 176.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.463 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.4 m-20 -61.56 -48.47 80.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.407 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.464 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -62.04 -52.35 64.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.274 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 0.4 OUTLIER -61.25 -38.36 86.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.274 -168.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -67.01 -37.61 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.47 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 60' ' ' ILE . 84.5 m -61.08 -52.26 65.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.421 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.531 ' HA ' HD13 ' B' ' 31' ' ' ILE . 4.1 tp -61.1 -42.3 98.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.335 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' B' ' 3' ' ' LEU . . . -60.76 -28.17 68.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.416 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -26.29 18.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' B' ' 28' ' ' LEU . 17.8 mt -60.87 -71.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.985 166.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.537 ' HB3' HD22 ' A' ' 32' ' ' LEU . 5.6 mp -59.44 -30.15 68.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.595 -168.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.52 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 7.1 tm-20 -75.83 -30.66 59.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.09 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.37 -44.79 96.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.065 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 12.6 mtt -62.37 -39.62 93.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.407 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -39.41 73.86 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -29.39 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 168.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.7 OUTLIER -82.31 -52.53 6.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.482 -169.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.499 HG12 HG21 ' B' ' 64' ' ' VAL . 5.6 mt -61.32 -34.28 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.185 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -77.6 -44.4 28.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.168 -164.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.414 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 4.4 t -70.62 -13.82 62.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.422 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 2.8 mm-40 -83.11 -44.76 14.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.993 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -80.59 -11.1 59.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.339 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.522 HD13 ' HB1' ' A' ' 17' ' ' ALA . 72.7 mt -93.85 -49.16 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -60.69 -24.1 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.344 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' B' ' 43' ' ' ALA . 2.9 mt -68.15 -54.13 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.367 170.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.53 ' HB3' HG12 ' B' ' 55' ' ' ILE . . . -61.13 -28.83 69.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.382 -167.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.46 -44.97 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.388 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -61.43 -37.36 83.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.327 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.5 75.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.197 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.92 47.86 4.33 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -165.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.67 -43.6 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.338 -166.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.58 118.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.473 -168.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 7.3 m 68.53 139.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.489 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' B' ' 47' ' ' ALA . 26.6 mt -105.19 163.21 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.374 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.511 ' N ' HG21 ' B' ' 55' ' ' ILE . 12.1 mtmt -149.51 166.24 29.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 -169.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -12.96 26.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.256 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 26.9 mt-10 -86.44 -19.0 30.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.078 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.463 ' CB ' HG22 ' B' ' 55' ' ' ILE . 0.8 OUTLIER -82.53 -33.71 28.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.288 174.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mp -61.88 -56.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.67 161.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 3.0 mt-10 -61.31 -30.29 70.4 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.71 -168.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 46' ' ' LEU . 12.0 tp -76.32 -46.69 26.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.639 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' B' ' 42' ' ' GLU . . . -61.27 -24.11 66.16 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.416 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.517 ' HA ' ' CD1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -110.65 -55.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -160.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -10.7 2.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.668 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -92.9 -65.64 0.98 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.613 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' B' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -155.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 3.5 Cg_exo -65.77 159.95 46.06 Favored 'Trans proline' 0 N--CA 1.484 0.967 0 C-N-CA 122.932 2.421 . . . . 0.0 113.542 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 2.6 pp -93.47 -26.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.394 -166.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -68.57 -56.49 9.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.698 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 2.0 Cg_endo -60.47 -47.65 13.5 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.121 1.881 . . . . 0.0 113.513 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 26.4 mt -60.87 -34.69 60.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.271 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.52 -26.82 65.02 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.541 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -84.35 -27.25 27.86 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.326 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.52 -58.44 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.454 169.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.515 HG21 HD13 ' B' ' 44' ' ' ILE . 8.7 mm -65.62 -42.64 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.198 -166.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -31.95 72.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.34 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.28 -33.71 75.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.756 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.66 55.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.447 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.76 19.46 0.57 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.711 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.66 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.281 165.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.041 167.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.67 110.53 22.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.347 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.534 HG21 ' HB ' ' B' ' 55' ' ' ILE . 45.7 t -145.78 148.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.353 -169.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 p -87.45 154.78 20.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.383 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.524 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 9.5 p30 -61.14 -31.46 71.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.472 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' HA ' HG23 ' A' ' 26' ' ' ILE . 1.1 m-20 -83.87 -25.3 30.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.397 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' B' ' 56' ' ' LYS . . . -61.03 -40.08 92.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.252 168.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' A' ' 22' ' ' ASP . 5.8 mtt180 -66.64 -47.53 72.27 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.476 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 23' ' ' ASP . 2.3 tp -65.16 -35.99 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.356 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 31' ' ' ILE . 13.3 m -61.16 -53.68 53.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.293 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.535 HD13 ' HB ' ' B' ' 39' ' ' ILE . 6.0 tp -60.86 -9.82 4.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.251 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -84.52 -58.55 2.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.423 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -61.77 -26.12 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.22 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 28' ' ' LEU . 2.3 mp -60.87 -74.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.961 161.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.537 HD11 ' HG ' ' B' ' 32' ' ' LEU . 2.3 mm? -57.79 -30.1 65.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.617 -161.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.512 ' HB3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.19 -44.18 47.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.262 178.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.58 -37.05 73.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.09 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.427 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 23.8 mmt -61.29 -40.48 94.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.38 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.32 -47.23 72.81 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -17.72 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.458 171.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -86.83 -49.94 7.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.385 -173.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 64' ' ' VAL . 4.8 mt -61.81 -23.84 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.081 171.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.87 -73.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.358 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 30.2 m -61.57 -13.05 18.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.312 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -78.47 -57.14 3.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.329 170.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -61.42 -11.9 12.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.529 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 96.9 mt -96.81 -51.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.791 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -60.21 -15.6 25.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.459 167.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 8.3 mt -79.17 -41.1 29.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.46 171.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 55' ' ' ILE . . . -61.23 -17.98 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.24 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 -48.01 7.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.49 170.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.75 -14.6 33.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.395 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.63 -48.56 7.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.271 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 42.15 3.42 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -165.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.99 160.47 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.356 -165.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -117.27 145.81 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.307 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 ' CG2' ' HG3' ' B' ' 19' ' ' ARG . 3.8 m 69.83 158.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -168.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' A' ' 47' ' ' ALA . 11.0 mm -109.48 160.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.462 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.42 173.57 11.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.339 -168.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -72.83 -16.7 61.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.403 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 4.9 mm-40 -80.69 -14.35 58.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.264 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -88.04 -40.4 13.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.307 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 HG23 HG21 ' B' ' 27' ' ' THR . 1.4 mp -61.5 -47.25 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.823 162.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 6.3 mt-10 -61.74 -42.22 98.68 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.983 -166.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.18 -28.71 27.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.433 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -60.26 -43.62 96.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.452 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.535 HG22 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -82.55 -55.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.009 -164.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -60.22 -24.61 64.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -14.96 23.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.462 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 46.0 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.409 171.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.431 ' HB3' HD12 ' B' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.46 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -61.33 149.6 88.69 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.599 2.199 . . . . 0.0 113.597 166.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -63.3 -13.14 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.786 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.89 -57.49 3.04 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.735 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.46 ' CG ' ' HG2' ' B' ' 4' ' ' PRO . 10.1 Cg_endo -54.94 -59.42 0.82 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.643 2.229 . . . . 0.0 113.596 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.488 HG23 HD11 ' B' ' 8' ' ' ILE . 26.7 mt -61.63 -49.05 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.371 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.71 -27.54 68.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 13.1 tpt180 -78.14 -26.55 47.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.509 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.447 HD12 HD12 ' A' ' 3' ' ' LEU . 66.4 mt -69.88 -46.54 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.491 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.521 HG21 ' HB3' ' A' ' 40' ' ' ALA . 10.4 mm -64.41 -38.97 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.191 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.65 -35.32 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.376 168.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -62.16 -33.6 74.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.729 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.5 57.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.358 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.2 14.65 0.62 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.256 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.59 147.54 41.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.318 162.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -55.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.114 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.451 ' HG3' ' CG2' ' A' ' 54' ' ' THR . 4.7 tpt180 -101.94 104.89 15.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.4 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -133.83 146.76 31.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.375 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 35.7 p -85.37 143.11 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.448 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -71.83 -28.46 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.31 -170.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -34.48 74.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.47 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -61.27 -54.04 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.258 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.536 ' HD3' ' HB ' ' B' ' 5' ' ' ILE . 5.7 mtt180 -64.96 -12.59 51.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.463 -170.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' B' ' 5' ' ' ILE . 86.4 mt -103.64 -25.63 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.447 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 60' ' ' ILE . 81.8 m -63.41 -44.06 95.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.528 ' HA ' HD11 ' B' ' 31' ' ' ILE . 1.9 tp -59.92 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.295 172.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.19 85.5 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.561 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -80.41 -28.52 37.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.203 -173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' B' ' 28' ' ' LEU . 2.7 mt -60.81 -70.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.996 160.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.75 -16.76 18.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.723 -166.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.18 -37.65 12.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.083 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.27 -57.64 11.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.254 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' B' ' 32' ' ' LEU . 19.0 ptp -62.33 -28.7 69.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.343 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.18 -46.24 51.52 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.566 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -14.54 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -89.97 -51.06 5.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.534 -173.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.535 ' HB ' HD13 ' A' ' 28' ' ' LEU . 6.8 mt -61.96 -26.3 39.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.053 171.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -62.14 -68.41 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.212 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 86.6 p -61.1 -10.65 6.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.534 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.0 OUTLIER -95.54 -36.04 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.035 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.461 ' CA ' ' HB1' ' B' ' 63' ' ' ALA . . . -75.52 -9.93 59.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.373 167.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 58.0 mt -98.6 -49.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.923 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.53 ' HA ' ' HG2' ' B' ' 48' ' ' ARG . 10.9 mttp -60.27 -27.79 67.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.453 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 63' ' ' ALA . 10.0 mt -61.5 -55.44 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.346 166.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -31.36 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.312 -168.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.53 ' HG2' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -74.3 -38.13 63.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.408 178.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.444 ' N ' ' HG3' ' B' ' 48' ' ' ARG . 38.2 t-80 -60.55 -32.28 71.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.229 168.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.36 -53.97 51.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.28 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.94 23.96 0.75 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.775 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 56.0 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.1 0.476 . . . . 0.0 111.914 169.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -67.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.391 168.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' B' ' 55' ' ' ILE . 93.6 m -146.28 166.47 26.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.364 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.534 ' HB ' HG21 ' A' ' 20' ' ' VAL . 65.7 mt -119.4 146.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.408 170.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.534 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -137.91 -172.92 3.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.424 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.45 -16.41 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 0.1 OUTLIER -79.36 -25.32 42.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.102 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HB3' HG22 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -85.94 -35.51 20.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.281 -176.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mp -61.77 -46.4 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.705 160.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -62.09 -40.29 95.34 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.823 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.486 HD11 ' N ' ' B' ' 62' ' ' LEU . 7.5 mp -74.76 -45.38 44.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.55 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.5 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -61.37 -31.81 71.71 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.387 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.527 HG21 HG12 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -95.16 -54.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.983 -165.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -16.68 34.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.697 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -11.81 15.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 3.2 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.278 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.5 HD12 HD13 ' B' ' 11' ' ' ILE . 6.3 mp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 121.991 0.9 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 25' ' ' ARG . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.491 HD12 ' HG3' ' B' ' 33' ' ' GLU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' HB ' ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HB3' HG23 ' A' ' 5' ' ' ILE . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.512 HG23 ' HB ' ' B' ' 60' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 28' ' ' LEU . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.475 ' HE1' ' HE2' ' B' ' 35' ' ' MET . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 HG22 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.514 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.539 ' HB ' HG23 ' B' ' 27' ' ' THR . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' B' ' 33' ' ' GLU . 3.4 mt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.485 0.659 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.5 HD13 HD12 ' A' ' 3' ' ' LEU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' B' ' 24' ' ' ALA . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 31' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 60' ' ' ILE . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 27' ' ' THR . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.512 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.475 ' HE2' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.504 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' B' ' 43' ' ' ALA . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 27' ' ' THR . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.467 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.504 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.516 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.5 mt . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.96 148.93 82.46 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.392 2.061 . . . . 0.0 113.44 167.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.47 HG23 HG12 ' A' ' 26' ' ' ILE . 2.5 pp -85.1 -28.91 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.14 -62.22 6.21 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.779 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -51.89 -46.24 33.46 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.48 2.12 . . . . 0.0 113.588 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -61.18 -59.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.76 -26.76 67.35 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.0 -32.97 61.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.348 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 HG21 ' HD2' ' B' ' 37' ' ' ARG . 44.2 mt -60.76 -40.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.493 169.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' B' ' 40' ' ' ALA . 19.4 mm -66.51 -34.58 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.405 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -29.93 65.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.392 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -62.6 -35.52 79.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.811 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.49 -53.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.395 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.63 18.46 0.32 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.834 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 20' ' ' VAL . . . -60.81 142.2 56.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.311 165.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.66 -33.58 3.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.117 -169.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 88.09 1.91 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.486 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.519 HG21 HD11 ' B' ' 55' ' ' ILE . 23.5 t -114.91 133.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.381 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -92.02 157.73 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.434 -169.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.02 -49.02 79.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.375 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.33 96.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.335 -175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 5.6 mtt180 -63.31 -47.21 83.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.434 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 5' ' ' ILE . 11.0 mm -60.69 -32.79 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.506 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.522 HG22 ' HB ' ' B' ' 60' ' ' ILE . 83.3 m -67.66 -43.08 81.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.335 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD11 HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -61.32 -34.13 74.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.314 177.014 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . . . -75.75 -47.92 23.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.203 -168.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.77 -32.8 72.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.32 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 28' ' ' LEU . 13.0 mt -60.91 -77.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.935 164.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -57.89 -29.06 64.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.718 -160.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -75.51 -41.82 54.28 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.165 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -68.16 -25.15 65.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.02 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.45 -33.6 31.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.478 174.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.03 -39.47 84.59 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.97 -33.54 73.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.261 165.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 1.6 t0 -64.57 -60.88 2.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.432 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 HG12 ' CE1' ' A' ' 67' ' ' PHE . 15.3 mt -61.17 -29.31 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.506 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.33 -63.45 1.28 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.261 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 88.5 p -61.66 -26.76 68.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.158 -175.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 28.4 mm-40 -61.05 -45.74 93.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.029 163.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.493 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -76.14 -8.14 56.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.903 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -90.7 -55.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.999 -169.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -63.49 -20.97 66.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.636 168.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 62' ' ' LEU . 2.0 mp -61.16 -58.17 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.442 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -61.69 -22.04 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.19 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -97.04 -31.44 12.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.267 -168.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -34.43 74.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.189 167.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . . . -61.12 -49.99 75.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.034 164.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 41.06 59.76 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -166.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -129.19 -166.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.344 -164.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 118.41 36.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.28 -165.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' B' ' 21' ' ' SER . 95.0 m 67.79 161.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.383 165.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.438 HG12 ' HB1' ' A' ' 47' ' ' ALA . 80.4 mt -100.93 147.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.54 173.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.85 -171.35 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.374 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' B' ' 23' ' ' ASP . . . -61.87 -42.48 99.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.322 -169.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -23.53 66.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.094 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -55.78 4.53 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.344 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.539 HG22 HD12 ' B' ' 28' ' ' LEU . 44.8 mm -61.09 -37.64 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.366 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.49 -45.88 92.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.513 ' HB3' HD22 ' A' ' 46' ' ' LEU . 2.1 mm? -62.76 -45.72 91.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.467 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB3' ' N ' ' A' ' 43' ' ' ALA . . . -61.64 -30.33 70.64 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.361 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.515 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -89.97 -62.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.16 -164.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -60.4 -18.36 50.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.595 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.7 tpt85 -64.39 -76.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.274 168.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE1' HG12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.044 -159.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.845 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.466 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.5 Cg_endo -59.41 140.32 93.74 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.623 2.216 . . . . 0.0 113.553 167.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.423 HG23 ' CG ' ' B' ' 25' ' ' ARG . 23.7 pt -77.04 -11.54 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.679 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.93 -64.03 0.81 Allowed Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.787 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.466 ' CG ' ' HG2' ' B' ' 4' ' ' PRO . 10.3 Cg_endo -51.29 -45.78 35.14 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.104 1.87 . . . . 0.0 113.279 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.429 HG23 HD11 ' B' ' 8' ' ' ILE . 28.0 mt -60.03 -43.82 93.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.493 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.67 99.73 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.571 -172.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.521 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.6 -22.34 50.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.437 -174.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' B' ' 8' ' ' ILE . 55.0 mt -68.24 -41.41 83.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.328 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' A' ' 40' ' ' ALA . 1.9 mm -61.46 -40.35 86.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.104 167.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 26.4 mtpp -62.21 -31.81 72.39 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.051 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -62.35 -31.91 72.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.683 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.62 -53.94 52.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.413 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 24.44 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.686 -172.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.525 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -71.3 -171.35 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.287 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -153.18 -38.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.953 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 104.0 4.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' B' ' 12' ' ' ILE . 11.4 t -101.16 102.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.179 167.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.462 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 45.9 t -62.13 177.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.399 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.512 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.8 OUTLIER -61.01 -34.58 75.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.315 -171.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 10.2 m-20 -60.99 -58.72 7.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.519 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.461 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -62.92 -45.16 93.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.512 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptp180 -61.91 -37.67 85.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.364 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.491 HG13 ' HG3' ' B' ' 25' ' ' ARG . 41.8 mt -75.78 -36.29 32.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.515 HG21 HG23 ' A' ' 60' ' ' ILE . 97.8 m -60.82 -52.36 65.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.392 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.539 HD12 HG22 ' A' ' 60' ' ' ILE . 4.8 tp -60.53 -47.14 87.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.447 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.1 70.41 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.31 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.69 -24.81 23.76 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.461 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' B' ' 28' ' ' LEU . 46.5 mt -61.9 -75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.965 165.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.526 ' HB3' HD22 ' A' ' 32' ' ' LEU . 5.5 mp -59.66 -20.78 58.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.729 -165.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.81 -57.73 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.193 170.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -38.02 89.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.024 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 6.0 ttp -60.71 -28.59 68.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.436 169.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.7 -45.85 16.19 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.427 ' HD2' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.42 -14.28 18.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.137 -0.531 . . . . 0.0 110.459 167.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -91.32 -51.94 5.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.412 -171.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' B' ' 63' ' ' ALA . 5.4 mt -61.42 -22.35 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.308 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 12' ' ' ILE . . . -63.1 -73.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.305 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.514 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 84.3 p -61.33 -13.79 22.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.536 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -78.2 -56.99 4.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.055 170.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.08 -12.6 12.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.392 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 73.3 mt -94.97 -51.8 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.106 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -60.67 -31.66 70.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.42 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.516 HD11 ' HA ' ' B' ' 43' ' ' ALA . 28.7 mt -60.66 -52.7 64.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.503 170.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.44 80.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.262 -172.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.8 -40.71 98.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.378 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -61.09 -38.03 84.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.414 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.52 68.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.131 167.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.6 36.92 0.7 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.453 -164.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 62.85 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.651 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.11 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.832 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.464 HG23 ' HG2' ' B' ' 56' ' ' LYS . 88.9 m -157.57 167.39 30.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.106 165.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 20' ' ' VAL . 24.0 mt -106.89 132.38 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.35 166.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.464 ' HG2' HG23 ' B' ' 54' ' ' THR . 5.6 mmmt -142.65 -176.21 4.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.458 -174.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -26.78 68.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.314 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.53 -52.71 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.026 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.26 -24.48 63.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.303 -170.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.522 ' HB ' HG22 ' A' ' 27' ' ' THR . 38.0 mm -75.51 -48.37 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.465 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.83 -30.4 70.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.026 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.468 ' HG ' ' CD2' ' B' ' 46' ' ' LEU . 14.8 tp -64.05 -50.05 69.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.394 169.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' B' ' 42' ' ' GLU . . . -61.28 -41.09 96.37 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.365 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -89.1 -57.83 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.172 -162.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -59.89 -25.84 65.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.793 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -29.94 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.409 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.514 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.468 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.5 HD12 HD13 ' B' ' 11' ' ' ILE . 6.3 mp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 121.991 0.9 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 25' ' ' ARG . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.491 HD12 ' HG3' ' B' ' 33' ' ' GLU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' HB ' ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HB3' HG23 ' A' ' 5' ' ' ILE . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.512 HG23 ' HB ' ' B' ' 60' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 28' ' ' LEU . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.475 ' HE1' ' HE2' ' B' ' 35' ' ' MET . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 HG22 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.514 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.539 ' HB ' HG23 ' B' ' 27' ' ' THR . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' B' ' 33' ' ' GLU . 3.4 mt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.485 0.659 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.5 HD13 HD12 ' A' ' 3' ' ' LEU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' B' ' 24' ' ' ALA . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 31' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 60' ' ' ILE . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 27' ' ' THR . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.512 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.475 ' HE2' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.504 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' B' ' 43' ' ' ALA . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 27' ' ' THR . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.467 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.504 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.516 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 8' ' ' ILE . 6.3 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 121.936 0.874 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 10.7 Cg_endo -61.16 142.18 95.94 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.144 2.563 . . . . 0.0 113.656 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 1.3 pp -95.49 -25.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.448 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.51 31.58 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.7 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.452 ' CG ' ' HB2' ' A' ' 4' ' ' PRO . 6.7 Cg_endo -58.32 -55.6 2.09 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.592 2.195 . . . . 0.0 113.565 175.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 3' ' ' LEU . 51.7 mt -61.48 -45.08 99.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.492 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.76 -38.07 95.33 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -21.94 39.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.406 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.63 -50.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.405 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' B' ' 40' ' ' ALA . 18.7 mm -63.47 -41.33 92.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.373 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -62.86 -34.29 77.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.298 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.46 -33.8 75.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.787 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.02 63.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.488 170.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.55 18.84 0.38 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 20' ' ' VAL . . . -60.86 136.9 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.515 -0.342 . . . . 0.0 110.189 164.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.29 -25.42 8.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -168.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 92.91 1.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG21 HD11 ' B' ' 55' ' ' ILE . 16.8 t -117.82 134.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.395 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -93.03 155.77 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.376 -170.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.11 -17.66 53.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.373 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -63.41 -50.24 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.441 168.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.55 96.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.277 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 4.9 mtt180 -61.45 -50.5 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.73 -31.9 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.536 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 HG21 HD13 ' A' ' 31' ' ' ILE . 85.9 m -66.23 -43.25 87.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD21 HG22 ' B' ' 60' ' ' ILE . 0.3 OUTLIER -61.22 -32.07 71.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.266 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 3' ' ' LEU . . . -78.13 -46.36 20.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.189 -168.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -60.84 -32.79 72.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.285 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.536 HG12 HG12 ' B' ' 64' ' ' VAL . 11.0 mt -60.83 -75.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.956 164.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.73 -28.19 63.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.735 -162.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 1.9 pp20? -77.11 -46.12 24.62 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.017 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.39 -26.54 67.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.055 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -73.59 -36.52 65.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.537 171.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.72 -42.27 71.6 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -60.95 -25.73 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.35 -0.425 . . . . 0.0 110.399 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -73.46 -59.28 2.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.509 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 64' ' ' VAL . 7.8 mt -62.64 -20.04 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' B' ' 12' ' ' ILE . . . -61.24 -71.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.355 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' HG23 ' A' ' 44' ' ' ILE . 85.8 p -61.56 -25.38 67.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.236 -172.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 37.8 mm-40 -61.71 -54.24 45.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.081 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -67.85 -10.32 52.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.775 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -89.39 -57.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.225 -167.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -64.89 -19.06 65.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.577 169.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 63' ' ' ALA . 3.0 mp -61.34 -55.78 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.323 168.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.61 -23.11 65.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.265 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.41 ' NH2' ' HG3' ' A' ' 45' ' ' LYS . 23.3 ttp-105 -100.76 -30.24 11.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.308 -165.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -34.95 75.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.127 165.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . . . -60.88 -50.74 72.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.977 163.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.46 43.25 78.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -165.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -134.03 -166.74 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.329 -161.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.469 -165.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.522 HG22 ' HB3' ' B' ' 21' ' ' SER . 7.2 t -60.57 168.66 2.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.507 -170.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 55' ' ' ILE . 26.6 mt -71.57 137.07 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.405 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.05 -175.7 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.358 -167.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' B' ' 23' ' ' ASP . . . -61.41 -47.99 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.258 -169.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -24.92 67.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.979 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.96 -53.11 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.373 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.533 HG23 HG21 ' B' ' 27' ' ' THR . 43.5 mm -65.82 -39.61 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -168.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.75 -41.96 98.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.05 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' HD22 ' A' ' 46' ' ' LEU . 2.4 mm? -62.56 -47.12 85.27 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.341 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.61 -31.45 71.52 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.379 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG22 HD11 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -89.97 -61.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.812 0.815 . . . . 0.0 109.029 -162.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -60.16 -19.07 52.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.667 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -63.3 -77.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.146 168.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.533 ' HB3' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.122 -159.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.458 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.0 Cg_endo -59.87 140.01 90.98 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.544 2.163 . . . . 0.0 113.528 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.479 HG23 ' HG3' ' B' ' 25' ' ' ARG . 33.0 pt -78.52 -10.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.631 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.7 -61.19 1.41 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.813 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' B' ' 10' ' ' ARG . 9.8 Cg_endo -55.49 -45.95 35.86 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 122.443 2.096 . . . . 0.0 113.453 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' B' ' 3' ' ' LEU . 31.0 mt -60.32 -44.56 96.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.459 172.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.25 97.32 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.549 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.534 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.19 -23.26 51.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 0.0 110.503 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' B' ' 8' ' ' ILE . 64.8 mt -67.85 -48.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.461 170.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.516 HD12 ' HB1' ' A' ' 40' ' ' ALA . 5.1 mm -61.92 -33.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.037 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 27.0 mtpp -61.34 -33.88 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.209 171.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.6 -32.78 73.85 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.638 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.86 -53.32 59.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.429 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.11 21.34 0.78 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.974 -170.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.516 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -65.63 147.03 54.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.34 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -40.79 3.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.045 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -148.55 139.14 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.507 168.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.462 HG11 ' CB ' ' B' ' 24' ' ' ALA . 88.8 t -129.45 113.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.205 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 54' ' ' THR . 25.0 p -62.28 174.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.381 -166.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.518 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.9 OUTLIER -61.67 -32.29 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.371 -177.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.51 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 4.3 m-20 -64.2 -55.55 20.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.468 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.462 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -62.12 -48.0 82.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.301 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 6.6 ptp180 -61.03 -37.85 84.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.394 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mt -72.05 -36.56 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.49 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 60' ' ' ILE . 97.9 m -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.365 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.508 HD12 HG22 ' A' ' 60' ' ' ILE . 4.4 tp -60.94 -47.04 88.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.383 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.98 70.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.384 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -87.15 -26.14 23.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.494 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' B' ' 28' ' ' LEU . 37.8 mt -61.83 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.015 165.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.524 ' HB3' HD22 ' A' ' 32' ' ' LEU . 6.0 mp -59.6 -17.45 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -53.43 10.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.139 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 -40.43 88.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.045 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.527 ' HE1' HD12 ' B' ' 39' ' ' ILE . 10.0 ttp -60.82 -28.68 68.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.477 170.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.79 -46.23 18.63 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 -13.88 16.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.534 167.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -91.22 -51.28 5.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.418 -172.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.527 HD12 ' HE1' ' B' ' 35' ' ' MET . 4.8 mt -61.6 -21.32 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.271 170.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -63.22 -73.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.315 172.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.527 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 81.8 p -61.45 -13.94 24.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.503 -173.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -77.92 -56.95 4.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 170.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.519 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -61.2 -13.18 16.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.323 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 81.4 mt -95.55 -51.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.96 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -60.67 -32.97 72.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.45 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' B' ' 43' ' ' ALA . 20.9 mt -60.47 -51.5 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.551 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.04 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.257 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.86 -40.77 98.51 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.418 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -61.24 -38.1 85.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.326 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.97 -51.41 69.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.124 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 37.21 0.72 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.448 -164.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 62.34 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.536 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -79.5 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.754 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.492 HG23 ' HG2' ' B' ' 56' ' ' LYS . 88.1 m -157.55 167.55 29.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.153 165.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 20' ' ' VAL . 23.6 mt -108.16 132.7 55.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.439 166.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.492 ' HG2' HG23 ' B' ' 54' ' ' THR . 5.2 mmmt -143.38 -177.14 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.387 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -27.03 68.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.52 -55.09 34.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.042 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -29.34 69.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.394 -170.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.531 HG22 HD21 ' A' ' 28' ' ' LEU . 37.1 mm -71.61 -48.7 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.402 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.6 -31.41 71.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.023 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.449 ' HG ' ' CD2' ' B' ' 46' ' ' LEU . 15.0 tp -62.11 -51.12 69.2 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.416 168.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' B' ' 42' ' ' GLU . . . -61.36 -41.08 96.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.376 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.536 HG12 HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -88.75 -58.65 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.13 -162.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.467 ' N ' HG11 ' B' ' 64' ' ' VAL . 6.5 tpp180 -59.74 -25.56 64.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.8 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 -30.4 43.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.388 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.511 171.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.489 HD13 HD13 ' B' ' 11' ' ' ILE . 6.2 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 122.064 0.935 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 1.7 Cg_endo -53.95 142.87 63.17 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.07 2.513 . . . . 0.0 113.513 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 13.5 pt -92.24 -13.2 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.374 -165.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -79.65 -54.65 0.92 Allowed Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.719 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 16.1 Cg_exo -51.55 -55.17 4.23 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.499 2.133 . . . . 0.0 113.627 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 45.0 mt -61.71 -44.23 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.248 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.45 ' CA ' ' HD3' ' A' ' 25' ' ' ARG . . . -61.14 -22.17 60.3 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.4 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -26.29 21.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.724 -0.738 . . . . 0.0 110.483 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.501 HG21 ' HG3' ' B' ' 37' ' ' ARG . 27.4 mt -63.44 -54.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.43 170.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' B' ' 40' ' ' ALA . 9.4 mm -65.32 -36.58 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.262 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -69.21 -32.58 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.331 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.41 -34.87 77.58 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.8 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.92 63.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.491 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.63 24.03 0.3 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.566 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB3' HG12 ' B' ' 44' ' ' ILE . . . -63.57 142.62 58.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.825 -0.688 . . . . 0.0 110.323 174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.49 124.52 41.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.98 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.5 116.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.435 174.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 24' ' ' ALA . 15.6 t -146.14 165.65 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.362 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -99.99 159.81 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.442 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.01 -33.78 73.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -37.24 86.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.354 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' A' ' 20' ' ' VAL . . . -60.93 -46.12 91.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.318 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.95 -36.85 84.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.407 -170.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 mt -79.64 -43.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.457 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.518 HG23 HG23 ' B' ' 60' ' ' ILE . 90.5 m -60.92 -47.89 84.35 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.285 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 31' ' ' ILE . 4.5 tp -59.19 -45.77 90.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.412 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.67 -21.06 62.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.659 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.66 -24.41 14.43 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.357 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mp -61.11 -68.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.884 162.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.7 OUTLIER -60.26 -33.41 72.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.599 -169.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.3 tm-20 -65.03 -55.12 20.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.1 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -61.68 -26.13 67.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.909 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -46.92 77.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.358 164.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -40.2 96.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -60.75 -31.99 71.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.302 172.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -51.63 60.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.628 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG22 HG21 ' A' ' 64' ' ' VAL . 2.0 mt -62.6 -32.74 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.694 -172.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' B' ' 12' ' ' ILE . . . -78.01 -52.15 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.342 -166.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.2 t -61.25 -14.37 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.273 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -87.61 -54.82 4.07 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.213 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.99 -33.59 74.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.176 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.531 HD13 ' HB1' ' B' ' 17' ' ' ALA . 55.7 mt -60.59 -46.21 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.175 164.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -60.33 -21.92 62.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.565 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 43' ' ' ALA . 9.9 mt -89.08 -23.57 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.452 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.16 -28.4 65.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.301 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -61.31 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.37 170.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -61.12 -23.08 65.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.374 -168.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 -47.54 62.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.308 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.39 27.9 4.27 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.12 121.92 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.819 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -161.41 15.43 0.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.502 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m 63.14 151.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.392 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 29.4 mt -78.22 138.09 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -153.65 -178.17 6.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.455 -170.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.97 80.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.262 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -50.0 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.196 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.476 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -62.1 -33.34 74.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.405 -173.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' B' ' 27' ' ' THR . 11.5 mm -75.27 -58.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.342 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 39.8 mt-10 -61.64 -9.86 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.319 172.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 59' ' ' ASP . 16.1 mt -85.95 -41.28 15.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.487 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 39' ' ' ILE . . . -61.15 -36.49 79.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.098 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 55.9 t -61.85 -76.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.723 168.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -14.91 23.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.396 -167.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -61.52 -66.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 165.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 64' ' ' VAL . 8.3 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.482 -168.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.527 ' HB2' HD13 ' B' ' 8' ' ' ILE . 6.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.326 0.584 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.82 153.5 43.35 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.485 2.123 . . . . 0.0 113.317 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' B' ' 25' ' ' ARG . 16.5 pt -92.35 -25.13 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.42 -168.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.15 -62.56 3.55 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.754 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.11 -45.39 33.4 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.39 2.06 . . . . 0.0 113.417 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 3' ' ' LEU . 21.5 mt -60.96 -38.2 78.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.407 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.47 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -61.65 -53.9 39.97 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.556 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -70.41 -15.09 62.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.432 -170.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.489 HD13 HD13 ' A' ' 3' ' ' LEU . 66.1 mt -73.33 -34.47 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.534 168.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.502 HG13 ' NH2' ' B' ' 25' ' ' ARG . 2.6 mm -70.03 -46.26 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.894 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.3 mtpt -62.33 -41.33 98.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.045 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -60.79 -31.09 70.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.015 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.04 -52.43 65.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.575 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.72 31.61 0.4 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.597 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.531 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -80.76 -177.56 6.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -171.06 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.94 167.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.03 106.68 17.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.428 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 14.7 t -141.48 171.9 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.395 171.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -127.07 156.45 41.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.308 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.71 -37.82 85.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.379 -170.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.92 71.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.391 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' B' ' 27' ' ' THR . . . -65.83 -43.84 87.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.314 171.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.502 ' NH2' HG13 ' B' ' 12' ' ' ILE . 0.0 OUTLIER -61.24 -47.66 85.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.339 -175.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.44 -38.84 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.542 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.527 HG23 ' HA ' ' B' ' 24' ' ' ALA . 1.5 t -69.77 -43.32 72.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.178 -167.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.534 ' HA ' HD11 ' B' ' 31' ' ' ILE . 2.6 tp -59.44 -36.86 76.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.523 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.0 93.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.207 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -27.14 23.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.491 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' B' ' 28' ' ' LEU . 24.8 mt -61.61 -67.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.04 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.0 mp -60.4 -34.71 74.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.57 -176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.464 ' HG3' HD12 ' A' ' 11' ' ' ILE . 34.6 tt0 -67.52 -37.9 83.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.933 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -35.16 77.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.891 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 3.3 mtp -65.06 -48.34 74.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.461 170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 32' ' ' LEU . . . -64.23 -40.22 97.77 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.501 ' HG3' HG21 ' A' ' 11' ' ' ILE . 12.2 mtp180 -60.93 -29.69 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.345 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -67.89 -55.27 13.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.503 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 28' ' ' LEU . 2.2 mt -63.31 -26.28 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.821 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -61.49 -70.07 0.21 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.292 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.46 -17.01 52.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.388 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.538 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 3.3 mm-40 -84.61 -38.49 19.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.051 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.526 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -78.04 -8.28 57.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.832 172.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 51.3 mt -96.99 -51.06 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.765 -175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -60.25 -22.24 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.375 166.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.6 mt -69.62 -53.74 17.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.379 168.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.486 ' HB1' HG12 ' B' ' 55' ' ' ILE . . . -61.59 -23.54 66.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.307 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 -34.3 15.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.252 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -60.55 -36.77 79.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.434 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.02 74.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.17 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.17 46.94 7.85 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 4.1 tpm_? -121.23 -18.54 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.451 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.28 18.68 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -145.47 138.35 26.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.406 170.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.486 HG12 ' HB1' ' B' ' 47' ' ' ALA . 45.2 mt -93.76 148.5 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.341 170.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.434 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 6.1 mtpp -147.94 178.36 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.381 -169.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.33 -17.82 55.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.331 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -81.2 -41.27 22.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.069 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -75.28 -26.77 59.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.373 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 28' ' ' LEU . 1.4 mp -64.43 -59.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.339 174.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.539 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 11.6 mt-10 -74.41 -12.44 60.51 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.557 -176.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 7.5 mt -81.67 -46.12 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 168.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.534 ' HB3' HD13 ' B' ' 46' ' ' LEU . . . -60.34 -41.62 93.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.398 172.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 37.9 t -62.72 -74.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.63 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -10.76 3.44 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.509 -164.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -85.77 -60.87 1.9 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.582 164.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.538 ' HB3' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.42 -155.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 29' ' ' ALA . 28.8 mt . . . . . 0 C--O 1.24 0.563 0 CA-C-O 121.763 0.792 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -48.3 150.99 4.84 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 122.388 2.058 . . . . 0.0 113.512 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.509 ' HB ' ' NE ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -69.21 -11.55 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.591 -166.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -75.6 -58.93 1.32 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.772 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HD3' ' HB1' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.12 -57.11 1.43 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.432 2.088 . . . . 0.0 113.437 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 29' ' ' ALA . 27.8 mt -60.6 -32.66 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.378 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.59 -26.65 64.95 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.357 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -78.02 -36.4 48.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.373 -0.914 . . . . 0.0 110.483 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.536 HG22 ' HG3' ' B' ' 37' ' ' ARG . 25.1 mt -60.63 -64.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.48 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 9.3 mm -60.91 -33.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -166.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -65.36 -40.45 93.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.468 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.11 -32.41 72.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.777 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.64 64.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.522 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.76 22.09 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.654 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -61.64 159.25 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.295 169.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.529 ' HG2' ' HB3' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.01 -63.34 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.054 -169.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -144.6 80.06 1.62 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.478 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.516 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 15.5 t -71.33 107.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.31 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -61.54 158.88 14.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.459 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -61.31 -18.66 59.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.269 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -66.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.773 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB2' ' CG1' ' B' ' 60' ' ' ILE . . . -60.69 -39.66 89.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.386 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -62.01 -37.78 86.17 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.448 -175.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.457 HG13 ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -76.28 -29.45 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.357 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.49 HG23 ' HB ' ' B' ' 60' ' ' ILE . 97.1 m -61.06 -60.75 3.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.341 171.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 31' ' ' ILE . 64.4 tp -68.33 -28.74 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.424 -171.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . . . -71.35 -40.38 70.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.116 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -60.38 -35.59 76.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.379 166.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD12 HG13 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -69.78 -38.96 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.378 -170.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.539 HD11 HD22 ' B' ' 32' ' ' LEU . 1.8 mm? -74.84 -67.74 0.61 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.479 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HG2' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.39 -17.85 64.89 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.811 -163.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.17 -49.57 64.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.108 164.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.577 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.516 ' N ' HD23 ' B' ' 32' ' ' LEU . . . -76.71 -36.15 38.27 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' N ' ' CG2' ' B' ' 11' ' ' ILE . 2.4 ttm-85 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.38 169.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.56 -51.7 33.05 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.429 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 64' ' ' VAL . 25.1 mt -63.9 -33.75 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.395 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.41 -66.23 0.57 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.275 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.21 -15.47 34.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.373 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -71.38 -63.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.135 167.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -60.99 -13.14 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.488 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 HD12 ' A' ' 55' ' ' ILE . 95.3 mt -97.2 -59.26 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -61.89 -17.43 56.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.333 174.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 ' HA ' ' A' ' 43' ' ' ALA . 16.7 mt -69.84 -58.66 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.363 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -25.57 67.33 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.398 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.71 -55.85 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.448 -170.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 2.4 p-80 -68.01 -24.95 65.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.389 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.02 62.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.347 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.22 26.42 2.04 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.61 165.6 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.416 -170.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -132.68 18.46 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.446 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.6 m -157.66 132.94 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.301 170.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 HD12 HG12 ' A' ' 44' ' ' ILE . 4.4 mp -100.36 133.26 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.309 166.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 -172.62 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.454 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -20.0 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.315 -171.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.18 -67.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.077 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -32.27 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.366 -167.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.53 HG22 HD12 ' B' ' 28' ' ' LEU . 37.9 mm -61.2 -64.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.387 172.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.453 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 3.4 mt-10 -61.1 -10.07 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.41 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.98 -39.5 12.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.457 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -76.26 -27.56 56.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.113 175.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 39' ' ' ILE . 15.3 t -62.48 -66.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.448 160.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -59.39 -11.19 3.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.002 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -30.65 15.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.453 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.236 0.357 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.617 163.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' B' ' 33' ' ' GLU . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.89 139.73 91.37 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.461 2.107 . . . . 0.0 113.407 165.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' B' ' 8' ' ' ILE . 22.7 pt -92.95 21.43 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.567 -167.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.02 0.41 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.733 170.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.91 -50.74 11.44 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' B' ' 5' ' ' ILE . 23.5 mt -60.85 -23.18 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.322 167.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.1 96.63 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.518 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.401 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 20.6 mmt180 -94.26 -18.03 22.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.986 -0.607 . . . . 0.0 110.347 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.495 HG13 ' HG3' ' A' ' 33' ' ' GLU . 7.7 mm -60.83 -72.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.002 163.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 40' ' ' ALA . 3.7 mm -63.38 -17.0 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.169 -171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.9 OUTLIER -83.04 -37.3 24.1 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.377 176.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -32.53 73.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.836 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -58.82 -52.88 63.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.516 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.21 23.06 0.35 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.702 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.8 147.05 53.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.772 -0.714 . . . . 0.0 110.424 173.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.77 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.939 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 80.33 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.381 168.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.89 137.73 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.472 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 58.9 p -74.49 150.89 39.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.365 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.16 -17.92 55.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.302 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -44.65 63.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.422 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 60' ' ' ILE . . . -62.45 -43.61 98.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.363 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.512 ' HD2' HD13 ' B' ' 5' ' ' ILE . 28.1 mtt-85 -62.23 -32.57 73.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.417 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -88.02 -30.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.445 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.521 HG23 HD13 ' B' ' 31' ' ' ILE . 97.8 m -61.1 -54.11 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.37 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 60' ' ' ILE . 4.3 tp -59.83 -45.38 92.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.556 172.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -31.16 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.362 -171.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -91.94 -23.2 19.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.521 HD13 HG23 ' B' ' 27' ' ' THR . 64.4 mt -61.36 -70.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.135 166.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.539 HD22 HD11 ' A' ' 32' ' ' LEU . 1.1 mp -60.47 -33.15 72.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.719 -170.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.464 ' HB2' HD13 ' B' ' 3' ' ' LEU . 18.5 tt0 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.12 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -32.11 72.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.945 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' B' ' 39' ' ' ILE . 2.1 ttt -60.46 -42.55 96.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.426 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.21 68.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -169.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.536 ' HG3' HG22 ' A' ' 11' ' ' ILE . 5.7 mtp180 -60.58 -28.51 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.49 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -70.18 -57.8 4.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.53 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.504 HG23 HG22 ' B' ' 64' ' ' VAL . 10.2 mt -61.04 -23.44 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.483 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 12' ' ' ILE . . . -61.73 -70.05 0.21 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.521 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.7 OUTLIER -61.22 -11.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.479 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.0 OUTLIER -78.62 -58.32 3.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.068 170.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.508 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -61.15 -17.44 52.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.47 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 90.0 mt -91.18 -50.17 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.983 -173.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -60.68 -27.91 68.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.377 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 15.4 mt -64.81 -54.72 26.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.354 167.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.462 ' CB ' HD12 ' B' ' 55' ' ' ILE . . . -61.27 -50.63 72.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.275 -169.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -42.63 99.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.12 -35.19 76.39 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.407 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.34 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.302 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.29 30.1 7.99 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.478 ' HD3' ' HB ' ' B' ' 54' ' ' THR . 0.0 OUTLIER -134.48 104.11 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.352 169.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.529 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 6.6 mttt -61.13 -16.98 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.335 -169.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' B' ' 52' ' ' ARG . 94.2 m -88.39 122.21 31.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.447 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.498 HG13 HG23 ' A' ' 20' ' ' VAL . 11.8 mm -75.1 138.29 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.515 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -130.2 158.55 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.324 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -62.86 -31.06 72.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.309 -167.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.95 -37.93 82.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.081 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -37.12 86.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.44 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' A' ' 27' ' ' THR . 48.8 mm -60.9 -55.9 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.432 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -70.64 -22.64 62.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.009 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.13 -36.17 40.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.449 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.99 -55.36 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.372 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 31' ' ' ILE 0.256 0.4 OUTLIER -70.16 -50.71 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.978 -165.806 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.506 ' N ' HG11 ' B' ' 64' ' ' VAL . 5.1 mmm180 -60.9 -43.06 99.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -20.73 64.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.4 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 50.5 t80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.306 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 8' ' ' ILE . 3.4 mt . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.609 0.719 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.97 144.16 94.84 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.172 1.915 . . . . 0.0 113.66 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -101.99 19.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.684 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -85.92 -58.81 0.31 Allowed Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 11.7 Cg_endo -59.46 -45.81 24.39 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.503 2.135 . . . . 0.0 113.557 168.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -69.06 -32.93 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.438 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -30.31 71.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.8 ttp-105 -92.39 -18.73 22.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.315 -174.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -61.01 -60.59 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.244 166.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' B' ' 40' ' ' ALA . 7.3 mm -72.32 -22.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.039 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -77.31 -34.27 55.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.296 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -61.45 -31.17 71.12 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.877 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' B' ' 41' ' ' SER . . . -57.94 -52.23 66.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.492 170.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.89 34.31 0.56 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.53 -167.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' B' ' 44' ' ' ILE . . . -84.25 145.92 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.255 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.05 -38.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.026 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -122.9 85.0 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.48 170.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG12 HG23 ' B' ' 55' ' ' ILE . 89.8 t -132.42 113.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.274 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -65.46 164.26 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.462 -167.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -30.56 71.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.36 -173.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -60.97 -43.38 98.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.402 176.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -61.56 -41.2 97.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.347 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -61.73 -42.26 98.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.389 -176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.435 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 3.3 mt -83.29 -28.42 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.447 -176.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.54 HG21 HD13 ' A' ' 31' ' ' ILE . 97.3 m -60.89 -47.7 85.21 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.293 174.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 HG22 ' B' ' 60' ' ' ILE . 4.4 tp -59.21 -45.54 90.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.453 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.12 -20.8 63.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.547 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.91 -28.86 14.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.323 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.54 HD13 HG21 ' A' ' 27' ' ' THR . 1.9 mp -60.7 -70.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.929 162.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.538 ' HG ' ' HG ' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -58.32 -35.16 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.796 -166.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HG3' HD13 ' B' ' 11' ' ' ILE . 9.9 tt0 -69.52 -61.71 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.201 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -61.55 -34.09 74.97 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.797 -170.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.5 ttm -62.2 -46.9 86.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.46 165.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.39 -47.69 85.32 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -23.0 64.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.368 170.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -75.6 -52.32 10.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.605 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HD12 ' B' ' 28' ' ' LEU . 5.3 mt -61.49 -28.75 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.071 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' B' ' 12' ' ' ILE . . . -62.04 -74.09 0.09 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.191 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.9 p -60.94 -11.38 7.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.489 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 5.4 mm-40 -79.92 -55.84 4.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.089 171.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 63' ' ' ALA . . . -61.16 -20.83 63.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.368 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.538 HD12 ' HB1' ' B' ' 17' ' ' ALA . 92.8 mt -88.82 -52.03 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.93 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -27.81 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.447 170.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 63' ' ' ALA . 6.3 mp -63.36 -61.02 2.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.375 171.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.241 -167.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.463 ' CD ' ' HG3' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -82.61 -41.1 19.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.411 -171.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -66.2 -21.27 66.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.247 167.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.27 59.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.23 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.71 9.92 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.64 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HG3' ' CD ' ' A' ' 48' ' ' ARG . 13.6 ttm-85 66.69 134.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.419 169.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.19 -65.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.303 169.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.5 HG23 ' HB2' ' B' ' 21' ' ' SER . 92.7 m -157.63 144.4 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.323 169.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 44' ' ' ILE . 25.4 mm -66.22 136.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.322 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -131.83 165.21 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.404 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' CB ' ' B' ' 23' ' ' ASP . . . -61.13 -17.72 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.246 169.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.29 -44.83 35.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.092 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.9 -35.05 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.278 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' B' ' 28' ' ' LEU . 1.4 mp -61.89 -56.15 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.763 162.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -33.22 73.39 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.909 -166.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 7.6 mp -75.91 -45.78 33.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.551 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -61.37 -27.05 68.24 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.434 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' CG2' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -96.09 -56.3 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.866 -164.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.509 ' NH1' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -60.13 -26.25 66.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.632 174.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 97.4 mtt180 -81.38 -23.86 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.411 171.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 5.5 t80 . . . . . 0 N--CA 1.455 -0.205 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.46 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 33' ' ' GLU . 1.5 mt . . . . . 0 CA--C 1.545 0.765 0 CA-C-O 121.264 0.554 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.434 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 12.0 Cg_endo -62.56 147.97 94.03 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.514 2.143 . . . . 0.0 113.401 165.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.16 19.21 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.955 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -94.55 -59.35 0.2 Allowed Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.737 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 10.9 Cg_endo -57.89 -46.97 22.79 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.484 2.123 . . . . 0.0 113.454 169.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.73 -37.06 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.391 168.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.57 -21.35 60.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -103.61 -18.39 14.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.067 -0.567 . . . . 0.0 110.327 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 33' ' ' GLU . 9.4 mm -60.78 -49.93 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.275 164.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 40' ' ' ALA . 6.2 mm -85.46 -31.26 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.967 -168.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.385 170.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.32 -32.52 73.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.748 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . . . -58.8 -53.47 57.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.521 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.82 24.04 0.48 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.618 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.538 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -61.02 144.2 53.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.73 -0.735 . . . . 0.0 110.409 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -146.01 122.02 10.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.036 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 64.28 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.367 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' B' ' 24' ' ' ALA . 25.8 t -101.4 123.65 54.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.337 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.5 ' HB2' HG23 ' A' ' 54' ' ' THR . 31.3 t -61.25 154.35 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.419 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.48 -37.08 82.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.395 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.461 ' CB ' ' HB3' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.72 -48.6 81.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.511 170.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.477 ' HB2' HG11 ' B' ' 20' ' ' VAL . . . -61.95 -48.61 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.297 -172.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.457 ' HG3' ' CG1' ' B' ' 20' ' ' VAL . 9.2 mtp180 -61.61 -36.97 82.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.392 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -89.2 -32.99 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.42 -167.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.46 HG21 HD13 ' B' ' 31' ' ' ILE . 90.1 m -67.21 -41.05 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.449 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.531 HD22 HD13 ' B' ' 12' ' ' ILE . 2.2 tp -62.97 -48.21 79.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.913 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.02 -25.78 67.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.553 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -95.96 -29.4 14.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.283 -175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.46 HD13 HG21 ' B' ' 27' ' ' THR . 15.4 mt -61.4 -59.9 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.845 166.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.538 ' HG ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.01 -22.05 47.82 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.77 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' B' ' 3' ' ' LEU . 8.9 tp10 -83.34 -65.05 1.06 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.011 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.68 -34.22 75.36 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.849 -174.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.451 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 8.2 ttm -62.15 -47.75 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.521 165.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -49.53 76.72 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HD3' ' N ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.59 -25.06 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.433 171.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -71.32 -49.91 37.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.61 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.535 HG22 HG21 ' B' ' 64' ' ' VAL . 6.0 mt -61.43 -34.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.261 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.8 -71.78 0.14 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.301 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 24.7 p -62.04 -17.88 58.79 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.557 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CB ' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -81.51 -50.85 8.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.26 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -62.4 -12.89 24.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.099 173.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 96.6 mt -95.47 -49.31 12.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.817 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -67.84 -7.4 27.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.182 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.516 HD11 ' HA ' ' B' ' 43' ' ' ALA . 3.9 mt -83.61 -43.05 16.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.26 169.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.49 -14.83 21.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.324 166.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -92.31 -35.29 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.498 168.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.485 ' HB2' ' HA ' ' B' ' 46' ' ' LEU . 23.8 t-80 -61.66 -39.56 91.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.266 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.51 ' HB2' ' NZ ' ' B' ' 53' ' ' LYS . . . -61.05 -52.63 64.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.212 165.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.84 9.53 10.87 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.539 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 179.23 -166.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.931 -0.635 . . . . 0.0 110.323 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' B' ' 50' ' ' ALA . 2.7 mppt? 65.73 162.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.41 167.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.463 HG21 ' N ' ' B' ' 55' ' ' ILE . 91.8 m -96.55 152.68 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.346 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.498 HG23 HG12 ' A' ' 20' ' ' VAL . 3.6 mp -69.3 133.66 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 168.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.535 ' HB2' ' HG2' ' B' ' 58' ' ' GLU . 0.3 OUTLIER -135.63 -171.36 2.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.376 177.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -61.75 -27.15 68.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.247 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' B' ' 56' ' ' LYS . 5.0 pt-20 -73.99 -49.0 26.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.1 OUTLIER -61.89 -31.56 71.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.401 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.539 HG22 HD12 ' A' ' 28' ' ' LEU . 25.3 mm -61.89 -68.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.268 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.539 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt-10 -61.06 -14.61 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 3.6 mp -70.66 -55.2 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.403 169.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' B' ' 39' ' ' ILE . . . -60.91 -37.03 80.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.484 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 40.2 t -62.43 -69.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.796 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.19 -9.17 4.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.508 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -50.29 21.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.488 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -174.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.531 ' HB2' HD13 ' A' ' 8' ' ' ILE . 3.3 mt . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 121.507 0.67 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.12 140.18 93.17 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.543 2.162 . . . . 0.0 113.533 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 pt -80.64 -31.23 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.366 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.527 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -63.75 -62.73 4.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.763 -173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -50.87 -42.85 50.06 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 C-N-CA 122.48 2.12 . . . . 0.0 113.524 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.531 HD13 ' HB2' ' A' ' 3' ' ' LEU . 50.3 mt -60.81 -39.15 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.435 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.458 ' HA2' ' CZ ' ' A' ' 25' ' ' ARG . . . -61.58 -26.12 66.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -91.14 -25.33 19.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.169 -0.515 . . . . 0.0 110.36 -176.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.503 HG22 ' HG3' ' B' ' 37' ' ' ARG . 53.7 mt -60.83 -62.43 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.296 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 9.2 mm -61.21 -35.18 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.249 -175.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.4 mtmt -60.79 -37.09 80.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.498 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.56 -35.21 78.76 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.789 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.32 -53.08 62.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.41 167.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.57 16.58 0.21 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.051 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -61.16 170.57 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 163.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.09 -57.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.941 165.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NH1' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -73.62 83.28 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.391 172.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.446 HG11 ' HB ' ' B' ' 55' ' ' ILE . 24.6 t -129.03 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 -170.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.3 p -85.24 156.48 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.423 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.8 t0 -61.42 -23.19 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.318 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -90.65 -28.62 18.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.394 -170.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -61.69 -42.04 98.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.157 166.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HG3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.76 -51.17 68.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.445 -178.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tt -62.68 -40.95 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.234 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.525 HG22 ' HG3' ' B' ' 61' ' ' GLU . 91.7 m -60.77 -59.06 5.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.369 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 ' HB ' ' B' ' 39' ' ' ILE . 9.3 tp -61.01 -10.5 5.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.344 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.37 -59.29 2.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.448 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -25.14 66.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.434 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 27' ' ' THR . 74.0 mt -61.65 -75.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.052 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HG ' ' HE1' ' B' ' 35' ' ' MET . 7.1 mp -60.57 -36.92 79.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -166.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 3' ' ' LEU . 8.4 tt0 -67.46 -42.75 82.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.053 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.12 -41.15 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.056 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.9 mmm -60.76 -42.1 96.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.506 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.57 -46.27 90.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' HD3' HG22 ' B' ' 11' ' ' ILE . 3.1 mtp180 -60.73 -33.83 73.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.378 168.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -65.69 -50.2 65.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 -175.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 64' ' ' VAL . 11.0 mt -65.1 -36.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.417 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB3' HD11 ' B' ' 12' ' ' ILE . . . -65.26 -54.08 34.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.32 -172.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.534 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 -34.33 75.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.298 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -38.26 85.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.063 169.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -79.82 -13.67 59.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -82.79 -57.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.372 -168.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HD2' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.29 -31.36 70.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.414 169.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.4 mt -59.96 -43.84 94.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.584 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -67.86 -26.37 65.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.103 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -60.67 -61.61 2.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.332 168.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -61.31 -10.09 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.584 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -84.16 -57.86 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.953 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.64 9.93 0.04 OUTLIER Glycine 0 C--N 1.344 0.996 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.666 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 0.3 OUTLIER 73.6 -58.22 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.424 0.689 . . . . 0.0 111.47 158.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.53 -23.3 49.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 111.182 -157.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.518 HG23 ' N ' ' B' ' 21' ' ' SER . 0.2 OUTLIER -155.43 154.97 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.354 169.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 44' ' ' ILE . 4.3 mm -72.44 150.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.015 159.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 156.33 40.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.413 -169.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.23 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.246 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -68.72 -38.99 80.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.902 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -48.0 83.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.618 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' B' ' 27' ' ' THR . 22.8 mm -61.55 -46.2 97.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -36.86 69.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.054 -170.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mp -63.51 -43.28 97.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.414 167.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HA ' ' CD1' ' A' ' 46' ' ' LEU . . . -61.54 -57.42 12.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.41 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.26 -52.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.042 -168.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -41.35 92.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.731 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -20.72 63.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.337 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 44.5 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.206 -171.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' B' ' 8' ' ' ILE . 1.5 mt . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.67 140.91 93.44 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.533 2.156 . . . . 0.0 113.405 164.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.422 HD11 HG22 ' B' ' 5' ' ' ILE . 13.2 pt -99.47 -17.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.389 -167.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.09 -62.0 0.46 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.754 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.48 -36.24 58.43 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 122.508 2.139 . . . . 0.0 113.522 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' B' ' 3' ' ' LEU . 54.0 mt -60.42 -42.22 90.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.362 168.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.453 ' CA ' ' HG2' ' B' ' 25' ' ' ARG . . . -61.54 -28.15 69.2 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.603 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -86.55 -21.84 26.67 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.511 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.467 HG22 ' HD3' ' A' ' 37' ' ' ARG . 26.4 mt -69.02 -44.0 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.399 167.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 40' ' ' ALA . 3.5 mm -62.65 -36.17 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.04 171.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.535 ' HG3' ' HA ' ' B' ' 10' ' ' ARG . 0.6 OUTLIER -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.387 172.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 37' ' ' ARG . 16.5 t70 -62.55 -32.78 73.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.75 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 40' ' ' ALA . . . -58.67 -52.57 65.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.443 169.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.41 18.88 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.051 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.533 ' HB2' HG22 ' B' ' 20' ' ' VAL . . . -64.43 165.76 9.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.311 168.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.21 -58.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.049 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 83.3 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.452 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' B' ' 17' ' ' ALA . 57.9 t -104.45 145.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.324 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 54' ' ' THR . 77.8 p -61.21 139.73 58.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.33 168.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.98 -24.25 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.261 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -53.17 56.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.454 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.414 ' HB1' HG11 ' B' ' 20' ' ' VAL . . . -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.336 -167.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.453 ' HG2' ' CA ' ' B' ' 9' ' ' GLY . 4.1 mpp_? -60.87 -49.03 79.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.417 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.11 -23.68 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.449 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.54 HG23 ' HB ' ' A' ' 60' ' ' ILE . 97.7 m -77.83 -40.08 41.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.362 -170.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.534 HD21 HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.68 -37.37 81.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.409 169.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.61 96.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.245 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -77.8 -31.41 51.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.369 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.527 HD13 HG21 ' B' ' 27' ' ' THR . 5.5 mt -61.35 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.035 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.467 ' CD1' HD11 ' B' ' 28' ' ' LEU . 3.5 mp -59.42 -35.4 73.93 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.611 -165.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.471 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -71.17 -37.44 72.18 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.125 -177.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.24 -52.08 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.097 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.534 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 6.3 ptm -65.03 -28.27 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.343 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.96 -45.8 48.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.503 ' HG3' HG22 ' A' ' 11' ' ' ILE . 1.7 mtt-85 -60.64 -18.29 52.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.452 169.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.9 OUTLIER -87.03 -54.7 4.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.454 -173.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD13 ' A' ' 28' ' ' LEU . 7.1 mt -61.54 -19.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.443 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 12' ' ' ILE . . . -65.7 -70.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.353 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t -61.07 -10.14 5.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.61 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.45 -45.02 9.24 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.097 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -63.51 -24.38 67.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.272 169.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 78.2 mt -86.31 -50.43 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.134 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -31.77 70.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.371 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 14.4 mt -60.78 -55.09 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.371 167.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.505 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.32 -30.42 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.292 -170.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.35 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -60.71 -35.05 75.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.371 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.61 -53.51 56.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.27 171.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.84 24.11 1.12 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.599 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.488 ' HD3' ' NH1' ' A' ' 19' ' ' ARG . 1.3 ptp85 59.57 33.51 22.1 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.226 -0.573 . . . . 0.0 111.169 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 77.37 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.407 169.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m 68.49 175.93 0.27 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.528 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.446 ' HB ' HG11 ' A' ' 20' ' ' VAL . 17.4 mm -118.41 137.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.235 166.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -142.94 166.34 24.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.429 -168.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.17 68.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.253 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.429 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 1.0 OUTLIER -64.18 -37.48 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.108 168.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HG2' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -79.5 -39.86 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.395 -176.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.461 HG13 ' CA ' ' A' ' 24' ' ' ALA . 38.2 mm -60.98 -54.4 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.421 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 27' ' ' THR . 4.5 mt-10 -68.59 -36.43 78.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.986 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.13 -44.41 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.338 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.41 -42.82 99.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.413 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.506 HG22 HD11 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -82.99 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.18 -167.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -11.89 8.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.565 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -94.61 -30.9 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.443 168.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 1.1 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.761 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . 6.2 mp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 122.294 1.045 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.9 Cg_endo -67.59 141.72 56.24 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.114 2.542 . . . . 0.0 113.67 -172.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -80.49 -9.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.023 -172.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.94 -60.33 1.23 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.727 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 4' ' ' PRO . 9.5 Cg_endo -56.92 -51.37 9.05 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.454 2.103 . . . . 0.0 113.497 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 30.2 mt -60.59 -45.91 96.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.45 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.58 -30.03 75.41 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.686 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.85 -20.57 27.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.493 -0.353 . . . . 0.0 110.329 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.512 HD13 HD22 ' B' ' 3' ' ' LEU . 30.1 mt -65.19 -49.7 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.446 166.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.533 HG23 HG22 ' A' ' 20' ' ' VAL . 13.9 mm -61.05 -46.61 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.418 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -62.32 -30.32 71.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.261 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.34 -35.39 78.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.77 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.54 -52.63 64.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.511 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.11 23.53 0.34 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.576 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -61.7 170.51 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.306 173.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.65 -58.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.952 167.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -125.76 104.57 8.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.36 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 12' ' ' ILE . 59.6 t -112.26 103.8 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.345 168.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB2' HG21 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.44 167.88 3.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.403 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -26.07 67.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.363 -170.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.21 -63.03 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.518 172.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 27' ' ' THR . . . -62.03 -39.54 92.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.3 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 21.7 mtm180 -61.56 -38.62 88.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.291 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.9 mm -76.25 -25.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.51 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 31' ' ' ILE . 71.3 m -74.4 -45.8 44.42 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.12 -168.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.541 HD11 HG12 ' B' ' 60' ' ' ILE . 5.6 tp -59.19 -47.76 84.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.36 164.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -18.46 58.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.531 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -99.68 -27.18 13.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.316 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 27' ' ' THR . 2.0 mp -60.79 -69.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.85 162.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' B' ' 32' ' ' LEU . 6.1 mp -59.67 -34.68 73.16 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.555 -168.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' CG ' HD11 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.67 -59.3 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.55 -20.24 63.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.83 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -52.2 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.223 160.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.87 95.15 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -61.31 -39.91 92.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.377 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -63.19 -56.49 16.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.434 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 64' ' ' VAL . 3.0 mt -61.57 -28.0 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.219 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -64.34 -61.33 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.231 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.533 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -80.71 -15.24 57.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.517 -167.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -78.98 -48.6 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.125 168.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.71 -37.46 86.59 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.041 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.536 HD13 ' HB1' ' B' ' 17' ' ' ALA . 48.2 mt -61.19 -50.3 81.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.147 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.91 -14.88 25.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.3 mt -91.63 -34.38 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.161 -172.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -47.2 87.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.428 168.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -62.01 -48.35 80.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.359 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -62.7 -35.28 79.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.37 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.24 47.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.183 168.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 24.71 0.57 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.618 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.31 96.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.215 -0.492 . . . . 0.0 110.531 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -153.61 78.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.239 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m 69.3 168.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.532 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 44' ' ' ILE . 86.2 mt -121.9 147.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.356 168.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -178.84 7.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.424 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' B' ' 27' ' ' THR . . . -64.23 -22.75 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.258 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.65 -68.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.155 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -25.94 67.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -169.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 ' CG2' HD11 ' B' ' 28' ' ' LEU . 16.0 mm -76.14 -60.05 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.343 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.3 mt-10 -61.75 -18.7 60.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.413 177.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 HD11 HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -78.88 -41.01 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.469 173.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.07 84.36 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.12 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 39' ' ' ILE . 41.2 t -61.02 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.713 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -60.27 -9.87 3.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.657 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.2 tpt180 -73.66 -48.52 31.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.408 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.7 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.365 168.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.512 HD22 HD13 ' A' ' 11' ' ' ILE . 7.6 mt . . . . . 0 C--O 1.244 0.786 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.91 146.51 94.91 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.722 2.281 . . . . 0.0 113.439 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 pt -93.78 21.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.49 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.494 ' HB1' ' HD3' ' B' ' 7' ' ' PRO . . . -88.58 -59.81 0.25 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.748 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.494 ' HD3' ' HB1' ' B' ' 6' ' ' ALA . 10.5 Cg_endo -56.48 -45.72 35.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.362 2.041 . . . . 0.0 113.506 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -61.15 -55.2 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.515 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.39 68.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -80.45 -25.75 38.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.456 -177.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.459 HD13 ' CD1' ' A' ' 3' ' ' LEU . 80.6 mt -68.38 -46.84 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.411 167.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 40' ' ' ALA . 8.1 mm -65.44 -40.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.212 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtpp -61.05 -36.88 80.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.453 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -62.0 -31.9 72.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.845 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.28 -52.35 65.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.52 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.59 22.57 0.85 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.744 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.536 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -64.3 146.29 54.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.807 -0.696 . . . . 0.0 110.405 172.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.32 -58.21 0.18 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.989 168.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -80.76 81.4 7.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.351 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' B' ' 17' ' ' ALA . 21.6 t -139.86 153.37 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.37 -168.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 99.0 p -101.71 150.36 23.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.393 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -16.97 49.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.32 168.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.96 -49.02 79.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.411 169.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -61.59 -45.84 92.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.388 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -30.05 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.404 -171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.81 -20.41 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.436 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 57' ' ' ALA . 88.8 m -61.03 -56.77 17.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.254 167.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.531 ' HA ' HD13 ' B' ' 31' ' ' ILE . 3.0 tp -60.7 -40.24 91.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.529 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.97 92.0 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.421 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.22 -21.12 31.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.399 -177.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' B' ' 28' ' ' LEU . 58.8 mt -61.4 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.018 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 32' ' ' LEU . 8.9 mp -60.79 -42.82 98.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.539 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.468 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 14.6 tm-20 -63.56 -36.67 84.55 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.065 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -43.98 97.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.063 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 34.5 mtp -60.78 -37.91 83.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.562 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.91 99.72 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -44.73 95.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.476 172.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 1.1 t70 -77.61 -45.87 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.559 -165.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 28' ' ' LEU . 5.8 mt -61.21 -30.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.253 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.37 -67.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.305 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' HD11 ' B' ' 44' ' ' ILE . 2.4 t -61.24 -9.19 4.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.471 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.75 -38.15 11.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.171 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' B' ' 60' ' ' ILE . . . -76.32 -16.11 59.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.46 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' B' ' 41' ' ' SER . 55.3 mt -87.45 -49.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.836 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -30.03 68.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.414 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.94 -47.23 85.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.405 166.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.93 -18.6 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.333 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -41.39 67.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.277 168.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -60.3 -30.74 69.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.415 170.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.77 -51.56 68.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.418 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.22 41.84 1.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.477 -174.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.53 18.97 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.43 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 140.66 29.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.191 165.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -61.03 168.25 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.361 -167.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 61.2 mt -92.96 141.22 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.559 -168.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 2.2 mtpt -138.25 -169.14 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.363 -171.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.466 ' HA ' ' CG2' ' A' ' 27' ' ' THR . . . -66.83 -45.87 76.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.037 -169.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.54 -31.0 71.0 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.26 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.54 -68.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.336 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.541 HG12 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -70.04 -32.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 -162.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -38.59 87.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -47.12 87.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.468 168.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' B' ' 39' ' ' ILE . . . -61.56 -13.96 25.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.615 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.533 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -113.64 -57.21 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -159.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -10.92 3.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.39 166.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -85.37 -69.67 0.64 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.632 166.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CE1' HG21 ' B' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -154.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 33' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.08 140.73 85.73 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.505 2.137 . . . . 0.0 113.444 163.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.518 HG13 ' HD3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -96.89 -10.97 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.698 -170.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -61.06 -53.75 60.67 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.691 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 4.0 Cg_endo -51.01 -57.21 2.39 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.613 2.209 . . . . 0.0 113.549 171.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.67 -25.98 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.422 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.95 32.69 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.549 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -76.43 -16.6 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.419 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 HD12 HD22 ' B' ' 3' ' ' LEU . 31.8 mt -60.99 -73.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.262 166.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.534 HG21 HD13 ' B' ' 44' ' ' ILE . 7.4 mm -61.89 -23.42 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.852 -170.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -69.27 -38.69 78.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.457 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' B' ' 37' ' ' ARG . 57.6 t0 -62.31 -33.68 75.13 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.802 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.23 60.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.454 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.59 15.88 0.32 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.277 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -64.37 -177.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.261 165.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -171.13 -52.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.991 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -92.0 99.03 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.409 170.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG11 ' HB2' ' A' ' 24' ' ' ALA . 46.5 t -113.67 117.88 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 169.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 35.5 t -61.6 159.34 13.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.38 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.0 -22.82 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.372 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' HG23 ' A' ' 26' ' ' ILE . 8.2 t70 -96.4 -35.25 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.291 -170.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -60.61 -38.49 84.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.065 164.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HD3' HG13 ' A' ' 5' ' ' ILE . 7.4 ttm180 -60.16 -52.37 65.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.514 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tp -72.65 -37.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 HG21 HG23 ' B' ' 60' ' ' ILE . 55.6 m -61.37 -51.86 67.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.262 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.531 HD22 HG13 ' A' ' 12' ' ' ILE . 11.8 tp -61.44 -25.5 67.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.189 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -53.36 15.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.534 169.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.03 -28.84 65.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.363 -170.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 27' ' ' THR . 88.2 mt -61.42 -72.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.054 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 HD13 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -59.92 -19.08 49.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.771 -166.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.507 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 2.5 pp20? -91.43 -41.89 10.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.027 -171.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.58 -35.14 76.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.904 167.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 mmt -61.05 -54.05 49.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.476 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.79 95.23 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -167.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.507 ' NH2' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -60.92 -33.9 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.315 170.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -53.88 48.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.541 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 28' ' ' LEU . 9.8 mt -61.37 -38.92 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.233 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -63.77 -57.11 10.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.384 -172.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.71 -30.62 70.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.254 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 3.7 mm-40 -60.76 -60.04 4.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.36 -11.93 12.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.535 -176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 HD13 ' HB1' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.76 -56.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.117 -169.107 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.4 65.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.439 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 7.0 mp -61.15 -49.04 78.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.293 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -61.38 -27.84 68.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.327 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -53.28 40.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.455 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.423 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -60.93 -55.08 37.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.124 170.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.3 32.94 0.37 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.508 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.03 -59.93 0.5 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.79 -0.705 . . . . 0.0 111.009 164.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -60.13 98.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.583 -163.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m 70.14 123.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.371 166.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' B' ' 20' ' ' VAL . 15.9 mt -79.02 140.21 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.273 164.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HD2' ' CB ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -144.47 -174.32 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -168.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' B' ' 27' ' ' THR . . . -61.7 -31.18 71.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.34 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.45 -42.33 83.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.115 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -35.43 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.323 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.53 HG22 HD12 ' B' ' 28' ' ' LEU . 33.6 mm -61.09 -40.05 84.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.326 169.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 37.5 mt-10 -80.34 -34.07 36.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.002 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -45.08 95.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.436 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -61.17 -36.96 81.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.518 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.51 ' HA ' ' CE1' ' A' ' 67' ' ' PHE 0.257 0.4 OUTLIER -75.22 -52.67 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.989 -167.155 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.17 62.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.596 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.27 -12.5 16.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.923 -163.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE1' HG12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 164.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.534 HD22 HD12 ' A' ' 11' ' ' ILE . 16.0 mt . . . . . 0 C--O 1.241 0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.5 Cg_endo -60.05 147.75 91.87 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.324 2.016 . . . . 0.0 113.496 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.402 HG12 ' N ' ' B' ' 6' ' ' ALA . 0.2 OUTLIER -85.23 -30.84 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.541 -177.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' B' ' 7' ' ' PRO . . . -69.24 -59.8 4.73 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.69 -171.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 5.4 Cg_endo -52.58 -46.15 35.26 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 122.552 2.168 . . . . 0.0 113.533 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' B' ' 3' ' ' LEU . 26.9 mt -60.5 -36.23 68.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.394 172.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.55 -27.2 67.64 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.439 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.5 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 tpt85 -86.6 -27.38 23.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.395 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.505 HD12 ' NH2' ' A' ' 37' ' ' ARG . 16.2 mt -60.63 -46.36 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.47 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 40' ' ' ALA . 4.0 mm -74.79 -31.62 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.922 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -60.71 -41.89 96.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.45 169.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.71 -31.9 72.09 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.853 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 40' ' ' ALA . . . -57.93 -53.81 54.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.428 167.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.17 30.53 0.27 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.722 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.482 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -80.87 171.81 14.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.67 -0.765 . . . . 0.0 110.26 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -171.1 -25.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.956 166.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 82.0 1.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.533 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -113.79 129.4 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.165 167.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.6 p -61.0 165.94 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.256 166.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -10.82 5.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.353 167.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.46 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -75.83 -55.28 5.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.453 176.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.526 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -62.1 -41.13 97.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.25 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -62.29 -48.13 81.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.386 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.25 -32.13 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.391 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.518 HG21 HG23 ' A' ' 60' ' ' ILE . 84.9 m -60.98 -52.02 66.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.461 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 39' ' ' ILE . 4.1 tp -61.34 -45.65 93.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.264 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -60.89 -28.52 68.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.449 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -27.98 21.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.455 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' B' ' 28' ' ' LEU . 16.7 mt -61.77 -72.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.989 165.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.51 -12.8 10.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.565 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.3 -57.95 3.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.054 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.96 79.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.042 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 7.2 tpp -60.82 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.428 166.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.94 89.9 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -170.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.484 ' HD2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -60.83 -26.82 67.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.317 170.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -48.09 38.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.522 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.517 HD13 HD12 ' A' ' 32' ' ' LEU . 1.2 mt -63.02 -28.83 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.474 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -65.34 -68.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.318 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.528 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 80.9 p -61.45 -16.06 43.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -69.06 -64.51 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.13 165.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.16 -10.92 7.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.624 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.534 HD13 HG21 ' A' ' 12' ' ' ILE . 96.0 mt -99.82 -50.42 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.769 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.27 -29.3 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.402 168.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.536 HD11 ' HA ' ' B' ' 43' ' ' ALA . 9.8 mt -60.82 -51.52 68.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.245 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' B' ' 55' ' ' ILE . . . -67.97 -38.19 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.293 -169.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -70.35 -39.9 74.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.403 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -60.78 -35.88 77.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.335 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.67 -54.38 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.195 167.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.96 22.37 0.74 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.725 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.52 -165.12 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.294 -0.533 . . . . 0.0 110.981 168.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 65.44 100.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.466 -167.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 2.0 m 70.14 124.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.377 167.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.459 ' CD1' ' HB1' ' B' ' 47' ' ' ALA . 5.6 mm -89.82 152.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.316 166.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.03 159.62 36.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.428 -168.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.93 -30.04 70.63 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.335 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -53.38 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.156 171.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -13.09 23.8 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.456 -174.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 24' ' ' ALA . 33.0 mm -84.01 -63.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.393 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.521 ' HG3' HD13 ' A' ' 31' ' ' ILE . 31.1 mt-10 -61.72 -13.74 25.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.625 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.6 -30.78 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.332 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.519 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -63.9 -37.52 87.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.755 161.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.524 HG23 HD12 ' A' ' 31' ' ' ILE . 41.0 t -61.45 -71.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.769 166.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -59.2 -11.51 3.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.811 -170.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -71.72 -50.02 34.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.439 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' B' ' 39' ' ' ILE . 29.5 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.543 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.502 ' HB3' HD12 ' A' ' 8' ' ' ILE . 10.4 mp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 121.898 0.856 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.13 138.49 28.28 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 C-N-CA 122.6 2.2 . . . . 0.0 113.348 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.529 HG13 ' HD3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -91.53 19.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.898 -167.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.35 -58.24 0.45 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.699 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -54.41 -53.27 6.48 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.497 2.131 . . . . 0.0 113.537 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 3' ' ' LEU . 26.2 mt -61.44 -59.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.522 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.6 -18.83 57.14 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -31.68 22.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.952 -0.624 . . . . 0.0 110.356 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.518 HG21 ' HG3' ' B' ' 37' ' ' ARG . 61.4 mt -60.53 -51.14 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.554 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.47 ' CD1' ' HB3' ' B' ' 40' ' ' ALA . 9.9 mm -61.27 -37.61 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.281 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -34.31 77.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.344 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -62.52 -34.42 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' B' ' 41' ' ' SER . . . -59.34 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.485 169.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.73 21.98 0.42 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.604 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.31 150.62 29.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.349 167.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.07 -51.81 2.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.036 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.52 132.12 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.37 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.73 123.1 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.333 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 21.4 t -66.29 156.73 33.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.454 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HA ' ' CG ' ' A' ' 25' ' ' ARG . 27.9 t0 -61.37 -24.07 66.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.346 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -53.69 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.513 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' CB ' HG13 ' B' ' 60' ' ' ILE . . . -62.18 -47.24 85.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.318 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HD3' HG13 ' A' ' 5' ' ' ILE . 1.4 ptp85 -70.96 -27.65 63.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 -168.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 78.5 mt -86.29 -27.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.421 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 HG23 HD13 ' A' ' 31' ' ' ILE . 99.3 m -60.95 -54.4 45.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.345 170.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.491 HD13 HD11 ' B' ' 39' ' ' ILE . 4.0 tp -60.14 -43.01 96.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.49 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 26' ' ' ILE . . . -61.19 -32.19 71.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.501 -174.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.86 -24.1 15.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.236 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 HG23 ' A' ' 27' ' ' THR . 84.4 mt -60.65 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.028 164.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD11 HD22 ' B' ' 32' ' ' LEU . 1.0 OUTLIER -59.04 -33.89 71.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.699 -172.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 3' ' ' LEU . 10.4 tm-20 -61.86 -59.33 5.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.047 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 2.3 tp10 -64.52 -30.57 71.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.838 -171.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.416 ' HE1' HD12 ' A' ' 39' ' ' ILE . 19.2 ttt -60.42 -41.14 93.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.292 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.62 -46.9 93.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.46 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -62.66 -24.75 67.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.049 -178.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 6.9 t0 -80.9 -45.25 17.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.504 -174.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.52 HG12 ' CE2' ' A' ' 67' ' ' PHE . 9.6 mt -61.65 -30.28 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.144 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -62.54 -77.31 0.05 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.25 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.504 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.81 -11.0 10.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.384 -172.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -81.35 -56.46 4.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.114 170.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.5 -17.2 43.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.612 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.53 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 78.3 mt -85.58 -51.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.854 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -60.63 -39.73 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.383 168.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 50.6 mt -60.76 -39.69 89.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.415 170.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 44' ' ' ILE . . . -61.46 -24.75 66.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.295 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -82.34 -48.85 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.343 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.01 64.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.242 167.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -60.28 -56.57 19.96 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.137 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.25 30.07 0.16 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.697 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.69 -60.96 0.49 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.923 161.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.05 93.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.306 0.574 . . . . 0.0 110.581 -161.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.524 HG23 ' HB2' ' B' ' 21' ' ' SER . 24.9 m 70.44 144.28 0.06 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.49 ' HB ' HG12 ' B' ' 20' ' ' VAL . 15.3 mm -73.32 138.35 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.221 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -135.94 170.32 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.429 -170.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.45 55.91 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.48 -165.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.81 68.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.946 -174.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.18 -39.5 92.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.499 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.522 HG21 HD23 ' B' ' 28' ' ' LEU . 36.5 mm -62.75 -67.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.391 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.6 mt-10 -61.09 -11.21 7.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.278 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -50.88 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.437 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.82 99.23 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.304 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 21.8 t -62.02 -68.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.856 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.17 -9.79 3.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.682 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -35.32 39.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.355 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 39' ' ' ILE . 96.9 m-85 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.367 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' B' ' 8' ' ' ILE . 3.2 mt . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.486 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 140.88 94.04 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.41 2.074 . . . . 0.0 113.481 167.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.61 -11.94 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.657 -173.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.495 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -71.45 -60.55 2.57 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.81 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 8.7 Cg_endo -55.64 -42.97 62.27 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.462 2.108 . . . . 0.0 113.546 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' B' ' 3' ' ' LEU . 57.4 mt -60.45 -39.76 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.472 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.72 -29.92 73.47 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.579 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 mtp180 -89.82 -23.13 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 110.383 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.441 HD12 HD12 ' A' ' 3' ' ' LEU . 36.5 mt -60.93 -58.39 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.317 166.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 10.3 mm -61.87 -36.53 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.274 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.98 -36.31 79.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.362 169.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.3 -32.78 73.57 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.835 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -53.41 58.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.425 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.59 20.85 0.76 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.725 -172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.455 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -60.24 120.08 9.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.35 166.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.41 -54.48 10.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.168 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 104.9 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.379 174.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.522 HG22 HG23 ' B' ' 12' ' ' ILE . 11.2 t -83.81 129.28 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.267 169.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.524 ' HB2' HG23 ' A' ' 54' ' ' THR . 27.0 t -61.49 148.29 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.279 166.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.514 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 10.9 p30 -61.54 -22.78 65.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.417 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.539 ' HA ' HG23 ' B' ' 26' ' ' ILE . 10.1 t70 -88.73 -25.56 22.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.387 -172.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' B' ' 20' ' ' VAL . . . -66.41 -44.14 83.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.24 168.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.514 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 2.3 ptt-85 -83.09 -18.17 40.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.414 -167.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.539 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -78.19 -35.43 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.41 168.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.515 HG21 HD13 ' B' ' 31' ' ' ILE . 68.7 m -61.11 -37.93 84.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.265 175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.53 HD11 HD13 ' B' ' 32' ' ' LEU . 1.1 mm? -60.84 -40.54 93.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.322 166.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' B' ' 26' ' ' ILE . . . -61.67 -52.13 65.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.337 -176.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.466 ' NZ ' HD13 ' B' ' 26' ' ' ILE . 0.2 OUTLIER -68.55 -33.47 74.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.464 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.524 HD12 HG23 ' A' ' 64' ' ' VAL . 41.1 mt -61.71 -71.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.16 170.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.53 HD13 HD11 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.8 -15.66 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.832 -169.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.41 -24.03 16.88 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.054 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -52.26 65.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.111 167.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -73.56 -27.41 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.327 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.32 91.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.518 ' HG3' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.75 -28.86 69.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.334 168.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.26 -58.18 4.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.557 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -61.44 -30.32 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.385 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.47 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -62.22 -73.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.296 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.539 ' HA ' HD13 ' B' ' 44' ' ' ILE . 24.5 p -62.13 -15.44 45.62 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.529 -170.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.515 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -89.67 -39.52 13.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.158 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -70.63 -9.07 56.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.486 168.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.539 HD13 ' HA ' ' B' ' 41' ' ' SER . 74.6 mt -94.34 -53.24 8.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.873 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.43 -18.21 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.382 168.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' B' ' 43' ' ' ALA . 5.1 mt -72.96 -48.75 33.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.398 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.3 -31.94 69.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.218 -170.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.423 ' CZ ' ' HB2' ' B' ' 48' ' ' ARG . 22.8 ttm105 -65.83 -40.02 91.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.282 168.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.23 -38.58 87.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.31 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.88 -51.21 70.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.287 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.14 4.31 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 148.02 22.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.415 -170.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -82.63 171.98 13.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -170.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.436 HG23 ' HD2' ' B' ' 56' ' ' LYS . 93.9 m 61.54 119.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.421 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' B' ' 44' ' ' ILE . 82.4 mt -88.6 148.31 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.388 170.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.436 ' HD2' HG23 ' B' ' 54' ' ' THR . 0.0 OUTLIER -135.75 179.69 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.45 -169.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.291 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 15.7 pt-20 -84.36 -43.86 14.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.063 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -61.61 -23.52 66.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.44 179.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.469 ' CG2' HD11 ' A' ' 28' ' ' LEU . 29.7 mm -88.61 -56.37 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.239 -171.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 36.5 mt-10 -62.09 -18.06 59.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 172.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' B' ' 59' ' ' ASP . 12.1 mt -67.17 -55.82 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.336 168.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' B' ' 43' ' ' ALA . . . -64.35 -35.64 81.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.219 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 49.2 t -62.1 -79.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.689 171.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -12.02 9.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.365 -168.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -53.68 48.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.36 167.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.515 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 5.0 m-85 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.375 173.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 33' ' ' GLU . 17.2 mt . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.599 0.714 . . . . 0.0 109.989 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 4.2 Cg_endo -46.52 140.45 11.94 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.4 2.067 . . . . 0.0 113.478 173.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.76 -13.41 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.755 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.76 -55.86 8.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.665 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.529 ' HG2' ' HG2' ' A' ' 4' ' ' PRO . 13.5 Cg_exo -48.68 -59.33 1.29 Allowed 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.705 2.27 . . . . 0.0 113.555 169.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 8' ' ' ILE . 30.7 mt -61.43 -35.87 69.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.458 -178.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.512 ' HA3' ' NH1' ' A' ' 25' ' ' ARG . . . -61.61 -37.73 94.68 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.556 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 9.4 ptp180 -90.23 -14.35 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.465 -171.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.52 -56.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.305 165.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.524 HG21 HD12 ' B' ' 44' ' ' ILE . 9.1 mm -61.34 -37.31 77.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.149 -177.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 mttm -60.37 -39.45 87.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.429 167.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.34 -33.35 74.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.751 -177.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.86 53.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.207 -1.361 . . . . 0.0 110.427 169.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.48 21.56 0.45 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.713 -175.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.56 137.95 58.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.409 168.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.9 -27.72 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.005 -170.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.82 117.99 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.445 169.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG21 HG12 ' B' ' 55' ' ' ILE . 89.5 t -141.41 132.24 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -172.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 p -83.34 151.23 25.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.406 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 p30 -62.03 -14.17 33.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HA ' HG23 ' A' ' 26' ' ' ILE . 11.7 m-20 -86.48 -27.9 23.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.394 -176.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -65.42 -39.28 91.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.109 165.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -61.66 -43.64 98.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.518 -178.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 27' ' ' THR . 6.4 tt -75.08 -40.45 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.269 -172.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 31' ' ' ILE . 83.1 m -60.66 -44.42 96.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.396 -174.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 HD11 ' B' ' 39' ' ' ILE . 2.2 tp -61.0 -35.41 76.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.288 169.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.07 98.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.405 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -29.42 40.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.539 HD12 HG23 ' A' ' 27' ' ' THR . 28.9 mt -61.28 -72.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.029 171.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD13 HG23 ' A' ' 31' ' ' ILE . 8.2 mp -60.11 -30.28 69.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 -167.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' B' ' 11' ' ' ILE . 3.4 tm-20 -81.53 -37.44 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.034 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -61.47 -39.79 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.955 166.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.421 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 95.3 mtp -61.36 -40.91 96.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.495 175.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.09 -38.21 63.7 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -166.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -61.02 -27.5 68.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.248 164.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -74.12 -51.47 15.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.53 -173.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.522 HG12 HG21 ' A' ' 64' ' ' VAL . 12.5 mt -61.14 -38.86 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.204 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' B' ' 12' ' ' ILE . . . -60.97 -58.68 7.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.388 -170.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.498 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 23.3 p -61.49 -28.79 69.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.365 178.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.0 -43.38 98.94 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.071 169.575 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -76.9 -12.73 60.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.354 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.511 HD12 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -84.27 -56.59 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.306 -168.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -59.79 -28.89 67.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.488 170.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 63' ' ' ALA . 13.5 mt -60.63 -47.02 88.09 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.457 174.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -63.23 -38.03 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.325 -176.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -44.94 75.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 -170.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -60.97 -31.48 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.336 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.27 -53.21 59.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.211 168.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.82 17.14 0.84 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 59.39 28.39 17.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.322 -0.516 . . . . 0.0 111.237 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 77.59 8.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.298 169.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.536 HG21 ' HG3' ' B' ' 19' ' ' ARG . 6.7 m 68.51 169.58 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.456 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 5.6 mm -106.08 137.29 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.195 164.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HD3' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -128.26 159.77 34.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.417 -167.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -62.28 -13.04 24.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.126 -172.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -81.69 -25.49 35.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 174.04 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.04 -36.43 23.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.27 -174.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG12 ' HB2' ' B' ' 28' ' ' LEU . 1.5 mp -62.82 -48.72 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.489 161.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.4 mm-40 -61.44 -43.85 98.15 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.81 -174.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' HG ' HD23 ' A' ' 46' ' ' LEU . 39.9 tp -65.38 -44.74 86.6 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.542 173.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.501 ' HB3' HD13 ' A' ' 46' ' ' LEU . . . -61.39 -45.05 95.96 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.426 -175.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG21 HG12 ' A' ' 39' ' ' ILE 0.25 0.4 OUTLIER -78.51 -53.52 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.085 -166.554 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -36.26 77.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.631 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -21.06 59.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.374 174.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CD1' ' HG2' ' A' ' 42' ' ' GLU . 29.9 t80 . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.259 -173.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' B' ' 33' ' ' GLU . 4.6 mt . . . . . 0 C--O 1.243 0.716 0 CA-C-O 121.324 0.583 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.07 142.93 76.05 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 122.613 2.209 . . . . 0.0 113.628 -172.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.528 HG23 ' HG3' ' B' ' 25' ' ' ARG . 0.1 OUTLIER -66.42 -18.3 23.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.571 -165.198 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.62 -62.47 0.94 Allowed Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.776 -170.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.72 -50.5 13.83 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.402 2.068 . . . . 0.0 113.444 175.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' B' ' 29' ' ' ALA . 27.2 mt -60.45 -31.74 49.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.393 168.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.99 67.97 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.484 -175.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 49.7 mmm-85 -91.66 -27.72 17.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.477 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.538 HD12 ' HG2' ' A' ' 33' ' ' GLU . 36.5 mt -60.92 -59.57 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.526 170.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.512 HD13 HD22 ' B' ' 28' ' ' LEU . 10.0 mm -61.37 -38.42 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -61.8 -34.01 75.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.349 175.739 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.22 -32.56 73.23 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.685 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -58.69 -54.0 51.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.45 169.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.45 28.62 0.26 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.67 -176.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.511 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -76.09 148.84 37.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.715 -0.743 . . . . 0.0 110.357 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.62 117.08 5.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.092 169.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.536 ' HG3' HG21 ' A' ' 54' ' ' THR . 3.1 tpp180 65.04 97.02 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.356 -173.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' B' ' 24' ' ' ALA . 46.2 t -110.8 150.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.292 168.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -61.13 149.41 37.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.315 169.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 1.7 m-20 -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.309 170.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.78 -60.25 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.593 174.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -62.09 -47.66 83.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.318 -171.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.528 ' HG3' HG23 ' B' ' 5' ' ' ILE . 5.7 ptt180 -61.09 -34.81 75.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.344 -172.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.15 -33.89 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.499 175.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.532 HG21 HD13 ' B' ' 31' ' ' ILE . 80.0 m -60.99 -44.93 96.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.407 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.536 ' HB2' HG12 ' A' ' 60' ' ' ILE . 3.9 tp -60.39 -54.47 45.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.268 173.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.526 ' HB3' HD13 ' B' ' 8' ' ' ILE . . . -61.54 -15.53 39.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.456 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.462 ' HA ' ' CG ' ' B' ' 33' ' ' GLU . 8.5 tmtt? -99.02 -25.46 14.55 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.266 -174.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.532 HD13 HG21 ' B' ' 27' ' ' THR . 2.1 mt -60.54 -69.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.951 162.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mp -59.92 -35.16 74.3 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.575 -167.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.496 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -70.35 -40.08 74.27 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.964 -176.771 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -44.17 97.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.122 173.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.503 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 63.1 mmm -61.01 -27.09 68.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.462 175.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.15 -43.47 13.45 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -60.34 -17.98 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.393 166.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -90.96 -52.13 5.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.358 -168.711 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 28' ' ' LEU . 4.3 mt -61.11 -23.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.206 167.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -61.84 -72.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.28 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.513 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.8 m -61.67 -11.4 11.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.358 -175.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -56.63 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.129 171.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.65 25.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.326 176.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.524 HD12 HG21 ' A' ' 12' ' ' ILE . 70.8 mt -90.62 -54.96 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.056 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.53 -11.62 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.414 170.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 6.4 mt -87.81 -42.47 12.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.443 176.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' B' ' 55' ' ' ILE . . . -61.47 -25.69 67.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.276 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -83.41 -50.75 8.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.45 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -61.31 -31.62 71.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.375 -178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.28 73.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.201 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.83 35.78 0.94 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -166.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 66.49 118.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.487 169.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' B' ' 53' ' ' LYS . 0.1 OUTLIER -167.82 13.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.321 179.387 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.96 162.37 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.494 -175.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.524 HG12 HG21 ' A' ' 20' ' ' VAL . 14.0 mm -75.21 137.47 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.339 173.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -154.32 -178.82 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.425 -169.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.69 66.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.34 172.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -26.48 21.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.123 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -35.5 13.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.317 -175.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 46.9 mm -61.15 -47.37 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.196 167.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.498 ' HG2' ' NH2' ' B' ' 65' ' ' ARG . 20.9 mt-10 -62.02 -44.53 96.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.971 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -45.98 92.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.464 172.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' B' ' 46' ' ' LEU . . . -61.49 -46.04 91.69 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.421 -177.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.509 HG22 HD11 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -80.02 -60.94 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.099 -165.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.498 ' NH2' ' HG2' ' B' ' 61' ' ' GLU . 4.6 mtm180 -60.22 -19.0 52.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.565 -175.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -89.54 -25.5 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.544 171.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.8 t80 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.46 -179.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 122.086 0.946 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.3 Cg_endo -63.82 141.21 77.41 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 113.646 -178.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -13.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.636 -166.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -73.44 -55.54 3.53 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.674 173.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 4' ' ' PRO . 13.2 Cg_exo -49.43 -61.17 0.62 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.749 2.299 . . . . 0.0 113.557 168.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 3' ' ' LEU . 54.9 mt -61.39 -49.58 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.4 91.27 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -172.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -40.99 96.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.081 -0.56 . . . . 0.0 110.407 176.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.55 -36.11 71.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.538 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' B' ' 40' ' ' ALA . 8.3 mm -72.79 -44.97 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.192 -172.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -31.96 72.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.255 176.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -61.89 -33.3 73.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.807 177.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.26 -53.21 60.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.462 170.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.4 25.79 0.63 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.496 -174.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -61.21 119.79 9.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.718 -0.741 . . . . 0.0 110.363 176.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.59 -71.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.12 131.84 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.368 168.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.529 HG23 HD11 ' B' ' 55' ' ' ILE . 60.0 t -124.62 133.14 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.422 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.9 p -73.47 136.02 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.04 -12.88 13.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.398 -174.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -86.67 -21.93 26.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.35 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -70.72 -38.47 73.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.123 164.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -61.48 -31.48 71.46 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.502 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 23' ' ' ASP . 3.5 tp -89.7 -34.61 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 -175.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 HG23 HD13 ' A' ' 31' ' ' ILE . 80.5 m -61.52 -41.16 96.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.18 177.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 HG21 ' B' ' 60' ' ' ILE . 3.8 tp -59.19 -45.48 90.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.541 167.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.52 -43.09 99.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.504 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -76.62 -28.09 55.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.235 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 HG23 ' A' ' 27' ' ' THR . 6.6 mt -59.59 -73.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.908 162.177 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.535 HD11 HD21 ' B' ' 32' ' ' LEU . 1.0 OUTLIER -56.15 -23.79 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.819 -159.646 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.83 -60.76 2.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.038 166.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -28.66 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.109 -164.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.523 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.3 mmm -71.58 -38.96 70.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.436 167.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.3 90.44 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HG3' HG21 ' B' ' 11' ' ' ILE . 6.1 mtp180 -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.399 168.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -66.35 -53.75 32.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.434 -178.003 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' CG2' HG22 ' A' ' 64' ' ' VAL . 8.1 mt -61.39 -45.48 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.388 -175.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' B' ' 12' ' ' ILE . . . -61.29 -48.36 81.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 -172.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.2 t -62.15 -27.46 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.385 177.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -68.37 -43.15 78.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.181 168.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -73.06 -7.78 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.676 177.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -86.84 -52.07 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.275 -174.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -31.1 68.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.667 168.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 12.7 mt -61.16 -51.13 70.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.405 175.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.99 67.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.348 -171.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -41.97 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.439 170.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -63.22 -31.6 72.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.389 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . . . -61.77 -48.7 79.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.261 169.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 35.01 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -170.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -148.15 133.68 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.375 169.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.4 mmpp? -61.35 -43.51 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.34 -169.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -66.41 126.21 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.412 -168.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' B' ' 17' ' ' ALA . 7.0 mt -91.67 154.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.362 168.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.487 ' N ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -158.84 173.53 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.377 -166.521 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -61.97 -15.85 46.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.255 -177.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.76 -41.59 17.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.087 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -59.94 -49.38 77.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.608 170.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' B' ' 27' ' ' THR . 32.2 mm -60.77 -59.92 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.415 -171.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 30.3 mt-10 -61.83 -29.17 69.99 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.968 -174.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.36 -45.6 92.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.469 168.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -61.14 -42.93 99.44 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.588 -176.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG22 ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -82.14 -55.07 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.054 -165.569 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -21.87 64.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.738 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -92.92 -14.33 27.72 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.736 177.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.509 ' CD2' ' HG2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.92 161.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' B' ' 33' ' ' GLU . 12.1 mt . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.311 0.577 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 5.1 Cg_endo -60.32 160.98 21.35 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.575 2.183 . . . . 0.0 113.407 164.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.27 -20.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.517 -175.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' B' ' 7' ' ' PRO . . . -70.14 -59.09 4.5 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.754 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 4.7 Cg_endo -48.66 -50.98 11.19 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.585 2.19 . . . . 0.0 113.467 171.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.519 ' HA ' HD11 ' B' ' 11' ' ' ILE . 66.9 mt -60.83 -27.91 42.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.317 174.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.44 -40.71 99.05 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.502 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.06 -21.68 39.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.495 -178.441 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.528 HG21 ' HG3' ' A' ' 37' ' ' ARG . 89.7 mt -67.19 -44.44 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.507 178.053 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.469 ' CD1' ' HG ' ' B' ' 28' ' ' LEU . 8.0 mm -69.17 -41.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.325 175.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 11.2 mtmt -61.51 -39.67 91.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.313 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.59 -31.31 71.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.908 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.402 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -58.07 -52.37 65.82 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.639 170.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.91 24.33 0.33 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.635 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -75.69 120.04 20.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.617 -0.791 . . . . 0.0 110.255 176.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 13.88 29.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.995 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 179.35 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.419 -174.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.461 HG23 ' CB ' ' B' ' 17' ' ' ALA . 10.7 t -99.85 125.58 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.338 -176.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -63.57 149.64 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.169 164.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.58 -12.23 9.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.502 169.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.521 ' HA ' HG23 ' B' ' 26' ' ' ILE . 0.5 OUTLIER -95.37 -32.67 12.83 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.428 -174.61 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.518 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -61.2 -41.33 96.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.182 169.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.15 -53.55 55.55 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.52 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.521 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.1 OUTLIER -67.21 -33.44 62.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.316 -171.915 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.523 HG23 ' HB ' ' A' ' 60' ' ' ILE . 85.0 m -70.1 -34.45 73.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.318 -174.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.529 HD11 HD13 ' B' ' 32' ' ' LEU . 0.9 OUTLIER -60.68 -40.76 93.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.21 166.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.57 -56.82 15.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.299 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -33.64 76.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.445 -174.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 69.7 mt -61.05 -74.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.935 167.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 32' ' ' LEU . 3.7 mt -59.33 -28.67 67.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.57 -164.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.524 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.6 pp20? -75.72 -39.5 57.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -35.73 79.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.969 175.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.517 170.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.91 -38.35 95.88 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -33.89 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.276 167.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.29 -55.7 19.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.438 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.532 HD11 HG22 ' B' ' 64' ' ' VAL . 4.9 mt -61.8 -33.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.09 -177.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.93 -65.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.27 -173.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.538 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.03 -18.26 64.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.521 -175.373 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -44.65 16.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.168 175.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -68.27 -32.53 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.148 175.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.539 HD13 ' HB1' ' A' ' 17' ' ' ALA . 21.7 mt -60.71 -47.39 93.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.097 164.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -30.29 69.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.429 177.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.0 mt -72.31 -34.34 68.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.366 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.13 -35.84 78.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.294 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.64 -44.06 96.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 172.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.74 -36.84 79.89 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.438 174.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.88 75.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 29.79 2.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -163.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.32 -169.58 0.14 Allowed 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.089 -0.654 . . . . 0.0 111.072 175.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.86 98.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.466 -169.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.94 122.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 165.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.529 HD11 HG23 ' A' ' 20' ' ' VAL . 4.1 mp -93.22 138.16 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.152 162.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -130.55 178.95 6.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.401 -167.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.88 62.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.267 -172.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.47 -28.67 21.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.043 -177.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.2 -34.94 21.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.338 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 46.7 mm -61.02 -50.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.403 168.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.1 -37.52 78.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.407 ' HB3' HD12 ' B' ' 46' ' ' LEU . 12.0 mt -61.04 -45.45 94.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.397 175.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.464 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -61.29 -49.48 76.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.385 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.532 HG22 HD11 ' B' ' 39' ' ' ILE 0.257 0.4 OUTLIER -74.87 -50.5 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.937 -160.89 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.52 ' N ' HG11 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -62.85 -30.19 71.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.439 178.553 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.55 84.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.377 -177.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.398 172.203 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.2 mt . . . . . 0 C--O 1.243 0.731 0 CA-C-O 121.394 0.616 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.21 141.55 58.83 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.85 1.7 . . . . 0.0 113.113 168.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -93.25 20.77 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.622 -164.319 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.56 -59.39 0.45 Allowed Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.716 172.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HB2' HD22 ' B' ' 3' ' ' LEU . 9.5 Cg_endo -58.0 -50.5 10.0 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.496 2.131 . . . . 0.0 113.498 173.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.526 ' HA ' HD13 ' A' ' 11' ' ' ILE . 57.4 mt -61.37 -44.03 97.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.499 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.41 98.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -170.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.53 -32.31 69.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.008 -0.596 . . . . 0.0 110.334 -178.244 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 8' ' ' ILE . 39.6 mt -61.76 -51.76 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.354 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' B' ' 40' ' ' ALA . 6.4 mm -65.78 -48.44 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.439 -173.024 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -35.14 78.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.253 177.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.83 -32.19 72.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.85 177.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.83 -52.47 65.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.522 170.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.54 20.65 0.61 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.737 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -63.77 119.54 10.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.181 -0.509 . . . . 0.0 110.319 168.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -112.69 18.47 18.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.893 176.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' B' ' 54' ' ' THR . 0.0 OUTLIER 179.89 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.332 -164.396 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG21 HD11 ' B' ' 55' ' ' ILE . 12.3 t -136.81 118.11 18.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.38 172.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -74.39 159.74 31.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.393 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.13 -23.59 65.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.412 -171.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.541 ' HA ' HG23 ' A' ' 26' ' ' ILE . 80.5 m-20 -90.67 -29.6 17.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -170.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -61.26 -42.81 99.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.143 162.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.507 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -77.31 -28.69 53.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 -167.519 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 23' ' ' ASP . 5.2 tp -72.94 -37.33 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.429 172.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 HG21 HD13 ' A' ' 31' ' ' ILE . 57.8 m -60.69 -39.98 90.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD13 ' HB ' ' B' ' 39' ' ' ILE . 3.5 tp -64.55 -44.37 90.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.014 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 8' ' ' ILE . . . -61.1 -32.63 72.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -79.35 -33.21 43.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.478 179.207 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 28' ' ' LEU . 11.6 mt -60.57 -69.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.003 169.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -58.09 -27.64 63.86 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.672 -168.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -84.55 -19.92 32.36 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.149 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -63.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.008 165.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 11.0 mtp -61.99 -31.04 71.37 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 -174.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.45 -42.96 71.61 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -177.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -22.02 63.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.547 . . . . 0.0 110.435 169.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.4 m-20 -90.46 -47.74 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.608 -168.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD13 ' B' ' 28' ' ' LEU . 5.9 mt -61.27 -29.66 46.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.243 171.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.98 -66.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.237 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 29.7 p -63.61 -17.57 63.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.542 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -69.7 -60.84 2.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.909 167.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' CA ' ' HB3' ' A' ' 63' ' ' ALA . . . -61.69 -14.68 33.63 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.417 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 84.2 mt -96.93 -48.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.664 -172.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -59.85 -11.62 5.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.482 164.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 63' ' ' ALA . 3.7 mp -87.17 -52.84 5.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.277 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -14.27 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.314 177.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 1.6 mmm-85 -91.94 -70.27 0.7 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.414 -178.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.511 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -67.87 -12.01 59.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.852 -170.078 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . . . -64.7 -45.96 84.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 163.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.08 4.31 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -166.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 14.6 mmm180 -126.09 172.54 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.448 -164.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 135.92 50.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.445 -170.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 m 62.82 146.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.469 -178.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 59' ' ' ASP . 64.3 mt -97.19 156.62 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.234 168.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' N ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -156.35 177.08 11.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.469 -171.241 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.87 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.3 173.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -65.34 -50.35 65.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.028 168.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -61.4 -51.93 66.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.334 179.41 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.529 HG22 HD12 ' B' ' 28' ' ' LEU . 47.6 mm -60.76 -44.13 96.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.342 -168.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -39.21 88.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.151 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.38 -48.31 81.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.328 176.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.525 ' HA ' HD23 ' A' ' 46' ' ' LEU . . . -61.37 -30.21 70.39 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.401 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG21 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -89.49 -56.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.129 -165.222 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -16.24 31.42 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.695 171.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -32.02 57.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.358 169.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.465 171.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' B' ' 33' ' ' GLU . 15.5 mt . . . . . 0 C--O 1.242 0.697 0 CA-C-O 121.507 0.67 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 4.4 Cg_endo -47.53 142.42 13.42 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.551 2.168 . . . . 0.0 113.424 168.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.66 -19.21 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.447 -167.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.66 1.51 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.744 -168.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.68 -42.86 59.77 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.5 2.133 . . . . 0.0 113.491 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 44.5 mt -60.41 -47.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.537 172.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.03 -26.13 67.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -173.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.24 -33.42 32.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.402 -177.725 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.522 HD12 ' HG2' ' A' ' 33' ' ' GLU . 67.5 mt -60.76 -52.4 62.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.447 169.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.538 HG21 ' HB1' ' B' ' 17' ' ' ALA . 11.8 mm -61.1 -35.13 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.199 177.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.5 mttt -67.58 -37.05 82.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.504 178.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -61.7 -31.42 71.57 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.687 -178.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.58 56.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.474 168.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.14 7.51 0.81 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.782 -166.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.538 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -63.7 -162.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.954 0.502 . . . . 0.0 110.691 168.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' B' ' 13' ' ' LYS . 4.0 tm-20 64.2 25.42 13.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -155.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 20.19 17.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.404 151.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' B' ' 17' ' ' ALA . 61.2 t -113.27 172.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.228 -161.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' B' ' 20' ' ' VAL . 24.6 p -108.63 169.21 8.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.587 175.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 1.8 p30 -78.54 -33.52 47.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.336 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.83 -30.81 70.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.334 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . . . -60.95 -69.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.269 169.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' B' ' 22' ' ' ASP . 1.3 ptt180 -61.06 -11.44 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.345 -166.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 29.7 mt -86.11 -35.3 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.424 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.504 HG21 HD13 ' B' ' 31' ' ' ILE . 73.1 m -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.419 176.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.539 HD13 ' HB ' ' A' ' 39' ' ' ILE . 2.8 tp -60.74 -40.45 92.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.42 177.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.32 96.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.511 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -74.63 -31.33 61.95 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.393 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.504 HD13 HG21 ' B' ' 27' ' ' THR . 54.0 mt -60.72 -75.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.964 170.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.504 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.93 -30.98 66.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 -162.439 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.505 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.5 tm-20 -85.81 -31.44 22.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.016 -173.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.49 -36.91 81.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.829 163.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 2.6 ttm -63.82 -43.52 95.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.446 176.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.49 -33.58 63.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -165.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -60.85 -33.22 72.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.27 164.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -51.07 54.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.712 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.535 HG12 HG21 ' B' ' 64' ' ' VAL . 1.1 mt -62.32 -35.59 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.758 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' A' ' 12' ' ' ILE . . . -61.35 -65.75 0.64 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.9 -20.51 63.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.418 -179.165 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -61.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.133 169.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.54 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -63.32 -5.88 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 17' ' ' ALA . 77.6 mt -101.41 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.885 -176.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -15.77 32.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.387 171.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.54 HD11 ' HA ' ' B' ' 43' ' ' ALA . 13.4 mt -79.86 -50.32 10.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.432 170.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.57 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.252 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -46.51 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.458 169.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -61.74 -37.97 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.335 -173.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.04 -47.65 85.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.24 169.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.19 33.07 5.57 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -166.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.15 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.439 -168.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -91.61 132.31 36.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.37 170.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER 66.24 142.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.344 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 20' ' ' VAL . 89.2 mt -89.52 132.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.213 166.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -118.12 171.7 7.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.332 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -14.35 20.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.366 172.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -52.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.183 169.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -68.91 -36.06 77.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.38 -178.083 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.527 HG21 HD12 ' A' ' 28' ' ' LEU . 39.2 mm -61.49 -62.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.342 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.41 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 46.4 mt-10 -61.81 -26.35 68.06 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.885 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 11.6 mt -60.46 -50.72 72.45 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.423 170.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -62.02 -32.91 73.46 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.479 -172.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.535 HG21 HG12 ' B' ' 39' ' ' ILE 0.274 0.5 OUTLIER -86.95 -48.84 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -162.512 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -66.69 -24.63 66.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.438 169.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.82 -37.08 80.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.415 173.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' B' ' 39' ' ' ILE . 10.5 p90 . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.333 -168.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 121.917 0.865 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.465 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.506 HD12 HD22 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' HD13 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 55' ' ' ILE . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.533 ' HB2' HG22 ' B' ' 54' ' ' THR . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HG3' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD13 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HA ' HD13 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' A' ' 67' ' ' PHE . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' A' ' 67' ' ' PHE . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.532 ' HA ' HD13 ' A' ' 55' ' ' ILE . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.537 HG21 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.527 ' HG2' HD13 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.528 HG21 HG23 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' A' ' 39' ' ' ILE . 31.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 11' ' ' ILE . 3.1 mt . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.405 ' HB2' ' CD ' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.501 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.486 HD12 HD13 ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.537 ' HB2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 24' ' ' ALA . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.458 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.531 ' HG3' HD11 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' B' ' 25' ' ' ARG . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' B' ' 24' ' ' ALA . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' B' ' 8' ' ' ILE . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.53 HD13 HG21 ' B' ' 27' ' ' THR . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.518 HD11 ' HG ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.525 HD11 HG22 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' B' ' 67' ' ' PHE . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.533 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 21' ' ' SER . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.609 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' A' ' 27' ' ' THR . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.525 HG22 HD11 ' B' ' 39' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 024 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.521 ' N ' HG11 ' B' ' 64' ' ' VAL . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . 0.401 ' NE ' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CZ ' ' HG2' ' B' ' 42' ' ' GLU . 7.3 m-85 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . 6.3 mp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 122.217 1.008 . . . . 0.0 112.43 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 4' ' ' PRO . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' HG2' ' B' ' 33' ' ' GLU . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 20' ' ' VAL . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 12' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.502 ' HB2' HG21 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 27' ' ' THR . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 31' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 HD11 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 27' ' ' THR . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD12 ' HG ' ' A' ' 28' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' CG ' HD11 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.519 HD12 HD11 ' A' ' 62' ' ' LEU . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 44' ' ' ILE . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' B' ' 27' ' ' THR . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.463 HG13 ' CB ' ' B' ' 24' ' ' ALA . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 39' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.407 ' HB2' HD13 ' B' ' 8' ' ' ILE . 2.8 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' CG ' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' B' ' 3' ' ' LEU . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.538 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 3' ' ' LEU . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.517 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.532 ' HG3' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' B' ' 17' ' ' ALA . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.463 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 57' ' ' ALA . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.528 ' HA ' HD13 ' B' ' 31' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' B' ' 28' ' ' LEU . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 32' ' ' LEU . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 11' ' ' ILE . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' HD11 ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' B' ' 41' ' ' SER . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' B' ' 39' ' ' ILE . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.535 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 121.917 0.865 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.465 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.506 HD12 HD22 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' HD13 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 55' ' ' ILE . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.533 ' HB2' HG22 ' B' ' 54' ' ' THR . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HG3' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD13 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HA ' HD13 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' A' ' 67' ' ' PHE . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' A' ' 67' ' ' PHE . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.532 ' HA ' HD13 ' A' ' 55' ' ' ILE . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.537 HG21 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.527 ' HG2' HD13 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.528 HG21 HG23 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' A' ' 39' ' ' ILE . 31.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 11' ' ' ILE . 3.1 mt . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.405 ' HB2' ' CD ' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.501 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.486 HD12 HD13 ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.537 ' HB2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 24' ' ' ALA . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.458 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.531 ' HG3' HD11 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' B' ' 25' ' ' ARG . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' B' ' 24' ' ' ALA . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' B' ' 8' ' ' ILE . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.53 HD13 HG21 ' B' ' 27' ' ' THR . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.518 HD11 ' HG ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.525 HD11 HG22 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' B' ' 67' ' ' PHE . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.533 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 21' ' ' SER . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.609 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' A' ' 27' ' ' THR . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.525 HG22 HD11 ' B' ' 39' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 026 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.521 ' N ' HG11 ' B' ' 64' ' ' VAL . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . 0.401 ' NE ' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CZ ' ' HG2' ' B' ' 42' ' ' GLU . 7.3 m-85 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . 6.3 mp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 122.217 1.008 . . . . 0.0 112.43 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 4' ' ' PRO . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' HG2' ' B' ' 33' ' ' GLU . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 20' ' ' VAL . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 12' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.502 ' HB2' HG21 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 27' ' ' THR . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 31' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 HD11 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 27' ' ' THR . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD12 ' HG ' ' A' ' 28' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.463 ' CG ' HD11 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.519 HD12 HD11 ' A' ' 62' ' ' LEU . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 44' ' ' ILE . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' B' ' 27' ' ' THR . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.463 HG13 ' CB ' ' B' ' 24' ' ' ALA . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 39' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.407 ' HB2' HD13 ' B' ' 8' ' ' ILE . 2.8 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' CG ' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' B' ' 3' ' ' LEU . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.538 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 3' ' ' LEU . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.517 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . 0.532 ' HG3' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' B' ' 17' ' ' ALA . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.463 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 57' ' ' ALA . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.528 ' HA ' HD13 ' B' ' 31' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' B' ' 28' ' ' LEU . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 32' ' ' LEU . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 11' ' ' ILE . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' HD11 ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' B' ' 41' ' ' SER . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' B' ' 39' ' ' ILE . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.535 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.514 HD12 HD13 ' B' ' 11' ' ' ILE . 6.3 mp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 122.099 0.952 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -60.22 150.0 82.16 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 123.016 2.477 . . . . 0.0 113.479 -172.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 25' ' ' ARG . 2.4 pp -100.65 17.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.809 -164.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.87 -56.86 0.27 Allowed Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.703 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.76 -58.83 1.17 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.596 2.198 . . . . 0.0 113.371 164.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 25.7 mt -61.74 -47.93 91.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.478 -178.049 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.88 93.42 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -39.98 95.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.412 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.506 HD12 ' HG3' ' B' ' 33' ' ' GLU . 75.0 mt -61.81 -48.08 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.438 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' B' ' 40' ' ' ALA . 12.8 mm -64.54 -36.78 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.426 -172.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -32.4 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.366 171.781 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.74 -34.99 78.33 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.827 -178.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.42 -53.71 54.99 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.376 169.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.68 21.06 0.38 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.715 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.23 135.3 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.153 -0.523 . . . . 0.0 110.385 166.489 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -157.65 31.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.024 174.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 81.24 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.268 168.061 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG11 ' HB ' ' B' ' 55' ' ' ILE . 14.2 t -131.16 142.33 43.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.387 -168.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.31 151.15 24.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.352 169.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -13.66 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.487 172.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.536 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -87.57 -30.55 20.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.324 -174.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.148 165.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB3' HG23 ' A' ' 5' ' ' ILE . 8.4 mmt85 -61.76 -34.39 75.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.424 -176.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.536 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.27 -37.44 22.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.317 -179.368 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 HG23 ' HB ' ' B' ' 60' ' ' ILE . 88.8 m -63.4 -44.05 95.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.294 -171.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 4.0 tp -59.6 -42.32 92.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.464 167.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.407 ' HB3' ' CB ' ' A' ' 3' ' ' LEU . . . -61.78 -39.4 91.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.312 -176.377 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 -20.88 23.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.302 -175.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 28' ' ' LEU . 32.3 mt -61.08 -71.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.92 162.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' B' ' 32' ' ' LEU . 6.0 mp -59.74 -20.22 55.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.745 -167.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.13 -55.3 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.115 170.925 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.74 -41.73 98.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.984 -172.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.491 ' HE1' ' HE2' ' B' ' 35' ' ' MET . 1.2 mmm -61.16 -43.53 98.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.447 168.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.42 -48.24 45.95 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -167.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.72 -19.14 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.277 167.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -75.95 -58.93 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.499 179.533 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 HG22 ' A' ' 64' ' ' VAL . 4.0 mt -60.89 -22.92 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.576 178.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -63.64 -77.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.266 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.24 -10.98 7.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.477 -172.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -82.54 -52.93 6.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.186 172.772 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.91 -19.0 59.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.41 173.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 95.7 mt -86.29 -51.25 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.949 -177.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -60.16 -11.28 5.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.444 167.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 63' ' ' ALA . 2.3 mp -85.21 -38.44 18.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.315 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.92 -30.93 70.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.37 170.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 29.5 mmt-85 -68.36 -53.31 24.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.409 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -19.98 60.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.375 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -53.74 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.245 168.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.02 24.05 0.53 Allowed Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.482 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.5 ttp-105 66.4 122.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.446 166.144 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.43 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.4 167.363 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.515 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 30.0 m -162.05 141.81 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.447 -178.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 17.1 mm -71.77 148.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.393 170.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 10.2 mttp -153.12 -177.85 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.523 177.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.01 75.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -173.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.11 -27.56 61.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -178.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.459 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -78.83 -36.64 42.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.413 178.309 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' B' ' 27' ' ' THR . 38.5 mm -60.83 -57.25 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.417 170.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -61.47 -30.68 70.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.02 -176.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -60.46 -51.57 68.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.412 169.209 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.509 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -60.97 -46.76 89.43 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.482 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.77 -51.47 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.892 -163.473 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.21 -21.71 66.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.708 176.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -61.29 -39.99 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.268 174.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.519 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 83.6 m-85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.279 166.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.535 HD22 ' HG3' ' B' ' 33' ' ' GLU . 3.5 mt . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.96 153.5 50.93 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.394 2.063 . . . . 0.0 113.49 169.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.6 pt -100.62 16.98 3.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.696 -176.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' B' ' 7' ' ' PRO . . . -86.41 -59.61 0.28 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.712 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' B' ' 6' ' ' ALA . 11.4 Cg_endo -58.25 -50.06 10.8 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.437 2.091 . . . . 0.0 113.375 168.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.415 HD13 ' HB2' ' B' ' 3' ' ' LEU . 64.7 mt -60.84 -28.99 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 175.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.4 77.8 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.526 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -82.4 -17.19 46.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.395 -170.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.514 HD13 HD12 ' A' ' 3' ' ' LEU . 11.0 mm -60.73 -66.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.439 168.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.1 mm -61.5 -31.39 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.077 -174.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -66.1 -37.72 86.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.455 172.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -62.13 -32.25 72.81 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.884 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.73 -52.96 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.454 170.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.86 27.5 0.72 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.523 -170.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.529 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.73 119.99 9.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.775 -0.712 . . . . 0.0 110.373 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.52 -38.69 65.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.13 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.32 100.2 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.533 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.22 140.18 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.275 165.6 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 95.9 p -66.95 165.71 15.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.27 167.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.98 -18.68 58.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.284 168.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -58.37 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.441 169.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.522 ' HB1' ' HB ' ' B' ' 20' ' ' VAL . . . -62.07 -42.57 99.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.334 -169.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.521 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 41.2 mtm180 -61.77 -50.04 73.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.386 -178.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.45 HD11 ' CG2' ' B' ' 5' ' ' ILE . 11.5 mm -61.49 -25.04 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.445 179.348 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.54 HG23 ' HB ' ' A' ' 60' ' ' ILE . 85.3 m -73.91 -42.46 60.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.37 -172.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 60' ' ' ILE . 2.0 mm? -60.76 -35.48 76.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.345 169.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.54 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.297 -173.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.55 -27.83 37.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.376 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.54 HD13 HG21 ' B' ' 27' ' ' THR . 52.4 mt -61.36 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.976 167.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.513 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.8 mp -59.11 -23.39 62.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.733 -164.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.535 ' HG3' HD22 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -85.0 -28.51 25.69 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.05 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.78 -31.76 71.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.862 163.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.491 ' HE2' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -81.23 -34.21 32.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.413 -176.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.52 42.23 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -176.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.377 169.547 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.357 176.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 7.2 mt -60.89 -21.72 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.307 -170.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.72 -69.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.324 173.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.44 -11.03 8.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.554 -177.275 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -92.91 -40.46 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.068 -179.7 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.508 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -69.93 -14.81 62.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 168.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 55.2 mt -97.3 -52.14 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.956 -173.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -19.71 56.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.368 169.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.6 mt -68.62 -53.49 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.344 166.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.427 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.37 -25.91 67.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.247 -173.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -38.73 75.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.328 168.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.57 -32.61 71.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.375 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.72 -48.52 81.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.35 173.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.26 38.14 1.05 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -167.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 65.27 102.53 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.392 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -171.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.451 177.148 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.2 m -78.41 130.22 35.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.416 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' B' ' 43' ' ' ALA . 28.8 mt -74.01 132.78 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.275 166.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.77 -170.13 2.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.391 -177.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.02 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.4 -34.11 21.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.25 -35.17 31.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.36 -177.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.52 ' HB ' HG23 ' A' ' 27' ' ' THR . 38.8 mm -61.18 -57.67 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.381 167.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.469 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 4.4 mt-10 -62.22 -37.59 85.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.951 -173.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.77 -43.86 97.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.38 172.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.12 -35.25 76.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.441 178.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.517 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -90.46 -59.92 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.271 -162.355 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -23.46 64.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.6 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -23.36 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 172.09 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.495 177.093 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 33' ' ' GLU . 6.8 mt . . . . . 0 C--O 1.242 0.692 0 CA-C-O 121.338 0.59 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.45 164.55 3.97 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.52 2.147 . . . . 0.0 113.395 164.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 25' ' ' ARG . 21.5 pt -95.88 38.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.314 -173.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -95.01 -58.47 0.2 Allowed Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.73 173.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' A' ' 6' ' ' ALA . 9.7 Cg_endo -59.91 -32.82 95.74 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.53 2.154 . . . . 0.0 113.653 173.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . 72.8 mt -96.81 -13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.62 -169.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -43.72 98.89 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -97.39 19.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.472 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 8' ' ' ILE . 22.9 mt -90.28 -49.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.208 166.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.522 HD11 ' HB1' ' B' ' 40' ' ' ALA . 3.9 mm -96.31 48.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.651 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.11 -26.45 0.1 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.748 169.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.68 -40.59 66.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.276 163.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' B' ' 37' ' ' ARG . . . -57.73 -72.87 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.727 172.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.7 36.39 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.149 152.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' CA ' HD12 ' B' ' 44' ' ' ILE . . . -73.29 123.15 23.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.153 -165.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -135.58 31.83 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.088 -165.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.95 102.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.423 168.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t -125.15 162.46 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.369 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 47.1 t -101.84 13.48 34.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.375 -169.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p30 60.47 23.56 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -140.67 -30.07 0.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.358 179.144 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.6 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.437 177.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.51 ' HB2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.39 -30.1 70.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.409 -178.907 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.515 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 9.1 mm -83.86 -30.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.413 179.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.53 HG23 HG23 ' B' ' 60' ' ' ILE . 74.6 m -60.79 -46.36 90.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.377 168.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.533 HD13 HD11 ' B' ' 39' ' ' ILE . 4.9 tp -61.0 -45.46 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.336 172.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.515 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.75 -12.69 18.09 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.548 -178.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.519 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -107.74 -37.51 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.24 -178.7 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 27' ' ' THR . 60.0 mt -60.88 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.078 168.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.532 HD21 HD21 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.02 -34.85 72.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 -166.329 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' HD12 ' B' ' 11' ' ' ILE . 2.5 tm-20 -68.05 -43.82 77.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.236 176.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.59 -17.02 63.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.029 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.461 ' CE ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 mtm -81.84 -43.4 18.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.466 169.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.46 ' CA ' HD23 ' B' ' 32' ' ' LEU . . . -69.27 -45.87 59.47 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -169.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.457 ' N ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -61.53 -16.62 49.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.316 169.25 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.1 -54.63 5.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.447 -179.543 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.469 HD13 HD13 ' B' ' 32' ' ' LEU . 15.2 mt -61.52 -28.62 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.343 -176.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -61.34 -65.67 0.66 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.22 -173.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' HD11 ' A' ' 44' ' ' ILE . 25.9 t -61.2 -10.49 6.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.524 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 12.1 mm-40 -85.01 -57.57 3.04 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.05 173.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . . . -61.92 -8.61 5.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.532 174.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.523 ' HA ' HD13 ' A' ' 55' ' ' ILE . 51.4 mt -95.93 -54.31 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.222 178.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -13.82 62.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.359 -178.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' A' ' 63' ' ' ALA . 7.6 mt -88.39 -21.41 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.403 173.307 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HB2' ' NH2' ' A' ' 48' ' ' ARG . . . -80.49 -29.97 37.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -165.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' NH2' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -94.47 -15.72 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.384 -168.574 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -9.92 59.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.42 164.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.73 -54.12 49.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.297 174.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.21 33.85 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.535 -169.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 67.17 121.25 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.638 -0.781 . . . . 0.0 110.587 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 -79.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.362 171.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.526 HG23 ' HB2' ' B' ' 21' ' ' SER . 72.5 m -167.51 159.97 12.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.134 -164.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' A' ' 44' ' ' ILE . 7.2 mm -90.09 137.62 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.3 165.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.406 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 7.7 mttm -153.37 -174.9 5.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.487 -166.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -21.42 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.148 -169.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -94.18 25.13 3.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.147 175.018 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 14.5 m-20 -119.21 -39.57 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.153 174.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' B' ' 27' ' ' THR . 3.1 mp -91.15 14.78 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.631 163.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.0 mm-40 -121.65 36.91 4.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 164.192 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 62' ' ' LEU . 10.6 tp -169.42 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.378 -174.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -84.86 -17.53 37.67 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.405 173.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.519 HG12 HG12 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -107.61 -67.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.265 -157.676 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.505 ' N ' HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -60.76 -23.89 65.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.39 177.187 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -78.35 -60.68 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.102 164.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.151 -157.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.464 ' CB ' HD12 ' B' ' 8' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 121.315 0.578 . . . . 0.0 109.66 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 5.7 Cg_endo -52.86 151.43 20.11 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.665 2.244 . . . . 0.0 113.527 172.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.499 HG23 HG13 ' B' ' 26' ' ' ILE . 1.1 pt -85.63 64.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.51 175.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.65 -57.97 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.619 177.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.08 -38.23 78.88 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.181 . . . . 0.0 113.589 170.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.464 HD12 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -73.4 -18.26 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.515 172.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.415 ' HA2' ' HD2' ' B' ' 25' ' ' ARG . . . -61.04 -52.91 49.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -166.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 5.1 mtt-85 -75.25 -20.66 59.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.411 -176.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.521 HD12 ' HG3' ' A' ' 33' ' ' GLU . 16.1 mt -63.58 -47.39 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.278 167.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' A' ' 40' ' ' ALA . 6.3 mm -95.77 45.41 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.835 175.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -149.47 -31.7 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.873 170.872 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.78 -31.28 70.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.92 172.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 41' ' ' SER . . . -58.74 -51.6 69.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.545 170.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.57 23.23 1.23 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.702 -171.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.513 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -65.81 131.58 46.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.349 173.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.6 -77.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.111 -177.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -146.83 144.12 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.318 -169.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.06 168.73 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -168.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.526 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -127.83 -162.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.244 -164.828 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.67 89.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.451 167.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.41 125.2 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.541 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.66 -48.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.977 163.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.415 ' HD2' ' HA2' ' B' ' 9' ' ' GLY . 15.1 ttp180 -77.22 -30.55 54.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.329 167.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.499 HG13 HG23 ' B' ' 5' ' ' ILE . 59.0 mt -72.72 -36.32 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.416 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.533 HG23 ' HB ' ' A' ' 60' ' ' ILE . 92.5 m -60.81 -43.27 98.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.325 169.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.52 HD22 HD13 ' B' ' 12' ' ' ILE . 0.9 OUTLIER -60.85 -45.81 93.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.149 174.414 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' B' ' 8' ' ' ILE . . . -61.16 -17.82 54.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.511 176.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.22 -32.6 11.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.412 -171.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.519 HG12 HG12 ' A' ' 64' ' ' VAL . 2.1 mp -62.11 -72.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.587 159.273 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.532 HD21 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -58.82 -14.12 7.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.931 -162.663 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -91.41 -26.36 18.9 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.17 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.28 -19.49 28.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.141 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 8.1 mtt -93.69 12.37 25.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.412 171.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . 0.47 ' CA ' HD12 ' A' ' 32' ' ' LEU . . . -121.36 -41.2 0.51 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.088 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 15' ' ' ALA . 1.4 tmt_? -61.17 -20.67 62.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.262 166.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.37 -35.3 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.436 -167.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 28' ' ' LEU . 7.6 mt -62.04 -33.97 61.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.288 171.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.522 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -61.19 -63.02 1.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.306 -169.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.531 ' HA ' HD11 ' B' ' 44' ' ' ILE . 15.3 m -61.9 -13.76 27.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 3.0 mm-40 -81.6 -45.33 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.104 176.08 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.496 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -73.25 -33.71 65.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.209 177.044 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' B' ' 41' ' ' SER . 15.2 mt -60.5 -56.35 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.351 167.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.65 69.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 -176.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' B' ' 63' ' ' ALA . 4.3 mt -76.24 -36.91 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.494 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.47 ' CB ' HD12 ' B' ' 55' ' ' ILE . . . -61.86 -45.24 94.63 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.262 -177.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -89.72 -25.72 21.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.373 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -64.04 -44.9 91.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.266 168.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.0 98.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.268 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.32 43.55 15.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -175.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -135.3 -166.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.398 -168.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -169.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.423 -167.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 0.8 OUTLIER -68.26 172.29 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.926 -167.903 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.47 HD12 ' CB ' ' B' ' 47' ' ' ALA . 31.9 mm -60.62 135.94 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.465 175.312 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -159.24 -176.59 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.423 -169.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.09 67.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 -170.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -103.52 23.1 13.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.104 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 4.0 m-20 -129.56 -34.63 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.424 168.319 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 27' ' ' THR . 36.7 mm -61.02 -65.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.328 165.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.4 -10.92 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.245 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 4.1 mm? -99.51 -18.66 17.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.515 176.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' B' ' 46' ' ' LEU . . . -92.06 14.53 15.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.561 164.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.52 HG22 HD12 ' A' ' 31' ' ' ILE . 40.1 t -115.7 -68.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.585 -176.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -60.18 -10.06 4.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.588 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -37.61 86.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.663 168.348 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' B' ' 39' ' ' ILE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.205 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 0.988 0 CA-C-O 121.983 0.897 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -45.2 148.78 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.868 2.378 . . . . 0.0 113.466 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' CG2' HG12 ' A' ' 26' ' ' ILE . 2.0 pt -70.96 58.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.373 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -160.28 -52.89 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.52 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 8.0 Cg_endo -55.71 -32.62 84.74 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 C-N-CA 122.781 2.321 . . . . 0.0 113.506 167.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 29' ' ' ALA . 9.4 mm -60.63 -39.66 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.485 168.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.4 98.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -166.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.14 18.63 13.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.41 -176.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' CD1' HD23 ' B' ' 3' ' ' LEU . 95.5 mt -103.32 -39.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.182 164.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' B' ' 40' ' ' ALA . 7.3 mm -81.08 -37.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 -179.094 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -41.41 95.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.428 169.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.89 -30.79 71.11 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.815 -175.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.29 59.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.55 168.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.09 32.33 0.35 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.562 -171.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.504 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -80.47 -167.63 1.42 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.3 177.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.05 93.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.997 165.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.3 104.93 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.32 162.8 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.069 164.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.475 ' HB2' HG23 ' B' ' 54' ' ' THR . 16.6 t -94.41 -84.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.411 -166.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 9.1 t70 -174.89 136.88 0.41 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 -171.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' HB3' ' CB ' ' B' ' 57' ' ' ALA . 0.4 OUTLIER 77.97 -51.69 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.014 -161.605 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.54 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.13 -39.37 89.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.304 -173.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.94 -40.52 97.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.412 -177.842 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' CG2' ' A' ' 5' ' ' ILE . 1.6 mp -94.64 -23.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.404 -170.087 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.464 HG23 ' CG2' ' B' ' 60' ' ' ILE . 92.0 m -60.79 -39.79 90.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.491 173.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD13 HD11 ' B' ' 39' ' ' ILE . 13.1 tp -88.35 -14.31 38.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.493 -171.577 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 8' ' ' ILE . . . -79.03 -45.33 20.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.198 164.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.0 -36.97 80.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.484 175.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 28' ' ' LEU . 23.0 mt -62.21 -78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.897 170.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HB3' HD22 ' B' ' 32' ' ' LEU . 2.0 mm? -57.09 -26.62 60.74 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.543 -158.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.24 -36.12 83.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.025 176.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -62.33 -39.58 93.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.818 -164.492 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.492 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 21.6 mtt -81.69 -25.94 35.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 -39.83 53.7 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.515 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.503 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -60.98 -17.06 49.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.395 168.902 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -99.83 -46.09 5.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.555 -164.664 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG12 HG21 ' A' ' 64' ' ' VAL . 7.2 mt -61.62 -26.28 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.183 172.123 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -62.33 -70.38 0.2 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.115 177.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.52 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.18 -18.17 56.82 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.525 179.472 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 6.5 mm-40 -72.3 -61.65 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.034 169.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.13 -9.49 4.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.539 179.1 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 90.1 mt -100.77 -67.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.048 -178.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -17.4 53.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.349 -176.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 43' ' ' ALA . 14.5 mt -60.93 -48.18 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.206 163.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . . . -87.49 -27.71 22.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.224 -168.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -21.65 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.33 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -60.98 -14.61 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.323 166.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.93 -43.95 15.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.305 175.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.1 15.54 23.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 172.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 178.93 84.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 169.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HE3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -108.91 151.94 25.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.462 -161.358 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.3 m -140.55 114.42 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.158 163.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' A' ' 59' ' ' ASP . 13.6 mm -60.52 153.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.349 -166.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 173.33 11.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.416 -171.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -11.94 10.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.3 168.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -113.64 30.72 7.02 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.06 179.759 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -120.83 -39.37 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.248 169.153 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.533 HG13 HD12 ' B' ' 28' ' ' LEU . 1.3 mp -62.12 -54.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.442 160.322 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 7.9 mm-40 -61.6 -9.23 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.19 -174.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD21 ' CG ' ' A' ' 66' ' ' ARG . 72.0 mt -138.32 35.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.454 175.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -130.62 10.41 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.907 163.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.541 HG21 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -134.09 -63.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.533 0.683 . . . . 0.0 109.237 -156.222 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -78.41 -27.26 46.64 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.232 162.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' CG ' HD21 ' A' ' 62' ' ' LEU . 6.7 mmt180 -75.49 -11.25 59.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.768 167.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.179 -176.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.52 ' HB2' HD13 ' B' ' 8' ' ' ILE . 17.2 mt . . . . . 0 C--O 1.243 0.748 0 CA-C-O 121.343 0.592 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.11 143.62 18.13 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.466 2.11 . . . . 0.0 113.367 166.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' B' ' 25' ' ' ARG . 1.3 pp -95.19 26.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.383 -168.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -58.14 0.44 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.694 169.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.89 -46.95 20.06 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.543 2.162 . . . . 0.0 113.568 171.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' B' ' 3' ' ' LEU . 29.7 mt -68.33 -18.83 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.411 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.436 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -60.95 -47.38 91.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -170.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.9 ttt180 -85.59 -17.51 36.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.371 -170.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 26.7 mt -60.97 -59.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.405 171.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 40' ' ' ALA . 14.8 mm -63.89 -36.38 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.458 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 6.8 mmtp -64.59 -33.31 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.298 176.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . 0.503 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 25.0 t0 -61.72 -31.5 71.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.834 177.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.507 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -58.67 -51.17 71.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.558 170.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 34.42 0.68 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.545 -168.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.509 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -70.97 157.93 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.02 99.61 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.136 179.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 63.14 132.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -176.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' B' ' 24' ' ' ALA . 11.5 t -119.46 160.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.369 170.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 21.6 p -84.43 -10.11 57.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.436 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.02 164.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.983 -161.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.32 -50.94 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 -162.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.484 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -60.42 -44.29 95.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.418 174.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.464 ' HG3' ' CG2' ' B' ' 5' ' ' ILE . 13.9 tpp85 -68.89 -16.82 63.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.524 -173.3 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.68 -30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.415 -168.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.47 HG21 ' CG2' ' A' ' 60' ' ' ILE . 89.1 m -61.12 -40.68 94.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.269 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 60' ' ' ILE . 2.0 tp -59.97 -43.78 94.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.322 172.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -12.91 13.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.662 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -105.57 -30.36 9.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.393 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 64' ' ' VAL . 3.3 mp -61.85 -74.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.655 161.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.71 -40.93 85.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.649 -163.572 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.519 ' HG3' HD22 ' B' ' 3' ' ' LEU . 4.7 tt0 -66.86 -20.43 65.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.044 -174.743 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.06 -53.53 7.68 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.077 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.03 -29.87 67.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.352 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.11 -30.54 78.07 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 169.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -81.79 -19.44 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.467 175.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -37.5 12.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.403 -169.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.535 HG12 HG21 ' B' ' 64' ' ' VAL . 12.0 mt -61.08 -27.9 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.296 168.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -68.29 -60.35 2.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.305 -177.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.527 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 48.9 m -61.68 -13.7 25.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.33 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' B' ' 46' ' ' LEU . 4.9 mm-40 -75.6 -53.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.091 171.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -70.9 -31.95 68.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.141 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 49.1 mt -60.81 -49.55 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.212 165.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.547 176.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' B' ' 42' ' ' GLU . 28.8 mt -65.32 -48.82 71.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.418 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.75 65.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.34 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -19.07 36.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.341 176.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -61.24 -37.41 82.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.244 166.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.1 -46.26 35.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.056 165.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.63 -7.03 24.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.81 168.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.11 98.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.354 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.5 160.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 166.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 21' ' ' SER . 95.1 m -69.31 159.27 33.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.457 168.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' B' ' 59' ' ' ASP . 55.5 mt -87.0 133.9 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 -170.154 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -118.39 -178.34 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.391 -178.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 23' ' ' ASP . . . -74.8 -32.07 61.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.269 -169.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.67 -13.44 22.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.097 168.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.533 ' HB3' HG22 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -94.2 -43.54 8.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.356 -179.368 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 24' ' ' ALA . 42.0 mm -61.1 -33.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.457 177.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.78 -22.17 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.849 -171.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.4 18.19 22.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.579 167.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.92 -14.8 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.273 166.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.535 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -121.2 -65.29 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.282 -165.569 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.435 ' N ' HG11 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -60.43 -11.84 7.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.501 172.21 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -82.34 -24.42 34.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.409 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.305 168.232 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.469 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 1.1 mt . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 121.482 0.658 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.83 154.47 9.72 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.673 2.249 . . . . 0.0 113.619 177.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -92.93 19.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.683 -170.45 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.15 0.55 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.625 170.286 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.19 -61.88 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.585 2.19 . . . . 0.0 113.55 170.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 62.7 mt -61.19 -14.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.452 177.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.63 99.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.97 25.44 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.386 -173.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 8' ' ' ILE . 39.8 mt -95.82 -40.06 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.508 169.817 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' B' ' 40' ' ' ALA . 17.4 mm -83.97 -39.94 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.423 -174.488 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -26.75 67.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.3 173.187 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.05 -34.1 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.814 177.756 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.09 -53.16 61.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.314 168.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.97 21.6 0.78 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.772 -172.125 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -65.26 127.02 30.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.415 170.448 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -102.25 -17.45 15.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.013 -171.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 163.16 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.33 168.855 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.521 HG22 ' HD3' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -118.0 163.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.305 168.594 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.521 ' HB3' HG23 ' B' ' 54' ' ' THR . 24.7 p -75.5 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.44 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.94 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.34 171.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.46 -18.45 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.408 -165.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.36 -40.44 94.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.304 -167.015 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.521 ' HD3' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -65.42 -60.08 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.446 176.198 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mt -65.23 -27.77 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.449 -171.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.528 HG23 HG23 ' B' ' 60' ' ' ILE . 79.8 m -61.02 -61.67 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.395 166.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.532 HD12 HG22 ' B' ' 60' ' ' ILE . 10.5 tp -61.51 -10.3 7.58 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.482 -171.441 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.66 -63.53 1.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.435 171.271 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 5.6 mtpm? -61.46 -21.27 64.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.515 HD13 HG23 ' A' ' 27' ' ' THR . 32.5 mt -61.89 -76.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.893 162.562 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.39 -30.71 68.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.697 -162.958 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -77.73 -18.61 56.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.018 -178.635 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -90.03 -17.82 27.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.037 169.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 9.8 mtp -99.58 18.83 17.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 170.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.525 ' HA2' HD13 ' B' ' 32' ' ' LEU . . . -119.4 -41.74 0.57 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 170.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -13.24 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.199 163.888 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.06 -55.01 4.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.385 -178.342 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 60' ' ' ILE . 7.3 mt -61.24 -19.74 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.463 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' B' ' 12' ' ' ILE . . . -72.57 -63.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.255 -169.176 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.526 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 35.1 t -60.64 -13.4 14.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.439 177.059 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -72.71 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.095 166.785 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' HA ' HD21 ' A' ' 46' ' ' LEU . . . -61.41 -15.52 37.69 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.502 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 97.1 mt -92.78 -51.9 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.894 -175.35 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.35 -11.81 7.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.477 166.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 43' ' ' ALA . 3.3 mp -82.85 -42.83 17.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.244 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.68 65.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.403 -176.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -27.52 38.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.438 -177.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -61.13 -27.75 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.347 169.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.94 -47.15 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.288 178.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.0 13.17 25.89 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -169.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -143.0 116.98 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.404 -179.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -62.72 -24.68 67.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.351 -167.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.475 HG21 ' HB3' ' B' ' 21' ' ' SER . 1.0 OUTLIER -60.96 116.12 4.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.42 -168.538 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 44' ' ' ILE . 15.3 mm -74.53 149.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.414 177.56 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.09 164.21 30.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -169.867 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' B' ' 23' ' ' ASP . . . -66.73 -18.26 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.316 168.74 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.83 29.26 3.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.083 169.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -117.52 -34.88 4.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.423 168.638 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.54 HG23 HG23 ' B' ' 27' ' ' THR . 4.1 mp -102.65 -12.32 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.383 -175.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -70.97 -10.8 60.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 161.712 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -145.07 25.04 1.43 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.468 -179.55 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -111.21 15.25 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.31 163.58 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -144.41 -65.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -155.359 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.407 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 1.1 mtp180 -62.13 -29.19 70.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.316 164.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -84.75 -21.0 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 172.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 4.4 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.429 176.774 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.511 HD22 ' HG3' ' B' ' 33' ' ' GLU . 4.4 mt . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.461 0.648 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.99 147.7 88.78 Favored 'Trans proline' 0 N--CA 1.484 0.942 0 C-N-CA 122.493 2.128 . . . . 0.0 113.617 172.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -82.39 76.36 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.525 177.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.53 -54.76 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.599 171.414 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.23 -11.34 21.83 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.658 2.238 . . . . 0.0 113.65 171.179 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' B' ' 3' ' ' LEU . 40.0 mt -114.92 -37.61 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.482 -179.101 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.83 -48.33 86.78 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 1.1 ptt180 -93.83 19.21 9.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.511 -179.285 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mm -83.62 -60.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.126 164.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 40' ' ' ALA . 9.7 mm -66.43 -36.05 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.218 -176.384 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 12.1 mttm -64.93 -39.07 92.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.425 178.217 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -62.11 -31.46 71.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.793 -177.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.68 -52.76 64.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.603 170.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.24 19.54 0.53 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.609 -179.098 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.466 ' CB ' HD12 ' A' ' 44' ' ' ILE . . . -60.67 125.9 25.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.332 165.494 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.78 -64.41 1.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.071 -170.036 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -110.02 111.32 22.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.411 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 t -90.24 152.05 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.294 172.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.475 ' HB3' HG21 ' A' ' 54' ' ' THR . 24.7 p -98.47 16.6 21.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.345 -176.616 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.55 163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.09 -162.332 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.527 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 75.33 -58.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.898 -166.699 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.2 82.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.345 -165.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -64.21 -13.51 49.34 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.555 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.56 -5.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -177.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 60' ' ' ILE . 98.9 m -60.64 -43.16 97.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.451 173.404 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 60' ' ' ILE . 2.9 mm? -61.21 -23.43 65.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.443 177.284 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' B' ' 8' ' ' ILE . . . -74.88 -11.12 60.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.436 -178.502 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.48 -32.6 6.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.482 -177.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.535 HD11 HG23 ' B' ' 27' ' ' THR . 2.6 mp -61.72 -75.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.821 163.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.525 HD13 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -58.1 -21.03 44.42 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.797 -160.494 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.511 ' HG3' HD22 ' B' ' 3' ' ' LEU . 4.3 tm-20 -89.2 -18.15 27.67 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -39.8 28.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.093 168.359 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.463 ' HA ' ' CB ' ' B' ' 38' ' ' ASP . 0.2 OUTLIER -93.34 19.56 8.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.422 178.838 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.68 -33.85 1.5 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 165.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.7 -20.78 59.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.191 165.25 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.463 ' CB ' ' HA ' ' B' ' 35' ' ' MET . 27.3 t0 -61.13 -60.88 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.346 171.337 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.529 HD11 HD13 ' A' ' 28' ' ' LEU . 22.0 mt -61.04 -33.95 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.46 -169.022 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.488 ' HB3' HG22 ' A' ' 12' ' ' ILE . . . -61.62 -53.48 55.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.315 -172.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -17.29 64.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.785 -173.487 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.21 -42.4 11.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.085 173.645 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.86 -12.43 10.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.479 172.106 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.526 HD13 ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.2 -61.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.611 -169.979 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' B' ' 44' ' ' ILE . 0.6 OUTLIER -67.64 -16.85 64.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.488 175.739 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -61.09 -32.03 71.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.287 166.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.454 ' HB1' ' CD1' ' B' ' 55' ' ' ILE . . . -73.42 -40.5 64.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.341 177.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -90.07 -33.73 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.374 -167.526 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -61.1 -37.57 83.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.377 171.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.7 94.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.339 168.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.87 27.19 17.33 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -179.007 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 179.11 4.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.415 -169.306 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 161.29 14.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.447 171.645 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 21' ' ' SER . 88.6 m 69.92 134.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.4 168.154 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.454 ' CD1' ' HB1' ' B' ' 47' ' ' ALA . 13.3 mm -90.82 135.52 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.384 168.209 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -135.73 177.13 8.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.464 179.262 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.93 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.347 -167.723 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.16 -16.61 27.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.129 -178.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.88 -18.53 30.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.413 168.455 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.532 HG22 HD12 ' A' ' 28' ' ' LEU . 46.7 mm -92.43 -42.11 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 -170.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.519 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 31.6 mt-10 -91.05 22.03 3.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.635 172.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.524 ' HG ' HD23 ' B' ' 46' ' ' LEU . 19.8 tp -126.53 -15.67 5.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.679 169.428 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.456 ' HB1' ' CA ' ' B' ' 43' ' ' ALA . . . -89.55 -35.72 15.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.827 163.649 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 53.9 t -62.32 -79.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.618 162.847 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -59.48 -12.68 6.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.718 -159.322 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -81.87 -17.99 45.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.5 -177.215 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.305 168.996 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 33' ' ' GLU . 1.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.472 0.654 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 5.0 Cg_endo -47.95 148.13 6.91 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.588 2.192 . . . . 0.0 113.589 172.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.516 ' HA ' ' NH2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.89 -26.67 41.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.352 -175.32 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.26 -62.37 3.19 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.684 -170.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.82 -22.67 10.27 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 122.594 2.196 . . . . 0.0 113.595 -177.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 29' ' ' ALA . 85.9 mt -107.23 -30.18 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.493 -169.691 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.72 80.51 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -169.597 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -79.62 -21.7 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.364 -174.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.517 HG21 ' HG2' ' B' ' 37' ' ' ARG . 26.8 mt -63.7 -52.27 59.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.417 170.907 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.468 ' CD1' ' HB3' ' B' ' 40' ' ' ALA . 14.7 mm -67.12 -35.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.428 -168.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -63.98 -28.34 69.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.2 177.942 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.93 -33.45 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.874 177.027 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' B' ' 40' ' ' ALA . . . -59.08 -51.32 70.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.496 169.515 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.92 10.89 0.44 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.69 -174.301 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HB3' HD13 ' B' ' 44' ' ' ILE . . . -73.18 170.2 15.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.025 -0.587 . . . . 0.0 110.316 175.458 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 4.6 tt0 -169.74 -46.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -168.952 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.34 170.94 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.459 171.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -151.85 161.01 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.359 -169.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.515 ' HB2' HG23 ' B' ' 54' ' ' THR . 27.4 t -77.32 -167.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.398 175.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -17.18 51.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.352 -173.029 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -170.57 124.74 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 168.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.75 -61.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.164 166.601 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -65.86 -14.94 62.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.361 -178.326 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.5 HG12 HG23 ' A' ' 5' ' ' ILE . 14.6 mt -86.43 -34.82 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.396 175.182 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.513 HG23 HG23 ' B' ' 60' ' ' ILE . 98.7 m -61.14 -53.98 50.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.228 165.409 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.54 ' HA ' HG23 ' A' ' 31' ' ' ILE . 16.7 tp -62.08 -23.52 66.55 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.347 -174.102 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 8' ' ' ILE . . . -82.16 -36.44 27.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.232 178.76 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.2 -16.13 60.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.51 172.529 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -83.07 -29.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.889 -165.33 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.519 HD21 HD22 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -89.39 -34.85 16.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -173.612 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.534 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.89 -34.91 76.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.982 -179.031 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.87 -26.62 60.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.05 168.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.513 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -95.25 22.75 6.44 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.428 178.758 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' HD23 ' B' ' 32' ' ' LEU . . . -138.26 -41.63 0.09 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -173.362 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.537 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -65.88 -26.01 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.417 -0.392 . . . . 0.0 110.177 167.507 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -87.44 -35.83 18.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.354 -168.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.534 HD13 HD13 ' B' ' 32' ' ' LEU . 6.6 mt -61.24 -32.1 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.423 174.149 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -62.48 -61.43 2.45 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.212 171.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.524 -175.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HG2' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -89.66 -53.67 4.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.169 171.238 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.94 -11.55 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.7 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.497 HD12 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -78.4 -60.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.402 -169.349 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mtmt -69.08 -18.56 64.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.468 173.108 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 4.1 mp -61.1 -18.38 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 166.462 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.45 -18.39 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.381 177.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -81.44 -33.32 32.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -170.71 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -61.11 -24.56 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.356 169.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.66 63.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.226 166.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.18 28.66 0.58 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.467 -177.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.49 93.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.465 175.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.86 -76.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.467 179.372 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -160.04 140.28 11.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.423 -169.666 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 59' ' ' ASP . 17.2 mm -61.58 165.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.267 167.209 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -170.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.397 168.868 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.37 -19.52 65.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.304 -166.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.36 23.64 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.255 170.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -121.22 -26.6 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.317 168.33 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.524 HG22 HD12 ' B' ' 28' ' ' LEU . 36.6 mm -95.99 -47.82 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.001 -163.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.92 -12.76 60.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.167 174.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -48.14 7.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.43 177.747 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -60.98 -31.21 70.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.228 172.115 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG23 HG23 ' B' ' 31' ' ' ILE . 25.3 t -61.33 -70.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.756 164.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -9.82 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.806 -170.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HD3' ' HG2' ' A' ' 42' ' ' GLU . 8.9 ttt85 -77.66 -34.14 53.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.904 172.628 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.513 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 5.6 m-85 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.437 178.598 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 5.6 mt . . . . . 0 C--O 1.242 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -46.93 157.54 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.229 1.953 . . . . 0.0 113.454 -179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.04 23.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.378 -167.157 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.23 -58.19 0.38 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 169.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.75 -65.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 122.505 2.137 . . . . 0.0 113.612 173.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' B' ' 3' ' ' LEU . 74.3 mt -60.8 -11.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.532 -170.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.82 55.53 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -178.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.533 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -94.96 17.36 14.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.588 . . . . 0.0 110.642 -178.895 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -95.27 -45.05 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.025 163.146 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.527 HG13 HD21 ' B' ' 28' ' ' LEU . 3.1 mm -94.29 46.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.849 171.551 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 19.8 mtpt -149.59 -30.56 0.23 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.945 171.52 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . 0.537 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 27.9 t0 -60.05 -30.49 69.23 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.065 171.264 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.96 74.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.638 170.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.64 22.33 2.28 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.552 -165.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.497 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -71.76 123.45 22.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.092 179.375 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -77.15 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.007 -164.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -109.84 -52.54 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.429 -177.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' B' ' 25' ' ' ARG . 11.5 t 62.84 132.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.331 -175.172 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -65.75 175.16 2.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.249 178.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -93.81 20.33 7.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.59 -44.86 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.446 169.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.461 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -62.0 -45.88 91.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.326 -170.347 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.523 ' HG3' HG13 ' B' ' 20' ' ' VAL . 14.6 mtt180 -66.97 -25.47 66.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.315 -171.446 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.92 -32.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.381 171.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.54 HG21 HD13 ' B' ' 31' ' ' ILE . 90.0 m -70.39 -45.69 65.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.276 -169.821 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' B' ' 31' ' ' ILE . 4.7 tp -59.78 -44.67 93.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.437 171.873 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -10.07 5.39 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.541 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -109.71 -29.51 8.3 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.475 -176.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.54 HD13 HG21 ' B' ' 27' ' ' THR . 2.8 mp -62.22 -74.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.854 164.108 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 39' ' ' ILE . 1.4 mp -59.36 -11.4 4.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 -160.632 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -92.17 -52.82 4.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.206 -176.401 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -29.43 70.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 170.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 35' ' ' MET . . . . . 0.526 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 4.4 mtt -64.28 -45.52 87.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.356 168.376 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.62 78.43 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . 0.517 ' HG2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -67.08 -33.52 75.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.248 167.124 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 3.2 m-20 -72.41 -54.5 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.432 -171.836 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.523 HG22 HG21 ' B' ' 64' ' ' VAL . 51.8 mt -60.83 -35.53 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.382 -174.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . . . -60.89 -57.77 11.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.167 -173.008 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.47 ' HA ' ' CG2' ' B' ' 44' ' ' ILE . 43.2 p -66.18 -14.61 62.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.76 176.796 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -35.5 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.974 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -77.36 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.286 170.322 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -85.57 -61.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.56 -172.508 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.504 ' HA ' ' HG3' ' B' ' 48' ' ' ARG . 2.2 mptm? -60.6 -17.57 47.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.573 172.083 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.426 HD11 ' HA ' ' B' ' 43' ' ' ALA . 0.8 OUTLIER -61.63 -27.73 68.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.233 167.895 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.55 -44.34 57.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.33 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.07 -31.28 34.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.346 -177.906 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . 0.481 ' N ' ' HD2' ' B' ' 48' ' ' ARG . 6.2 t60 -60.98 -36.64 79.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 168.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.83 63.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.152 165.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.87 28.37 0.74 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.533 -173.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . 0.493 ' NE ' ' HB2' ' B' ' 48' ' ' ARG . 6.1 mpt_? 65.11 96.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.521 169.371 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -152.36 -73.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.433 -177.019 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.517 HG21 ' N ' ' B' ' 55' ' ' ILE . 90.5 m -165.14 148.26 8.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.298 -173.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.517 ' N ' HG21 ' B' ' 54' ' ' THR . 31.8 mt -94.25 147.82 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.42 168.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.61 -174.61 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.4 -169.602 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.4 77.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.217 -168.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.514 ' HG2' HD12 ' B' ' 62' ' ' LEU . 2.0 tm-20 -93.97 23.49 4.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.076 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.8 -17.26 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.511 166.664 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.524 HG23 HD11 ' A' ' 31' ' ' ILE . 32.9 mm -92.27 -59.92 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.292 -175.58 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 71.2 mt-10 -60.48 -10.44 4.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.228 168.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -100.47 -14.94 18.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.876 177.952 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' B' ' 39' ' ' ILE . . . -102.22 5.85 40.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.553 165.184 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 55.7 t -113.83 -84.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.572 -177.576 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.501 ' HB3' ' NH1' ' B' ' 65' ' ' ARG . 0.4 OUTLIER -60.8 -22.36 64.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.187 -178.73 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -46.7 13.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 160.504 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.335 -163.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 121.331 0.586 . . . . 0.0 109.514 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.45 156.19 4.36 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.503 2.135 . . . . 0.0 113.537 168.056 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -87.69 62.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.38 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.25 -57.42 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.696 -177.388 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.35 -41.37 59.18 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.548 2.165 . . . . 0.0 113.657 170.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -61.41 -23.67 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.43 170.913 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.8 -57.54 18.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -167.524 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -20.92 64.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.402 -170.507 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.5 HD12 HD22 ' B' ' 3' ' ' LEU . 28.0 mt -61.65 -49.75 83.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.183 167.115 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.519 HG23 ' NH1' ' A' ' 25' ' ' ARG . 1.8 mm -96.61 45.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 -35.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.779 173.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.37 -31.47 70.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.929 170.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.04 62.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.502 170.103 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.88 33.09 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.552 -169.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.83 138.46 33.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.296 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.82 -50.34 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.001 -170.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.83 171.25 15.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.412 -168.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.464 HG11 ' NH2' ' A' ' 25' ' ' ARG . 17.1 m -115.24 -173.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 167.295 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.52 ' HA ' HG23 ' B' ' 54' ' ' THR . 54.0 p -90.33 -65.38 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.125 175.248 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -141.52 -34.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.71 161.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 47.7 m-20 -107.76 -106.15 0.34 Allowed 'General case' 0 C--O 1.253 1.277 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.657 165.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . 88.98 -56.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.026 1.331 . . . . 0.0 109.695 -168.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.519 ' NH1' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.11 -21.45 46.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.647 -179.067 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -64.07 -43.26 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.806 173.618 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.52 HG23 HG23 ' B' ' 60' ' ' ILE . 51.2 m -60.66 -46.05 91.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.205 172.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.509 HD12 HG22 ' B' ' 60' ' ' ILE . 2.1 tp -60.82 -33.89 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.269 173.445 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -71.91 -26.25 62.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.384 175.279 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 28.87 2.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.528 176.373 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.513 HG23 HG23 ' B' ' 64' ' ' VAL . 66.8 mt -145.15 -64.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.109 -170.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD12 ' HA3' ' B' ' 36' ' ' GLY . 0.1 OUTLIER -60.06 -38.64 83.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.69 177.21 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' B' ' 11' ' ' ILE . 5.0 tm-20 -86.35 -23.57 26.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.101 -169.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.57 19.26 6.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 173.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpp -126.21 -32.4 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.11 164.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.9 98.98 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.695 -179.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -18.77 65.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.481 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 33.0 m-20 -101.73 -18.85 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.369 -167.476 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 64' ' ' VAL . 14.9 mt -80.75 -24.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.377 171.422 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' B' ' 12' ' ' ILE . . . -72.85 -70.04 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.396 -166.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -60.74 -10.0 4.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.503 -176.753 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 54.2 mm-40 -88.13 -47.66 8.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.216 177.094 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -62.45 -27.17 68.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.187 170.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 97.9 mt -77.95 -52.1 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.18 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -26.69 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.494 174.33 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 43' ' ' ALA . 4.6 mt -62.27 -40.5 96.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.319 176.533 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -61.21 -25.56 67.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.272 -167.756 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -103.95 -25.72 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.35 -176.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -64.33 -37.8 88.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.339 169.473 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.33 97.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.334 168.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.83 18.95 14.01 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 169.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 179.18 -167.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.274 170.339 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 137.08 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.562 170.013 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' B' ' 21' ' ' SER . 86.6 m -60.82 171.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.386 167.51 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.527 ' HB ' HG12 ' B' ' 20' ' ' VAL . 18.8 mm -60.6 136.9 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.481 175.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HA ' ' HB1' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -159.97 -178.27 6.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.366 -167.092 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -18.68 61.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.245 -171.057 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.34 -17.79 23.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.057 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.23 -43.54 28.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.373 168.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' HB ' HG23 ' B' ' 27' ' ' THR . 37.7 mm -72.22 -57.64 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.404 -170.371 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.77 -40.4 84.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.074 -166.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -37.47 82.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.442 170.049 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 43' ' ' ALA . . . -61.56 -16.41 47.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.438 -175.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 39' ' ' ILE 0.256 0.4 OUTLIER -104.57 -50.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.042 -160.582 . . . . . . . . 4 4 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' N ' HG11 ' A' ' 64' ' ' VAL . 3.1 ttt-85 -93.69 23.8 4.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.526 -178.077 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -122.05 -55.71 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.481 -176.74 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' HB3' ' HG3' ' A' ' 42' ' ' GLU . 1.5 p90 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.3 -163.443 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 3' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' B' ' 33' ' ' GLU . 4.0 mt . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 121.316 0.579 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.96 157.15 30.15 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.357 2.038 . . . . 0.0 113.221 164.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 pt -93.02 23.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.519 178.7 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 6' ' ' ALA . . . . . 0.488 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -90.87 -57.81 0.25 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.763 170.063 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 7' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 9.2 Cg_endo -60.7 -54.62 1.87 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.532 2.155 . . . . 0.0 113.57 173.325 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.496 HD12 HD13 ' B' ' 3' ' ' LEU . 28.7 mt -60.5 -13.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.498 169.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.41 -61.49 1.98 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.509 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -93.82 17.06 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.593 -167.13 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 11' ' ' ILE . . . . . 0.525 HD12 ' HG2' ' A' ' 33' ' ' GLU . 29.0 mt -96.73 -49.62 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 162.79 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.515 HD12 ' HB1' ' A' ' 40' ' ' ALA . 5.1 mm -68.04 -38.28 79.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.211 178.557 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.8 mttt -61.57 -35.25 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.355 174.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.54 -34.02 76.09 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.862 -177.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.39 65.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.433 169.385 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.79 15.82 0.3 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.221 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.519 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -62.83 125.72 24.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.219 164.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.36 -53.96 2.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.039 -167.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.55 93.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.412 171.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.527 HG12 ' HB ' ' A' ' 55' ' ' ILE . 27.8 t -67.94 166.0 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.282 168.367 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 21' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 26.5 t -102.32 -166.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.388 170.39 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.31 167.36 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.284 166.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.65 -61.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.498 171.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 56' ' ' LYS . . . -61.88 -47.07 86.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.388 -167.212 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -60.83 -12.11 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.601 178.99 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mm -114.03 -15.88 9.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.645 -175.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.527 HG23 ' HB ' ' A' ' 60' ' ' ILE . 41.4 m -73.77 -33.82 64.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.436 -171.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 60' ' ' ILE . 2.7 mm? -62.71 -21.76 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.407 168.399 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.07 -12.79 60.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.382 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' B' ' 27' ' ' THR . 4.6 mttm -95.75 -29.1 14.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.493 172.229 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 31' ' ' ILE . . . . . 0.527 HD13 HG21 ' B' ' 27' ' ' THR . 2.9 mp -78.73 -79.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.184 170.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.494 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.91 -12.89 8.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.649 -161.918 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . 0.539 ' HG2' HD22 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -93.39 -31.52 14.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.102 178.212 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.25 -29.74 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.148 169.022 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -99.45 36.24 1.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.278 172.78 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . 0.513 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . -144.94 -40.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 170.658 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -43.48 98.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.179 165.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.82 -38.81 92.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.438 -171.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.533 HG22 HG21 ' B' ' 64' ' ' VAL . 9.8 mt -70.6 -37.86 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 -175.583 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -60.77 -64.39 0.97 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.355 -168.767 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.538 ' HA ' HD11 ' B' ' 44' ' ' ILE . 1.2 t -61.69 -11.21 10.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.419 -176.588 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 42' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -88.03 -51.9 5.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.183 174.408 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.496 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.79 -9.63 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.364 171.23 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' B' ' 41' ' ' SER . 57.9 mt -99.11 -54.37 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.127 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -23.67 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.343 -177.658 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.514 HD21 HD22 ' B' ' 62' ' ' LEU . 12.1 mt -60.71 -48.36 82.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.373 170.791 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.9 -60.32 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.371 171.303 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -20.64 62.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.365 -169.612 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.5 -44.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 169.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 -51.7 59.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 29.6 5.37 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 169.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.62 -171.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.3 169.854 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 64.34 163.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.439 -178.056 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 21' ' ' SER . 6.1 t -88.52 -167.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.382 -169.399 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' B' ' 44' ' ' ILE . 10.6 mm -100.63 142.6 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.327 173.146 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 56' ' ' LYS . . . . . 0.45 ' HD3' ' HG2' ' B' ' 58' ' ' GLU . 1.9 tmtt? -160.56 172.52 17.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.312 -165.132 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.23 73.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.369 -168.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' HD3' ' B' ' 56' ' ' LYS . 1.8 pt-20 -83.62 15.7 3.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 177.705 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -130.65 -20.79 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.54 167.303 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 60' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 27' ' ' THR . 10.1 mm -79.49 -50.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 61' ' ' GLU . . . . . 0.52 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 20.4 mt-10 -61.31 -39.46 90.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.027 166.212 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -62.22 -32.2 72.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.508 178.351 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.485 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -81.03 -35.68 31.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.207 175.054 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.533 HG21 HG22 ' B' ' 39' ' ' ILE . 19.9 t -62.39 -79.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.637 175.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -58.99 -12.73 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.664 -164.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -60.42 -26.0 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.512 171.501 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG3' ' B' ' 42' ' ' GLU . 17.4 m-85 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.409 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.04 -162.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.173 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.459 HD11 ' CB ' ' A' ' 33' ' ' GLU . 6.2 mp -57.22 102.29 0.3 Allowed Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.553 -169.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.5 Cg_endo -56.74 140.3 90.59 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.751 2.301 . . . . 0.0 113.49 171.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.2 -14.11 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.456 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.23 -55.37 3.78 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.653 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.531 ' HG2' ' HG2' ' A' ' 4' ' ' PRO . 15.5 Cg_exo -49.77 -49.59 15.51 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.655 2.237 . . . . 0.0 113.644 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 8' ' ' ILE . 63.0 mt -61.25 -45.74 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.521 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.05 59.23 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.37 -29.44 18.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.475 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD11 ' HG2' ' B' ' 33' ' ' GLU . 27.8 mt -61.5 -57.63 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.309 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.529 HG21 HD13 ' B' ' 44' ' ' ILE . 10.9 mm -61.21 -36.19 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.331 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.502 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mttm -62.98 -36.68 84.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.444 170.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.63 -34.02 76.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.753 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.24 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.376 169.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.42 20.61 0.34 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.691 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.21 149.34 33.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.401 166.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.23 -55.17 2.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 111.59 10.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -169.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG13 ' HD2' ' A' ' 25' ' ' ARG . 94.3 t -133.04 132.15 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.384 -169.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.4 p -65.92 157.17 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.351 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.92 -18.56 63.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.428 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' HA ' HG21 ' A' ' 26' ' ' ILE . 24.2 m-20 -81.0 -34.57 32.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.455 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB3' HD11 ' B' ' 60' ' ' ILE . . . -61.52 -40.36 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.192 166.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.504 ' HD2' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -66.08 -40.51 90.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.333 -177.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.537 HG21 ' HA ' ' A' ' 23' ' ' ASP . 7.3 tt -81.39 -34.88 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.375 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 HG23 HG23 ' B' ' 60' ' ' ILE . 84.9 m -63.58 -45.96 88.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.091 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.535 ' HB2' HG12 ' B' ' 60' ' ' ILE . 3.3 tp -60.36 -42.84 96.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.289 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 26' ' ' ILE . . . -61.53 -42.93 99.54 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.268 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -78.62 -27.15 45.43 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.384 -176.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 27' ' ' THR . 23.3 mt -61.42 -73.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 166.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.53 -26.66 65.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.848 -166.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -79.52 -48.14 14.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.081 -176.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -63.98 -26.41 68.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.017 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.523 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 13.5 ttm -71.92 -43.49 65.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.452 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.456 ' CA ' HD23 ' B' ' 32' ' ' LEU . . . -65.06 -45.33 92.39 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -60.69 -22.16 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.39 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.07 -54.83 5.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.489 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.523 ' HB ' HD13 ' B' ' 28' ' ' LEU . 10.1 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.208 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB3' HD12 ' B' ' 12' ' ' ILE . . . -61.24 -54.24 46.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.309 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.49 ' N ' ' HB3' ' B' ' 15' ' ' ALA . 84.3 p -61.48 -28.17 69.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.393 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -62.06 -56.37 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.061 165.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -65.18 -4.52 5.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.023 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.529 HD13 ' HB1' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -94.1 -56.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.248 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -62.49 -17.12 58.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.74 167.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 5.1 mp -67.18 -61.03 2.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.112 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.53 -14.21 18.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.462 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . 18.4 ttt-85 -97.41 -23.21 16.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.016 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -36.1 76.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.051 163.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.3 -56.76 8.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 161.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.96 -14.05 21.79 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.358 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 172.47 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.785 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.66 28.81 0.0 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.991 164.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.519 HG21 ' N ' ' A' ' 55' ' ' ILE . 100.0 m 63.45 150.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.407 177.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' HG21 ' A' ' 54' ' ' THR . 9.6 mm -69.73 134.25 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.014 169.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HA ' ' HB1' ' B' ' 24' ' ' ALA . 41.1 mtmt -142.38 175.31 9.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.504 -164.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -63.86 -55.13 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.289 -173.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 3.4 mt-10 -68.5 -16.05 63.75 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.992 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.05 -39.3 69.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.325 172.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.541 HG13 HD12 ' B' ' 28' ' ' LEU . 1.5 mp -62.83 -56.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.501 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 22.1 mt-10 -60.6 -43.22 97.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.877 -161.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HB3' HD22 ' A' ' 46' ' ' LEU . 5.5 tp -61.03 -45.45 94.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.468 167.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.54 -29.09 69.79 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.452 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -86.22 -52.2 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.62 -168.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -18.73 60.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.589 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -76.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.316 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -67.04 -29.39 69.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.184 -162.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -70.1 146.88 50.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.341 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp . . . . . 0 C--O 1.241 0.633 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.362 -170.852 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -97.67 47.42 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.808 0.813 . . . . 0.0 109.815 167.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' B' ' 29' ' ' ALA . 18.9 mt 58.56 86.28 0.16 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.312 -172.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.458 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 7.9 Cg_endo -48.81 138.09 26.62 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.16 1.907 . . . . 0.0 113.353 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.524 HG23 ' HB3' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -80.91 -11.33 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.627 -165.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.47 6.54 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.764 172.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.458 ' CG ' ' HG2' ' B' ' 4' ' ' PRO . 3.7 Cg_endo -58.74 -48.83 13.35 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 122.504 2.136 . . . . 0.0 113.499 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' B' ' 3' ' ' LEU . 26.8 mt -60.89 -21.11 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.321 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.82 -53.55 44.31 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.6 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.512 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 10.7 mtp-105 -79.28 -21.56 45.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.372 -172.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.459 HD13 HD13 ' A' ' 3' ' ' LEU . 64.0 mt -61.36 -57.6 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.153 165.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.537 HD12 ' HB3' ' A' ' 40' ' ' ALA . 5.6 mt -78.55 -12.93 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.944 -172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtmm -68.47 -40.38 81.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 162.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.35 -32.98 73.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.876 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' B' ' 12' ' ' ILE . . . -57.48 -52.06 66.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.554 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.9 25.61 0.26 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.732 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.536 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -77.94 145.48 36.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.289 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.725 162.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.53 100.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.423 -163.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.511 HG11 ' HB ' ' A' ' 55' ' ' ILE . 12.7 t -100.91 169.27 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.1 t -117.14 141.52 48.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.393 174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.87 -27.48 68.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.332 -167.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.89 -40.12 91.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.464 172.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -63.84 -57.97 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.524 ' HB3' HG23 ' B' ' 5' ' ' ILE . 0.0 OUTLIER -61.06 -33.25 73.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.388 -167.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.7 mt -82.18 -38.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.449 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.457 HG21 HD13 ' B' ' 31' ' ' ILE . 85.3 m -61.26 -47.07 87.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.541 HD12 HG13 ' A' ' 60' ' ' ILE . 4.4 tp -60.49 -47.83 84.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.382 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.504 ' HA ' HD13 ' B' ' 3' ' ' LEU . . . -61.31 -27.1 68.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.373 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -36.18 40.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.389 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.519 HD11 ' HA ' ' B' ' 28' ' ' LEU . 4.9 mt -61.14 -72.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.051 172.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.456 HD23 ' CA ' ' A' ' 36' ' ' GLY . 3.0 mp -60.06 -31.99 70.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 -165.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.408 ' HG2' HD11 ' A' ' 11' ' ' ILE . 3.3 tm-20 -76.82 -33.61 57.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.061 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.2 89.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.064 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.64 -43.5 80.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.527 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.61 -40.33 97.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -32.9 71.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.429 171.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -63.73 -56.88 12.23 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.539 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' A' ' 28' ' ' LEU . 5.0 mt -62.52 -26.38 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.787 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 12' ' ' ILE . . . -61.88 -70.53 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.317 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.9 OUTLIER -62.14 -17.29 57.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.371 -173.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.446 ' HB3' ' CB ' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -73.36 -59.04 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.067 170.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.52 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.8 -14.45 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.53 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 62.8 mt -94.3 -54.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.97 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -60.46 -14.88 21.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.373 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' B' ' 43' ' ' ALA . 16.8 mt -75.83 -53.81 7.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.465 169.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.23 -16.43 61.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.27 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -34.57 14.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.373 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.65 -34.26 74.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.12 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.336 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.3 12.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.31 -176.34 2.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.009 -0.595 . . . . 0.0 110.431 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -115.07 -46.29 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.336 -170.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -87.45 117.54 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.42 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' B' ' 59' ' ' ASP . 9.8 mt -78.72 143.55 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.327 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.416 ' N ' HG21 ' B' ' 55' ' ' ILE . 2.1 mtmp? -125.92 177.33 6.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.455 -167.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -21.37 64.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.273 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 30.2 tt0 -69.08 -48.61 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.044 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.485 ' HB2' HG21 ' B' ' 55' ' ' ILE . 7.6 m-20 -63.51 -37.49 87.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.4 -168.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.537 HG23 HG23 ' A' ' 27' ' ' THR . 1.4 mp -62.7 -39.13 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.777 163.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -62.28 -39.46 93.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -170.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 22.9 mt -84.53 -39.26 19.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.479 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.461 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.49 -49.18 78.59 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.393 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.486 HG12 HD12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -72.66 -52.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.015 -170.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -60.3 -31.45 70.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . 0.514 ' NH2' HD22 ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.31 -40.36 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.325 178.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 14.8 m-85 -60.85 -73.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.336 169.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt 178.43 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.402 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.414 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 58.88 45.24 15.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.262 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.9 mt 60.3 81.16 0.25 Allowed Pre-proline 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.035 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -46.66 141.34 11.34 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.387 2.058 . . . . 0.0 113.438 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 HG23 ' HB3' ' A' ' 25' ' ' ARG . 42.3 pt -89.83 17.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.975 -167.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.0 -55.98 0.65 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.627 166.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.05 -54.64 2.12 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.659 2.239 . . . . 0.0 113.575 171.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.513 ' HA ' HD11 ' A' ' 11' ' ' ILE . 23.8 mt -65.02 -45.25 95.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.361 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.58 62.3 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -88.02 -27.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.513 HD11 ' HA ' ' A' ' 8' ' ' ILE . 44.8 mt -62.07 -55.27 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 169.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 HG21 HD13 ' B' ' 44' ' ' ILE . 10.0 mm -67.89 -36.21 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.33 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -33.27 72.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.286 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -62.43 -34.66 77.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.824 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.56 -52.35 65.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.435 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.79 23.88 0.35 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.544 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.86 150.57 32.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.436 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -122.55 -75.32 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.033 -167.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -121.92 104.97 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.434 -174.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.44 ' CG2' ' NH2' ' A' ' 25' ' ' ARG . 19.8 t -116.13 150.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.323 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -87.79 148.84 24.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.365 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -60.95 -20.14 61.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.375 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -60.8 -54.73 41.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.441 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' B' ' 56' ' ' LYS . . . -62.22 -42.61 99.47 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.385 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.534 ' HB3' HG23 ' A' ' 5' ' ' ILE . 4.6 mmt85 -61.71 -46.12 91.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.354 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HD12 ' CG2' ' A' ' 5' ' ' ILE . 40.3 mm -73.31 -32.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.451 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.529 HG22 ' HB3' ' B' ' 57' ' ' ALA . 97.1 m -60.95 -44.33 97.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.497 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 7.4 tp -83.43 -14.07 53.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.078 -172.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . . . -81.73 -21.76 37.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.407 163.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.52 ' HA ' ' HB2' ' A' ' 33' ' ' GLU . 6.3 tttt -88.57 -31.14 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.37 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.473 HD12 HG23 ' B' ' 60' ' ' ILE . 3.1 mp -61.08 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.658 159.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' B' ' 32' ' ' LEU . 4.3 mm? -59.04 -14.86 10.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.634 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' HG3' HD11 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -71.02 -69.11 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.699 163.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.8 -32.3 71.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.097 -167.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.455 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -66.42 -34.92 79.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.433 166.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.23 -53.96 12.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.512 ' HD3' ' HA ' ' B' ' 15' ' ' ALA . 0.0 OUTLIER -64.31 -26.09 68.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.458 173.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 15.0 m-20 -60.89 -62.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.477 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 3.2 mt -62.59 -17.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.583 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -80.78 -69.17 0.62 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.254 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -61.04 -13.57 17.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.459 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -73.2 -63.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.077 166.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -60.93 -11.26 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.556 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.537 HD12 HG21 ' B' ' 12' ' ' ILE . 95.8 mt -93.28 -49.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.803 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -60.28 -33.12 71.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.395 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 43' ' ' ALA . 15.6 mt -60.34 -42.72 96.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.334 166.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -61.23 -54.36 45.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.277 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -68.09 -14.94 63.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.431 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -71.27 -56.54 5.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.219 172.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.34 24.08 0.23 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.909 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD3' ' HG3' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 55.21 -162.71 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 O-C-N 122.184 -0.598 . . . . 0.0 111.428 158.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 0.4 OUTLIER 70.23 -81.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.559 -165.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 m -115.45 137.87 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.379 -160.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 44' ' ' ILE . 8.3 mm -94.28 137.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.164 161.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 167.42 23.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.547 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.261 -167.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.1 -42.86 99.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.942 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.8 -45.42 94.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.5 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG21 HD23 ' B' ' 28' ' ' LEU . 37.0 mm -66.86 -47.2 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.401 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.68 -33.89 74.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.23 -53.85 51.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.384 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -61.02 -49.46 77.3 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.328 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -67.37 -53.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.931 -164.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -20.26 66.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.818 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -43.87 98.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.255 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 43.0 m-85 -60.41 -46.49 89.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.465 168.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.97 -170.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.372 -168.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.239 0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.383 -169.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.308 0.575 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.6 22.47 4.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.471 -168.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' B' ' 29' ' ' ALA . 0.3 OUTLIER -91.68 150.81 41.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.317 164.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.52 ' HB2' ' HG2' ' B' ' 7' ' ' PRO . 19.3 Cg_endo -62.09 143.37 94.71 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.397 2.064 . . . . 0.0 113.463 164.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.496 HD13 ' NH2' ' B' ' 25' ' ' ARG . 12.2 pt -108.23 -14.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.444 -167.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.0 -54.76 1.51 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.682 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.52 ' HG2' ' HB2' ' B' ' 4' ' ' PRO . 17.2 Cg_exo -50.23 -46.48 28.49 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.722 2.281 . . . . 0.0 113.617 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.6 -47.61 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.459 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.84 -29.07 71.28 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.552 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -89.19 -19.99 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.332 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.523 HD11 ' HG3' ' A' ' 33' ' ' GLU . 46.1 mm -61.61 -48.39 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.106 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.537 HG21 HD12 ' A' ' 44' ' ' ILE . 4.8 mm -70.22 -39.27 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.711 -174.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.1 OUTLIER -60.44 -43.11 97.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.442 169.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.96 -31.99 72.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.857 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.512 ' HA ' ' HD3' ' A' ' 37' ' ' ARG . . . -58.45 -53.62 56.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.492 169.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.48 20.83 0.61 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.536 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.45 119.88 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.272 167.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.94 -61.18 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.057 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 108.83 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.468 167.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.515 HG21 ' HB2' ' B' ' 17' ' ' ALA . 11.6 t -75.17 114.47 15.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.232 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -60.73 151.59 29.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.409 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 60.2 m-20 -61.59 -19.23 61.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.363 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.528 ' HA ' HG23 ' B' ' 26' ' ' ILE . 2.3 t0 -89.42 -26.08 21.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.32 -175.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -63.78 -47.74 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.251 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.496 ' NH2' HD13 ' B' ' 5' ' ' ILE . 12.6 ptt180 -71.4 -29.14 64.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.402 -169.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.528 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -73.13 -42.21 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.443 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.482 HG21 HG23 ' A' ' 60' ' ' ILE . 67.1 m -60.93 -37.57 82.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.242 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.106 167.431 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.537 ' HA ' HD13 ' B' ' 3' ' ' LEU . . . -62.86 -32.57 73.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.27 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -45.14 68.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.587 174.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' B' ' 28' ' ' LEU . 3.2 mt -61.15 -73.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.211 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.532 ' HB3' HD13 ' A' ' 32' ' ' LEU . 6.5 mp -55.55 -28.51 55.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.32 -167.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -65.24 -57.8 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.88 -38.2 87.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.986 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 22.1 mmm -72.0 -38.24 69.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.54 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.11 -40.71 95.14 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.388 170.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -58.86 4.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.511 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 4.1 mt -61.51 -31.71 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.339 -173.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 12' ' ' ILE . . . -61.92 -70.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.244 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 16.1 t -62.27 -12.42 20.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.444 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' CZ ' ' B' ' 67' ' ' PHE . 1.2 mp0 -93.84 -48.24 6.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.175 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.55 -10.89 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.378 167.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.524 HD13 HG21 ' A' ' 12' ' ' ILE . 56.7 mt -100.74 -49.15 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.793 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.01 -11.38 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.454 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' B' ' 43' ' ' ALA . 8.1 mt -84.1 -59.52 2.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.422 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.501 ' HB2' HD12 ' B' ' 55' ' ' ILE . . . -60.69 -18.21 52.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.523 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.11 -28.48 20.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.052 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -60.23 -35.7 76.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.174 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.48 -55.59 17.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.998 162.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 2.98 44.76 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.762 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 178.71 -163.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.638 -166.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt 76.02 -93.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' B' ' 55' ' ' ILE . 99.7 m -172.08 168.81 5.74 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.824 -0.548 . . . . 0.0 109.955 -160.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' B' ' 47' ' ' ALA . 7.3 mm -114.74 135.41 54.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.903 155.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.535 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -147.22 -177.46 5.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 -165.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 27' ' ' THR . . . -61.74 -15.49 41.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.346 -176.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 1.8 tp10 -100.76 -30.15 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.047 -170.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -36.36 79.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.136 167.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mp -61.39 -64.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.814 162.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.519 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -61.08 -22.46 64.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 -163.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.67 -39.67 15.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.458 175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.84 -36.17 78.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.355 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.529 HG21 HG12 ' B' ' 39' ' ' ILE 0.274 0.5 OUTLIER -88.15 -45.1 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.876 -166.167 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.38 -27.17 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.53 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.5 95.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.107 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' B' ' 42' ' ' GLU . 18.3 m-85 -60.37 -61.96 2.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 162.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -70.84 101.69 2.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.386 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.578 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.67 112.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.6 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.524 HD22 HD12 ' B' ' 11' ' ' ILE . 2.5 mt -66.87 139.99 95.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.638 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.29 144.31 95.14 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.484 2.123 . . . . 0.0 113.52 164.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.495 HG23 HG12 ' A' ' 26' ' ' ILE . 2.2 pp -107.84 16.54 7.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.879 -169.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.84 -55.87 0.51 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.699 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.534 ' HB2' ' HA ' ' B' ' 2' ' ' GLU . 7.7 Cg_endo -61.09 -42.49 35.9 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.555 2.17 . . . . 0.0 113.561 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.7 mt -60.63 -35.04 60.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.472 172.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -46.82 93.46 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.585 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -18.57 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.347 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' HG3' ' B' ' 33' ' ' GLU . 93.6 mt -60.91 -40.22 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.162 163.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.536 HD12 ' HB3' ' B' ' 40' ' ' ALA . 7.8 mt -93.22 -25.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.51 -162.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -64.02 -36.88 85.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.05 -32.97 74.71 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.088 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 12' ' ' ILE . . . -58.02 -52.36 65.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.509 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.7 28.51 0.25 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.978 -1.464 . . . . 0.0 110.713 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HB3' HD12 ' B' ' 44' ' ' ILE . . . -75.18 127.77 33.96 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.531 -175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.22 -25.47 11.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.96 107.71 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.462 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.14 133.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.418 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 p -70.64 157.18 38.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.351 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.64 -33.3 72.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.406 171.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -44.61 96.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.429 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 -52.66 62.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.24 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -79.17 -14.23 59.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.38 -167.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.495 HG12 HG23 ' A' ' 5' ' ' ILE . 37.3 mt -96.81 -32.16 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.4 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.524 HG21 HD11 ' A' ' 31' ' ' ILE . 58.6 m -60.43 -35.4 75.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 168.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.521 ' HB2' HG12 ' B' ' 60' ' ' ILE . 3.5 tp -60.01 -48.44 81.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.294 165.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.0 -29.8 69.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.386 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.57 -40.75 15.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.444 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 27' ' ' THR . 18.4 mt -59.79 -69.37 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.982 171.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' B' ' 32' ' ' LEU . 2.7 tt -59.38 -31.2 69.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.846 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HG3' HD12 ' B' ' 11' ' ' ILE . 0.6 OUTLIER -62.05 -53.74 51.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.007 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 58.4 tt0 -64.59 -20.95 66.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.958 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.509 ' HB3' HD22 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -63.06 -44.59 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 160.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA2' ' CD1' ' B' ' 32' ' ' LEU . . . -61.28 -51.96 54.74 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.699 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 8.3 ptm180 -61.46 -27.41 68.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.208 -0.496 . . . . 0.0 109.904 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -59.83 -54.44 46.21 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.669 169.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 28' ' ' LEU . 1.7 mt -62.44 -37.49 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.776 -174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -61.12 -68.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.401 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' HG23 ' A' ' 44' ' ' ILE . 4.7 t -62.52 -31.75 72.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.152 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -53.6 54.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.227 171.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -69.66 -13.25 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.528 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -83.77 -55.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.197 -168.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -76.19 -16.74 59.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.574 173.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 HD23 ' HD2' ' A' ' 66' ' ' ARG . 11.4 mt -61.3 -45.11 95.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.16 166.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.527 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -79.85 -24.36 41.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.253 -167.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.444 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -79.32 -52.5 8.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.494 178.067 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.05 66.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -60.71 -55.96 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.178 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 6.95 0.08 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.755 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 54.21 80.05 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.616 0.722 . . . . 0.0 112.182 162.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 -68.36 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.143 165.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.524 HG22 ' HB2' ' B' ' 21' ' ' SER . 6.0 t -138.13 -169.37 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.049 164.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 9.0 mm -100.93 135.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.738 161.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.461 ' N ' ' HB3' ' B' ' 24' ' ' ALA . 3.4 mttt -136.29 159.78 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.527 -164.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.504 ' HA ' HG23 ' B' ' 27' ' ' THR . . . -61.26 -20.42 62.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.307 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.29 -59.23 4.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.979 165.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 1.3 m-20 -66.51 -40.47 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.392 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.467 ' CG2' HD11 ' B' ' 28' ' ' LEU . 16.8 mm -61.93 -56.56 16.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.396 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.6 mt-10 -61.67 -19.48 62.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -64.26 -53.94 41.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.322 167.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 39' ' ' ILE . . . -61.06 -31.35 71.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.353 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 50.2 t -62.45 -67.72 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.6 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.493 ' NH2' ' HG2' ' A' ' 69' ' ' LYS . 1.9 mtp85 -60.52 -12.84 10.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.749 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HD2' HD23 ' A' ' 46' ' ' LEU . 1.1 tpm_? -79.47 -36.95 37.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.14 -170.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.513 ' CZ ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -62.41 -67.6 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.452 158.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.69 -169.63 0.1 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.298 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HG2' ' NH2' ' A' ' 65' ' ' ARG . 17.5 tptp . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.402 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.143 0.497 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 1.6 pm0 -90.12 122.41 33.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.908 175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' B' ' 29' ' ' ALA . 17.8 mt 58.68 57.98 5.95 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.65 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 7.3 Cg_exo -46.33 148.78 3.01 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.612 2.208 . . . . 0.0 113.389 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.536 ' HA ' HG23 ' B' ' 8' ' ' ILE . 1.8 pp -66.89 -10.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.467 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.86 -56.9 0.31 Allowed Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.868 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 6.3 Cg_endo -60.3 -39.96 62.97 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.609 2.206 . . . . 0.0 113.463 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.536 HG23 ' HA ' ' B' ' 5' ' ' ILE . 0.1 OUTLIER -61.72 -55.78 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.829 167.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.05 -17.11 50.9 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.894 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.1 ttm105 -82.06 -37.93 25.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.295 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.527 HD12 ' HG3' ' A' ' 33' ' ' GLU . 64.6 mt -58.31 -50.36 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.9 164.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' A' ' 40' ' ' ALA . 3.6 mm -68.72 -30.18 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.322 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 17.5 mtmt -61.98 -38.45 88.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.181 170.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -61.16 -30.56 70.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.884 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . . . -57.83 -52.04 67.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.508 169.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.38 34.74 0.6 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.59 -164.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.524 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -83.32 149.21 26.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.278 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.05 -25.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.984 169.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -106.21 34.24 3.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.307 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -82.34 138.15 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.253 167.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.524 ' HB2' HG22 ' A' ' 54' ' ' THR . 31.2 t -80.05 152.31 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.386 163.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.2 -15.25 32.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.5 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.538 ' HA ' HG23 ' B' ' 26' ' ' ILE . 9.2 t70 -90.31 -29.3 18.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.389 -171.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -68.28 -44.27 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.207 167.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.464 ' HG3' HG13 ' B' ' 20' ' ' VAL . 1.2 mtt180 -61.82 -43.98 97.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.279 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.1 OUTLIER -62.9 -49.5 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.256 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.504 HG23 ' HA ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -62.27 -29.13 70.2 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.949 -170.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 39' ' ' ILE . 3.8 tp -61.82 -42.73 99.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.943 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -64.12 -34.76 78.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.446 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.465 ' HD3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -83.94 -41.51 17.28 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.687 -175.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.503 HG22 HG23 ' A' ' 64' ' ' VAL . 21.8 mt -60.45 -65.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.048 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.53 ' HB3' HD22 ' A' ' 32' ' ' LEU . 5.2 mt -55.81 -23.01 27.65 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.234 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.515 ' HG2' ' HG3' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -61.6 -62.63 1.68 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.663 169.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.35 -20.95 63.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.888 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.5 mmt -66.32 -48.82 69.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.176 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.01 -46.04 95.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.911 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -33.93 74.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.255 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.74 -61.69 2.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.974 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' B' ' 67' ' ' PHE . 3.1 mt -61.14 -41.35 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.241 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 12' ' ' ILE . . . -67.2 -53.44 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.308 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 30.6 t -63.82 -30.36 71.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.53 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.464 ' HB3' ' CB ' ' B' ' 63' ' ' ALA . 1.4 tm-20 -62.03 -62.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.904 170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -60.92 -9.88 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.533 HD13 HG21 ' A' ' 12' ' ' ILE . 39.1 mt -95.07 -48.23 12.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.783 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.05 -16.29 30.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.336 166.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.535 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.7 mt -82.84 -46.64 12.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.247 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -80.45 -32.67 37.2 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.367 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -60.4 -35.89 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.268 168.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.82 -50.39 73.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.18 165.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 41.26 23.55 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -130.61 -173.76 3.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.405 -167.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -75.04 98.06 3.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.48 -165.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t 60.34 -176.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.952 166.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.517 HD12 HG12 ' B' ' 44' ' ' ILE . 3.3 mt -112.05 142.24 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.428 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -125.11 -176.68 3.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.384 -167.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.3 93.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.289 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -31.43 71.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.256 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 3.1 m-20 -80.22 -36.38 34.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.409 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.0 OUTLIER -64.2 -47.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.607 174.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.517 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 7.9 mt-10 -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.138 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.521 ' HG ' HD23 ' B' ' 46' ' ' LEU . 8.6 tp -64.47 -51.93 60.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.378 171.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.503 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -66.88 -32.95 74.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 41.5 t -61.54 -67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.715 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.59 4.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.772 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -73.97 -39.45 63.7 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.069 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' B' ' 39' ' ' ILE . 12.3 m-85 -59.63 -41.9 91.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.493 164.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt 61.59 -169.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.335 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tptm . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.395 169.444 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 58.48 103.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.54 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.465 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -89.27 97.33 0.91 Allowed Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.54 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.5 Cg_endo -46.22 139.13 12.49 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.444 2.096 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.28 -8.26 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.915 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' HB1' ' CD ' ' A' ' 7' ' ' PRO . . . -69.25 -57.8 6.85 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.663 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.467 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 1.7 Cg_endo -51.87 -60.39 0.79 Allowed 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.615 2.21 . . . . 0.0 113.584 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 26.4 mt -61.02 -49.09 86.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.521 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.05 -22.88 63.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -171.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -82.74 -35.34 26.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.364 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' B' ' 33' ' ' GLU . 62.6 mt -59.69 -58.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.648 166.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.519 HD13 HD22 ' A' ' 28' ' ' LEU . 5.5 mm -61.94 -20.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.063 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 18' ' ' GLU . 3.6 mmmt -74.63 -36.77 62.91 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.299 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.85 -32.76 73.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.821 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB2' HD12 ' B' ' 44' ' ' ILE . . . -59.1 -53.41 58.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.383 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.51 17.62 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.316 -167.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -66.51 -163.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.678 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 61.6 24.2 14.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.612 -158.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -110.78 22.63 15.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 154.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG21 HD13 ' B' ' 55' ' ' ILE . 14.6 t -117.35 176.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.192 -162.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.466 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 16.6 t -125.08 168.37 13.47 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.526 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 65.6 m-20 -61.8 -25.75 67.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.19 -55.96 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.447 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . . . -62.12 -52.73 62.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.329 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -61.07 -37.37 82.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.263 -168.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.38 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.422 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.46 HG21 ' CD1' ' A' ' 31' ' ' ILE . 82.9 m -61.05 -44.7 97.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.245 -168.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 HD11 ' B' ' 39' ' ' ILE . 4.5 tp -59.79 -45.66 91.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.34 171.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -16.82 44.68 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.494 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.459 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 1.3 tptp -101.32 -26.15 13.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.326 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD11 ' HA ' ' A' ' 28' ' ' LEU . 1.6 mp -60.6 -68.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.792 161.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' B' ' 32' ' ' LEU . 3.7 mm? -58.48 -34.72 71.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.743 -168.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.459 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 0.8 OUTLIER -74.24 -50.2 20.1 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.001 -175.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -61.7 -44.09 97.59 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.952 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.511 ' HA ' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -60.46 -35.16 75.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.574 172.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.37 -49.32 32.69 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -60.3 -14.28 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.417 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -88.8 -47.13 8.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.52 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.537 HD13 HD12 ' B' ' 32' ' ' LEU . 20.5 mt -60.64 -30.73 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.285 170.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -61.72 -74.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.304 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.94 -18.9 61.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.462 -174.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -69.22 -61.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.013 167.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.97 -9.96 5.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.587 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HA ' HD13 ' A' ' 55' ' ' ILE . 65.8 mt -94.26 -52.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.946 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -60.32 -10.65 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.487 167.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.498 HD23 ' HB1' ' A' ' 63' ' ' ALA . 3.8 mp -82.96 -47.05 12.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.217 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.19 96.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.355 167.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -54.53 27.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.375 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.48 -28.78 68.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.332 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.07 92.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.317 169.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.66 17.83 2.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -98.77 -167.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.4 -171.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -127.23 -37.05 2.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.398 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.1 m -101.41 149.55 23.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.424 -168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' A' ' 44' ' ' ILE . 13.9 mm -91.44 137.8 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.365 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.74 175.46 9.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 178.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.66 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.227 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.58 -40.47 69.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.111 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -33.67 71.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.399 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.533 HG21 HD12 ' B' ' 28' ' ' LEU . 44.5 mm -61.15 -69.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.29 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -61.66 -12.09 14.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.269 -170.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mt -75.47 -48.93 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.391 168.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HB1' HD23 ' A' ' 46' ' ' LEU . . . -64.24 -35.72 81.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.361 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 25.0 t -66.09 -72.01 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.65 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.45 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -59.66 -11.16 4.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -169.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -29.36 14.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.367 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.49 ' CE2' HG12 ' A' ' 39' ' ' ILE . 1.5 m-85 -59.5 -22.97 62.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.445 163.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.64 82.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.443 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.631 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.369 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.46 ' HB3' ' CB ' ' A' ' 7' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.077 0.465 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -134.24 -159.2 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.039 171.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -107.9 97.79 22.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.529 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 2.4 Cg_endo -57.88 163.26 9.65 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.476 2.117 . . . . 0.0 113.509 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 pt -86.21 -25.25 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.4 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.64 -59.88 4.32 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.781 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 1.2 Cg_endo -54.48 -48.72 19.9 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 C-N-CA 122.498 2.132 . . . . 0.0 113.517 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.472 HD13 ' HB2' ' B' ' 3' ' ' LEU . 38.9 mt -61.03 -43.73 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.369 169.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -16.18 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.7 OUTLIER -96.38 -26.76 15.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.359 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -61.27 -56.02 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.325 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.475 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.8 mm -64.04 -36.11 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.168 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.8 OUTLIER -62.68 -36.9 84.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.435 171.205 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.57 -34.2 76.5 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.777 -1.102 . . . . 0.0 109.817 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -59.26 -53.34 59.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.488 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.58 19.93 0.35 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.806 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.513 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -60.2 120.9 10.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.311 -0.445 . . . . 0.0 110.335 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.27 -74.65 0.34 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.048 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -122.19 109.25 14.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.407 -169.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.505 HG13 ' HG2' ' B' ' 25' ' ' ARG . 47.5 t -112.14 150.27 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.74 150.04 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.311 169.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -60.85 -12.97 12.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.357 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -55.35 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.457 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -61.98 -40.69 96.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.304 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.505 ' HG2' HG13 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -61.61 -45.39 94.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.456 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 51.8 mt -77.73 -21.56 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.422 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.534 HG23 HD13 ' B' ' 31' ' ' ILE . 88.3 m -72.79 -50.58 23.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.312 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.533 HD12 HG21 ' A' ' 60' ' ' ILE . 3.2 tp -59.19 -37.86 78.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.561 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.09 75.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.32 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -26.42 23.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.43 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.534 HD13 HG23 ' B' ' 27' ' ' THR . 67.5 mt -61.04 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.033 170.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 39' ' ' ILE . 7.2 mp -60.03 -38.34 82.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.715 -170.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.537 ' HG2' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.37 -30.09 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.929 -170.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.02 -45.45 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.122 167.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 33.9 mtt -61.43 -42.33 98.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.517 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.07 99.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -170.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.498 ' HG3' HG22 ' A' ' 11' ' ' ILE . 2.4 mtp180 -60.43 -35.35 75.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.552 171.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -77.95 -45.7 23.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.499 -167.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 HD11 HD13 ' A' ' 28' ' ' LEU . 11.9 mt -60.85 -35.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.099 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.501 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -60.65 -59.55 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.341 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.537 ' HA ' HG23 ' B' ' 44' ' ' ILE . 72.0 p -68.79 -24.33 64.39 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.224 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -55.93 26.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.041 165.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -65.82 -13.68 59.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.602 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -87.62 -56.46 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.309 -164.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -72.26 -17.29 61.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.467 172.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' B' ' 43' ' ' ALA . 8.3 mt -60.83 -44.16 97.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.369 167.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.15 -44.02 97.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.362 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -50.99 25.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.43 -171.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -61.54 -34.29 75.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.32 91.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.335 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.1 29.99 5.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -110.46 135.63 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.404 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.88 -42.95 47.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.382 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.466 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 7.0 m -111.07 119.8 40.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.399 -168.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.525 HD13 HG21 ' A' ' 20' ' ' VAL . 79.9 mt -76.74 139.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.291 168.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.424 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 5.5 mtmt -141.8 -170.33 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.463 -169.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.36 73.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.241 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -30.43 69.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.064 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.19 -39.14 19.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.415 -166.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 28' ' ' LEU . 0.8 OUTLIER -65.2 -42.19 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.216 162.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.53 -31.15 71.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.977 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.7 -33.27 18.8 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.357 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.54 -42.9 97.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.436 172.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.529 HG21 HG12 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -82.44 -52.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -164.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.28 78.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.799 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.98 -17.93 54.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.9 t80 -60.97 -60.41 3.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.327 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.17 -76.58 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.441 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.585 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.373 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' HE3' ' HG2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.299 0.571 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.503 ' N ' ' HB3' ' B' ' 7' ' ' PRO . 4.2 mt-10 58.44 -161.48 0.24 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.727 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' CD1' ' HG3' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -102.77 96.83 8.19 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.589 174.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.4 Cg_endo -57.68 162.66 10.21 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.614 2.21 . . . . 0.0 113.545 170.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -84.82 -15.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.526 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -63.42 -58.59 14.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.762 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -59.3 -57.65 0.85 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.595 2.197 . . . . 0.0 113.619 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.437 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 27.5 mt -61.71 -43.33 97.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.372 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.536 ' HA2' ' HG2' ' A' ' 25' ' ' ARG . . . -61.74 -41.06 99.56 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.539 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -72.82 -18.47 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.455 -174.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.489 HD12 ' HG2' ' B' ' 33' ' ' GLU . 69.7 mt -77.67 -41.18 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.53 172.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' B' ' 40' ' ' ALA . 7.5 mm -63.99 -43.96 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.149 171.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.8 mttt -62.07 -35.68 79.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.244 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.49 -31.15 71.12 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.845 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.63 -52.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.521 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.1 24.6 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.493 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 20' ' ' VAL . . . -60.91 120.27 9.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.314 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -90.35 -48.02 7.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.189 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.52 90.43 2.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.501 168.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 17' ' ' ALA . 97.8 t -96.41 129.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.126 166.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 p -60.84 146.2 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.546 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -61.16 -21.97 64.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.34 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.14 -27.17 64.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.42 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' HB1' HG11 ' A' ' 20' ' ' VAL . . . -78.06 -41.76 34.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.288 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.536 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -60.7 -45.7 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.503 172.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.9 mt -66.55 -27.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.437 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.473 HG21 HG22 ' B' ' 60' ' ' ILE . 1.3 t -76.5 -33.19 58.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.228 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 31' ' ' ILE . 1.1 mm? -59.9 -39.13 84.34 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.434 170.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.05 98.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.396 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -25.69 24.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.415 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 28' ' ' LEU . 17.4 mt -61.42 -72.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.925 165.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.816 -167.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HG2' ' CD1' ' B' ' 11' ' ' ILE . 9.8 mt-10 -63.29 -55.69 22.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 170.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.77 -32.82 73.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.966 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.446 ' HB3' HD23 ' B' ' 32' ' ' LEU . 3.0 tpp -66.36 -44.83 82.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.414 167.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.24 99.14 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -35.17 75.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.195 -0.503 . . . . 0.0 110.427 169.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -61.42 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.533 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.537 HD11 HG21 ' A' ' 64' ' ' VAL . 8.7 mt -61.79 -31.78 51.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.353 -171.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' B' ' 12' ' ' ILE . . . -66.86 -61.18 2.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.253 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.531 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.1 OUTLIER -60.87 -10.52 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.412 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CE1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -81.37 -57.94 3.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.412 169.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -66.01 -5.47 9.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.818 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' A' ' 41' ' ' SER . 77.5 mt -85.95 -65.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.906 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -21.96 64.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.951 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 8.4 mp -60.01 -57.18 13.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.21 158.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.76 99.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.236 -169.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -56.57 13.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.472 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -64.45 -23.7 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.419 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.11 -55.71 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.016 164.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.27 19.67 0.26 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 113.85 -1.523 . . . . 0.0 111.035 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.64 -167.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.358 -0.495 . . . . 0.0 111.012 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 98.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 -164.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.4 m 71.65 117.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.622 165.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.52 ' HB ' HG12 ' B' ' 20' ' ' VAL . 14.6 mt -71.76 147.72 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.614 157.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' N ' HG21 ' A' ' 55' ' ' ILE . 27.9 mttt -141.97 160.63 39.83 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.323 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' B' ' 23' ' ' ASP . . . -61.99 -28.0 69.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -41.02 96.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.977 166.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.268 0.0 OUTLIER -67.6 -40.41 84.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.352 -173.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.528 HG12 ' HB3' ' B' ' 24' ' ' ALA . 45.7 mm -73.14 -36.12 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.288 -169.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -87.48 -17.56 31.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.157 177.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.489 HD21 ' N ' ' A' ' 62' ' ' LEU . 3.8 mm? -72.16 -47.17 52.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.104 164.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.65 94.76 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.063 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 39' ' ' ILE . 23.9 t -61.22 -73.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.616 171.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.85 -11.05 6.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.387 -167.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.484 ' HD2' HD22 ' A' ' 46' ' ' LEU . 7.4 mtt180 -70.4 -47.58 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.314 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -61.52 -58.31 8.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.311 167.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 105.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.405 -160.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.589 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.363 166.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttp . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.008 0.432 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.57 -166.44 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.693 171.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.531 ' HG ' ' HG3' ' B' ' 33' ' ' GLU . 0.3 OUTLIER -108.25 90.82 7.31 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.545 173.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.465 ' HG2' ' HE3' ' A' ' 1' ' ' MET . 15.7 Cg_exo -50.48 152.86 8.29 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 122.617 2.211 . . . . 0.0 113.622 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.468 ' CG2' HD12 ' B' ' 26' ' ' ILE . 17.4 pt -85.28 -10.61 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.858 -170.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.05 -62.69 1.76 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.781 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.503 ' HB3' ' N ' ' A' ' 2' ' ' GLU . 10.0 Cg_endo -53.93 -52.3 8.74 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.337 2.025 . . . . 0.0 113.505 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' B' ' 11' ' ' ILE . 26.3 mt -60.26 -38.43 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.461 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.77 95.17 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.622 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.521 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -80.7 -16.52 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.361 -0.42 . . . . 0.0 110.443 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' B' ' 8' ' ' ILE . 17.7 mt -80.15 -39.1 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.772 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.509 HG22 ' NH2' ' B' ' 25' ' ' ARG . 20.1 mm -61.18 -46.99 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.243 168.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 5.7 mtpt -63.65 -36.93 85.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.225 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.4 -30.82 70.79 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.878 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -57.28 -53.4 58.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.681 169.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.06 30.4 0.27 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.707 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -88.44 -175.5 5.0 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 114.763 -0.718 . . . . 0.0 110.296 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.25 -72.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.047 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -99.11 122.01 41.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.354 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.54 HG13 ' HG2' ' B' ' 25' ' ' ARG . 14.0 t -145.52 155.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.303 -166.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.452 ' N ' HG11 ' B' ' 20' ' ' VAL . 46.5 t -93.2 149.51 21.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 167.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.85 -13.07 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.267 167.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . 1.2 m-20 -60.4 -59.64 5.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.529 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.528 ' HB3' HG12 ' A' ' 60' ' ' ILE . . . -63.8 -43.97 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.315 -175.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.54 ' HG2' HG13 ' B' ' 20' ' ' VAL . 5.3 mmt-85 -67.62 -33.32 74.74 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.486 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.468 HD12 ' CG2' ' B' ' 5' ' ' ILE . 26.0 mm -84.25 -19.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.403 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 60' ' ' ILE . 89.5 m -71.77 -48.83 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.426 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.532 HD13 HD13 ' A' ' 39' ' ' ILE . 4.4 tp -60.53 -46.86 88.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.404 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -61.99 -29.69 70.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.467 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -26.02 15.03 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.319 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.528 HD11 HG23 ' A' ' 60' ' ' ILE . 79.4 mt -60.87 -70.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.961 163.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.46 ' CD2' ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.32 -27.23 67.17 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.551 -170.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.531 ' HG3' ' HG ' ' B' ' 3' ' ' LEU . 6.5 mt-10 -61.27 -47.2 87.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.203 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.8 -29.24 70.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.005 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.401 ' HA ' ' HE2' ' B' ' 35' ' ' MET . 0.2 OUTLIER -64.52 -49.8 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.427 166.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.0 98.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -32.4 71.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.393 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.47 -58.73 5.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.427 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' B' ' 67' ' ' PHE . 2.9 mt -65.61 -24.88 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.157 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 12' ' ' ILE . . . -64.2 -75.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.312 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.517 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.5 p -61.43 -16.81 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.583 -171.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.491 ' HG3' ' CE1' ' B' ' 67' ' ' PHE . 0.0 OUTLIER -72.45 -59.46 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.082 168.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -60.89 -12.72 11.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.41 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 17' ' ' ALA . 96.6 mt -94.45 -50.34 11.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.724 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.27 -21.37 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.547 168.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -71.61 -46.67 58.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.391 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -45.09 14.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.387 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -61.55 -35.93 79.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.356 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.85 -46.83 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.35 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 29.46 6.91 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 174.04 7.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.343 170.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.18 151.29 48.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.389 -168.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 99.1 m 70.1 127.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.463 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.527 ' HB ' HG23 ' A' ' 20' ' ' VAL . 4.6 mp -87.58 140.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.265 166.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -137.65 -171.25 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 27' ' ' THR . . . -61.13 -16.91 49.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 -166.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 1.3 tm-20 -90.15 -20.73 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.042 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.522 ' HB2' HG22 ' B' ' 55' ' ' ILE . 18.2 m-20 -81.06 -34.08 32.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.389 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.536 HG22 HD21 ' A' ' 28' ' ' LEU . 35.9 mm -60.53 -68.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.348 167.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.426 ' HA ' HG13 ' B' ' 64' ' ' VAL . 41.4 mt-10 -61.38 -15.29 34.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.772 -170.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 11.5 mt -68.31 -50.82 50.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.284 165.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.439 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.49 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -75.52 -56.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.861 -162.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -21.31 59.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.875 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -48.85 79.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.281 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' B' ' 39' ' ' ILE . 4.5 m-85 -60.67 -64.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.301 164.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' B' ' 68' ' ' LYS . 4.7 ttmm 178.69 169.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.343 -170.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.614 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.311 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -109.95 -40.12 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.993 169.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -87.67 126.06 63.02 Favored Pre-proline 0 C--O 1.243 0.761 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.224 -172.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 20.4 Cg_endo -60.89 148.1 93.43 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.099 1.866 . . . . 0.0 113.469 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 -12.48 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.846 -175.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.14 -56.3 7.25 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.701 173.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CG ' ' HB2' ' A' ' 4' ' ' PRO . 9.9 Cg_endo -63.22 -51.8 2.49 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.586 2.191 . . . . 0.0 113.542 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HA ' HD11 ' A' ' 11' ' ' ILE . 45.9 mt -60.88 -55.45 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.39 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -30.04 74.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -68.49 -36.33 78.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.397 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 8' ' ' ILE . 23.9 mt -60.63 -40.6 85.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.509 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.518 HG21 HD12 ' B' ' 44' ' ' ILE . 8.8 mm -68.09 -41.03 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.277 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.62 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.275 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -62.25 -35.11 77.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.855 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.75 -53.09 62.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.428 169.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.74 24.99 0.28 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.583 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.87 129.15 40.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.393 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.64 -37.64 6.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.115 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 109.64 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.37 169.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.501 HG23 HD11 ' B' ' 55' ' ' ILE . 17.5 t -107.51 127.69 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.308 169.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.45 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 26.6 t -62.5 146.45 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.352 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -30.28 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.347 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.8 -45.83 92.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.432 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' B' ' 56' ' ' LYS . . . -65.73 -59.06 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.297 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -62.55 -23.72 67.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -82.49 -32.72 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.564 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.4 m -61.21 -39.36 89.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.397 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD13 ' HB ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -60.79 -45.03 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.135 170.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -61.35 -42.95 99.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.461 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 1.3 ttpm? -76.15 -25.29 55.15 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.224 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.528 HG12 HG12 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -61.82 -50.42 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.402 162.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 ' HG ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -58.63 -36.4 74.03 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.608 -172.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HB2' HD23 ' A' ' 3' ' ' LEU . 22.3 tp10 -81.26 -41.37 22.31 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.978 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.526 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -86.34 -18.99 30.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.889 -170.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -44.35 48.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.9 160.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.29 99.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.696 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.526 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.38 -35.66 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.023 175.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -49.89 75.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.507 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.521 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 28.2 mt -61.62 -53.03 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.272 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' HG22 ' B' ' 12' ' ' ILE . . . -63.33 -47.83 80.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.28 -167.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.482 ' N ' ' HB3' ' B' ' 15' ' ' ALA . 7.1 t -64.68 -19.93 66.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.156 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -78.67 -50.05 12.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.124 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -71.67 -32.05 67.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.987 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.53 HD13 ' HB3' ' B' ' 17' ' ' ALA . 65.5 mt -60.58 -44.06 95.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.935 161.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.57 -31.05 70.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.477 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 6.5 mt -80.47 -43.44 20.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.279 -169.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.75 -38.87 86.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.221 165.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' HA ' ' HD3' ' A' ' 48' ' ' ARG . 8.0 tpp180 -71.71 -47.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.37 -169.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -34.47 74.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.446 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.72 83.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.242 168.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.61 43.66 5.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -168.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 tpt85 -119.45 160.8 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.334 -168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG2' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -93.65 147.37 23.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.393 -177.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.509 ' N ' ' HG2' ' A' ' 53' ' ' LYS . 98.8 m 68.16 128.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.475 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.524 HG23 HG11 ' B' ' 20' ' ' VAL . 41.1 mm -91.61 138.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.375 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -144.3 -171.76 3.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.316 -166.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' N ' ' HB3' ' B' ' 23' ' ' ASP . . . -74.13 -38.94 63.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.21 -167.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -61.34 -36.34 79.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.11 169.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -42.76 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.405 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' B' ' 24' ' ' ALA . 29.2 mm -61.11 -56.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.345 168.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HA ' HG13 ' A' ' 64' ' ' VAL . 7.6 mt-10 -62.06 -22.8 66.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.931 -172.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -52.6 64.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.312 165.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 43' ' ' ALA . . . -60.25 -44.81 94.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.588 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.514 ' HA ' ' CD2' ' A' ' 67' ' ' PHE . 0.4 OUTLIER -79.91 -55.52 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.043 -160.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -29.18 68.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.74 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.381 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 11.0 m-85 -60.73 -54.71 41.91 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.419 170.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -66.68 115.37 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.444 -168.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.629 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.324 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtm . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.535 ' HG3' ' HG3' ' B' ' 30' ' ' LYS . 0.0 OUTLIER 58.48 27.64 15.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.701 169.147 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.424 ' CB ' HD13 ' B' ' 8' ' ' ILE . 14.5 mt 60.24 86.25 0.16 Allowed Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.154 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.03 151.9 11.13 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.328 2.019 . . . . 0.0 113.547 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.535 HG23 ' HB2' ' B' ' 25' ' ' ARG . 1.1 pt -92.42 18.31 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.685 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.04 -58.67 0.59 Allowed Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.673 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.65 -54.57 2.76 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.18 . . . . 0.0 113.496 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.424 HD13 ' CB ' ' B' ' 3' ' ' LEU . 26.4 mt -67.83 -23.84 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.386 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.11 97.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.444 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -86.9 -14.2 42.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.477 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mt -60.97 -49.57 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 163.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.528 HG22 ' HB3' ' A' ' 40' ' ' ALA . 5.7 mt -92.03 -19.69 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.484 -166.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 9.3 mttm -62.48 -41.63 98.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.459 159.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.62 -33.01 73.18 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.09 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' B' ' 12' ' ' ILE . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.397 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.78 38.35 0.54 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.565 -163.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -79.8 164.09 23.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.767 -0.717 . . . . 0.0 110.26 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -132.0 -39.04 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.78 100.2 2.05 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.345 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -92.53 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.055 160.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.7 t -68.51 171.19 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.2 165.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' B' ' 25' ' ' ARG . 0.5 OUTLIER -60.58 -22.34 63.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.407 172.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.513 ' HB3' ' N ' ' A' ' 57' ' ' ALA . 1.8 m-20 -61.17 -61.67 2.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.48 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.516 ' HB3' HG12 ' A' ' 60' ' ' ILE . . . -62.4 -51.2 68.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.243 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HB2' HG23 ' B' ' 5' ' ' ILE . 1.4 ptm180 -60.89 -48.0 83.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.361 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' B' ' 22' ' ' ASP . 86.0 mt -62.08 -43.59 97.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.457 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.18 -45.84 89.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 -167.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' B' ' 31' ' ' ILE . 1.9 tp -59.51 -33.69 71.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.665 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -61.42 -41.55 97.34 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.311 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.535 ' HG3' ' HG3' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -96.49 -18.97 19.47 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.331 -174.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.54 HD11 ' HA ' ' B' ' 28' ' ' LEU . 42.7 mt -60.22 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.891 161.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.541 ' HG ' HD12 ' A' ' 32' ' ' LEU . 1.1 mp -58.49 -25.9 62.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.705 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -56.97 14.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.011 171.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -30.6 70.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.935 -168.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.434 ' CG ' HD12 ' B' ' 39' ' ' ILE . 3.4 tpp -61.98 -45.08 95.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.297 164.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.51 -41.44 94.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.422 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.41 -57.46 8.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.493 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 28' ' ' LEU . 1.9 mt -62.16 -29.42 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.872 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -62.28 -75.14 0.08 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -62.13 -12.71 21.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.454 -170.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.5 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -88.27 -44.52 10.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.23 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.517 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -66.64 -10.76 49.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.344 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.537 HD12 ' HB1' ' A' ' 17' ' ' ALA . 74.0 mt -95.39 -53.98 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.113 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -60.69 -21.36 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.468 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' B' ' 43' ' ' ALA . 5.9 mt -66.72 -63.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.429 168.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.05 75.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.22 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -38.23 51.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.419 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.63 -35.96 77.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.331 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' B' ' 52' ' ' ARG . . . -60.75 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.301 167.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 52.39 5.96 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -130.22 21.94 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.341 -169.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt 65.31 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.472 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 1.7 m -89.09 140.54 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.366 -167.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.501 HD11 HG23 ' A' ' 20' ' ' VAL . 3.6 mt -92.83 140.85 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.391 168.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.526 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.61 178.71 5.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.45 -169.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.92 -22.48 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.376 174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.511 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 4.4 tp10 -71.37 -22.44 61.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.166 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.59 -35.4 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.297 -172.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 28' ' ' LEU . 1.3 mp -64.2 -36.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.487 160.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 1.1 mt-10 -62.06 -46.23 90.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.84 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.42 -50.35 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.525 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.65 -56.61 19.22 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.521 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.528 HG12 HG12 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -64.2 -52.62 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.227 -170.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -60.49 -37.23 80.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.742 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . 0.462 ' HA ' ' HD2' ' B' ' 66' ' ' ARG . 1.4 tpt180 -61.6 -40.57 95.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -171.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 1.2 m-85 -60.86 -61.82 2.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.398 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -86.47 93.63 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? . . . . . 0 C--O 1.24 0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.336 171.774 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.514 ' N ' ' HB2' ' A' ' 33' ' ' GLU . 7.1 tpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 1' ' ' MET . 1.2 tp10 59.44 28.32 17.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.515 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.474 HD23 HD12 ' B' ' 11' ' ' ILE . 0.2 OUTLIER -106.51 84.87 1.56 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.458 160.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.469 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 8.0 Cg_endo -61.31 144.14 98.41 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.472 2.115 . . . . 0.0 113.525 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.44 HD11 ' NH2' ' A' ' 25' ' ' ARG . 2.5 pp -64.96 -7.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.911 -169.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . . . -81.19 -55.17 0.67 Allowed Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.81 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 3.5 Cg_endo -59.7 -49.8 9.36 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.469 2.112 . . . . 0.0 113.599 176.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 27.8 mt -60.83 -37.77 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.232 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.79 -16.03 44.27 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.564 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 3.8 tpp85 -96.3 -26.66 15.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG22 ' HG3' ' B' ' 37' ' ' ARG . 8.6 mm -60.28 -54.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.394 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.531 HG21 HD13 ' B' ' 44' ' ' ILE . 8.1 mm -76.73 -35.88 25.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.271 -164.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -65.1 -34.62 78.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.338 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.33 -33.39 74.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.77 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' B' ' 40' ' ' ALA . . . -58.64 -54.18 50.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.461 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.19 30.4 0.31 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.613 -173.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -75.99 147.3 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.727 -0.737 . . . . 0.0 110.344 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' HG3' ' NH1' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -171.13 47.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.013 166.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.508 ' NH1' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -164.88 24.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.42 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 24' ' ' ALA . 37.3 t -85.85 119.65 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.31 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB3' ' CG2' ' B' ' 54' ' ' THR . 25.1 p -62.2 164.23 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.297 168.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 11.7 t70 -60.65 -21.89 63.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.535 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -90.04 -31.94 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.448 -168.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -69.39 -44.03 72.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.22 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.99 -21.99 59.78 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.383 -173.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -83.45 -42.81 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.361 178.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.538 HG23 HG23 ' B' ' 60' ' ' ILE . 57.3 m -61.34 -38.49 87.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.447 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 HG23 ' B' ' 39' ' ' ILE . 3.6 tp -62.02 -41.37 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.131 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.58 98.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.354 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 2.4 tppt? -83.32 -29.05 28.62 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.396 -172.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.525 HG23 HG23 ' B' ' 64' ' ' VAL . 45.4 mt -60.53 -66.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.011 165.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 HD11 HD22 ' B' ' 32' ' ' LEU . 0.7 OUTLIER -58.15 -32.96 68.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.787 -169.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.514 ' HB2' ' N ' ' A' ' 1' ' ' MET . 1.8 pp20? -82.67 -30.96 28.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.081 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -61.64 -33.92 74.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 168.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -55.58 8.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.509 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.442 ' CA ' HD12 ' B' ' 32' ' ' LEU . . . -61.15 -45.11 97.2 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -60.69 -33.92 73.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.419 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.76 -56.78 8.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.481 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.531 ' HB ' HD13 ' B' ' 28' ' ' LEU . 4.5 mt -61.51 -26.1 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.289 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' HB1' ' CD1' ' B' ' 12' ' ' ILE . . . -61.82 -74.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.211 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.459 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 15.5 t -62.2 -12.88 22.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.351 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -80.55 -57.88 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.07 171.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HA ' HD21 ' A' ' 46' ' ' LEU . . . -60.78 -10.49 5.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.595 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 HD13 HG21 ' B' ' 12' ' ' ILE . 96.9 mt -98.89 -51.42 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.662 -174.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 12.2 ttpt -60.04 -10.58 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.348 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 62' ' ' LEU . 3.8 mp -82.73 -42.6 17.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.246 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.09 77.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.353 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -82.71 -43.93 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.415 -168.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.44 ' N ' ' HD3' ' A' ' 48' ' ' ARG . 7.1 m-70 -61.22 -23.86 65.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.191 168.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.94 -54.34 46.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.082 165.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.12 29.85 0.38 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.532 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.64 99.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.782 -0.709 . . . . 0.0 110.446 169.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.69 -169.08 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.297 168.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -65.22 125.53 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.378 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 44' ' ' ILE . 44.6 mt -62.53 147.8 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.301 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -145.95 164.02 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.509 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.06 64.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.247 -168.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -58.14 9.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.034 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.89 -21.79 65.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.434 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 HG23 HG21 ' B' ' 27' ' ' THR . 29.8 mm -72.68 -76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.224 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.538 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.5 OUTLIER -62.74 -8.44 6.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.454 -176.011 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 46' ' ' LEU . 3.4 tt -90.12 -27.56 19.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.586 172.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 66' ' ' ARG . . . -81.53 -31.98 32.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.005 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 25.7 t -60.64 -69.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.637 160.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -14.3 19.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.565 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -62.09 -51.12 69.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.358 167.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 54.0 m-85 -60.58 -52.27 65.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.537 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.533 ' HD3' ' HE2' ' B' ' 69' ' ' LYS . 5.8 ttmt 62.74 14.9 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.429 -169.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm . . . . . 0 C--O 1.24 0.568 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.485 -174.32 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.175 0.512 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -161.12 113.12 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.971 170.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' B' ' 33' ' ' GLU . 2.8 mt -69.42 139.8 89.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.699 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -61.12 142.63 97.52 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 122.471 2.114 . . . . 0.0 113.558 167.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.433 HG21 HD11 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -67.78 -20.19 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.381 -170.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.35 -62.2 6.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.736 -170.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.07 -50.56 13.52 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.455 2.103 . . . . 0.0 113.623 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' B' ' 29' ' ' ALA . 7.5 mt -62.22 -21.7 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.449 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.86 97.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.624 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -86.44 -15.32 40.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.522 -173.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.474 HD12 HD23 ' A' ' 3' ' ' LEU . 11.1 mm -60.85 -73.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.234 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.535 HG21 ' HB1' ' B' ' 17' ' ' ALA . 8.0 mm -63.27 -20.96 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.936 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.483 ' HB3' ' NZ ' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -73.51 -36.35 65.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.391 172.016 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.92 -31.88 72.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.825 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.64 64.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.455 170.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.96 33.5 0.51 Allowed Glycine 0 CA--C 1.527 0.783 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.607 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' B' ' 12' ' ' ILE . . . -77.45 147.1 36.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.28 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -106.48 -67.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.977 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 112.14 9.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.418 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.461 ' CG2' HD11 ' A' ' 55' ' ' ILE . 80.6 t -103.62 137.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.31 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 54.0 p -61.11 146.55 47.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.427 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.502 ' HA ' ' NH1' ' B' ' 25' ' ' ARG . 2.3 p30 -61.69 -24.4 66.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.412 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.53 ' HA ' HG21 ' B' ' 26' ' ' ILE . 4.9 t0 -84.04 -26.0 29.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.382 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.413 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -62.7 -45.05 94.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.171 168.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.502 ' NH1' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptt-85 -85.88 -13.27 48.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.554 -166.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.53 HG21 ' HA ' ' B' ' 23' ' ' ASP . 0.1 OUTLIER -84.12 -38.33 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.444 168.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 31' ' ' ILE . 59.4 m -61.33 -43.15 99.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.218 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 39' ' ' ILE . 2.6 tp -60.22 -37.59 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.272 166.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' B' ' 8' ' ' ILE . . . -61.33 -43.04 99.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -26.13 33.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.448 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 27' ' ' THR . 34.7 mt -60.95 -71.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.539 HD22 HD11 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.99 -32.19 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.681 -166.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.529 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.7 pp20? -80.85 -39.68 26.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.175 -170.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -61.59 -39.23 90.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.007 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 4.8 mtp -61.0 -54.86 39.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.535 168.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.485 ' HA2' HD22 ' A' ' 32' ' ' LEU . . . -61.3 -45.81 95.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -165.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.501 ' HG3' HG22 ' A' ' 11' ' ' ILE . 9.2 mtp-105 -61.21 -32.33 72.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.235 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.5 -49.58 76.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.604 175.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.537 HG23 HD12 ' A' ' 28' ' ' LEU . 2.8 mt -62.06 -37.17 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.524 ' HB3' HD13 ' A' ' 12' ' ' ILE . . . -61.59 -69.0 0.27 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.315 -175.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 1.4 p -62.17 -10.27 10.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -93.84 -50.78 5.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.279 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.531 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.72 -10.57 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.376 170.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 12' ' ' ILE . 87.4 mt -101.24 -50.77 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.752 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' B' ' 45' ' ' LYS . 15.3 tptp -60.42 -11.71 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.463 168.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.531 HD11 ' HA ' ' B' ' 43' ' ' ALA . 6.0 mt -83.97 -54.05 5.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.395 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.462 ' CB ' HD12 ' B' ' 55' ' ' ILE . . . -61.22 -21.15 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.386 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -44.91 15.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.311 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -60.41 -30.51 69.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.398 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.64 -49.78 76.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.423 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.26 37.6 0.79 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -168.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mtt85 66.05 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.492 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -130.77 -177.65 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.351 167.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 21' ' ' SER . 87.7 m -78.16 130.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.468 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 13.5 mm -69.97 134.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.249 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -139.73 175.51 9.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.527 -171.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -25.37 67.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.279 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.17 -63.59 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.11 169.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.524 ' HA ' HD11 ' B' ' 62' ' ' LEU . 1.0 OUTLIER -61.06 -12.44 11.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.468 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.538 HG23 HG23 ' A' ' 27' ' ' THR . 41.4 mm -88.39 -57.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.178 -177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.467 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 9.6 mt-10 -61.48 -16.89 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.177 170.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -67.56 -59.73 3.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.324 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' B' ' 39' ' ' ILE . . . -65.09 -30.77 71.75 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.119 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.525 HG23 HG23 ' A' ' 31' ' ' ILE . 43.4 t -61.61 -71.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.693 169.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -61.16 -9.17 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.497 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.51 48.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.296 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' B' ' 39' ' ' ILE . 38.1 m-85 -60.67 -53.62 55.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.34 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 64.46 -76.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.359 -167.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.533 ' HE2' ' HD3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.548 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.358 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.101 0.477 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.9 167.27 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.962 -170.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 mt -61.36 107.89 1.3 Allowed Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.916 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.29 148.8 13.62 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.341 2.027 . . . . 0.0 113.285 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.1 pp -93.03 20.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.628 -167.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.53 -59.54 0.31 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.68 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.05 -50.46 14.0 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.493 2.129 . . . . 0.0 113.522 172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG21 HD13 ' A' ' 12' ' ' ILE . 86.3 mt -69.05 -30.36 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.382 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.04 99.66 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.47 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -78.25 -31.91 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.353 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HD12 ' CD2' ' B' ' 3' ' ' LEU . 85.5 mt -60.81 -40.05 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.379 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.538 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . 12.1 mt -97.86 -15.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.516 -162.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -38.1 85.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 158.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.85 -33.57 76.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.022 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 12' ' ' ILE . . . -57.85 -52.11 66.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.483 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.0 25.15 0.2 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.772 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -76.09 152.4 36.81 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 114.665 -0.768 . . . . 0.0 110.262 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 -42.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.194 169.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 113.56 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.421 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' B' ' 55' ' ' ILE . 22.4 t -137.3 161.93 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.393 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.8 p -88.42 133.93 33.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.414 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.99 -25.4 68.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.358 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.93 -36.38 79.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.421 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.17 -52.67 61.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.272 169.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -68.82 -18.0 64.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.477 -168.629 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.25 -37.79 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.44 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.6 m -60.74 -32.29 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.457 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' HB2' HG12 ' B' ' 60' ' ' ILE . 10.9 tp -92.03 -33.74 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.024 -171.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 8' ' ' ILE . . . -61.02 -41.9 97.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.153 166.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -36.11 83.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.517 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.135 -167.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' B' ' 32' ' ' LEU . 2.8 mp -65.71 -57.61 7.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.507 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HG2' HD11 ' B' ' 11' ' ' ILE . 9.5 tm-20 -61.47 -32.97 72.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.166 -166.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -40.25 95.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.93 170.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt -65.17 -38.02 89.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.581 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.466 ' CA ' HD22 ' B' ' 32' ' ' LEU . . . -76.98 -40.54 25.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -24.41 66.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.165 164.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -60.6 2.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.514 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.529 HD13 HD12 ' B' ' 32' ' ' LEU . 5.0 mt -61.37 -31.73 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.3 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -61.43 -61.36 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.347 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.6 -27.35 68.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.33 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -61.13 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.011 166.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 46' ' ' LEU . . . -72.28 -12.24 61.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.576 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -85.86 -56.67 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.268 -168.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HD2' ' NH2' ' A' ' 48' ' ' ARG . 20.5 ttpp -66.52 -19.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.457 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.503 HD21 ' HA ' ' A' ' 43' ' ' ALA . 3.2 mp -60.88 -44.05 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.294 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.6 -58.83 6.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.401 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.511 ' NH2' ' HD2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -71.07 -28.8 64.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.304 -165.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -60.54 -39.69 88.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.324 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.28 -54.98 39.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.007 164.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.74 32.85 0.31 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.583 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 69.42 -87.89 0.03 OUTLIER 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.769 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt 58.44 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.055 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -157.8 168.47 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.129 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.417 ' HB ' HG21 ' B' ' 20' ' ' VAL . 6.7 mm -82.44 137.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.214 165.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.22 155.87 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.418 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' CB ' ' HB3' ' B' ' 23' ' ' ASP . . . -61.33 -29.2 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.236 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.54 -42.43 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 169.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.03 -43.12 79.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.487 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG13 ' CB ' ' B' ' 24' ' ' ALA . 44.7 mm -61.24 -45.72 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.499 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.74 -28.47 60.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.106 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.08 -43.3 87.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.31 169.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 39' ' ' ILE . . . -61.49 -41.44 97.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.4 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG22 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -83.81 -55.08 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.143 -169.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -27.61 66.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.839 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -69.8 -36.29 75.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.377 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -27.95 68.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 170.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.22 169.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 165.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mttm . . . . . 0 C--O 1.238 0.499 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.368 168.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.8 ttm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 58.48 -164.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.67 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 3.9 mt -68.96 138.87 90.26 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.874 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -58.02 144.44 94.59 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.368 2.046 . . . . 0.0 113.509 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.08 -24.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.375 -168.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' B' ' 7' ' ' PRO . . . -64.98 -56.39 21.12 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 6' ' ' ALA . 5.8 Cg_endo -48.37 -53.83 6.2 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 122.507 2.138 . . . . 0.0 113.446 171.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.479 ' HA ' HD13 ' B' ' 11' ' ' ILE . 36.2 mt -61.1 -33.95 58.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.514 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -29.04 71.17 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.529 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 11.6 mtp-105 -87.88 -28.29 21.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.795 -0.703 . . . . 0.0 110.494 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.528 HD11 ' HG2' ' A' ' 33' ' ' GLU . 65.5 mt -60.9 -53.07 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.419 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.528 HD13 ' HB3' ' A' ' 40' ' ' ALA . 7.0 mm -63.87 -37.88 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.259 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 3.1 mtpm? -61.49 -35.78 78.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.265 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.82 -32.43 72.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.794 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 44' ' ' ILE . . . -58.6 -53.58 56.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.506 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.92 21.61 0.29 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.956 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.508 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -76.21 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.275 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -167.69 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.048 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -130.8 98.98 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.459 168.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.417 HG21 ' HB ' ' A' ' 55' ' ' ILE . 58.3 t -106.22 145.21 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.322 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.7 p -70.06 155.99 39.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.321 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.413 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 1.0 OUTLIER -61.89 -32.09 72.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.353 176.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.463 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 1.4 m-20 -61.56 -48.47 80.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.407 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.464 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -62.04 -52.35 64.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.274 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 0.4 OUTLIER -61.25 -38.36 86.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.274 -168.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -67.01 -37.61 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.47 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 60' ' ' ILE . 84.5 m -61.08 -52.26 65.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.421 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.531 ' HA ' HD13 ' B' ' 31' ' ' ILE . 4.1 tp -61.1 -42.3 98.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.335 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.421 ' HA ' HD13 ' B' ' 3' ' ' LEU . . . -60.76 -28.17 68.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.416 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -26.29 18.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' B' ' 28' ' ' LEU . 17.8 mt -60.87 -71.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.985 166.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.537 ' HB3' HD22 ' A' ' 32' ' ' LEU . 5.6 mp -59.44 -30.15 68.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.595 -168.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.52 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 7.1 tm-20 -75.83 -30.66 59.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.09 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.37 -44.79 96.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.065 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 12.6 mtt -62.37 -39.62 93.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.407 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -39.41 73.86 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -29.39 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 168.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.7 OUTLIER -82.31 -52.53 6.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.482 -169.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.499 HG12 HG21 ' B' ' 64' ' ' VAL . 5.6 mt -61.32 -34.28 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.185 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -77.6 -44.4 28.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.168 -164.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.414 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 4.4 t -70.62 -13.82 62.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.422 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 2.8 mm-40 -83.11 -44.76 14.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.993 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -80.59 -11.1 59.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.339 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.522 HD13 ' HB1' ' A' ' 17' ' ' ALA . 72.7 mt -93.85 -49.16 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -60.69 -24.1 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.344 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' B' ' 43' ' ' ALA . 2.9 mt -68.15 -54.13 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.367 170.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.53 ' HB3' HG12 ' B' ' 55' ' ' ILE . . . -61.13 -28.83 69.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.382 -167.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.46 -44.97 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.388 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -61.43 -37.36 83.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.327 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.5 75.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.197 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.92 47.86 4.33 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -165.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.67 -43.6 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.338 -166.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.58 118.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.473 -168.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 7.3 m 68.53 139.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.489 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' B' ' 47' ' ' ALA . 26.6 mt -105.19 163.21 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.374 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.511 ' N ' HG21 ' B' ' 55' ' ' ILE . 12.1 mtmt -149.51 166.24 29.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 -169.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -12.96 26.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.256 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.522 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 26.9 mt-10 -86.44 -19.0 30.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.078 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.463 ' CB ' HG22 ' B' ' 55' ' ' ILE . 0.8 OUTLIER -82.53 -33.71 28.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.288 174.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mp -61.88 -56.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.67 161.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 3.0 mt-10 -61.31 -30.29 70.4 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.71 -168.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 46' ' ' LEU . 12.0 tp -76.32 -46.69 26.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.639 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' B' ' 42' ' ' GLU . . . -61.27 -24.11 66.16 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.416 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.517 ' HA ' ' CD1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -110.65 -55.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -160.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -10.7 2.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.668 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -92.9 -65.64 0.98 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.613 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' B' ' 64' ' ' VAL . 0.1 OUTLIER -62.49 -23.67 67.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -155.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -96.22 87.07 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.417 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.565 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.35 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 mtt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.149 0.499 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -63.1 -158.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.196 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp -56.5 102.36 0.3 Allowed Pre-proline 0 C--O 1.251 1.134 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.598 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 3.5 Cg_exo -65.77 159.95 46.06 Favored 'Trans proline' 0 N--CA 1.484 0.967 0 C-N-CA 122.932 2.421 . . . . 0.0 113.542 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 2.6 pp -93.47 -26.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.394 -166.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -68.57 -56.49 9.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.698 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 2.0 Cg_endo -60.47 -47.65 13.5 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.121 1.881 . . . . 0.0 113.513 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 26.4 mt -60.87 -34.69 60.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.271 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.52 -26.82 65.02 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.541 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -84.35 -27.25 27.86 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.326 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.52 -58.44 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.454 169.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.515 HG21 HD13 ' B' ' 44' ' ' ILE . 8.7 mm -65.62 -42.64 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.198 -166.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -31.95 72.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.34 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.28 -33.71 75.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.756 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.27 -53.66 55.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.447 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.76 19.46 0.57 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.711 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.66 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.281 165.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.041 167.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.67 110.53 22.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.347 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.534 HG21 ' HB ' ' B' ' 55' ' ' ILE . 45.7 t -145.78 148.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.353 -169.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 p -87.45 154.78 20.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.383 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.524 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 9.5 p30 -61.14 -31.46 71.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.472 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.517 ' HA ' HG23 ' A' ' 26' ' ' ILE . 1.1 m-20 -83.87 -25.3 30.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.397 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' B' ' 56' ' ' LYS . . . -61.03 -40.08 92.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.252 168.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' A' ' 22' ' ' ASP . 5.8 mtt180 -66.64 -47.53 72.27 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.476 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 HG23 ' HA ' ' A' ' 23' ' ' ASP . 2.3 tp -65.16 -35.99 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.356 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 31' ' ' ILE . 13.3 m -61.16 -53.68 53.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.293 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.535 HD13 ' HB ' ' B' ' 39' ' ' ILE . 6.0 tp -60.86 -9.82 4.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.251 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -84.52 -58.55 2.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.423 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -61.77 -26.12 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.22 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD11 ' HA ' ' A' ' 28' ' ' LEU . 2.3 mp -60.87 -74.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.961 161.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.537 HD11 ' HG ' ' B' ' 32' ' ' LEU . 2.3 mm? -57.79 -30.1 65.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.617 -161.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.512 ' HB3' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.19 -44.18 47.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.262 178.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.58 -37.05 73.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.09 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 23.8 mmt -61.29 -40.48 94.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.38 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.32 -47.23 72.81 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -17.72 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.458 171.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -86.83 -49.94 7.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.385 -173.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 64' ' ' VAL . 4.8 mt -61.81 -23.84 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.081 171.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.87 -73.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.358 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.519 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 30.2 m -61.57 -13.05 18.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.312 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -78.47 -57.14 3.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.329 170.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -61.42 -11.9 12.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.529 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.519 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 96.9 mt -96.81 -51.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.791 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -60.21 -15.6 25.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.459 167.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 8.3 mt -79.17 -41.1 29.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.46 171.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' A' ' 55' ' ' ILE . . . -61.23 -17.98 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.24 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 -48.01 7.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.49 170.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.75 -14.6 33.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.395 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.63 -48.56 7.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.271 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 42.15 3.42 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -165.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.99 160.47 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.356 -165.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -117.27 145.81 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.307 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 ' CG2' ' HG3' ' B' ' 19' ' ' ARG . 3.8 m 69.83 158.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -168.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' A' ' 47' ' ' ALA . 11.0 mm -109.48 160.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.462 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.42 173.57 11.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.339 -168.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -72.83 -16.7 61.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.403 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 4.9 mm-40 -80.69 -14.35 58.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.264 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -88.04 -40.4 13.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.307 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG23 HG21 ' B' ' 27' ' ' THR . 1.4 mp -61.5 -47.25 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.823 162.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 6.3 mt-10 -61.74 -42.22 98.68 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.983 -166.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.18 -28.71 27.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.433 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -60.26 -43.62 96.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.452 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 HG22 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -82.55 -55.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.009 -164.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -60.22 -24.61 64.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -14.96 23.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.462 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 46.0 t80 -60.77 -57.3 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.409 171.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.96 -76.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.484 -175.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 69' ' ' LYS . 9.8 mtmt . . . . . 0 C--O 1.241 0.615 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.371 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -68.54 -157.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.431 ' HB3' HD12 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -103.86 83.03 0.61 Allowed Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.546 177.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.46 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -61.33 149.6 88.69 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.599 2.199 . . . . 0.0 113.597 166.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -63.3 -13.14 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.786 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.89 -57.49 3.04 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.735 -178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.46 ' CG ' ' HG2' ' B' ' 4' ' ' PRO . 10.1 Cg_endo -54.94 -59.42 0.82 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.643 2.229 . . . . 0.0 113.596 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.488 HG23 HD11 ' B' ' 8' ' ' ILE . 26.7 mt -61.63 -49.05 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.371 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.71 -27.54 68.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 13.1 tpt180 -78.14 -26.55 47.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.509 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.447 HD12 HD12 ' A' ' 3' ' ' LEU . 66.4 mt -69.88 -46.54 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.491 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.521 HG21 ' HB3' ' A' ' 40' ' ' ALA . 10.4 mm -64.41 -38.97 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.191 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.65 -35.32 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.376 168.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -62.16 -33.6 74.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.729 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.5 57.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.358 169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.2 14.65 0.62 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.256 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.59 147.54 41.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.318 162.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -55.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.114 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.451 ' HG3' ' CG2' ' A' ' 54' ' ' THR . 4.7 tpt180 -101.94 104.89 15.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.4 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -133.83 146.76 31.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.375 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 35.7 p -85.37 143.11 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.448 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -71.83 -28.46 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.31 -170.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -34.48 74.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.47 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -61.27 -54.04 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.258 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.536 ' HD3' ' HB ' ' B' ' 5' ' ' ILE . 5.7 mtt180 -64.96 -12.59 51.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.463 -170.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.466 HG13 ' CG2' ' B' ' 5' ' ' ILE . 86.4 mt -103.64 -25.63 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.447 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 60' ' ' ILE . 81.8 m -63.41 -44.06 95.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.528 ' HA ' HD11 ' B' ' 31' ' ' ILE . 1.9 tp -59.92 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.295 172.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.13 -38.19 85.5 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.561 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -80.41 -28.52 37.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.203 -173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' B' ' 28' ' ' LEU . 2.7 mt -60.81 -70.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.996 160.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.75 -16.76 18.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.723 -166.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.18 -37.65 12.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.083 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -61.27 -57.64 11.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.254 171.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' B' ' 32' ' ' LEU . 19.0 ptp -62.33 -28.7 69.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.343 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.18 -46.24 51.52 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.566 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -14.54 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -89.97 -51.06 5.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.534 -173.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.535 ' HB ' HD13 ' A' ' 28' ' ' LEU . 6.8 mt -61.96 -26.3 39.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.053 171.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -62.14 -68.41 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.212 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.529 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 86.6 p -61.1 -10.65 6.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.534 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.0 OUTLIER -95.54 -36.04 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.035 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.461 ' CA ' ' HB1' ' B' ' 63' ' ' ALA . . . -75.52 -9.93 59.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.373 167.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 58.0 mt -98.6 -49.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.923 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.53 ' HA ' ' HG2' ' B' ' 48' ' ' ARG . 10.9 mttp -60.27 -27.79 67.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.453 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' B' ' 63' ' ' ALA . 10.0 mt -61.5 -55.44 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.346 166.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -31.36 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.312 -168.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.53 ' HG2' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -74.3 -38.13 63.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.408 178.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.444 ' N ' ' HG3' ' B' ' 48' ' ' ARG . 38.2 t-80 -60.55 -32.28 71.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.229 168.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.36 -53.97 51.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.28 170.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.94 23.96 0.75 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.775 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 56.0 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.1 0.476 . . . . 0.0 111.914 169.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -67.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.391 168.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' B' ' 55' ' ' ILE . 93.6 m -146.28 166.47 26.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.364 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.534 ' HB ' HG21 ' A' ' 20' ' ' VAL . 65.7 mt -119.4 146.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.408 170.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.534 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -137.91 -172.92 3.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.424 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.45 -16.41 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 0.1 OUTLIER -79.36 -25.32 42.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.102 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HB3' HG22 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -85.94 -35.51 20.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.281 -176.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 28' ' ' LEU . 1.2 mp -61.77 -46.4 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.705 160.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -62.09 -40.29 95.34 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.823 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.486 HD11 ' N ' ' B' ' 62' ' ' LEU . 7.5 mp -74.76 -45.38 44.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.55 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.5 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -61.37 -31.81 71.71 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.387 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.527 HG21 HG12 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -95.16 -54.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.983 -165.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -16.68 34.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.697 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -11.81 15.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 3.2 t80 -61.1 -52.52 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.278 166.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.81 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.366 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.238 0.497 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.682 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 58.84 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.714 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.5 HD12 HD13 ' B' ' 11' ' ' ILE . 6.3 mp -57.47 98.91 0.17 Allowed Pre-proline 0 C--O 1.251 1.178 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.499 -172.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 25' ' ' ARG . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.491 HD12 ' HG3' ' B' ' 33' ' ' GLU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' HB ' ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HB3' HG23 ' A' ' 5' ' ' ILE . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.512 HG23 ' HB ' ' B' ' 60' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 28' ' ' LEU . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.475 ' HE1' ' HE2' ' B' ' 35' ' ' MET . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 HG22 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 ' HB ' HG23 ' B' ' 27' ' ' THR . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 -60.56 -61.8 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 65.16 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.486 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.543 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.32 -168.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.09 0.472 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 59.15 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.783 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' B' ' 33' ' ' GLU . 3.4 mt -73.84 137.2 76.62 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.783 -168.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.5 HD13 HD12 ' A' ' 3' ' ' LEU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' B' ' 24' ' ' ALA . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 31' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 60' ' ' ILE . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 27' ' ' THR . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.512 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.475 ' HE2' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.504 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' B' ' 43' ' ' ALA . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 27' ' ' THR . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.467 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.504 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.516 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.93 -46.57 90.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.81 -76.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.382 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.353 -169.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptp . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 121.12 0.486 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.408 ' HG2' ' N ' ' A' ' 3' ' ' LEU . 45.8 tt0 -78.23 174.71 10.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.055 169.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.5 mt -63.02 138.76 97.41 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.791 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.96 148.93 82.46 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.392 2.061 . . . . 0.0 113.44 167.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.47 HG23 HG12 ' A' ' 26' ' ' ILE . 2.5 pp -85.1 -28.91 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.14 -62.22 6.21 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.779 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HB3' ' HB3' ' B' ' 2' ' ' GLU . 5.7 Cg_endo -51.89 -46.24 33.46 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.48 2.12 . . . . 0.0 113.588 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -61.18 -59.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.76 -26.76 67.35 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.0 -32.97 61.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.348 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG21 ' HD2' ' B' ' 37' ' ' ARG . 44.2 mt -60.76 -40.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.493 169.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' HA ' ' CB ' ' B' ' 40' ' ' ALA . 19.4 mm -66.51 -34.58 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.405 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -29.93 65.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.392 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -62.6 -35.52 79.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.811 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.49 -53.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.395 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.63 18.46 0.32 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.834 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 20' ' ' VAL . . . -60.81 142.2 56.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.311 165.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.66 -33.58 3.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.117 -169.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 88.09 1.91 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.486 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.519 HG21 HD11 ' B' ' 55' ' ' ILE . 23.5 t -114.91 133.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.381 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -92.02 157.73 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.434 -169.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.02 -49.02 79.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.375 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.33 96.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.335 -175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 5.6 mtt180 -63.31 -47.21 83.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.434 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG12 HG23 ' A' ' 5' ' ' ILE . 11.0 mm -60.69 -32.79 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.506 172.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.522 HG22 ' HB ' ' B' ' 60' ' ' ILE . 83.3 m -67.66 -43.08 81.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.335 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD11 HD13 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -61.32 -34.13 74.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.314 177.014 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 3' ' ' LEU . . . -75.75 -47.92 23.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.203 -168.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.77 -32.8 72.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.32 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 28' ' ' LEU . 13.0 mt -60.91 -77.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.935 164.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -57.89 -29.06 64.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.718 -160.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -75.51 -41.82 54.28 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.165 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -68.16 -25.15 65.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.02 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.45 -33.6 31.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.478 174.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.03 -39.47 84.59 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.97 -33.54 73.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.261 165.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 1.6 t0 -64.57 -60.88 2.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.432 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 HG12 ' CE1' ' A' ' 67' ' ' PHE . 15.3 mt -61.17 -29.31 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.506 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.33 -63.45 1.28 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.261 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 88.5 p -61.66 -26.76 68.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.158 -175.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.514 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 28.4 mm-40 -61.05 -45.74 93.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.029 163.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.493 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -76.14 -8.14 56.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.903 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -90.7 -55.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.999 -169.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -63.49 -20.97 66.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.636 168.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 62' ' ' LEU . 2.0 mp -61.16 -58.17 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.442 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HB1' HG12 ' A' ' 55' ' ' ILE . . . -61.69 -22.04 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.19 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.4 ttp-105 -97.04 -31.44 12.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.267 -168.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -34.43 74.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.189 167.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . . . -61.12 -49.99 75.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.034 164.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 41.06 59.76 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -166.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -129.19 -166.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.344 -164.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 118.41 36.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.28 -165.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.462 ' CG2' ' HB2' ' B' ' 21' ' ' SER . 95.0 m 67.79 161.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.383 165.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.438 HG12 ' HB1' ' A' ' 47' ' ' ALA . 80.4 mt -100.93 147.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.54 173.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.85 -171.35 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.374 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' B' ' 23' ' ' ASP . . . -61.87 -42.48 99.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.322 -169.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.99 -23.53 66.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.094 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.14 -55.78 4.53 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.344 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 HG22 HD12 ' B' ' 28' ' ' LEU . 44.8 mm -61.09 -37.64 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.366 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.49 -45.88 92.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.513 ' HB3' HD22 ' A' ' 46' ' ' LEU . 2.1 mm? -62.76 -45.72 91.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.467 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB3' ' N ' ' A' ' 43' ' ' ALA . . . -61.64 -30.33 70.64 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.361 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.515 ' HA ' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -89.97 -62.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.16 -164.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.512 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.5 mtt180 -60.4 -18.36 50.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.595 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.7 tpt85 -64.39 -76.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.274 168.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE1' HG12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -64.8 -22.28 66.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.044 -159.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -60.67 -35.29 75.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.473 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.558 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.724 171.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.517 ' HA ' ' HG3' ' B' ' 33' ' ' GLU . 2.7 ptt? . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.174 0.511 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 7' ' ' PRO . 10.2 tt0 -170.77 43.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.996 170.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.414 ' HB3' HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -100.1 101.71 15.37 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.52 173.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.466 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.5 Cg_endo -59.41 140.32 93.74 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.623 2.216 . . . . 0.0 113.553 167.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.423 HG23 ' CG ' ' B' ' 25' ' ' ARG . 23.7 pt -77.04 -11.54 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.679 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.93 -64.03 0.81 Allowed Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.787 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.466 ' CG ' ' HG2' ' B' ' 4' ' ' PRO . 10.3 Cg_endo -51.29 -45.78 35.14 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.104 1.87 . . . . 0.0 113.279 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.429 HG23 HD11 ' B' ' 8' ' ' ILE . 28.0 mt -60.03 -43.82 93.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.493 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.67 99.73 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.571 -172.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.521 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.6 -22.34 50.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.437 -174.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' B' ' 8' ' ' ILE . 55.0 mt -68.24 -41.41 83.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.328 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.543 HG21 ' HB3' ' A' ' 40' ' ' ALA . 1.9 mm -61.46 -40.35 86.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.104 167.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.521 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 26.4 mtpp -62.21 -31.81 72.39 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.051 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -62.35 -31.91 72.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.683 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.62 -53.94 52.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.413 170.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 24.44 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.686 -172.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.525 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -71.3 -171.35 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.287 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -153.18 -38.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.953 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 104.0 4.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' B' ' 12' ' ' ILE . 11.4 t -101.16 102.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.179 167.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.462 ' HB2' ' CG2' ' A' ' 54' ' ' THR . 45.9 t -62.13 177.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.399 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.512 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.8 OUTLIER -61.01 -34.58 75.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.315 -171.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.528 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 10.2 m-20 -60.99 -58.72 7.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.519 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.461 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -62.92 -45.16 93.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.512 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptp180 -61.91 -37.67 85.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.364 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.491 HG13 ' HG3' ' B' ' 25' ' ' ARG . 41.8 mt -75.78 -36.29 32.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.515 HG21 HG23 ' A' ' 60' ' ' ILE . 97.8 m -60.82 -52.36 65.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.392 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.539 HD12 HG22 ' A' ' 60' ' ' ILE . 4.8 tp -60.53 -47.14 87.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.447 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.1 70.41 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.31 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.69 -24.81 23.76 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.461 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' B' ' 28' ' ' LEU . 46.5 mt -61.9 -75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.965 165.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.526 ' HB3' HD22 ' A' ' 32' ' ' LEU . 5.5 mp -59.66 -20.78 58.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.729 -165.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' B' ' 1' ' ' MET . 2.3 tt0 -66.81 -57.73 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.193 170.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -38.02 89.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.024 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.516 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 6.0 ttp -60.71 -28.59 68.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.436 169.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.7 -45.85 16.19 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.427 ' HD2' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.42 -14.28 18.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.137 -0.531 . . . . 0.0 110.459 167.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -91.32 -51.94 5.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.412 -171.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' B' ' 63' ' ' ALA . 5.4 mt -61.42 -22.35 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.308 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 12' ' ' ILE . . . -63.1 -73.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.305 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.514 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 84.3 p -61.33 -13.79 22.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.536 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -78.2 -56.99 4.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.055 170.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.08 -12.6 12.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.392 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.514 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 73.3 mt -94.97 -51.8 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.106 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -60.67 -31.66 70.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.42 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.516 HD11 ' HA ' ' B' ' 43' ' ' ALA . 28.7 mt -60.66 -52.7 64.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.503 170.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.58 -36.44 80.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.262 -172.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.8 -40.71 98.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.378 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -61.09 -38.03 84.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.414 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.94 -51.52 68.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.131 167.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.6 36.92 0.7 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.453 -164.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 62.85 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.651 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.11 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.832 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.464 HG23 ' HG2' ' B' ' 56' ' ' LYS . 88.9 m -157.57 167.39 30.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.106 165.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 20' ' ' VAL . 24.0 mt -106.89 132.38 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.35 166.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.464 ' HG2' HG23 ' B' ' 54' ' ' THR . 5.6 mmmt -142.65 -176.21 4.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.458 -174.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -26.78 68.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.314 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.53 -52.71 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.026 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.26 -24.48 63.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.303 -170.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.522 ' HB ' HG22 ' A' ' 27' ' ' THR . 38.0 mm -75.51 -48.37 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.465 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.83 -30.4 70.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.026 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.468 ' HG ' ' CD2' ' B' ' 46' ' ' LEU . 14.8 tp -64.05 -50.05 69.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.394 169.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' B' ' 42' ' ' GLU . . . -61.28 -41.09 96.37 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.365 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -89.1 -57.83 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.172 -162.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -59.89 -25.84 65.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.793 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -29.94 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.409 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.514 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.2 OUTLIER -60.35 -67.03 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.468 170.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 60.93 101.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.495 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.51 ' NZ ' ' HD2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.348 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 58.84 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.714 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.5 HD12 HD13 ' B' ' 11' ' ' ILE . 6.3 mp -57.47 98.91 0.17 Allowed Pre-proline 0 C--O 1.251 1.178 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.499 -172.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.53 HG23 ' HB3' ' A' ' 25' ' ' ARG . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.491 HD12 ' HG3' ' B' ' 33' ' ' GLU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 HG21 ' HB3' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' HB ' ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.538 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HB3' HG23 ' A' ' 5' ' ' ILE . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.512 HG23 ' HB ' ' B' ' 60' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 HD11 ' HA ' ' A' ' 28' ' ' LEU . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.471 ' HG2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.475 ' HE1' ' HE2' ' B' ' 35' ' ' MET . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 HG22 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.539 ' HB ' HG23 ' B' ' 27' ' ' THR . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 -60.56 -61.8 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 65.16 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.486 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.543 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.32 -168.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.09 0.472 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 59.15 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.783 -174.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.516 HD22 ' HG3' ' B' ' 33' ' ' GLU . 3.4 mt -73.84 137.2 76.62 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.783 -168.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.435 HD13 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.5 HD13 HD12 ' A' ' 3' ' ' LEU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' B' ' 24' ' ' ALA . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.519 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.454 HD11 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.541 HG21 HD13 ' B' ' 31' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 60' ' ' ILE . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.541 HD13 HG21 ' B' ' 27' ' ' THR . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.512 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.516 ' HG3' HD22 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.475 ' HE2' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.443 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.492 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.422 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.504 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.441 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' B' ' 43' ' ' ALA . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.512 ' HB ' HG23 ' A' ' 27' ' ' THR . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.467 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.504 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.516 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.93 -46.57 90.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.81 -76.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.382 -171.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.353 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.75 156.49 42.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.077 -166.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.52 ' HB3' HD13 ' A' ' 8' ' ' ILE . 6.3 mp -56.9 138.98 78.51 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.587 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 10.7 Cg_endo -61.16 142.18 95.94 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.144 2.563 . . . . 0.0 113.656 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.535 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 1.3 pp -95.49 -25.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.448 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.51 31.58 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.7 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' CG ' ' HB2' ' A' ' 4' ' ' PRO . 6.7 Cg_endo -58.32 -55.6 2.09 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.592 2.195 . . . . 0.0 113.565 175.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' A' ' 3' ' ' LEU . 51.7 mt -61.48 -45.08 99.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.492 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.506 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.76 -38.07 95.33 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -21.94 39.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.406 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.63 -50.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.405 168.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' B' ' 40' ' ' ALA . 18.7 mm -63.47 -41.33 92.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.373 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -62.86 -34.29 77.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.298 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.46 -33.8 75.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.787 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.16 -53.02 63.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.488 170.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.55 18.84 0.38 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 20' ' ' VAL . . . -60.86 136.9 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.515 -0.342 . . . . 0.0 110.189 164.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.29 -25.42 8.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -168.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 92.91 1.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG21 HD11 ' B' ' 55' ' ' ILE . 16.8 t -117.82 134.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.395 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -93.03 155.77 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.376 -170.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.11 -17.66 53.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.373 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -63.41 -50.24 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.441 168.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.55 96.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.277 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 4.9 mtt180 -61.45 -50.5 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.73 -31.9 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.536 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 HG21 HD13 ' A' ' 31' ' ' ILE . 85.9 m -66.23 -43.25 87.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD21 HG22 ' B' ' 60' ' ' ILE . 0.3 OUTLIER -61.22 -32.07 71.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.266 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 3' ' ' LEU . . . -78.13 -46.36 20.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.189 -168.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -60.84 -32.79 72.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.285 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.536 HG12 HG12 ' B' ' 64' ' ' VAL . 11.0 mt -60.83 -75.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.956 164.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.73 -28.19 63.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.735 -162.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 1.9 pp20? -77.11 -46.12 24.62 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.017 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.39 -26.54 67.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.055 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.47 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -73.59 -36.52 65.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.537 171.011 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.72 -42.27 71.6 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -60.95 -25.73 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.35 -0.425 . . . . 0.0 110.399 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -73.46 -59.28 2.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.509 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.528 HD11 HG22 ' A' ' 64' ' ' VAL . 7.8 mt -62.64 -20.04 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB1' HD12 ' B' ' 12' ' ' ILE . . . -61.24 -71.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.355 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' HG23 ' A' ' 44' ' ' ILE . 85.8 p -61.56 -25.38 67.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.236 -172.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 37.8 mm-40 -61.71 -54.24 45.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.081 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -67.85 -10.32 52.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.775 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.538 HG23 ' HA ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -89.39 -57.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.225 -167.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' N ' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -64.89 -19.06 65.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.577 169.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 63' ' ' ALA . 3.0 mp -61.34 -55.78 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.323 168.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.61 -23.11 65.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.265 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.41 ' NH2' ' HG3' ' A' ' 45' ' ' LYS . 23.3 ttp-105 -100.76 -30.24 11.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.308 -165.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -34.95 75.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.127 165.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . . . -60.88 -50.74 72.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.977 163.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.46 43.25 78.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -165.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -134.03 -166.74 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.329 -161.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.469 -165.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.522 HG22 ' HB3' ' B' ' 21' ' ' SER . 7.2 t -60.57 168.66 2.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.507 -170.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 55' ' ' ILE . 26.6 mt -71.57 137.07 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.405 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.05 -175.7 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.358 -167.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' B' ' 23' ' ' ASP . . . -61.41 -47.99 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.258 -169.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -24.92 67.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.979 -176.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.96 -53.11 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.373 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.533 HG23 HG21 ' B' ' 27' ' ' THR . 43.5 mm -65.82 -39.61 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -168.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.75 -41.96 98.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.05 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' HD22 ' A' ' 46' ' ' LEU . 2.4 mm? -62.56 -47.12 85.27 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.341 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.528 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -61.61 -31.45 71.52 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.379 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG22 HD11 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -89.97 -61.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.812 0.815 . . . . 0.0 109.029 -162.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.515 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.9 mtt180 -60.16 -19.07 52.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.667 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -63.3 -77.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.146 168.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.533 ' HB3' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -64.96 -21.61 66.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.122 -159.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.523 ' HB3' ' HG3' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -60.58 -35.77 76.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.54 175.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' N ' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.616 171.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.517 ' HA ' ' HG3' ' B' ' 33' ' ' GLU . 2.6 ptt? . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -170.75 43.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.12 170.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.454 ' HB3' HD12 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -101.52 101.12 15.99 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.618 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.458 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.0 Cg_endo -59.87 140.01 90.98 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.544 2.163 . . . . 0.0 113.528 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.479 HG23 ' HG3' ' B' ' 25' ' ' ARG . 33.0 pt -78.52 -10.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.631 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.7 -61.19 1.41 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.813 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' B' ' 10' ' ' ARG . 9.8 Cg_endo -55.49 -45.95 35.86 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 122.443 2.096 . . . . 0.0 113.453 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.454 HD12 ' HB3' ' B' ' 3' ' ' LEU . 31.0 mt -60.32 -44.56 96.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.459 172.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.25 97.32 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.549 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.534 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.19 -23.26 51.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 0.0 110.503 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' B' ' 8' ' ' ILE . 64.8 mt -67.85 -48.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.461 170.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.516 HD12 ' HB1' ' A' ' 40' ' ' ALA . 5.1 mm -61.92 -33.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.037 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.534 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 27.0 mtpp -61.34 -33.88 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.209 171.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.6 -32.78 73.85 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.638 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.86 -53.32 59.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.429 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.11 21.34 0.78 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.974 -170.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.516 ' HB3' HD13 ' A' ' 44' ' ' ILE . . . -65.63 147.03 54.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.34 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -40.79 3.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.045 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -148.55 139.14 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.507 168.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.462 HG11 ' CB ' ' B' ' 24' ' ' ALA . 88.8 t -129.45 113.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.205 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.522 ' HB3' HG22 ' A' ' 54' ' ' THR . 25.0 p -62.28 174.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.381 -166.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.518 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.9 OUTLIER -61.67 -32.29 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.371 -177.153 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.51 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 4.3 m-20 -64.2 -55.55 20.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.468 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.462 ' CA ' HG13 ' A' ' 60' ' ' ILE . . . -62.12 -48.0 82.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.301 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 6.6 ptp180 -61.03 -37.85 84.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.394 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 34.3 mt -72.05 -36.56 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.49 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.533 HG21 HG23 ' A' ' 60' ' ' ILE . 97.9 m -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.365 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.508 HD12 HG22 ' A' ' 60' ' ' ILE . 4.4 tp -60.94 -47.04 88.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.383 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.98 70.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.384 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -87.15 -26.14 23.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.494 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' B' ' 28' ' ' LEU . 37.8 mt -61.83 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.015 165.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.524 ' HB3' HD22 ' A' ' 32' ' ' LEU . 6.0 mp -59.6 -17.45 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.517 ' HG3' ' HA ' ' B' ' 1' ' ' MET . 2.0 tt0 -73.61 -53.43 10.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.139 173.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 -40.43 88.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.045 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.527 ' HE1' HD12 ' B' ' 39' ' ' ILE . 10.0 ttp -60.82 -28.68 68.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.477 170.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.79 -46.23 18.63 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.44 -13.88 16.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.534 167.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -91.22 -51.28 5.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.418 -172.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.527 HD12 ' HE1' ' B' ' 35' ' ' MET . 4.8 mt -61.6 -21.32 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.271 170.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -63.22 -73.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.315 172.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.527 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 81.8 p -61.45 -13.94 24.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.503 -173.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -77.92 -56.95 4.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 170.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.519 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -61.2 -13.18 16.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.323 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 81.4 mt -95.55 -51.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.96 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -60.67 -32.97 72.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.45 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' B' ' 43' ' ' ALA . 20.9 mt -60.47 -51.5 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.551 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.04 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.257 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.86 -40.77 98.51 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.418 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -61.24 -38.1 85.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.326 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.97 -51.41 69.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.124 167.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 37.21 0.72 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.448 -164.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 62.34 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.536 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -79.5 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.754 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.492 HG23 ' HG2' ' B' ' 56' ' ' LYS . 88.1 m -157.55 167.55 29.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.153 165.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 20' ' ' VAL . 23.6 mt -108.16 132.7 55.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.439 166.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.492 ' HG2' HG23 ' B' ' 54' ' ' THR . 5.2 mmmt -143.38 -177.14 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.387 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -27.03 68.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.52 -55.09 34.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.042 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.79 -29.34 69.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.394 -170.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.531 HG22 HD21 ' A' ' 28' ' ' LEU . 37.1 mm -71.61 -48.7 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.402 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.6 -31.41 71.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.023 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.449 ' HG ' ' CD2' ' B' ' 46' ' ' LEU . 15.0 tp -62.11 -51.12 69.2 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.416 168.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' B' ' 42' ' ' GLU . . . -61.36 -41.08 96.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.376 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.536 HG12 HG12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -88.75 -58.65 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.13 -162.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.467 ' N ' HG11 ' B' ' 64' ' ' VAL . 6.5 tpp180 -59.74 -25.56 64.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.8 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 -30.4 43.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.388 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.4 OUTLIER -60.2 -65.14 0.73 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.511 171.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' B' ' 68' ' ' LYS . 3.2 tppt? 61.07 101.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.528 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.523 ' HG3' ' HB3' ' A' ' 68' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.519 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.361 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -79.31 -157.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.89 165.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD13 HD13 ' B' ' 11' ' ' ILE . 6.2 mp -56.87 100.76 0.23 Allowed Pre-proline 0 C--O 1.251 1.173 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.53 -168.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HB2' ' HG2' ' A' ' 7' ' ' PRO . 1.7 Cg_endo -53.95 142.87 63.17 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.07 2.513 . . . . 0.0 113.513 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 13.5 pt -92.24 -13.2 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.374 -165.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.463 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -79.65 -54.65 0.92 Allowed Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.719 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HG2' ' HB2' ' A' ' 4' ' ' PRO . 16.1 Cg_exo -51.55 -55.17 4.23 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.499 2.133 . . . . 0.0 113.627 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 45.0 mt -61.71 -44.23 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.248 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.45 ' CA ' ' HD3' ' A' ' 25' ' ' ARG . . . -61.14 -22.17 60.3 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.4 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -26.29 21.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.724 -0.738 . . . . 0.0 110.483 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.501 HG21 ' HG3' ' B' ' 37' ' ' ARG . 27.4 mt -63.44 -54.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.43 170.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.511 HG22 ' HA ' ' B' ' 40' ' ' ALA . 9.4 mm -65.32 -36.58 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.262 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -69.21 -32.58 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.331 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.41 -34.87 77.58 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.8 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.92 63.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.491 169.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.63 24.03 0.3 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.566 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB3' HG12 ' B' ' 44' ' ' ILE . . . -63.57 142.62 58.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.825 -0.688 . . . . 0.0 110.323 174.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.49 124.52 41.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.98 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.5 116.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.435 174.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 24' ' ' ALA . 15.6 t -146.14 165.65 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.362 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -99.99 159.81 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.442 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.01 -33.78 73.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 169.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -37.24 86.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.354 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' A' ' 20' ' ' VAL . . . -60.93 -46.12 91.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.318 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HG2' ' HB ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.95 -36.85 84.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.407 -170.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.2 mt -79.64 -43.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.457 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 HG23 HG23 ' B' ' 60' ' ' ILE . 90.5 m -60.92 -47.89 84.35 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.285 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 31' ' ' ILE . 4.5 tp -59.19 -45.77 90.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.412 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.67 -21.06 62.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.659 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.66 -24.41 14.43 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.357 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 28' ' ' LEU . 1.8 mp -61.11 -68.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.884 162.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.7 OUTLIER -60.26 -33.41 72.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.599 -169.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HB2' HD11 ' A' ' 3' ' ' LEU . 2.3 tm-20 -65.03 -55.12 20.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.1 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -61.68 -26.13 67.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.909 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -46.92 77.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.358 164.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -40.2 96.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -60.75 -31.99 71.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.302 172.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -51.63 60.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.628 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG22 HG21 ' A' ' 64' ' ' VAL . 2.0 mt -62.6 -32.74 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.694 -172.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' B' ' 12' ' ' ILE . . . -78.01 -52.15 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.342 -166.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.2 t -61.25 -14.37 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.273 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -87.61 -54.82 4.07 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.213 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.99 -33.59 74.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.176 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.531 HD13 ' HB1' ' B' ' 17' ' ' ALA . 55.7 mt -60.59 -46.21 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.175 164.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -60.33 -21.92 62.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.565 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 43' ' ' ALA . 9.9 mt -89.08 -23.57 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.452 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.16 -28.4 65.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.301 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -61.31 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.37 170.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -61.12 -23.08 65.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.374 -168.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 -47.54 62.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.308 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.39 27.9 4.27 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.12 121.92 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.819 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -161.41 15.43 0.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.502 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.4 m 63.14 151.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.392 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 29.4 mt -78.22 138.09 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -153.65 -178.17 6.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.455 -170.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.97 80.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.262 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -50.0 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.196 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.476 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -62.1 -33.34 74.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.405 -173.235 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' B' ' 27' ' ' THR . 11.5 mm -75.27 -58.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.342 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 39.8 mt-10 -61.64 -9.86 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.319 172.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 59' ' ' ASP . 16.1 mt -85.95 -41.28 15.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.487 172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 39' ' ' ILE . . . -61.15 -36.49 79.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.098 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 55.9 t -61.85 -76.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.723 168.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -14.91 23.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.396 -167.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -61.52 -66.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 165.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 64' ' ' VAL . 8.3 p90 -77.5 -17.08 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.482 -168.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.496 ' HD3' HG13 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -61.18 130.94 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.404 -168.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.597 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.433 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 58.94 116.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.774 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.527 ' HB2' HD13 ' B' ' 8' ' ' ILE . 6.1 mt -61.47 141.38 94.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.814 -172.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.82 153.5 43.35 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.485 2.123 . . . . 0.0 113.317 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' B' ' 25' ' ' ARG . 16.5 pt -92.35 -25.13 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.42 -168.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.15 -62.56 3.55 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.754 -170.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.11 -45.39 33.4 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.39 2.06 . . . . 0.0 113.417 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 3' ' ' LEU . 21.5 mt -60.96 -38.2 78.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.407 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.47 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -61.65 -53.9 39.97 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.556 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -70.41 -15.09 62.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.432 -170.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.489 HD13 HD13 ' A' ' 3' ' ' LEU . 66.1 mt -73.33 -34.47 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.534 168.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.502 HG13 ' NH2' ' B' ' 25' ' ' ARG . 2.6 mm -70.03 -46.26 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.894 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.3 mtpt -62.33 -41.33 98.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.045 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -60.79 -31.09 70.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.015 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.04 -52.43 65.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.575 171.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.72 31.61 0.4 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.597 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.531 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -80.76 -177.56 6.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -171.06 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.94 167.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.03 106.68 17.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.428 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 14.7 t -141.48 171.9 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.395 171.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -127.07 156.45 41.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.308 -176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.71 -37.82 85.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.379 -170.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.92 71.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.391 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HA ' HG23 ' B' ' 27' ' ' THR . . . -65.83 -43.84 87.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.314 171.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.502 ' NH2' HG13 ' B' ' 12' ' ' ILE . 0.0 OUTLIER -61.24 -47.66 85.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.339 -175.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.44 -38.84 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.542 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.527 HG23 ' HA ' ' B' ' 24' ' ' ALA . 1.5 t -69.77 -43.32 72.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.178 -167.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.534 ' HA ' HD11 ' B' ' 31' ' ' ILE . 2.6 tp -59.44 -36.86 76.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.523 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.71 -40.0 93.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.207 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -27.14 23.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.491 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' B' ' 28' ' ' LEU . 24.8 mt -61.61 -67.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.04 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.0 mp -60.4 -34.71 74.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.57 -176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.464 ' HG3' HD12 ' A' ' 11' ' ' ILE . 34.6 tt0 -67.52 -37.9 83.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.933 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -35.16 77.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.891 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 3.3 mtp -65.06 -48.34 74.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.461 170.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 32' ' ' LEU . . . -64.23 -40.22 97.77 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.501 ' HG3' HG21 ' A' ' 11' ' ' ILE . 12.2 mtp180 -60.93 -29.69 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.345 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -67.89 -55.27 13.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.503 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' A' ' 28' ' ' LEU . 2.2 mt -63.31 -26.28 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.821 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.511 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -61.49 -70.07 0.21 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.292 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.541 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.46 -17.01 52.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.388 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.538 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 3.3 mm-40 -84.61 -38.49 19.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.051 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.526 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -78.04 -8.28 57.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.832 172.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 51.3 mt -96.99 -51.06 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.765 -175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -60.25 -22.24 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.375 166.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.534 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.6 mt -69.62 -53.74 17.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.379 168.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.486 ' HB1' HG12 ' B' ' 55' ' ' ILE . . . -61.59 -23.54 66.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.307 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 -34.3 15.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.252 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -60.55 -36.77 79.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.434 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.02 74.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.17 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.17 46.94 7.85 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 4.1 tpm_? -121.23 -18.54 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.451 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.28 18.68 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -145.47 138.35 26.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.406 170.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.486 HG12 ' HB1' ' B' ' 47' ' ' ALA . 45.2 mt -93.76 148.5 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.341 170.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.434 ' HA ' ' HB1' ' A' ' 24' ' ' ALA . 6.1 mtpp -147.94 178.36 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.381 -169.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.33 -17.82 55.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.331 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -81.2 -41.27 22.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.069 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -75.28 -26.77 59.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.373 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.526 HG21 HD11 ' A' ' 28' ' ' LEU . 1.4 mp -64.43 -59.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.339 174.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.539 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 11.6 mt-10 -74.41 -12.44 60.51 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.557 -176.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 7.5 mt -81.67 -46.12 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 168.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.534 ' HB3' HD13 ' B' ' 46' ' ' LEU . . . -60.34 -41.62 93.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.398 172.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 37.9 t -62.72 -74.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.63 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -10.76 3.44 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.509 -164.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -85.77 -60.87 1.9 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.582 164.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.538 ' HB3' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -64.36 -8.82 14.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.42 -155.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.443 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.7 tptt -75.97 -33.31 59.77 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.371 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm . . . . . 0 C--O 1.239 0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 171.395 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mmm . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.178 0.513 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.46 28.29 16.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.841 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 29' ' ' ALA . 28.8 mt 59.8 75.07 0.51 Allowed Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 121.763 0.792 . . . . 0.0 110.358 166.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -48.3 150.99 4.84 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 122.388 2.058 . . . . 0.0 113.512 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.509 ' HB ' ' NE ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -69.21 -11.55 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.591 -166.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -75.6 -58.93 1.32 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.772 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HD3' ' HB1' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.12 -57.11 1.43 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.432 2.088 . . . . 0.0 113.437 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 29' ' ' ALA . 27.8 mt -60.6 -32.66 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.378 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.59 -26.65 64.95 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.357 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -78.02 -36.4 48.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.373 -0.914 . . . . 0.0 110.483 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.536 HG22 ' HG3' ' B' ' 37' ' ' ARG . 25.1 mt -60.63 -64.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.48 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 9.3 mm -60.91 -33.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -166.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -65.36 -40.45 93.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.468 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.11 -32.41 72.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.777 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.64 64.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.522 170.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.76 22.09 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.654 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -61.64 159.25 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.295 169.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.529 ' HG2' ' HB3' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.01 -63.34 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.054 -169.334 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 -144.6 80.06 1.62 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.478 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 15.5 t -71.33 107.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.31 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -61.54 158.88 14.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.459 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -61.31 -18.66 59.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.269 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -66.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.773 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB2' ' CG1' ' B' ' 60' ' ' ILE . . . -60.69 -39.66 89.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.386 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HD2' ' HB ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -62.01 -37.78 86.17 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.448 -175.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.457 HG13 ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -76.28 -29.45 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.357 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.49 HG23 ' HB ' ' B' ' 60' ' ' ILE . 97.1 m -61.06 -60.75 3.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.341 171.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.529 HD11 HG23 ' A' ' 31' ' ' ILE . 64.4 tp -68.33 -28.74 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.424 -171.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 3' ' ' LEU . . . -71.35 -40.38 70.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.116 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -60.38 -35.59 76.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.379 166.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 HD12 HG13 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -69.78 -38.96 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.378 -170.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.539 HD11 HD22 ' B' ' 32' ' ' LEU . 1.8 mm? -74.84 -67.74 0.61 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.479 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HG2' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.39 -17.85 64.89 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.811 -163.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.17 -49.57 64.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.108 164.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.577 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.516 ' N ' HD23 ' B' ' 32' ' ' LEU . . . -76.71 -36.15 38.27 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' N ' ' CG2' ' B' ' 11' ' ' ILE . 2.4 ttm-85 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.38 169.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.56 -51.7 33.05 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.429 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 64' ' ' VAL . 25.1 mt -63.9 -33.75 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.395 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.41 -66.23 0.57 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.275 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.21 -15.47 34.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.373 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -71.38 -63.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.135 167.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -60.99 -13.14 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.488 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 HD12 ' A' ' 55' ' ' ILE . 95.3 mt -97.2 -59.26 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -61.89 -17.43 56.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.333 174.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 ' HA ' ' A' ' 43' ' ' ALA . 16.7 mt -69.84 -58.66 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.363 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -25.57 67.33 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.398 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.71 -55.85 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.448 -170.597 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 2.4 p-80 -68.01 -24.95 65.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.389 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.02 62.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.347 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.22 26.42 2.04 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.61 165.6 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.416 -170.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -132.68 18.46 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.446 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.6 m -157.66 132.94 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.301 170.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 HD12 HG12 ' A' ' 44' ' ' ILE . 4.4 mp -100.36 133.26 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.309 166.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 -172.62 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.454 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.35 -20.0 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.315 -171.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.18 -67.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.077 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.15 -32.27 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.366 -167.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG22 HD12 ' B' ' 28' ' ' LEU . 37.9 mm -61.2 -64.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.387 172.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.453 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 3.4 mt-10 -61.1 -10.07 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.41 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.98 -39.5 12.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.457 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -76.26 -27.56 56.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.113 175.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 39' ' ' ILE . 15.3 t -62.48 -66.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.448 160.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -59.39 -11.19 3.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.002 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -30.65 15.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.31 -22.58 53.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.617 163.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.74 -176.72 0.08 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.331 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.544 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.389 -170.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.046 0.451 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -106.07 -11.83 15.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.174 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' B' ' 33' ' ' GLU . 0.7 OUTLIER -98.48 103.02 16.25 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.642 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.89 139.73 91.37 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.461 2.107 . . . . 0.0 113.407 165.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.526 ' HA ' ' HB ' ' B' ' 8' ' ' ILE . 22.7 pt -92.95 21.43 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.567 -167.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.57 -58.02 0.41 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.733 170.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.91 -50.74 11.44 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' B' ' 5' ' ' ILE . 23.5 mt -60.85 -23.18 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.322 167.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.1 96.63 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.518 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.401 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 20.6 mmt180 -94.26 -18.03 22.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.986 -0.607 . . . . 0.0 110.347 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.495 HG13 ' HG3' ' A' ' 33' ' ' GLU . 7.7 mm -60.83 -72.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.002 163.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.538 HG21 ' HB3' ' A' ' 40' ' ' ALA . 3.7 mm -63.38 -17.0 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.169 -171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.9 OUTLIER -83.04 -37.3 24.1 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.377 176.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -32.53 73.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.836 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -58.82 -52.88 63.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.516 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.21 23.06 0.35 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.702 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 44' ' ' ILE . . . -67.8 147.05 53.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.772 -0.714 . . . . 0.0 110.424 173.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.77 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.939 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 80.33 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.381 168.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.89 137.73 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.472 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 58.9 p -74.49 150.89 39.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.365 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.16 -17.92 55.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.302 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -44.65 63.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.422 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 60' ' ' ILE . . . -62.45 -43.61 98.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.363 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.512 ' HD2' HD13 ' B' ' 5' ' ' ILE . 28.1 mtt-85 -62.23 -32.57 73.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.417 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -88.02 -30.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.445 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.521 HG23 HD13 ' B' ' 31' ' ' ILE . 97.8 m -61.1 -54.11 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.37 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 60' ' ' ILE . 4.3 tp -59.83 -45.38 92.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.556 172.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -31.16 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.362 -171.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -91.94 -23.2 19.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.521 HD13 HG23 ' B' ' 27' ' ' THR . 64.4 mt -61.36 -70.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.135 166.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.539 HD22 HD11 ' A' ' 32' ' ' LEU . 1.1 mp -60.47 -33.15 72.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.719 -170.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.464 ' HB2' HD13 ' B' ' 3' ' ' LEU . 18.5 tt0 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.12 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -32.11 72.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.945 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.404 ' HG2' ' CD1' ' B' ' 39' ' ' ILE . 2.1 ttt -60.46 -42.55 96.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.426 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.21 68.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -169.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.536 ' HG3' HG22 ' A' ' 11' ' ' ILE . 5.7 mtp180 -60.58 -28.51 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.49 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -70.18 -57.8 4.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.53 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.504 HG23 HG22 ' B' ' 64' ' ' VAL . 10.2 mt -61.04 -23.44 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.483 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 12' ' ' ILE . . . -61.73 -70.05 0.21 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.521 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.7 OUTLIER -61.22 -11.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.479 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.0 OUTLIER -78.62 -58.32 3.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.068 170.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.508 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -61.15 -17.44 52.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.47 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 90.0 mt -91.18 -50.17 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.983 -173.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -60.68 -27.91 68.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.377 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 15.4 mt -64.81 -54.72 26.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.354 167.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.462 ' CB ' HD12 ' B' ' 55' ' ' ILE . . . -61.27 -50.63 72.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.275 -169.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -42.63 99.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.12 -35.19 76.39 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.407 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.75 -47.34 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.302 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.29 30.1 7.99 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.478 ' HD3' ' HB ' ' B' ' 54' ' ' THR . 0.0 OUTLIER -134.48 104.11 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.352 169.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.529 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 6.6 mttt -61.13 -16.98 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.335 -169.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.478 ' HB ' ' HD3' ' B' ' 52' ' ' ARG . 94.2 m -88.39 122.21 31.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.447 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.498 HG13 HG23 ' A' ' 20' ' ' VAL . 11.8 mm -75.1 138.29 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.515 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -130.2 158.55 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.324 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -62.86 -31.06 72.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.309 -167.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.95 -37.93 82.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.081 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.88 -37.12 86.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.44 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.49 ' HB ' HG23 ' A' ' 27' ' ' THR . 48.8 mm -60.9 -55.9 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.432 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -70.64 -22.64 62.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.009 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.13 -36.17 40.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.449 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -60.99 -55.36 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.372 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 31' ' ' ILE 0.256 0.4 OUTLIER -70.16 -50.71 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.978 -165.806 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.506 ' N ' HG11 ' B' ' 64' ' ' VAL . 5.1 mmm180 -60.9 -43.06 99.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -20.73 64.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.4 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 50.5 t80 -80.16 -40.84 26.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.306 -172.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.484 ' HB3' ' NZ ' ' B' ' 68' ' ' LYS . 0.2 OUTLIER -85.06 96.66 9.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.381 170.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.554 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.429 -170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.98 170.93 6.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.966 171.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 8' ' ' ILE . 3.4 mt -63.36 134.49 95.86 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.746 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.97 144.16 94.84 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.172 1.915 . . . . 0.0 113.66 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' HA ' ' HB ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -101.99 19.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.684 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -85.92 -58.81 0.31 Allowed Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 11.7 Cg_endo -59.46 -45.81 24.39 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.503 2.135 . . . . 0.0 113.557 168.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.519 HD13 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -69.06 -32.93 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.438 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -30.31 71.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.8 ttp-105 -92.39 -18.73 22.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.315 -174.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.3 mm -61.01 -60.59 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.244 166.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' B' ' 40' ' ' ALA . 7.3 mm -72.32 -22.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.039 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -77.31 -34.27 55.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.296 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -61.45 -31.17 71.12 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.877 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' B' ' 41' ' ' SER . . . -57.94 -52.23 66.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.492 170.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.89 34.31 0.56 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.53 -167.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' B' ' 44' ' ' ILE . . . -84.25 145.92 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.255 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.05 -38.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.026 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.451 ' N ' ' CD ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -122.9 85.0 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.48 170.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG12 HG23 ' B' ' 55' ' ' ILE . 89.8 t -132.42 113.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.274 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -65.46 164.26 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.462 -167.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.42 -30.56 71.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.36 -173.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -60.97 -43.38 98.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.402 176.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -61.56 -41.2 97.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.347 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -61.73 -42.26 98.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.389 -176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.435 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 3.3 mt -83.29 -28.42 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.447 -176.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.54 HG21 HD13 ' A' ' 31' ' ' ILE . 97.3 m -60.89 -47.7 85.21 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.293 174.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 HG22 ' B' ' 60' ' ' ILE . 4.4 tp -59.21 -45.54 90.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.453 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.12 -20.8 63.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.547 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.91 -28.86 14.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.323 -177.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.54 HD13 HG21 ' A' ' 27' ' ' THR . 1.9 mp -60.7 -70.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.929 162.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.538 ' HG ' ' HG ' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -58.32 -35.16 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.796 -166.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.516 ' HG3' HD13 ' B' ' 11' ' ' ILE . 9.9 tt0 -69.52 -61.71 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.201 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -61.55 -34.09 74.97 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.797 -170.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.5 ttm -62.2 -46.9 86.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.46 165.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.39 -47.69 85.32 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -23.0 64.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.368 170.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -75.6 -52.32 10.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.605 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HD12 ' B' ' 28' ' ' LEU . 5.3 mt -61.49 -28.75 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.071 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB3' HD11 ' B' ' 12' ' ' ILE . . . -62.04 -74.09 0.09 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.191 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.9 p -60.94 -11.38 7.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.489 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 5.4 mm-40 -79.92 -55.84 4.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.089 171.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 63' ' ' ALA . . . -61.16 -20.83 63.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.368 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.538 HD12 ' HB1' ' B' ' 17' ' ' ALA . 92.8 mt -88.82 -52.03 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.93 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -27.81 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.447 170.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.537 HD21 ' HB1' ' A' ' 63' ' ' ALA . 6.3 mp -63.36 -61.02 2.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.375 171.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.78 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.241 -167.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.463 ' CD ' ' HG3' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -82.61 -41.1 19.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.411 -171.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -66.2 -21.27 66.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.247 167.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.16 -53.27 59.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.23 166.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.71 9.92 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.64 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HG3' ' CD ' ' A' ' 48' ' ' ARG . 13.6 ttm-85 66.69 134.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.419 169.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.19 -65.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.303 169.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.5 HG23 ' HB2' ' B' ' 21' ' ' SER . 92.7 m -157.63 144.4 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.323 169.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 44' ' ' ILE . 25.4 mm -66.22 136.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.322 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 tptt -131.83 165.21 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.404 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' CB ' ' B' ' 23' ' ' ASP . . . -61.13 -17.72 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.246 169.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -76.29 -44.83 35.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.092 170.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.9 -35.05 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.278 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.525 HG12 ' HB2' ' B' ' 28' ' ' LEU . 1.4 mp -61.89 -56.15 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.763 162.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -33.22 73.39 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.909 -166.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 7.6 mp -75.91 -45.78 33.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.551 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.537 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -61.37 -27.05 68.24 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.434 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' CG2' HG22 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -96.09 -56.3 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.866 -164.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.509 ' NH1' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -60.13 -26.25 66.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.632 174.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 97.4 mtt180 -81.38 -23.86 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.411 171.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 5.5 t80 -61.12 -48.46 81.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.46 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.509 ' HG3' ' HD2' ' A' ' 69' ' ' LYS . 12.0 tppt? 179.28 128.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.449 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.509 ' HD2' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.394 166.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 121.171 0.51 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.15 -65.75 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.095 -170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 33' ' ' GLU . 1.5 mt -89.13 138.83 28.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.568 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.434 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 12.0 Cg_endo -62.56 147.97 94.03 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.514 2.143 . . . . 0.0 113.401 165.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.16 19.21 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.955 174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -94.55 -59.35 0.2 Allowed Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.737 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.434 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 10.9 Cg_endo -57.89 -46.97 22.79 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.484 2.123 . . . . 0.0 113.454 169.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.73 -37.06 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.391 168.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.57 -21.35 60.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -103.61 -18.39 14.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.067 -0.567 . . . . 0.0 110.327 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 33' ' ' GLU . 9.4 mm -60.78 -49.93 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.275 164.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 40' ' ' ALA . 6.2 mm -85.46 -31.26 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.967 -168.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.385 170.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.32 -32.52 73.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.748 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 40' ' ' ALA . . . -58.8 -53.47 57.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.521 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.82 24.04 0.48 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.618 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.538 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -61.02 144.2 53.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.73 -0.735 . . . . 0.0 110.409 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -146.01 122.02 10.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.036 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 64.28 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.367 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.477 HG11 ' HB2' ' B' ' 24' ' ' ALA . 25.8 t -101.4 123.65 54.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.337 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.5 ' HB2' HG23 ' A' ' 54' ' ' THR . 31.3 t -61.25 154.35 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.419 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.48 -37.08 82.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.395 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.461 ' CB ' ' HB3' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.72 -48.6 81.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.511 170.303 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.477 ' HB2' HG11 ' B' ' 20' ' ' VAL . . . -61.95 -48.61 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.297 -172.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.457 ' HG3' ' CG1' ' B' ' 20' ' ' VAL . 9.2 mtp180 -61.61 -36.97 82.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.392 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -89.2 -32.99 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.42 -167.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.46 HG21 HD13 ' B' ' 31' ' ' ILE . 90.1 m -67.21 -41.05 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.449 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.531 HD22 HD13 ' B' ' 12' ' ' ILE . 2.2 tp -62.97 -48.21 79.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.913 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.02 -25.78 67.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.553 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -95.96 -29.4 14.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.283 -175.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.46 HD13 HG21 ' B' ' 27' ' ' THR . 15.4 mt -61.4 -59.9 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.845 166.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.538 ' HG ' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.01 -22.05 47.82 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.77 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' B' ' 3' ' ' LEU . 8.9 tp10 -83.34 -65.05 1.06 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.011 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.68 -34.22 75.36 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.849 -174.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.513 ' HE3' ' HD2' ' B' ' 68' ' ' LYS . 8.2 ttm -62.15 -47.75 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.521 165.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.29 -49.53 76.72 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -173.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HD3' ' N ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.59 -25.06 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.433 171.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.451 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -71.32 -49.91 37.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.61 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.535 HG22 HG21 ' B' ' 64' ' ' VAL . 6.0 mt -61.43 -34.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.261 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.8 -71.78 0.14 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.301 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.533 ' HB3' ' HB3' ' A' ' 15' ' ' ALA . 24.7 p -62.04 -17.88 58.79 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.557 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.401 ' CB ' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -81.51 -50.85 8.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.26 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -62.4 -12.89 24.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.099 173.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.491 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 96.6 mt -95.47 -49.31 12.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.817 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -67.84 -7.4 27.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.182 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.516 HD11 ' HA ' ' B' ' 43' ' ' ALA . 3.9 mt -83.61 -43.05 16.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.26 169.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.49 -14.83 21.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.324 166.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -92.31 -35.29 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.498 168.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.485 ' HB2' ' HA ' ' B' ' 46' ' ' LEU . 23.8 t-80 -61.66 -39.56 91.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.266 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.51 ' HB2' ' NZ ' ' B' ' 53' ' ' LYS . . . -61.05 -52.63 64.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.212 165.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.84 9.53 10.87 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.539 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 179.23 -166.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.931 -0.635 . . . . 0.0 110.323 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' B' ' 50' ' ' ALA . 2.7 mppt? 65.73 162.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.41 167.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.463 HG21 ' N ' ' B' ' 55' ' ' ILE . 91.8 m -96.55 152.68 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.346 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.498 HG23 HG12 ' A' ' 20' ' ' VAL . 3.6 mp -69.3 133.66 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 168.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.535 ' HB2' ' HG2' ' B' ' 58' ' ' GLU . 0.3 OUTLIER -135.63 -171.36 2.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.376 177.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . . . -61.75 -27.15 68.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.247 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' B' ' 56' ' ' LYS . 5.0 pt-20 -73.99 -49.0 26.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.1 OUTLIER -61.89 -31.56 71.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.401 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.539 HG22 HD12 ' A' ' 28' ' ' LEU . 25.3 mm -61.89 -68.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.268 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.539 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt-10 -61.06 -14.61 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 3.6 mp -70.66 -55.2 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.403 169.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' B' ' 39' ' ' ILE . . . -60.91 -37.03 80.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.484 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 40.2 t -62.43 -69.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.796 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.19 -9.17 4.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.508 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -50.29 21.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.488 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -80.51 -48.89 12.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -174.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.513 ' HD2' ' HE3' ' B' ' 35' ' ' MET . 4.9 mttm -150.31 -173.16 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 -166.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? . . . . . 0 C--O 1.241 0.639 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.42 -177.71 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 mtm . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 121.074 0.464 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.05 146.64 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.749 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.531 ' HB2' HD13 ' A' ' 8' ' ' ILE . 3.3 mt -69.89 146.74 95.64 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.792 172.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.12 140.18 93.17 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.543 2.162 . . . . 0.0 113.533 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 pt -80.64 -31.23 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.366 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.527 ' HB2' ' HD3' ' A' ' 7' ' ' PRO . . . -63.75 -62.73 4.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.763 -173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -50.87 -42.85 50.06 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 C-N-CA 122.48 2.12 . . . . 0.0 113.524 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.531 HD13 ' HB2' ' A' ' 3' ' ' LEU . 50.3 mt -60.81 -39.15 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.435 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.458 ' HA2' ' CZ ' ' A' ' 25' ' ' ARG . . . -61.58 -26.12 66.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -91.14 -25.33 19.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.169 -0.515 . . . . 0.0 110.36 -176.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.503 HG22 ' HG3' ' B' ' 37' ' ' ARG . 53.7 mt -60.83 -62.43 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.296 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 9.2 mm -61.21 -35.18 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.249 -175.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.4 mtmt -60.79 -37.09 80.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.498 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.56 -35.21 78.76 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.789 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.32 -53.08 62.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.41 167.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.57 16.58 0.21 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.051 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -61.16 170.57 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 163.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.09 -57.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.941 165.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NH1' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -73.62 83.28 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.391 172.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.446 HG11 ' HB ' ' B' ' 55' ' ' ILE . 24.6 t -129.03 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 -170.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.3 p -85.24 156.48 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.423 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.8 t0 -61.42 -23.19 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.318 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -90.65 -28.62 18.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.394 -170.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -61.69 -42.04 98.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.157 166.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HG3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.76 -51.17 68.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.445 -178.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.522 HG23 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tt -62.68 -40.95 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.234 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.525 HG22 ' HG3' ' B' ' 61' ' ' GLU . 91.7 m -60.77 -59.06 5.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.369 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD13 ' HB ' ' B' ' 39' ' ' ILE . 9.3 tp -61.01 -10.5 5.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.344 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.37 -59.29 2.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.448 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -25.14 66.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.434 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.499 HD13 HG23 ' A' ' 27' ' ' THR . 74.0 mt -61.65 -75.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.052 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HG ' ' HE1' ' B' ' 35' ' ' MET . 7.1 mp -60.57 -36.92 79.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -166.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' HB2' ' CG ' ' A' ' 3' ' ' LEU . 8.4 tt0 -67.46 -42.75 82.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.053 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.12 -41.15 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.056 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.9 mmm -60.76 -42.1 96.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.506 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.57 -46.27 90.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' HD3' HG22 ' B' ' 11' ' ' ILE . 3.1 mtp180 -60.73 -33.83 73.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.378 168.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -65.69 -50.2 65.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 -175.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 64' ' ' VAL . 11.0 mt -65.1 -36.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.417 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.539 ' HB3' HD11 ' B' ' 12' ' ' ILE . . . -65.26 -54.08 34.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.32 -172.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.534 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 -34.33 75.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.298 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -38.26 85.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.063 169.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -79.82 -13.67 59.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.534 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -82.79 -57.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.372 -168.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' HD2' HG21 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.29 -31.36 70.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.414 169.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 11.4 mt -59.96 -43.84 94.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.584 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -67.86 -26.37 65.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.103 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -60.67 -61.61 2.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.332 168.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -61.31 -10.09 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.584 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -84.16 -57.86 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.953 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.64 9.93 0.04 OUTLIER Glycine 0 C--N 1.344 0.996 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.666 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 0.3 OUTLIER 73.6 -58.22 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.424 0.689 . . . . 0.0 111.47 158.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.53 -23.3 49.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 111.182 -157.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.518 HG23 ' N ' ' B' ' 21' ' ' SER . 0.2 OUTLIER -155.43 154.97 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.354 169.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 44' ' ' ILE . 4.3 mm -72.44 150.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.015 159.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 156.33 40.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.413 -169.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.23 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.246 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -68.72 -38.99 80.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.902 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -48.0 83.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.618 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' B' ' 27' ' ' THR . 22.8 mm -61.55 -46.2 97.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -36.86 69.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.054 -170.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mp -63.51 -43.28 97.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.414 167.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HA ' ' CD1' ' A' ' 46' ' ' LEU . . . -61.54 -57.42 12.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.41 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.26 -52.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.042 -168.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -41.35 92.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.731 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -69.51 -20.72 63.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.337 174.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 44.5 t80 -80.93 -28.9 35.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.206 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.52 ' HD2' ' HG2' ' B' ' 69' ' ' LYS . 2.5 tppt? -118.7 86.81 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 168.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HD2' ' HG2' ' A' ' 66' ' ' ARG . 9.8 ptmt . . . . . 0 C--O 1.239 0.515 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.355 -169.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 58.56 171.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.73 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.526 ' HB2' HD13 ' B' ' 8' ' ' ILE . 1.5 mt -80.46 161.83 63.16 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.625 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -60.67 140.91 93.44 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.533 2.156 . . . . 0.0 113.405 164.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.422 HD11 HG22 ' B' ' 5' ' ' ILE . 13.2 pt -99.47 -17.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.389 -167.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.09 -62.0 0.46 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.754 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.48 -36.24 58.43 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 122.508 2.139 . . . . 0.0 113.522 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' B' ' 3' ' ' LEU . 54.0 mt -60.42 -42.22 90.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.362 168.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.453 ' CA ' ' HG2' ' B' ' 25' ' ' ARG . . . -61.54 -28.15 69.2 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.603 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' HG3' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -86.55 -21.84 26.67 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.511 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.467 HG22 ' HD3' ' A' ' 37' ' ' ARG . 26.4 mt -69.02 -44.0 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.399 167.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 40' ' ' ALA . 3.5 mm -62.65 -36.17 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.04 171.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.535 ' HG3' ' HA ' ' B' ' 10' ' ' ARG . 0.6 OUTLIER -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.387 172.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 37' ' ' ARG . 16.5 t70 -62.55 -32.78 73.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.75 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 40' ' ' ALA . . . -58.67 -52.57 65.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.443 169.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.41 18.88 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.051 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.533 ' HB2' HG22 ' B' ' 20' ' ' VAL . . . -64.43 165.76 9.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.311 168.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.21 -58.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.049 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 83.3 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.452 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' B' ' 17' ' ' ALA . 57.9 t -104.45 145.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.324 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 54' ' ' THR . 77.8 p -61.21 139.73 58.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.33 168.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.98 -24.25 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.261 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -53.17 56.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.454 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.414 ' HB1' HG11 ' B' ' 20' ' ' VAL . . . -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.336 -167.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.453 ' HG2' ' CA ' ' B' ' 9' ' ' GLY . 4.1 mpp_? -60.87 -49.03 79.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.417 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.11 -23.68 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.449 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.54 HG23 ' HB ' ' A' ' 60' ' ' ILE . 97.7 m -77.83 -40.08 41.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.362 -170.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.534 HD21 HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.68 -37.37 81.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.409 169.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.61 96.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.245 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -77.8 -31.41 51.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.369 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.527 HD13 HG21 ' B' ' 27' ' ' THR . 5.5 mt -61.35 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.035 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.467 ' CD1' HD11 ' B' ' 28' ' ' LEU . 3.5 mp -59.42 -35.4 73.93 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.611 -165.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.471 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -71.17 -37.44 72.18 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.125 -177.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -65.24 -52.08 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.097 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.534 ' HE1' ' HG ' ' A' ' 32' ' ' LEU . 6.3 ptm -65.03 -28.27 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.343 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.96 -45.8 48.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.503 ' HG3' HG22 ' A' ' 11' ' ' ILE . 1.7 mtt-85 -60.64 -18.29 52.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.452 169.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.9 OUTLIER -87.03 -54.7 4.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.454 -173.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD13 ' A' ' 28' ' ' LEU . 7.1 mt -61.54 -19.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.443 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 12' ' ' ILE . . . -65.7 -70.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.353 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 32.3 t -61.07 -10.14 5.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.61 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.45 -45.02 9.24 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.097 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -63.51 -24.38 67.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.272 169.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 78.2 mt -86.31 -50.43 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.134 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -31.77 70.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.371 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 14.4 mt -60.78 -55.09 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.371 167.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.505 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.32 -30.42 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.292 -170.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.35 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -60.71 -35.05 75.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.371 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.505 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.61 -53.51 56.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.27 171.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.84 24.11 1.12 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.599 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.488 ' HD3' ' NH1' ' A' ' 19' ' ' ARG . 1.3 ptp85 59.57 33.51 22.1 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.226 -0.573 . . . . 0.0 111.169 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 77.37 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.407 169.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m 68.49 175.93 0.27 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.528 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.446 ' HB ' HG11 ' A' ' 20' ' ' VAL . 17.4 mm -118.41 137.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.235 166.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -142.94 166.34 24.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.429 -168.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.21 -25.17 68.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.253 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.429 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 1.0 OUTLIER -64.18 -37.48 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.108 168.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HG2' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -79.5 -39.86 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.395 -176.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.461 HG13 ' CA ' ' A' ' 24' ' ' ALA . 38.2 mm -60.98 -54.4 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.421 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.525 ' HG3' HG22 ' A' ' 27' ' ' THR . 4.5 mt-10 -68.59 -36.43 78.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.986 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 tp -61.13 -44.41 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.338 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.41 -42.82 99.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.413 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.506 HG22 HD11 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -82.99 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.18 -167.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -11.89 8.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.565 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -94.61 -30.9 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.443 168.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 1.1 t80 -61.27 -14.08 23.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.761 171.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 125.34 23.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.689 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.52 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 7.2 mttm . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.382 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG2' ' NH1' ' B' ' 10' ' ' ARG . 44.3 mtp . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.141 0.495 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.39 137.04 49.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.201 -172.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . 6.2 mp -57.34 100.2 0.21 Allowed Pre-proline 0 C--O 1.25 1.117 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.487 -168.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.9 Cg_endo -67.59 141.72 56.24 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.114 2.542 . . . . 0.0 113.67 -172.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -80.49 -9.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.023 -172.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.94 -60.33 1.23 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.727 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 4' ' ' PRO . 9.5 Cg_endo -56.92 -51.37 9.05 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.454 2.103 . . . . 0.0 113.497 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 30.2 mt -60.59 -45.91 96.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.45 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.58 -30.03 75.41 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.686 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.85 -20.57 27.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.493 -0.353 . . . . 0.0 110.329 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.512 HD13 HD22 ' B' ' 3' ' ' LEU . 30.1 mt -65.19 -49.7 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.446 166.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.533 HG23 HG22 ' A' ' 20' ' ' VAL . 13.9 mm -61.05 -46.61 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.418 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -62.32 -30.32 71.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.261 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.34 -35.39 78.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.77 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.54 -52.63 64.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.511 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.11 23.53 0.34 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.576 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -61.7 170.51 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.306 173.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.65 -58.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.952 167.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -125.76 104.57 8.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.36 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 12' ' ' ILE . 59.6 t -112.26 103.8 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.345 168.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB2' HG21 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.44 167.88 3.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.403 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -26.07 67.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.363 -170.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.21 -63.03 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.518 172.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 27' ' ' THR . . . -62.03 -39.54 92.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.3 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 21.7 mtm180 -61.56 -38.62 88.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.291 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.9 mm -76.25 -25.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.51 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 31' ' ' ILE . 71.3 m -74.4 -45.8 44.42 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.12 -168.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.541 HD11 HG12 ' B' ' 60' ' ' ILE . 5.6 tp -59.19 -47.76 84.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.36 164.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -18.46 58.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.531 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -99.68 -27.18 13.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.316 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 27' ' ' THR . 2.0 mp -60.79 -69.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.85 162.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.537 HD21 ' HB3' ' B' ' 32' ' ' LEU . 6.1 mp -59.67 -34.68 73.16 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.555 -168.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' CG ' HD11 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.67 -59.3 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.55 -20.24 63.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.83 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -52.2 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.223 160.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.87 95.15 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -61.31 -39.91 92.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.377 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -63.19 -56.49 16.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.434 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.522 HG23 HG22 ' A' ' 64' ' ' VAL . 3.0 mt -61.57 -28.0 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.219 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -64.34 -61.33 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.231 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.533 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -80.71 -15.24 57.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.517 -167.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -78.98 -48.6 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.125 168.322 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.71 -37.46 86.59 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.041 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.536 HD13 ' HB1' ' B' ' 17' ' ' ALA . 48.2 mt -61.19 -50.3 81.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.147 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.91 -14.88 25.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.3 mt -91.63 -34.38 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.161 -172.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.5 -47.2 87.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.428 168.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -62.01 -48.35 80.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.359 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -62.7 -35.28 79.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.37 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.24 47.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.183 168.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 24.71 0.57 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.618 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.31 96.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.215 -0.492 . . . . 0.0 110.531 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -153.61 78.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.239 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.4 m 69.3 168.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.532 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 44' ' ' ILE . 86.2 mt -121.9 147.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.356 168.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -178.84 7.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.424 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' B' ' 27' ' ' THR . . . -64.23 -22.75 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.258 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.65 -68.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.155 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -25.94 67.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -169.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 ' CG2' HD11 ' B' ' 28' ' ' LEU . 16.0 mm -76.14 -60.05 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.343 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.3 mt-10 -61.75 -18.7 60.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.413 177.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 HD11 HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -78.88 -41.01 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.469 173.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 -37.07 84.36 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.12 173.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 39' ' ' ILE . 41.2 t -61.02 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.713 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -60.27 -9.87 3.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.657 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.2 tpt180 -73.66 -48.52 31.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.408 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.7 m-85 -60.64 -52.32 65.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.365 168.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.43 -72.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.469 -164.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.496 ' HE3' ' HD3' ' B' ' 30' ' ' LYS . 3.1 mtp . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.167 0.508 . . . . 0.0 109.801 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.53 ' HG3' HD22 ' B' ' 3' ' ' LEU . 9.4 tp10 -114.87 -78.9 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.903 -170.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.53 HD22 ' HG3' ' B' ' 2' ' ' GLU . 7.6 mt -68.98 123.19 87.57 Favored Pre-proline 0 C--O 1.244 0.786 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.58 168.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.91 146.51 94.91 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.722 2.281 . . . . 0.0 113.439 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 pt -93.78 21.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.49 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.494 ' HB1' ' HD3' ' B' ' 7' ' ' PRO . . . -88.58 -59.81 0.25 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.748 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.494 ' HD3' ' HB1' ' B' ' 6' ' ' ALA . 10.5 Cg_endo -56.48 -45.72 35.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.362 2.041 . . . . 0.0 113.506 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -61.15 -55.2 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.515 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.39 68.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -80.45 -25.75 38.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.456 -177.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.459 HD13 ' CD1' ' A' ' 3' ' ' LEU . 80.6 mt -68.38 -46.84 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.411 167.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.53 HG21 ' HB3' ' A' ' 40' ' ' ALA . 8.1 mm -65.44 -40.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.212 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtpp -61.05 -36.88 80.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.453 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -62.0 -31.9 72.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.845 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.28 -52.35 65.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.52 170.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.59 22.57 0.85 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.744 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.536 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -64.3 146.29 54.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.807 -0.696 . . . . 0.0 110.405 172.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.32 -58.21 0.18 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.989 168.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -80.76 81.4 7.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.351 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' B' ' 17' ' ' ALA . 21.6 t -139.86 153.37 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.37 -168.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 99.0 p -101.71 150.36 23.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.393 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -16.97 49.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.32 168.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.96 -49.02 79.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.411 169.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -61.59 -45.84 92.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.388 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -30.05 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.404 -171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.81 -20.41 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.436 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 57' ' ' ALA . 88.8 m -61.03 -56.77 17.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.254 167.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.531 ' HA ' HD13 ' B' ' 31' ' ' ILE . 3.0 tp -60.7 -40.24 91.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.529 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.97 92.0 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.421 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.496 ' HD3' ' HE3' ' B' ' 1' ' ' MET . 0.9 OUTLIER -84.22 -21.12 31.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.399 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' B' ' 28' ' ' LEU . 58.8 mt -61.4 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.018 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.537 ' HB3' HD21 ' A' ' 32' ' ' LEU . 8.9 mp -60.79 -42.82 98.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.539 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.468 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 14.6 tm-20 -63.56 -36.67 84.55 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.065 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.48 -43.98 97.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.063 173.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 34.5 mtp -60.78 -37.91 83.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.562 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.91 99.72 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -44.73 95.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.476 172.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 1.1 t70 -77.61 -45.87 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.559 -165.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 28' ' ' LEU . 5.8 mt -61.21 -30.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.253 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.37 -67.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.305 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' HD11 ' B' ' 44' ' ' ILE . 2.4 t -61.24 -9.19 4.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.471 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.75 -38.15 11.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.171 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' B' ' 60' ' ' ILE . . . -76.32 -16.11 59.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.46 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' B' ' 41' ' ' SER . 55.3 mt -87.45 -49.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.836 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -30.03 68.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.414 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.94 -47.23 85.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.405 166.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.529 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.93 -18.6 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.333 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -41.39 67.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.277 168.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -60.3 -30.74 69.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.415 170.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.77 -51.56 68.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.418 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.22 41.84 1.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.477 -174.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.53 18.97 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.43 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 140.66 29.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.191 165.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -61.03 168.25 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.361 -167.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.513 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 61.2 mt -92.96 141.22 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.559 -168.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 2.2 mtpt -138.25 -169.14 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.363 -171.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.466 ' HA ' ' CG2' ' A' ' 27' ' ' THR . . . -66.83 -45.87 76.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.037 -169.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -61.54 -31.0 71.0 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.26 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.54 -68.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.336 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.541 HG12 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -70.04 -32.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 -162.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -38.59 87.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -47.12 87.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.468 168.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' B' ' 39' ' ' ILE . . . -61.56 -13.96 25.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.615 -175.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.533 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -113.64 -57.21 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -159.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -10.92 3.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.39 166.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -85.37 -69.67 0.64 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.632 166.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CE1' HG21 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -62.03 -28.45 69.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -154.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -146.99 109.48 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.491 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.274 169.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.272 0.558 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.79 -78.22 0.32 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.002 -170.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -89.23 143.84 31.56 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.552 171.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.08 140.73 85.73 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.505 2.137 . . . . 0.0 113.444 163.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG13 ' HD3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -96.89 -10.97 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.698 -170.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -61.06 -53.75 60.67 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.691 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 4.0 Cg_endo -51.01 -57.21 2.39 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.613 2.209 . . . . 0.0 113.549 171.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.67 -25.98 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.422 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.95 32.69 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.549 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -76.43 -16.6 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.419 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 HD12 HD22 ' B' ' 3' ' ' LEU . 31.8 mt -60.99 -73.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.262 166.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.534 HG21 HD13 ' B' ' 44' ' ' ILE . 7.4 mm -61.89 -23.42 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.852 -170.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -69.27 -38.69 78.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.457 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' B' ' 37' ' ' ARG . 57.6 t0 -62.31 -33.68 75.13 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.802 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.91 -53.23 60.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.454 169.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.59 15.88 0.32 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.277 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -64.37 -177.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.261 165.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -171.13 -52.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.991 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -92.0 99.03 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.409 170.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG11 ' HB2' ' A' ' 24' ' ' ALA . 46.5 t -113.67 117.88 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 169.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.455 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 35.5 t -61.6 159.34 13.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.38 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.0 -22.82 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.372 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' HG23 ' A' ' 26' ' ' ILE . 8.2 t70 -96.4 -35.25 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.291 -170.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -60.61 -38.49 84.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.065 164.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HD3' HG13 ' A' ' 5' ' ' ILE . 7.4 ttm180 -60.16 -52.37 65.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.514 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tp -72.65 -37.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 HG21 HG23 ' B' ' 60' ' ' ILE . 55.6 m -61.37 -51.86 67.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.262 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.531 HD22 HG13 ' A' ' 12' ' ' ILE . 11.8 tp -61.44 -25.5 67.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.189 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -53.36 15.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.534 169.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.03 -28.84 65.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.363 -170.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 27' ' ' THR . 88.2 mt -61.42 -72.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.054 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 HD12 HD13 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -59.92 -19.08 49.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.771 -166.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.507 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 2.5 pp20? -91.43 -41.89 10.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.027 -171.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.58 -35.14 76.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.904 167.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 mmt -61.05 -54.05 49.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.476 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.79 95.23 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -167.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.507 ' NH2' ' HB2' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -60.92 -33.9 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.315 170.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -53.88 48.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.541 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.533 HD11 HD13 ' B' ' 28' ' ' LEU . 9.8 mt -61.37 -38.92 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.233 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -63.77 -57.11 10.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.384 -172.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 t -61.71 -30.62 70.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.254 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 3.7 mm-40 -60.76 -60.04 4.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.36 -11.93 12.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.535 -176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 HD13 ' HB1' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.76 -56.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.117 -169.107 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.4 65.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.439 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 7.0 mp -61.15 -49.04 78.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.293 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -61.38 -27.84 68.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.327 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -53.28 40.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.455 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.423 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -60.93 -55.08 37.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.124 170.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.3 32.94 0.37 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.508 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.03 -59.93 0.5 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.79 -0.705 . . . . 0.0 111.009 164.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -60.13 98.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.583 -163.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m 70.14 123.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.371 166.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' B' ' 20' ' ' VAL . 15.9 mt -79.02 140.21 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.273 164.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HD2' ' CB ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -144.47 -174.32 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -168.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' B' ' 27' ' ' THR . . . -61.7 -31.18 71.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.34 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.45 -42.33 83.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.115 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -35.43 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.323 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG22 HD12 ' B' ' 28' ' ' LEU . 33.6 mm -61.09 -40.05 84.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.326 169.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 37.5 mt-10 -80.34 -34.07 36.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.002 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -45.08 95.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.436 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -61.17 -36.96 81.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.518 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.51 ' HA ' ' CE1' ' A' ' 67' ' ' PHE 0.257 0.4 OUTLIER -75.22 -52.67 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.989 -167.155 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.17 62.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.596 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.27 -12.5 16.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.923 -163.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE1' HG12 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -101.23 -22.34 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 164.325 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 105.92 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.438 -170.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.595 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.334 -168.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpp . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.18 0.515 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.16 -76.96 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.03 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.534 HD22 HD12 ' A' ' 11' ' ' ILE . 16.0 mt -62.23 133.23 94.22 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.743 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.525 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.5 Cg_endo -60.05 147.75 91.87 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.324 2.016 . . . . 0.0 113.496 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.402 HG12 ' N ' ' B' ' 6' ' ' ALA . 0.2 OUTLIER -85.23 -30.84 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.541 -177.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' B' ' 7' ' ' PRO . . . -69.24 -59.8 4.73 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.69 -171.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 5.4 Cg_endo -52.58 -46.15 35.26 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 122.552 2.168 . . . . 0.0 113.533 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' B' ' 3' ' ' LEU . 26.9 mt -60.5 -36.23 68.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.394 172.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.55 -27.2 67.64 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.439 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.5 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 tpt85 -86.6 -27.38 23.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.395 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.505 HD12 ' NH2' ' A' ' 37' ' ' ARG . 16.2 mt -60.63 -46.36 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.47 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 40' ' ' ALA . 4.0 mm -74.79 -31.62 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.922 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -60.71 -41.89 96.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.45 169.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.71 -31.9 72.09 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.853 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 40' ' ' ALA . . . -57.93 -53.81 54.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.428 167.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.17 30.53 0.27 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.722 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.482 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -80.87 171.81 14.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.67 -0.765 . . . . 0.0 110.26 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -171.1 -25.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.956 166.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 82.0 1.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.533 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.468 ' CG1' ' HB ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -113.79 129.4 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.165 167.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.6 p -61.0 165.94 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.256 166.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -10.82 5.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.353 167.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.46 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -75.83 -55.28 5.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.453 176.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.526 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -62.1 -41.13 97.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.25 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -62.29 -48.13 81.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.386 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.25 -32.13 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.391 -174.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.518 HG21 HG23 ' A' ' 60' ' ' ILE . 84.9 m -60.98 -52.02 66.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.461 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 39' ' ' ILE . 4.1 tp -61.34 -45.65 93.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.264 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' B' ' 3' ' ' LEU . . . -60.89 -28.52 68.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.449 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -27.98 21.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.455 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' B' ' 28' ' ' LEU . 16.7 mt -61.77 -72.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.989 165.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.51 -12.8 10.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.565 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.3 -57.95 3.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.054 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.96 79.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.042 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 7.2 tpp -60.82 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.428 166.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.94 89.9 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -170.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.484 ' HD2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -60.83 -26.82 67.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.317 170.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -48.09 38.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.522 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.517 HD13 HD12 ' A' ' 32' ' ' LEU . 1.2 mt -63.02 -28.83 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.474 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 12' ' ' ILE . . . -65.34 -68.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.318 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.528 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 80.9 p -61.45 -16.06 43.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -69.06 -64.51 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.13 165.817 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.16 -10.92 7.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.624 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.534 HD13 HG21 ' A' ' 12' ' ' ILE . 96.0 mt -99.82 -50.42 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.769 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.27 -29.3 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.402 168.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.536 HD11 ' HA ' ' B' ' 43' ' ' ALA . 9.8 mt -60.82 -51.52 68.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.245 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.459 ' HB1' ' CD1' ' B' ' 55' ' ' ILE . . . -67.97 -38.19 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.293 -169.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -70.35 -39.9 74.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.403 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -60.78 -35.88 77.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.335 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.67 -54.38 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.195 167.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.96 22.37 0.74 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.725 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.52 -165.12 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.294 -0.533 . . . . 0.0 110.981 168.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 65.44 100.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.466 -167.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 2.0 m 70.14 124.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.377 167.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.459 ' CD1' ' HB1' ' B' ' 47' ' ' ALA . 5.6 mm -89.82 152.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.316 166.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.03 159.62 36.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.428 -168.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.93 -30.04 70.63 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.335 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -53.38 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.156 171.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -13.09 23.8 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.456 -174.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 24' ' ' ALA . 33.0 mm -84.01 -63.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.393 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.521 ' HG3' HD13 ' A' ' 31' ' ' ILE . 31.1 mt-10 -61.72 -13.74 25.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.625 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.6 -30.78 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.332 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.519 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -63.9 -37.52 87.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.755 161.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.524 HG23 HD12 ' A' ' 31' ' ' ILE . 41.0 t -61.45 -71.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.769 166.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.463 ' HA ' ' CB ' ' B' ' 68' ' ' LYS . 4.8 mtt-85 -59.2 -11.51 3.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.811 -170.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -71.72 -50.02 34.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.439 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CE2' HG12 ' B' ' 39' ' ' ILE . 29.5 p90 -90.97 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.543 173.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.463 ' CB ' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -119.84 78.24 1.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.348 171.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mttm . . . . . 0 C--O 1.239 0.505 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.496 -175.318 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.35 37.97 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.972 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.502 ' HB3' HD12 ' A' ' 8' ' ' ILE . 10.4 mp 58.83 92.62 0.06 OUTLIER Pre-proline 0 C--O 1.248 1.002 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.551 170.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -49.13 138.49 28.28 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 C-N-CA 122.6 2.2 . . . . 0.0 113.348 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.529 HG13 ' HD3' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -91.53 19.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.898 -167.214 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.35 -58.24 0.45 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.699 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -54.41 -53.27 6.48 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.497 2.131 . . . . 0.0 113.537 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 3' ' ' LEU . 26.2 mt -61.44 -59.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.522 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.6 -18.83 57.14 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -31.68 22.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.952 -0.624 . . . . 0.0 110.356 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.518 HG21 ' HG3' ' B' ' 37' ' ' ARG . 61.4 mt -60.53 -51.14 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.554 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.47 ' CD1' ' HB3' ' B' ' 40' ' ' ALA . 9.9 mm -61.27 -37.61 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.281 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -34.31 77.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.344 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -62.52 -34.42 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' B' ' 41' ' ' SER . . . -59.34 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.485 169.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.73 21.98 0.42 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.604 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.31 150.62 29.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.349 167.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.07 -51.81 2.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.036 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.52 132.12 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.37 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.73 123.1 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.333 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 21.4 t -66.29 156.73 33.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.454 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HA ' ' CG ' ' A' ' 25' ' ' ARG . 27.9 t0 -61.37 -24.07 66.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.346 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -53.69 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.513 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' CB ' HG13 ' B' ' 60' ' ' ILE . . . -62.18 -47.24 85.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.318 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.529 ' HD3' HG13 ' A' ' 5' ' ' ILE . 1.4 ptp85 -70.96 -27.65 63.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 -168.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 78.5 mt -86.29 -27.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.421 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 HG23 HD13 ' A' ' 31' ' ' ILE . 99.3 m -60.95 -54.4 45.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.345 170.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.491 HD13 HD11 ' B' ' 39' ' ' ILE . 4.0 tp -60.14 -43.01 96.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.49 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 26' ' ' ILE . . . -61.19 -32.19 71.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.501 -174.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.86 -24.1 15.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.236 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 HG23 ' A' ' 27' ' ' THR . 84.4 mt -60.65 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.028 164.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD11 HD22 ' B' ' 32' ' ' LEU . 1.0 OUTLIER -59.04 -33.89 71.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.699 -172.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HB2' ' CD1' ' A' ' 3' ' ' LEU . 10.4 tm-20 -61.86 -59.33 5.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.047 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 2.3 tp10 -64.52 -30.57 71.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.838 -171.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.416 ' HE1' HD12 ' A' ' 39' ' ' ILE . 19.2 ttt -60.42 -41.14 93.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.292 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.62 -46.9 93.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.46 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -62.66 -24.75 67.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.049 -178.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 6.9 t0 -80.9 -45.25 17.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.504 -174.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.52 HG12 ' CE2' ' A' ' 67' ' ' PHE . 9.6 mt -61.65 -30.28 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.144 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -62.54 -77.31 0.05 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.25 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.504 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.81 -11.0 10.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.384 -172.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -81.35 -56.46 4.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.114 170.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.5 -17.2 43.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.612 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.53 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 78.3 mt -85.58 -51.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.854 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -60.63 -39.73 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.383 168.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 50.6 mt -60.76 -39.69 89.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.415 170.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 44' ' ' ILE . . . -61.46 -24.75 66.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.295 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -82.34 -48.85 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.343 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.01 64.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.242 167.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -60.28 -56.57 19.96 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.137 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.25 30.07 0.16 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.697 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.69 -60.96 0.49 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.923 161.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.05 93.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.306 0.574 . . . . 0.0 110.581 -161.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.524 HG23 ' HB2' ' B' ' 21' ' ' SER . 24.9 m 70.44 144.28 0.06 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.49 ' HB ' HG12 ' B' ' 20' ' ' VAL . 15.3 mm -73.32 138.35 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.221 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -135.94 170.32 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.429 -170.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.45 55.91 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.48 -165.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -26.81 68.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.946 -174.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -65.18 -39.5 92.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.499 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.522 HG21 HD23 ' B' ' 28' ' ' LEU . 36.5 mm -62.75 -67.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.391 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.6 mt-10 -61.09 -11.21 7.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.278 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.1 -50.88 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.437 166.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.82 99.23 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.304 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 21.8 t -62.02 -68.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.856 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.17 -9.79 3.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.682 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -35.32 39.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.355 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 39' ' ' ILE . 96.9 m-85 -59.72 -59.78 4.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.367 163.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tptp -65.09 140.78 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.416 -168.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.579 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.363 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.096 0.474 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -71.3 -179.29 2.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.022 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' B' ' 8' ' ' ILE . 3.2 mt -69.23 138.51 89.47 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -170.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.486 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 140.88 94.04 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.41 2.074 . . . . 0.0 113.481 167.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.61 -11.94 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.657 -173.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.495 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -71.45 -60.55 2.57 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.81 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 8.7 Cg_endo -55.64 -42.97 62.27 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.462 2.108 . . . . 0.0 113.546 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' B' ' 3' ' ' LEU . 57.4 mt -60.45 -39.76 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.472 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.72 -29.92 73.47 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.579 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 mtp180 -89.82 -23.13 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 110.383 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.441 HD12 HD12 ' A' ' 3' ' ' LEU . 36.5 mt -60.93 -58.39 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.317 166.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 10.3 mm -61.87 -36.53 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.274 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.98 -36.31 79.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.362 169.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.3 -32.78 73.57 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.835 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.79 -53.41 58.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.425 169.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.59 20.85 0.76 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.725 -172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.455 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -60.24 120.08 9.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.35 166.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.41 -54.48 10.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.168 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 104.9 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.379 174.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.522 HG22 HG23 ' B' ' 12' ' ' ILE . 11.2 t -83.81 129.28 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.267 169.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.524 ' HB2' HG23 ' A' ' 54' ' ' THR . 27.0 t -61.49 148.29 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.279 166.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.514 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 10.9 p30 -61.54 -22.78 65.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.417 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.539 ' HA ' HG23 ' B' ' 26' ' ' ILE . 10.1 t70 -88.73 -25.56 22.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.387 -172.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' B' ' 20' ' ' VAL . . . -66.41 -44.14 83.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.24 168.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.514 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 2.3 ptt-85 -83.09 -18.17 40.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.414 -167.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.539 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -78.19 -35.43 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.41 168.543 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.515 HG21 HD13 ' B' ' 31' ' ' ILE . 68.7 m -61.11 -37.93 84.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.265 175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.53 HD11 HD13 ' B' ' 32' ' ' LEU . 1.1 mm? -60.84 -40.54 93.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.322 166.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' B' ' 26' ' ' ILE . . . -61.67 -52.13 65.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.337 -176.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.466 ' NZ ' HD13 ' B' ' 26' ' ' ILE . 0.2 OUTLIER -68.55 -33.47 74.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.464 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.524 HD12 HG23 ' A' ' 64' ' ' VAL . 41.1 mt -61.71 -71.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.16 170.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.53 HD13 HD11 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.8 -15.66 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.832 -169.679 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.41 -24.03 16.88 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.054 -177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -52.26 65.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.111 167.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -73.56 -27.41 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.327 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.32 91.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.518 ' HG3' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.75 -28.86 69.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.334 168.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.26 -58.18 4.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.557 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 28' ' ' LEU . 4.2 mt -61.44 -30.32 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.385 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.47 ' HB3' ' CD1' ' A' ' 12' ' ' ILE . . . -62.22 -73.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.296 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.539 ' HA ' HD13 ' B' ' 44' ' ' ILE . 24.5 p -62.13 -15.44 45.62 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.529 -170.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.515 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -89.67 -39.52 13.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.158 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -70.63 -9.07 56.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.486 168.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.539 HD13 ' HA ' ' B' ' 41' ' ' SER . 74.6 mt -94.34 -53.24 8.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.873 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.43 -18.21 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.382 168.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' B' ' 43' ' ' ALA . 5.1 mt -72.96 -48.75 33.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.398 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.3 -31.94 69.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.218 -170.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.423 ' CZ ' ' HB2' ' B' ' 48' ' ' ARG . 22.8 ttm105 -65.83 -40.02 91.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.282 168.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.23 -38.58 87.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.31 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.88 -51.21 70.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.287 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.14 4.31 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 148.02 22.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.415 -170.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -82.63 171.98 13.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -170.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.436 HG23 ' HD2' ' B' ' 56' ' ' LYS . 93.9 m 61.54 119.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.421 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' B' ' 44' ' ' ILE . 82.4 mt -88.6 148.31 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.388 170.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.436 ' HD2' HG23 ' B' ' 54' ' ' THR . 0.0 OUTLIER -135.75 179.69 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.45 -169.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.291 -171.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.423 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 15.7 pt-20 -84.36 -43.86 14.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.063 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -61.61 -23.52 66.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.44 179.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.469 ' CG2' HD11 ' A' ' 28' ' ' LEU . 29.7 mm -88.61 -56.37 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.239 -171.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 36.5 mt-10 -62.09 -18.06 59.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 172.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' B' ' 59' ' ' ASP . 12.1 mt -67.17 -55.82 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.336 168.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' B' ' 43' ' ' ALA . . . -64.35 -35.64 81.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.219 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 49.2 t -62.1 -79.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.689 171.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -12.02 9.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.365 -168.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -53.68 48.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.36 167.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.515 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 5.0 m-85 -61.07 -56.59 19.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.375 173.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.64 26.89 13.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.349 -169.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.24 0.557 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HE1' ' HB3' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.096 0.474 . . . . 0.0 109.984 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.86 -29.7 2.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.074 -169.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 33' ' ' GLU . 17.2 mt -61.81 104.6 0.49 Allowed Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.989 -177.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.529 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 4.2 Cg_endo -46.52 140.45 11.94 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.4 2.067 . . . . 0.0 113.478 173.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.76 -13.41 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.755 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.76 -55.86 8.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.665 173.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' HG2' ' HG2' ' A' ' 4' ' ' PRO . 13.5 Cg_exo -48.68 -59.33 1.29 Allowed 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.705 2.27 . . . . 0.0 113.555 169.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG23 HD11 ' A' ' 8' ' ' ILE . 30.7 mt -61.43 -35.87 69.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.458 -178.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.512 ' HA3' ' NH1' ' A' ' 25' ' ' ARG . . . -61.61 -37.73 94.68 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.556 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 9.4 ptp180 -90.23 -14.35 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.465 -171.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.52 -56.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.305 165.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.524 HG21 HD12 ' B' ' 44' ' ' ILE . 9.1 mm -61.34 -37.31 77.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.149 -177.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 mttm -60.37 -39.45 87.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.429 167.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.34 -33.35 74.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.751 -177.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.11 -53.86 53.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.207 -1.361 . . . . 0.0 110.427 169.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.48 21.56 0.45 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.713 -175.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB1' HD12 ' B' ' 44' ' ' ILE . . . -60.56 137.95 58.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.409 168.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.9 -27.72 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.005 -170.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.82 117.99 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.445 169.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG21 HG12 ' B' ' 55' ' ' ILE . 89.5 t -141.41 132.24 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -172.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 p -83.34 151.23 25.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.406 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 p30 -62.03 -14.17 33.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' HA ' HG23 ' A' ' 26' ' ' ILE . 11.7 m-20 -86.48 -27.9 23.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.394 -176.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -65.42 -39.28 91.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.109 165.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.4 OUTLIER -61.66 -43.64 98.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.518 -178.892 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 27' ' ' THR . 6.4 tt -75.08 -40.45 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.269 -172.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 31' ' ' ILE . 83.1 m -60.66 -44.42 96.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.396 -174.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 HD11 ' B' ' 39' ' ' ILE . 2.2 tp -61.0 -35.41 76.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.288 169.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.07 98.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.405 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -29.42 40.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.539 HD12 HG23 ' A' ' 27' ' ' THR . 28.9 mt -61.28 -72.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.029 171.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD13 HG23 ' A' ' 31' ' ' ILE . 8.2 mp -60.11 -30.28 69.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 -167.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' B' ' 11' ' ' ILE . 3.4 tm-20 -81.53 -37.44 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.034 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -61.47 -39.79 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.955 166.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.421 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 95.3 mtp -61.36 -40.91 96.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.495 175.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.09 -38.21 63.7 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -166.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -61.02 -27.5 68.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.248 164.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -74.12 -51.47 15.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.53 -173.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.522 HG12 HG21 ' A' ' 64' ' ' VAL . 12.5 mt -61.14 -38.86 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.204 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' B' ' 12' ' ' ILE . . . -60.97 -58.68 7.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.388 -170.016 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.498 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 23.3 p -61.49 -28.79 69.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.365 178.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' HG2' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.0 -43.38 98.94 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.071 169.575 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -76.9 -12.73 60.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.354 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.511 HD12 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -84.27 -56.59 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.306 -168.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -59.79 -28.89 67.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.488 170.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 63' ' ' ALA . 13.5 mt -60.63 -47.02 88.09 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.457 174.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.439 ' HB1' ' CD1' ' A' ' 55' ' ' ILE . . . -63.23 -38.03 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.325 -176.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -44.94 75.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 -170.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -60.97 -31.48 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.336 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.27 -53.21 59.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.211 168.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.82 17.14 0.84 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 59.39 28.39 17.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.322 -0.516 . . . . 0.0 111.237 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 77.59 8.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.298 169.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.536 HG21 ' HG3' ' B' ' 19' ' ' ARG . 6.7 m 68.51 169.58 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.456 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 5.6 mm -106.08 137.29 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.195 164.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' HD3' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -128.26 159.77 34.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.417 -167.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -62.28 -13.04 24.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.126 -172.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.535 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -81.69 -25.49 35.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 174.04 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.04 -36.43 23.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.27 -174.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG12 ' HB2' ' B' ' 28' ' ' LEU . 1.5 mp -62.82 -48.72 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.489 161.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.4 mm-40 -61.44 -43.85 98.15 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.81 -174.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' HG ' HD23 ' A' ' 46' ' ' LEU . 39.9 tp -65.38 -44.74 86.6 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.542 173.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.501 ' HB3' HD13 ' A' ' 46' ' ' LEU . . . -61.39 -45.05 95.96 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.426 -175.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG21 HG12 ' A' ' 39' ' ' ILE 0.25 0.4 OUTLIER -78.51 -53.52 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.085 -166.554 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -36.26 77.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.631 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -21.06 59.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.374 174.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CD1' ' HG2' ' A' ' 42' ' ' GLU . 29.9 t80 -68.89 -64.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.259 -173.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.96 -168.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.312 178.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 tttp . . . . . 0 C--O 1.24 0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.299 167.45 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttt . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 121.071 0.463 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -81.3 145.0 31.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.938 -168.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.496 ' HG ' ' HB3' ' B' ' 33' ' ' GLU . 4.6 mt -61.07 99.41 0.18 Allowed Pre-proline 0 C--O 1.243 0.716 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.71 166.292 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.07 142.93 76.05 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 122.613 2.209 . . . . 0.0 113.628 -172.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.528 HG23 ' HG3' ' B' ' 25' ' ' ARG . 0.1 OUTLIER -66.42 -18.3 23.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.571 -165.198 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.62 -62.47 0.94 Allowed Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.776 -170.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.72 -50.5 13.83 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.402 2.068 . . . . 0.0 113.444 175.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.526 HD13 ' HB3' ' B' ' 29' ' ' ALA . 27.2 mt -60.45 -31.74 49.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.393 168.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.99 67.97 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.484 -175.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 49.7 mmm-85 -91.66 -27.72 17.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.477 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.538 HD12 ' HG2' ' A' ' 33' ' ' GLU . 36.5 mt -60.92 -59.57 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.526 170.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.512 HD13 HD22 ' B' ' 28' ' ' LEU . 10.0 mm -61.37 -38.42 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -61.8 -34.01 75.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.349 175.739 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.22 -32.56 73.23 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.685 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -58.69 -54.0 51.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.45 169.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.45 28.62 0.26 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.67 -176.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.511 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -76.09 148.84 37.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.715 -0.743 . . . . 0.0 110.357 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.62 117.08 5.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.092 169.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.536 ' HG3' HG21 ' A' ' 54' ' ' THR . 3.1 tpp180 65.04 97.02 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.356 -173.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' B' ' 24' ' ' ALA . 46.2 t -110.8 150.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.292 168.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -61.13 149.41 37.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.315 169.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 1.7 m-20 -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.309 170.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.78 -60.25 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.593 174.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . . . -62.09 -47.66 83.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.318 -171.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.528 ' HG3' HG23 ' B' ' 5' ' ' ILE . 5.7 ptt180 -61.09 -34.81 75.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.344 -172.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.15 -33.89 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.499 175.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.532 HG21 HD13 ' B' ' 31' ' ' ILE . 80.0 m -60.99 -44.93 96.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.407 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.536 ' HB2' HG12 ' A' ' 60' ' ' ILE . 3.9 tp -60.39 -54.47 45.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.268 173.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.526 ' HB3' HD13 ' B' ' 8' ' ' ILE . . . -61.54 -15.53 39.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.456 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.462 ' HA ' ' CG ' ' B' ' 33' ' ' GLU . 8.5 tmtt? -99.02 -25.46 14.55 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.266 -174.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.532 HD13 HG21 ' B' ' 27' ' ' THR . 2.1 mt -60.54 -69.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.951 162.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mp -59.92 -35.16 74.3 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.575 -167.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.496 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -70.35 -40.08 74.27 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.964 -176.771 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -44.17 97.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.122 173.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.503 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 63.1 mmm -61.01 -27.09 68.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.462 175.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.15 -43.47 13.45 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -60.34 -17.98 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.393 166.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -90.96 -52.13 5.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.358 -168.711 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 28' ' ' LEU . 4.3 mt -61.11 -23.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.206 167.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -61.84 -72.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.28 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.513 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.8 m -61.67 -11.4 11.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.358 -175.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.22 -56.63 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.129 171.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.1 -14.65 25.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.326 176.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.524 HD12 HG21 ' A' ' 12' ' ' ILE . 70.8 mt -90.62 -54.96 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.056 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.53 -11.62 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.414 170.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 6.4 mt -87.81 -42.47 12.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.443 176.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.472 ' HB3' HD12 ' B' ' 55' ' ' ILE . . . -61.47 -25.69 67.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.276 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -83.41 -50.75 8.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.45 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -61.31 -31.62 71.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.375 -178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.28 73.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.201 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.83 35.78 0.94 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -166.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 66.49 118.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.487 169.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' B' ' 53' ' ' LYS . 0.1 OUTLIER -167.82 13.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.321 179.387 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.96 162.37 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.494 -175.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.524 HG12 HG21 ' A' ' 20' ' ' VAL . 14.0 mm -75.21 137.47 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.339 173.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -154.32 -178.82 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.425 -169.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.69 66.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.34 172.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -26.48 21.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.123 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -35.5 13.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.317 -175.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 46.9 mm -61.15 -47.37 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.196 167.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.498 ' HG2' ' NH2' ' B' ' 65' ' ' ARG . 20.9 mt-10 -62.02 -44.53 96.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.971 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -45.98 92.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.464 172.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' B' ' 46' ' ' LEU . . . -61.49 -46.04 91.69 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.421 -177.153 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.509 HG22 HD11 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -80.02 -60.94 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.099 -165.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.498 ' NH2' ' HG2' ' B' ' 61' ' ' GLU . 4.6 mtm180 -60.22 -19.0 52.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.565 -175.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -89.54 -25.5 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.544 171.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.8 t80 -61.29 -41.64 97.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.46 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.69 129.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.3 -165.635 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.376 -170.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptt? . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.128 0.489 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.56 121.0 12.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.062 -168.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 33' ' ' GLU . 6.3 mp -57.1 138.9 79.68 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.569 -172.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.3 Cg_endo -63.82 141.21 77.41 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 113.646 -178.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -13.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.636 -166.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -73.44 -55.54 3.53 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.674 173.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 4' ' ' PRO . 13.2 Cg_exo -49.43 -61.17 0.62 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.749 2.299 . . . . 0.0 113.557 168.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 3' ' ' LEU . 54.9 mt -61.39 -49.58 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.4 91.27 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -172.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -40.99 96.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.081 -0.56 . . . . 0.0 110.407 176.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.55 -36.11 71.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.538 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' B' ' 40' ' ' ALA . 8.3 mm -72.79 -44.97 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.192 -172.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -31.96 72.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.255 176.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -61.89 -33.3 73.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.807 177.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.26 -53.21 60.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.462 170.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.4 25.79 0.63 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.496 -174.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -61.21 119.79 9.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.718 -0.741 . . . . 0.0 110.363 176.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.59 -71.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.12 131.84 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.368 168.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.529 HG23 HD11 ' B' ' 55' ' ' ILE . 60.0 t -124.62 133.14 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.422 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.9 p -73.47 136.02 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.04 -12.88 13.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.398 -174.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -86.67 -21.93 26.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.35 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.468 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -70.72 -38.47 73.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.123 164.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -61.48 -31.48 71.46 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.502 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 23' ' ' ASP . 3.5 tp -89.7 -34.61 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 -175.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 HG23 HD13 ' A' ' 31' ' ' ILE . 80.5 m -61.52 -41.16 96.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.18 177.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 HG21 ' B' ' 60' ' ' ILE . 3.8 tp -59.19 -45.48 90.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.541 167.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.52 -43.09 99.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.504 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -76.62 -28.09 55.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.235 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 HG23 ' A' ' 27' ' ' THR . 6.6 mt -59.59 -73.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.908 162.177 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.535 HD11 HD21 ' B' ' 32' ' ' LEU . 1.0 OUTLIER -56.15 -23.79 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.819 -159.646 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.83 -60.76 2.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.038 166.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -28.66 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.109 -164.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.523 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.3 mmm -71.58 -38.96 70.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.436 167.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.49 -44.3 90.44 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -174.404 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HG3' HG21 ' B' ' 11' ' ' ILE . 6.1 mtp180 -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.399 168.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -66.35 -53.75 32.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.434 -178.003 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' CG2' HG22 ' A' ' 64' ' ' VAL . 8.1 mt -61.39 -45.48 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.388 -175.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' B' ' 12' ' ' ILE . . . -61.29 -48.36 81.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 -172.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.2 t -62.15 -27.46 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.385 177.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -68.37 -43.15 78.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.181 168.978 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -73.06 -7.78 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.676 177.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -86.84 -52.07 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.275 -174.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -31.1 68.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.667 168.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 12.7 mt -61.16 -51.13 70.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.405 175.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.99 67.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.348 -171.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -41.97 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.439 170.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -63.22 -31.6 72.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.389 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB2' ' HG3' ' A' ' 52' ' ' ARG . . . -61.77 -48.7 79.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.261 169.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 35.01 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -170.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -148.15 133.68 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.375 169.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.4 mmpp? -61.35 -43.51 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.34 -169.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -66.41 126.21 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.412 -168.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' B' ' 17' ' ' ALA . 7.0 mt -91.67 154.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.362 168.062 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.487 ' N ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -158.84 173.53 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.377 -166.521 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' N ' ' HE3' ' A' ' 56' ' ' LYS . . . -61.97 -15.85 46.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.255 -177.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.76 -41.59 17.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.087 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -59.94 -49.38 77.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.608 170.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' B' ' 27' ' ' THR . 32.2 mm -60.77 -59.92 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.415 -171.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 30.3 mt-10 -61.83 -29.17 69.99 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.968 -174.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.36 -45.6 92.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.469 168.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -61.14 -42.93 99.44 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.588 -176.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG22 ' CG2' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -82.14 -55.07 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.054 -165.569 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -21.87 64.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.738 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -92.92 -14.33 27.72 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.736 177.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.509 ' CD2' ' HG2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.27 -75.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.92 161.248 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 59.13 15.93 4.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.767 158.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.241 0.611 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.207 -162.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.56 -172.55 0.1 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 169.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' B' ' 33' ' ' GLU . 12.1 mt -61.61 138.28 95.08 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.603 -166.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 5.1 Cg_endo -60.32 160.98 21.35 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.575 2.183 . . . . 0.0 113.407 164.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -102.27 -20.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.517 -175.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' B' ' 7' ' ' PRO . . . -70.14 -59.09 4.5 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.754 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' B' ' 4' ' ' PRO . 4.7 Cg_endo -48.66 -50.98 11.19 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.585 2.19 . . . . 0.0 113.467 171.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.519 ' HA ' HD11 ' B' ' 11' ' ' ILE . 66.9 mt -60.83 -27.91 42.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.317 174.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.44 -40.71 99.05 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.502 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.06 -21.68 39.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.495 -178.441 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.528 HG21 ' HG3' ' A' ' 37' ' ' ARG . 89.7 mt -67.19 -44.44 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.507 178.053 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.469 ' CD1' ' HG ' ' B' ' 28' ' ' LEU . 8.0 mm -69.17 -41.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.325 175.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 11.2 mtmt -61.51 -39.67 91.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.313 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.59 -31.31 71.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.908 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.402 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -58.07 -52.37 65.82 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.639 170.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.91 24.33 0.33 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.635 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.527 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -75.69 120.04 20.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.617 -0.791 . . . . 0.0 110.255 176.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 13.88 29.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.995 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 179.35 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.419 -174.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.461 HG23 ' CB ' ' B' ' 17' ' ' ALA . 10.7 t -99.85 125.58 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.338 -176.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -63.57 149.64 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.169 164.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.58 -12.23 9.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.502 169.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.521 ' HA ' HG23 ' B' ' 26' ' ' ILE . 0.5 OUTLIER -95.37 -32.67 12.83 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.428 -174.61 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.518 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -61.2 -41.33 96.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.182 169.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.15 -53.55 55.55 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.52 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.521 HG23 ' HA ' ' B' ' 23' ' ' ASP . 0.1 OUTLIER -67.21 -33.44 62.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.316 -171.915 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.523 HG23 ' HB ' ' A' ' 60' ' ' ILE . 85.0 m -70.1 -34.45 73.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.318 -174.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.529 HD11 HD13 ' B' ' 32' ' ' LEU . 0.9 OUTLIER -60.68 -40.76 93.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.21 166.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.57 -56.82 15.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.299 -179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -33.64 76.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.445 -174.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . . . . . . . . . 69.7 mt -61.05 -74.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.935 167.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 32' ' ' LEU . 3.7 mt -59.33 -28.67 67.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.57 -164.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.524 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.6 pp20? -75.72 -39.5 57.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -35.73 79.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.969 175.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.517 170.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.91 -38.35 95.88 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -33.89 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.276 167.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.29 -55.7 19.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.438 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.532 HD11 HG22 ' B' ' 64' ' ' VAL . 4.9 mt -61.8 -33.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.09 -177.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.93 -65.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.27 -173.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.538 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.03 -18.26 64.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.521 -175.373 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -44.65 16.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.168 175.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -68.27 -32.53 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.148 175.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.539 HD13 ' HB1' ' A' ' 17' ' ' ALA . 21.7 mt -60.71 -47.39 93.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.097 164.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -30.29 69.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.429 177.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.0 mt -72.31 -34.34 68.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.366 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.13 -35.84 78.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.294 176.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.64 -44.06 96.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 172.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.74 -36.84 79.89 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.438 174.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.88 75.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 172.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 29.79 2.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -163.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.32 -169.58 0.14 Allowed 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.089 -0.654 . . . . 0.0 111.072 175.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.86 98.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.466 -169.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.94 122.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 165.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.529 HD11 HG23 ' A' ' 20' ' ' VAL . 4.1 mp -93.22 138.16 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.152 162.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.446 ' HE3' ' HB3' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -130.55 178.95 6.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.401 -167.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.34 -19.88 62.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.267 -172.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.47 -28.67 21.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.043 -177.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.2 -34.94 21.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.338 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.53 HG21 HD11 ' A' ' 28' ' ' LEU . 46.7 mm -61.02 -50.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.403 168.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -69.1 -37.52 78.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -175.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.407 ' HB3' HD12 ' B' ' 46' ' ' LEU . 12.0 mt -61.04 -45.45 94.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.397 175.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.464 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -61.29 -49.48 76.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.385 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.532 HG22 HD11 ' B' ' 39' ' ' ILE 0.257 0.4 OUTLIER -74.87 -50.5 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.937 -160.89 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.52 ' N ' HG11 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -62.85 -30.19 71.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.439 178.553 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.55 84.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.377 -177.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.98 -65.12 0.74 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.398 172.203 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -154.92 173.54 16.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.464 -171.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mttt . . . . . 0 C--O 1.241 0.622 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.376 169.975 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmm . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 121.155 0.502 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -68.54 -178.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.994 -171.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.2 mt -61.06 102.78 0.33 Allowed Pre-proline 0 C--O 1.243 0.731 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.975 175.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.21 141.55 58.83 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.85 1.7 . . . . 0.0 113.113 168.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -93.25 20.77 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.622 -164.319 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.56 -59.39 0.45 Allowed Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.716 172.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.475 ' HA ' ' N ' ' B' ' 1' ' ' MET . 9.5 Cg_endo -58.0 -50.5 10.0 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.496 2.131 . . . . 0.0 113.498 173.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.526 ' HA ' HD13 ' A' ' 11' ' ' ILE . 57.4 mt -61.37 -44.03 97.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.499 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.41 98.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -170.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.53 -32.31 69.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.008 -0.596 . . . . 0.0 110.334 -178.244 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 8' ' ' ILE . 39.6 mt -61.76 -51.76 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.354 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.535 HG22 ' HB3' ' B' ' 40' ' ' ALA . 6.4 mm -65.78 -48.44 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.439 -173.024 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -35.14 78.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.253 177.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.83 -32.19 72.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.85 177.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.83 -52.47 65.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.522 170.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.54 20.65 0.61 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.737 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -63.77 119.54 10.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.181 -0.509 . . . . 0.0 110.319 168.005 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -112.69 18.47 18.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.893 176.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' B' ' 54' ' ' THR . 0.0 OUTLIER 179.89 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.332 -164.396 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG21 HD11 ' B' ' 55' ' ' ILE . 12.3 t -136.81 118.11 18.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.38 172.267 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -74.39 159.74 31.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.393 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.13 -23.59 65.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.412 -171.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' HA ' HG23 ' A' ' 26' ' ' ILE . 80.5 m-20 -90.67 -29.6 17.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -170.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -61.26 -42.81 99.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.143 162.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.507 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -77.31 -28.69 53.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 -167.519 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.541 HG23 ' HA ' ' A' ' 23' ' ' ASP . 5.2 tp -72.94 -37.33 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.429 172.276 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 HG21 HD13 ' A' ' 31' ' ' ILE . 57.8 m -60.69 -39.98 90.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD13 ' HB ' ' B' ' 39' ' ' ILE . 3.5 tp -64.55 -44.37 90.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.014 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 8' ' ' ILE . . . -61.1 -32.63 72.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -79.35 -33.21 43.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.478 179.207 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 28' ' ' LEU . 11.6 mt -60.57 -69.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.003 169.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -58.09 -27.64 63.86 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.672 -168.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -84.55 -19.92 32.36 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.149 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -63.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.008 165.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.43 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 11.0 mtp -61.99 -31.04 71.37 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 -174.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.45 -42.96 71.61 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -177.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -22.02 63.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.547 . . . . 0.0 110.435 169.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.4 m-20 -90.46 -47.74 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.608 -168.368 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD13 ' B' ' 28' ' ' LEU . 5.9 mt -61.27 -29.66 46.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.243 171.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.536 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -61.98 -66.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.237 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 29.7 p -63.61 -17.57 63.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.542 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -69.7 -60.84 2.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.909 167.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' CA ' ' HB3' ' A' ' 63' ' ' ALA . . . -61.69 -14.68 33.63 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.417 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 84.2 mt -96.93 -48.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.664 -172.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -59.85 -11.62 5.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.482 164.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 63' ' ' ALA . 3.7 mp -87.17 -52.84 5.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.277 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -14.27 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.314 177.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 1.6 mmm-85 -91.94 -70.27 0.7 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.414 -178.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.511 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -67.87 -12.01 59.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.852 -170.078 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' CB ' ' HG2' ' A' ' 52' ' ' ARG . . . -64.7 -45.96 84.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 163.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.08 4.31 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -166.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 14.6 mmm180 -126.09 172.54 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.448 -164.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 135.92 50.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.445 -170.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.2 m 62.82 146.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.469 -178.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 59' ' ' ASP . 64.3 mt -97.19 156.62 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.234 168.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' N ' HG21 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -156.35 177.08 11.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.469 -171.241 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.87 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.3 173.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -65.34 -50.35 65.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.028 168.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' HG22 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -61.4 -51.93 66.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.334 179.41 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.529 HG22 HD12 ' B' ' 28' ' ' LEU . 47.6 mm -60.76 -44.13 96.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.342 -168.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -39.21 88.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.151 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.38 -48.31 81.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.328 176.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.525 ' HA ' HD23 ' A' ' 46' ' ' LEU . . . -61.37 -30.21 70.39 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.401 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG21 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -89.49 -56.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.129 -165.222 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -16.24 31.42 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.695 171.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -32.02 57.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.358 169.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.95 -35.24 74.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.465 171.828 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -60.7 99.95 0.1 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.45 172.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.535 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.327 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.475 ' N ' ' HA ' ' A' ' 7' ' ' PRO . 1.5 ttt . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.137 0.494 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -62.71 138.96 58.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.029 170.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' B' ' 33' ' ' GLU . 15.5 mt -61.87 107.89 1.34 Allowed Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.915 -177.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 4.4 Cg_endo -47.53 142.42 13.42 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.551 2.168 . . . . 0.0 113.424 168.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.66 -19.21 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.447 -167.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.99 -62.66 1.51 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.744 -168.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.68 -42.86 59.77 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.5 2.133 . . . . 0.0 113.491 178.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 44.5 mt -60.41 -47.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.537 172.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.03 -26.13 67.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -173.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.24 -33.42 32.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.402 -177.725 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.522 HD12 ' HG2' ' A' ' 33' ' ' GLU . 67.5 mt -60.76 -52.4 62.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.447 169.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.538 HG21 ' HB1' ' B' ' 17' ' ' ALA . 11.8 mm -61.1 -35.13 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.199 177.662 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.535 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.5 mttt -67.58 -37.05 82.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.504 178.074 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -61.7 -31.42 71.57 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.687 -178.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.81 -53.58 56.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.474 168.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.14 7.51 0.81 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.782 -166.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.538 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -63.7 -162.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.954 0.502 . . . . 0.0 110.691 168.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' B' ' 13' ' ' LYS . 4.0 tm-20 64.2 25.42 13.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -155.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 20.19 17.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.404 151.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' B' ' 17' ' ' ALA . 61.2 t -113.27 172.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.228 -161.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.449 ' N ' ' CG1' ' B' ' 20' ' ' VAL . 24.6 p -108.63 169.21 8.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.587 175.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.539 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 1.8 p30 -78.54 -33.52 47.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.336 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.83 -30.81 70.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.334 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' CG1' ' A' ' 60' ' ' ILE . . . -60.95 -69.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.269 169.295 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' B' ' 22' ' ' ASP . 1.3 ptt180 -61.06 -11.44 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.345 -166.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 29.7 mt -86.11 -35.3 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.424 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.504 HG21 HD13 ' B' ' 31' ' ' ILE . 73.1 m -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.419 176.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.539 HD13 ' HB ' ' A' ' 39' ' ' ILE . 2.8 tp -60.74 -40.45 92.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.42 177.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.32 96.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.511 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -74.63 -31.33 61.95 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.393 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.504 HD13 HG21 ' B' ' 27' ' ' THR . 54.0 mt -60.72 -75.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.964 170.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.504 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.93 -30.98 66.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 -162.439 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.505 ' HB2' HD13 ' B' ' 3' ' ' LEU . 2.5 tm-20 -85.81 -31.44 22.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.016 -173.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -61.49 -36.91 81.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.829 163.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 2.6 ttm -63.82 -43.52 95.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.446 176.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.49 -33.58 63.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -165.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -60.85 -33.22 72.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.27 164.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -51.07 54.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.712 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.535 HG12 HG21 ' B' ' 64' ' ' VAL . 1.1 mt -62.32 -35.59 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.758 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' A' ' 12' ' ' ILE . . . -61.35 -65.75 0.64 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.489 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.9 -20.51 63.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.418 -179.165 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -61.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.133 169.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.54 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -63.32 -5.88 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 17' ' ' ALA . 77.6 mt -101.41 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.885 -176.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -15.77 32.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.387 171.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.54 HD11 ' HA ' ' B' ' 43' ' ' ALA . 13.4 mt -79.86 -50.32 10.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.432 170.177 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.35 -17.57 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.252 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -46.51 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.458 169.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -61.74 -37.97 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.335 -173.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.04 -47.65 85.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.24 169.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.19 33.07 5.57 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -166.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.15 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.439 -168.628 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -91.61 132.31 36.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.37 170.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER 66.24 142.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.344 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 20' ' ' VAL . 89.2 mt -89.52 132.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.213 166.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -118.12 171.7 7.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.332 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -14.35 20.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.366 172.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -52.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.183 169.387 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -68.91 -36.06 77.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.38 -178.083 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.527 HG21 HD12 ' A' ' 28' ' ' LEU . 39.2 mm -61.49 -62.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.342 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.41 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 46.4 mt-10 -61.81 -26.35 68.06 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.885 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 11.6 mt -60.46 -50.72 72.45 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.423 170.324 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -62.02 -32.91 73.46 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.479 -172.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.535 HG21 HG12 ' B' ' 39' ' ' ILE 0.274 0.5 OUTLIER -86.95 -48.84 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -162.512 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -66.69 -24.63 66.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.438 169.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.82 -37.08 80.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.415 173.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.523 ' CE2' HG12 ' B' ' 39' ' ' ILE . 10.5 p90 -108.34 -18.71 13.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.333 -168.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 110.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.365 -174.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 tttm . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.403 166.155 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.1 mtt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 20.7 mm-40 -126.64 -179.82 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.006 -164.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 10.4 mp 58.65 77.42 0.4 Allowed Pre-proline 0 C--O 1.248 1.0 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.626 178.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.465 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 HD12 HD22 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' HD13 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 55' ' ' ILE . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.533 ' HB2' HG22 ' B' ' 54' ' ' THR . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HG3' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD13 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HA ' HD13 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 2' ' ' GLU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' A' ' 67' ' ' PHE . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' A' ' 67' ' ' PHE . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.532 ' HA ' HD13 ' A' ' 55' ' ' ILE . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.537 HG21 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.527 ' HG2' HD13 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.528 HG21 HG23 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' A' ' 39' ' ' ILE . 31.5 m-85 -60.3 -54.49 45.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? 64.53 -74.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.333 -165.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.319 168.178 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.085 0.469 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -51.8 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.093 -170.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 11' ' ' ILE . 3.1 mt -62.49 138.81 96.6 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.778 -173.102 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.405 ' HB2' ' CD ' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.501 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.486 HD12 HD13 ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.537 ' HB2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 24' ' ' ALA . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.458 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.531 ' HG3' HD11 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' B' ' 25' ' ' ARG . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' B' ' 24' ' ' ALA . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' B' ' 8' ' ' ILE . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.53 HD13 HG21 ' B' ' 27' ' ' THR . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.518 HD11 ' HG ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.525 HD11 HG22 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' B' ' 67' ' ' PHE . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.533 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 21' ' ' SER . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.609 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' A' ' 27' ' ' THR . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.525 HG22 HD11 ' B' ' 39' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 024 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.521 ' N ' HG11 ' B' ' 64' ' ' VAL . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . 0.401 ' NE ' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CZ ' ' HG2' ' B' ' 42' ' ' GLU . 7.3 m-85 -61.15 -57.49 12.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 87.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.401 -168.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 tptm . . . . . 0 C--O 1.241 0.608 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.412 -170.133 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.099 0.476 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.25 137.4 46.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -171.137 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . 6.3 mp -57.86 99.49 0.19 Allowed Pre-proline 0 C--O 1.25 1.082 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.43 -168.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 4' ' ' PRO . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' HG2' ' B' ' 33' ' ' GLU . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 20' ' ' VAL . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 12' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.502 ' HB2' HG21 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 27' ' ' THR . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 31' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 HD11 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 27' ' ' THR . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD12 ' HG ' ' A' ' 28' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' CG ' HD11 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.519 HD12 HD11 ' A' ' 62' ' ' LEU . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 44' ' ' ILE . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' B' ' 27' ' ' THR . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.463 HG13 ' CB ' ' B' ' 24' ' ' ALA . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 39' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 -60.48 -52.25 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.33 -74.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.351 -164.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.337 170.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -158.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.992 168.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.407 ' HB2' HD13 ' B' ' 8' ' ' ILE . 2.8 mt -66.8 139.5 95.79 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.713 -173.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' CG ' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' B' ' 3' ' ' LEU . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.538 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 3' ' ' LEU . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.517 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.532 ' HG3' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' B' ' 17' ' ' ALA . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.463 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 57' ' ' ALA . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.528 ' HA ' HD13 ' B' ' 31' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' B' ' 28' ' ' LEU . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 32' ' ' LEU . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 11' ' ' ILE . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' HD11 ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' B' ' 41' ' ' SER . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' B' ' 39' ' ' ILE . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.535 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER -62.01 -29.63 70.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -145.63 109.96 4.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.428 170.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.415 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.1 mtt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.537 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 20.7 mm-40 -126.64 -179.82 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.006 -164.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 10.4 mp 58.65 77.42 0.4 Allowed Pre-proline 0 C--O 1.248 1.0 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.626 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.465 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 HD12 HD22 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' HD13 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' B' ' 55' ' ' ILE . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.533 ' HB2' HG22 ' B' ' 54' ' ' THR . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' HG3' HG23 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.513 HG21 HD13 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HA ' HD13 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 HD13 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HG3' ' HB2' ' A' ' 2' ' ' GLU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG12 ' CE2' ' A' ' 67' ' ' PHE . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' A' ' 67' ' ' PHE . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.532 ' HA ' HD13 ' A' ' 55' ' ' ILE . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' HB1' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.537 HG21 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 44' ' ' ILE . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.527 ' HG2' HD13 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.528 HG21 HG23 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' HG12 ' A' ' 39' ' ' ILE . 31.5 m-85 -60.3 -54.49 45.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? 64.53 -74.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.333 -165.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.319 168.178 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.085 0.469 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -51.8 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.093 -170.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.506 HD22 HD12 ' A' ' 11' ' ' ILE . 3.1 mt -62.49 138.81 96.6 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.778 -173.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.405 ' HB2' ' CD ' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.501 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.517 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.486 HD12 HD13 ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.476 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.517 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.537 ' HB2' HG21 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.475 HG11 ' HB2' ' B' ' 24' ' ' ALA . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.468 ' N ' HG23 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.458 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.531 ' HG3' HD11 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' B' ' 25' ' ' ARG . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' B' ' 24' ' ' ALA . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' B' ' 8' ' ' ILE . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.53 HD13 HG21 ' B' ' 27' ' ' THR . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.518 HD11 ' HG ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.509 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.525 HD11 HG22 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.531 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' B' ' 67' ' ' PHE . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.533 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.533 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 21' ' ' SER . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.475 ' HB ' HG23 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.609 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.468 ' CG2' HG23 ' A' ' 27' ' ' THR . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.525 HG22 HD11 ' B' ' 39' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 026 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.521 ' N ' HG11 ' B' ' 64' ' ' VAL . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . 0.401 ' NE ' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CZ ' ' HG2' ' B' ' 42' ' ' GLU . 7.3 m-85 -61.15 -57.49 12.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 87.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.401 -168.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 tptm . . . . . 0 C--O 1.241 0.608 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.412 -170.133 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.099 0.476 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.25 137.4 46.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -171.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 8' ' ' ILE . 6.3 mp -57.86 99.49 0.19 Allowed Pre-proline 0 C--O 1.25 1.082 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.43 -168.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 4' ' ' PRO . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 HD12 ' HG2' ' B' ' 33' ' ' GLU . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 20' ' ' VAL . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 12' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.502 ' HB2' HG21 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 27' ' ' THR . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.508 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.531 HG21 HD13 ' A' ' 31' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 HD11 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 HG21 ' A' ' 27' ' ' THR . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD12 ' HG ' ' A' ' 28' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' CG ' HD11 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.519 HD12 HD11 ' A' ' 62' ' ' LEU . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 44' ' ' ILE . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' HA ' HG22 ' B' ' 27' ' ' THR . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.463 HG13 ' CB ' ' B' ' 24' ' ' ALA . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 HD11 HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 39' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 -60.48 -52.25 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.33 -74.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.351 -164.3 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.337 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -158.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.992 168.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.407 ' HB2' HD13 ' B' ' 8' ' ' ILE . 2.8 mt -66.8 139.5 95.79 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.713 -173.152 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' CG ' ' B' ' 25' ' ' ARG . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' B' ' 3' ' ' LEU . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.538 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 3' ' ' LEU . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.522 HG21 ' HB3' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.517 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . 0.532 ' HG3' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' B' ' 17' ' ' ALA . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.463 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 57' ' ' ALA . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.528 ' HA ' HD13 ' B' ' 31' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' B' ' 28' ' ' LEU . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 32' ' ' LEU . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 11' ' ' ILE . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.515 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.52 ' HA ' HD11 ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' B' ' 41' ' ' SER . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.528 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.502 HG21 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.469 ' HA ' ' CG2' ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.54 HG12 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.431 ' HB2' ' CG2' ' B' ' 39' ' ' ILE . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.535 HG22 HG23 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.519 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER -62.01 -29.63 70.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -145.63 109.96 4.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.428 170.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.415 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 58.82 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.73 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.514 HD12 HD13 ' B' ' 11' ' ' ILE . 6.3 mp -57.43 100.09 0.21 Allowed Pre-proline 0 C--O 1.251 1.147 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.564 -172.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -60.22 150.0 82.16 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 123.016 2.477 . . . . 0.0 113.479 -172.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 25' ' ' ARG . 2.4 pp -100.65 17.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.809 -164.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.87 -56.86 0.27 Allowed Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.703 175.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -53.76 -58.83 1.17 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.596 2.198 . . . . 0.0 113.371 164.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 3' ' ' LEU . 25.7 mt -61.74 -47.93 91.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.478 -178.049 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.88 93.42 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -39.98 95.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.412 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 HD12 ' HG3' ' B' ' 33' ' ' GLU . 75.0 mt -61.81 -48.08 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.438 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' B' ' 40' ' ' ALA . 12.8 mm -64.54 -36.78 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.426 -172.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -32.4 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.366 171.781 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.74 -34.99 78.33 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.827 -178.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' B' ' 41' ' ' SER . . . -59.42 -53.71 54.99 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.376 169.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.68 21.06 0.38 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.715 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' N ' HD12 ' B' ' 44' ' ' ILE . . . -60.23 135.3 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.153 -0.523 . . . . 0.0 110.385 166.489 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -157.65 31.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.024 174.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 81.24 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.268 168.061 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG11 ' HB ' ' B' ' 55' ' ' ILE . 14.2 t -131.16 142.33 43.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.387 -168.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.31 151.15 24.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.352 169.068 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -13.66 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.487 172.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.536 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -87.57 -30.55 20.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.324 -174.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' B' ' 60' ' ' ILE . . . -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.148 165.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HB3' HG23 ' A' ' 5' ' ' ILE . 8.4 mmt85 -61.76 -34.39 75.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.424 -176.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.536 HG23 ' HA ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.27 -37.44 22.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.317 -179.368 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 HG23 ' HB ' ' B' ' 60' ' ' ILE . 88.8 m -63.4 -44.05 95.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.294 -171.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.539 HD12 ' HB ' ' B' ' 39' ' ' ILE . 4.0 tp -59.6 -42.32 92.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.464 167.559 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.407 ' HB3' ' CB ' ' A' ' 3' ' ' LEU . . . -61.78 -39.4 91.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.312 -176.377 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 -20.88 23.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.302 -175.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 28' ' ' LEU . 32.3 mt -61.08 -71.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.92 162.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' B' ' 32' ' ' LEU . 6.0 mp -59.74 -20.22 55.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.745 -167.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.13 -55.3 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.115 170.925 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.74 -41.73 98.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.984 -172.364 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.491 ' HE1' ' HE2' ' B' ' 35' ' ' MET . 1.2 mmm -61.16 -43.53 98.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.447 168.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.42 -48.24 45.95 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -167.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.72 -19.14 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.277 167.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.1 OUTLIER -75.95 -58.93 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.499 179.533 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 HG22 ' A' ' 64' ' ' VAL . 4.0 mt -60.89 -22.92 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.576 178.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' B' ' 12' ' ' ILE . . . -63.64 -77.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.266 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.539 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -61.24 -10.98 7.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.477 -172.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -82.54 -52.93 6.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.186 172.772 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.91 -19.0 59.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.41 173.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 95.7 mt -86.29 -51.25 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.949 -177.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -60.16 -11.28 5.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.444 167.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.509 HD23 ' HB3' ' A' ' 63' ' ' ALA . 2.3 mp -85.21 -38.44 18.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.315 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' HD12 ' A' ' 55' ' ' ILE . . . -60.92 -30.93 70.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.37 170.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 29.5 mmt-85 -68.36 -53.31 24.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.409 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -19.98 60.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.375 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.07 -53.74 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.245 168.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.02 24.05 0.53 Allowed Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.482 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.5 ttp-105 66.4 122.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.446 166.144 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.43 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.4 167.363 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.515 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 30.0 m -162.05 141.81 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.447 -178.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' B' ' 20' ' ' VAL . 17.1 mm -71.77 148.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.393 170.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 10.2 mttp -153.12 -177.85 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.523 177.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.01 75.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -173.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -73.11 -27.56 61.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -178.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.459 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -78.83 -36.64 42.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.413 178.309 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.54 ' HB ' HG23 ' B' ' 27' ' ' THR . 38.5 mm -60.83 -57.25 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.417 170.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -61.47 -30.68 70.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.02 -176.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -60.46 -51.57 68.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.412 169.209 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.509 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . -60.97 -46.76 89.43 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.482 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.77 -51.47 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.892 -163.473 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.21 -21.71 66.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.708 176.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -61.29 -39.99 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.268 174.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.519 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 83.6 m-85 -60.6 -62.27 1.99 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.279 166.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 64.95 -77.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.449 170.042 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.312 -167.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 59.16 121.39 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.746 -175.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.535 HD22 ' HG3' ' B' ' 33' ' ' GLU . 3.5 mt -73.5 137.26 77.74 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.79 -168.225 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.96 153.5 50.93 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.394 2.063 . . . . 0.0 113.49 169.264 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.6 pt -100.62 16.98 3.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.696 -176.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.401 ' CB ' ' CD ' ' B' ' 7' ' ' PRO . . . -86.41 -59.61 0.28 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.712 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' B' ' 6' ' ' ALA . 11.4 Cg_endo -58.25 -50.06 10.8 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.437 2.091 . . . . 0.0 113.375 168.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.415 HD13 ' HB2' ' B' ' 3' ' ' LEU . 64.7 mt -60.84 -28.99 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 175.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.4 77.8 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.526 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -82.4 -17.19 46.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.395 -170.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.514 HD13 HD12 ' A' ' 3' ' ' LEU . 11.0 mm -60.73 -66.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.439 168.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 40' ' ' ALA . 9.1 mm -61.5 -31.39 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.077 -174.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -66.1 -37.72 86.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.455 172.276 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -62.13 -32.25 72.81 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.884 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.73 -52.96 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.454 170.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.86 27.5 0.72 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.523 -170.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.529 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -60.73 119.99 9.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.775 -0.712 . . . . 0.0 110.373 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.52 -38.69 65.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.13 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.32 100.2 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.533 ' HA ' ' HB ' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.22 140.18 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.275 165.6 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 95.9 p -66.95 165.71 15.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.27 167.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.98 -18.68 58.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.284 168.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -58.37 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.441 169.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.522 ' HB1' ' HB ' ' B' ' 20' ' ' VAL . . . -62.07 -42.57 99.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.334 -169.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.521 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 41.2 mtm180 -61.77 -50.04 73.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.386 -178.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.45 HD11 ' CG2' ' B' ' 5' ' ' ILE . 11.5 mm -61.49 -25.04 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.445 179.348 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.54 HG23 ' HB ' ' A' ' 60' ' ' ILE . 85.3 m -73.91 -42.46 60.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.37 -172.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 60' ' ' ILE . 2.0 mm? -60.76 -35.48 76.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.345 169.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.67 -43.54 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.297 -173.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.55 -27.83 37.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.376 -179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.54 HD13 HG21 ' B' ' 27' ' ' THR . 52.4 mt -61.36 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.976 167.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.513 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.8 mp -59.11 -23.39 62.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.733 -164.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.535 ' HG3' HD22 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -85.0 -28.51 25.69 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.05 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.78 -31.76 71.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.862 163.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.491 ' HE2' ' HE1' ' A' ' 35' ' ' MET . 0.0 OUTLIER -81.23 -34.21 32.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.413 -176.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.52 42.23 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -176.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.437 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.377 169.547 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.357 176.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.539 ' HB ' HD12 ' A' ' 28' ' ' LEU . 7.2 mt -60.89 -21.72 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.307 -170.238 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -61.72 -69.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.324 173.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.535 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.44 -11.03 8.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.554 -177.275 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -92.91 -40.46 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.068 -179.7 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.508 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -69.93 -14.81 62.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 168.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 55.2 mt -97.3 -52.14 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.956 -173.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -19.71 56.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.368 169.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' B' ' 63' ' ' ALA . 9.6 mt -68.62 -53.49 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.344 166.042 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.427 ' HA ' ' HB1' ' B' ' 50' ' ' ALA . . . -61.37 -25.91 67.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.247 -173.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -38.73 75.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.328 168.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.57 -32.61 71.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.375 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 47' ' ' ALA . . . -60.72 -48.52 81.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.35 173.298 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.26 38.14 1.05 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -167.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 65.27 102.53 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.392 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -171.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.451 177.148 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.2 m -78.41 130.22 35.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.416 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' B' ' 43' ' ' ALA . 28.8 mt -74.01 132.78 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.275 166.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.77 -170.13 2.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.391 -177.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.02 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.251 178.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.4 -34.11 21.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.25 -35.17 31.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.36 -177.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.52 ' HB ' HG23 ' A' ' 27' ' ' THR . 38.8 mm -61.18 -57.67 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.381 167.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.469 ' HG3' ' CG2' ' A' ' 27' ' ' THR . 4.4 mt-10 -62.22 -37.59 85.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.951 -173.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 tp -60.77 -43.86 97.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.38 172.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.508 ' HB3' ' N ' ' B' ' 43' ' ' ALA . . . -61.12 -35.25 76.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.441 178.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.517 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -90.46 -59.92 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.271 -162.355 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -23.46 64.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.6 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -23.36 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 172.09 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -60.83 -46.62 89.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.495 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 -77.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.388 -171.344 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.389 -169.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 mmt . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.108 0.48 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -130.75 -179.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.048 -169.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.471 ' CD1' ' HB2' ' A' ' 33' ' ' GLU . 6.8 mt -71.21 112.68 14.44 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.741 -168.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -55.45 164.55 3.97 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.52 2.147 . . . . 0.0 113.395 164.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 25' ' ' ARG . 21.5 pt -95.88 38.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.314 -173.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 7' ' ' PRO . . . -95.01 -58.47 0.2 Allowed Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.73 173.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HB1' ' A' ' 6' ' ' ALA . 9.7 Cg_endo -59.91 -32.82 95.74 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.53 2.154 . . . . 0.0 113.653 173.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . 72.8 mt -96.81 -13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.62 -169.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -43.72 98.89 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -97.39 19.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.472 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 8' ' ' ILE . 22.9 mt -90.28 -49.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.208 166.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.522 HD11 ' HB1' ' B' ' 40' ' ' ALA . 3.9 mm -96.31 48.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.651 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.11 -26.45 0.1 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.748 169.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.68 -40.59 66.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.276 163.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' B' ' 37' ' ' ARG . . . -57.73 -72.87 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.727 172.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.7 36.39 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.149 152.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' CA ' HD12 ' B' ' 44' ' ' ILE . . . -73.29 123.15 23.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.153 -165.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -135.58 31.83 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.088 -165.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.95 102.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.423 168.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t -125.15 162.46 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.369 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 47.1 t -101.84 13.48 34.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.375 -169.324 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p30 60.47 23.56 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -140.67 -30.07 0.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.358 179.144 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.12 -40.6 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.437 177.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.51 ' HB2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.39 -30.1 70.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.409 -178.907 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.515 ' HA ' ' HB1' ' A' ' 29' ' ' ALA . 9.1 mm -83.86 -30.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.413 179.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.53 HG23 HG23 ' B' ' 60' ' ' ILE . 74.6 m -60.79 -46.36 90.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.377 168.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.533 HD13 HD11 ' B' ' 39' ' ' ILE . 4.9 tp -61.0 -45.46 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.336 172.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -61.75 -12.69 18.09 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.548 -178.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.519 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -107.74 -37.51 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.24 -178.7 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 27' ' ' THR . 60.0 mt -60.88 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.078 168.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.532 HD21 HD21 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.02 -34.85 72.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 -166.329 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' HD12 ' B' ' 11' ' ' ILE . 2.5 tm-20 -68.05 -43.82 77.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.236 176.607 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.59 -17.02 63.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.029 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.461 ' CE ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 mtm -81.84 -43.4 18.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.466 169.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.46 ' CA ' HD23 ' B' ' 32' ' ' LEU . . . -69.27 -45.87 59.47 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -169.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.457 ' N ' HG21 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -61.53 -16.62 49.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.316 169.25 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.1 -54.63 5.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.447 -179.543 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.469 HD13 HD13 ' B' ' 32' ' ' LEU . 15.2 mt -61.52 -28.62 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.343 -176.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' B' ' 12' ' ' ILE . . . -61.34 -65.67 0.66 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.22 -173.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' HD11 ' A' ' 44' ' ' ILE . 25.9 t -61.2 -10.49 6.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.524 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 12.1 mm-40 -85.01 -57.57 3.04 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.05 173.724 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . . . -61.92 -8.61 5.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.532 174.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.523 ' HA ' HD13 ' A' ' 55' ' ' ILE . 51.4 mt -95.93 -54.31 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.222 178.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -13.82 62.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.359 -178.574 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' A' ' 63' ' ' ALA . 7.6 mt -88.39 -21.41 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.403 173.307 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.505 ' HB2' ' NH2' ' A' ' 48' ' ' ARG . . . -80.49 -29.97 37.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -165.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' NH2' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -94.47 -15.72 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.384 -168.574 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -9.92 59.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.42 164.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.73 -54.12 49.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.297 174.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.21 33.85 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.535 -169.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 67.17 121.25 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.638 -0.781 . . . . 0.0 110.587 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.86 -79.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.362 171.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.526 HG23 ' HB2' ' B' ' 21' ' ' SER . 72.5 m -167.51 159.97 12.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.134 -164.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' A' ' 44' ' ' ILE . 7.2 mm -90.09 137.62 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.3 165.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 7.7 mttm -153.37 -174.9 5.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.487 -166.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -21.42 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.148 -169.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -94.18 25.13 3.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.147 175.018 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 14.5 m-20 -119.21 -39.57 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.153 174.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.533 ' HB ' HG23 ' B' ' 27' ' ' THR . 3.1 mp -91.15 14.78 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.631 163.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.0 mm-40 -121.65 36.91 4.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 164.192 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 62' ' ' LEU . 10.6 tp -169.42 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.378 -174.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -84.86 -17.53 37.67 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.405 173.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.519 HG12 HG12 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -107.61 -67.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.265 -157.676 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.505 ' N ' HG11 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -60.76 -23.89 65.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.39 177.187 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 69' ' ' LYS . 5.5 mmt180 -78.35 -60.68 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.102 164.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER 60.37 67.66 0.83 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.151 -157.653 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.21 112.21 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.449 -176.054 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.606 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.412 169.229 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.106 0.479 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . 0.511 ' HB2' ' HG3' ' B' ' 33' ' ' GLU . 1.5 mt-10 -66.21 -35.8 81.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.464 ' CB ' HD12 ' B' ' 8' ' ' ILE . 0.7 OUTLIER -97.42 101.79 11.05 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.66 175.747 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 5.7 Cg_endo -52.86 151.43 20.11 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.665 2.244 . . . . 0.0 113.527 172.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.499 HG23 HG13 ' B' ' 26' ' ' ILE . 1.1 pt -85.63 64.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.51 175.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.65 -57.97 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.619 177.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -60.08 -38.23 78.88 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.181 . . . . 0.0 113.589 170.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.464 HD12 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -73.4 -18.26 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.515 172.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.415 ' HA2' ' HD2' ' B' ' 25' ' ' ARG . . . -61.04 -52.91 49.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -166.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 5.1 mtt-85 -75.25 -20.66 59.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.411 -176.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.521 HD12 ' HG3' ' A' ' 33' ' ' GLU . 16.1 mt -63.58 -47.39 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.278 167.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' A' ' 40' ' ' ALA . 6.3 mm -95.77 45.41 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.835 175.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -149.47 -31.7 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.873 170.872 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.78 -31.28 70.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.92 172.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 41' ' ' SER . . . -58.74 -51.6 69.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.545 170.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.57 23.23 1.23 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.702 -171.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.513 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -65.81 131.58 46.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.349 173.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.6 -77.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.111 -177.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -146.83 144.12 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.318 -169.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.06 168.73 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -168.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.526 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -127.83 -162.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.244 -164.828 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.67 89.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.451 167.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.41 125.2 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.541 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.66 -48.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.977 163.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.415 ' HD2' ' HA2' ' B' ' 9' ' ' GLY . 15.1 ttp180 -77.22 -30.55 54.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.329 167.246 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.499 HG13 HG23 ' B' ' 5' ' ' ILE . 59.0 mt -72.72 -36.32 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.416 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.533 HG23 ' HB ' ' A' ' 60' ' ' ILE . 92.5 m -60.81 -43.27 98.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.325 169.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.52 HD22 HD13 ' B' ' 12' ' ' ILE . 0.9 OUTLIER -60.85 -45.81 93.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.149 174.414 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' B' ' 8' ' ' ILE . . . -61.16 -17.82 54.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.511 176.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.22 -32.6 11.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.412 -171.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.519 HG12 HG12 ' A' ' 64' ' ' VAL . 2.1 mp -62.11 -72.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.587 159.273 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.532 HD21 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -58.82 -14.12 7.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.931 -162.663 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' B' ' 2' ' ' GLU . 1.9 tm-20 -91.41 -26.36 18.9 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.17 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.28 -19.49 28.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.141 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 8.1 mtt -93.69 12.37 25.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.412 171.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.47 ' CA ' HD12 ' A' ' 32' ' ' LEU . . . -121.36 -41.2 0.51 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.088 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 15' ' ' ALA . 1.4 tmt_? -61.17 -20.67 62.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.262 166.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.37 -35.3 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.436 -167.704 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.533 HD11 HD13 ' A' ' 28' ' ' LEU . 7.6 mt -62.04 -33.97 61.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.288 171.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.522 ' HB1' HD11 ' A' ' 12' ' ' ILE . . . -61.19 -63.02 1.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.306 -169.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.531 ' HA ' HD11 ' B' ' 44' ' ' ILE . 15.3 m -61.9 -13.76 27.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' B' ' 63' ' ' ALA . 3.0 mm-40 -81.6 -45.33 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.104 176.08 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.496 ' N ' ' HB3' ' B' ' 63' ' ' ALA . . . -73.25 -33.71 65.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.209 177.044 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.531 HD11 ' HA ' ' B' ' 41' ' ' SER . 15.2 mt -60.5 -56.35 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.351 167.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.65 69.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 -176.715 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.524 HD11 ' HB3' ' B' ' 63' ' ' ALA . 4.3 mt -76.24 -36.91 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.494 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.47 ' CB ' HD12 ' B' ' 55' ' ' ILE . . . -61.86 -45.24 94.63 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.262 -177.141 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -89.72 -25.72 21.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.373 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -64.04 -44.9 91.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.266 168.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.0 98.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.268 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.32 43.55 15.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -175.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -135.3 -166.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.398 -168.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -169.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.423 -167.385 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.436 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 0.8 OUTLIER -68.26 172.29 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.926 -167.903 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.47 HD12 ' CB ' ' B' ' 47' ' ' ALA . 31.9 mm -60.62 135.94 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.465 175.312 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -159.24 -176.59 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.423 -169.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.48 -24.09 67.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 -170.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -103.52 23.1 13.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.104 179.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 4.0 m-20 -129.56 -34.63 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.424 168.319 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 27' ' ' THR . 36.7 mm -61.02 -65.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.328 165.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.4 -10.92 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.245 -177.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 4.1 mm? -99.51 -18.66 17.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.515 176.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' B' ' 46' ' ' LEU . . . -92.06 14.53 15.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.561 164.917 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.52 HG22 HD12 ' A' ' 31' ' ' ILE . 40.1 t -115.7 -68.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.585 -176.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -60.18 -10.06 4.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.588 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -37.61 86.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.663 168.348 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.514 ' CZ ' HG12 ' B' ' 39' ' ' ILE . 3.1 m-85 -61.13 -35.01 75.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.205 168.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt 65.0 -75.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 -165.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.6 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.377 -174.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.113 0.482 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -119.32 82.95 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -173.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 10.4 mp 58.59 69.81 1.34 Allowed Pre-proline 0 C--O 1.248 0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.682 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -45.2 148.78 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.868 2.378 . . . . 0.0 113.466 177.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' CG2' HG12 ' A' ' 26' ' ' ILE . 2.0 pt -70.96 58.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.373 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 7' ' ' PRO . . . -160.28 -52.89 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.52 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 6' ' ' ALA . 8.0 Cg_endo -55.71 -32.62 84.74 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 C-N-CA 122.781 2.321 . . . . 0.0 113.506 167.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 29' ' ' ALA . 9.4 mm -60.63 -39.66 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.485 168.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.4 98.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -166.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.14 18.63 13.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.41 -176.605 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' CD1' HD23 ' B' ' 3' ' ' LEU . 95.5 mt -103.32 -39.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.182 164.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' B' ' 40' ' ' ALA . 7.3 mm -81.08 -37.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 -179.094 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -41.41 95.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.428 169.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.89 -30.79 71.11 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.815 -175.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.29 59.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.55 168.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.09 32.33 0.35 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.562 -171.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.504 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -80.47 -167.63 1.42 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.3 177.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.05 93.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.997 165.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.3 104.93 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.32 162.8 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.069 164.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.475 ' HB2' HG23 ' B' ' 54' ' ' THR . 16.6 t -94.41 -84.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.411 -166.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 9.1 t70 -174.89 136.88 0.41 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 -171.305 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' HB3' ' CB ' ' B' ' 57' ' ' ALA . 0.4 OUTLIER 77.97 -51.69 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.014 -161.605 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.54 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.13 -39.37 89.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.304 -173.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.94 -40.52 97.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.412 -177.842 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HG12 ' CG2' ' A' ' 5' ' ' ILE . 1.6 mp -94.64 -23.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.404 -170.087 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.464 HG23 ' CG2' ' B' ' 60' ' ' ILE . 92.0 m -60.79 -39.79 90.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.491 173.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD13 HD11 ' B' ' 39' ' ' ILE . 13.1 tp -88.35 -14.31 38.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.493 -171.577 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HA ' HD12 ' A' ' 8' ' ' ILE . . . -79.03 -45.33 20.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.198 164.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.0 -36.97 80.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.484 175.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 28' ' ' LEU . 23.0 mt -62.21 -78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.897 170.672 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HB3' HD22 ' B' ' 32' ' ' LEU . 2.0 mm? -57.09 -26.62 60.74 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.543 -158.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -64.24 -36.12 83.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.025 176.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -62.33 -39.58 93.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.818 -164.492 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.492 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 21.6 mtt -81.69 -25.94 35.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.89 -39.83 53.7 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.515 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.503 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -60.98 -17.06 49.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.395 168.902 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -99.83 -46.09 5.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.555 -164.664 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG12 HG21 ' A' ' 64' ' ' VAL . 7.2 mt -61.62 -26.28 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.183 172.123 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -62.33 -70.38 0.2 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.115 177.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.52 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.18 -18.17 56.82 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.525 179.472 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 63' ' ' ALA . 6.5 mm-40 -72.3 -61.65 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.034 169.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.13 -9.49 4.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.539 179.1 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 90.1 mt -100.77 -67.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.048 -178.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -17.4 53.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.349 -176.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 43' ' ' ALA . 14.5 mt -60.93 -48.18 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.206 163.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 53' ' ' LYS . . . -87.49 -27.71 22.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.224 -168.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -21.65 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.33 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -60.98 -14.61 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.323 166.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.93 -43.95 15.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.305 175.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.1 15.54 23.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 172.175 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 178.93 84.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 169.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' HE3' HD12 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -108.91 151.94 25.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.462 -161.358 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.3 m -140.55 114.42 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.158 163.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' A' ' 59' ' ' ASP . 13.6 mm -60.52 153.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.349 -166.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 173.33 11.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.416 -171.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -11.94 10.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.3 168.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -113.64 30.72 7.02 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.06 179.759 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.496 ' HB3' HG21 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -120.83 -39.37 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.248 169.153 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.533 HG13 HD12 ' B' ' 28' ' ' LEU . 1.3 mp -62.12 -54.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.442 160.322 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 7.9 mm-40 -61.6 -9.23 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.19 -174.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD21 ' CG ' ' A' ' 66' ' ' ARG . 72.0 mt -138.32 35.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.454 175.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -130.62 10.41 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.907 163.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.541 HG21 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -134.09 -63.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.533 0.683 . . . . 0.0 109.237 -156.222 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -78.41 -27.26 46.64 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.232 162.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' CG ' HD21 ' A' ' 62' ' ' LEU . 6.7 mmt180 -75.49 -11.25 59.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.768 167.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -60.98 -48.68 80.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.179 -176.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.528 165.426 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttt . . . . . 0 C--O 1.24 0.584 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.326 -168.131 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpt . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.91 -164.71 1.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.972 -170.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.52 ' HB2' HD13 ' B' ' 8' ' ' ILE . 17.2 mt -61.67 107.68 1.23 Allowed Pre-proline 0 C--O 1.243 0.748 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.889 -178.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.11 143.62 18.13 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.466 2.11 . . . . 0.0 113.367 166.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' B' ' 25' ' ' ARG . 1.3 pp -95.19 26.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.383 -168.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.67 -58.14 0.44 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.694 169.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.89 -46.95 20.06 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.543 2.162 . . . . 0.0 113.568 171.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' B' ' 3' ' ' LEU . 29.7 mt -68.33 -18.83 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.411 -179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.436 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -60.95 -47.38 91.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -170.534 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.9 ttt180 -85.59 -17.51 36.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.371 -170.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 26.7 mt -60.97 -59.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.405 171.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 40' ' ' ALA . 14.8 mm -63.89 -36.38 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.458 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 6.8 mmtp -64.59 -33.31 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.298 176.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . 0.503 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 25.0 t0 -61.72 -31.5 71.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.834 177.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.507 ' HB3' ' HB2' ' A' ' 41' ' ' SER . . . -58.67 -51.17 71.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.558 170.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 34.42 0.68 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.545 -168.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.509 ' HB1' HD12 ' A' ' 44' ' ' ILE . . . -70.97 157.93 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.02 99.61 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.136 179.439 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 63.14 132.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -176.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' B' ' 24' ' ' ALA . 11.5 t -119.46 160.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.369 170.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 21.6 p -84.43 -10.11 57.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.436 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 71.02 164.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.983 -161.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.32 -50.94 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 -162.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.484 ' HB3' HG23 ' A' ' 55' ' ' ILE . . . -60.42 -44.29 95.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.418 174.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.464 ' HG3' ' CG2' ' B' ' 5' ' ' ILE . 13.9 tpp85 -68.89 -16.82 63.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.524 -173.3 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.68 -30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.415 -168.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.47 HG21 ' CG2' ' A' ' 60' ' ' ILE . 89.1 m -61.12 -40.68 94.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.269 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.533 HD12 HG13 ' A' ' 60' ' ' ILE . 2.0 tp -59.97 -43.78 94.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.322 172.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -12.91 13.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.662 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -105.57 -30.36 9.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.393 -175.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.494 HG12 HG12 ' A' ' 64' ' ' VAL . 3.3 mp -61.85 -74.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.655 161.093 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.71 -40.93 85.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.649 -163.572 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.519 ' HG3' HD22 ' B' ' 3' ' ' LEU . 4.7 tt0 -66.86 -20.43 65.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.044 -174.743 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -77.06 -53.53 7.68 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.077 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.03 -29.87 67.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.352 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.11 -30.54 78.07 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 169.182 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -81.79 -19.44 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.467 175.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -37.5 12.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.403 -169.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.535 HG12 HG21 ' B' ' 64' ' ' VAL . 12.0 mt -61.08 -27.9 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.296 168.173 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.534 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -68.29 -60.35 2.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.305 -177.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.527 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 48.9 m -61.68 -13.7 25.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.33 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.579 ' O ' ' HG ' ' B' ' 46' ' ' LEU . 4.9 mm-40 -75.6 -53.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.091 171.439 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -70.9 -31.95 68.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.141 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.527 ' HB ' ' HA ' ' B' ' 41' ' ' SER . 49.1 mt -60.81 -49.55 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.212 165.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.547 176.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' B' ' 42' ' ' GLU . 28.8 mt -65.32 -48.82 71.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.418 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.75 65.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.34 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -19.07 36.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.341 176.562 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -61.24 -37.41 82.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.244 166.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.1 -46.26 35.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.056 165.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.63 -7.03 24.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.81 168.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.11 98.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.354 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.5 160.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 166.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.475 HG23 ' HB2' ' A' ' 21' ' ' SER . 95.1 m -69.31 159.27 33.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.457 168.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' B' ' 59' ' ' ASP . 55.5 mt -87.0 133.9 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 -170.154 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -118.39 -178.34 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.391 -178.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 23' ' ' ASP . . . -74.8 -32.07 61.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.269 -169.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.67 -13.44 22.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.097 168.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.533 ' HB3' HG22 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -94.2 -43.54 8.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.356 -179.368 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.54 HG13 ' HA ' ' A' ' 24' ' ' ALA . 42.0 mm -61.1 -33.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.457 177.681 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.78 -22.17 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.849 -171.426 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 24.7 tp -106.4 18.19 22.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.579 167.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.92 -14.8 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.273 166.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.535 HG21 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -121.2 -65.29 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.282 -165.569 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.435 ' N ' HG11 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -60.43 -11.84 7.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.501 172.21 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -82.34 -24.42 34.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.409 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.4 -72.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.305 168.232 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 -172.07 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.285 170.183 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.321 168.785 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.181 0.515 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -170.75 -164.77 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.059 -171.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.469 ' HB2' ' CD1' ' A' ' 8' ' ' ILE . 1.1 mt -96.61 104.81 19.36 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.706 177.366 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -51.83 154.47 9.72 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.673 2.249 . . . . 0.0 113.619 177.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -92.93 19.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.683 -170.45 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.74 -58.15 0.55 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.625 170.286 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.19 -61.88 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.585 2.19 . . . . 0.0 113.55 170.329 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 62.7 mt -61.19 -14.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.452 177.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.63 99.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.97 25.44 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.386 -173.862 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 8' ' ' ILE . 39.8 mt -95.82 -40.06 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.508 169.817 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.488 HG22 ' HB3' ' B' ' 40' ' ' ALA . 17.4 mm -83.97 -39.94 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.423 -174.488 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -26.75 67.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.3 173.187 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.05 -34.1 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.814 177.756 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.09 -53.16 61.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.314 168.27 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.97 21.6 0.78 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.772 -172.125 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' HB1' HD13 ' B' ' 44' ' ' ILE . . . -65.26 127.02 30.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.415 170.448 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -102.25 -17.45 15.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.013 -171.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 163.16 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.33 168.855 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.521 HG22 ' HD3' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -118.0 163.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.305 168.594 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.521 ' HB3' HG23 ' B' ' 54' ' ' THR . 24.7 p -75.5 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.44 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.94 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.34 171.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.46 -18.45 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.408 -165.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.36 -40.44 94.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.304 -167.015 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.521 ' HD3' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -65.42 -60.08 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.446 176.198 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mt -65.23 -27.77 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.449 -171.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.528 HG23 HG23 ' B' ' 60' ' ' ILE . 79.8 m -61.02 -61.67 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.395 166.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.532 HD12 HG22 ' B' ' 60' ' ' ILE . 10.5 tp -61.51 -10.3 7.58 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.482 -171.441 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.66 -63.53 1.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.435 171.271 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 5.6 mtpm? -61.46 -21.27 64.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.515 HD13 HG23 ' A' ' 27' ' ' THR . 32.5 mt -61.89 -76.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.893 162.562 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.39 -30.71 68.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.697 -162.958 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -77.73 -18.61 56.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.018 -178.635 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -90.03 -17.82 27.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.037 169.312 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.512 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 9.8 mtp -99.58 18.83 17.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 170.768 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.525 ' HA2' HD13 ' B' ' 32' ' ' LEU . . . -119.4 -41.74 0.57 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 170.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -13.24 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.199 163.888 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.06 -55.01 4.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.385 -178.342 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 60' ' ' ILE . 7.3 mt -61.24 -19.74 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.463 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' B' ' 12' ' ' ILE . . . -72.57 -63.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.255 -169.176 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.526 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 35.1 t -60.64 -13.4 14.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.439 177.059 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.538 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -72.71 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.095 166.785 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' HA ' HD21 ' A' ' 46' ' ' LEU . . . -61.41 -15.52 37.69 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.502 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 97.1 mt -92.78 -51.9 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.894 -175.35 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.35 -11.81 7.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.477 166.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 43' ' ' ALA . 3.3 mp -82.85 -42.83 17.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.244 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -23.68 65.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.403 -176.684 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -27.52 38.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.438 -177.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -61.13 -27.75 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.347 169.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.94 -47.15 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.288 178.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.0 13.17 25.89 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -169.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -143.0 116.98 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.404 -179.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -62.72 -24.68 67.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.351 -167.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.475 HG21 ' HB3' ' B' ' 21' ' ' SER . 1.0 OUTLIER -60.96 116.12 4.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.42 -168.538 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 ' HA ' ' A' ' 44' ' ' ILE . 15.3 mm -74.53 149.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.414 177.56 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -139.09 164.21 30.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -169.867 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' B' ' 23' ' ' ASP . . . -66.73 -18.26 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.316 168.74 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -96.83 29.26 3.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.083 169.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -117.52 -34.88 4.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.423 168.638 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.54 HG23 HG23 ' B' ' 27' ' ' THR . 4.1 mp -102.65 -12.32 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.383 -175.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -70.97 -10.8 60.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 161.712 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -145.07 25.04 1.43 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.468 -179.55 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 42' ' ' GLU . . . -111.21 15.25 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.31 163.58 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -144.41 -65.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -155.359 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.407 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 1.1 mtp180 -62.13 -29.19 70.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.316 164.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -84.75 -21.0 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 172.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 4.4 t80 -60.96 -16.03 38.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.429 176.774 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -69.05 -69.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.348 167.542 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? . . . . . 0 C--O 1.241 0.647 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.407 -178.864 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.185 0.517 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -91.84 116.71 29.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.086 -171.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.511 HD22 ' HG3' ' B' ' 33' ' ' GLU . 4.4 mt -63.57 140.14 97.72 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.805 171.199 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.99 147.7 88.78 Favored 'Trans proline' 0 N--CA 1.484 0.942 0 C-N-CA 122.493 2.128 . . . . 0.0 113.617 172.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -82.39 76.36 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.525 177.611 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.53 -54.76 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.599 171.414 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.23 -11.34 21.83 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.658 2.238 . . . . 0.0 113.65 171.179 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' B' ' 3' ' ' LEU . 40.0 mt -114.92 -37.61 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.482 -179.101 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.83 -48.33 86.78 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 1.1 ptt180 -93.83 19.21 9.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.511 -179.285 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mm -83.62 -60.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.126 164.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 40' ' ' ALA . 9.7 mm -66.43 -36.05 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.218 -176.384 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 12.1 mttm -64.93 -39.07 92.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.425 178.217 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -62.11 -31.46 71.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.793 -177.738 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.68 -52.76 64.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.603 170.621 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.24 19.54 0.53 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.609 -179.098 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.466 ' CB ' HD12 ' A' ' 44' ' ' ILE . . . -60.67 125.9 25.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.332 165.494 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.78 -64.41 1.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.071 -170.036 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -110.02 111.32 22.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.411 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 t -90.24 152.05 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.294 172.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.475 ' HB3' HG21 ' A' ' 54' ' ' THR . 24.7 p -98.47 16.6 21.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.345 -176.616 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.55 163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.09 -162.332 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.527 ' HB3' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 75.33 -58.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.898 -166.699 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.22 -38.2 82.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.345 -165.004 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -64.21 -13.51 49.34 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.555 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 2.9 mp -122.56 -5.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -177.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 60' ' ' ILE . 98.9 m -60.64 -43.16 97.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.451 173.404 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 60' ' ' ILE . 2.9 mm? -61.21 -23.43 65.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.443 177.284 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' B' ' 8' ' ' ILE . . . -74.88 -11.12 60.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.436 -178.502 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.48 -32.6 6.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.482 -177.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.535 HD11 HG23 ' B' ' 27' ' ' THR . 2.6 mp -61.72 -75.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.821 163.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.525 HD13 ' HA2' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -58.1 -21.03 44.42 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.797 -160.494 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.511 ' HG3' HD22 ' B' ' 3' ' ' LEU . 4.3 tm-20 -89.2 -18.15 27.67 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -39.8 28.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.093 168.359 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.463 ' HA ' ' CB ' ' B' ' 38' ' ' ASP . 0.2 OUTLIER -93.34 19.56 8.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.422 178.838 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.68 -33.85 1.5 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 165.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.7 -20.78 59.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.191 165.25 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.463 ' CB ' ' HA ' ' B' ' 35' ' ' MET . 27.3 t0 -61.13 -60.88 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.346 171.337 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.529 HD11 HD13 ' A' ' 28' ' ' LEU . 22.0 mt -61.04 -33.95 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.46 -169.022 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.488 ' HB3' HG22 ' A' ' 12' ' ' ILE . . . -61.62 -53.48 55.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.315 -172.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -17.29 64.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.785 -173.487 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.21 -42.4 11.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.085 173.645 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.533 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.86 -12.43 10.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.479 172.106 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.526 HD13 ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.2 -61.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.611 -169.979 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' B' ' 44' ' ' ILE . 0.6 OUTLIER -67.64 -16.85 64.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.488 175.739 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -61.09 -32.03 71.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.287 166.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.454 ' HB1' ' CD1' ' B' ' 55' ' ' ILE . . . -73.42 -40.5 64.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.341 177.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -90.07 -33.73 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.374 -167.526 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -61.1 -37.57 83.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.377 171.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.7 94.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.339 168.657 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.87 27.19 17.33 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -179.007 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 179.11 4.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.415 -169.306 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 161.29 14.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.447 171.645 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 21' ' ' SER . 88.6 m 69.92 134.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.4 168.154 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.454 ' CD1' ' HB1' ' B' ' 47' ' ' ALA . 13.3 mm -90.82 135.52 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.384 168.209 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -135.73 177.13 8.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.464 179.262 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.93 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.347 -167.723 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.16 -16.61 27.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.129 -178.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.88 -18.53 30.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.413 168.455 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.532 HG22 HD12 ' A' ' 28' ' ' LEU . 46.7 mm -92.43 -42.11 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 -170.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.519 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 31.6 mt-10 -91.05 22.03 3.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.635 172.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.524 ' HG ' HD23 ' B' ' 46' ' ' LEU . 19.8 tp -126.53 -15.67 5.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.679 169.428 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.456 ' HB1' ' CA ' ' B' ' 43' ' ' ALA . . . -89.55 -35.72 15.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.827 163.649 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 53.9 t -62.32 -79.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.618 162.847 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -59.48 -12.68 6.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.718 -159.322 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -81.87 -17.99 45.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.5 -177.215 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -70.7 -65.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.305 168.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 105.8 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.379 -176.142 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.38 -169.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 mtp . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -108.38 163.14 13.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.029 -169.238 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 33' ' ' GLU . 1.1 mt -93.33 100.07 3.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.595 -172.492 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 5.0 Cg_endo -47.95 148.13 6.91 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.588 2.192 . . . . 0.0 113.589 172.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.516 ' HA ' ' NH2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -63.89 -26.67 41.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.352 -175.32 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.26 -62.37 3.19 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.684 -170.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -50.82 -22.67 10.27 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 122.594 2.196 . . . . 0.0 113.595 -177.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 29' ' ' ALA . 85.9 mt -107.23 -30.18 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.493 -169.691 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.72 80.51 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -169.597 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -79.62 -21.7 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.364 -174.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.517 HG21 ' HG2' ' B' ' 37' ' ' ARG . 26.8 mt -63.7 -52.27 59.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.417 170.907 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.468 ' CD1' ' HB3' ' B' ' 40' ' ' ALA . 14.7 mm -67.12 -35.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.428 -168.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -63.98 -28.34 69.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.2 177.942 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.93 -33.45 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.874 177.027 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' B' ' 40' ' ' ALA . . . -59.08 -51.32 70.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.496 169.515 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.92 10.89 0.44 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.69 -174.301 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' HB3' HD13 ' B' ' 44' ' ' ILE . . . -73.18 170.2 15.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.025 -0.587 . . . . 0.0 110.316 175.458 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 4.6 tt0 -169.74 -46.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -168.952 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.34 170.94 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.459 171.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.9 t -151.85 161.01 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.359 -169.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.515 ' HB2' HG23 ' B' ' 54' ' ' THR . 27.4 t -77.32 -167.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.398 175.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -17.18 51.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.352 -173.029 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -170.57 124.74 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 168.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.75 -61.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.164 166.601 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' NH2' ' HA ' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -65.86 -14.94 62.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.361 -178.326 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.5 HG12 HG23 ' A' ' 5' ' ' ILE . 14.6 mt -86.43 -34.82 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.396 175.182 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.513 HG23 HG23 ' B' ' 60' ' ' ILE . 98.7 m -61.14 -53.98 50.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.228 165.409 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' HA ' HG23 ' A' ' 31' ' ' ILE . 16.7 tp -62.08 -23.52 66.55 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.347 -174.102 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HB3' HD11 ' A' ' 8' ' ' ILE . . . -82.16 -36.44 27.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.232 178.76 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.2 -16.13 60.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.51 172.529 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -83.07 -29.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.889 -165.33 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.519 HD21 HD22 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -89.39 -34.85 16.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -173.612 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.534 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.89 -34.91 76.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.982 -179.031 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.87 -26.62 60.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.05 168.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.513 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -95.25 22.75 6.44 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.428 178.758 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' HD23 ' B' ' 32' ' ' LEU . . . -138.26 -41.63 0.09 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -173.362 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.537 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -65.88 -26.01 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.417 -0.392 . . . . 0.0 110.177 167.507 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -87.44 -35.83 18.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.354 -168.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.534 HD13 HD13 ' B' ' 32' ' ' LEU . 6.6 mt -61.24 -32.1 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.423 174.149 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' HB3' HG21 ' B' ' 12' ' ' ILE . . . -62.48 -61.43 2.45 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.212 171.792 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.524 -175.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.463 ' HG2' ' HD3' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -89.66 -53.67 4.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.169 171.238 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.94 -11.55 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.7 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.497 HD12 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -78.4 -60.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.402 -169.349 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mtmt -69.08 -18.56 64.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.468 173.108 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 4.1 mp -61.1 -18.38 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 166.462 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.45 -18.39 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.381 177.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -81.44 -33.32 32.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -170.71 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -61.11 -24.56 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.356 169.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.66 63.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.226 166.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.18 28.66 0.58 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.467 -177.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.49 93.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.465 175.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.86 -76.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.467 179.372 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -160.04 140.28 11.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.423 -169.666 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 59' ' ' ASP . 17.2 mm -61.58 165.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.267 167.209 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -170.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.397 168.868 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.37 -19.52 65.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.304 -166.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.36 23.64 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.255 170.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -121.22 -26.6 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.317 168.33 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.524 HG22 HD12 ' B' ' 28' ' ' LEU . 36.6 mm -95.99 -47.82 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.001 -163.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.92 -12.76 60.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.167 174.442 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -48.14 7.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.43 177.747 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . . . -60.98 -31.21 70.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.228 172.115 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG23 HG23 ' B' ' 31' ' ' ILE . 25.3 t -61.33 -70.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.756 164.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -9.82 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.806 -170.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HD3' ' HG2' ' A' ' 42' ' ' GLU . 8.9 ttt85 -77.66 -34.14 53.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.904 172.628 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.513 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 5.6 m-85 -59.98 -37.16 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.437 178.598 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 13.5 tptp -60.78 -14.5 21.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.523 -168.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 tttm . . . . . 0 C--O 1.24 0.565 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.427 165.8 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptm . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.104 0.478 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -160.82 134.9 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.102 170.139 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.53 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 5.6 mt -61.33 99.63 0.19 Allowed Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.839 -173.037 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -46.93 157.54 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.229 1.953 . . . . 0.0 113.454 -179.07 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.04 23.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.378 -167.157 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.23 -58.19 0.38 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 169.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.75 -65.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 122.505 2.137 . . . . 0.0 113.612 173.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' B' ' 3' ' ' LEU . 74.3 mt -60.8 -11.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.532 -170.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.82 55.53 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -178.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.533 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -94.96 17.36 14.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.588 . . . . 0.0 110.642 -178.895 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 23.1 mt -95.27 -45.05 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.025 163.146 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.527 HG13 HD21 ' B' ' 28' ' ' LEU . 3.1 mm -94.29 46.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.849 171.551 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.533 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 19.8 mtpt -149.59 -30.56 0.23 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.945 171.52 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . 0.537 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 27.9 t0 -60.05 -30.49 69.23 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.065 171.264 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.96 74.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.638 170.907 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.64 22.33 2.28 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.552 -165.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.497 ' N ' HD12 ' A' ' 44' ' ' ILE . . . -71.76 123.45 22.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.092 179.375 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -77.15 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.007 -164.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -109.84 -52.54 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.429 -177.841 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' B' ' 25' ' ' ARG . 11.5 t 62.84 132.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.331 -175.172 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -65.75 175.16 2.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.249 178.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -93.81 20.33 7.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.59 -44.86 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.446 169.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.461 ' CB ' HG13 ' A' ' 60' ' ' ILE . . . -62.0 -45.88 91.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.326 -170.347 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.523 ' HG3' HG13 ' B' ' 20' ' ' VAL . 14.6 mtt180 -66.97 -25.47 66.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.315 -171.446 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.92 -32.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.381 171.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.54 HG21 HD13 ' B' ' 31' ' ' ILE . 90.0 m -70.39 -45.69 65.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.276 -169.821 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HA ' HD11 ' B' ' 31' ' ' ILE . 4.7 tp -59.78 -44.67 93.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.437 171.873 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.03 -10.07 5.39 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.541 177.636 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -109.71 -29.51 8.3 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.475 -176.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.54 HD13 HG21 ' B' ' 27' ' ' THR . 2.8 mp -62.22 -74.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.854 164.108 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 39' ' ' ILE . 1.4 mp -59.36 -11.4 4.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 -160.632 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.53 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -92.17 -52.82 4.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.206 -176.401 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -29.43 70.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 170.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 35' ' ' MET . . . . . 0.526 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 4.4 mtt -64.28 -45.52 87.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.356 168.376 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.62 78.43 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.517 ' HG2' HG21 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -67.08 -33.52 75.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.248 167.124 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 3.2 m-20 -72.41 -54.5 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.432 -171.836 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.523 HG22 HG21 ' B' ' 64' ' ' VAL . 51.8 mt -60.83 -35.53 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.382 -174.797 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . . . -60.89 -57.77 11.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.167 -173.008 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.47 ' HA ' ' CG2' ' B' ' 44' ' ' ILE . 43.2 p -66.18 -14.61 62.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.76 176.796 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.515 ' HG3' ' HB3' ' B' ' 68' ' ' LYS . 0.0 OUTLIER -87.56 -35.5 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.974 179.501 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -77.36 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.286 170.322 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.51 HD13 ' HB3' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -85.57 -61.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.56 -172.508 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.504 ' HA ' ' HG3' ' B' ' 48' ' ' ARG . 2.2 mptm? -60.6 -17.57 47.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.573 172.083 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' B' ' 68' ' ' LYS . 0.8 OUTLIER -61.63 -27.73 68.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.233 167.895 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.55 -44.34 57.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.33 179.712 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.07 -31.28 34.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.346 -177.906 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . 0.481 ' N ' ' HD2' ' B' ' 48' ' ' ARG . 6.2 t60 -60.98 -36.64 79.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 168.674 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.99 -52.83 63.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.152 165.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.87 28.37 0.74 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.533 -173.825 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.493 ' NE ' ' HB2' ' B' ' 48' ' ' ARG . 6.1 mpt_? 65.11 96.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.521 169.371 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -152.36 -73.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.433 -177.019 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.517 HG21 ' N ' ' B' ' 55' ' ' ILE . 90.5 m -165.14 148.26 8.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.298 -173.731 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.517 ' N ' HG21 ' B' ' 54' ' ' THR . 31.8 mt -94.25 147.82 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.42 168.282 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.61 -174.61 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.4 -169.602 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.4 77.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.217 -168.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.514 ' HG2' HD12 ' B' ' 62' ' ' LEU . 2.0 tm-20 -93.97 23.49 4.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.076 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.8 -17.26 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.511 166.664 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.524 HG23 HD11 ' A' ' 31' ' ' ILE . 32.9 mm -92.27 -59.92 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.292 -175.58 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 71.2 mt-10 -60.48 -10.44 4.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.228 168.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.514 HD12 ' HG2' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -100.47 -14.94 18.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.876 177.952 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' B' ' 39' ' ' ILE . . . -102.22 5.85 40.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.553 165.184 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' B' ' 61' ' ' GLU . 55.7 t -113.83 -84.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.572 -177.576 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.501 ' HB3' ' NH1' ' B' ' 65' ' ' ARG . 0.4 OUTLIER -60.8 -22.36 64.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.187 -178.73 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . 0.462 ' HD2' ' CG ' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -82.18 -46.7 13.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 160.504 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.17 31.71 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.335 -163.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.516 ' HD3' ' HG ' ' B' ' 46' ' ' LEU . 4.1 tptt 62.85 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.583 178.683 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.462 ' CG ' ' HD2' ' B' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.598 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.354 166.483 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 121.067 0.461 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 58.45 172.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.704 170.228 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.512 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -98.64 104.35 23.96 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.514 -175.908 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -50.45 156.19 4.36 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.503 2.135 . . . . 0.0 113.537 168.056 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -87.69 62.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.38 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.25 -57.42 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.696 -177.388 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.35 -41.37 59.18 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.548 2.165 . . . . 0.0 113.657 170.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -61.41 -23.67 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.43 170.913 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.8 -57.54 18.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -167.524 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -20.92 64.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.402 -170.507 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.5 HD12 HD22 ' B' ' 3' ' ' LEU . 28.0 mt -61.65 -49.75 83.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.183 167.115 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.519 HG23 ' NH1' ' A' ' 25' ' ' ARG . 1.8 mm -96.61 45.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 -35.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.779 173.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.37 -31.47 70.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.929 170.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.04 62.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.502 170.103 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.88 33.09 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.552 -169.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.83 138.46 33.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.296 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.82 -50.34 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.001 -170.6 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.83 171.25 15.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.412 -168.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.464 HG11 ' NH2' ' A' ' 25' ' ' ARG . 17.1 m -115.24 -173.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 167.295 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.52 ' HA ' HG23 ' B' ' 54' ' ' THR . 54.0 p -90.33 -65.38 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.125 175.248 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -141.52 -34.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.71 161.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 47.7 m-20 -107.76 -106.15 0.34 Allowed 'General case' 0 C--O 1.253 1.277 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.657 165.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . 88.98 -56.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.026 1.331 . . . . 0.0 109.695 -168.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' NH1' HG23 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.11 -21.45 46.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.647 -179.067 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -64.07 -43.26 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.806 173.618 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.52 HG23 HG23 ' B' ' 60' ' ' ILE . 51.2 m -60.66 -46.05 91.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.205 172.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.509 HD12 HG22 ' B' ' 60' ' ' ILE . 2.1 tp -60.82 -33.89 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.269 173.445 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' A' ' 26' ' ' ILE . . . -71.91 -26.25 62.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.384 175.279 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 28.87 2.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.528 176.373 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.513 HG23 HG23 ' B' ' 64' ' ' VAL . 66.8 mt -145.15 -64.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.109 -170.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD12 ' HA3' ' B' ' 36' ' ' GLY . 0.1 OUTLIER -60.06 -38.64 83.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.69 177.21 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' B' ' 11' ' ' ILE . 5.0 tm-20 -86.35 -23.57 26.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.101 -169.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.57 19.26 6.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 173.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpp -126.21 -32.4 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.11 164.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.9 -40.9 98.98 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.695 -179.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -18.77 65.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.481 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 33.0 m-20 -101.73 -18.85 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.369 -167.476 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 64' ' ' VAL . 14.9 mt -80.75 -24.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.377 171.422 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.515 ' HB1' HD12 ' B' ' 12' ' ' ILE . . . -72.85 -70.04 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.396 -166.916 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -60.74 -10.0 4.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.503 -176.753 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 54.2 mm-40 -88.13 -47.66 8.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.216 177.094 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' N ' ' HB3' ' A' ' 63' ' ' ALA . . . -62.45 -27.17 68.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.187 170.355 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 41' ' ' SER . 97.9 mt -77.95 -52.1 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.18 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -26.69 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.494 174.33 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 43' ' ' ALA . 4.6 mt -62.27 -40.5 96.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.319 176.533 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' CB ' HD12 ' A' ' 55' ' ' ILE . . . -61.21 -25.56 67.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.272 -167.756 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -103.95 -25.72 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.35 -176.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -64.33 -37.8 88.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.339 169.473 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.33 97.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.334 168.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.83 18.95 14.01 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 169.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 179.18 -167.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.274 170.339 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 137.08 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.562 170.013 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' B' ' 21' ' ' SER . 86.6 m -60.82 171.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.386 167.51 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.527 ' HB ' HG12 ' B' ' 20' ' ' VAL . 18.8 mm -60.6 136.9 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.481 175.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.508 ' HA ' ' HB1' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -159.97 -178.27 6.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.366 -167.092 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -18.68 61.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.245 -171.057 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.34 -17.79 23.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.057 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.23 -43.54 28.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.373 168.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' HB ' HG23 ' B' ' 27' ' ' THR . 37.7 mm -72.22 -57.64 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.404 -170.371 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.77 -40.4 84.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.074 -166.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -37.47 82.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.442 170.049 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.517 ' HB3' ' N ' ' A' ' 43' ' ' ALA . . . -61.56 -16.41 47.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.438 -175.752 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 39' ' ' ILE 0.256 0.4 OUTLIER -104.57 -50.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.042 -160.582 . . . . . . . . 4 4 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' N ' HG11 ' A' ' 64' ' ' VAL . 3.1 ttt-85 -93.69 23.8 4.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.526 -178.077 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -122.05 -55.71 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.481 -176.74 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' HB3' ' HG3' ' A' ' 42' ' ' GLU . 1.5 p90 -61.26 -46.88 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.3 -163.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.98 158.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.415 -168.451 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.556 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.393 -169.331 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.162 0.506 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.88 161.0 40.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 -173.594 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' B' ' 33' ' ' GLU . 4.0 mt -74.05 138.56 75.91 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.799 -168.091 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.96 157.15 30.15 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.357 2.038 . . . . 0.0 113.221 164.703 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 pt -93.02 23.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.519 178.7 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . 0.488 ' HB2' ' HD3' ' B' ' 7' ' ' PRO . . . -90.87 -57.81 0.25 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.763 170.063 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 7' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' B' ' 6' ' ' ALA . 9.2 Cg_endo -60.7 -54.62 1.87 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.532 2.155 . . . . 0.0 113.57 173.325 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.496 HD12 HD13 ' B' ' 3' ' ' LEU . 28.7 mt -60.5 -13.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.498 169.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.41 -61.49 1.98 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.509 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -93.82 17.06 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.593 -167.13 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.525 HD12 ' HG2' ' A' ' 33' ' ' GLU . 29.0 mt -96.73 -49.62 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 162.79 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.515 HD12 ' HB1' ' A' ' 40' ' ' ALA . 5.1 mm -68.04 -38.28 79.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.211 178.557 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.8 mttt -61.57 -35.25 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.355 174.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.54 -34.02 76.09 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.862 -177.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.26 -52.39 65.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.433 169.385 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.79 15.82 0.3 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.221 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.519 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -62.83 125.72 24.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.219 164.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.36 -53.96 2.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.039 -167.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.55 93.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.412 171.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.527 HG12 ' HB ' ' A' ' 55' ' ' ILE . 27.8 t -67.94 166.0 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.282 168.367 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 21' ' ' SER . . . . . 0.536 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 26.5 t -102.32 -166.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.388 170.39 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.31 167.36 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.284 166.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.65 -61.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.498 171.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 56' ' ' LYS . . . -61.88 -47.07 86.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.388 -167.212 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -60.83 -12.11 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.601 178.99 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mm -114.03 -15.88 9.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.645 -175.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.527 HG23 ' HB ' ' A' ' 60' ' ' ILE . 41.4 m -73.77 -33.82 64.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.436 -171.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 60' ' ' ILE . 2.7 mm? -62.71 -21.76 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.407 168.399 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.07 -12.79 60.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.382 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.518 ' HD2' ' HA ' ' B' ' 27' ' ' THR . 4.6 mttm -95.75 -29.1 14.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.493 172.229 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 31' ' ' ILE . . . . . 0.527 HD13 HG21 ' B' ' 27' ' ' THR . 2.9 mp -78.73 -79.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.184 170.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.494 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.91 -12.89 8.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.649 -161.918 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . 0.539 ' HG2' HD22 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -93.39 -31.52 14.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.102 178.212 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -72.25 -29.74 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.148 169.022 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -99.45 36.24 1.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.278 172.78 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.513 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . -144.94 -40.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 170.658 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -43.48 98.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.179 165.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.82 -38.81 92.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.438 -171.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.533 HG22 HG21 ' B' ' 64' ' ' VAL . 9.8 mt -70.6 -37.86 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 -175.583 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 12' ' ' ILE . . . -60.77 -64.39 0.97 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.355 -168.767 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.538 ' HA ' HD11 ' B' ' 44' ' ' ILE . 1.2 t -61.69 -11.21 10.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.419 -176.588 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 42' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -88.03 -51.9 5.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.183 174.408 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.496 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.79 -9.63 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.364 171.23 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' B' ' 41' ' ' SER . 57.9 mt -99.11 -54.37 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.127 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -23.67 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.343 -177.658 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.514 HD21 HD22 ' B' ' 62' ' ' LEU . 12.1 mt -60.71 -48.36 82.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.373 170.791 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.9 -60.32 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.371 171.303 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -20.64 62.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.365 -169.612 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.5 -44.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 169.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 -51.7 59.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 29.6 5.37 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 169.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.62 -171.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.3 169.854 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 64.34 163.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.439 -178.056 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.52 HG23 ' HA ' ' A' ' 21' ' ' SER . 6.1 t -88.52 -167.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.382 -169.399 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' B' ' 44' ' ' ILE . 10.6 mm -100.63 142.6 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.327 173.146 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . 0.45 ' HD3' ' HG2' ' B' ' 58' ' ' GLU . 1.9 tmtt? -160.56 172.52 17.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.312 -165.132 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.23 73.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.369 -168.444 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 58' ' ' GLU . . . . . 0.45 ' HG2' ' HD3' ' B' ' 56' ' ' LYS . 1.8 pt-20 -83.62 15.7 3.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 177.705 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -130.65 -20.79 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.54 167.303 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 60' ' ' ILE . . . . . 0.52 HG23 HG23 ' A' ' 27' ' ' THR . 10.1 mm -79.49 -50.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 61' ' ' GLU . . . . . 0.52 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 20.4 mt-10 -61.31 -39.46 90.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.027 166.212 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -62.22 -32.2 72.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.508 178.351 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.485 ' HA ' HD13 ' B' ' 46' ' ' LEU . . . -81.03 -35.68 31.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.207 175.054 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.533 HG21 HG22 ' B' ' 39' ' ' ILE . 19.9 t -62.39 -79.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.637 175.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -58.99 -12.73 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.664 -164.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -60.42 -26.0 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.512 171.501 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HG3' ' B' ' 42' ' ' GLU . 17.4 m-85 -88.01 -50.41 6.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.409 -175.404 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -134.27 119.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.39 -172.315 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.587 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.306 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.252 1.187 0 CA-C-O 122.016 0.912 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.642 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.5 Cg_endo -56.74 140.3 90.59 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.751 2.301 . . . . 0.0 113.49 171.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.2 -14.11 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.456 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.23 -55.37 3.78 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.653 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 15.5 Cg_exo -49.77 -49.59 15.51 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.655 2.237 . . . . 0.0 113.644 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 3' ' ' LEU . 63.0 mt -61.25 -45.74 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.521 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.05 59.23 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.37 -29.44 18.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.475 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.595 HD13 ' HG2' ' B' ' 33' ' ' GLU . 27.8 mt -61.5 -57.63 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.309 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' B' ' 40' ' ' ALA . 10.9 mm -61.21 -36.19 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.331 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mttm -62.98 -36.68 84.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.444 170.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.63 -34.02 76.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.753 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.376 169.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.42 20.61 0.34 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.691 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.21 149.34 33.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.401 166.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.23 -55.17 2.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 111.59 10.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' B' ' 55' ' ' ILE . 94.3 t -133.04 132.15 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.384 -169.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.4 p -65.92 157.17 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.351 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.92 -18.56 63.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.428 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.629 ' HA ' HG22 ' A' ' 26' ' ' ILE . 24.2 m-20 -81.0 -34.57 32.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.455 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' B' ' 60' ' ' ILE . . . -61.52 -40.36 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.192 166.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -40.51 90.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.333 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 23' ' ' ASP . 7.3 tt -81.39 -34.88 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.375 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.477 HG22 HG22 ' B' ' 60' ' ' ILE . 84.9 m -63.58 -45.96 88.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.091 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HG13 ' B' ' 60' ' ' ILE . 3.3 tp -60.36 -42.84 96.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.289 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.53 -42.93 99.54 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.268 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -78.62 -27.15 45.43 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.384 -176.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.735 HG21 HG21 ' B' ' 64' ' ' VAL . 23.3 mt -61.42 -73.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 166.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -59.53 -26.66 65.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.848 -166.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.894 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.52 -48.14 14.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.081 -176.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 2.5 mt-10 -63.98 -26.41 68.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.017 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.532 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 13.5 ttm -71.92 -43.49 65.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.452 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -65.06 -45.33 92.39 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -60.69 -22.16 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.39 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.07 -54.83 5.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.489 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 64' ' ' VAL . 10.1 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.208 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -61.24 -54.24 46.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.309 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 44' ' ' ILE . 84.3 p -61.48 -28.17 69.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.393 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 46' ' ' LEU . 1.2 mm-40 -62.06 -56.37 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.061 165.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -65.18 -4.52 5.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.023 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.839 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -94.1 -56.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.248 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -62.49 -17.12 58.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.74 167.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 42' ' ' GLU . 5.1 mp -67.18 -61.03 2.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.112 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.53 -14.21 18.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.462 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . 18.4 ttt-85 -97.41 -23.21 16.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.016 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -36.1 76.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.051 163.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -67.3 -56.76 8.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 161.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.96 -14.05 21.79 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.358 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 172.47 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.785 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.66 28.81 0.0 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.991 164.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.784 HG23 ' O ' ' B' ' 19' ' ' ARG . 100.0 m 63.45 150.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.407 177.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.793 ' HB ' HG13 ' B' ' 20' ' ' VAL . 9.6 mm -69.73 134.25 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.014 169.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.802 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 41.1 mtmt -142.38 175.31 9.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.504 -164.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -63.86 -55.13 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.289 -173.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 3.4 mt-10 -68.5 -16.05 63.75 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.992 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -72.05 -39.3 69.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.325 172.293 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.823 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.83 -56.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.501 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 22.1 mt-10 -60.6 -43.22 97.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.877 -161.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.03 -45.45 94.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.468 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.54 -29.09 69.79 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.452 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.748 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -86.22 -52.2 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.62 -168.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -18.73 60.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.589 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -76.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.316 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.184 -162.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 8' ' ' ILE . 18.9 mt . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.481 0.658 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.496 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 7.9 Cg_endo -48.81 138.09 26.62 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.16 1.907 . . . . 0.0 113.353 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.655 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -80.91 -11.33 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.627 -165.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.45 -56.47 6.54 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.764 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 3.7 Cg_endo -58.74 -48.83 13.35 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 122.504 2.136 . . . . 0.0 113.499 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.93 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.8 mt -60.89 -21.11 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.321 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.82 -53.55 44.31 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.6 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 10.7 mtp-105 -79.28 -21.56 45.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.372 -172.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 3' ' ' LEU . 64.0 mt -61.36 -57.6 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.153 165.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.956 HG23 ' HB1' ' A' ' 40' ' ' ALA . 5.6 mt -78.55 -12.93 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.944 -172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtmm -68.47 -40.38 81.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 162.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.35 -32.98 73.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.876 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.48 -52.06 66.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.554 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.9 25.61 0.26 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.732 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.839 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -77.94 145.48 36.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.289 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.725 162.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 66.53 100.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.423 -163.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.793 HG13 ' HB ' ' A' ' 55' ' ' ILE . 12.7 t -100.91 169.27 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 20' ' ' VAL . 15.1 t -117.14 141.52 48.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.393 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.602 ' O ' HD12 ' B' ' 26' ' ' ILE . 0.3 OUTLIER -60.87 -27.48 68.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.332 -167.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -60.89 -40.12 91.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.464 172.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -63.84 -57.97 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.466 ' HB3' ' CG2' ' B' ' 5' ' ' ILE . 0.0 OUTLIER -61.06 -33.25 73.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.388 -167.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 22' ' ' ASP . 21.7 mt -82.18 -38.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.449 -173.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.436 ' C ' HD12 ' B' ' 31' ' ' ILE . 85.3 m -61.26 -47.07 87.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.887 HD23 HD11 ' B' ' 12' ' ' ILE . 4.4 tp -60.49 -47.83 84.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.382 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 3' ' ' LEU . . . -61.31 -27.1 68.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.373 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -36.18 40.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.389 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.748 HG21 HG21 ' A' ' 64' ' ' VAL . 4.9 mt -61.14 -72.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.051 172.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 28' ' ' LEU . 3.0 mp -60.06 -31.99 70.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 -165.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' A' ' 11' ' ' ILE . 3.3 tm-20 -76.82 -33.61 57.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.061 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.2 89.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.064 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.64 -43.5 80.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.527 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.61 -40.33 97.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.5 -32.9 71.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.429 171.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -63.73 -56.88 12.23 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.539 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.88 HD13 HG23 ' B' ' 64' ' ' VAL . 5.0 mt -62.52 -26.38 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.787 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.648 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.88 -70.53 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.317 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.9 OUTLIER -62.14 -17.29 57.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.371 -173.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.646 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -73.36 -59.04 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.067 170.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.8 -14.45 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.679 HD11 ' HB2' ' A' ' 17' ' ' ALA . 62.8 mt -94.3 -54.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.97 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -60.46 -14.88 21.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.373 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.726 HD21 ' NH2' ' B' ' 66' ' ' ARG . 16.8 mt -75.83 -53.81 7.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.465 169.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.23 -16.43 61.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.27 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -34.57 14.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.373 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.65 -34.26 74.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.12 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.336 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.3 12.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.31 -176.34 2.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.009 -0.595 . . . . 0.0 110.431 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -115.07 -46.29 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.336 -170.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -87.45 117.54 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.42 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.771 HG23 ' HB2' ' B' ' 59' ' ' ASP . 9.8 mt -78.72 143.55 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.327 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.476 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 2.1 mtmp? -125.92 177.33 6.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.455 -167.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.57 -21.37 64.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.273 170.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 30.2 tt0 -69.08 -48.61 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.044 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' B' ' 55' ' ' ILE . 7.6 m-20 -63.51 -37.49 87.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.4 -168.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.829 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -62.7 -39.13 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.777 163.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -62.28 -39.46 93.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -170.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 62' ' ' LEU . 22.9 mt -84.53 -39.26 19.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.479 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.49 -49.18 78.59 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.393 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.88 HG23 HD13 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -72.66 -52.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.015 -170.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -60.3 -31.45 70.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ARG . . . . . 0.726 ' NH2' HD21 ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.31 -40.36 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.325 178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 14.8 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.336 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 8' ' ' ILE . 4.9 mt . . . . . 0 C--O 1.243 0.739 0 CA-C-O 121.241 0.543 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -46.66 141.34 11.34 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.387 2.058 . . . . 0.0 113.438 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.3 pt -89.83 17.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.975 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.0 -55.98 0.65 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.627 166.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.6 Cg_endo -60.05 -54.64 2.12 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.659 2.239 . . . . 0.0 113.575 171.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 11' ' ' ILE . 23.8 mt -65.02 -45.25 95.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.361 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.58 62.3 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -88.02 -27.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.8 mt -62.07 -55.27 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 169.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' B' ' 40' ' ' ALA . 10.0 mm -67.89 -36.21 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.33 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -33.27 72.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.286 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -62.43 -34.66 77.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.824 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.779 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.56 -52.35 65.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.435 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.79 23.88 0.35 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.544 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 150.57 32.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.436 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -122.55 -75.32 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.033 -167.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -121.92 104.97 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.434 -174.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' NH2' ' A' ' 25' ' ' ARG . 19.8 t -116.13 150.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.323 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -87.79 148.84 24.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.365 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -60.95 -20.14 61.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.375 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -60.8 -54.73 41.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.441 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.913 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -62.22 -42.61 99.47 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.385 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.978 ' NH2' HG21 ' A' ' 20' ' ' VAL . 4.6 mmt85 -61.71 -46.12 91.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.354 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.31 -32.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.451 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.696 HG22 HG21 ' B' ' 60' ' ' ILE . 97.1 m -60.95 -44.33 97.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.497 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.892 HD22 HG13 ' B' ' 60' ' ' ILE . 7.4 tp -83.43 -14.07 53.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.078 -172.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -81.73 -21.76 37.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.407 163.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 33' ' ' GLU . 6.3 tttt -88.57 -31.14 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.37 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.017 HG21 HG21 ' B' ' 64' ' ' VAL . 3.1 mp -61.08 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.658 159.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 32' ' ' LEU . 4.3 mm? -59.04 -14.86 10.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.634 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HG3' HD12 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -71.02 -69.11 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.699 163.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.8 -32.3 71.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.097 -167.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.466 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -66.42 -34.92 79.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.433 166.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.23 -53.96 12.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' B' ' 15' ' ' ALA . 0.0 OUTLIER -64.31 -26.09 68.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.458 173.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 15.0 m-20 -60.89 -62.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.477 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.697 HG21 HG23 ' A' ' 64' ' ' VAL . 3.2 mt -62.59 -17.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.583 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -80.78 -69.17 0.62 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.254 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -61.04 -13.57 17.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.459 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -73.2 -63.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.077 166.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -60.93 -11.26 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.556 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -93.28 -49.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.803 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -60.28 -33.12 71.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.395 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 43' ' ' ALA . 15.6 mt -60.34 -42.72 96.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.334 166.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -61.23 -54.36 45.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.277 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -68.09 -14.94 63.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.431 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -71.27 -56.54 5.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.219 172.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.34 24.08 0.23 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.909 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' NE ' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 55.21 -162.71 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 O-C-N 122.184 -0.598 . . . . 0.0 111.428 158.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' H ' ' NE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER 70.23 -81.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.559 -165.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 m -115.45 137.87 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.379 -160.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 47' ' ' ALA . 8.3 mm -94.28 137.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.164 161.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 167.42 23.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.547 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.261 -167.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.1 -42.86 99.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.942 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.8 -45.42 94.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.5 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.818 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.0 mm -66.86 -47.2 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.401 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.68 -33.89 74.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HB3' HD13 ' A' ' 46' ' ' LEU . 1.7 mp -61.23 -53.85 51.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.384 175.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.02 -49.46 77.3 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.328 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -67.37 -53.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.931 -164.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -20.26 66.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.818 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -43.87 98.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.255 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 43.0 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.465 168.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.846 HD22 HD11 ' A' ' 11' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HG2' ' B' ' 7' ' ' PRO . 19.3 Cg_endo -62.09 143.37 94.71 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.397 2.064 . . . . 0.0 113.463 164.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.451 HD12 ' NH2' ' B' ' 25' ' ' ARG . 12.2 pt -108.23 -14.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.444 -167.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -77.0 -54.76 1.51 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.682 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 17.2 Cg_exo -50.23 -46.48 28.49 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.722 2.281 . . . . 0.0 113.617 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.6 -47.61 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.459 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.84 -29.07 71.28 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.552 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -89.19 -19.99 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.332 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 33' ' ' GLU . 46.1 mm -61.61 -48.39 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.106 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.8 mm -70.22 -39.27 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.711 -174.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.1 OUTLIER -60.44 -43.11 97.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.442 169.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.96 -31.99 72.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.857 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -53.62 56.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.492 169.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.48 20.83 0.61 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.45 119.88 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.272 167.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.94 -61.18 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.057 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 108.83 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.468 167.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' B' ' 12' ' ' ILE . 11.6 t -75.17 114.47 15.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.232 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -60.73 151.59 29.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.409 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.467 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 60.2 m-20 -61.59 -19.23 61.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.363 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 26' ' ' ILE . 2.3 t0 -89.42 -26.08 21.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.32 -175.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -63.78 -47.74 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.251 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 12.6 ptt180 -71.4 -29.14 64.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.402 -169.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.724 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -73.13 -42.21 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.443 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.779 ' O ' HD12 ' B' ' 31' ' ' ILE . 67.1 m -60.93 -37.57 82.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.242 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.818 HD22 ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.106 167.431 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -62.86 -32.57 73.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.27 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -69.94 -45.14 68.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.587 174.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.779 HD12 ' O ' ' B' ' 27' ' ' THR . 3.2 mt -61.15 -73.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.211 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -55.55 -28.51 55.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.32 -167.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.605 ' HB2' HD11 ' B' ' 3' ' ' LEU . 8.0 tp10 -65.24 -57.8 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.88 -38.2 87.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.986 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 22.1 mmm -72.0 -38.24 69.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.54 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.11 -40.71 95.14 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.5 mtp85 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.388 170.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.3 OUTLIER -65.26 -58.86 4.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.511 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.637 HG12 HG23 ' B' ' 64' ' ' VAL . 4.1 mt -61.51 -31.71 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.339 -173.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.92 -70.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.244 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.779 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 16.1 t -62.27 -12.42 20.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.444 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.511 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 1.2 mp0 -93.84 -48.24 6.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.175 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.55 -10.89 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.378 167.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 17' ' ' ALA . 56.7 mt -100.74 -49.15 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.793 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.01 -11.38 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.454 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.76 HD22 HD23 ' B' ' 62' ' ' LEU . 8.1 mt -84.1 -59.52 2.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.422 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -60.69 -18.21 52.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.523 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.11 -28.48 20.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.052 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -60.23 -35.7 76.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.174 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -65.48 -55.59 17.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.998 162.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 2.98 44.76 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.762 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 178.71 -163.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.638 -166.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt 76.02 -93.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.535 HG22 ' O ' ' B' ' 55' ' ' ILE . 99.7 m -172.08 168.81 5.74 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.824 -0.548 . . . . 0.0 109.955 -160.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' B' ' 47' ' ' ALA . 7.3 mm -114.74 135.41 54.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.903 155.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -147.22 -177.46 5.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 -165.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -61.74 -15.49 41.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.346 -176.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 1.8 tp10 -100.76 -30.15 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.047 -170.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -36.36 79.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.136 167.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.892 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.39 -64.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.814 162.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -61.08 -22.46 64.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 -163.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.76 HD23 HD22 ' B' ' 46' ' ' LEU . 5.2 tp -86.67 -39.67 15.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.458 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.84 -36.17 78.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.355 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -88.15 -45.1 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.876 -166.167 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.38 -27.17 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.53 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.5 95.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.107 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 18.3 m-85 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 162.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' B' ' 11' ' ' ILE . 2.5 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.267 0.556 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.29 144.31 95.14 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.484 2.123 . . . . 0.0 113.52 164.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.852 HG21 HG12 ' A' ' 26' ' ' ILE . 2.2 pp -107.84 16.54 7.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.879 -169.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.84 -55.87 0.51 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.699 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -61.09 -42.49 35.9 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.555 2.17 . . . . 0.0 113.561 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' HD12 ' A' ' 11' ' ' ILE . 25.7 mt -60.63 -35.04 60.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.472 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -46.82 93.46 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.585 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -18.57 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.347 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 8' ' ' ILE . 93.6 mt -60.91 -40.22 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.162 163.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.933 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.8 mt -93.22 -25.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.51 -162.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -64.02 -36.88 85.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.05 -32.97 74.71 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.088 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.02 -52.36 65.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.509 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' C ' HG21 ' B' ' 44' ' ' ILE . . . 138.7 28.51 0.25 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.978 -1.464 . . . . 0.0 110.713 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -75.18 127.77 33.96 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.531 -175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.22 -25.47 11.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.96 107.71 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.462 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' HB1' ' A' ' 17' ' ' ALA . 18.7 t -120.14 133.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.418 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 p -70.64 157.18 38.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.351 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.3 m-20 -60.64 -33.3 72.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.406 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -44.61 96.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.429 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' B' ' 55' ' ' ILE . . . -62.98 -52.66 62.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.24 -174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.717 ' NH1' HD13 ' A' ' 5' ' ' ILE . 8.9 ptt180 -79.17 -14.23 59.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.38 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.852 HG12 HG21 ' A' ' 5' ' ' ILE . 37.3 mt -96.81 -32.16 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.4 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.877 HG22 HG22 ' B' ' 60' ' ' ILE . 58.6 m -60.43 -35.4 75.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 168.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 12' ' ' ILE . 3.5 tp -60.01 -48.44 81.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.294 165.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.8 69.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.386 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.57 -40.75 15.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.444 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.498 HD12 ' CG2' ' B' ' 60' ' ' ILE . 18.4 mt -59.79 -69.37 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.982 171.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.529 HD11 ' N ' ' B' ' 36' ' ' GLY . 2.7 tt -59.38 -31.2 69.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.846 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.05 -53.74 51.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.007 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 58.4 tt0 -64.59 -20.95 66.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.958 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.47 ' HB3' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -63.06 -44.59 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 160.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -61.28 -51.96 54.74 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.699 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 8.3 ptm180 -61.46 -27.41 68.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.208 -0.496 . . . . 0.0 109.904 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t70 -59.83 -54.44 46.21 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.669 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.804 ' HB ' HD11 ' B' ' 28' ' ' LEU . 1.7 mt -62.44 -37.49 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.776 -174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.12 -68.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.401 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.7 t -62.52 -31.75 72.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.152 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.13 -53.6 54.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.227 171.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -69.66 -13.25 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.528 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -83.77 -55.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.197 -168.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -16.74 59.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.574 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 66' ' ' ARG . 11.4 mt -61.3 -45.11 95.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.16 166.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.696 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -79.85 -24.36 41.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.253 -167.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -79.32 -52.5 8.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.494 178.067 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.05 66.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.71 -55.96 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.178 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 6.95 0.08 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.755 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.21 80.05 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.616 0.722 . . . . 0.0 112.182 162.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 -68.36 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.143 165.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.619 HG21 ' HB2' ' B' ' 21' ' ' SER . 6.0 t -138.13 -169.37 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.049 164.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.98 HG13 HG22 ' B' ' 20' ' ' VAL . 9.0 mm -100.93 135.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.738 161.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' NZ ' HG22 ' A' ' 54' ' ' THR . 3.4 mttt -136.29 159.78 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.527 -164.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.89 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.26 -20.42 62.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.307 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.29 -59.23 4.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.979 165.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 1.3 m-20 -66.51 -40.47 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.392 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.883 HG23 HD13 ' B' ' 28' ' ' LEU . 16.8 mm -61.93 -56.56 16.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.396 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' B' ' 31' ' ' ILE . 14.6 mt-10 -61.67 -19.48 62.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -64.26 -53.94 41.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.322 167.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -61.06 -31.35 71.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.353 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 50.2 t -62.45 -67.72 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.6 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -60.52 -12.84 10.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.749 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' CD ' HD21 ' A' ' 46' ' ' LEU . 1.1 tpm_? -79.47 -36.95 37.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.14 -170.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' CZ ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.452 158.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.924 ' HB3' HD12 ' B' ' 8' ' ' ILE . 17.8 mt . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.474 0.654 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 7.3 Cg_exo -46.33 148.78 3.01 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.612 2.208 . . . . 0.0 113.389 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' B' ' 8' ' ' ILE . 1.8 pp -66.89 -10.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.467 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -87.86 -56.9 0.31 Allowed Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.868 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.3 Cg_endo -60.3 -39.96 62.97 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.609 2.206 . . . . 0.0 113.463 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.924 HD12 ' HB3' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.72 -55.78 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.829 167.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.05 -17.11 50.9 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.894 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HE3' ' B' ' 13' ' ' LYS . 6.1 ttm105 -82.06 -37.93 25.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.295 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 3' ' ' LEU . 64.6 mt -58.31 -50.36 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.9 164.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.958 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.6 mm -68.72 -30.18 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.322 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' B' ' 10' ' ' ARG . 17.5 mtmt -61.98 -38.45 88.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.181 170.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -61.16 -30.56 70.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.884 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.83 -52.04 67.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.508 169.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.38 34.74 0.6 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.59 -164.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 44' ' ' ILE . . . -83.32 149.21 26.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.278 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.05 -25.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.984 169.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -106.21 34.24 3.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.307 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 55' ' ' ILE . 22.6 t -82.34 138.15 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.253 167.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.619 ' HB2' HG21 ' A' ' 54' ' ' THR . 31.2 t -80.05 152.31 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.386 163.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.2 -15.25 32.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.5 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.481 ' O ' HG22 ' B' ' 26' ' ' ILE . 9.2 t70 -90.31 -29.3 18.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.389 -171.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.704 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -68.28 -44.27 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.207 167.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -61.82 -43.98 97.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.279 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.482 ' CD1' ' HD3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -62.9 -49.5 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.256 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -62.27 -29.13 70.2 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.949 -170.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.883 HD13 HG23 ' A' ' 60' ' ' ILE . 3.8 tp -61.82 -42.73 99.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.943 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -64.12 -34.76 78.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.446 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -83.94 -41.51 17.28 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.687 -175.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.538 HD12 ' O ' ' B' ' 27' ' ' THR . 21.8 mt -60.45 -65.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.048 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.97 HD11 ' HA2' ' A' ' 36' ' ' GLY . 5.2 mt -55.81 -23.01 27.65 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.234 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.1 OUTLIER -61.6 -62.63 1.68 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.663 169.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.35 -20.95 63.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.888 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.5 mmt -66.32 -48.82 69.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.176 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -61.01 -46.04 95.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.911 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -33.93 74.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.255 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -59.74 -61.69 2.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.974 173.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.742 ' HB ' HD11 ' A' ' 28' ' ' LEU . 3.1 mt -61.14 -41.35 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.241 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.933 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -67.2 -53.44 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.308 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.581 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 30.6 t -63.82 -30.36 71.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.53 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.687 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 1.4 tm-20 -62.03 -62.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.904 170.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -60.92 -9.88 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.601 HD12 ' C ' ' B' ' 40' ' ' ALA . 39.1 mt -95.07 -48.23 12.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.783 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.05 -16.29 30.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.336 166.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.7 mt -82.84 -46.64 12.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -76.53 -32.66 58.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.247 -173.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -80.45 -32.67 37.2 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.367 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -60.4 -35.89 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.268 168.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.82 -50.39 73.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.18 165.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 41.26 23.55 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -130.61 -173.76 3.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.405 -167.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.513 ' O ' HG22 ' B' ' 54' ' ' THR . 5.0 mtmm -75.04 98.06 3.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.48 -165.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.8 t 60.34 -176.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.952 166.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.3 mt -112.05 142.24 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.428 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.546 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 3.3 mmmt -125.11 -176.68 3.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.384 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.3 93.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.289 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -31.43 71.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.256 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.546 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 3.1 m-20 -80.22 -36.38 34.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.409 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 27' ' ' THR . 1.0 OUTLIER -64.2 -47.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.607 174.368 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 7.9 mt-10 -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.138 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 8.6 tp -64.47 -51.93 60.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.378 171.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -66.88 -32.95 74.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 60' ' ' ILE . 41.5 t -61.54 -67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.715 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.59 4.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.772 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -73.97 -39.45 63.7 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.069 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' HG12 ' B' ' 39' ' ' ILE . 12.3 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.493 164.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HG2' ' HG3' ' A' ' 7' ' ' PRO . 7.5 Cg_endo -46.22 139.13 12.49 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.444 2.096 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.28 -8.26 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.915 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.25 -57.8 6.85 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.663 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -51.87 -60.39 0.79 Allowed 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.615 2.21 . . . . 0.0 113.584 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 3' ' ' LEU . 26.4 mt -61.02 -49.09 86.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.521 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.05 -22.88 63.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -171.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -82.74 -35.34 26.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.364 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.942 HG23 ' HG3' ' B' ' 37' ' ' ARG . 62.6 mt -59.69 -58.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.648 166.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.037 HG22 ' HB2' ' A' ' 17' ' ' ALA . 5.5 mm -61.94 -20.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.063 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 18' ' ' GLU . 3.6 mmmt -74.63 -36.77 62.91 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.299 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.85 -32.76 73.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.821 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.1 -53.41 58.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.383 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.51 17.62 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.316 -167.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -66.51 -163.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.678 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 61.6 24.2 14.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.612 -158.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -110.78 22.63 15.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 154.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.781 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 14.6 t -117.35 176.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.192 -162.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.605 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.6 t -125.08 168.37 13.47 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.526 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 65.6 m-20 -61.8 -25.75 67.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 3.4 t0 -61.19 -55.96 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.447 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -62.12 -52.73 62.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.329 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -61.07 -37.37 82.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.263 -168.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.38 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.422 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 31' ' ' ILE . 82.9 m -61.05 -44.7 97.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.245 -168.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.615 HD22 HG12 ' B' ' 60' ' ' ILE . 4.5 tp -59.79 -45.66 91.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.34 171.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -16.82 44.68 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.494 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 1.3 tptp -101.32 -26.15 13.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.326 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 27' ' ' THR . 1.6 mp -60.6 -68.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.792 161.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' B' ' 32' ' ' LEU . 3.7 mm? -58.48 -34.72 71.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.743 -168.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -74.24 -50.2 20.1 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.001 -175.383 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.0 tt0 -61.7 -44.09 97.59 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.952 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -35.16 75.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.574 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.37 -49.32 32.69 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -60.3 -14.28 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.417 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.4 t0 -88.8 -47.13 8.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.52 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.757 HD12 HD11 ' B' ' 32' ' ' LEU . 20.5 mt -60.64 -30.73 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.285 170.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.72 -74.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.304 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.94 -18.9 61.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.462 -174.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.9 mm-40 -69.22 -61.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.013 167.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -9.96 5.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.587 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.8 mt -94.26 -52.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.946 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -60.32 -10.65 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.487 167.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.8 mp -82.96 -47.05 12.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.217 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.19 96.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.355 167.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -54.53 27.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.375 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.48 -28.78 68.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.332 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.07 92.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.317 169.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.66 17.83 2.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HD3' ' NZ ' ' A' ' 56' ' ' LYS . 4.4 mmp_? -98.77 -167.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.4 -171.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -127.23 -37.05 2.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.398 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 ' O ' ' B' ' 19' ' ' ARG . 31.1 m -101.41 149.55 23.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.424 -168.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 44' ' ' ILE . 13.9 mm -91.44 137.8 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.365 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' NZ ' ' HD3' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -138.74 175.46 9.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.66 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.227 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.58 -40.47 69.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.111 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -33.67 71.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.399 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.652 ' CG1' ' HB1' ' B' ' 24' ' ' ALA . 44.5 mm -61.15 -69.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.29 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -61.66 -12.09 14.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.269 -170.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mt -75.47 -48.93 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.391 168.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -64.24 -35.72 81.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.361 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.001 HG21 HD13 ' B' ' 31' ' ' ILE . 25.0 t -66.09 -72.01 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.65 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -59.66 -11.16 4.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -169.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -29.36 14.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.367 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.514 ' CE2' HG12 ' A' ' 39' ' ' ILE . 1.5 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.445 163.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.661 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 2.4 Cg_endo -57.88 163.26 9.65 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.476 2.117 . . . . 0.0 113.509 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 pt -86.21 -25.25 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.4 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.64 -59.88 4.32 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.781 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 1.2 Cg_endo -54.48 -48.72 19.9 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 C-N-CA 122.498 2.132 . . . . 0.0 113.517 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' B' ' 3' ' ' LEU . 38.9 mt -61.03 -43.73 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.369 169.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -16.18 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.7 OUTLIER -96.38 -26.76 15.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.359 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -61.27 -56.02 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.325 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 40' ' ' ALA . 9.8 mm -64.04 -36.11 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.168 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.8 OUTLIER -62.68 -36.9 84.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.435 171.205 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.57 -34.2 76.5 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.777 -1.102 . . . . 0.0 109.817 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -59.26 -53.34 59.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.488 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.58 19.93 0.35 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.806 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.2 120.9 10.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.311 -0.445 . . . . 0.0 110.335 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.27 -74.65 0.34 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.048 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.669 ' O ' HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -122.19 109.25 14.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.407 -169.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.66 HG21 HH21 ' B' ' 25' ' ' ARG . 47.5 t -112.14 150.27 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.74 150.04 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.311 169.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.454 ' O ' HD12 ' B' ' 26' ' ' ILE . 2.4 p30 -60.85 -12.97 12.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.357 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -55.35 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -61.98 -40.69 96.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.304 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.66 HH21 HG21 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -61.61 -45.39 94.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.456 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.454 HD12 ' O ' ' B' ' 22' ' ' ASP . 51.8 mt -77.73 -21.56 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.422 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.754 HG22 HD11 ' B' ' 31' ' ' ILE . 88.3 m -72.79 -50.58 23.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.312 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' B' ' 31' ' ' ILE . 3.2 tp -59.19 -37.86 78.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.561 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.09 75.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.32 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -26.42 23.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.43 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 1.001 HD13 HG21 ' A' ' 64' ' ' VAL . 67.5 mt -61.04 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.033 170.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD12 ' A' ' 32' ' ' LEU . 7.2 mp -60.03 -38.34 82.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.715 -170.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.574 ' HG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.37 -30.09 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.929 -170.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.02 -45.45 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.122 167.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 33.9 mtt -61.43 -42.33 98.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.517 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.07 99.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -170.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.942 ' HG3' HG23 ' A' ' 11' ' ' ILE . 2.4 mtp180 -60.43 -35.35 75.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.552 171.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -77.95 -45.7 23.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.499 -167.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.614 HD13 ' CG2' ' B' ' 64' ' ' VAL . 11.9 mt -60.85 -35.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.099 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.905 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.65 -59.55 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.341 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.501 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 72.0 p -68.79 -24.33 64.39 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.224 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.588 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.5 OUTLIER -61.19 -55.93 26.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.041 165.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.468 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -65.82 -13.68 59.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.602 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.825 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -87.62 -56.46 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.309 -164.185 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -72.26 -17.29 61.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.467 172.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.507 HD12 ' C ' ' B' ' 42' ' ' GLU . 8.3 mt -60.83 -44.16 97.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.369 167.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.859 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.15 -44.02 97.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.362 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -50.99 25.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.43 -171.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -61.54 -34.29 75.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.32 91.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.335 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.1 29.99 5.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -110.46 135.63 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.404 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.88 -42.95 47.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.382 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 7.0 m -111.07 119.8 40.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.399 -168.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.859 HG12 ' HB2' ' B' ' 47' ' ' ALA . 79.9 mt -76.74 139.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.291 168.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.904 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 5.5 mtmt -141.8 -170.33 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.463 -169.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.76 -33.36 73.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.241 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -30.43 69.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.064 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.73 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.6 OUTLIER -84.19 -39.14 19.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.415 -166.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -65.2 -42.19 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.216 162.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 3.8 mt-10 -61.53 -31.15 71.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.977 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.7 -33.27 18.8 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.357 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.54 -42.9 97.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.436 172.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.44 -52.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -164.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.28 78.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.799 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.98 -17.93 54.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.9 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.327 173.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.84 ' CB ' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.4 Cg_endo -57.68 162.66 10.21 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.614 2.21 . . . . 0.0 113.545 170.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -84.82 -15.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.526 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.42 -58.59 14.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.762 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.5 Cg_endo -59.3 -57.65 0.85 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.595 2.197 . . . . 0.0 113.619 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.5 mt -61.71 -43.33 97.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.372 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' A' ' 25' ' ' ARG . . . -61.74 -41.06 99.56 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -72.82 -18.47 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.455 -174.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG23 ' HD2' ' B' ' 37' ' ' ARG . 69.7 mt -77.67 -41.18 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.53 172.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.5 mm -63.99 -43.96 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.149 171.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.8 mttt -62.07 -35.68 79.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.244 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.49 -31.15 71.12 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.845 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.63 -52.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.521 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.1 24.6 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.493 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -60.91 120.27 9.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.314 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -90.35 -48.02 7.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.189 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.52 90.43 2.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.501 168.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' B' ' 55' ' ' ILE . 97.8 t -96.41 129.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.126 166.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 p -60.84 146.2 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.546 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -61.16 -21.97 64.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.34 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.14 -27.17 64.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.42 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.797 ' O ' HG22 ' A' ' 27' ' ' THR . . . -78.06 -41.76 34.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.288 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -60.7 -45.7 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.503 172.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 19.9 mt -66.55 -27.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.437 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 24' ' ' ALA . 1.3 t -76.5 -33.19 58.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.228 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.771 HD22 HG21 ' B' ' 60' ' ' ILE . 1.1 mm? -59.9 -39.13 84.34 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.434 170.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -61.49 -42.05 98.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.396 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -25.69 24.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.415 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 27' ' ' THR . 17.4 mt -61.42 -72.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.925 165.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.816 -167.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HG3' HD11 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.29 -55.69 22.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 170.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.77 -32.82 73.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.966 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.521 ' HB3' HD21 ' B' ' 32' ' ' LEU . 3.0 tpp -66.36 -44.83 82.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.414 167.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.24 99.14 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -35.17 75.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.195 -0.503 . . . . 0.0 110.427 169.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -61.42 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.533 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 HG22 ' A' ' 64' ' ' VAL . 8.7 mt -61.79 -31.78 51.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.353 -171.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -66.86 -61.18 2.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.253 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.519 ' CB ' ' HB1' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -60.87 -10.52 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.412 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -81.37 -57.94 3.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.412 169.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 59' ' ' ASP . . . -66.01 -5.47 9.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.818 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.94 HD11 ' HB2' ' B' ' 17' ' ' ALA . 77.5 mt -85.95 -65.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.906 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -21.96 64.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.951 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 42' ' ' GLU . 8.4 mp -60.01 -57.18 13.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.21 158.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.746 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.87 -42.76 99.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.236 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -56.57 13.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.472 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -64.45 -23.7 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.419 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.11 -55.71 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.016 164.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.27 19.67 0.26 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 113.85 -1.523 . . . . 0.0 111.035 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.64 -167.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.358 -0.495 . . . . 0.0 111.012 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 98.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 -164.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.4 m 71.65 117.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.622 165.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.913 HD11 HG12 ' A' ' 44' ' ' ILE . 14.6 mt -71.76 147.72 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.614 157.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 27.9 mttt -141.97 160.63 39.83 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.323 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.99 -28.0 69.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.704 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -61.38 -41.02 96.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.977 166.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.842 ' CG ' ' HB1' ' A' ' 43' ' ' ALA 0.268 0.0 OUTLIER -67.6 -40.41 84.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.352 -173.865 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.903 HG23 HD13 ' B' ' 28' ' ' LEU . 45.7 mm -73.14 -36.12 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.288 -169.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -87.48 -17.56 31.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.157 177.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 58' ' ' GLU . 3.8 mm? -72.16 -47.17 52.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.104 164.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -64.84 -42.65 94.76 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.063 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.036 HG21 HD13 ' B' ' 31' ' ' ILE . 23.9 t -61.22 -73.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.616 171.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.85 -11.05 6.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.387 -167.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HD2' HD21 ' A' ' 46' ' ' LEU . 7.4 mtt180 -70.4 -47.58 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.314 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.311 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.815 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.486 0.66 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -50.48 152.86 8.29 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 122.617 2.211 . . . . 0.0 113.622 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 pt -85.28 -10.61 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.858 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.752 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.05 -62.69 1.76 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.781 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -53.93 -52.3 8.74 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.337 2.025 . . . . 0.0 113.505 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.815 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.3 mt -60.26 -38.43 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.461 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.77 95.17 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.622 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -80.7 -16.52 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.361 -0.42 . . . . 0.0 110.443 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' B' ' 8' ' ' ILE . 17.7 mt -80.15 -39.1 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.772 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 40' ' ' ALA . 20.1 mm -61.18 -46.99 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.243 168.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 5.7 mtpt -63.65 -36.93 85.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.225 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.4 -30.82 70.79 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.878 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.28 -53.4 58.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.681 169.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.06 30.4 0.27 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.707 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.94 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -88.44 -175.5 5.0 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 114.763 -0.718 . . . . 0.0 110.296 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.25 -72.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.047 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -99.11 122.01 41.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.354 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.838 HG11 ' CZ ' ' B' ' 25' ' ' ARG . 14.0 t -145.52 155.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.303 -166.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -93.2 149.51 21.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 167.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.85 -13.07 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.267 167.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m-20 -60.4 -59.64 5.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.529 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.688 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -63.8 -43.97 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.315 -175.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.924 ' NH2' HG21 ' B' ' 12' ' ' ILE . 5.3 mmt-85 -67.62 -33.32 74.74 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.486 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.25 -19.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.403 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 60' ' ' ILE . 89.5 m -71.77 -48.83 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.426 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.53 -46.86 88.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.404 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -61.99 -29.69 70.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.467 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -26.02 15.03 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.319 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 1.036 HD13 HG21 ' A' ' 64' ' ' VAL . 79.4 mt -60.87 -70.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.961 163.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.654 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.32 -27.23 67.17 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.551 -170.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.5 ' HG3' ' HG ' ' B' ' 3' ' ' LEU . 6.5 mt-10 -61.27 -47.2 87.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.203 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.8 -29.24 70.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.005 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -49.8 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.427 166.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.0 98.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.6 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.62 -32.4 71.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.393 170.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.2 t0 -64.47 -58.73 5.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.427 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.63 HG21 HG23 ' B' ' 64' ' ' VAL . 2.9 mt -65.61 -24.88 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.157 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.771 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -64.2 -75.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.312 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.513 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 p -61.43 -16.81 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.583 -171.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.512 ' HG3' ' CZ ' ' B' ' 67' ' ' PHE . 0.0 OUTLIER -72.45 -59.46 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.082 168.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.89 -12.72 11.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.41 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.689 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.6 mt -94.45 -50.34 11.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.724 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.27 -21.37 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.547 168.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -71.61 -46.67 58.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.391 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -45.09 14.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.387 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -61.55 -35.93 79.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.356 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.85 -46.83 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.35 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 29.46 6.91 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 174.04 7.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.343 170.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.18 151.29 48.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.389 -168.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 99.1 m 70.1 127.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.463 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.878 ' HB ' HG22 ' A' ' 20' ' ' VAL . 4.6 mp -87.58 140.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.265 166.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 ptpp? -137.65 -171.25 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 166.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.13 -16.91 49.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 1.3 tm-20 -90.15 -20.73 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.042 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.842 ' HB2' HG23 ' B' ' 55' ' ' ILE . 18.2 m-20 -81.06 -34.08 32.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.389 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.771 HG21 HD22 ' A' ' 28' ' ' LEU . 35.9 mm -60.53 -68.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.348 167.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.408 ' HA ' HG12 ' B' ' 64' ' ' VAL . 41.4 mt-10 -61.38 -15.29 34.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.772 -170.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 11.5 mt -68.31 -50.82 50.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.284 165.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.439 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -75.52 -56.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.861 -162.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -21.31 59.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.875 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -48.85 79.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.281 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' B' ' 39' ' ' ILE . 4.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.301 164.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.953 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.761 0 CA-C-O 121.647 0.737 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 20.4 Cg_endo -60.89 148.1 93.43 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.099 1.866 . . . . 0.0 113.469 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -115.87 -12.48 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.846 -175.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -70.14 -56.3 7.25 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.701 173.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -63.22 -51.8 2.49 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.586 2.191 . . . . 0.0 113.542 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.536 ' HA ' HD12 ' A' ' 11' ' ' ILE . 45.9 mt -60.88 -55.45 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.39 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -30.04 74.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -68.49 -36.33 78.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.397 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 8' ' ' ILE . 23.9 mt -60.63 -40.6 85.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.509 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.8 mm -68.09 -41.03 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.277 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.62 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.275 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -62.25 -35.11 77.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.855 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.842 ' HB1' ' CB ' ' B' ' 41' ' ' SER . . . -59.75 -53.09 62.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.428 169.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.74 24.99 0.28 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.583 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.87 129.15 40.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.393 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.64 -37.64 6.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.115 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 109.64 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.37 169.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 t -107.51 127.69 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.308 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 26.6 t -62.5 146.45 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.352 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -30.28 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.347 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.8 -45.83 92.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.432 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.783 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -65.73 -59.06 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.297 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 25' ' ' ARG . 11.5 ptm180 -62.55 -23.72 67.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -82.49 -32.72 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.564 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 60' ' ' ILE . 72.4 m -61.21 -39.36 89.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.397 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.883 HD22 HG13 ' B' ' 60' ' ' ILE . 0.4 OUTLIER -60.79 -45.03 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.135 170.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.953 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -61.35 -42.95 99.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.461 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.15 -25.29 55.15 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.224 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.738 HG21 HG21 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -61.82 -50.42 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.402 162.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.882 HD13 ' HG ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -58.63 -36.4 74.03 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.608 -172.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB2' HD21 ' A' ' 3' ' ' LEU . 22.3 tp10 -81.26 -41.37 22.31 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.978 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -86.34 -18.99 30.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.889 -170.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -44.35 48.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.9 160.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.29 99.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.696 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.38 -35.66 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.023 175.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -49.89 75.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.507 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 HG23 ' A' ' 64' ' ' VAL . 28.2 mt -61.62 -53.03 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.272 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.87 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -63.33 -47.83 80.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.28 -167.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.409 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 7.1 t -64.68 -19.93 66.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.156 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -78.67 -50.05 12.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.124 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.793 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -71.67 -32.05 67.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.987 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.5 mt -60.58 -44.06 95.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.935 161.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.57 -31.05 70.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.477 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 6.5 mt -80.47 -43.44 20.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.279 -169.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -60.75 -38.87 86.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.221 165.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.71 -47.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.37 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -34.47 74.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.446 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.72 83.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.242 168.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.61 43.66 5.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -168.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HG3' ' H ' ' A' ' 53' ' ' LYS . 4.3 tpt85 -119.45 160.8 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.334 -168.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -93.65 147.37 23.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.393 -177.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.503 ' N ' ' HG2' ' A' ' 53' ' ' LYS . 98.8 m 68.16 128.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.475 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 44' ' ' ILE . 41.1 mm -91.61 138.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.375 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -144.3 -171.76 3.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.316 -166.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -74.13 -38.94 63.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.21 -167.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.737 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.9 mp0 -61.34 -36.34 79.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.11 169.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -42.76 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.405 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.707 ' CG2' HD13 ' B' ' 28' ' ' LEU . 29.2 mm -61.11 -56.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.345 168.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.6 mt-10 -62.06 -22.8 66.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.931 -172.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -60.54 -52.6 64.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.312 165.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -60.25 -44.81 94.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.588 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.829 HG23 HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.91 -55.52 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.043 -160.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -29.18 68.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.74 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.381 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 11.0 m-85 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.419 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' B' ' 8' ' ' ILE . 14.5 mt . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.03 151.9 11.13 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.328 2.019 . . . . 0.0 113.547 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' B' ' 25' ' ' ARG . 1.1 pt -92.42 18.31 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.685 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -80.04 -58.67 0.59 Allowed Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.673 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.2 Cg_endo -58.65 -54.57 2.76 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.18 . . . . 0.0 113.496 168.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.787 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.4 mt -67.83 -23.84 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.386 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.11 97.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -86.9 -14.2 42.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.477 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mt -60.97 -49.57 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 163.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.982 HD11 HD23 ' B' ' 28' ' ' LEU . 5.7 mt -92.03 -19.69 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.484 -166.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 9.3 mttm -62.48 -41.63 98.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.459 159.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.62 -33.01 73.18 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.09 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.397 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.78 38.35 0.54 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.565 -163.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.917 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -79.8 164.09 23.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.767 -0.717 . . . . 0.0 110.26 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -132.0 -39.04 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.78 100.2 2.05 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.345 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.511 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -92.53 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.055 160.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.7 t -68.51 171.19 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.2 165.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 25' ' ' ARG . 0.5 OUTLIER -60.58 -22.34 63.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.407 172.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.8 m-20 -61.17 -61.67 2.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.48 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.4 -51.2 68.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.243 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.568 ' CZ ' HD13 ' B' ' 5' ' ' ILE . 1.4 ptm180 -60.89 -48.0 83.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.361 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 86.0 mt -62.08 -43.59 97.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.457 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.566 ' C ' HD12 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -63.18 -45.84 89.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 -167.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.982 HD23 HD11 ' B' ' 12' ' ' ILE . 1.9 tp -59.51 -33.69 71.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.665 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.669 ' O ' HD12 ' B' ' 3' ' ' LEU . . . -61.42 -41.55 97.34 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.311 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 -18.97 19.47 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.331 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.736 HG21 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -60.22 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.891 161.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.882 ' HG ' HD13 ' A' ' 32' ' ' LEU . 1.1 mp -58.49 -25.9 62.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.705 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.627 ' OE1' HD11 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.22 -56.97 14.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.011 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -30.6 70.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.935 -168.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.626 ' CG ' HD11 ' B' ' 39' ' ' ILE . 3.4 tpp -61.98 -45.08 95.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.297 164.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.51 -41.44 94.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.422 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 1.8 t70 -65.41 -57.46 8.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.493 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.713 ' CG1' HG23 ' B' ' 64' ' ' VAL . 1.9 mt -62.16 -29.42 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.872 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.28 -75.14 0.08 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.842 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -62.13 -12.71 21.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.454 -170.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -88.27 -44.52 10.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.23 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -66.64 -10.76 49.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.344 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.0 mt -95.39 -53.98 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.113 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -60.69 -21.36 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.468 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.9 mt -66.72 -63.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.429 168.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.05 75.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.22 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -38.23 51.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.419 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.63 -35.96 77.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.331 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' B' ' 52' ' ' ARG . . . -60.75 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.301 167.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 52.39 5.96 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -130.22 21.94 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.341 -169.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt 65.31 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.472 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 1.7 m -89.09 140.54 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.366 -167.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.615 HG23 ' HB3' ' B' ' 59' ' ' ASP . 3.6 mt -92.83 140.85 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.391 168.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.783 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.61 178.71 5.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.45 -169.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -22.48 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.376 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 4.4 tp10 -71.37 -22.44 61.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.166 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.3 OUTLIER -93.59 -35.4 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.297 -172.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.883 HG13 HD22 ' A' ' 28' ' ' LEU . 1.3 mp -64.2 -36.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.487 160.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 1.1 mt-10 -62.06 -46.23 90.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.84 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.42 -50.35 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.525 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.65 -56.61 19.22 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.521 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.738 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -64.2 -52.62 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.227 -170.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -60.49 -37.23 80.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.742 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' B' ' 66' ' ' ARG . 1.4 tpt180 -61.6 -40.57 95.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -171.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 1.2 m-85 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.398 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.866 HD21 HD11 ' B' ' 11' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 8.0 Cg_endo -61.31 144.14 98.41 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.472 2.115 . . . . 0.0 113.525 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.888 HD13 ' NH2' ' A' ' 25' ' ' ARG . 2.5 pp -64.96 -7.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.911 -169.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.19 -55.17 0.67 Allowed Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.81 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.5 Cg_endo -59.7 -49.8 9.36 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.469 2.112 . . . . 0.0 113.599 176.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.8 mt -60.83 -37.77 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.232 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.79 -16.03 44.27 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.564 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 3.8 tpp85 -96.3 -26.66 15.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' B' ' 3' ' ' LEU . 8.6 mm -60.28 -54.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.394 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 17' ' ' ALA . 8.1 mm -76.73 -35.88 25.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.271 -164.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -65.1 -34.62 78.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.338 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.33 -33.39 74.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.77 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.64 -54.18 50.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.461 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.19 30.4 0.31 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.613 -173.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -75.99 147.3 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.727 -0.737 . . . . 0.0 110.344 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' NH1' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -171.13 47.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.013 166.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -164.88 24.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.42 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 24' ' ' ALA . 37.3 t -85.85 119.65 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.31 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' ' CG2' ' B' ' 54' ' ' THR . 25.1 p -62.2 164.23 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.297 168.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 11.7 t70 -60.65 -21.89 63.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.535 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.594 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -90.04 -31.94 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.448 -168.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -69.39 -44.03 72.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.22 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.888 ' NH2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -73.99 -21.99 59.78 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.383 -173.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.743 ' O ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -83.45 -42.81 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.361 178.058 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.479 HG22 ' CG2' ' B' ' 60' ' ' ILE . 57.3 m -61.34 -38.49 87.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.447 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 3.6 tp -62.02 -41.37 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.131 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.58 98.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.354 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 2.4 tppt? -83.32 -29.05 28.62 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.396 -172.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.922 HD13 HG21 ' B' ' 64' ' ' VAL . 45.4 mt -60.53 -66.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.011 165.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.914 HD12 HD23 ' B' ' 32' ' ' LEU . 0.7 OUTLIER -58.15 -32.96 68.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.787 -169.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 1.8 pp20? -82.67 -30.96 28.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.081 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.5 mt-10 -61.64 -33.92 74.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -55.58 8.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.509 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -61.15 -45.11 97.2 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.2 ttp180 -60.69 -33.92 73.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.419 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.7 m-20 -66.76 -56.78 8.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.481 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 64' ' ' VAL . 4.5 mt -61.51 -26.1 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.289 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.664 ' CB ' HG23 ' B' ' 12' ' ' ILE . . . -61.82 -74.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.211 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.431 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 15.5 t -62.2 -12.88 22.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.351 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.55 -57.88 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.07 171.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.78 -10.49 5.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.595 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -98.89 -51.42 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.662 -174.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 12.2 ttpt -60.04 -10.58 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.348 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.738 HD22 ' HB2' ' A' ' 63' ' ' ALA . 3.8 mp -82.73 -42.6 17.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.246 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -68.74 -36.09 77.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -82.71 -43.93 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.415 -168.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.43 ' N ' ' HD3' ' A' ' 48' ' ' ARG . 7.1 m-70 -61.22 -23.86 65.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.191 168.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.94 -54.34 46.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.082 165.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.12 29.85 0.38 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.532 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.64 99.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.782 -0.709 . . . . 0.0 110.446 169.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.69 -169.08 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.297 168.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -65.22 125.53 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.378 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.623 HD12 HG22 ' B' ' 20' ' ' VAL . 44.6 mt -62.53 147.8 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.301 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -145.95 164.02 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.509 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.06 64.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.247 -168.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -58.14 9.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.034 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.89 -21.79 65.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.434 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.812 HG23 HD13 ' B' ' 28' ' ' LEU . 29.8 mm -72.68 -76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.224 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.546 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -62.74 -8.44 6.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.454 -176.011 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.12 -27.56 19.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.586 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.738 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -81.53 -31.98 32.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.005 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.786 HG21 HD13 ' B' ' 31' ' ' ILE . 25.7 t -60.64 -69.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.637 160.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -14.3 19.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.565 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -62.09 -51.12 69.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.358 167.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 54.0 m-85 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.537 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 11' ' ' ILE . 2.8 mt . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.325 0.584 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.412 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.1 Cg_endo -61.12 142.63 97.52 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 122.471 2.114 . . . . 0.0 113.558 167.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.703 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -67.78 -20.19 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.381 -170.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -61.35 -62.2 6.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.736 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.07 -50.56 13.52 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.455 2.103 . . . . 0.0 113.623 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' B' ' 3' ' ' LEU . 7.5 mt -62.22 -21.7 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.449 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.86 97.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.624 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -86.44 -15.32 40.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.522 -173.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 3' ' ' LEU . 11.1 mm -60.85 -73.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.234 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.812 HD13 HG22 ' B' ' 11' ' ' ILE . 8.0 mm -63.27 -20.96 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.936 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB3' ' NZ ' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -73.51 -36.35 65.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.391 172.016 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.92 -31.88 72.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.825 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.18 -52.64 64.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.455 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.96 33.5 0.51 Allowed Glycine 0 CA--C 1.527 0.783 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.607 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -77.45 147.1 36.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.28 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -106.48 -67.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.977 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 112.14 9.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.418 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.678 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 80.6 t -103.62 137.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.31 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 54.0 p -61.11 146.55 47.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.427 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH1' ' B' ' 25' ' ' ARG . 2.3 p30 -61.69 -24.4 66.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.412 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.575 ' HA ' HG22 ' B' ' 26' ' ' ILE . 4.9 t0 -84.04 -26.0 29.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.382 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.678 ' HB3' ' CG1' ' B' ' 20' ' ' VAL . . . -62.7 -45.05 94.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.171 168.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptt-85 -85.88 -13.27 48.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.554 -166.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.76 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -84.12 -38.33 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.444 168.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.472 HG22 HD11 ' B' ' 31' ' ' ILE . 59.4 m -61.33 -43.15 99.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.218 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.812 HD13 HG23 ' A' ' 60' ' ' ILE . 2.6 tp -60.22 -37.59 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.272 166.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.33 -43.04 99.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -82.2 -26.13 33.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.448 -177.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.786 HD13 HG21 ' A' ' 64' ' ' VAL . 34.7 mt -60.95 -71.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.99 -32.19 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.681 -166.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.7 pp20? -80.85 -39.68 26.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.175 -170.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 3.2 mm-40 -61.59 -39.23 90.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.007 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 4.8 mtp -61.0 -54.86 39.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.535 168.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.3 -45.81 95.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -165.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.845 ' HG3' HG23 ' A' ' 11' ' ' ILE . 9.2 mtp-105 -61.21 -32.33 72.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.235 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -61.5 -49.58 76.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.604 175.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.852 HD13 HG22 ' B' ' 64' ' ' VAL . 2.8 mt -62.06 -37.17 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.59 -69.0 0.27 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.315 -175.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 1.4 p -62.17 -10.27 10.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.498 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.4 OUTLIER -93.84 -50.78 5.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.279 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.72 -10.57 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.376 170.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 17' ' ' ALA . 87.4 mt -101.24 -50.77 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.752 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -60.42 -11.71 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.463 168.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.498 HD12 ' C ' ' B' ' 42' ' ' GLU . 6.0 mt -83.97 -54.05 5.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.395 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.22 -21.15 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.386 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -44.91 15.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.311 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -60.41 -30.51 69.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.398 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.64 -49.78 76.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.423 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.26 37.6 0.79 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -168.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mtt85 66.05 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.492 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -130.77 -177.65 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.351 167.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 21' ' ' SER . 87.7 m -78.16 130.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.468 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.678 HG22 ' HB1' ' A' ' 24' ' ' ALA . 13.5 mm -69.97 134.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.249 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.516 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -139.73 175.51 9.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.527 -171.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -25.37 67.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.279 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.441 ' C ' HD12 ' B' ' 62' ' ' LEU . 0.6 OUTLIER -62.17 -63.59 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.11 169.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -61.06 -12.44 11.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.468 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 31' ' ' ILE . 41.4 mm -88.39 -57.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.178 -177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 9.6 mt-10 -61.48 -16.89 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.177 170.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -67.56 -59.73 3.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.324 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.77 71.75 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.119 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.922 HG21 HD13 ' A' ' 31' ' ' ILE . 43.4 t -61.61 -71.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.693 169.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -61.16 -9.17 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.497 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.51 48.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.296 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 38.1 m-85 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.34 171.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 mt . . . . . 0 C--O 1.242 0.688 0 CA-C-O 121.511 0.672 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.29 148.8 13.62 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.341 2.027 . . . . 0.0 113.285 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.559 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.1 pp -93.03 20.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.628 -167.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.53 -59.54 0.31 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.68 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.7 Cg_endo -53.05 -50.46 14.0 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.493 2.129 . . . . 0.0 113.522 172.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 29' ' ' ALA . 86.3 mt -69.05 -30.36 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.382 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.04 99.66 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.47 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -78.25 -31.91 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.353 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' ILE . 85.5 mt -60.81 -40.05 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.379 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.945 HG23 ' HB1' ' B' ' 40' ' ' ALA . 12.1 mt -97.86 -15.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.516 -162.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -38.1 85.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 158.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.85 -33.57 76.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.022 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.85 -52.11 66.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.483 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.0 25.15 0.2 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.772 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -76.09 152.4 36.81 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 114.665 -0.768 . . . . 0.0 110.262 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 -42.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.194 169.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 113.56 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.421 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.714 HG13 ' HB ' ' B' ' 55' ' ' ILE . 22.4 t -137.3 161.93 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.393 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 81.8 p -88.42 133.93 33.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.414 169.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.99 -25.4 68.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.358 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.93 -36.38 79.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.421 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -63.17 -52.67 61.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.272 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.636 HH21 HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -68.82 -18.0 64.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.477 -168.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.25 -37.79 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.44 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 HG21 ' B' ' 60' ' ' ILE . 94.6 m -60.74 -32.29 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.457 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.947 HD22 HG13 ' B' ' 60' ' ' ILE . 10.9 tp -92.03 -33.74 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.024 -171.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 8' ' ' ILE . . . -61.02 -41.9 97.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.153 166.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -36.11 83.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.517 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.631 HG21 HG21 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.135 -167.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' B' ' 32' ' ' LEU . 2.8 mp -65.71 -57.61 7.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.507 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.808 ' HG2' HD13 ' B' ' 11' ' ' ILE . 9.5 tm-20 -61.47 -32.97 72.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.166 -166.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -40.25 95.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.93 170.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt -65.17 -38.02 89.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.581 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.653 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -76.98 -40.54 25.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -24.41 66.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.165 164.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -60.6 2.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.514 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.855 ' HB ' HD11 ' B' ' 28' ' ' LEU . 5.0 mt -61.37 -31.73 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.3 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.887 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.43 -61.36 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.347 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.516 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.6 -27.35 68.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.33 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 46' ' ' LEU . 43.3 mt-10 -61.13 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.011 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -72.28 -12.24 61.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.576 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.815 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -85.86 -56.67 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.268 -168.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD2' ' NH2' ' A' ' 48' ' ' ARG . 20.5 ttpp -66.52 -19.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.457 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -60.88 -44.05 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.294 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.6 -58.83 6.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.401 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' NH2' ' HD2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -71.07 -28.8 64.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.304 -165.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -60.54 -39.69 88.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.324 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -54.98 39.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.007 164.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.74 32.85 0.31 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.583 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 69.42 -87.89 0.03 OUTLIER 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.769 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt 58.44 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.055 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -157.8 168.47 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.129 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 47' ' ' ALA . 6.7 mm -82.44 137.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.214 165.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.22 155.87 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.418 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.33 -29.2 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.236 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 62' ' ' LEU . 7.9 mm-40 -61.54 -42.43 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 169.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.03 -43.12 79.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.487 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.731 HG23 HD13 ' B' ' 28' ' ' LEU . 44.7 mm -61.24 -45.72 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.499 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.74 -28.47 60.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.106 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 58' ' ' GLU . 6.4 mp -66.08 -43.3 87.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.31 169.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.49 -41.44 97.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.4 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -83.81 -55.08 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.143 -169.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -27.61 66.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.839 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -69.8 -36.29 75.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.377 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 3.9 mt . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.47 0.652 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -58.02 144.44 94.59 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.368 2.046 . . . . 0.0 113.509 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.595 HD13 ' NE ' ' B' ' 25' ' ' ARG . 1.4 pp -93.08 -24.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.375 -168.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.569 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -64.98 -56.39 21.12 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.8 Cg_endo -48.37 -53.83 6.2 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 122.507 2.138 . . . . 0.0 113.446 171.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.463 ' HA ' HD12 ' B' ' 11' ' ' ILE . 36.2 mt -61.1 -33.95 58.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.514 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -29.04 71.17 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 11.6 mtp-105 -87.88 -28.29 21.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.795 -0.703 . . . . 0.0 110.494 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 33' ' ' GLU . 65.5 mt -60.9 -53.07 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.419 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 40' ' ' ALA . 7.0 mm -63.87 -37.88 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.259 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 3.1 mtpm? -61.49 -35.78 78.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.265 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.82 -32.43 72.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.794 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.6 -53.58 56.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.506 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.92 21.61 0.29 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.956 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.815 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.21 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.275 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -167.69 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.048 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -130.8 98.98 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.459 168.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 58.3 t -106.22 145.21 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.322 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.7 p -70.06 155.99 39.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.321 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -32.09 72.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.353 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m-20 -61.56 -48.47 80.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.407 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.689 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.04 -52.35 64.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.274 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.595 ' NE ' HD13 ' B' ' 5' ' ' ILE . 0.4 OUTLIER -61.25 -38.36 86.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.274 -168.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -67.01 -37.61 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.47 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.645 HG22 HD11 ' B' ' 31' ' ' ILE . 84.5 m -61.08 -52.26 65.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.421 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 39' ' ' ILE . 4.1 tp -61.1 -42.3 98.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.335 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -60.76 -28.17 68.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.416 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -26.29 18.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.729 HG21 HG21 ' A' ' 64' ' ' VAL . 17.8 mt -60.87 -71.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.985 166.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.659 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.6 mp -59.44 -30.15 68.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.595 -168.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.535 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 7.1 tm-20 -75.83 -30.66 59.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.09 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.37 -44.79 96.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.065 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 12.6 mtt -62.37 -39.62 93.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.407 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -39.41 73.86 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -29.39 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 168.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.531 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.7 OUTLIER -82.31 -52.53 6.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.482 -169.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.672 HG12 HG23 ' B' ' 64' ' ' VAL . 5.6 mt -61.32 -34.28 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.185 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.945 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -77.6 -44.4 28.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.168 -164.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 4.4 t -70.62 -13.82 62.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.422 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.657 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 2.8 mm-40 -83.11 -44.76 14.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.993 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' B' ' 59' ' ' ASP . . . -80.59 -11.1 59.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.339 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ALA . 72.7 mt -93.85 -49.16 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -60.69 -24.1 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.344 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.945 HD22 HD23 ' B' ' 62' ' ' LEU . 2.9 mt -68.15 -54.13 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.367 170.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.639 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.13 -28.83 69.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.382 -167.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.46 -44.97 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.388 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -61.43 -37.36 83.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.327 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.5 75.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.197 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.92 47.86 4.33 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -165.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.67 -43.6 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.338 -166.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.58 118.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.473 -168.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 7.3 m 68.53 139.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.489 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.714 ' HB ' HG13 ' A' ' 20' ' ' VAL . 26.6 mt -105.19 163.21 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.374 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 mtmt -149.51 166.24 29.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 -169.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -12.96 26.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.256 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 26.9 mt-10 -86.44 -19.0 30.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.078 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.548 ' HB3' ' HB1' ' B' ' 43' ' ' ALA . 0.8 OUTLIER -82.53 -33.71 28.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.288 174.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.947 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.88 -56.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.67 161.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 3.0 mt-10 -61.31 -30.29 70.4 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.71 -168.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.945 HD23 HD22 ' B' ' 46' ' ' LEU . 12.0 tp -76.32 -46.69 26.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.639 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -61.27 -24.11 66.16 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.416 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.672 HG23 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -110.65 -55.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -160.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -10.7 2.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.668 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -92.9 -65.64 0.98 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.613 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -155.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.577 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 3.5 Cg_exo -65.77 159.95 46.06 Favored 'Trans proline' 0 N--CA 1.484 0.967 0 C-N-CA 122.932 2.421 . . . . 0.0 113.542 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 2.6 pp -93.47 -26.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.394 -166.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.57 -56.49 9.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.698 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.0 Cg_endo -60.47 -47.65 13.5 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.121 1.881 . . . . 0.0 113.513 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.4 mt -60.87 -34.69 60.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.271 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.52 -26.82 65.02 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.541 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -84.35 -27.25 27.86 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.326 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.52 -58.44 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.454 169.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.705 HG23 ' CB ' ' B' ' 40' ' ' ALA . 8.7 mm -65.62 -42.64 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.198 -166.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -31.95 72.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.34 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.28 -33.71 75.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.756 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.27 -53.66 55.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.447 169.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.76 19.46 0.57 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.711 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.66 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.281 165.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.041 167.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.67 110.53 22.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.347 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' B' ' 55' ' ' ILE . 45.7 t -145.78 148.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.353 -169.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 p -87.45 154.78 20.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.383 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 9.5 p30 -61.14 -31.46 71.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.472 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.1 m-20 -83.87 -25.3 30.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.397 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -61.03 -40.08 92.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.252 168.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 5' ' ' ILE . 5.8 mtt180 -66.64 -47.53 72.27 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.476 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.715 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 tp -65.16 -35.99 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.356 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.785 ' O ' HD12 ' A' ' 31' ' ' ILE . 13.3 m -61.16 -53.68 53.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.293 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.889 HD22 HG13 ' B' ' 60' ' ' ILE . 6.0 tp -60.86 -9.82 4.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.251 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -84.52 -58.55 2.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.423 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -61.77 -26.12 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.22 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 27' ' ' THR . 2.3 mp -60.87 -74.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.961 161.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.765 ' O ' HD21 ' B' ' 32' ' ' LEU . 2.3 mm? -57.79 -30.1 65.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.617 -161.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.787 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.19 -44.18 47.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.262 178.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.58 -37.05 73.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.09 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 23.8 mmt -61.29 -40.48 94.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.38 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.32 -47.23 72.81 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -60.66 -17.72 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.458 171.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -86.83 -49.94 7.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.385 -173.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.818 ' HB ' HD11 ' B' ' 28' ' ' LEU . 4.8 mt -61.81 -23.84 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.081 171.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.674 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.87 -73.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.358 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.622 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 30.2 m -61.57 -13.05 18.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.312 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.67 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -78.47 -57.14 3.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.329 170.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.42 -11.9 12.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.529 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.862 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -96.81 -51.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.791 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -60.21 -15.6 25.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.459 167.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' ALA . 8.3 mt -79.17 -41.1 29.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.46 171.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.751 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -61.23 -17.98 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.24 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 -48.01 7.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.49 170.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.75 -14.6 33.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.395 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.63 -48.56 7.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.271 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 42.15 3.42 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -165.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.99 160.47 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.356 -165.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -117.27 145.81 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.307 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.884 HG23 ' HG3' ' B' ' 19' ' ' ARG . 3.8 m 69.83 158.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -168.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.751 HD13 ' HB2' ' A' ' 47' ' ' ALA . 11.0 mm -109.48 160.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.462 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -143.42 173.57 11.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.339 -168.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -72.83 -16.7 61.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.403 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 4.9 mm-40 -80.69 -14.35 58.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.264 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 73.9 m-20 -88.04 -40.4 13.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.307 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.817 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.5 -47.25 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.823 162.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 6.3 mt-10 -61.74 -42.22 98.68 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.983 -166.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.18 -28.71 27.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.433 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.67 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -60.26 -43.62 96.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.452 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.699 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.55 -55.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.009 -164.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -60.22 -24.61 64.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -14.96 23.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.462 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 46.0 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.409 171.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.829 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -61.33 149.6 88.69 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.599 2.199 . . . . 0.0 113.597 166.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.677 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -63.3 -13.14 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.786 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -72.89 -57.49 3.04 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.1 Cg_endo -54.94 -59.42 0.82 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.643 2.229 . . . . 0.0 113.596 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.829 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.7 mt -61.63 -49.05 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.371 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.71 -27.54 68.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 13.1 tpt180 -78.14 -26.55 47.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.509 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 3' ' ' LEU . 66.4 mt -69.88 -46.54 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.491 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.4 mm -64.41 -38.97 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.191 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.65 -35.32 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.376 168.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -62.16 -33.6 74.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.729 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -59.16 -53.5 57.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.358 169.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.2 14.65 0.62 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.256 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.862 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.59 147.54 41.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.318 162.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -55.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.114 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.884 ' HG3' HG23 ' A' ' 54' ' ' THR . 4.7 tpt180 -101.94 104.89 15.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.4 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -133.83 146.76 31.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.375 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 35.7 p -85.37 143.11 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.448 170.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -71.83 -28.46 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.31 -170.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -34.48 74.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.47 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -61.27 -54.04 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.258 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.512 ' HD3' ' HB ' ' B' ' 5' ' ' ILE . 5.7 mtt180 -64.96 -12.59 51.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.463 -170.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.752 HG22 ' HD2' ' B' ' 30' ' ' LYS . 86.4 mt -103.64 -25.63 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.447 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.811 ' O ' HD12 ' B' ' 31' ' ' ILE . 81.8 m -63.41 -44.06 95.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 39' ' ' ILE . 1.9 tp -59.92 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.295 172.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.13 -38.19 85.5 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.561 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.752 ' HD2' HG22 ' B' ' 26' ' ' ILE . 3.3 mtpt -80.41 -28.52 37.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.203 -173.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.811 HD12 ' O ' ' B' ' 27' ' ' THR . 2.7 mt -60.81 -70.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.996 160.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.75 -16.76 18.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.723 -166.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.18 -37.65 12.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.083 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 11.4 mt-10 -61.27 -57.64 11.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.254 171.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' B' ' 32' ' ' LEU . 19.0 ptp -62.33 -28.7 69.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.343 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.18 -46.24 51.52 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.566 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -14.54 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -89.97 -51.06 5.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.534 -173.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.685 HD13 ' CG2' ' B' ' 64' ' ' VAL . 6.8 mt -61.96 -26.3 39.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.053 171.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -62.14 -68.41 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.212 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.498 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 86.6 p -61.1 -10.65 6.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.534 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.0 OUTLIER -95.54 -36.04 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.035 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.515 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -75.52 -9.93 59.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.373 167.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 58.0 mt -98.6 -49.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.923 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' B' ' 48' ' ' ARG . 10.9 mttp -60.27 -27.79 67.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.453 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' B' ' 63' ' ' ALA . 10.0 mt -61.5 -55.44 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.346 166.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.715 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.33 -31.36 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.312 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.496 ' HG2' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -74.3 -38.13 63.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.408 178.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.444 ' N ' ' HG3' ' B' ' 48' ' ' ARG . 38.2 t-80 -60.55 -32.28 71.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.229 168.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.36 -53.97 51.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.28 170.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.94 23.96 0.75 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.775 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 56.0 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.1 0.476 . . . . 0.0 111.914 169.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -67.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.391 168.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.48 HG22 ' N ' ' B' ' 55' ' ' ILE . 93.6 m -146.28 166.47 26.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.364 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.941 HG23 ' HB3' ' B' ' 59' ' ' ASP . 65.7 mt -119.4 146.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.408 170.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -137.91 -172.92 3.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.424 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.45 -16.41 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.646 ' O ' HD13 ' B' ' 62' ' ' LEU . 0.1 OUTLIER -79.36 -25.32 42.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.102 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.941 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -85.94 -35.51 20.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.281 -176.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.889 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.77 -46.4 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.705 160.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -62.09 -40.29 95.34 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.823 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.646 HD13 ' O ' ' B' ' 58' ' ' GLU . 7.5 mp -74.76 -45.38 44.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.55 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.37 -31.81 71.71 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.387 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -95.16 -54.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.983 -165.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -16.68 34.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.697 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -11.81 15.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 3.2 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.278 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 121.991 0.9 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.485 0.659 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 33' ' ' GLU . 11.5 mt . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 5.2 Cg_endo -58.96 148.93 82.46 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.392 2.061 . . . . 0.0 113.44 167.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 2.5 pp -85.1 -28.91 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -62.14 -62.22 6.21 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.779 -171.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -51.89 -46.24 33.46 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.48 2.12 . . . . 0.0 113.588 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.45 ' HA ' HD12 ' A' ' 11' ' ' ILE . 59.9 mt -61.18 -59.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.76 -26.76 67.35 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.0 -32.97 61.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.348 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.2 mt -60.76 -40.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.493 169.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' B' ' 40' ' ' ALA . 19.4 mm -66.51 -34.58 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.405 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -29.93 65.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.392 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -62.6 -35.52 79.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.811 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.49 -53.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.395 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.63 18.46 0.32 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.834 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.81 142.2 56.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.311 165.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.66 -33.58 3.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.117 -169.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 88.09 1.91 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.486 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.787 HG22 HD12 ' B' ' 55' ' ' ILE . 23.5 t -114.91 133.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.381 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -92.02 157.73 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.434 -169.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.02 -49.02 79.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.375 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -44.33 96.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.335 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 5.6 mtt180 -63.31 -47.21 83.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.434 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 mm -60.69 -32.79 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.506 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.3 m -67.66 -43.08 81.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.335 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.5 OUTLIER -61.32 -34.13 74.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.314 177.014 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.75 -47.92 23.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.203 -168.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.77 -32.8 72.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.32 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.87 HG21 HG21 ' B' ' 64' ' ' VAL . 13.0 mt -60.91 -77.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.935 164.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.89 -29.06 64.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.718 -160.318 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 3' ' ' LEU . 2.1 pp20? -75.51 -41.82 54.28 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.165 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -68.16 -25.15 65.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.02 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.45 -33.6 31.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.478 174.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.03 -39.47 84.59 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.97 -33.54 73.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.261 165.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 1.6 t0 -64.57 -60.88 2.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.432 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 64' ' ' VAL . 15.3 mt -61.17 -29.31 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.506 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.863 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.33 -63.45 1.28 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.261 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 88.5 p -61.66 -26.76 68.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.158 -175.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 46' ' ' LEU . 28.4 mm-40 -61.05 -45.74 93.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.029 163.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -76.14 -8.14 56.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.903 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -90.7 -55.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.999 -169.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -20.97 66.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.636 168.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.0 mp -61.16 -58.17 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.442 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -61.69 -22.04 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.19 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.472 HH12 HG23 ' A' ' 44' ' ' ILE . 21.4 ttp-105 -97.04 -31.44 12.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.267 -168.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -34.43 74.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.189 167.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -61.12 -49.99 75.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.034 164.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 41.06 59.76 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -166.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -129.19 -166.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.344 -164.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 118.41 36.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.28 -165.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' B' ' 21' ' ' SER . 95.0 m 67.79 161.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.383 165.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 47' ' ' ALA . 80.4 mt -100.93 147.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.54 173.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -145.85 -171.35 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.374 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.87 -42.48 99.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.322 -169.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.757 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -61.99 -23.53 66.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.094 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 10.6 m-20 -81.14 -55.78 4.53 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.862 HG23 HD13 ' B' ' 28' ' ' LEU . 44.8 mm -61.09 -37.64 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.366 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.49 -45.88 92.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.1 mm? -62.76 -45.72 91.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.467 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.64 -30.33 70.64 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.361 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.84 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -62.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.16 -164.199 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -60.4 -18.36 50.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.595 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.7 tpt85 -64.39 -76.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.274 168.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.044 -159.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.845 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.511 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.5 Cg_endo -59.41 140.32 93.74 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.623 2.216 . . . . 0.0 113.553 167.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' B' ' 25' ' ' ARG . 23.7 pt -77.04 -11.54 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.679 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.93 -64.03 0.81 Allowed Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.787 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -51.29 -45.78 35.14 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.104 1.87 . . . . 0.0 113.279 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' B' ' 3' ' ' LEU . 28.0 mt -60.03 -43.82 93.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.493 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.67 99.73 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.571 -172.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.6 -22.34 50.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.437 -174.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' B' ' 8' ' ' ILE . 55.0 mt -68.24 -41.41 83.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.328 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.863 HD13 ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm -61.46 -40.35 86.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.104 167.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 26.4 mtpp -62.21 -31.81 72.39 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.051 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -62.35 -31.91 72.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.683 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.62 -53.94 52.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.413 170.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 24.44 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.686 -172.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.847 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.3 -171.35 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.287 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -153.18 -38.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.953 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 104.0 4.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.763 HG21 HG21 ' B' ' 12' ' ' ILE . 11.4 t -101.16 102.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.179 167.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 54' ' ' THR . 45.9 t -62.13 177.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.399 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.8 OUTLIER -61.01 -34.58 75.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.315 -171.038 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 10.2 m-20 -60.99 -58.72 7.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.519 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.634 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.92 -45.16 93.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.654 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.0 ptp180 -61.91 -37.67 85.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.364 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.502 HG13 ' HG3' ' B' ' 25' ' ' ARG . 41.8 mt -75.78 -36.29 32.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.575 HG22 HD11 ' B' ' 31' ' ' ILE . 97.8 m -60.82 -52.36 65.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.392 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.862 HD13 HG23 ' A' ' 60' ' ' ILE . 4.8 tp -60.53 -47.14 87.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.447 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.1 70.41 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.31 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.69 -24.81 23.76 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.461 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 64' ' ' VAL . 46.5 mt -61.9 -75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.965 165.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.714 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.5 mp -59.66 -20.78 58.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.729 -165.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.81 -57.73 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.193 170.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -38.02 89.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.024 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 6.0 ttp -60.71 -28.59 68.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.436 169.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.7 -45.85 16.19 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.421 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.42 -14.28 18.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.137 -0.531 . . . . 0.0 110.459 167.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -91.32 -51.94 5.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.412 -171.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' B' ' 64' ' ' VAL . 5.4 mt -61.42 -22.35 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.308 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -63.1 -73.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.305 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 84.3 p -61.33 -13.79 22.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.536 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -78.2 -56.99 4.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.055 170.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.08 -12.6 12.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.392 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 17' ' ' ALA . 73.3 mt -94.97 -51.8 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.106 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -60.67 -31.66 70.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.42 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.744 HD22 ' HG ' ' B' ' 62' ' ' LEU . 28.7 mt -60.66 -52.7 64.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.503 170.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.58 -36.44 80.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.262 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.8 -40.71 98.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.378 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -61.09 -38.03 84.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.414 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.94 -51.52 68.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.131 167.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.6 36.92 0.7 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.453 -164.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 62.85 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.651 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.11 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.832 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.9 m -157.57 167.39 30.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.106 165.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.787 HD12 HG22 ' A' ' 20' ' ' VAL . 24.0 mt -106.89 132.38 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.35 166.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -142.65 -176.21 4.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.458 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -26.78 68.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.314 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.53 -52.71 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.026 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.26 -24.48 63.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.303 -170.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.795 ' CG2' HD22 ' A' ' 28' ' ' LEU . 38.0 mm -75.51 -48.37 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.465 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.83 -30.4 70.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.026 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.744 ' HG ' HD22 ' B' ' 46' ' ' LEU . 14.8 tp -64.05 -50.05 69.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.394 169.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.727 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.28 -41.09 96.37 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.365 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.87 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -89.1 -57.83 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.172 -162.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -59.89 -25.84 65.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.793 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -29.94 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.409 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.468 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 121.991 0.9 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.485 0.659 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.036 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 6.3 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 121.936 0.874 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 10.7 Cg_endo -61.16 142.18 95.94 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.144 2.563 . . . . 0.0 113.656 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 1.3 pp -95.49 -25.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.448 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.739 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.82 -56.51 31.58 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.7 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 6.7 Cg_endo -58.32 -55.6 2.09 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.592 2.195 . . . . 0.0 113.565 175.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 11' ' ' ILE . 51.7 mt -61.48 -45.08 99.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.492 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.497 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.76 -38.07 95.33 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -21.94 39.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.406 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 8' ' ' ILE . 54.9 mt -62.63 -50.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.405 168.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.667 HG23 ' CB ' ' B' ' 40' ' ' ALA . 18.7 mm -63.47 -41.33 92.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.373 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -62.86 -34.29 77.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.298 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.46 -33.8 75.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.787 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.16 -53.02 63.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.488 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.55 18.84 0.38 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 136.9 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.515 -0.342 . . . . 0.0 110.189 164.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.29 -25.42 8.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -168.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 92.91 1.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HD12 ' B' ' 55' ' ' ILE . 16.8 t -117.82 134.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.395 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -93.03 155.77 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.376 -170.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.11 -17.66 53.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.373 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -63.41 -50.24 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.441 168.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.662 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -62.09 -44.55 96.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.277 -174.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.512 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 4.9 mtt180 -61.45 -50.5 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.73 -31.9 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.536 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.58 ' O ' HD12 ' A' ' 31' ' ' ILE . 85.9 m -66.23 -43.25 87.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.3 OUTLIER -61.22 -32.07 71.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.266 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.036 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -78.13 -46.36 20.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.189 -168.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -60.84 -32.79 72.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.285 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.04 HG21 HG21 ' B' ' 64' ' ' VAL . 11.0 mt -60.83 -75.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.956 164.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.73 -28.19 63.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.735 -162.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' HD13 ' A' ' 3' ' ' LEU . 1.9 pp20? -77.11 -46.12 24.62 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.017 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.39 -26.54 67.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.055 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -73.59 -36.52 65.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.537 171.011 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.72 -42.27 71.6 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 9.8 ttp180 -60.95 -25.73 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.35 -0.425 . . . . 0.0 110.399 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -73.46 -59.28 2.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.509 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.71 HD12 HD11 ' B' ' 32' ' ' LEU . 7.8 mt -62.64 -20.04 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.24 -71.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.355 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 44' ' ' ILE . 85.8 p -61.56 -25.38 67.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.236 -172.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.8 mm-40 -61.71 -54.24 45.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.081 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -67.85 -10.32 52.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.775 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -89.39 -57.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.225 -167.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -64.89 -19.06 65.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.577 169.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -61.34 -55.78 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.323 168.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.61 -23.11 65.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.265 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' NH2' ' HG3' ' A' ' 45' ' ' LYS . 23.3 ttp-105 -100.76 -30.24 11.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.308 -165.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -34.95 75.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.127 165.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -60.88 -50.74 72.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.977 163.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.46 43.25 78.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -165.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.723 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -134.03 -166.74 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.329 -161.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.469 -165.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -60.57 168.66 2.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.507 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.661 ' HB ' HG22 ' B' ' 20' ' ' VAL . 26.6 mt -71.57 137.07 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.405 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -145.05 -175.7 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.358 -167.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.41 -47.99 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.258 -169.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.749 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.41 -24.92 67.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.979 -176.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.96 -53.11 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.373 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.781 HG23 HD13 ' B' ' 28' ' ' LEU . 43.5 mm -65.82 -39.61 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -168.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.75 -41.96 98.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.05 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.4 mm? -62.56 -47.12 85.27 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.341 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.61 -31.45 71.52 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.379 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.81 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -61.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.812 0.815 . . . . 0.0 109.029 -162.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -60.16 -19.07 52.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.667 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -63.3 -77.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.146 168.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.122 -159.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.916 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.0 Cg_endo -59.87 140.01 90.98 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.544 2.163 . . . . 0.0 113.528 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' B' ' 25' ' ' ARG . 33.0 pt -78.52 -10.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.631 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.7 -61.19 1.41 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.8 Cg_endo -55.49 -45.95 35.86 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 122.443 2.096 . . . . 0.0 113.453 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.916 HD11 ' HB3' ' B' ' 3' ' ' LEU . 31.0 mt -60.32 -44.56 96.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.459 172.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.25 97.32 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.549 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' B' ' 7' ' ' PRO . 0.0 OUTLIER -77.19 -23.26 51.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 0.0 110.503 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' B' ' 8' ' ' ILE . 64.8 mt -67.85 -48.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.461 170.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -61.92 -33.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.037 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 27.0 mtpp -61.34 -33.88 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.209 171.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.6 -32.78 73.85 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.638 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.86 -53.32 59.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.429 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.11 21.34 0.78 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.974 -170.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.833 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -65.63 147.03 54.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.34 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -40.79 3.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.045 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -148.55 139.14 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.507 168.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 55' ' ' ILE . 88.8 t -129.45 113.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.205 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -62.28 174.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.381 -166.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.9 OUTLIER -61.67 -32.29 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.371 -177.153 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 4.3 m-20 -64.2 -55.55 20.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.468 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.666 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.12 -48.0 82.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.301 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.6 ptp180 -61.03 -37.85 84.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.394 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.443 HD12 ' O ' ' B' ' 22' ' ' ASP . 34.3 mt -72.05 -36.56 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.49 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.569 HG22 HD11 ' B' ' 31' ' ' ILE . 97.9 m -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.365 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.781 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.94 -47.04 88.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.383 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.98 70.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.384 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -87.15 -26.14 23.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.494 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.81 HG21 HG21 ' A' ' 64' ' ' VAL . 37.8 mt -61.83 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.015 165.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.774 ' HB3' HD23 ' A' ' 32' ' ' LEU . 6.0 mp -59.6 -17.45 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -53.43 10.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.139 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 -40.43 88.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.045 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.526 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 10.0 ttp -60.82 -28.68 68.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.477 170.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.79 -46.23 18.63 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.44 -13.88 16.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.534 167.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -91.22 -51.28 5.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.418 -172.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.54 ' CG2' HG23 ' B' ' 64' ' ' VAL . 4.8 mt -61.6 -21.32 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.271 170.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.667 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -63.22 -73.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.315 172.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 81.8 p -61.45 -13.94 24.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.503 -173.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.489 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -77.92 -56.95 4.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 170.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.2 -13.18 16.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.323 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.812 HD11 ' HB2' ' A' ' 17' ' ' ALA . 81.4 mt -95.55 -51.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.96 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -60.67 -32.97 72.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.45 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' B' ' 62' ' ' LEU . 20.9 mt -60.47 -51.5 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.551 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.5 -36.04 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.257 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.86 -40.77 98.51 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.418 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -61.24 -38.1 85.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.326 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.97 -51.41 69.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.124 167.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 37.21 0.72 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.448 -164.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 62.34 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.536 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -79.5 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.754 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.494 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.1 m -157.55 167.55 29.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.153 165.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 20' ' ' VAL . 23.6 mt -108.16 132.7 55.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.439 166.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 5.2 mmmt -143.38 -177.14 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.387 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -27.03 68.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.52 -55.09 34.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.042 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.1 OUTLIER -65.79 -29.34 69.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.394 -170.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.836 ' CG2' HD22 ' A' ' 28' ' ' LEU . 37.1 mm -71.61 -48.7 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.402 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.6 -31.41 71.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.023 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' B' ' 46' ' ' LEU . 15.0 tp -62.11 -51.12 69.2 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.416 168.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.36 -41.08 96.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.376 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -88.75 -58.65 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.13 -162.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -59.74 -25.56 64.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.8 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 -30.4 43.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.388 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.511 171.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 122.064 0.935 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 1.7 Cg_endo -53.95 142.87 63.17 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.07 2.513 . . . . 0.0 113.513 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.514 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 13.5 pt -92.24 -13.2 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.374 -165.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -79.65 -54.65 0.92 Allowed Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.719 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 16.1 Cg_exo -51.55 -55.17 4.23 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.499 2.133 . . . . 0.0 113.627 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 3' ' ' LEU . 45.0 mt -61.71 -44.23 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.248 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.14 -22.17 60.3 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.4 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -26.29 21.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.724 -0.738 . . . . 0.0 110.483 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' B' ' 3' ' ' LEU . 27.4 mt -63.44 -54.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.43 170.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.69 HG23 ' CB ' ' B' ' 40' ' ' ALA . 9.4 mm -65.32 -36.58 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.262 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -69.21 -32.58 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.331 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.41 -34.87 77.58 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.8 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -52.92 63.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.491 169.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.63 24.03 0.3 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.566 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.811 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.57 142.62 58.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.825 -0.688 . . . . 0.0 110.323 174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.49 124.52 41.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.98 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.5 116.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.435 174.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.738 HG11 HH21 ' A' ' 25' ' ' ARG . 15.6 t -146.14 165.65 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.362 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 20' ' ' VAL . 15.7 p -99.99 159.81 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.442 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.746 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.4 m-20 -61.01 -33.78 73.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -37.24 86.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.354 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -60.93 -46.12 91.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.318 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.738 HH21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.95 -36.85 84.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.407 -170.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.2 mt -79.64 -43.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.457 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.816 ' O ' HD12 ' A' ' 31' ' ' ILE . 90.5 m -60.92 -47.89 84.35 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.285 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD22 HG13 ' B' ' 60' ' ' ILE . 4.5 tp -59.19 -45.77 90.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.412 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.67 -21.06 62.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.659 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.66 -24.41 14.43 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.357 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 27' ' ' THR . 1.8 mp -61.11 -68.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.884 162.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.26 -33.41 72.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.599 -169.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.809 ' HB2' HD13 ' A' ' 3' ' ' LEU . 2.3 tm-20 -65.03 -55.12 20.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.1 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -61.68 -26.13 67.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.909 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -46.92 77.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.358 164.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -40.2 96.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -60.75 -31.99 71.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.302 172.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -51.63 60.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.628 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.66 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mt -62.6 -32.74 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.694 -172.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -78.01 -52.15 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.342 -166.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.2 t -61.25 -14.37 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.273 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -87.61 -54.82 4.07 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.213 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.99 -33.59 74.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.176 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' B' ' 17' ' ' ALA . 55.7 mt -60.59 -46.21 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.175 164.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -60.33 -21.92 62.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.565 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 9.9 mt -89.08 -23.57 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.452 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.16 -28.4 65.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.301 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -61.31 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.37 170.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -61.12 -23.08 65.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.374 -168.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 -47.54 62.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.308 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.39 27.9 4.27 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.12 121.92 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.819 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -161.41 15.43 0.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.502 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 55' ' ' ILE . 90.4 m 63.14 151.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.392 -167.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' B' ' 20' ' ' VAL . 29.4 mt -78.22 138.09 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.5 mtmt -153.65 -178.17 6.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.455 -170.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.97 80.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.262 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -50.0 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.196 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -33.34 74.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.405 -173.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' B' ' 28' ' ' LEU . 11.5 mm -75.27 -58.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.342 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 39.8 mt-10 -61.64 -9.86 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.319 172.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 mt -85.95 -41.28 15.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.487 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.617 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.15 -36.49 79.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.098 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 55.9 t -61.85 -76.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.723 168.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -14.91 23.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.396 -167.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -61.52 -66.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 165.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 39' ' ' ILE . 8.3 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.482 -168.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.656 ' CD2' HD11 ' A' ' 11' ' ' ILE . 6.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.326 0.584 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.82 153.5 43.35 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.485 2.123 . . . . 0.0 113.317 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' B' ' 25' ' ' ARG . 16.5 pt -92.35 -25.13 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.42 -168.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.15 -62.56 3.55 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.754 -170.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 7.9 Cg_endo -50.11 -45.39 33.4 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.39 2.06 . . . . 0.0 113.417 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.746 HG22 HH12 ' B' ' 25' ' ' ARG . 21.5 mt -60.96 -38.2 78.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.407 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -61.65 -53.9 39.97 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.556 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -70.41 -15.09 62.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.432 -170.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 3' ' ' LEU . 66.1 mt -73.33 -34.47 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.534 168.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.877 HG23 ' HB1' ' A' ' 40' ' ' ALA . 2.6 mm -70.03 -46.26 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.894 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.3 mtpt -62.33 -41.33 98.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.045 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -60.79 -31.09 70.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.015 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.04 -52.43 65.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.575 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.72 31.61 0.4 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.597 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -80.76 -177.56 6.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -171.06 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.94 167.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.03 106.68 17.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.428 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 55' ' ' ILE . 14.7 t -141.48 171.9 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.395 171.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.556 ' H ' HG12 ' B' ' 20' ' ' VAL . 16.1 t -127.07 156.45 41.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.308 -176.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.71 -37.82 85.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.379 -170.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.92 71.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.391 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.649 ' O ' HG22 ' B' ' 27' ' ' THR . . . -65.83 -43.84 87.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.314 171.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.746 HH12 HG22 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -61.24 -47.66 85.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.339 -175.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 52.3 mt -61.44 -38.84 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.542 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 24' ' ' ALA . 1.5 t -69.77 -43.32 72.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.178 -167.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 60' ' ' ILE . 2.6 tp -59.44 -36.86 76.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.523 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.71 -40.0 93.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.207 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -27.14 23.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.491 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.64 HD12 ' C ' ' B' ' 27' ' ' THR . 24.8 mt -61.61 -67.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.04 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.693 ' HB3' HD23 ' A' ' 32' ' ' LEU . 3.0 mp -60.4 -34.71 74.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.57 -176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.553 ' HG3' HD13 ' A' ' 11' ' ' ILE . 34.6 tt0 -67.52 -37.9 83.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.933 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -35.16 77.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.891 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 3.3 mtp -65.06 -48.34 74.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.461 170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.23 -40.22 97.77 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.555 ' HG3' HG23 ' A' ' 11' ' ' ILE . 12.2 mtp180 -60.93 -29.69 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.345 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -67.89 -55.27 13.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.503 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.73 HG21 HG23 ' B' ' 64' ' ' VAL . 2.2 mt -63.31 -26.28 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.821 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.69 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.49 -70.07 0.21 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.292 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.497 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.46 -17.01 52.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.388 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 3.3 mm-40 -84.61 -38.49 19.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.051 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -78.04 -8.28 57.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.832 172.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 17' ' ' ALA . 51.3 mt -96.99 -51.06 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.765 -175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -60.25 -22.24 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.375 166.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 43' ' ' ALA . 9.6 mt -69.62 -53.74 17.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.379 168.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.63 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.59 -23.54 66.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.307 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 -34.3 15.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.252 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -60.55 -36.77 79.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.434 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.02 74.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.17 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.17 46.94 7.85 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 4.1 tpm_? -121.23 -18.54 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.451 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.28 18.68 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -145.47 138.35 26.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.406 170.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' B' ' 47' ' ' ALA . 45.2 mt -93.76 148.5 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.341 170.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 6.1 mtpp -147.94 178.36 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.381 -169.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.33 -17.82 55.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.331 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.699 ' C ' HD12 ' B' ' 62' ' ' LEU . 5.6 mp0 -81.2 -41.27 22.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.069 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -75.28 -26.77 59.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.373 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.772 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -64.43 -59.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.339 174.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 11.6 mt-10 -74.41 -12.44 60.51 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.557 -176.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 58' ' ' GLU . 7.5 mt -81.67 -46.12 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 168.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' B' ' 39' ' ' ILE . . . -60.34 -41.62 93.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.398 172.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.73 HG23 HG21 ' B' ' 39' ' ' ILE . 37.9 t -62.72 -74.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.63 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -10.76 3.44 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.509 -164.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -85.77 -60.87 1.9 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.582 164.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.539 ' HB3' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.42 -155.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.817 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 28.8 mt . . . . . 0 C--O 1.24 0.563 0 CA-C-O 121.763 0.792 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 7.0 Cg_exo -48.3 150.99 4.84 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 122.388 2.058 . . . . 0.0 113.512 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -69.21 -11.55 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.591 -166.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.6 -58.93 1.32 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.772 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.12 -57.11 1.43 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.432 2.088 . . . . 0.0 113.437 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.8 mt -60.6 -32.66 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.378 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.59 -26.65 64.95 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.357 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -78.02 -36.4 48.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.373 -0.914 . . . . 0.0 110.483 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.739 HG23 ' HG3' ' B' ' 37' ' ' ARG . 25.1 mt -60.63 -64.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.48 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.3 mm -60.91 -33.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -166.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -65.36 -40.45 93.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.468 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.11 -32.41 72.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.777 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.99 -52.64 64.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.522 170.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.76 22.09 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.654 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.64 159.25 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.295 169.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.01 -63.34 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.054 -169.334 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.588 ' O ' HG23 ' B' ' 54' ' ' THR . 9.4 mtp180 -144.6 80.06 1.62 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.478 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.736 HG22 HG13 ' B' ' 55' ' ' ILE . 15.5 t -71.33 107.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.31 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -61.54 158.88 14.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.459 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.7 p30 -61.31 -18.66 59.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.269 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -66.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.773 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -60.69 -39.66 89.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.386 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.676 ' HB3' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -62.01 -37.78 86.17 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.448 -175.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -76.28 -29.45 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.357 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.588 HG22 ' CG2' ' B' ' 60' ' ' ILE . 97.1 m -61.06 -60.75 3.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.341 171.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.923 HD12 ' CG2' ' A' ' 31' ' ' ILE . 64.4 tp -68.33 -28.74 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.424 -171.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -71.35 -40.38 70.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.116 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -60.38 -35.59 76.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.379 166.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.923 ' CG2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -69.78 -38.96 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.378 -170.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.8 mm? -74.84 -67.74 0.61 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.479 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.806 ' O ' HD12 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -67.39 -17.85 64.89 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.811 -163.57 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.17 -49.57 64.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.108 164.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.577 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.488 ' N ' HD21 ' B' ' 32' ' ' LEU . . . -76.71 -36.15 38.27 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' N ' ' CG2' ' B' ' 11' ' ' ILE . 2.4 ttm-85 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.38 169.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.56 -51.7 33.05 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.429 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.719 HD13 HG22 ' A' ' 64' ' ' VAL . 25.1 mt -63.9 -33.75 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.395 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.41 -66.23 0.57 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.275 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.738 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.21 -15.47 34.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.373 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.78 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -71.38 -63.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.135 167.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -13.14 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.488 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.3 mt -97.2 -59.26 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -61.89 -17.43 56.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.333 174.062 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 42' ' ' GLU . 16.7 mt -69.84 -58.66 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.363 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -25.57 67.33 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.398 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.71 -55.85 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.448 -170.597 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -68.01 -24.95 65.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.389 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.02 62.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.347 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.22 26.42 2.04 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.61 165.6 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.416 -170.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -132.68 18.46 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.446 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.6 m -157.66 132.94 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.301 170.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 59' ' ' ASP . 4.4 mp -100.36 133.26 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.309 166.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 -172.62 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.454 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -61.35 -20.0 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.315 -171.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.18 -67.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.077 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.583 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -61.15 -32.27 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.366 -167.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 HD13 ' B' ' 28' ' ' LEU . 37.9 mm -61.2 -64.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.387 172.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 3.4 mt-10 -61.1 -10.07 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.41 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.98 -39.5 12.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.457 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.78 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -76.26 -27.56 56.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.113 175.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.081 HG21 HD13 ' B' ' 31' ' ' ILE . 15.3 t -62.48 -66.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.448 160.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -59.39 -11.19 3.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.002 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -30.65 15.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.236 0.357 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.617 163.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 12.4 Cg_endo -57.89 139.73 91.37 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.461 2.107 . . . . 0.0 113.407 165.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' B' ' 25' ' ' ARG . 22.7 pt -92.95 21.43 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.567 -167.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -83.57 -58.02 0.41 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.733 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.7 Cg_endo -55.91 -50.74 11.44 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' B' ' 5' ' ' ILE . 23.5 mt -60.85 -23.18 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.322 167.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.1 96.63 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.518 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -94.26 -18.03 22.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.986 -0.607 . . . . 0.0 110.347 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 33' ' ' GLU . 7.7 mm -60.83 -72.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.002 163.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.7 mm -63.38 -17.0 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.169 -171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -37.3 24.1 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.377 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -32.53 73.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.836 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.738 ' HB1' ' CA ' ' A' ' 41' ' ' SER . . . -58.82 -52.88 63.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.516 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.21 23.06 0.35 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.702 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.638 ' HB1' HG21 ' B' ' 20' ' ' VAL . . . -67.8 147.05 53.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.772 -0.714 . . . . 0.0 110.424 173.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.77 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.939 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 80.33 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.381 168.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.638 HG21 ' HB1' ' B' ' 17' ' ' ALA . 59.4 t -134.89 137.73 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.472 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 58.9 p -74.49 150.89 39.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.365 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.16 -17.92 55.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.302 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -44.65 63.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.422 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.672 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.45 -43.61 98.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.363 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' B' ' 5' ' ' ILE . 28.1 mtt-85 -62.23 -32.57 73.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.417 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -88.02 -30.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.445 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.442 ' CG2' ' HG3' ' A' ' 61' ' ' GLU . 97.8 m -61.1 -54.11 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.37 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.768 HD13 HG23 ' A' ' 60' ' ' ILE . 4.3 tp -59.83 -45.38 92.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.556 172.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -31.16 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.362 -171.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -91.94 -23.2 19.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 64' ' ' VAL . 64.4 mt -61.36 -70.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.135 166.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.717 ' O ' HD11 ' A' ' 32' ' ' LEU . 1.1 mp -60.47 -33.15 72.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.719 -170.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' B' ' 3' ' ' LEU . 18.5 tt0 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.12 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -32.11 72.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.945 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.675 ' HG2' HD11 ' B' ' 39' ' ' ILE . 2.1 ttt -60.46 -42.55 96.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.426 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.21 68.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -169.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.739 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.7 mtp180 -60.58 -28.51 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.49 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -70.18 -57.8 4.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.53 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.725 HG21 HG23 ' B' ' 64' ' ' VAL . 10.2 mt -61.04 -23.44 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.483 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.73 -70.05 0.21 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.504 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.7 OUTLIER -61.22 -11.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.479 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.525 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -78.62 -58.32 3.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.068 170.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.519 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.15 -17.44 52.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.47 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 90.0 mt -91.18 -50.17 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.983 -173.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -60.68 -27.91 68.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.377 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 15.4 mt -64.81 -54.72 26.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.354 167.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.27 -50.63 72.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.275 -169.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -42.63 99.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.12 -35.19 76.39 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.407 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.75 -47.34 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.302 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.29 30.1 7.99 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' B' ' 54' ' ' THR . 0.0 OUTLIER -134.48 104.11 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.352 169.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 6.6 mttt -61.13 -16.98 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.335 -169.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' ARG . 94.2 m -88.39 122.21 31.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.447 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 20' ' ' VAL . 11.8 mm -75.1 138.29 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.515 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 1.1 mmmt -130.2 158.55 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.324 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -62.86 -31.06 72.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.309 -167.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.95 -37.93 82.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.081 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.7 OUTLIER -64.88 -37.12 86.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.44 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.588 ' CG2' HG22 ' A' ' 27' ' ' THR . 48.8 mm -60.9 -55.9 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.432 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -70.64 -22.64 62.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.009 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.13 -36.17 40.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.449 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.99 -55.36 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.372 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.725 HG23 HG21 ' B' ' 39' ' ' ILE 0.256 0.4 OUTLIER -70.16 -50.71 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.978 -165.806 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' B' ' 65' ' ' ARG . 5.1 mmm180 -60.9 -43.06 99.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -20.73 64.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.4 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 50.5 t80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.306 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 33' ' ' GLU . 3.4 mt . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.609 0.719 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.97 144.16 94.84 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.172 1.915 . . . . 0.0 113.66 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.624 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -101.99 19.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.684 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.92 -58.81 0.31 Allowed Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 11.7 Cg_endo -59.46 -45.81 24.39 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.503 2.135 . . . . 0.0 113.557 168.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 27.9 mt -69.06 -32.93 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.438 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -30.31 71.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.8 ttp-105 -92.39 -18.73 22.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.315 -174.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.791 HD11 HD21 ' B' ' 3' ' ' LEU . 10.3 mm -61.01 -60.59 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.244 166.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.3 mm -72.32 -22.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.039 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -77.31 -34.27 55.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.296 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -61.45 -31.17 71.12 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.877 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.94 -52.23 66.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.492 170.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.89 34.31 0.56 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.53 -167.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -84.25 145.92 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.255 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.05 -38.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.026 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.824 ' NH2' HG23 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -122.9 85.0 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.48 170.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 55' ' ' ILE . 89.8 t -132.42 113.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.274 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -65.46 164.26 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.462 -167.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.775 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -65.42 -30.56 71.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.36 -173.007 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.853 ' HB2' ' HB2' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -60.97 -43.38 98.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.402 176.066 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.682 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.56 -41.2 97.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.347 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -61.73 -42.26 98.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.389 -176.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.3 mt -83.29 -28.42 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.447 -176.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.82 ' O ' HD12 ' A' ' 31' ' ' ILE . 97.3 m -60.89 -47.7 85.21 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.293 174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.74 HD13 HG23 ' B' ' 60' ' ' ILE . 4.4 tp -59.21 -45.54 90.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.453 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.12 -20.8 63.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.547 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -96.91 -28.86 14.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.323 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 27' ' ' THR . 1.9 mp -60.7 -70.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.929 162.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -58.32 -35.16 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.796 -166.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 3' ' ' LEU . 9.9 tt0 -69.52 -61.71 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.201 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 80.0 mt-10 -61.55 -34.09 74.97 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.797 -170.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.5 ttm -62.2 -46.9 86.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.46 165.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -63.39 -47.69 85.32 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -60.65 -23.0 64.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.368 170.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -75.6 -52.32 10.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.605 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.673 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.3 mt -61.49 -28.75 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.071 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.811 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.04 -74.09 0.09 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.191 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.521 ' HB3' ' HB1' ' B' ' 15' ' ' ALA . 1.9 p -60.94 -11.38 7.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.489 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.707 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.4 mm-40 -79.92 -55.84 4.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.089 171.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.16 -20.83 63.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.368 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' B' ' 17' ' ' ALA . 92.8 mt -88.82 -52.03 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.93 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -27.81 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.447 170.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -63.36 -61.02 2.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.375 171.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.817 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.78 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.241 -167.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.449 ' CD ' ' NH1' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -82.61 -41.1 19.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.411 -171.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -66.2 -21.27 66.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.247 167.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.16 -53.27 59.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.23 166.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.71 9.92 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.64 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.449 ' NH1' ' CD ' ' A' ' 48' ' ' ARG . 13.6 ttm-85 66.69 134.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.419 169.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.19 -65.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.303 169.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 55' ' ' ILE . 92.7 m -157.63 144.4 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.323 169.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' THR . 25.4 mm -66.22 136.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.322 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.833 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.3 tptt -131.83 165.21 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.404 -167.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -61.13 -17.72 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.246 169.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.55 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.4 tp10 -76.29 -44.83 35.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.092 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 3.1 m-20 -68.9 -35.05 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.278 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.89 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.89 -56.15 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.763 162.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -61.47 -33.22 73.39 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.909 -166.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.6 mp -75.91 -45.78 33.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.551 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.37 -27.05 68.24 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.434 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.791 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -96.09 -56.3 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.866 -164.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH1' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -60.13 -26.25 66.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.632 174.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' NH2' HD23 ' A' ' 62' ' ' LEU . 97.4 mtt180 -81.38 -23.86 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.411 171.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 5.5 t80 . . . . . 0 N--CA 1.455 -0.205 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.46 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 11' ' ' ILE . 1.5 mt . . . . . 0 CA--C 1.545 0.765 0 CA-C-O 121.264 0.554 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.562 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 12.0 Cg_endo -62.56 147.97 94.03 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.514 2.143 . . . . 0.0 113.401 165.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.66 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -99.16 19.21 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.955 174.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -94.55 -59.35 0.2 Allowed Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.737 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.9 Cg_endo -57.89 -46.97 22.79 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.484 2.123 . . . . 0.0 113.454 169.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.73 -37.06 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.391 168.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.57 -21.35 60.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -103.61 -18.39 14.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.067 -0.567 . . . . 0.0 110.327 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.725 HG22 HD13 ' B' ' 12' ' ' ILE . 9.4 mm -60.78 -49.93 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.275 164.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' B' ' 17' ' ' ALA . 6.2 mm -85.46 -31.26 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.967 -168.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.385 170.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.32 -32.52 73.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.748 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.8 -53.47 57.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.521 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.82 24.04 0.48 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.618 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.833 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -61.02 144.2 53.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.73 -0.735 . . . . 0.0 110.409 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -146.01 122.02 10.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.036 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 64.28 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.367 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' HG3' ' B' ' 25' ' ' ARG . 25.8 t -101.4 123.65 54.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.337 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -61.25 154.35 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.419 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.48 -37.08 82.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.395 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.72 -48.6 81.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.511 170.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.833 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.95 -48.61 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.297 -172.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.444 ' HG3' ' CG1' ' B' ' 20' ' ' VAL . 9.2 mtp180 -61.61 -36.97 82.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.392 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -89.2 -32.99 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.42 -167.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.475 HG22 HD12 ' B' ' 31' ' ' ILE . 90.1 m -67.21 -41.05 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.449 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 60' ' ' ILE . 2.2 tp -62.97 -48.21 79.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.913 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.02 -25.78 67.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.553 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -95.96 -29.4 14.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.283 -175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 64' ' ' VAL . 15.4 mt -61.4 -59.9 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.845 166.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.01 -22.05 47.82 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.77 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.513 ' OE1' HD21 ' B' ' 3' ' ' LEU . 8.9 tp10 -83.34 -65.05 1.06 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.011 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.68 -34.22 75.36 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.849 -174.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.46 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 8.2 ttm -62.15 -47.75 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.521 165.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -61.29 -49.53 76.72 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.59 -25.06 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.433 171.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -71.32 -49.91 37.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.61 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.527 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.0 mt -61.43 -34.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.261 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.8 -71.78 0.14 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.301 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 24.7 p -62.04 -17.88 58.79 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.557 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.543 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -81.51 -50.85 8.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.26 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.4 -12.89 24.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.099 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.824 HG23 ' NH2' ' A' ' 19' ' ' ARG . 96.6 mt -95.47 -49.31 12.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.817 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -67.84 -7.4 27.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.182 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.543 HD12 ' O ' ' B' ' 42' ' ' GLU . 3.9 mt -83.61 -43.05 16.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.26 169.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -60.49 -14.83 21.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.324 166.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -92.31 -35.29 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.498 168.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 46' ' ' LEU . 23.8 t-80 -61.66 -39.56 91.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.266 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.681 ' HB1' ' NZ ' ' B' ' 53' ' ' LYS . . . -61.05 -52.63 64.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.212 165.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.84 9.53 10.87 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.539 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 179.23 -166.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.931 -0.635 . . . . 0.0 110.323 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.681 ' NZ ' ' HB1' ' B' ' 50' ' ' ALA . 2.7 mppt? 65.73 162.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.41 167.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.621 HG22 ' O ' ' B' ' 55' ' ' ILE . 91.8 m -96.55 152.68 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.346 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 20' ' ' VAL . 3.6 mp -69.3 133.66 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 168.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' B' ' 58' ' ' GLU . 0.3 OUTLIER -135.63 -171.36 2.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.376 177.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.853 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -61.75 -27.15 68.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.247 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.538 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.0 pt-20 -73.99 -49.0 26.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.1 OUTLIER -61.89 -31.56 71.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.401 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.74 HG23 HD13 ' A' ' 28' ' ' LEU . 25.3 mm -61.89 -68.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.268 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt-10 -61.06 -14.61 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 3.6 mp -70.66 -55.2 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.403 169.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.483 ' HB1' ' CZ ' ' B' ' 67' ' ' PHE . . . -60.91 -37.03 80.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.484 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HG12 ' A' ' 31' ' ' ILE . 40.2 t -62.43 -69.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.796 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.19 -9.17 4.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.508 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -50.29 21.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.488 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -174.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 33' ' ' GLU . 3.3 mt . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 121.507 0.67 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.12 140.18 93.17 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.543 2.162 . . . . 0.0 113.533 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 pt -80.64 -31.23 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.366 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.75 -62.73 4.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.763 -173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -50.87 -42.85 50.06 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 C-N-CA 122.48 2.12 . . . . 0.0 113.524 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 3' ' ' LEU . 50.3 mt -60.81 -39.15 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.435 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 25' ' ' ARG . . . -61.58 -26.12 66.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -91.14 -25.33 19.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.169 -0.515 . . . . 0.0 110.36 -176.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' B' ' 3' ' ' LEU . 53.7 mt -60.83 -62.43 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.296 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.2 mm -61.21 -35.18 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.249 -175.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.4 mtmt -60.79 -37.09 80.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.498 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.56 -35.21 78.76 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.789 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.32 -53.08 62.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.41 167.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.57 16.58 0.21 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.051 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.809 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.16 170.57 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 163.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.09 -57.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.941 165.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' NH1' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -73.62 83.28 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.391 172.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HB ' ' B' ' 55' ' ' ILE . 24.6 t -129.03 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 -170.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.3 p -85.24 156.48 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.423 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.8 t0 -61.42 -23.19 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.318 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -90.65 -28.62 18.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.394 -170.066 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -61.69 -42.04 98.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.157 166.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HG3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.76 -51.17 68.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.445 -178.122 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.3 tt -62.68 -40.95 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.234 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.639 HG22 HD11 ' A' ' 31' ' ' ILE . 91.7 m -60.77 -59.06 5.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.369 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.3 tp -61.01 -10.5 5.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.344 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -82.37 -59.29 2.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.448 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -61.33 -25.14 66.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.434 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 28' ' ' LEU . 74.0 mt -61.65 -75.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.052 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 31' ' ' ILE . 7.1 mp -60.57 -36.92 79.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -166.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 3' ' ' LEU . 8.4 tt0 -67.46 -42.75 82.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.053 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.4 mt-10 -62.12 -41.15 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.056 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.9 mmm -60.76 -42.1 96.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.506 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.57 -46.27 90.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' B' ' 11' ' ' ILE . 3.1 mtp180 -60.73 -33.83 73.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.378 168.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -65.69 -50.2 65.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 -175.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.622 HG21 HG23 ' A' ' 64' ' ' VAL . 11.0 mt -65.1 -36.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.417 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -65.26 -54.08 34.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.32 -172.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 -34.33 75.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.298 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -60.91 -38.26 85.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.063 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -79.82 -13.67 59.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.794 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -82.79 -57.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.372 -168.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.29 -31.36 70.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.414 169.29 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 42' ' ' GLU . 11.4 mt -59.96 -43.84 94.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.584 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.831 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -67.86 -26.37 65.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.103 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -60.67 -61.61 2.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.332 168.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -61.31 -10.09 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.584 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -84.16 -57.86 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.953 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.64 9.93 0.04 OUTLIER Glycine 0 C--N 1.344 0.996 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.666 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 0.3 OUTLIER 73.6 -58.22 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.424 0.689 . . . . 0.0 111.47 158.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.53 -23.3 49.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 111.182 -157.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.524 HG22 ' N ' ' B' ' 21' ' ' SER . 0.2 OUTLIER -155.43 154.97 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.354 169.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.927 ' HB ' HG13 ' B' ' 20' ' ' VAL . 4.3 mm -72.44 150.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.015 159.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 156.33 40.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.413 -169.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.23 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.246 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -68.72 -38.99 80.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.902 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -48.0 83.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.618 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.781 ' CG2' HD22 ' B' ' 28' ' ' LEU . 22.8 mm -61.55 -46.2 97.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -36.86 69.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.054 -170.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mp -63.51 -43.28 97.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.414 167.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 46' ' ' LEU . . . -61.54 -57.42 12.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.41 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.802 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -68.26 -52.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.042 -168.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -41.35 92.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.731 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -20.72 63.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.337 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 44.5 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.206 -171.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 11' ' ' ILE . 1.5 mt . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' B' ' 7' ' ' PRO . 12.6 Cg_endo -60.67 140.91 93.44 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.533 2.156 . . . . 0.0 113.405 164.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -99.47 -17.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.389 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -79.09 -62.0 0.46 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.754 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.48 -36.24 58.43 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 122.508 2.139 . . . . 0.0 113.522 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' B' ' 3' ' ' LEU . 54.0 mt -60.42 -42.22 90.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.362 168.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' B' ' 25' ' ' ARG . . . -61.54 -28.15 69.2 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.603 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HG3' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -86.55 -21.84 26.67 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.511 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.491 HG23 ' HD3' ' A' ' 37' ' ' ARG . 26.4 mt -69.02 -44.0 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.399 167.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.5 mm -62.65 -36.17 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.04 171.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' HA ' ' B' ' 10' ' ' ARG . 0.6 OUTLIER -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.387 172.107 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 37' ' ' ARG . 16.5 t70 -62.55 -32.78 73.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.75 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -52.57 65.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.443 169.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.41 18.88 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.051 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.842 ' HB1' ' CG2' ' B' ' 20' ' ' VAL . . . -64.43 165.76 9.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.311 168.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.21 -58.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.049 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 83.3 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.452 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.927 HG13 ' HB ' ' A' ' 55' ' ' ILE . 57.9 t -104.45 145.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.324 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 54' ' ' THR . 77.8 p -61.21 139.73 58.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.33 168.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.98 -24.25 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.261 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -53.17 56.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.454 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.336 -167.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.463 ' HG2' ' CA ' ' B' ' 9' ' ' GLY . 4.1 mpp_? -60.87 -49.03 79.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.417 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.11 -23.68 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.449 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.716 ' O ' HD12 ' B' ' 31' ' ' ILE . 97.7 m -77.83 -40.08 41.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.362 -170.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.839 HD12 HD11 ' B' ' 32' ' ' LEU . 0.8 OUTLIER -60.68 -37.37 81.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.409 169.226 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.61 96.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.245 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.2 mmmm -77.8 -31.41 51.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.369 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.802 HG21 HG21 ' A' ' 64' ' ' VAL . 5.5 mt -61.35 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.035 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.839 HD11 HD12 ' B' ' 28' ' ' LEU . 3.5 mp -59.42 -35.4 73.93 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.611 -165.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.537 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -71.17 -37.44 72.18 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.125 -177.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 17.1 mm-40 -65.24 -52.08 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.3 ptm -65.03 -28.27 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.343 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.96 -45.8 48.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 11' ' ' ILE . 1.7 mtt-85 -60.64 -18.29 52.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.452 169.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.9 OUTLIER -87.03 -54.7 4.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.454 -173.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 64' ' ' VAL . 7.1 mt -61.54 -19.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.443 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -65.7 -70.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.353 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.544 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 32.3 t -61.07 -10.14 5.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.61 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.485 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -90.45 -45.02 9.24 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.097 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.456 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -63.51 -24.38 67.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.272 169.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 17' ' ' ALA . 78.2 mt -86.31 -50.43 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.134 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -31.77 70.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.371 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.793 HD22 HD23 ' B' ' 62' ' ' LEU . 14.4 mt -60.78 -55.09 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.371 167.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.32 -30.42 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.292 -170.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.35 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -60.71 -35.05 75.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.371 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.61 -53.51 56.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.27 171.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.84 24.11 1.12 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.599 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HD3' ' NH1' ' A' ' 19' ' ' ARG . 1.3 ptp85 59.57 33.51 22.1 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.226 -0.573 . . . . 0.0 111.169 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 77.37 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.407 169.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.417 HG22 ' H ' ' B' ' 55' ' ' ILE . 1.5 m 68.49 175.93 0.27 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.528 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 20' ' ' VAL . 17.4 mm -118.41 137.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.235 166.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -142.94 166.34 24.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.429 -168.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' OE2' ' B' ' 61' ' ' GLU . . . -63.21 -25.17 68.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.253 -172.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 1.0 OUTLIER -64.18 -37.48 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.108 168.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HG2' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -79.5 -39.86 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.395 -176.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.473 HG13 ' CA ' ' A' ' 24' ' ' ALA . 38.2 mm -60.98 -54.4 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.421 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.768 ' OE2' ' HB1' ' B' ' 57' ' ' ALA . 4.5 mt-10 -68.59 -36.43 78.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.986 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.793 HD23 HD22 ' B' ' 46' ' ' LEU . 16.4 tp -61.13 -44.41 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.338 168.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.548 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.41 -42.82 99.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.413 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.929 HG23 HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -82.99 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.18 -167.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -11.89 8.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.565 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -94.61 -30.9 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.443 168.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 1.1 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.761 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.891 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 122.294 1.045 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.9 Cg_endo -67.59 141.72 56.24 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.114 2.542 . . . . 0.0 113.67 -172.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.49 -9.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.023 -172.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.94 -60.33 1.23 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.727 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -56.92 -51.37 9.05 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.454 2.103 . . . . 0.0 113.497 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.2 mt -60.59 -45.91 96.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.45 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.58 -30.03 75.41 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.686 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.85 -20.57 27.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.493 -0.353 . . . . 0.0 110.329 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.19 -49.7 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.446 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.656 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.9 mm -61.05 -46.61 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.418 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -62.32 -30.32 71.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.261 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.34 -35.39 78.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.77 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.54 -52.63 64.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.511 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.11 23.53 0.34 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.576 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.7 170.51 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.306 173.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.65 -58.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.952 167.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -125.76 104.57 8.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.36 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.882 HG22 HD12 ' B' ' 55' ' ' ILE . 59.6 t -112.26 103.8 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.345 168.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.44 167.88 3.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.403 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -26.07 67.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.363 -170.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.21 -63.03 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.518 172.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.79 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.03 -39.54 92.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.3 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.7 mtm180 -61.56 -38.62 88.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.291 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.9 mm -76.25 -25.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.51 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.044 HG22 HG22 ' B' ' 60' ' ' ILE . 71.3 m -74.4 -45.8 44.42 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.12 -168.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD13 HG12 ' B' ' 60' ' ' ILE . 5.6 tp -59.19 -47.76 84.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.36 164.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -61.1 -18.46 58.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.531 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -99.68 -27.18 13.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.316 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.836 HG21 HG21 ' B' ' 64' ' ' VAL . 2.0 mp -60.79 -69.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.85 162.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.1 mp -59.67 -34.68 73.16 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.555 -168.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.891 ' CG ' HD13 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.67 -59.3 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.55 -20.24 63.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.83 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -52.2 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.223 160.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.87 95.15 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -61.31 -39.91 92.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.377 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -63.19 -56.49 16.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.434 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.932 HG21 HG23 ' A' ' 64' ' ' VAL . 3.0 mt -61.57 -28.0 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.219 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -64.34 -61.33 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.231 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.3 OUTLIER -80.71 -15.24 57.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.517 -167.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -78.98 -48.6 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.125 168.322 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.71 -37.46 86.59 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.041 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' B' ' 17' ' ' ALA . 48.2 mt -61.19 -50.3 81.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.147 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.91 -14.88 25.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.3 mt -91.63 -34.38 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.161 -172.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.5 -47.2 87.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.428 168.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -62.01 -48.35 80.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.359 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -62.7 -35.28 79.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.37 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.99 -54.24 47.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.183 168.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 24.71 0.57 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.618 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.31 96.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.215 -0.492 . . . . 0.0 110.531 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -153.61 78.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.239 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 55' ' ' ILE . 16.4 m 69.3 168.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.532 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.656 HD12 HG22 ' B' ' 20' ' ' VAL . 86.2 mt -121.9 147.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.356 168.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -178.84 7.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.424 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -64.23 -22.75 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.258 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.65 -68.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.155 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -25.94 67.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -169.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.959 HG23 HD13 ' B' ' 28' ' ' LEU . 16.0 mm -76.14 -60.05 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.343 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.3 mt-10 -61.75 -18.7 60.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.413 177.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.88 -41.01 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.469 173.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.459 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -66.43 -37.07 84.36 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.12 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.954 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.02 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.713 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -60.27 -9.87 3.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.657 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.2 tpt180 -73.66 -48.52 31.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.408 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.7 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.365 168.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' B' ' 33' ' ' GLU . 7.6 mt . . . . . 0 C--O 1.244 0.786 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.91 146.51 94.91 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.722 2.281 . . . . 0.0 113.439 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 pt -93.78 21.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.49 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -88.58 -59.81 0.25 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.748 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.5 Cg_endo -56.48 -45.72 35.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.362 2.041 . . . . 0.0 113.506 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -61.15 -55.2 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.515 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.39 68.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -80.45 -25.75 38.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.456 -177.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 3' ' ' LEU . 80.6 mt -68.38 -46.84 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.411 167.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.1 mm -65.44 -40.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.212 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtpp -61.05 -36.88 80.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.453 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -62.0 -31.9 72.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.845 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -52.35 65.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.52 170.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.59 22.57 0.85 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.744 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -64.3 146.29 54.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.807 -0.696 . . . . 0.0 110.405 172.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.32 -58.21 0.18 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.989 168.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -80.76 81.4 7.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.351 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.656 HG22 HD12 ' A' ' 55' ' ' ILE . 21.6 t -139.86 153.37 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.37 -168.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 99.0 p -101.71 150.36 23.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.393 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -16.97 49.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.32 168.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.96 -49.02 79.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.411 169.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.565 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.59 -45.84 92.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.388 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -30.05 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.404 -171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 58.3 mt -94.81 -20.41 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.436 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.668 HG22 HD11 ' B' ' 31' ' ' ILE . 88.8 m -61.03 -56.77 17.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.254 167.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.959 HD13 HG23 ' A' ' 60' ' ' ILE . 3.0 tp -60.7 -40.24 91.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.529 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.12 -39.97 92.0 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.421 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -84.22 -21.12 31.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.399 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.954 HD13 HG21 ' A' ' 64' ' ' VAL . 58.8 mt -61.4 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.018 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.901 ' HB3' HD23 ' A' ' 32' ' ' LEU . 8.9 mp -60.79 -42.82 98.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.539 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 14.6 tm-20 -63.56 -36.67 84.55 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.065 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -61.48 -43.98 97.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.063 173.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.625 ' HB3' HD11 ' B' ' 39' ' ' ILE . 34.5 mtp -60.78 -37.91 83.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.562 174.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.91 99.72 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -44.73 95.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.476 172.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.1 t70 -77.61 -45.87 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.559 -165.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' B' ' 35' ' ' MET . 5.8 mt -61.21 -30.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.253 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -67.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.305 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.455 ' N ' HD12 ' B' ' 44' ' ' ILE . 2.4 t -61.24 -9.19 4.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.471 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.75 -38.15 11.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.171 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.602 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.32 -16.11 59.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.46 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -87.45 -49.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.836 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -30.03 68.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.414 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.94 -47.23 85.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.405 166.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.679 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.93 -18.6 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.333 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -41.39 67.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.277 168.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -60.3 -30.74 69.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.415 170.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.77 -51.56 68.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.418 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.22 41.84 1.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.477 -174.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.53 18.97 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.43 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 140.66 29.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.191 165.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -61.03 168.25 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.361 -167.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -92.96 141.22 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.559 -168.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.58 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -138.25 -169.14 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.363 -171.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.612 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -66.83 -45.87 76.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.037 -169.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.468 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.8 mt-10 -61.54 -31.0 71.0 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.26 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.55 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.54 -68.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.336 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.04 -32.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 -162.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -38.59 87.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.468 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.55 -47.12 87.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.468 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.96 25.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.615 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.64 -57.21 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -159.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -10.92 3.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.39 166.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -85.37 -69.67 0.64 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.632 166.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -154.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' B' ' 11' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 7' ' ' PRO . 18.0 Cg_endo -62.08 140.73 85.73 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.505 2.137 . . . . 0.0 113.444 163.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -96.89 -10.97 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.698 -170.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.06 -53.75 60.67 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.691 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.0 Cg_endo -51.01 -57.21 2.39 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.613 2.209 . . . . 0.0 113.549 171.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.67 -25.98 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.422 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.95 32.69 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.549 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -76.43 -16.6 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.419 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.992 HD11 HD21 ' B' ' 3' ' ' LEU . 31.8 mt -60.99 -73.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.262 166.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.678 HD13 HG22 ' A' ' 11' ' ' ILE . 7.4 mm -61.89 -23.42 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.852 -170.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -69.27 -38.69 78.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.457 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' B' ' 37' ' ' ARG . 57.6 t0 -62.31 -33.68 75.13 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.802 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.91 -53.23 60.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.454 169.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.59 15.88 0.32 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.277 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -64.37 -177.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.261 165.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -171.13 -52.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.991 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -92.0 99.03 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.409 170.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.67 117.88 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.486 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.5 t -61.6 159.34 13.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.38 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.0 -22.82 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.372 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.685 ' HA ' HG22 ' A' ' 26' ' ' ILE . 8.2 t70 -96.4 -35.25 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.291 -170.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -60.61 -38.49 84.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.065 164.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HD3' HG21 ' A' ' 5' ' ' ILE . 7.4 ttm180 -60.16 -52.37 65.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.514 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tp -72.65 -37.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' CG2' ' B' ' 60' ' ' ILE . 55.6 m -61.37 -51.86 67.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.262 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 ' N ' HG21 ' B' ' 60' ' ' ILE . 11.8 tp -61.44 -25.5 67.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.189 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -53.36 15.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.534 169.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.03 -28.84 65.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.363 -170.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.826 HD12 HG22 ' B' ' 60' ' ' ILE . 88.2 mt -61.42 -72.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.054 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.913 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -59.92 -19.08 49.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.771 -166.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 2.5 pp20? -91.43 -41.89 10.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.027 -171.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.58 -35.14 76.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.904 167.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 mmt -61.05 -54.05 49.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.476 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.79 95.23 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -167.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.704 ' NE ' HG23 ' B' ' 11' ' ' ILE . 0.1 OUTLIER -60.92 -33.9 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.315 170.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -53.88 48.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.541 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 64' ' ' VAL . 9.8 mt -61.37 -38.92 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.233 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.77 -57.11 10.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.384 -172.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.5 t -61.71 -30.62 70.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.254 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.7 mm-40 -60.76 -60.04 4.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.36 -11.93 12.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.535 -176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.76 -56.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.117 -169.107 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.4 65.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.439 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 42' ' ' GLU . 7.0 mp -61.15 -49.04 78.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.293 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.723 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.38 -27.84 68.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.327 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -53.28 40.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.455 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.423 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.93 -55.08 37.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.124 170.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.3 32.94 0.37 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.508 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.03 -59.93 0.5 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.79 -0.705 . . . . 0.0 111.009 164.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -60.13 98.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.583 -163.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m 70.14 123.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.371 166.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' B' ' 20' ' ' VAL . 15.9 mt -79.02 140.21 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.273 164.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD2' ' CB ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -144.47 -174.32 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -168.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.7 -31.18 71.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.34 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.45 -42.33 83.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.115 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -35.43 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.323 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.839 HG23 HD13 ' B' ' 28' ' ' LEU . 33.6 mm -61.09 -40.05 84.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.326 169.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 37.5 mt-10 -80.34 -34.07 36.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.002 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -45.08 95.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.436 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.17 -36.96 81.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.518 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 1.14 HG21 HG21 ' B' ' 31' ' ' ILE 0.257 0.4 OUTLIER -75.22 -52.67 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.989 -167.155 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.17 62.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.596 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.488 ' HE ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -104.27 -12.5 16.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.923 -163.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 164.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.992 HD21 HD11 ' A' ' 11' ' ' ILE . 16.0 mt . . . . . 0 C--O 1.241 0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.664 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.5 Cg_endo -60.05 147.75 91.87 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.324 2.016 . . . . 0.0 113.496 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.67 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -85.23 -30.84 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.541 -177.052 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.24 -59.8 4.73 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.69 -171.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.4 Cg_endo -52.58 -46.15 35.26 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 122.552 2.168 . . . . 0.0 113.533 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.9 mt -60.5 -36.23 68.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.394 172.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.55 -27.2 67.64 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.439 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 tpt85 -86.6 -27.38 23.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.395 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.704 HG23 ' NE ' ' A' ' 37' ' ' ARG . 16.2 mt -60.63 -46.36 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.47 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.0 mm -74.79 -31.62 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.922 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -60.71 -41.89 96.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.45 169.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.71 -31.9 72.09 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.853 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.93 -53.81 54.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.428 167.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.17 30.53 0.27 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.722 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.735 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -80.87 171.81 14.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.67 -0.765 . . . . 0.0 110.26 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -171.1 -25.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.956 166.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 82.0 1.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.533 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.745 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -113.79 129.4 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.165 167.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.6 p -61.0 165.94 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.256 166.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -10.82 5.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.353 167.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -75.83 -55.28 5.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.453 176.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -62.1 -41.13 97.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.25 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.514 HH21 HG23 ' B' ' 20' ' ' VAL . 3.3 ttm180 -62.29 -48.13 81.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.386 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.467 HD11 HG21 ' B' ' 5' ' ' ILE . 11.2 mm -76.25 -32.13 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.391 -174.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 57' ' ' ALA . 84.9 m -60.98 -52.02 66.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.461 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.839 HD13 HG23 ' A' ' 60' ' ' ILE . 4.1 tp -61.34 -45.65 93.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.264 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -60.89 -28.52 68.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.449 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -27.98 21.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.455 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 1.14 HG21 HG21 ' A' ' 64' ' ' VAL . 16.7 mt -61.77 -72.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.989 165.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.51 -12.8 10.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.565 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.3 -57.95 3.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.054 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.96 79.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.042 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 7.2 tpp -60.82 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.428 166.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.94 89.9 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -170.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -60.83 -26.82 67.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.317 170.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -48.09 38.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.522 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.913 HD12 HD11 ' A' ' 32' ' ' LEU . 1.2 mt -63.02 -28.83 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.474 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.668 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -65.34 -68.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.318 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 80.9 p -61.45 -16.06 43.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.629 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -69.06 -64.51 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.13 165.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.16 -10.92 7.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.624 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.0 mt -99.82 -50.42 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.769 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.27 -29.3 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.402 168.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.8 mt -60.82 -51.52 68.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.245 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.699 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -67.97 -38.19 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.293 -169.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -70.35 -39.9 74.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.403 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -60.78 -35.88 77.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.335 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.67 -54.38 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.195 167.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.96 22.37 0.74 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.725 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.52 -165.12 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.294 -0.533 . . . . 0.0 110.981 168.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 65.44 100.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.466 -167.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 21' ' ' SER . 2.0 m 70.14 124.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.377 167.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' B' ' 47' ' ' ALA . 5.6 mm -89.82 152.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.316 166.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.502 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -131.03 159.62 36.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.428 -168.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.93 -30.04 70.63 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.335 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -53.38 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.156 171.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -13.09 23.8 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.456 -174.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.826 HG22 HD12 ' A' ' 31' ' ' ILE . 33.0 mm -84.01 -63.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.393 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' A' ' 31' ' ' ILE . 31.1 mt-10 -61.72 -13.74 25.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.625 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.6 -30.78 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.332 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -63.9 -37.52 87.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.755 161.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 31' ' ' ILE . 41.0 t -61.45 -71.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.769 166.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -59.2 -11.51 3.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.811 -170.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -71.72 -50.02 34.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.439 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.714 ' HE2' HG23 ' B' ' 39' ' ' ILE . 29.5 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.543 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 33' ' ' GLU . 10.4 mp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 121.898 0.856 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 9.3 Cg_endo -49.13 138.49 28.28 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 C-N-CA 122.6 2.2 . . . . 0.0 113.348 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.68 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -91.53 19.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.898 -167.214 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.35 -58.24 0.45 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.699 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -54.41 -53.27 6.48 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.497 2.131 . . . . 0.0 113.537 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.2 mt -61.44 -59.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.522 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.6 -18.83 57.14 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -31.68 22.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.952 -0.624 . . . . 0.0 110.356 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' B' ' 3' ' ' LEU . 61.4 mt -60.53 -51.14 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.554 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.9 mm -61.27 -37.61 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.281 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -34.31 77.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.344 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -62.52 -34.42 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' B' ' 41' ' ' SER . . . -59.34 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.485 169.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.73 21.98 0.42 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.604 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.31 150.62 29.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.349 167.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.07 -51.81 2.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.036 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.52 132.12 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.37 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 45.5 t -124.73 123.1 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.333 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.441 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 21.4 t -66.29 156.73 33.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.454 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HA ' ' CG ' ' A' ' 25' ' ' ARG . 27.9 t0 -61.37 -24.07 66.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.346 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 0.7 OUTLIER -60.65 -53.69 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.513 172.386 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' B' ' 60' ' ' ILE . . . -62.18 -47.24 85.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.318 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HD3' HG13 ' A' ' 5' ' ' ILE . 1.4 ptp85 -70.96 -27.65 63.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 -168.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 78.5 mt -86.29 -27.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.421 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.505 HG22 HD12 ' A' ' 31' ' ' ILE . 99.3 m -60.95 -54.4 45.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.345 170.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.976 HD13 HG23 ' B' ' 60' ' ' ILE . 4.0 tp -60.14 -43.01 96.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.49 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.19 -32.19 71.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.501 -174.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.86 -24.1 15.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.236 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.067 HD13 HG21 ' B' ' 64' ' ' VAL . 84.4 mt -60.65 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.028 164.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -59.04 -33.89 71.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.699 -172.021 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.796 ' HB2' HD13 ' A' ' 3' ' ' LEU . 10.4 tm-20 -61.86 -59.33 5.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.047 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 2.3 tp10 -64.52 -30.57 71.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.838 -171.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.42 -41.14 93.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.292 164.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.62 -46.9 93.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.46 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -62.66 -24.75 67.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.049 -178.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.9 t0 -80.9 -45.25 17.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.504 -174.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 67' ' ' PHE . 9.6 mt -61.65 -30.28 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.144 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.652 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.54 -77.31 0.05 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.25 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.774 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.81 -11.0 10.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.384 -172.428 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.35 -56.46 4.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.114 170.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -60.5 -17.2 43.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.612 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' B' ' 17' ' ' ALA . 78.3 mt -85.58 -51.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.854 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -60.63 -39.73 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.383 168.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 63' ' ' ALA . 50.6 mt -60.76 -39.69 89.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.415 170.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.46 -24.75 66.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.295 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -82.34 -48.85 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.343 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.01 64.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.242 167.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -56.57 19.96 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.137 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.25 30.07 0.16 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.697 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.69 -60.96 0.49 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.923 161.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.05 93.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.306 0.574 . . . . 0.0 110.581 -161.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.532 HG21 ' HB2' ' B' ' 21' ' ' SER . 24.9 m 70.44 144.28 0.06 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HB ' HG13 ' B' ' 20' ' ' VAL . 15.3 mm -73.32 138.35 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.221 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -135.94 170.32 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.429 -170.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.45 55.91 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.48 -165.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.717 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.23 -26.81 68.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.946 -174.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.8 m-20 -65.18 -39.5 92.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.499 173.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.829 HD12 ' CD2' ' B' ' 28' ' ' LEU . 36.5 mm -62.75 -67.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.391 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.6 mt-10 -61.09 -11.21 7.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.278 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -73.1 -50.88 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.437 166.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -61.14 -42.82 99.23 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.304 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.854 HG21 HD13 ' B' ' 31' ' ' ILE . 21.8 t -62.02 -68.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.856 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.17 -9.79 3.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.682 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -35.32 39.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.355 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CE2' HG12 ' A' ' 39' ' ' ILE . 96.9 m-85 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.367 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.642 ' CD2' HD11 ' A' ' 11' ' ' ILE . 3.2 mt . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 140.88 94.04 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.41 2.074 . . . . 0.0 113.481 167.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.671 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -88.61 -11.94 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.657 -173.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.45 -60.55 2.57 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.81 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.7 Cg_endo -55.64 -42.97 62.27 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.462 2.108 . . . . 0.0 113.546 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' B' ' 3' ' ' LEU . 57.4 mt -60.45 -39.76 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.472 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.72 -29.92 73.47 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.579 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.495 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 mtp180 -89.82 -23.13 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 110.383 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 3' ' ' LEU . 36.5 mt -60.93 -58.39 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.317 166.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.652 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.3 mm -61.87 -36.53 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.274 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.98 -36.31 79.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.362 169.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.3 -32.78 73.57 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.835 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.774 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.79 -53.41 58.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.425 169.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.59 20.85 0.76 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.725 -172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.24 120.08 9.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.35 166.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.41 -54.48 10.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.168 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 104.9 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.379 174.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.795 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.2 t -83.81 129.28 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.267 169.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 54' ' ' THR . 27.0 t -61.49 148.29 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.279 166.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 10.9 p30 -61.54 -22.78 65.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.417 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG22 ' B' ' 26' ' ' ILE . 10.1 t70 -88.73 -25.56 22.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.387 -172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -66.41 -44.14 83.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.24 168.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.503 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 2.3 ptt-85 -83.09 -18.17 40.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.414 -167.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.675 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -78.19 -35.43 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.41 168.543 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.555 HG22 HG21 ' A' ' 60' ' ' ILE . 68.7 m -61.11 -37.93 84.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.265 175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.829 ' CD2' HD12 ' A' ' 60' ' ' ILE . 1.1 mm? -60.84 -40.54 93.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.322 166.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.67 -52.13 65.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.337 -176.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.479 ' NZ ' HD11 ' B' ' 26' ' ' ILE . 0.2 OUTLIER -68.55 -33.47 74.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.464 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 64' ' ' VAL . 41.1 mt -61.71 -71.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.16 170.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.724 ' CD1' HD12 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.8 -15.66 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.832 -169.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.417 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 2.7 tt0 -95.41 -24.03 16.88 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.054 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -61.43 -52.26 65.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.111 167.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -73.56 -27.41 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.327 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.32 91.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.86 69.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.334 168.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 2.2 t70 -70.26 -58.18 4.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.557 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.668 HG21 HG23 ' B' ' 64' ' ' VAL . 4.2 mt -61.44 -30.32 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.385 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.22 -73.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.296 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.921 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 24.5 p -62.13 -15.44 45.62 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.529 -170.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.53 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -89.67 -39.52 13.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.158 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.63 -9.07 56.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.486 168.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.786 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.6 mt -94.34 -53.24 8.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.873 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.43 -18.21 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.382 168.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.1 mt -72.96 -48.75 33.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.398 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -70.3 -31.94 69.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.218 -170.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.429 ' CZ ' ' HB2' ' B' ' 48' ' ' ARG . 22.8 ttm105 -65.83 -40.02 91.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.282 168.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.23 -38.58 87.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.31 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.88 -51.21 70.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.287 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.14 4.31 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 148.02 22.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.415 -170.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -82.63 171.98 13.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -170.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 93.9 m 61.54 119.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.421 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.761 HG23 ' HB3' ' B' ' 59' ' ' ASP . 82.4 mt -88.6 148.31 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.388 170.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 0.0 OUTLIER -135.75 179.69 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.45 -169.234 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -61.6 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.291 -171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 15.7 pt-20 -84.36 -43.86 14.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.063 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.761 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.4 OUTLIER -61.61 -23.52 66.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.44 179.278 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 28' ' ' LEU . 29.7 mm -88.61 -56.37 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.239 -171.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 36.5 mt-10 -62.09 -18.06 59.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 172.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' B' ' 62' ' ' LEU . 12.1 mt -67.17 -55.82 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.336 168.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.64 81.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.219 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 31' ' ' ILE . 49.2 t -62.1 -79.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.689 171.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -12.02 9.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.365 -168.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -53.68 48.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.36 167.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 5.0 m-85 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.375 173.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 8' ' ' ILE . 17.2 mt . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.599 0.714 . . . . 0.0 109.989 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 4.2 Cg_endo -46.52 140.45 11.94 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.4 2.067 . . . . 0.0 113.478 173.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.661 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -89.76 -13.41 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.755 -168.799 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.76 -55.86 8.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.665 173.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.5 Cg_exo -48.68 -59.33 1.29 Allowed 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.705 2.27 . . . . 0.0 113.555 169.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.7 mt -61.43 -35.87 69.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.458 -178.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 25' ' ' ARG . . . -61.61 -37.73 94.68 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.556 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 9.4 ptp180 -90.23 -14.35 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.465 -171.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.52 -56.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.305 165.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.699 HD11 HD23 ' A' ' 28' ' ' LEU . 9.1 mm -61.34 -37.31 77.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.149 -177.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 mttm -60.37 -39.45 87.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.429 167.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.34 -33.35 74.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.751 -177.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -59.11 -53.86 53.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.207 -1.361 . . . . 0.0 110.427 169.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.48 21.56 0.45 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.713 -175.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.56 137.95 58.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.409 168.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.9 -27.72 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.005 -170.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.82 117.99 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.445 169.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' CG1' ' B' ' 55' ' ' ILE . 89.5 t -141.41 132.24 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -172.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 p -83.34 151.23 25.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.406 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 p30 -62.03 -14.17 33.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 26' ' ' ILE . 11.7 m-20 -86.48 -27.9 23.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.394 -176.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -65.42 -39.28 91.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.109 165.018 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -61.66 -43.64 98.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.518 -178.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.605 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 tt -75.08 -40.45 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.269 -172.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD11 ' A' ' 31' ' ' ILE . 83.1 m -60.66 -44.42 96.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.396 -174.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.782 HD13 HG23 ' B' ' 60' ' ' ILE . 2.2 tp -61.0 -35.41 76.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.288 169.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -62.05 -42.07 98.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.405 178.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -29.42 40.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 28.9 mt -61.28 -72.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.029 171.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 31' ' ' ILE . 8.2 mp -60.11 -30.28 69.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 -167.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.4 tm-20 -81.53 -37.44 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.034 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -61.47 -39.79 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.955 166.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.427 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 95.3 mtp -61.36 -40.91 96.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.495 175.205 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.09 -38.21 63.7 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -166.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -61.02 -27.5 68.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.248 164.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -74.12 -51.47 15.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.53 -173.82 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 64' ' ' VAL . 12.5 mt -61.14 -38.86 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.204 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.878 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -60.97 -58.68 7.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.388 -170.016 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 23.3 p -61.49 -28.79 69.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.365 178.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.0 -43.38 98.94 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.071 169.575 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -76.9 -12.73 60.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.354 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.849 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -84.27 -56.59 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.306 -168.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -59.79 -28.89 67.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.488 170.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.79 HD22 HD23 ' A' ' 62' ' ' LEU . 13.5 mt -60.63 -47.02 88.09 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.457 174.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.73 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.23 -38.03 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.325 -176.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -44.94 75.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 -170.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -60.97 -31.48 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.336 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.27 -53.21 59.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.211 168.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.82 17.14 0.84 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 59.39 28.39 17.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.322 -0.516 . . . . 0.0 111.237 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 77.59 8.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.298 169.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.583 HG23 ' HG3' ' B' ' 19' ' ' ARG . 6.7 m 68.51 169.58 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.709 ' HB ' HG22 ' B' ' 20' ' ' VAL . 5.6 mm -106.08 137.29 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.195 164.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.737 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -128.26 159.77 34.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.417 -167.475 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -62.28 -13.04 24.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.126 -172.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 1.0 OUTLIER -81.69 -25.49 35.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 174.04 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -84.04 -36.43 23.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.27 -174.673 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.831 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.82 -48.72 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.489 161.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.4 mm-40 -61.44 -43.85 98.15 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.81 -174.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 HD22 ' A' ' 46' ' ' LEU . 39.9 tp -65.38 -44.74 86.6 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.542 173.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.39 -45.05 95.96 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.426 -175.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.887 HG21 HG21 ' B' ' 31' ' ' ILE 0.25 0.4 OUTLIER -78.51 -53.52 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.085 -166.554 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -36.26 77.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.631 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -21.06 59.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.374 174.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.9 t80 . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.259 -173.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.671 ' CB ' HD11 ' B' ' 8' ' ' ILE . 4.6 mt . . . . . 0 C--O 1.243 0.716 0 CA-C-O 121.324 0.583 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.3 Cg_endo -55.07 142.93 76.05 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 122.613 2.209 . . . . 0.0 113.628 -172.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.789 HG21 ' HE ' ' B' ' 25' ' ' ARG . 0.1 OUTLIER -66.42 -18.3 23.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.571 -165.198 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -74.62 -62.47 0.94 Allowed Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.776 -170.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.9 Cg_endo -52.72 -50.5 13.83 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.402 2.068 . . . . 0.0 113.444 175.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.671 HD11 ' CB ' ' B' ' 3' ' ' LEU . 27.2 mt -60.45 -31.74 49.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.393 168.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.99 67.97 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.484 -175.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 49.7 mmm-85 -91.66 -27.72 17.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.477 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.476 HD13 ' HG2' ' A' ' 33' ' ' GLU . 36.5 mt -60.92 -59.57 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.526 170.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.878 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.0 mm -61.37 -38.42 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -61.8 -34.01 75.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.349 175.739 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.22 -32.56 73.23 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.685 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.69 -54.0 51.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.45 169.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.45 28.62 0.26 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.67 -176.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.849 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.09 148.84 37.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.715 -0.743 . . . . 0.0 110.357 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.62 117.08 5.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.092 169.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.583 ' HG3' HG23 ' A' ' 54' ' ' THR . 3.1 tpp180 65.04 97.02 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.356 -173.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 55' ' ' ILE . 46.2 t -110.8 150.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.292 168.255 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -61.13 149.41 37.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.315 169.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.449 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 1.7 m-20 -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.309 170.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.78 -60.25 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.593 174.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -62.09 -47.66 83.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.318 -171.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.789 ' HE ' HG21 ' B' ' 5' ' ' ILE . 5.7 ptt180 -61.09 -34.81 75.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.344 -172.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.15 -33.89 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.499 175.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.81 ' O ' HD12 ' B' ' 31' ' ' ILE . 80.0 m -60.99 -44.93 96.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.407 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.831 HD22 HG13 ' A' ' 60' ' ' ILE . 3.9 tp -60.39 -54.47 45.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.268 173.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -61.54 -15.53 39.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.456 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' CG ' ' B' ' 33' ' ' GLU . 8.5 tmtt? -99.02 -25.46 14.55 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.266 -174.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mt -60.54 -69.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.951 162.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 28' ' ' LEU . 2.5 mp -59.92 -35.16 74.3 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.575 -167.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.515 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -70.35 -40.08 74.27 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.964 -176.771 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -44.17 97.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.122 173.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.511 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 63.1 mmm -61.01 -27.09 68.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.462 175.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.15 -43.47 13.45 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -60.34 -17.98 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.393 166.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -90.96 -52.13 5.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.358 -168.711 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.734 HD13 ' CG2' ' B' ' 64' ' ' VAL . 4.3 mt -61.11 -23.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.206 167.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.66 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.84 -72.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.28 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.828 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 11.8 m -61.67 -11.4 11.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.358 -175.544 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.432 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -80.22 -56.63 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.129 171.304 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.4 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -61.1 -14.65 25.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.326 176.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 17' ' ' ALA . 70.8 mt -90.62 -54.96 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.056 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.53 -11.62 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.414 170.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 6.4 mt -87.81 -42.47 12.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.443 176.448 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.47 -25.69 67.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.276 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -83.41 -50.75 8.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.45 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -61.31 -31.62 71.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.375 -178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.28 73.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.201 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.83 35.78 0.94 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -166.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 66.49 118.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.487 169.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.598 ' O ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -167.82 13.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.321 179.387 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.598 HG22 ' O ' ' B' ' 53' ' ' LYS . 0.7 OUTLIER 60.96 162.37 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.494 -175.947 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.895 ' CG1' HG22 ' A' ' 20' ' ' VAL . 14.0 mm -75.21 137.47 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.339 173.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 18.9 mtmt -154.32 -178.82 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.425 -169.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -24.69 66.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.34 172.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -26.48 21.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.123 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -35.5 13.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.317 -175.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 28' ' ' LEU . 46.9 mm -61.15 -47.37 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.196 167.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.492 ' HG2' ' NH2' ' B' ' 65' ' ' ARG . 20.9 mt-10 -62.02 -44.53 96.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.971 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -45.98 92.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.464 172.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' B' ' 46' ' ' LEU . . . -61.49 -46.04 91.69 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.421 -177.153 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.734 ' CG2' HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -80.02 -60.94 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.099 -165.984 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' B' ' 61' ' ' GLU . 4.6 mtm180 -60.22 -19.0 52.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.565 -175.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -89.54 -25.5 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.544 171.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.8 t80 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.46 -179.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 122.086 0.946 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.665 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.3 Cg_endo -63.82 141.21 77.41 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 113.646 -178.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 HH21 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -100.24 -13.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.636 -166.859 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.44 -55.54 3.53 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.674 173.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.2 Cg_exo -49.43 -61.17 0.62 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.749 2.299 . . . . 0.0 113.557 168.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 3' ' ' LEU . 54.9 mt -61.39 -49.58 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.4 91.27 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -172.286 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -40.99 96.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.081 -0.56 . . . . 0.0 110.407 176.088 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 8' ' ' ILE . 68.1 mt -61.55 -36.11 71.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.538 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.673 HG23 ' HB1' ' B' ' 40' ' ' ALA . 8.3 mm -72.79 -44.97 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.192 -172.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -31.96 72.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.255 176.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -61.89 -33.3 73.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.807 177.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.26 -53.21 60.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.462 170.215 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.4 25.79 0.63 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.496 -174.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.21 119.79 9.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.718 -0.741 . . . . 0.0 110.363 176.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.59 -71.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.12 131.84 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.368 168.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.557 ' CG2' ' HB1' ' A' ' 17' ' ' ALA . 60.0 t -124.62 133.14 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.422 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.9 p -73.47 136.02 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.04 -12.88 13.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.398 -174.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -86.67 -21.93 26.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.35 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.719 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -70.72 -38.47 73.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.123 164.036 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.487 HH21 HD13 ' A' ' 5' ' ' ILE . 2.3 mtp180 -61.48 -31.48 71.46 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.502 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.5 tp -89.7 -34.61 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 -175.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.665 ' O ' HD12 ' A' ' 31' ' ' ILE . 80.5 m -61.52 -41.16 96.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.18 177.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.8 tp -59.19 -45.48 90.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.541 167.314 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.52 -43.09 99.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.504 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -76.62 -28.09 55.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.235 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.02 HG21 HG21 ' B' ' 64' ' ' VAL . 6.6 mt -59.59 -73.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.908 162.177 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.687 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -56.15 -23.79 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.819 -159.646 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.785 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.83 -60.76 2.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.038 166.558 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -28.66 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.109 -164.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.531 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.3 mmm -71.58 -38.96 70.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.436 167.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -66.49 -44.3 90.44 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -174.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.399 168.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -66.35 -53.75 32.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.434 -178.003 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.639 ' HB ' HD11 ' B' ' 28' ' ' LEU . 8.1 mt -61.39 -45.48 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.388 -175.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.29 -48.36 81.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 -172.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.2 t -62.15 -27.46 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.385 177.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -68.37 -43.15 78.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.181 168.978 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -73.06 -7.78 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.676 177.283 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.831 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.84 -52.07 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.275 -174.609 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -31.1 68.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.667 168.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 43' ' ' ALA . 12.7 mt -61.16 -51.13 70.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.405 175.009 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.99 67.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.348 -171.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -41.97 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.439 170.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -63.22 -31.6 72.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.389 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.261 169.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 35.01 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -170.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.15 133.68 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.375 169.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.4 mmpp? -61.35 -43.51 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.34 -169.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -66.41 126.21 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.412 -168.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 59' ' ' ASP . 7.0 mt -91.67 154.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.362 168.062 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HE3' ' H ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -158.84 173.53 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.377 -166.521 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' H ' ' HE3' ' A' ' 56' ' ' LYS . . . -61.97 -15.85 46.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.255 -177.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.718 ' O ' HD13 ' A' ' 62' ' ' LEU . 1.3 tt0 -83.76 -41.59 17.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.087 175.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -59.94 -49.38 77.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.608 170.985 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 28' ' ' LEU . 32.2 mm -60.77 -59.92 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.415 -171.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 30.3 mt-10 -61.83 -29.17 69.99 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.968 -174.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.1 mp -60.36 -45.6 92.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.469 168.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.14 -42.93 99.44 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.588 -176.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.76 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.14 -55.07 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.054 -165.569 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -21.87 64.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.738 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -92.92 -14.33 27.72 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.736 177.056 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CD2' ' HG2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.92 161.248 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.578 ' CB ' HD11 ' B' ' 8' ' ' ILE . 12.1 mt . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.311 0.577 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 5.1 Cg_endo -60.32 160.98 21.35 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.575 2.183 . . . . 0.0 113.407 164.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.412 HD13 ' OD1' ' B' ' 22' ' ' ASP . 2.4 pp -102.27 -20.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.517 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.14 -59.09 4.5 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.754 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 4.7 Cg_endo -48.66 -50.98 11.19 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.585 2.19 . . . . 0.0 113.467 171.027 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.853 ' HA ' HD12 ' B' ' 11' ' ' ILE . 66.9 mt -60.83 -27.91 42.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.317 174.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.44 -40.71 99.05 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.502 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.06 -21.68 39.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.495 -178.441 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' B' ' 8' ' ' ILE . 89.7 mt -67.19 -44.44 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.507 178.053 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.0 mm -69.17 -41.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.325 175.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 11.2 mtmt -61.51 -39.67 91.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.313 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.59 -31.31 71.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.908 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.07 -52.37 65.82 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.639 170.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.91 24.33 0.33 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.635 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.831 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -75.69 120.04 20.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.617 -0.791 . . . . 0.0 110.255 176.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 13.88 29.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.995 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 179.35 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.419 -174.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.8 HG22 ' HB1' ' B' ' 17' ' ' ALA . 10.7 t -99.85 125.58 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.338 -176.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -63.57 149.64 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.169 164.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' B' ' 5' ' ' ILE . 35.9 t70 -60.58 -12.23 9.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.502 169.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' B' ' 26' ' ' ILE . 0.5 OUTLIER -95.37 -32.67 12.83 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.428 -174.61 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -61.2 -41.33 96.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.182 169.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.15 -53.55 55.55 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.52 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.77 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -67.21 -33.44 62.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.316 -171.915 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.444 HG22 ' CG2' ' A' ' 60' ' ' ILE . 85.0 m -70.1 -34.45 73.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.318 -174.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.918 HD21 HD12 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -60.68 -40.76 93.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.21 166.591 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.57 -56.82 15.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.299 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -33.64 76.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.445 -174.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 64' ' ' VAL . 69.7 mt -61.05 -74.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.935 167.296 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.687 ' O ' HD11 ' A' ' 32' ' ' LEU . 3.7 mt -59.33 -28.67 67.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.57 -164.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.557 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.6 pp20? -75.72 -39.5 57.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -35.73 79.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.969 175.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.517 170.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.91 -38.35 95.88 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -33.89 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.276 167.696 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.1 t70 -64.29 -55.7 19.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.438 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.685 ' HB ' HD11 ' A' ' 28' ' ' LEU . 4.9 mt -61.8 -33.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.09 -177.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.93 -65.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.27 -173.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.51 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.03 -18.26 64.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.521 -175.373 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.3 OUTLIER -81.71 -44.65 16.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.168 175.796 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -68.27 -32.53 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.148 175.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.996 HD11 ' HB2' ' A' ' 17' ' ' ALA . 21.7 mt -60.71 -47.39 93.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.097 164.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -30.29 69.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.429 177.1 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.0 mt -72.31 -34.34 68.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.366 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -61.13 -35.84 78.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.294 176.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.64 -44.06 96.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 172.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.74 -36.84 79.89 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.438 174.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.81 -49.88 75.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 172.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 29.79 2.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -163.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.32 -169.58 0.14 Allowed 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.089 -0.654 . . . . 0.0 111.072 175.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.86 98.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.466 -169.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.94 122.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 165.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' B' ' 47' ' ' ALA . 4.1 mp -93.22 138.16 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.152 162.612 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -130.55 178.95 6.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.401 -167.825 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.34 -19.88 62.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.47 -28.67 21.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.043 -177.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.2 -34.94 21.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.338 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.719 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 46.7 mm -61.02 -50.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.403 168.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 5.5 mt-10 -69.1 -37.52 78.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -175.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.04 -45.45 94.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.397 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.435 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.29 -49.48 76.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.385 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 31' ' ' ILE 0.257 0.4 OUTLIER -74.87 -50.5 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.937 -160.89 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -30.19 71.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.439 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.55 84.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.377 -177.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.398 172.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 8' ' ' ILE . 13.2 mt . . . . . 0 C--O 1.243 0.731 0 CA-C-O 121.394 0.616 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.21 141.55 58.83 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.85 1.7 . . . . 0.0 113.113 168.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -93.25 20.77 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.622 -164.319 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.56 -59.39 0.45 Allowed Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.716 172.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -58.0 -50.5 10.0 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.496 2.131 . . . . 0.0 113.498 173.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.846 ' HA ' HD12 ' A' ' 11' ' ' ILE . 57.4 mt -61.37 -44.03 97.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.499 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.41 98.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -170.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.53 -32.31 69.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.008 -0.596 . . . . 0.0 110.334 -178.244 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 8' ' ' ILE . 39.6 mt -61.76 -51.76 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.354 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mm -65.78 -48.44 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.439 -173.024 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -35.14 78.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.253 177.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.83 -32.19 72.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.85 177.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.83 -52.47 65.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.522 170.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.54 20.65 0.61 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.737 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.77 119.54 10.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.181 -0.509 . . . . 0.0 110.319 168.005 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -112.69 18.47 18.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.893 176.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' B' ' 54' ' ' THR . 0.0 OUTLIER 179.89 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.332 -164.396 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.868 HG22 HD12 ' B' ' 55' ' ' ILE . 12.3 t -136.81 118.11 18.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.38 172.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -74.39 159.74 31.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.393 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.13 -23.59 65.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.412 -171.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' ILE . 80.5 m-20 -90.67 -29.6 17.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -170.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.755 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.26 -42.81 99.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.143 162.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.543 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -77.31 -28.69 53.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 -167.519 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 23' ' ' ASP . 5.2 tp -72.94 -37.33 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.429 172.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 31' ' ' ILE . 57.8 m -60.69 -39.98 90.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.727 HD13 HG23 ' B' ' 60' ' ' ILE . 3.5 tp -64.55 -44.37 90.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.014 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.63 72.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.452 173.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -79.35 -33.21 43.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.478 179.207 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.737 HG21 HG21 ' B' ' 64' ' ' VAL . 11.6 mt -60.57 -69.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.003 169.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.739 ' O ' HD21 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -58.09 -27.64 63.86 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.672 -168.496 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -84.55 -19.92 32.36 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.149 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -63.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.008 165.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.419 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 11.0 mtp -61.99 -31.04 71.37 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 -174.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.45 -42.96 71.61 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -177.113 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -22.02 63.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.547 . . . . 0.0 110.435 169.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.4 m-20 -90.46 -47.74 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.608 -168.368 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.9 mt -61.27 -29.66 46.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.243 171.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.98 -66.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.237 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 29.7 p -63.61 -17.57 63.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.542 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.696 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -69.7 -60.84 2.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.909 167.896 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' CA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.69 -14.68 33.63 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.417 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.961 HD11 ' HB2' ' B' ' 17' ' ' ALA . 84.2 mt -96.93 -48.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.664 -172.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -59.85 -11.62 5.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.482 164.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.7 mp -87.17 -52.84 5.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.277 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -14.27 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.314 177.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.94 -70.27 0.7 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.414 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -67.87 -12.01 59.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.852 -170.078 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 52' ' ' ARG . . . -64.7 -45.96 84.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 163.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.08 4.31 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -166.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.516 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 14.6 mmm180 -126.09 172.54 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.448 -164.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 135.92 50.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.445 -170.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 55' ' ' ILE . 70.2 m 62.82 146.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.469 -178.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.972 HD12 HG22 ' B' ' 20' ' ' VAL . 64.3 mt -97.19 156.62 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.234 168.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 177.08 11.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.469 -171.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.87 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.3 173.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -65.34 -50.35 65.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.028 168.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.785 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -61.4 -51.93 66.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.334 179.41 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.813 HG23 HD13 ' B' ' 28' ' ' LEU . 47.6 mm -60.76 -44.13 96.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.342 -168.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -39.21 88.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.151 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.38 -48.31 81.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.328 176.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.37 -30.21 70.39 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.401 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.694 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -89.49 -56.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.129 -165.222 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -16.24 31.42 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.695 171.2 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -32.02 57.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.358 169.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.465 171.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.672 ' CB ' HD11 ' B' ' 8' ' ' ILE . 15.5 mt . . . . . 0 C--O 1.242 0.697 0 CA-C-O 121.507 0.67 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 4.4 Cg_endo -47.53 142.42 13.42 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.551 2.168 . . . . 0.0 113.424 168.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.66 -19.21 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.447 -167.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.99 -62.66 1.51 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.744 -168.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.3 Cg_endo -52.68 -42.86 59.77 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.5 2.133 . . . . 0.0 113.491 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.672 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -60.41 -47.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.537 172.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.03 -26.13 67.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -173.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.24 -33.42 32.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.402 -177.725 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' HD21 ' A' ' 3' ' ' LEU . 67.5 mt -60.76 -52.4 62.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.447 169.766 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.956 HG22 ' HB2' ' B' ' 17' ' ' ALA . 11.8 mm -61.1 -35.13 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.199 177.662 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.5 mttt -67.58 -37.05 82.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.504 178.074 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -61.7 -31.42 71.57 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.687 -178.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.81 -53.58 56.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.474 168.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.14 7.51 0.81 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.782 -166.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -63.7 -162.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.954 0.502 . . . . 0.0 110.691 168.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' HG2' ' B' ' 13' ' ' LYS . 4.0 tm-20 64.2 25.42 13.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -155.533 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 20.19 17.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.404 151.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.972 HG22 HD12 ' A' ' 55' ' ' ILE . 61.2 t -113.27 172.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.228 -161.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.671 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 24.6 p -108.63 169.21 8.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.587 175.104 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 1.8 p30 -78.54 -33.52 47.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.336 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.83 -30.81 70.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.334 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' B' ' 21' ' ' SER . . . -60.95 -69.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.269 169.295 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' B' ' 22' ' ' ASP . 1.3 ptt180 -61.06 -11.44 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.345 -166.558 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 29.7 mt -86.11 -35.3 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.424 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.652 HG22 HD11 ' B' ' 31' ' ' ILE . 73.1 m -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.419 176.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 60' ' ' ILE . 2.8 tp -60.74 -40.45 92.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.42 177.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.32 96.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.511 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 5.7 tttt -74.63 -31.33 61.95 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.393 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.694 HG21 HG21 ' A' ' 64' ' ' VAL . 54.0 mt -60.72 -75.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.964 170.559 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.93 -30.98 66.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 -162.439 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 2.5 tm-20 -85.81 -31.44 22.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.016 -173.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.6 mm-40 -61.49 -36.91 81.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.829 163.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 2.6 ttm -63.82 -43.52 95.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.446 176.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.72 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -71.49 -33.58 63.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -165.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -60.85 -33.22 72.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.27 164.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -51.07 54.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.712 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.72 HD12 ' HA2' ' B' ' 36' ' ' GLY . 1.1 mt -62.32 -35.59 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.758 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 12' ' ' ILE . . . -61.35 -65.75 0.64 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.9 -20.51 63.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.418 -179.165 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.714 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -70.16 -61.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.133 169.763 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.32 -5.88 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' A' ' 17' ' ' ALA . 77.6 mt -101.41 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.885 -176.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -15.77 32.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.387 171.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.714 HD12 ' C ' ' B' ' 42' ' ' GLU . 13.4 mt -79.86 -50.32 10.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.432 170.177 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.35 -17.57 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.252 -171.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -46.51 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.458 169.09 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -61.74 -37.97 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.335 -173.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.04 -47.65 85.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.24 169.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.19 33.07 5.57 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -166.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.15 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.439 -168.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -91.61 132.31 36.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.37 170.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER 66.24 142.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.344 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 20' ' ' VAL . 89.2 mt -89.52 132.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.213 166.442 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -118.12 171.7 7.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.332 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -14.35 20.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.366 172.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.443 ' OE1' HD11 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -71.41 -52.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.183 169.387 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -68.91 -36.06 77.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.38 -178.083 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.755 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 39.2 mm -61.49 -62.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.342 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.81 -26.35 68.06 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.885 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 11.6 mt -60.46 -50.72 72.45 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.423 170.324 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -62.02 -32.91 73.46 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.479 -172.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -86.95 -48.84 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -162.512 . . . . . . . . 4 4 . 1 . 023 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -66.69 -24.63 66.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.438 169.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.82 -37.08 80.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.415 173.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' B' ' 64' ' ' VAL . 10.5 p90 . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.333 -168.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 121.917 0.865 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 3' ' ' LEU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 122.217 1.008 . . . . 0.0 112.43 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 121.917 0.865 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 3' ' ' LEU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 122.217 1.008 . . . . 0.0 112.43 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.681 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 122.099 0.952 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -60.22 150.0 82.16 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 123.016 2.477 . . . . 0.0 113.479 -172.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -100.65 17.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.809 -164.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -89.87 -56.86 0.27 Allowed Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.703 175.538 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.3 Cg_exo -53.76 -58.83 1.17 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.596 2.198 . . . . 0.0 113.371 164.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 3' ' ' LEU . 25.7 mt -61.74 -47.93 91.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.478 -178.049 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.88 93.42 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -39.98 95.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.412 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 3' ' ' LEU . 75.0 mt -61.81 -48.08 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.438 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.8 mm -64.54 -36.78 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.426 -172.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -32.4 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.366 171.781 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.74 -34.99 78.33 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.827 -178.098 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.42 -53.71 54.99 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.376 169.548 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.68 21.06 0.38 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.715 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.23 135.3 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.153 -0.523 . . . . 0.0 110.385 166.489 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -157.65 31.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.024 174.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 81.24 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.268 168.061 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG22 HD12 ' B' ' 55' ' ' ILE . 14.2 t -131.16 142.33 43.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.387 -168.185 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.31 151.15 24.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.352 169.068 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -13.66 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.487 172.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.724 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -87.57 -30.55 20.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.324 -174.901 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.148 165.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -61.76 -34.39 75.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.424 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.27 -37.44 22.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.317 -179.368 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.553 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -63.4 -44.05 95.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.294 -171.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.938 HD11 ' HB ' ' B' ' 39' ' ' ILE . 4.0 tp -59.6 -42.32 92.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.464 167.559 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.78 -39.4 91.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.312 -176.377 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 -20.88 23.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.302 -175.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.77 HG21 HG21 ' B' ' 64' ' ' VAL . 32.3 mt -61.08 -71.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.92 162.448 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.0 mp -59.74 -20.22 55.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.745 -167.725 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.681 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.13 -55.3 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.115 170.925 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.74 -41.73 98.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.984 -172.364 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.433 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.2 mmm -61.16 -43.53 98.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.447 168.322 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.42 -48.24 45.95 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -167.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.72 -19.14 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.277 167.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -75.95 -58.93 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.499 179.533 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.771 HG21 HG23 ' A' ' 64' ' ' VAL . 4.0 mt -60.89 -22.92 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.576 178.301 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.64 -77.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.266 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.79 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.24 -10.98 7.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.477 -172.577 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.54 -52.93 6.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.186 172.772 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.91 -19.0 59.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.41 173.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.795 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.7 mt -86.29 -51.25 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.949 -177.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -60.16 -11.28 5.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.444 167.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.3 mp -85.21 -38.44 18.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.315 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.92 -30.93 70.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.37 170.739 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 29.5 mmt-85 -68.36 -53.31 24.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.409 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -19.98 60.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.375 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.07 -53.74 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.245 168.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.02 24.05 0.53 Allowed Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.482 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.5 ttp-105 66.4 122.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.446 166.144 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.43 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.4 167.363 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 30.0 m -162.05 141.81 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.447 -178.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.938 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.1 mm -71.77 148.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.393 170.432 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 10.2 mttp -153.12 -177.85 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.523 177.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.01 75.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -173.129 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.697 ' O ' HD12 ' A' ' 62' ' ' LEU . 24.9 tt0 -73.11 -27.56 61.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -178.715 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -36.64 42.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.413 178.309 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.708 ' CG2' HD22 ' B' ' 28' ' ' LEU . 38.5 mm -60.83 -57.25 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.417 170.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -61.47 -30.68 70.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.02 -176.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.46 -51.57 68.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.412 169.209 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -46.76 89.43 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.482 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.771 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.77 -51.47 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.892 -163.473 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.21 -21.71 66.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.708 176.345 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD2' HD11 ' A' ' 46' ' ' LEU . 6.4 ttt-85 -61.29 -39.99 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.268 174.116 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 83.6 m-85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.279 166.034 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 11' ' ' ILE . 3.5 mt . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.96 153.5 50.93 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.394 2.063 . . . . 0.0 113.49 169.264 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.6 pt -100.62 16.98 3.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.696 -176.021 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.41 -59.61 0.28 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.712 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.4 Cg_endo -58.25 -50.06 10.8 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.437 2.091 . . . . 0.0 113.375 168.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.84 -28.99 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 175.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.4 77.8 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.526 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -82.4 -17.19 46.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.395 -170.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.0 mm -60.73 -66.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.439 168.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.72 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.5 -31.39 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.077 -174.291 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -66.1 -37.72 86.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.455 172.276 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -62.13 -32.25 72.81 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.884 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.79 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.73 -52.96 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.454 170.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.86 27.5 0.72 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.523 -170.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.795 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.73 119.99 9.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.775 -0.712 . . . . 0.0 110.373 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.52 -38.69 65.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.13 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.32 100.2 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.718 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.22 140.18 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.275 165.6 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 95.9 p -66.95 165.71 15.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.27 167.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.98 -18.68 58.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.284 168.104 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -58.37 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.441 169.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -62.07 -42.57 99.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.334 -169.396 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.572 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 41.2 mtm180 -61.77 -50.04 73.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.386 -178.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.457 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.5 mm -61.49 -25.04 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.445 179.348 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.566 HG21 ' HB ' ' A' ' 60' ' ' ILE . 85.3 m -73.91 -42.46 60.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.37 -172.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.744 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.76 -35.48 76.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.345 169.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -63.67 -43.54 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.297 -173.31 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -80.55 -27.83 37.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.376 -179.558 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 64' ' ' VAL . 52.4 mt -61.36 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.976 167.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.744 HD11 HD12 ' B' ' 28' ' ' LEU . 3.8 mp -59.11 -23.39 62.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.733 -164.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -85.0 -28.51 25.69 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.05 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.78 -31.76 71.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.862 163.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -34.21 32.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.413 -176.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.52 42.23 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -176.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.425 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.377 169.547 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.357 176.872 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.938 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.2 mt -60.89 -21.72 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.307 -170.238 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.72 -69.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.324 173.41 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.513 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.44 -11.03 8.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.554 -177.275 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.91 -40.46 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.068 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.473 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -69.93 -14.81 62.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 168.562 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.2 mt -97.3 -52.14 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.956 -173.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -19.71 56.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.368 169.229 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.6 mt -68.62 -53.49 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.344 166.042 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.37 -25.91 67.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.247 -173.45 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -38.73 75.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.328 168.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.57 -32.61 71.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.375 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.72 -48.52 81.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.35 173.298 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.26 38.14 1.05 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -167.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 65.27 102.53 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.392 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -171.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.451 177.148 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.2 m -78.41 130.22 35.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.416 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.809 HD12 HG22 ' A' ' 20' ' ' VAL . 28.8 mt -74.01 132.78 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.275 166.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -136.77 -170.13 2.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.391 -177.338 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.99 -22.02 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.251 178.095 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.4 -34.11 21.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -81.25 -35.17 31.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.36 -177.579 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 28' ' ' LEU . 38.8 mm -61.18 -57.67 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.381 167.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.4 mt-10 -62.22 -37.59 85.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.951 -173.721 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.51 ' CD2' HD22 ' B' ' 46' ' ' LEU . 34.5 tp -60.77 -43.86 97.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.38 172.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.12 -35.25 76.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.441 178.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.77 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -90.46 -59.92 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.271 -162.355 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -23.46 64.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.6 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -23.36 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 172.09 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.495 177.093 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.058 HD21 HD11 ' B' ' 11' ' ' ILE . 6.8 mt . . . . . 0 C--O 1.242 0.692 0 CA-C-O 121.338 0.59 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 10.9 Cg_endo -55.45 164.55 3.97 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.52 2.147 . . . . 0.0 113.395 164.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 25' ' ' ARG . 21.5 pt -95.88 38.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.314 -173.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -95.01 -58.47 0.2 Allowed Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.73 173.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.7 Cg_endo -59.91 -32.82 95.74 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.53 2.154 . . . . 0.0 113.653 173.398 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HA ' HD12 ' A' ' 11' ' ' ILE . 72.8 mt -96.81 -13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.62 -169.245 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -43.72 98.89 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -97.39 19.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.472 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.724 HG22 HD13 ' A' ' 12' ' ' ILE . 22.9 mt -90.28 -49.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.208 166.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.792 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 3.9 mm -96.31 48.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.651 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HA ' ' H ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -156.11 -26.45 0.1 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.748 169.72 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.68 -40.59 66.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.276 163.521 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.793 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.73 -72.87 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.727 172.545 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.7 36.39 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.149 152.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.099 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -73.29 123.15 23.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.153 -165.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -135.58 31.83 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.088 -165.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.95 102.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.423 168.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t -125.15 162.46 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.369 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 47.1 t -101.84 13.48 34.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.375 -169.324 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p30 60.47 23.56 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -140.67 -30.07 0.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.358 179.144 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.12 -40.6 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.437 177.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HG3' HG21 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.39 -30.1 70.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.409 -178.907 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 5' ' ' ILE . 9.1 mm -83.86 -30.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.413 179.288 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD12 ' A' ' 31' ' ' ILE . 74.6 m -60.79 -46.36 90.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.377 168.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.929 HD13 HG23 ' B' ' 60' ' ' ILE . 4.9 tp -61.0 -45.46 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.336 172.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 3' ' ' LEU . . . -61.75 -12.69 18.09 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.548 -178.689 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -107.74 -37.51 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.24 -178.7 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.966 HD13 HG21 ' B' ' 64' ' ' VAL . 60.0 mt -60.88 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.078 168.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.02 -34.85 72.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 -166.329 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 3' ' ' LEU . 2.5 tm-20 -68.05 -43.82 77.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.236 176.607 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.59 -17.02 63.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.029 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.438 ' CE ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 mtm -81.84 -43.4 18.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.466 169.165 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -69.27 -45.87 59.47 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -169.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' N ' HG22 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -61.53 -16.62 49.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.316 169.25 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.1 -54.63 5.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.447 -179.543 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.703 ' HB ' HD11 ' B' ' 28' ' ' LEU . 15.2 mt -61.52 -28.62 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.343 -176.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.34 -65.67 0.66 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.22 -173.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.755 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 25.9 t -61.2 -10.49 6.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.524 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 46' ' ' LEU . 12.1 mm-40 -85.01 -57.57 3.04 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.05 173.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.92 -8.61 5.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.532 174.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' B' ' 17' ' ' ALA . 51.4 mt -95.93 -54.31 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.222 178.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -13.82 62.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.359 -178.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 42' ' ' GLU . 7.6 mt -88.39 -21.41 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.403 173.307 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -80.49 -29.97 37.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -165.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.47 -15.72 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.384 -168.574 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -9.92 59.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.42 164.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.73 -54.12 49.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.297 174.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.21 33.85 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.535 -169.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 67.17 121.25 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.638 -0.781 . . . . 0.0 110.587 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' H ' ' NH1' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 179.86 -79.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.362 171.631 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.586 HG21 ' OG ' ' B' ' 21' ' ' SER . 72.5 m -167.51 159.97 12.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.134 -164.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.564 HD13 ' CB ' ' A' ' 47' ' ' ALA . 7.2 mm -90.09 137.62 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.3 165.165 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 7.7 mttm -153.37 -174.9 5.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.487 -166.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -66.33 -21.42 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.148 -169.445 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -94.18 25.13 3.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.147 175.018 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.624 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . 14.5 m-20 -119.21 -39.57 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.153 174.163 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.714 HG22 HG22 ' B' ' 27' ' ' THR . 3.1 mp -91.15 14.78 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.631 163.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.0 mm-40 -121.65 36.91 4.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 164.192 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 62' ' ' LEU . 10.6 tp -169.42 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.378 -174.828 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HB2' ' CA ' ' A' ' 43' ' ' ALA . . . -84.86 -17.53 37.67 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.405 173.54 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.69 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -107.61 -67.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.265 -157.676 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -60.76 -23.89 65.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.39 177.187 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -78.35 -60.68 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.102 164.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.151 -157.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 121.315 0.578 . . . . 0.0 109.66 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 5.7 Cg_endo -52.86 151.43 20.11 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.665 2.244 . . . . 0.0 113.527 172.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.519 HG21 ' CG1' ' B' ' 26' ' ' ILE . 1.1 pt -85.63 64.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.51 175.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -151.65 -57.97 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.619 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.8 Cg_endo -60.08 -38.23 78.88 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.181 . . . . 0.0 113.589 170.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.642 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -73.4 -18.26 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.515 172.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' B' ' 25' ' ' ARG . . . -61.04 -52.91 49.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -166.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 5.1 mtt-85 -75.25 -20.66 59.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.411 -176.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 3' ' ' LEU . 16.1 mt -63.58 -47.39 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.278 167.282 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 40' ' ' ALA . 6.3 mm -95.77 45.41 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.835 175.07 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -149.47 -31.7 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.873 170.872 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.78 -31.28 70.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.92 172.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.755 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -58.74 -51.6 69.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.545 170.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.57 23.23 1.23 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.702 -171.2 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -65.81 131.58 46.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.349 173.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.6 -77.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.111 -177.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -146.83 144.12 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.318 -169.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.593 HG12 ' H ' ' B' ' 21' ' ' SER . 11.0 t -113.06 168.73 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -168.058 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.593 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -127.83 -162.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.244 -164.828 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.67 89.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.451 167.663 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.41 125.2 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.541 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . . . -176.66 -48.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.977 163.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.467 ' CZ ' HG21 ' B' ' 20' ' ' VAL . 15.1 ttp180 -77.22 -30.55 54.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.329 167.246 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.519 ' CG1' HG21 ' B' ' 5' ' ' ILE . 59.0 mt -72.72 -36.32 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.416 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 60' ' ' ILE . 92.5 m -60.81 -43.27 98.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.325 169.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -60.85 -45.81 93.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.149 174.414 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -17.82 54.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.511 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.22 -32.6 11.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.412 -171.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mp -62.11 -72.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.587 159.273 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -58.82 -14.12 7.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.931 -162.663 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.402 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 1.9 tm-20 -91.41 -26.36 18.9 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.17 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.28 -19.49 28.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.141 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 8.1 mtt -93.69 12.37 25.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.412 171.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.69 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 -41.2 0.51 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.088 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 15' ' ' ALA . 1.4 tmt_? -61.17 -20.67 62.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.262 166.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.37 -35.3 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.436 -167.704 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.795 HG23 ' O ' ' B' ' 63' ' ' ALA . 7.6 mt -62.04 -33.97 61.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.288 171.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.19 -63.02 1.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.306 -169.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.793 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 15.3 m -61.9 -13.76 27.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.592 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 3.0 mm-40 -81.6 -45.33 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.104 176.08 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -73.25 -33.71 65.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.209 177.044 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 1.099 HD11 ' HB2' ' A' ' 17' ' ' ALA . 15.2 mt -60.5 -56.35 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.351 167.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.65 69.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 -176.715 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' B' ' 63' ' ' ALA . 4.3 mt -76.24 -36.91 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.494 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.86 -45.24 94.63 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.262 -177.141 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -89.72 -25.72 21.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.373 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -64.04 -44.9 91.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.266 168.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.0 98.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.268 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.32 43.55 15.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -175.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -135.3 -166.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.398 -168.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -169.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.423 -167.385 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 0.8 OUTLIER -68.26 172.29 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.926 -167.903 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' B' ' 47' ' ' ALA . 31.9 mm -60.62 135.94 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.465 175.312 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -159.24 -176.59 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.423 -169.413 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -62.48 -24.09 67.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 -170.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.701 ' C ' HD23 ' B' ' 62' ' ' LEU . 1.1 pp20? -103.52 23.1 13.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.104 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.56 -34.63 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.424 168.319 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.929 HG23 HD13 ' A' ' 28' ' ' LEU . 36.7 mm -61.02 -65.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.328 165.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.732 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.2 mt-10 -61.4 -10.92 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.245 -177.187 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.701 HD23 ' C ' ' B' ' 58' ' ' GLU . 4.1 mm? -99.51 -18.66 17.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.515 176.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.795 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -92.06 14.53 15.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.561 164.917 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 31' ' ' ILE . 40.1 t -115.7 -68.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.585 -176.356 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -60.18 -10.06 4.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.588 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -37.61 86.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.663 168.348 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CZ ' HG12 ' B' ' 39' ' ' ILE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.205 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.678 HD13 ' HB3' ' A' ' 33' ' ' GLU . 10.4 mp . . . . . 0 C--O 1.248 0.988 0 CA-C-O 121.983 0.897 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 10.8 Cg_exo -45.2 148.78 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.868 2.378 . . . . 0.0 113.466 177.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 26' ' ' ILE . 2.0 pt -70.96 58.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.373 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -160.28 -52.89 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.52 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.0 Cg_endo -55.71 -32.62 84.74 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 C-N-CA 122.781 2.321 . . . . 0.0 113.506 167.022 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 29' ' ' ALA . 9.4 mm -60.63 -39.66 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.485 168.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.4 98.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -166.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.14 18.63 13.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.41 -176.605 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' B' ' 37' ' ' ARG . 95.5 mt -103.32 -39.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.182 164.576 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.711 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.3 mm -81.08 -37.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 -179.094 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -41.41 95.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.428 169.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.89 -30.79 71.11 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.815 -175.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.63 -53.29 59.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.55 168.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.09 32.33 0.35 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.562 -171.439 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.054 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -80.47 -167.63 1.42 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.3 177.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.05 93.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.997 165.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.3 104.93 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.32 162.8 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.069 164.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 16.6 t -94.41 -84.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.411 -166.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 9.1 t70 -174.89 136.88 0.41 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 -171.305 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.914 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 0.4 OUTLIER 77.97 -51.69 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.014 -161.605 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.13 -39.37 89.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.304 -173.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.94 -40.52 97.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.412 -177.842 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 5' ' ' ILE . 1.6 mp -94.64 -23.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.404 -170.087 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.625 HG22 HD11 ' A' ' 31' ' ' ILE . 92.0 m -60.79 -39.79 90.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.491 173.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD23 ' CD1' ' A' ' 12' ' ' ILE . 13.1 tp -88.35 -14.31 38.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.493 -171.577 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . -79.03 -45.33 20.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.198 164.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -61.0 -36.97 80.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.484 175.554 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.726 HG21 HG21 ' B' ' 64' ' ' VAL . 23.0 mt -62.21 -78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.897 170.672 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD21 HD12 ' B' ' 39' ' ' ILE . 2.0 mm? -57.09 -26.62 60.74 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.543 -158.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.678 ' HB3' HD13 ' A' ' 3' ' ' LEU . 11.5 pt-20 -64.24 -36.12 83.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.025 176.411 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -62.33 -39.58 93.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.818 -164.492 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.467 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 21.6 mtt -81.69 -25.94 35.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -72.89 -39.83 53.7 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.515 -176.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -60.98 -17.06 49.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.395 168.902 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -99.83 -46.09 5.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.555 -164.664 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.677 HD13 ' CG2' ' A' ' 64' ' ' VAL . 7.2 mt -61.62 -26.28 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.183 172.123 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.33 -70.38 0.2 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.115 177.153 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.18 -18.17 56.82 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.525 179.472 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 46' ' ' LEU . 6.5 mm-40 -72.3 -61.65 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.034 169.311 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.13 -9.49 4.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.539 179.1 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' B' ' 17' ' ' ALA . 90.1 mt -100.77 -67.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.048 -178.366 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -17.4 53.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.349 -176.823 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.763 HD12 ' C ' ' A' ' 42' ' ' GLU . 14.5 mt -60.93 -48.18 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.206 163.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB1' ' HB3' ' A' ' 53' ' ' LYS . . . -87.49 -27.71 22.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.224 -168.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -21.65 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.33 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -60.98 -14.61 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.323 166.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -82.93 -43.95 15.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.305 175.535 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.1 15.54 23.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 172.175 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 178.93 84.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 169.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -108.91 151.94 25.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.462 -161.358 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.493 HG22 ' HB3' ' B' ' 21' ' ' SER . 98.3 m -140.55 114.42 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.158 163.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.776 ' HB ' HG13 ' B' ' 20' ' ' VAL . 13.6 mm -60.52 153.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.349 -166.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.7 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -140.88 173.33 11.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.416 -171.968 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.16 -11.94 10.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.3 168.226 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -113.64 30.72 7.02 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.06 179.759 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -120.83 -39.37 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.248 169.153 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.83 HG13 HD22 ' B' ' 28' ' ' LEU . 1.3 mp -62.12 -54.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.442 160.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.9 mm-40 -61.6 -9.23 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.19 -174.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 61' ' ' GLU . 72.0 mt -138.32 35.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.454 175.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -130.62 10.41 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.907 163.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.677 ' CG2' HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -134.09 -63.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.533 0.683 . . . . 0.0 109.237 -156.222 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.449 ' H ' HG12 ' A' ' 64' ' ' VAL . 10.3 ttp180 -78.41 -27.26 46.64 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.232 162.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 6.7 mmt180 -75.49 -11.25 59.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.768 167.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.546 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.179 -176.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.61 HD21 ' HG3' ' B' ' 33' ' ' GLU . 17.2 mt . . . . . 0 C--O 1.243 0.748 0 CA-C-O 121.343 0.592 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 8.0 Cg_endo -49.11 143.62 18.13 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.466 2.11 . . . . 0.0 113.367 166.797 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.472 ' CG2' ' HG3' ' B' ' 25' ' ' ARG . 1.3 pp -95.19 26.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.383 -168.343 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -82.67 -58.14 0.44 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.694 169.427 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -58.89 -46.95 20.06 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.543 2.162 . . . . 0.0 113.568 171.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 mt -68.33 -18.83 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.411 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.434 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -60.95 -47.38 91.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -170.534 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.9 ttt180 -85.59 -17.51 36.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.371 -170.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 3' ' ' LEU . 26.7 mt -60.97 -59.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.405 171.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 14.8 mm -63.89 -36.38 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.458 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 6.8 mmtp -64.59 -33.31 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.298 176.493 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 25.0 t0 -61.72 -31.5 71.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.834 177.407 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -51.17 71.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.558 170.65 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 34.42 0.68 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.545 -168.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.697 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -70.97 157.93 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.02 99.61 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.136 179.439 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 63.14 132.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -176.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.776 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t -119.46 160.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.369 170.251 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' THR . 21.6 p -84.43 -10.11 57.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.436 178.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.404 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.2 OUTLIER 71.02 164.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.983 -161.342 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 74.32 -50.94 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 -162.375 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 55' ' ' ILE . . . -60.42 -44.29 95.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.418 174.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.676 ' HE ' HG21 ' B' ' 20' ' ' VAL . 13.9 tpp85 -68.89 -16.82 63.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.524 -173.3 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.68 -30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.415 -168.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.648 ' O ' HD12 ' B' ' 31' ' ' ILE . 89.1 m -61.12 -40.68 94.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.269 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.83 HD22 HG13 ' A' ' 60' ' ' ILE . 2.0 tp -59.97 -43.78 94.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.322 172.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -12.91 13.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.662 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.9 mmtp -105.57 -30.36 9.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.393 -175.552 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.796 HD13 ' CG2' ' A' ' 60' ' ' ILE . 3.3 mp -61.85 -74.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.655 161.093 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.826 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.71 -40.93 85.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.649 -163.572 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' B' ' 3' ' ' LEU . 4.7 tt0 -66.86 -20.43 65.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.044 -174.743 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 4.7 tt0 -77.06 -53.53 7.68 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.077 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.03 -29.87 67.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.352 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.11 -30.54 78.07 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 169.182 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 11' ' ' ILE . 3.0 mtp85 -81.79 -19.44 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.467 175.052 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -37.5 12.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.403 -169.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.916 HD12 HD21 ' A' ' 32' ' ' LEU . 12.0 mt -61.08 -27.9 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.296 168.173 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -68.29 -60.35 2.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.305 -177.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.656 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 48.9 m -61.68 -13.7 25.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.33 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.588 ' O ' ' HG ' ' B' ' 46' ' ' LEU . 4.9 mm-40 -75.6 -53.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.091 171.439 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.9 -31.95 68.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.141 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 1.054 HD11 ' HB2' ' A' ' 17' ' ' ALA . 49.1 mt -60.81 -49.55 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.212 165.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.547 176.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' B' ' 43' ' ' ALA . 28.8 mt -65.32 -48.82 71.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.418 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.75 65.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.34 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -19.07 36.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.341 176.562 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -61.24 -37.41 82.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.244 166.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.1 -46.26 35.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.056 165.13 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.63 -7.03 24.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.81 168.341 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.11 98.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.354 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.5 160.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 166.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 95.1 m -69.31 159.27 33.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.457 168.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.631 ' CG2' ' HB1' ' B' ' 43' ' ' ALA . 55.5 mt -87.0 133.9 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 -170.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -118.39 -178.34 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.391 -178.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . . . -74.8 -32.07 61.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.269 -169.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.67 -13.44 22.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.097 168.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -94.2 -43.54 8.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.356 -179.368 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 24' ' ' ALA . 42.0 mm -61.1 -33.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.457 177.681 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.78 -22.17 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.849 -171.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.652 ' O ' HD11 ' B' ' 46' ' ' LEU . 24.7 tp -106.4 18.19 22.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.579 167.189 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.551 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -106.92 -14.8 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.273 166.17 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -121.2 -65.29 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.282 -165.569 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG12 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -60.43 -11.84 7.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.501 172.21 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -82.34 -24.42 34.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.409 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.305 168.232 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 33' ' ' GLU . 1.1 mt . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 121.482 0.658 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 2.2 Cg_endo -51.83 154.47 9.72 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.673 2.249 . . . . 0.0 113.619 177.392 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -92.93 19.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.683 -170.45 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -80.74 -58.15 0.55 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.625 170.286 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.7 Cg_endo -59.19 -61.88 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.585 2.19 . . . . 0.0 113.55 170.329 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 62.7 mt -61.19 -14.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.452 177.672 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.63 99.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.97 25.44 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.386 -173.862 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.82 -40.06 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.508 169.817 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 40' ' ' ALA . 17.4 mm -83.97 -39.94 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.423 -174.488 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -26.75 67.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.3 173.187 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.05 -34.1 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.814 177.756 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.09 -53.16 61.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.314 168.27 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.97 21.6 0.78 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.772 -172.125 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.837 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -65.26 127.02 30.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.415 170.448 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -102.25 -17.45 15.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.013 -171.791 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 163.16 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.33 168.855 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG21 ' CD ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -118.0 163.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.305 168.594 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.532 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 24.7 p -75.5 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.44 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.94 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.34 171.798 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.46 -18.45 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.408 -165.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.36 -40.44 94.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.304 -167.015 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.791 ' CD ' HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -65.42 -60.08 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.446 176.198 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mt -65.23 -27.77 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.449 -171.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 31' ' ' ILE . 79.8 m -61.02 -61.67 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.395 166.869 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 HG23 ' B' ' 60' ' ' ILE . 10.5 tp -61.51 -10.3 7.58 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.482 -171.441 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.66 -63.53 1.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.435 171.271 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 5.6 mtpm? -61.46 -21.27 64.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.993 HD13 HG21 ' B' ' 64' ' ' VAL . 32.5 mt -61.89 -76.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.893 162.562 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.39 -30.71 68.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.697 -162.958 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -77.73 -18.61 56.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.018 -178.635 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -90.03 -17.82 27.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.037 169.312 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 9.8 mtp -99.58 18.83 17.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 170.768 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.674 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -119.4 -41.74 0.57 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 170.877 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -13.24 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.199 163.888 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.06 -55.01 4.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.385 -178.342 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 63' ' ' ALA . 7.3 mt -61.24 -19.74 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.463 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -72.57 -63.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.255 -169.176 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 35.1 t -60.64 -13.4 14.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.439 177.059 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -72.71 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.095 166.785 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 60' ' ' ILE . . . -61.41 -15.52 37.69 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.502 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.1 mt -92.78 -51.9 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.894 -175.35 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.35 -11.81 7.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.477 166.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.3 mp -82.85 -42.83 17.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.244 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 52' ' ' ARG . . . -61.33 -23.68 65.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.403 -176.684 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -27.52 38.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.438 -177.474 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -61.13 -27.75 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.347 169.683 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.94 -47.15 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.288 178.795 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.0 13.17 25.89 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -169.235 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 mtp85 -143.0 116.98 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.404 -179.5 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -62.72 -24.68 67.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.351 -167.937 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.625 HG22 ' HB3' ' B' ' 21' ' ' SER . 1.0 OUTLIER -60.96 116.12 4.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.42 -168.538 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.53 149.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.414 177.56 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' OD2' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -139.09 164.21 30.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -169.867 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -66.73 -18.26 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.316 168.74 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 62' ' ' LEU . 74.3 mm-40 -96.83 29.26 3.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.083 169.792 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 56' ' ' LYS . 76.5 m-20 -117.52 -34.88 4.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.423 168.638 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.711 HG12 HD21 ' B' ' 28' ' ' LEU . 4.1 mp -102.65 -12.32 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.383 -175.324 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 62' ' ' LEU . 12.5 mt-10 -70.97 -10.8 60.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 161.712 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -145.07 25.04 1.43 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.468 -179.55 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.827 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -111.21 15.25 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.31 163.58 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -144.41 -65.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -155.359 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.1 mtp180 -62.13 -29.19 70.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.316 164.744 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -84.75 -21.0 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 172.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 42' ' ' GLU . 4.4 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.429 176.774 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.792 HD21 ' CG ' ' B' ' 33' ' ' GLU . 4.4 mt . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.461 0.648 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 4' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -58.99 147.7 88.78 Favored 'Trans proline' 0 N--CA 1.484 0.942 0 C-N-CA 122.493 2.128 . . . . 0.0 113.617 172.845 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -82.39 76.36 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.525 177.611 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -153.53 -54.76 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.599 171.414 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -62.23 -11.34 21.83 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.658 2.238 . . . . 0.0 113.65 171.179 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' B' ' 3' ' ' LEU . 40.0 mt -114.92 -37.61 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.482 -179.101 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.83 -48.33 86.78 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.849 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 1.1 ptt180 -93.83 19.21 9.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.511 -179.285 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mm -83.62 -60.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.126 164.308 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.71 HD11 ' HG ' ' B' ' 28' ' ' LEU . 9.7 mm -66.43 -36.05 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.218 -176.384 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 12.1 mttm -64.93 -39.07 92.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.425 178.217 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -62.11 -31.46 71.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.793 -177.738 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.68 -52.76 64.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.603 170.621 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.24 19.54 0.53 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.609 -179.098 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.882 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.67 125.9 25.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.332 165.494 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.78 -64.41 1.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.071 -170.036 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -110.02 111.32 22.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.411 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.665 HG21 ' HG3' ' B' ' 25' ' ' ARG . 11.3 t -90.24 152.05 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.294 172.126 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 54' ' ' THR . 24.7 p -98.47 16.6 21.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.345 -176.616 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.55 163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.09 -162.332 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 75.33 -58.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.898 -166.699 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' B' ' 20' ' ' VAL . . . -60.22 -38.2 82.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.345 -165.004 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.665 ' HG3' HG21 ' B' ' 20' ' ' VAL . 7.7 mtp180 -64.21 -13.51 49.34 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.555 -179.417 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 2.9 mp -122.56 -5.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -177.852 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.621 HG22 HD13 ' B' ' 31' ' ' ILE . 98.9 m -60.64 -43.16 97.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.451 173.404 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 60' ' ' ILE . 2.9 mm? -61.21 -23.43 65.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.443 177.284 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -74.88 -11.12 60.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.436 -178.502 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.48 -32.6 6.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.482 -177.65 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.985 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 mp -61.72 -75.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.821 163.803 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.1 -21.03 44.42 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.797 -160.494 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.792 ' CG ' HD21 ' B' ' 3' ' ' LEU . 4.3 tm-20 -89.2 -18.15 27.67 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -39.8 28.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.093 168.359 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.473 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -93.34 19.56 8.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.422 178.838 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.68 -33.85 1.5 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 165.917 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.7 -20.78 59.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.191 165.25 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' B' ' 35' ' ' MET . 27.3 t0 -61.13 -60.88 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.346 171.337 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 64' ' ' VAL . 22.0 mt -61.04 -33.95 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.46 -169.022 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.62 -53.48 55.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.315 -172.749 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -17.29 64.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.785 -173.487 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.453 ' C ' HD12 ' B' ' 46' ' ' LEU . 2.6 mp0 -89.21 -42.4 11.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.085 173.645 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.601 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -60.86 -12.43 10.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.479 172.106 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.837 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.2 -61.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.611 -169.979 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' B' ' 44' ' ' ILE . 0.6 OUTLIER -67.64 -16.85 64.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.488 175.739 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.816 HD22 HD23 ' B' ' 62' ' ' LEU . 4.0 mt -61.09 -32.03 71.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.287 166.924 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' B' ' 55' ' ' ILE . . . -73.42 -40.5 64.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.341 177.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -90.07 -33.73 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.374 -167.526 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -61.1 -37.57 83.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.377 171.807 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.7 94.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.339 168.657 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.87 27.19 17.33 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -179.007 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 179.11 4.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.415 -169.306 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 161.29 14.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.447 171.645 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 21' ' ' SER . 88.6 m 69.92 134.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.4 168.154 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' B' ' 47' ' ' ALA . 13.3 mm -90.82 135.52 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.384 168.209 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.532 ' HG3' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -135.73 177.13 8.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.464 179.262 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.93 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.347 -167.723 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.16 -16.61 27.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.129 -178.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.8 OUTLIER -86.88 -18.53 30.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.413 168.455 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 28' ' ' LEU . 46.7 mm -92.43 -42.11 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 -170.956 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.505 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 31.6 mt-10 -91.05 22.03 3.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.635 172.477 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.816 HD23 HD22 ' B' ' 46' ' ' LEU . 19.8 tp -126.53 -15.67 5.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.679 169.428 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.601 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -89.55 -35.72 15.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.827 163.649 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.993 HG21 HD13 ' A' ' 31' ' ' ILE . 53.9 t -62.32 -79.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.618 162.847 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -59.48 -12.68 6.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.718 -159.322 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -81.87 -17.99 45.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.5 -177.215 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.498 ' HE2' HG12 ' B' ' 39' ' ' ILE . 13.2 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.305 168.996 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' A' ' 8' ' ' ILE . 1.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.472 0.654 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 5.0 Cg_endo -47.95 148.13 6.91 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.588 2.192 . . . . 0.0 113.589 172.486 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -63.89 -26.67 41.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.352 -175.32 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.26 -62.37 3.19 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.684 -170.21 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.5 Cg_endo -50.82 -22.67 10.27 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 122.594 2.196 . . . . 0.0 113.595 -177.088 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 3' ' ' LEU . 85.9 mt -107.23 -30.18 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.493 -169.691 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.72 80.51 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -169.597 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -79.62 -21.7 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.364 -174.558 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' B' ' 37' ' ' ARG . 26.8 mt -63.7 -52.27 59.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.417 170.907 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.704 HD12 ' HB2' ' B' ' 40' ' ' ALA . 14.7 mm -67.12 -35.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.428 -168.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -28.34 69.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.2 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.93 -33.45 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.874 177.027 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.08 -51.32 70.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.496 169.515 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.92 10.89 0.44 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.69 -174.301 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -73.18 170.2 15.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.025 -0.587 . . . . 0.0 110.316 175.458 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.74 -46.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -168.952 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.34 170.94 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.459 171.958 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.687 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 96.9 t -151.85 161.01 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.359 -169.128 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 27.4 t -77.32 -167.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.398 175.863 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -17.18 51.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.352 -173.029 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -170.57 124.74 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 168.347 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -146.75 -61.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.164 166.601 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.665 ' NH1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -65.86 -14.94 62.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.361 -178.326 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.6 mt -86.43 -34.82 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.396 175.182 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.472 HG22 HD12 ' A' ' 31' ' ' ILE . 98.7 m -61.14 -53.98 50.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.228 165.409 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.705 HD12 ' CG2' ' A' ' 31' ' ' ILE . 16.7 tp -62.08 -23.52 66.55 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.347 -174.102 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 3' ' ' LEU . . . -82.16 -36.44 27.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.232 178.76 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.2 -16.13 60.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.51 172.529 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.999 HG12 HG11 ' B' ' 64' ' ' VAL . 0.7 OUTLIER -83.07 -29.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.889 -165.33 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -89.39 -34.85 16.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -173.612 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.89 -34.91 76.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.982 -179.031 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 8.3 mm-40 -73.87 -26.62 60.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.05 168.994 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -95.25 22.75 6.44 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.428 178.758 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.26 -41.63 0.09 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -173.362 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -65.88 -26.01 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.417 -0.392 . . . . 0.0 110.177 167.507 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -87.44 -35.83 18.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.354 -168.512 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.737 HD13 HG22 ' A' ' 64' ' ' VAL . 6.6 mt -61.24 -32.1 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.423 174.149 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.933 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.48 -61.43 2.45 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.212 171.792 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.524 -175.563 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.756 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.66 -53.67 4.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.169 171.238 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.94 -11.55 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.7 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.87 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -78.4 -60.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.402 -169.349 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mtmt -69.08 -18.56 64.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.468 173.108 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 42' ' ' GLU . 4.1 mp -61.1 -18.38 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 166.462 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -91.45 -18.39 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.381 177.754 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -81.44 -33.32 32.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -170.71 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -61.11 -24.56 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.356 169.81 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.26 -52.66 63.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.226 166.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.18 28.66 0.58 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.467 -177.334 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.49 93.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.465 175.911 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.86 -76.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.467 179.372 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 55' ' ' ILE . 96.7 m -160.04 140.28 11.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.423 -169.666 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.2 mm -61.58 165.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.267 167.209 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -170.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.397 168.868 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.37 -19.52 65.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.304 -166.525 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.36 23.64 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.255 170.654 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -121.22 -26.6 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.317 168.33 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HD13 ' B' ' 28' ' ' LEU . 36.6 mm -95.99 -47.82 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.001 -163.985 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -75.92 -12.76 60.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.167 174.442 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -48.14 7.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.43 177.747 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.98 -31.21 70.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.228 172.115 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.737 HG22 HD13 ' A' ' 39' ' ' ILE . 25.3 t -61.33 -70.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.756 164.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -9.82 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.806 -170.099 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HD3' ' HG2' ' A' ' 42' ' ' GLU . 8.9 ttt85 -77.66 -34.14 53.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.904 172.628 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.498 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 5.6 m-85 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.437 178.598 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.594 ' HB2' HD11 ' B' ' 8' ' ' ILE . 5.6 mt . . . . . 0 C--O 1.242 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -46.93 157.54 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.229 1.953 . . . . 0.0 113.454 -179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.04 23.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.378 -167.157 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.732 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -84.23 -58.19 0.38 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 169.931 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.2 Cg_endo -57.75 -65.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 122.505 2.137 . . . . 0.0 113.612 173.667 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' B' ' 3' ' ' LEU . 74.3 mt -60.8 -11.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.532 -170.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.82 55.53 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -178.707 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -94.96 17.36 14.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.588 . . . . 0.0 110.642 -178.895 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.49 HG22 HD13 ' B' ' 12' ' ' ILE . 23.1 mt -95.27 -45.05 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.025 163.146 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.933 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm -94.29 46.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.849 171.551 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 19.8 mtpt -149.59 -30.56 0.23 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.945 171.52 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 27.9 t0 -60.05 -30.49 69.23 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.065 171.264 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.96 74.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.638 170.907 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.64 22.33 2.28 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.552 -165.876 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.87 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.76 123.45 22.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.092 179.375 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -77.15 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.007 -164.667 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -109.84 -52.54 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.429 -177.841 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.766 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t 62.84 132.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.331 -175.172 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -65.75 175.16 2.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.249 178.785 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -93.81 20.33 7.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.59 -44.86 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.446 169.02 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.0 -45.88 91.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.326 -170.347 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -66.97 -25.47 66.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.315 -171.446 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.92 -32.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.381 171.762 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.829 ' O ' HD12 ' B' ' 31' ' ' ILE . 90.0 m -70.39 -45.69 65.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.276 -169.821 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.79 HD13 HG23 ' A' ' 60' ' ' ILE . 4.7 tp -59.78 -44.67 93.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.437 171.873 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -61.03 -10.07 5.39 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.541 177.636 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -109.71 -29.51 8.3 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.475 -176.134 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.829 HD12 ' O ' ' B' ' 27' ' ' THR . 2.8 mp -62.22 -74.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.854 164.108 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' A' ' 32' ' ' LEU . 1.4 mp -59.36 -11.4 4.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 -160.632 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -92.17 -52.82 4.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.206 -176.401 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -29.43 70.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 170.387 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 35' ' ' MET . . . . . 0.551 ' HE3' HG23 ' B' ' 31' ' ' ILE . 4.4 mtt -64.28 -45.52 87.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.356 168.376 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.62 78.43 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 37' ' ' ARG . . . . . 0.84 ' HG2' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -67.08 -33.52 75.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.248 167.124 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 38' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 3.2 m-20 -72.41 -54.5 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.432 -171.836 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.826 HG23 ' O ' ' B' ' 63' ' ' ALA . 51.8 mt -60.83 -35.53 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.382 -174.797 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.704 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.89 -57.77 11.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.167 -173.008 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.456 ' HA ' ' CG2' ' B' ' 44' ' ' ILE . 43.2 p -66.18 -14.61 62.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.76 176.796 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -35.5 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.974 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -77.36 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.286 170.322 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.79 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -85.57 -61.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.56 -172.508 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HA ' ' HG3' ' B' ' 48' ' ' ARG . 2.2 mptm? -60.6 -17.57 47.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.573 172.083 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.784 HD22 ' OD1' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -61.63 -27.73 68.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.233 167.895 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.714 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -73.55 -44.34 57.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.505 ' HB2' ' NE ' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -81.07 -31.28 34.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.346 -177.906 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 49' ' ' HIS . . . . . 0.482 ' N ' ' HD2' ' B' ' 48' ' ' ARG . 6.2 t60 -60.98 -36.64 79.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 168.674 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.99 -52.83 63.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.152 165.777 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.87 28.37 0.74 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.533 -173.825 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 52' ' ' ARG . . . . . 0.505 ' NE ' ' HB2' ' B' ' 48' ' ' ARG . 6.1 mpt_? 65.11 96.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.521 169.371 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -152.36 -73.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.433 -177.019 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.465 HG22 ' O ' ' B' ' 55' ' ' ILE . 90.5 m -165.14 148.26 8.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.298 -173.731 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.465 ' O ' HG22 ' B' ' 54' ' ' THR . 31.8 mt -94.25 147.82 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.42 168.282 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.61 -174.61 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.4 -169.602 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.4 77.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.217 -168.25 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.69 ' O ' HD22 ' B' ' 62' ' ' LEU . 2.0 tm-20 -93.97 23.49 4.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.076 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.784 ' OD1' HD22 ' B' ' 46' ' ' LEU . 0.8 OUTLIER -117.8 -17.26 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.511 166.664 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 64' ' ' VAL . 32.9 mm -92.27 -59.92 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.292 -175.58 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.645 ' HG2' HD11 ' A' ' 31' ' ' ILE . 71.2 mt-10 -60.48 -10.44 4.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.228 168.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.69 HD22 ' O ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -100.47 -14.94 18.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.876 177.952 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.826 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -102.22 5.85 40.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.553 165.184 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.999 HG11 HG12 ' A' ' 31' ' ' ILE . 55.7 t -113.83 -84.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.572 -177.576 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' NH1' ' B' ' 65' ' ' ARG . 0.4 OUTLIER -60.8 -22.36 64.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.187 -178.73 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -46.7 13.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 160.504 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.335 -163.947 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 121.331 0.586 . . . . 0.0 109.514 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 8.1 Cg_exo -50.45 156.19 4.36 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.503 2.135 . . . . 0.0 113.537 168.056 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -87.69 62.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.38 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -153.25 -57.42 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.696 -177.388 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.8 Cg_endo -59.35 -41.37 59.18 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.548 2.165 . . . . 0.0 113.657 170.654 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.908 HD11 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -61.41 -23.67 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.43 170.913 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.8 -57.54 18.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -167.524 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -20.92 64.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.402 -170.507 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.856 HG22 HD13 ' A' ' 12' ' ' ILE . 28.0 mt -61.65 -49.75 83.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.183 167.115 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.867 HD12 ' HB2' ' B' ' 40' ' ' ALA . 1.8 mm -96.61 45.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 -35.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.779 173.883 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.37 -31.47 70.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.929 170.419 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.04 62.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.502 170.103 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.88 33.09 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.552 -169.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -82.83 138.46 33.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.82 -50.34 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.001 -170.6 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.83 171.25 15.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.412 -168.708 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.797 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 17.1 m -115.24 -173.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 167.295 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.734 ' HA ' HG21 ' B' ' 54' ' ' THR . 54.0 p -90.33 -65.38 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.125 175.248 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -141.52 -34.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.71 161.761 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 47.7 m-20 -107.76 -106.15 0.34 Allowed 'General case' 0 C--O 1.253 1.277 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.657 165.048 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.797 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . 88.98 -56.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.026 1.331 . . . . 0.0 109.695 -168.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.504 ' NH1' ' HB ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.11 -21.45 46.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.647 -179.067 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -64.07 -43.26 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.806 173.618 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.637 HG22 ' CD1' ' A' ' 31' ' ' ILE . 51.2 m -60.66 -46.05 91.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.205 172.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 2.1 tp -60.82 -33.89 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.269 173.445 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.91 -26.25 62.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.384 175.279 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 28.87 2.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.528 176.373 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.977 HD13 HG21 ' B' ' 64' ' ' VAL . 66.8 mt -145.15 -64.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.109 -170.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.06 -38.64 83.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.69 177.21 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 5.0 tm-20 -86.35 -23.57 26.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.101 -169.681 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.57 19.26 6.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 173.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpp -126.21 -32.4 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.11 164.502 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.678 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -60.9 -40.9 98.98 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -18.77 65.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.481 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 33.0 m-20 -101.73 -18.85 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.369 -167.476 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.645 ' CG2' HG23 ' A' ' 64' ' ' VAL . 14.9 mt -80.75 -24.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.377 171.422 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -72.85 -70.04 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.396 -166.916 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -60.74 -10.0 4.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.503 -176.753 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 54.2 mm-40 -88.13 -47.66 8.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.216 177.094 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.45 -27.17 68.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.187 170.355 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.9 mt -77.95 -52.1 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.18 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -26.69 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.494 174.33 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 43' ' ' ALA . 4.6 mt -62.27 -40.5 96.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.319 176.533 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.711 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . . . -61.21 -25.56 67.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.272 -167.756 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -103.95 -25.72 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.35 -176.176 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -64.33 -37.8 88.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.339 169.473 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.33 97.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.334 168.61 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.83 18.95 14.01 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 169.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 179.18 -167.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.274 170.339 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 137.08 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.562 170.013 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' B' ' 21' ' ' SER . 86.6 m -60.82 171.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.386 167.51 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.711 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 18.8 mm -60.6 136.9 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.481 175.391 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.866 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -159.97 -178.27 6.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.366 -167.092 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -18.68 61.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.245 -171.057 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.34 -17.79 23.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.057 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 m-20 -78.23 -43.54 28.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.373 168.283 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.809 HG23 HD22 ' B' ' 28' ' ' LEU . 37.7 mm -72.22 -57.64 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.404 -170.371 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.77 -40.4 84.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.074 -166.521 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -37.47 82.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.442 170.049 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 59' ' ' ASP . . . -61.56 -16.41 47.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.438 -175.752 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.645 HG23 ' CG2' ' A' ' 39' ' ' ILE 0.256 0.4 OUTLIER -104.57 -50.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.042 -160.582 . . . . . . . . 4 4 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.69 23.8 4.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.526 -178.077 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -122.05 -55.71 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.481 -176.74 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 38' ' ' ASP . 1.5 p90 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.3 -163.443 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 3' ' ' LEU . . . . . 0.785 ' CD2' HD11 ' A' ' 11' ' ' ILE . 4.0 mt . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 121.316 0.579 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.96 157.15 30.15 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.357 2.038 . . . . 0.0 113.221 164.703 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 5' ' ' ILE . . . . . 0.404 ' CG2' HD13 ' B' ' 26' ' ' ILE . 49.6 pt -93.02 23.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.519 178.7 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -90.87 -57.81 0.25 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.763 170.063 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.2 Cg_endo -60.7 -54.62 1.87 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.532 2.155 . . . . 0.0 113.57 173.325 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 HD12 ' B' ' 3' ' ' LEU . 28.7 mt -60.5 -13.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.498 169.901 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.41 -61.49 1.98 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.282 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -93.82 17.06 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.593 -167.13 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 11' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 3' ' ' LEU . 29.0 mt -96.73 -49.62 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 162.79 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -68.04 -38.28 79.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.211 178.557 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.8 mttt -61.57 -35.25 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.355 174.574 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.54 -34.02 76.09 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.862 -177.774 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -59.26 -52.39 65.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.433 169.385 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.79 15.82 0.3 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.221 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.83 125.72 24.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.219 164.777 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.36 -53.96 2.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.039 -167.808 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -130.55 93.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.412 171.653 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 55' ' ' ILE . 27.8 t -67.94 166.0 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.282 168.367 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 21' ' ' SER . . . . . 0.622 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 26.5 t -102.32 -166.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.388 170.39 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.31 167.36 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.284 166.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.65 -61.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.498 171.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.866 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.88 -47.07 86.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.388 -167.212 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -60.83 -12.11 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.601 178.99 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.9 mm -114.03 -15.88 9.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.645 -175.906 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.834 ' O ' HD12 ' B' ' 31' ' ' ILE . 41.4 m -73.77 -33.82 64.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.436 -171.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.809 HD22 HG23 ' A' ' 60' ' ' ILE . 2.7 mm? -62.71 -21.76 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.407 168.399 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -79.07 -12.79 60.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.382 175.032 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 4.6 mttm -95.75 -29.1 14.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.493 172.229 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 31' ' ' ILE . . . . . 0.834 HD12 ' O ' ' B' ' 27' ' ' THR . 2.9 mp -78.73 -79.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.184 170.683 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.91 -12.89 8.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.649 -161.918 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 33' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -93.39 -31.52 14.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.102 178.212 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.5 mt-10 -72.25 -29.74 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.148 169.022 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -99.45 36.24 1.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.278 172.78 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.644 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -144.94 -40.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 170.658 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -43.48 98.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.179 165.527 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.82 -38.81 92.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.438 -171.245 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 28' ' ' LEU . 9.8 mt -70.6 -37.86 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 -175.583 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.77 -64.39 0.97 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.355 -168.767 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 1.2 t -61.69 -11.21 10.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.419 -176.588 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 42' ' ' GLU . . . . . 0.754 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -88.03 -51.9 5.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.183 174.408 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.661 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -60.79 -9.63 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.364 171.23 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 17' ' ' ALA . 57.9 mt -99.11 -54.37 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.127 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -23.67 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.343 -177.658 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.928 HD22 HD23 ' B' ' 62' ' ' LEU . 12.1 mt -60.71 -48.36 82.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.373 170.791 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.9 -60.32 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.371 171.303 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -20.64 62.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.365 -169.612 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.5 -44.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 169.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 -51.7 59.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 29.6 5.37 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 169.347 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.62 -171.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.3 169.854 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 64.34 163.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.439 -178.056 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.734 HG21 ' HA ' ' A' ' 21' ' ' SER . 6.1 t -88.52 -167.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.382 -169.399 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.661 HD12 ' O ' ' B' ' 43' ' ' ALA . 10.6 mm -100.63 142.6 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.327 173.146 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 56' ' ' LYS . . . . . 0.528 ' HE2' ' H ' ' B' ' 57' ' ' ALA . 1.9 tmtt? -160.56 172.52 17.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.312 -165.132 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.528 ' H ' ' HE2' ' B' ' 56' ' ' LYS . . . -61.72 -33.23 73.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.369 -168.444 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 56' ' ' LYS . 1.8 pt-20 -83.62 15.7 3.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 177.705 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -130.65 -20.79 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.54 167.303 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 60' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 28' ' ' LEU . 10.1 mm -79.49 -50.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 20.4 mt-10 -61.31 -39.46 90.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.027 166.212 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.928 HD23 HD22 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -62.22 -32.2 72.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.508 178.351 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.577 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -81.03 -35.68 31.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.207 175.054 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.977 HG21 HD13 ' A' ' 31' ' ' ILE . 19.9 t -62.39 -79.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.637 175.652 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -58.99 -12.73 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.664 -164.239 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -60.42 -26.0 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.512 171.501 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG3' ' B' ' 42' ' ' GLU . 17.4 m-85 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.409 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.04 -162.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.173 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp -57.22 102.29 0.3 Allowed Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.553 -169.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.642 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.5 Cg_endo -56.74 140.3 90.59 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.751 2.301 . . . . 0.0 113.49 171.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.2 -14.11 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.456 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.23 -55.37 3.78 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.653 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 15.5 Cg_exo -49.77 -49.59 15.51 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.655 2.237 . . . . 0.0 113.644 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 3' ' ' LEU . 63.0 mt -61.25 -45.74 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.521 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.05 59.23 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.37 -29.44 18.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.475 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.595 HD13 ' HG2' ' B' ' 33' ' ' GLU . 27.8 mt -61.5 -57.63 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.309 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' B' ' 40' ' ' ALA . 10.9 mm -61.21 -36.19 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.331 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mttm -62.98 -36.68 84.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.444 170.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.63 -34.02 76.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.753 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.376 169.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.42 20.61 0.34 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.691 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.21 149.34 33.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.401 166.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.23 -55.17 2.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 111.59 10.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' B' ' 55' ' ' ILE . 94.3 t -133.04 132.15 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.384 -169.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.4 p -65.92 157.17 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.351 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.92 -18.56 63.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.428 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.629 ' HA ' HG22 ' A' ' 26' ' ' ILE . 24.2 m-20 -81.0 -34.57 32.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.455 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' B' ' 60' ' ' ILE . . . -61.52 -40.36 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.192 166.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -40.51 90.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.333 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 23' ' ' ASP . 7.3 tt -81.39 -34.88 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.375 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.477 HG22 HG22 ' B' ' 60' ' ' ILE . 84.9 m -63.58 -45.96 88.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.091 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HG13 ' B' ' 60' ' ' ILE . 3.3 tp -60.36 -42.84 96.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.289 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.53 -42.93 99.54 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.268 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -78.62 -27.15 45.43 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.384 -176.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.735 HG21 HG21 ' B' ' 64' ' ' VAL . 23.3 mt -61.42 -73.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 166.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -59.53 -26.66 65.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.848 -166.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.894 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.52 -48.14 14.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.081 -176.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 2.5 mt-10 -63.98 -26.41 68.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.017 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.532 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 13.5 ttm -71.92 -43.49 65.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.452 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -65.06 -45.33 92.39 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -60.69 -22.16 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.39 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.07 -54.83 5.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.489 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 64' ' ' VAL . 10.1 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.208 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -61.24 -54.24 46.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.309 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 44' ' ' ILE . 84.3 p -61.48 -28.17 69.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.393 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 46' ' ' LEU . 1.2 mm-40 -62.06 -56.37 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.061 165.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -65.18 -4.52 5.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.023 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.839 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -94.1 -56.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.248 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -62.49 -17.12 58.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.74 167.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 42' ' ' GLU . 5.1 mp -67.18 -61.03 2.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.112 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.53 -14.21 18.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.462 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . 18.4 ttt-85 -97.41 -23.21 16.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.016 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -36.1 76.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.051 163.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -67.3 -56.76 8.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 161.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.96 -14.05 21.79 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.358 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 172.47 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.785 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.66 28.81 0.0 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.991 164.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.784 HG23 ' O ' ' B' ' 19' ' ' ARG . 100.0 m 63.45 150.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.407 177.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.793 ' HB ' HG13 ' B' ' 20' ' ' VAL . 9.6 mm -69.73 134.25 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.014 169.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.802 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 41.1 mtmt -142.38 175.31 9.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.504 -164.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -63.86 -55.13 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.289 -173.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 3.4 mt-10 -68.5 -16.05 63.75 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.992 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -72.05 -39.3 69.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.325 172.293 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.823 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.83 -56.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.501 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 22.1 mt-10 -60.6 -43.22 97.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.877 -161.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.03 -45.45 94.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.468 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.54 -29.09 69.79 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.452 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.748 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -86.22 -52.2 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.62 -168.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -18.73 60.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.589 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -76.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.316 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -67.04 -29.39 69.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.184 -162.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -70.1 146.88 50.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.341 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp . . . . . 0 C--O 1.241 0.633 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.362 -170.852 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -97.67 47.42 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.808 0.813 . . . . 0.0 109.815 167.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 8' ' ' ILE . 18.9 mt 58.56 86.28 0.16 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.312 -172.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.496 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 7.9 Cg_endo -48.81 138.09 26.62 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.16 1.907 . . . . 0.0 113.353 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.655 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -80.91 -11.33 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.627 -165.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.45 -56.47 6.54 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.764 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 3.7 Cg_endo -58.74 -48.83 13.35 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 122.504 2.136 . . . . 0.0 113.499 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.93 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.8 mt -60.89 -21.11 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.321 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.82 -53.55 44.31 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.6 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 10.7 mtp-105 -79.28 -21.56 45.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.372 -172.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 3' ' ' LEU . 64.0 mt -61.36 -57.6 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.153 165.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.956 HG23 ' HB1' ' A' ' 40' ' ' ALA . 5.6 mt -78.55 -12.93 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.944 -172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtmm -68.47 -40.38 81.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 162.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.35 -32.98 73.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.876 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.48 -52.06 66.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.554 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.9 25.61 0.26 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.732 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.839 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -77.94 145.48 36.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.289 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.725 162.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 66.53 100.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.423 -163.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.793 HG13 ' HB ' ' A' ' 55' ' ' ILE . 12.7 t -100.91 169.27 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 20' ' ' VAL . 15.1 t -117.14 141.52 48.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.393 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.602 ' O ' HD12 ' B' ' 26' ' ' ILE . 0.3 OUTLIER -60.87 -27.48 68.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.332 -167.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -60.89 -40.12 91.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.464 172.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -63.84 -57.97 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.466 ' HB3' ' CG2' ' B' ' 5' ' ' ILE . 0.0 OUTLIER -61.06 -33.25 73.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.388 -167.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 22' ' ' ASP . 21.7 mt -82.18 -38.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.449 -173.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.436 ' C ' HD12 ' B' ' 31' ' ' ILE . 85.3 m -61.26 -47.07 87.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.887 HD23 HD11 ' B' ' 12' ' ' ILE . 4.4 tp -60.49 -47.83 84.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.382 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 3' ' ' LEU . . . -61.31 -27.1 68.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.373 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -36.18 40.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.389 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.748 HG21 HG21 ' A' ' 64' ' ' VAL . 4.9 mt -61.14 -72.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.051 172.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 28' ' ' LEU . 3.0 mp -60.06 -31.99 70.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 -165.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' A' ' 11' ' ' ILE . 3.3 tm-20 -76.82 -33.61 57.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.061 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.2 89.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.064 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.64 -43.5 80.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.527 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.61 -40.33 97.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.5 -32.9 71.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.429 171.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -63.73 -56.88 12.23 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.539 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.88 HD13 HG23 ' B' ' 64' ' ' VAL . 5.0 mt -62.52 -26.38 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.787 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.648 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.88 -70.53 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.317 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.9 OUTLIER -62.14 -17.29 57.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.371 -173.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.646 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -73.36 -59.04 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.067 170.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.8 -14.45 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.679 HD11 ' HB2' ' A' ' 17' ' ' ALA . 62.8 mt -94.3 -54.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.97 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -60.46 -14.88 21.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.373 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.726 HD21 ' NH2' ' B' ' 66' ' ' ARG . 16.8 mt -75.83 -53.81 7.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.465 169.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.23 -16.43 61.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.27 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -34.57 14.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.373 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.65 -34.26 74.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.12 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.336 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.3 12.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.31 -176.34 2.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.009 -0.595 . . . . 0.0 110.431 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -115.07 -46.29 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.336 -170.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -87.45 117.54 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.42 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.771 HG23 ' HB2' ' B' ' 59' ' ' ASP . 9.8 mt -78.72 143.55 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.327 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.476 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 2.1 mtmp? -125.92 177.33 6.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.455 -167.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.57 -21.37 64.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.273 170.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 30.2 tt0 -69.08 -48.61 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.044 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' B' ' 55' ' ' ILE . 7.6 m-20 -63.51 -37.49 87.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.4 -168.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.829 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -62.7 -39.13 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.777 163.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -62.28 -39.46 93.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -170.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 62' ' ' LEU . 22.9 mt -84.53 -39.26 19.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.479 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.49 -49.18 78.59 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.393 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.88 HG23 HD13 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -72.66 -52.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.015 -170.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -60.3 -31.45 70.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ARG . . . . . 0.726 ' NH2' HD21 ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.31 -40.36 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.325 178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 14.8 m-85 -60.85 -73.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.336 169.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt 178.43 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.402 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.414 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.825 ' OE2' HD12 ' A' ' 26' ' ' ILE . 5.4 pt-20 58.88 45.24 15.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.262 169.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 8' ' ' ILE . 4.9 mt 60.3 81.16 0.25 Allowed Pre-proline 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.035 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -46.66 141.34 11.34 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.387 2.058 . . . . 0.0 113.438 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.3 pt -89.83 17.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.975 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.0 -55.98 0.65 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.627 166.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.6 Cg_endo -60.05 -54.64 2.12 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.659 2.239 . . . . 0.0 113.575 171.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 11' ' ' ILE . 23.8 mt -65.02 -45.25 95.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.361 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.58 62.3 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -88.02 -27.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.8 mt -62.07 -55.27 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 169.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' B' ' 40' ' ' ALA . 10.0 mm -67.89 -36.21 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.33 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -33.27 72.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.286 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -62.43 -34.66 77.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.824 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.779 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.56 -52.35 65.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.435 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.79 23.88 0.35 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.544 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 150.57 32.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.436 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -122.55 -75.32 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.033 -167.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -121.92 104.97 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.434 -174.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' NH2' ' A' ' 25' ' ' ARG . 19.8 t -116.13 150.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.323 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -87.79 148.84 24.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.365 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -60.95 -20.14 61.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.375 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -60.8 -54.73 41.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.441 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.913 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -62.22 -42.61 99.47 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.385 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.978 ' NH2' HG21 ' A' ' 20' ' ' VAL . 4.6 mmt85 -61.71 -46.12 91.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.354 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.825 HD12 ' OE2' ' A' ' 2' ' ' GLU . 40.3 mm -73.31 -32.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.451 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.696 HG22 HG21 ' B' ' 60' ' ' ILE . 97.1 m -60.95 -44.33 97.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.497 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.892 HD22 HG13 ' B' ' 60' ' ' ILE . 7.4 tp -83.43 -14.07 53.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.078 -172.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 2' ' ' GLU . . . -81.73 -21.76 37.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.407 163.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 33' ' ' GLU . 6.3 tttt -88.57 -31.14 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.37 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.017 HG21 HG21 ' B' ' 64' ' ' VAL . 3.1 mp -61.08 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.658 159.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 32' ' ' LEU . 4.3 mm? -59.04 -14.86 10.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.634 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HG3' HD12 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -71.02 -69.11 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.699 163.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.8 -32.3 71.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.097 -167.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.466 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -66.42 -34.92 79.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.433 166.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.23 -53.96 12.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' B' ' 15' ' ' ALA . 0.0 OUTLIER -64.31 -26.09 68.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.458 173.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 15.0 m-20 -60.89 -62.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.477 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.697 HG21 HG23 ' A' ' 64' ' ' VAL . 3.2 mt -62.59 -17.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.583 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -80.78 -69.17 0.62 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.254 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -61.04 -13.57 17.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.459 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -73.2 -63.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.077 166.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -60.93 -11.26 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.556 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -93.28 -49.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.803 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -60.28 -33.12 71.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.395 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 43' ' ' ALA . 15.6 mt -60.34 -42.72 96.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.334 166.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -61.23 -54.36 45.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.277 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -68.09 -14.94 63.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.431 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -71.27 -56.54 5.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.219 172.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.34 24.08 0.23 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.909 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' NE ' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 55.21 -162.71 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 O-C-N 122.184 -0.598 . . . . 0.0 111.428 158.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' H ' ' NE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER 70.23 -81.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.559 -165.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 m -115.45 137.87 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.379 -160.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 47' ' ' ALA . 8.3 mm -94.28 137.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.164 161.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 167.42 23.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.547 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.261 -167.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.1 -42.86 99.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.942 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.8 -45.42 94.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.5 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.818 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.0 mm -66.86 -47.2 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.401 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.68 -33.89 74.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HB3' HD13 ' A' ' 46' ' ' LEU . 1.7 mp -61.23 -53.85 51.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.384 175.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.02 -49.46 77.3 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.328 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -67.37 -53.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.931 -164.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -20.26 66.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.818 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -43.87 98.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.255 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 43.0 m-85 -60.41 -46.49 89.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.465 168.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.97 -170.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.372 -168.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.239 0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.383 -169.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.308 0.575 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.6 22.47 4.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.471 -168.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.846 HD22 HD11 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -91.68 150.81 41.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.317 164.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HG2' ' B' ' 7' ' ' PRO . 19.3 Cg_endo -62.09 143.37 94.71 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.397 2.064 . . . . 0.0 113.463 164.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.451 HD12 ' NH2' ' B' ' 25' ' ' ARG . 12.2 pt -108.23 -14.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.444 -167.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -77.0 -54.76 1.51 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.682 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 17.2 Cg_exo -50.23 -46.48 28.49 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.722 2.281 . . . . 0.0 113.617 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.6 -47.61 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.459 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.84 -29.07 71.28 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.552 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -89.19 -19.99 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.332 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 33' ' ' GLU . 46.1 mm -61.61 -48.39 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.106 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.8 mm -70.22 -39.27 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.711 -174.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.1 OUTLIER -60.44 -43.11 97.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.442 169.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.96 -31.99 72.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.857 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -53.62 56.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.492 169.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.48 20.83 0.61 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.45 119.88 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.272 167.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.94 -61.18 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.057 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 108.83 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.468 167.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' B' ' 12' ' ' ILE . 11.6 t -75.17 114.47 15.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.232 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -60.73 151.59 29.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.409 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.467 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 60.2 m-20 -61.59 -19.23 61.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.363 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 26' ' ' ILE . 2.3 t0 -89.42 -26.08 21.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.32 -175.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -63.78 -47.74 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.251 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 12.6 ptt180 -71.4 -29.14 64.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.402 -169.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.724 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -73.13 -42.21 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.443 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.779 ' O ' HD12 ' B' ' 31' ' ' ILE . 67.1 m -60.93 -37.57 82.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.242 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.818 HD22 ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.106 167.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -62.86 -32.57 73.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.27 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -69.94 -45.14 68.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.587 174.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.779 HD12 ' O ' ' B' ' 27' ' ' THR . 3.2 mt -61.15 -73.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.211 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -55.55 -28.51 55.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.32 -167.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.605 ' HB2' HD11 ' B' ' 3' ' ' LEU . 8.0 tp10 -65.24 -57.8 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.88 -38.2 87.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.986 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 22.1 mmm -72.0 -38.24 69.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.54 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.11 -40.71 95.14 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.5 mtp85 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.388 170.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.3 OUTLIER -65.26 -58.86 4.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.511 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.637 HG12 HG23 ' B' ' 64' ' ' VAL . 4.1 mt -61.51 -31.71 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.339 -173.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.92 -70.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.244 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.779 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 16.1 t -62.27 -12.42 20.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.444 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.511 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 1.2 mp0 -93.84 -48.24 6.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.175 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.55 -10.89 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.378 167.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 17' ' ' ALA . 56.7 mt -100.74 -49.15 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.793 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.01 -11.38 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.454 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.76 HD22 HD23 ' B' ' 62' ' ' LEU . 8.1 mt -84.1 -59.52 2.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.422 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -60.69 -18.21 52.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.523 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.11 -28.48 20.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.052 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -60.23 -35.7 76.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.174 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -65.48 -55.59 17.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.998 162.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 2.98 44.76 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.762 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 178.71 -163.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.638 -166.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt 76.02 -93.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.535 HG22 ' O ' ' B' ' 55' ' ' ILE . 99.7 m -172.08 168.81 5.74 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.824 -0.548 . . . . 0.0 109.955 -160.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' B' ' 47' ' ' ALA . 7.3 mm -114.74 135.41 54.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.903 155.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -147.22 -177.46 5.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 -165.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -61.74 -15.49 41.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.346 -176.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 1.8 tp10 -100.76 -30.15 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.047 -170.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -36.36 79.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.136 167.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.892 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.39 -64.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.814 162.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -61.08 -22.46 64.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 -163.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.76 HD23 HD22 ' B' ' 46' ' ' LEU . 5.2 tp -86.67 -39.67 15.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.458 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.84 -36.17 78.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.355 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -88.15 -45.1 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.876 -166.167 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.38 -27.17 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.53 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.5 95.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.107 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 18.3 m-85 -60.37 -61.96 2.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 162.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -70.84 101.69 2.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.386 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.578 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.67 112.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.6 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' B' ' 11' ' ' ILE . 2.5 mt -66.87 139.99 95.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.638 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.29 144.31 95.14 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.484 2.123 . . . . 0.0 113.52 164.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.852 HG21 HG12 ' A' ' 26' ' ' ILE . 2.2 pp -107.84 16.54 7.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.879 -169.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.84 -55.87 0.51 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.699 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -61.09 -42.49 35.9 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.555 2.17 . . . . 0.0 113.561 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' HD12 ' A' ' 11' ' ' ILE . 25.7 mt -60.63 -35.04 60.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.472 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -46.82 93.46 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.585 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -18.57 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.347 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' B' ' 2' ' ' GLU . 93.6 mt -60.91 -40.22 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.162 163.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.933 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.8 mt -93.22 -25.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.51 -162.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -64.02 -36.88 85.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.05 -32.97 74.71 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.088 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.02 -52.36 65.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.509 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' C ' HG21 ' B' ' 44' ' ' ILE . . . 138.7 28.51 0.25 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.978 -1.464 . . . . 0.0 110.713 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -75.18 127.77 33.96 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.531 -175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.22 -25.47 11.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.96 107.71 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.462 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' HB1' ' A' ' 17' ' ' ALA . 18.7 t -120.14 133.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.418 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 p -70.64 157.18 38.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.351 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.3 m-20 -60.64 -33.3 72.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.406 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -44.61 96.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.429 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' B' ' 55' ' ' ILE . . . -62.98 -52.66 62.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.24 -174.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.717 ' NH1' HD13 ' A' ' 5' ' ' ILE . 8.9 ptt180 -79.17 -14.23 59.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.38 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.852 HG12 HG21 ' A' ' 5' ' ' ILE . 37.3 mt -96.81 -32.16 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.4 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.877 HG22 HG22 ' B' ' 60' ' ' ILE . 58.6 m -60.43 -35.4 75.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 168.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 12' ' ' ILE . 3.5 tp -60.01 -48.44 81.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.294 165.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.8 69.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.386 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.57 -40.75 15.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.444 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.498 HD12 ' CG2' ' B' ' 60' ' ' ILE . 18.4 mt -59.79 -69.37 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.982 171.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.529 HD11 ' N ' ' B' ' 36' ' ' GLY . 2.7 tt -59.38 -31.2 69.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.846 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.05 -53.74 51.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.007 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 58.4 tt0 -64.59 -20.95 66.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.958 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.47 ' HB3' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -63.06 -44.59 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 160.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -61.28 -51.96 54.74 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.699 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 8.3 ptm180 -61.46 -27.41 68.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.208 -0.496 . . . . 0.0 109.904 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t70 -59.83 -54.44 46.21 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.669 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.804 ' HB ' HD11 ' B' ' 28' ' ' LEU . 1.7 mt -62.44 -37.49 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.776 -174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.12 -68.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.401 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.7 t -62.52 -31.75 72.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.152 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.13 -53.6 54.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.227 171.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -69.66 -13.25 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.528 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -83.77 -55.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.197 -168.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -16.74 59.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.574 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 66' ' ' ARG . 11.4 mt -61.3 -45.11 95.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.16 166.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.696 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -79.85 -24.36 41.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.253 -167.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -79.32 -52.5 8.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.494 178.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.05 66.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.71 -55.96 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.178 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 6.95 0.08 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.755 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.21 80.05 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.616 0.722 . . . . 0.0 112.182 162.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 -68.36 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.143 165.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.619 HG21 ' HB2' ' B' ' 21' ' ' SER . 6.0 t -138.13 -169.37 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.049 164.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.98 HG13 HG22 ' B' ' 20' ' ' VAL . 9.0 mm -100.93 135.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.738 161.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' NZ ' HG22 ' A' ' 54' ' ' THR . 3.4 mttt -136.29 159.78 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.527 -164.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.89 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.26 -20.42 62.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.307 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.29 -59.23 4.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.979 165.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 1.3 m-20 -66.51 -40.47 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.392 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.883 HG23 HD13 ' B' ' 28' ' ' LEU . 16.8 mm -61.93 -56.56 16.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.396 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' B' ' 31' ' ' ILE . 14.6 mt-10 -61.67 -19.48 62.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -64.26 -53.94 41.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.322 167.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -61.06 -31.35 71.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.353 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 50.2 t -62.45 -67.72 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.6 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' NH2' ' HG2' ' A' ' 69' ' ' LYS . 1.9 mtp85 -60.52 -12.84 10.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.749 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' CD ' HD21 ' A' ' 46' ' ' LEU . 1.1 tpm_? -79.47 -36.95 37.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.14 -170.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' CZ ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -62.41 -67.6 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.452 158.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.69 -169.63 0.1 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.298 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HG2' ' NH2' ' A' ' 65' ' ' ARG . 17.5 tptp . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.402 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.143 0.497 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 1.6 pm0 -90.12 122.41 33.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.908 175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.924 ' HB3' HD12 ' B' ' 8' ' ' ILE . 17.8 mt 58.68 57.98 5.95 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.65 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 7.3 Cg_exo -46.33 148.78 3.01 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.612 2.208 . . . . 0.0 113.389 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' B' ' 8' ' ' ILE . 1.8 pp -66.89 -10.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.467 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -87.86 -56.9 0.31 Allowed Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.868 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.3 Cg_endo -60.3 -39.96 62.97 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.609 2.206 . . . . 0.0 113.463 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.924 HD12 ' HB3' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.72 -55.78 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.829 167.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.05 -17.11 50.9 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.894 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HE3' ' B' ' 13' ' ' LYS . 6.1 ttm105 -82.06 -37.93 25.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.295 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 3' ' ' LEU . 64.6 mt -58.31 -50.36 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.9 164.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.958 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.6 mm -68.72 -30.18 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.322 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' B' ' 10' ' ' ARG . 17.5 mtmt -61.98 -38.45 88.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.181 170.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -61.16 -30.56 70.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.884 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.83 -52.04 67.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.508 169.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.38 34.74 0.6 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.59 -164.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 44' ' ' ILE . . . -83.32 149.21 26.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.278 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.05 -25.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.984 169.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -106.21 34.24 3.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.307 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 55' ' ' ILE . 22.6 t -82.34 138.15 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.253 167.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.619 ' HB2' HG21 ' A' ' 54' ' ' THR . 31.2 t -80.05 152.31 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.386 163.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.2 -15.25 32.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.5 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.481 ' O ' HG22 ' B' ' 26' ' ' ILE . 9.2 t70 -90.31 -29.3 18.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.389 -171.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.704 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -68.28 -44.27 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.207 167.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -61.82 -43.98 97.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.279 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.482 ' CD1' ' HD3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -62.9 -49.5 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.256 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -62.27 -29.13 70.2 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.949 -170.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.883 HD13 HG23 ' A' ' 60' ' ' ILE . 3.8 tp -61.82 -42.73 99.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.943 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -64.12 -34.76 78.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.446 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -83.94 -41.51 17.28 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.687 -175.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.538 HD12 ' O ' ' B' ' 27' ' ' THR . 21.8 mt -60.45 -65.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.048 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.97 HD11 ' HA2' ' A' ' 36' ' ' GLY . 5.2 mt -55.81 -23.01 27.65 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.234 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -61.6 -62.63 1.68 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.663 169.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.35 -20.95 63.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.888 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.5 mmt -66.32 -48.82 69.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.176 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -61.01 -46.04 95.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.911 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -33.93 74.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.255 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -59.74 -61.69 2.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.974 173.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.742 ' HB ' HD11 ' A' ' 28' ' ' LEU . 3.1 mt -61.14 -41.35 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.241 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.933 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -67.2 -53.44 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.308 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.581 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 30.6 t -63.82 -30.36 71.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.53 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.687 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 1.4 tm-20 -62.03 -62.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.904 170.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -60.92 -9.88 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.601 HD12 ' C ' ' B' ' 40' ' ' ALA . 39.1 mt -95.07 -48.23 12.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.783 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.05 -16.29 30.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.336 166.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.7 mt -82.84 -46.64 12.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -76.53 -32.66 58.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.247 -173.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -80.45 -32.67 37.2 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.367 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -60.4 -35.89 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.268 168.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.82 -50.39 73.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.18 165.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 41.26 23.55 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -130.61 -173.76 3.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.405 -167.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.513 ' O ' HG22 ' B' ' 54' ' ' THR . 5.0 mtmm -75.04 98.06 3.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.48 -165.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.8 t 60.34 -176.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.952 166.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.3 mt -112.05 142.24 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.428 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.546 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 3.3 mmmt -125.11 -176.68 3.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.384 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.3 93.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.289 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -31.43 71.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.256 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.546 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 3.1 m-20 -80.22 -36.38 34.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.409 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 27' ' ' THR . 1.0 OUTLIER -64.2 -47.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.607 174.368 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 7.9 mt-10 -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.138 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 8.6 tp -64.47 -51.93 60.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.378 171.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -66.88 -32.95 74.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 60' ' ' ILE . 41.5 t -61.54 -67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.715 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.59 4.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.772 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -73.97 -39.45 63.7 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.069 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' HG12 ' B' ' 39' ' ' ILE . 12.3 m-85 -59.63 -41.9 91.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.493 164.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt 61.59 -169.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.335 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tptm . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.395 169.444 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 mt-10 58.48 103.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.54 167.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -89.27 97.33 0.91 Allowed Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.54 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HG2' ' HG3' ' A' ' 7' ' ' PRO . 7.5 Cg_endo -46.22 139.13 12.49 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.444 2.096 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.28 -8.26 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.915 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.25 -57.8 6.85 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.663 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -51.87 -60.39 0.79 Allowed 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.615 2.21 . . . . 0.0 113.584 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 3' ' ' LEU . 26.4 mt -61.02 -49.09 86.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.521 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.05 -22.88 63.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -171.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -82.74 -35.34 26.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.364 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.942 HG23 ' HG3' ' B' ' 37' ' ' ARG . 62.6 mt -59.69 -58.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.648 166.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.037 HG22 ' HB2' ' A' ' 17' ' ' ALA . 5.5 mm -61.94 -20.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.063 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 18' ' ' GLU . 3.6 mmmt -74.63 -36.77 62.91 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.299 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.85 -32.76 73.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.821 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.1 -53.41 58.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.383 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.51 17.62 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.316 -167.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -66.51 -163.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.678 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 61.6 24.2 14.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.612 -158.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -110.78 22.63 15.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 154.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.781 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 14.6 t -117.35 176.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.192 -162.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.605 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.6 t -125.08 168.37 13.47 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.526 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 65.6 m-20 -61.8 -25.75 67.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 3.4 t0 -61.19 -55.96 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.447 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -62.12 -52.73 62.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.329 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -61.07 -37.37 82.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.263 -168.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.38 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.422 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 31' ' ' ILE . 82.9 m -61.05 -44.7 97.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.245 -168.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.615 HD22 HG12 ' B' ' 60' ' ' ILE . 4.5 tp -59.79 -45.66 91.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.34 171.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -16.82 44.68 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.494 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 1.3 tptp -101.32 -26.15 13.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.326 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 27' ' ' THR . 1.6 mp -60.6 -68.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.792 161.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' B' ' 32' ' ' LEU . 3.7 mm? -58.48 -34.72 71.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.743 -168.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -74.24 -50.2 20.1 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.001 -175.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.0 tt0 -61.7 -44.09 97.59 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.952 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -35.16 75.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.574 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.37 -49.32 32.69 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -60.3 -14.28 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.417 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.4 t0 -88.8 -47.13 8.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.52 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD12 HD11 ' B' ' 32' ' ' LEU . 20.5 mt -60.64 -30.73 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.285 170.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.72 -74.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.304 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.94 -18.9 61.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.462 -174.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.9 mm-40 -69.22 -61.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.013 167.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -9.96 5.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.587 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.8 mt -94.26 -52.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.946 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -60.32 -10.65 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.487 167.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.8 mp -82.96 -47.05 12.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.217 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.19 96.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.355 167.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -54.53 27.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.375 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.48 -28.78 68.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.332 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.07 92.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.317 169.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.66 17.83 2.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HD3' ' NZ ' ' A' ' 56' ' ' LYS . 4.4 mmp_? -98.77 -167.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.4 -171.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -127.23 -37.05 2.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.398 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 ' O ' ' B' ' 19' ' ' ARG . 31.1 m -101.41 149.55 23.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.424 -168.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 44' ' ' ILE . 13.9 mm -91.44 137.8 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.365 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' NZ ' ' HD3' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -138.74 175.46 9.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.66 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.227 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.58 -40.47 69.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.111 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -33.67 71.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.399 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.652 ' CG1' ' HB1' ' B' ' 24' ' ' ALA . 44.5 mm -61.15 -69.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.29 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -61.66 -12.09 14.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.269 -170.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mt -75.47 -48.93 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.391 168.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -64.24 -35.72 81.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.361 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.001 HG21 HD13 ' B' ' 31' ' ' ILE . 25.0 t -66.09 -72.01 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.65 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -59.66 -11.16 4.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -169.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -29.36 14.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.367 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.514 ' CE2' HG12 ' A' ' 39' ' ' ILE . 1.5 m-85 -59.5 -22.97 62.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.445 163.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.64 82.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.443 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.631 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.369 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.444 ' HB3' ' CB ' ' A' ' 7' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.077 0.465 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.537 ' C ' HD23 ' B' ' 3' ' ' LEU . 98.3 mt-10 -134.24 -159.2 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.039 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -107.9 97.79 22.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.529 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.661 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 2.4 Cg_endo -57.88 163.26 9.65 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.476 2.117 . . . . 0.0 113.509 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 pt -86.21 -25.25 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.4 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.64 -59.88 4.32 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.781 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 1.2 Cg_endo -54.48 -48.72 19.9 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 C-N-CA 122.498 2.132 . . . . 0.0 113.517 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' B' ' 3' ' ' LEU . 38.9 mt -61.03 -43.73 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.369 169.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -16.18 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.7 OUTLIER -96.38 -26.76 15.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.359 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -61.27 -56.02 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.325 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 40' ' ' ALA . 9.8 mm -64.04 -36.11 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.168 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.8 OUTLIER -62.68 -36.9 84.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.435 171.205 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.57 -34.2 76.5 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.777 -1.102 . . . . 0.0 109.817 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -59.26 -53.34 59.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.488 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.58 19.93 0.35 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.806 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.2 120.9 10.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.311 -0.445 . . . . 0.0 110.335 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.27 -74.65 0.34 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.048 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.669 ' O ' HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -122.19 109.25 14.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.407 -169.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.66 HG21 HH21 ' B' ' 25' ' ' ARG . 47.5 t -112.14 150.27 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.74 150.04 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.311 169.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.454 ' O ' HD12 ' B' ' 26' ' ' ILE . 2.4 p30 -60.85 -12.97 12.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.357 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -55.35 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -61.98 -40.69 96.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.304 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.66 HH21 HG21 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -61.61 -45.39 94.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.456 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.454 HD12 ' O ' ' B' ' 22' ' ' ASP . 51.8 mt -77.73 -21.56 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.422 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.754 HG22 HD11 ' B' ' 31' ' ' ILE . 88.3 m -72.79 -50.58 23.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.312 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' B' ' 31' ' ' ILE . 3.2 tp -59.19 -37.86 78.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.561 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.09 75.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.32 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -26.42 23.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.43 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 1.001 HD13 HG21 ' A' ' 64' ' ' VAL . 67.5 mt -61.04 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.033 170.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD12 ' A' ' 32' ' ' LEU . 7.2 mp -60.03 -38.34 82.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.715 -170.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.574 ' HG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.37 -30.09 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.929 -170.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.02 -45.45 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.122 167.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 33.9 mtt -61.43 -42.33 98.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.517 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.07 99.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -170.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.942 ' HG3' HG23 ' A' ' 11' ' ' ILE . 2.4 mtp180 -60.43 -35.35 75.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.552 171.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -77.95 -45.7 23.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.499 -167.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.614 HD13 ' CG2' ' B' ' 64' ' ' VAL . 11.9 mt -60.85 -35.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.099 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.905 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.65 -59.55 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.341 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.501 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 72.0 p -68.79 -24.33 64.39 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.224 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.588 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.5 OUTLIER -61.19 -55.93 26.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.041 165.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.468 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -65.82 -13.68 59.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.602 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.825 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -87.62 -56.46 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.309 -164.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -72.26 -17.29 61.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.467 172.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.507 HD12 ' C ' ' B' ' 42' ' ' GLU . 8.3 mt -60.83 -44.16 97.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.369 167.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.859 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.15 -44.02 97.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.362 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -50.99 25.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.43 -171.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -61.54 -34.29 75.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.32 91.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.335 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.1 29.99 5.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -110.46 135.63 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.404 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.88 -42.95 47.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.382 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 7.0 m -111.07 119.8 40.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.399 -168.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.859 HG12 ' HB2' ' B' ' 47' ' ' ALA . 79.9 mt -76.74 139.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.291 168.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.904 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 5.5 mtmt -141.8 -170.33 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.463 -169.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.76 -33.36 73.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.241 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -30.43 69.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.064 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.73 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.6 OUTLIER -84.19 -39.14 19.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.415 -166.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -65.2 -42.19 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.216 162.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 3.8 mt-10 -61.53 -31.15 71.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.977 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.7 -33.27 18.8 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.357 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.54 -42.9 97.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.436 172.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.44 -52.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -164.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.28 78.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.799 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.98 -17.93 54.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.9 t80 -60.97 -60.41 3.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.327 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.17 -76.58 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.441 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.585 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.373 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HE2' ' HG2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.299 0.571 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.604 ' N ' ' HB3' ' B' ' 7' ' ' PRO . 4.2 mt-10 58.44 -161.48 0.24 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.727 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.84 ' CB ' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -102.77 96.83 8.19 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.589 174.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.4 Cg_endo -57.68 162.66 10.21 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.614 2.21 . . . . 0.0 113.545 170.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -84.82 -15.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.526 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.42 -58.59 14.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.762 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.5 Cg_endo -59.3 -57.65 0.85 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.595 2.197 . . . . 0.0 113.619 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.5 mt -61.71 -43.33 97.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.372 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' A' ' 25' ' ' ARG . . . -61.74 -41.06 99.56 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -72.82 -18.47 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.455 -174.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG23 ' HD2' ' B' ' 37' ' ' ARG . 69.7 mt -77.67 -41.18 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.53 172.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.5 mm -63.99 -43.96 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.149 171.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.8 mttt -62.07 -35.68 79.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.244 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.49 -31.15 71.12 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.845 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.63 -52.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.521 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.1 24.6 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.493 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -60.91 120.27 9.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.314 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -90.35 -48.02 7.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.189 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.52 90.43 2.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.501 168.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' B' ' 55' ' ' ILE . 97.8 t -96.41 129.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.126 166.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 p -60.84 146.2 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.546 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -61.16 -21.97 64.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.34 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.14 -27.17 64.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.42 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.797 ' O ' HG22 ' A' ' 27' ' ' THR . . . -78.06 -41.76 34.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.288 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -60.7 -45.7 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.503 172.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 19.9 mt -66.55 -27.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.437 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 24' ' ' ALA . 1.3 t -76.5 -33.19 58.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.228 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.771 HD22 HG21 ' B' ' 60' ' ' ILE . 1.1 mm? -59.9 -39.13 84.34 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.434 170.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -61.49 -42.05 98.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.396 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -25.69 24.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.415 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 27' ' ' THR . 17.4 mt -61.42 -72.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.925 165.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.816 -167.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HG3' HD11 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.29 -55.69 22.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 170.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.77 -32.82 73.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.966 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.521 ' HB3' HD21 ' B' ' 32' ' ' LEU . 3.0 tpp -66.36 -44.83 82.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.414 167.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.24 99.14 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -35.17 75.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.195 -0.503 . . . . 0.0 110.427 169.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -61.42 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.533 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 HG22 ' A' ' 64' ' ' VAL . 8.7 mt -61.79 -31.78 51.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.353 -171.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -66.86 -61.18 2.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.253 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.519 ' CB ' ' HB1' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -60.87 -10.52 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.412 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -81.37 -57.94 3.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.412 169.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 59' ' ' ASP . . . -66.01 -5.47 9.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.818 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.94 HD11 ' HB2' ' B' ' 17' ' ' ALA . 77.5 mt -85.95 -65.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.906 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -21.96 64.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.951 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 42' ' ' GLU . 8.4 mp -60.01 -57.18 13.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.21 158.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.746 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.87 -42.76 99.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.236 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -56.57 13.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.472 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -64.45 -23.7 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.419 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.11 -55.71 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.016 164.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.27 19.67 0.26 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 113.85 -1.523 . . . . 0.0 111.035 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.64 -167.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.358 -0.495 . . . . 0.0 111.012 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 98.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 -164.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.4 m 71.65 117.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.622 165.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.913 HD11 HG12 ' A' ' 44' ' ' ILE . 14.6 mt -71.76 147.72 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.614 157.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 27.9 mttt -141.97 160.63 39.83 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.323 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.99 -28.0 69.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.704 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -61.38 -41.02 96.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.977 166.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.842 ' CG ' ' HB1' ' A' ' 43' ' ' ALA 0.268 0.0 OUTLIER -67.6 -40.41 84.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.352 -173.865 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.903 HG23 HD13 ' B' ' 28' ' ' LEU . 45.7 mm -73.14 -36.12 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.288 -169.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -87.48 -17.56 31.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.157 177.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 58' ' ' GLU . 3.8 mm? -72.16 -47.17 52.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.104 164.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -64.84 -42.65 94.76 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.063 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.036 HG21 HD13 ' B' ' 31' ' ' ILE . 23.9 t -61.22 -73.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.616 171.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.85 -11.05 6.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.387 -167.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HD2' HD21 ' A' ' 46' ' ' LEU . 7.4 mtt180 -70.4 -47.58 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.314 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -61.52 -58.31 8.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.311 167.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 105.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.405 -160.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.589 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.363 166.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttp . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.008 0.432 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.559 ' C ' HD23 ' B' ' 3' ' ' LEU . 0.7 OUTLIER 58.57 -166.44 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.693 171.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.815 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -108.25 90.82 7.31 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.545 173.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.558 ' HG2' ' HE2' ' A' ' 1' ' ' MET . 15.7 Cg_exo -50.48 152.86 8.29 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 122.617 2.211 . . . . 0.0 113.622 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 pt -85.28 -10.61 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.858 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.752 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.05 -62.69 1.76 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.781 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -53.93 -52.3 8.74 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.337 2.025 . . . . 0.0 113.505 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.815 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.3 mt -60.26 -38.43 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.461 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.77 95.17 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.622 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -80.7 -16.52 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.361 -0.42 . . . . 0.0 110.443 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' B' ' 8' ' ' ILE . 17.7 mt -80.15 -39.1 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.772 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 40' ' ' ALA . 20.1 mm -61.18 -46.99 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.243 168.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 5.7 mtpt -63.65 -36.93 85.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.225 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.4 -30.82 70.79 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.878 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.28 -53.4 58.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.681 169.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.06 30.4 0.27 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.707 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.94 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -88.44 -175.5 5.0 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 114.763 -0.718 . . . . 0.0 110.296 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.25 -72.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.047 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -99.11 122.01 41.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.354 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.838 HG11 ' CZ ' ' B' ' 25' ' ' ARG . 14.0 t -145.52 155.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.303 -166.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -93.2 149.51 21.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 167.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.85 -13.07 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.267 167.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m-20 -60.4 -59.64 5.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.529 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.688 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -63.8 -43.97 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.315 -175.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.924 ' NH2' HG21 ' B' ' 12' ' ' ILE . 5.3 mmt-85 -67.62 -33.32 74.74 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.486 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.25 -19.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.403 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 60' ' ' ILE . 89.5 m -71.77 -48.83 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.426 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.53 -46.86 88.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.404 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -61.99 -29.69 70.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.467 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -26.02 15.03 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.319 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 1.036 HD13 HG21 ' A' ' 64' ' ' VAL . 79.4 mt -60.87 -70.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.961 163.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.654 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.32 -27.23 67.17 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.551 -170.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.5 ' HG3' ' HG ' ' B' ' 3' ' ' LEU . 6.5 mt-10 -61.27 -47.2 87.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.203 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.8 -29.24 70.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.005 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -49.8 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.427 166.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.0 98.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.6 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.62 -32.4 71.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.393 170.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.2 t0 -64.47 -58.73 5.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.427 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.63 HG21 HG23 ' B' ' 64' ' ' VAL . 2.9 mt -65.61 -24.88 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.157 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.771 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -64.2 -75.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.312 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.513 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 p -61.43 -16.81 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.583 -171.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.512 ' HG3' ' CZ ' ' B' ' 67' ' ' PHE . 0.0 OUTLIER -72.45 -59.46 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.082 168.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.89 -12.72 11.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.41 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.689 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.6 mt -94.45 -50.34 11.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.724 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.27 -21.37 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.547 168.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -71.61 -46.67 58.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.391 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -45.09 14.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.387 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -61.55 -35.93 79.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.356 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.85 -46.83 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.35 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 29.46 6.91 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 174.04 7.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.343 170.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.18 151.29 48.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.389 -168.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 99.1 m 70.1 127.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.463 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.878 ' HB ' HG22 ' A' ' 20' ' ' VAL . 4.6 mp -87.58 140.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.265 166.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 ptpp? -137.65 -171.25 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 166.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.13 -16.91 49.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 1.3 tm-20 -90.15 -20.73 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.042 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.842 ' HB2' HG23 ' B' ' 55' ' ' ILE . 18.2 m-20 -81.06 -34.08 32.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.389 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.771 HG21 HD22 ' A' ' 28' ' ' LEU . 35.9 mm -60.53 -68.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.348 167.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.408 ' HA ' HG12 ' B' ' 64' ' ' VAL . 41.4 mt-10 -61.38 -15.29 34.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.772 -170.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 11.5 mt -68.31 -50.82 50.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.284 165.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.439 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -75.52 -56.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.861 -162.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -21.31 59.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.875 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -48.85 79.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.281 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' B' ' 39' ' ' ILE . 4.5 m-85 -60.67 -64.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.301 164.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' B' ' 68' ' ' LYS . 4.7 ttmm 178.69 169.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.343 -170.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.614 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.311 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HB2' HD23 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -109.95 -40.12 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.993 169.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.953 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -87.67 126.06 63.02 Favored Pre-proline 0 C--O 1.243 0.761 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.224 -172.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 20.4 Cg_endo -60.89 148.1 93.43 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.099 1.866 . . . . 0.0 113.469 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -115.87 -12.48 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.846 -175.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -70.14 -56.3 7.25 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.701 173.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -63.22 -51.8 2.49 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.586 2.191 . . . . 0.0 113.542 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.536 ' HA ' HD12 ' A' ' 11' ' ' ILE . 45.9 mt -60.88 -55.45 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.39 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -30.04 74.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -68.49 -36.33 78.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.397 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 8' ' ' ILE . 23.9 mt -60.63 -40.6 85.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.509 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.8 mm -68.09 -41.03 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.277 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.62 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.275 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -62.25 -35.11 77.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.855 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.842 ' HB1' ' CB ' ' B' ' 41' ' ' SER . . . -59.75 -53.09 62.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.428 169.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.74 24.99 0.28 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.583 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.87 129.15 40.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.393 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.64 -37.64 6.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.115 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 109.64 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.37 169.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 t -107.51 127.69 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.308 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 26.6 t -62.5 146.45 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.352 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -30.28 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.347 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.8 -45.83 92.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.432 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.783 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -65.73 -59.06 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.297 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 25' ' ' ARG . 11.5 ptm180 -62.55 -23.72 67.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -82.49 -32.72 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.564 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 60' ' ' ILE . 72.4 m -61.21 -39.36 89.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.397 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.883 HD22 HG13 ' B' ' 60' ' ' ILE . 0.4 OUTLIER -60.79 -45.03 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.135 170.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.953 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -61.35 -42.95 99.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.461 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.15 -25.29 55.15 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.224 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.738 HG21 HG21 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -61.82 -50.42 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.402 162.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.882 HD13 ' HG ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -58.63 -36.4 74.03 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.608 -172.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB2' HD21 ' A' ' 3' ' ' LEU . 22.3 tp10 -81.26 -41.37 22.31 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.978 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -86.34 -18.99 30.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.889 -170.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -44.35 48.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.9 160.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.29 99.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.696 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.38 -35.66 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.023 175.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -49.89 75.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.507 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 HG23 ' A' ' 64' ' ' VAL . 28.2 mt -61.62 -53.03 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.272 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.87 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -63.33 -47.83 80.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.28 -167.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.409 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 7.1 t -64.68 -19.93 66.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.156 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -78.67 -50.05 12.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.124 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.793 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -71.67 -32.05 67.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.987 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.5 mt -60.58 -44.06 95.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.935 161.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.57 -31.05 70.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.477 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 6.5 mt -80.47 -43.44 20.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.279 -169.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -60.75 -38.87 86.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.221 165.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.71 -47.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.37 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -34.47 74.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.446 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.72 83.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.242 168.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.61 43.66 5.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -168.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HG3' ' H ' ' A' ' 53' ' ' LYS . 4.3 tpt85 -119.45 160.8 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.334 -168.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -93.65 147.37 23.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.393 -177.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.503 ' N ' ' HG2' ' A' ' 53' ' ' LYS . 98.8 m 68.16 128.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.475 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 44' ' ' ILE . 41.1 mm -91.61 138.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.375 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -144.3 -171.76 3.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.316 -166.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -74.13 -38.94 63.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.21 -167.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.737 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.9 mp0 -61.34 -36.34 79.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.11 169.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -42.76 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.405 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.707 ' CG2' HD13 ' B' ' 28' ' ' LEU . 29.2 mm -61.11 -56.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.345 168.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.6 mt-10 -62.06 -22.8 66.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.931 -172.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -60.54 -52.6 64.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.312 165.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -60.25 -44.81 94.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.588 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.829 HG23 HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.91 -55.52 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.043 -160.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -29.18 68.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.74 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.381 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 11.0 m-85 -60.73 -54.71 41.91 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.419 170.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -66.68 115.37 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.444 -168.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.629 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.324 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtm . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.787 ' O ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 58.48 27.64 15.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.701 169.147 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' B' ' 8' ' ' ILE . 14.5 mt 60.24 86.25 0.16 Allowed Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.154 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.03 151.9 11.13 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.328 2.019 . . . . 0.0 113.547 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' B' ' 25' ' ' ARG . 1.1 pt -92.42 18.31 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.685 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -80.04 -58.67 0.59 Allowed Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.673 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.2 Cg_endo -58.65 -54.57 2.76 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.18 . . . . 0.0 113.496 168.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.787 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.4 mt -67.83 -23.84 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.386 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.11 97.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -86.9 -14.2 42.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.477 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mt -60.97 -49.57 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 163.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.982 HD11 HD23 ' B' ' 28' ' ' LEU . 5.7 mt -92.03 -19.69 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.484 -166.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 9.3 mttm -62.48 -41.63 98.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.459 159.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.62 -33.01 73.18 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.09 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.397 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.78 38.35 0.54 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.565 -163.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.917 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -79.8 164.09 23.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.767 -0.717 . . . . 0.0 110.26 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -132.0 -39.04 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.78 100.2 2.05 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.345 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.511 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -92.53 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.055 160.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.7 t -68.51 171.19 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.2 165.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 25' ' ' ARG . 0.5 OUTLIER -60.58 -22.34 63.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.407 172.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.8 m-20 -61.17 -61.67 2.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.48 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.4 -51.2 68.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.243 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.568 ' CZ ' HD13 ' B' ' 5' ' ' ILE . 1.4 ptm180 -60.89 -48.0 83.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.361 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 86.0 mt -62.08 -43.59 97.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.457 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.566 ' C ' HD12 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -63.18 -45.84 89.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 -167.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.982 HD23 HD11 ' B' ' 12' ' ' ILE . 1.9 tp -59.51 -33.69 71.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.665 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' B' ' 2' ' ' GLU . . . -61.42 -41.55 97.34 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.311 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.522 ' HG3' ' HG3' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -96.49 -18.97 19.47 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.331 -174.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.736 HG21 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -60.22 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.891 161.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.882 ' HG ' HD13 ' A' ' 32' ' ' LEU . 1.1 mp -58.49 -25.9 62.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.705 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.627 ' OE1' HD11 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.22 -56.97 14.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.011 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -30.6 70.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.935 -168.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.626 ' CG ' HD11 ' B' ' 39' ' ' ILE . 3.4 tpp -61.98 -45.08 95.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.297 164.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.51 -41.44 94.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.422 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 1.8 t70 -65.41 -57.46 8.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.493 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.713 ' CG1' HG23 ' B' ' 64' ' ' VAL . 1.9 mt -62.16 -29.42 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.872 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.28 -75.14 0.08 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.842 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -62.13 -12.71 21.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.454 -170.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -88.27 -44.52 10.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.23 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -66.64 -10.76 49.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.344 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.0 mt -95.39 -53.98 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.113 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -60.69 -21.36 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.468 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.9 mt -66.72 -63.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.429 168.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.05 75.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.22 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -38.23 51.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.419 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.63 -35.96 77.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.331 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' B' ' 52' ' ' ARG . . . -60.75 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.301 167.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 52.39 5.96 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -130.22 21.94 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.341 -169.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt 65.31 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.472 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 1.7 m -89.09 140.54 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.366 -167.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.615 HG23 ' HB3' ' B' ' 59' ' ' ASP . 3.6 mt -92.83 140.85 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.391 168.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.783 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.61 178.71 5.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.45 -169.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -22.48 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.376 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 4.4 tp10 -71.37 -22.44 61.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.166 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.3 OUTLIER -93.59 -35.4 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.297 -172.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.883 HG13 HD22 ' A' ' 28' ' ' LEU . 1.3 mp -64.2 -36.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.487 160.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 1.1 mt-10 -62.06 -46.23 90.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.84 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.42 -50.35 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.525 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.65 -56.61 19.22 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.521 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.738 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -64.2 -52.62 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.227 -170.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -60.49 -37.23 80.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.742 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' B' ' 66' ' ' ARG . 1.4 tpt180 -61.6 -40.57 95.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -171.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 1.2 m-85 -60.86 -61.82 2.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.398 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -86.47 93.63 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? . . . . . 0 C--O 1.24 0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.336 171.774 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' N ' ' HB2' ' A' ' 33' ' ' GLU . 7.1 tpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.563 ' C ' HD23 ' A' ' 3' ' ' LEU . 1.2 tp10 59.44 28.32 17.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.515 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.866 HD21 HD11 ' B' ' 11' ' ' ILE . 0.2 OUTLIER -106.51 84.87 1.56 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.458 160.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 8.0 Cg_endo -61.31 144.14 98.41 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.472 2.115 . . . . 0.0 113.525 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.888 HD13 ' NH2' ' A' ' 25' ' ' ARG . 2.5 pp -64.96 -7.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.911 -169.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.19 -55.17 0.67 Allowed Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.81 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.5 Cg_endo -59.7 -49.8 9.36 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.469 2.112 . . . . 0.0 113.599 176.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.8 mt -60.83 -37.77 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.232 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.79 -16.03 44.27 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.564 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 3.8 tpp85 -96.3 -26.66 15.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' B' ' 3' ' ' LEU . 8.6 mm -60.28 -54.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.394 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 17' ' ' ALA . 8.1 mm -76.73 -35.88 25.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.271 -164.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -65.1 -34.62 78.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.338 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.33 -33.39 74.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.77 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.64 -54.18 50.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.461 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.19 30.4 0.31 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.613 -173.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -75.99 147.3 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.727 -0.737 . . . . 0.0 110.344 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' NH1' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -171.13 47.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.013 166.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -164.88 24.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.42 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 24' ' ' ALA . 37.3 t -85.85 119.65 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.31 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' ' CG2' ' B' ' 54' ' ' THR . 25.1 p -62.2 164.23 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.297 168.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 11.7 t70 -60.65 -21.89 63.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.535 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.594 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -90.04 -31.94 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.448 -168.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -69.39 -44.03 72.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.22 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.888 ' NH2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -73.99 -21.99 59.78 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.383 -173.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.743 ' O ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -83.45 -42.81 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.361 178.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.479 HG22 ' CG2' ' B' ' 60' ' ' ILE . 57.3 m -61.34 -38.49 87.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.447 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 3.6 tp -62.02 -41.37 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.131 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.58 98.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.354 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 2.4 tppt? -83.32 -29.05 28.62 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.396 -172.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.922 HD13 HG21 ' B' ' 64' ' ' VAL . 45.4 mt -60.53 -66.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.011 165.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.914 HD12 HD23 ' B' ' 32' ' ' LEU . 0.7 OUTLIER -58.15 -32.96 68.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.787 -169.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HB2' ' N ' ' A' ' 1' ' ' MET . 1.8 pp20? -82.67 -30.96 28.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.081 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.5 mt-10 -61.64 -33.92 74.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -55.58 8.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.509 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -61.15 -45.11 97.2 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.2 ttp180 -60.69 -33.92 73.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.419 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.7 m-20 -66.76 -56.78 8.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.481 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 64' ' ' VAL . 4.5 mt -61.51 -26.1 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.289 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.664 ' CB ' HG23 ' B' ' 12' ' ' ILE . . . -61.82 -74.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.211 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.431 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 15.5 t -62.2 -12.88 22.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.351 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.55 -57.88 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.07 171.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.78 -10.49 5.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.595 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -98.89 -51.42 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.662 -174.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 12.2 ttpt -60.04 -10.58 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.348 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.738 HD22 ' HB2' ' A' ' 63' ' ' ALA . 3.8 mp -82.73 -42.6 17.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.246 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -68.74 -36.09 77.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -82.71 -43.93 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.415 -168.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.43 ' N ' ' HD3' ' A' ' 48' ' ' ARG . 7.1 m-70 -61.22 -23.86 65.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.191 168.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.94 -54.34 46.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.082 165.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.12 29.85 0.38 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.532 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.64 99.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.782 -0.709 . . . . 0.0 110.446 169.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.69 -169.08 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.297 168.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -65.22 125.53 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.378 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.623 HD12 HG22 ' B' ' 20' ' ' VAL . 44.6 mt -62.53 147.8 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.301 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -145.95 164.02 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.509 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.06 64.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.247 -168.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -58.14 9.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.034 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.89 -21.79 65.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.434 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.812 HG23 HD13 ' B' ' 28' ' ' LEU . 29.8 mm -72.68 -76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.224 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.546 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -62.74 -8.44 6.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.454 -176.011 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.12 -27.56 19.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.586 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.738 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -81.53 -31.98 32.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.005 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.786 HG21 HD13 ' B' ' 31' ' ' ILE . 25.7 t -60.64 -69.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.637 160.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -14.3 19.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.565 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -62.09 -51.12 69.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.358 167.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 54.0 m-85 -60.58 -52.27 65.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.537 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HD3' ' HE2' ' B' ' 69' ' ' LYS . 5.8 ttmt 62.74 14.9 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.429 -169.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm . . . . . 0 C--O 1.24 0.568 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.485 -174.32 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.175 0.512 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -161.12 113.12 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.971 170.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 11' ' ' ILE . 2.8 mt -69.42 139.8 89.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.699 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.412 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.1 Cg_endo -61.12 142.63 97.52 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 122.471 2.114 . . . . 0.0 113.558 167.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.703 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -67.78 -20.19 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.381 -170.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -61.35 -62.2 6.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.736 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.07 -50.56 13.52 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.455 2.103 . . . . 0.0 113.623 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' B' ' 3' ' ' LEU . 7.5 mt -62.22 -21.7 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.449 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.86 97.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.624 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -86.44 -15.32 40.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.522 -173.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 3' ' ' LEU . 11.1 mm -60.85 -73.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.234 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.812 HD13 HG22 ' B' ' 11' ' ' ILE . 8.0 mm -63.27 -20.96 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.936 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB3' ' NZ ' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -73.51 -36.35 65.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.391 172.016 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.92 -31.88 72.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.825 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.18 -52.64 64.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.455 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.96 33.5 0.51 Allowed Glycine 0 CA--C 1.527 0.783 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.607 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -77.45 147.1 36.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.28 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -106.48 -67.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.977 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 112.14 9.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.418 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.678 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 80.6 t -103.62 137.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.31 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 54.0 p -61.11 146.55 47.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.427 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH1' ' B' ' 25' ' ' ARG . 2.3 p30 -61.69 -24.4 66.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.412 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.575 ' HA ' HG22 ' B' ' 26' ' ' ILE . 4.9 t0 -84.04 -26.0 29.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.382 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.678 ' HB3' ' CG1' ' B' ' 20' ' ' VAL . . . -62.7 -45.05 94.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.171 168.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptt-85 -85.88 -13.27 48.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.554 -166.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.76 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -84.12 -38.33 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.444 168.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.472 HG22 HD11 ' B' ' 31' ' ' ILE . 59.4 m -61.33 -43.15 99.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.218 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.812 HD13 HG23 ' A' ' 60' ' ' ILE . 2.6 tp -60.22 -37.59 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.272 166.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.33 -43.04 99.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -82.2 -26.13 33.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.448 -177.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.786 HD13 HG21 ' A' ' 64' ' ' VAL . 34.7 mt -60.95 -71.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.99 -32.19 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.681 -166.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.7 pp20? -80.85 -39.68 26.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.175 -170.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 3.2 mm-40 -61.59 -39.23 90.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.007 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 4.8 mtp -61.0 -54.86 39.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.535 168.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.3 -45.81 95.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -165.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.845 ' HG3' HG23 ' A' ' 11' ' ' ILE . 9.2 mtp-105 -61.21 -32.33 72.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.235 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -61.5 -49.58 76.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.604 175.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.852 HD13 HG22 ' B' ' 64' ' ' VAL . 2.8 mt -62.06 -37.17 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.59 -69.0 0.27 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.315 -175.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 1.4 p -62.17 -10.27 10.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.498 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.4 OUTLIER -93.84 -50.78 5.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.279 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.72 -10.57 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.376 170.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 17' ' ' ALA . 87.4 mt -101.24 -50.77 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.752 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -60.42 -11.71 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.463 168.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.498 HD12 ' C ' ' B' ' 42' ' ' GLU . 6.0 mt -83.97 -54.05 5.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.395 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.22 -21.15 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.386 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -44.91 15.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.311 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -60.41 -30.51 69.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.398 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.64 -49.78 76.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.423 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.26 37.6 0.79 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -168.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mtt85 66.05 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.492 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -130.77 -177.65 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.351 167.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 21' ' ' SER . 87.7 m -78.16 130.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.468 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.678 HG22 ' HB1' ' A' ' 24' ' ' ALA . 13.5 mm -69.97 134.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.249 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.516 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -139.73 175.51 9.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.527 -171.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -25.37 67.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.279 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.441 ' C ' HD12 ' B' ' 62' ' ' LEU . 0.6 OUTLIER -62.17 -63.59 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.11 169.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -61.06 -12.44 11.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.468 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 31' ' ' ILE . 41.4 mm -88.39 -57.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.178 -177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 9.6 mt-10 -61.48 -16.89 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.177 170.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -67.56 -59.73 3.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.324 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.77 71.75 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.119 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.922 HG21 HD13 ' A' ' 31' ' ' ILE . 43.4 t -61.61 -71.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.693 169.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -61.16 -9.17 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.497 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.51 48.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.296 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 38.1 m-85 -60.67 -53.62 55.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.34 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 64.46 -76.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.359 -167.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.513 ' HE2' ' HD3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.548 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.358 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.101 0.477 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.9 167.27 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.962 -170.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 mt -61.36 107.89 1.3 Allowed Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.916 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.29 148.8 13.62 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.341 2.027 . . . . 0.0 113.285 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.559 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.1 pp -93.03 20.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.628 -167.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.53 -59.54 0.31 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.68 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.7 Cg_endo -53.05 -50.46 14.0 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.493 2.129 . . . . 0.0 113.522 172.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 29' ' ' ALA . 86.3 mt -69.05 -30.36 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.382 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.04 99.66 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.47 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -78.25 -31.91 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.353 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' ILE . 85.5 mt -60.81 -40.05 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.379 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.945 HG23 ' HB1' ' B' ' 40' ' ' ALA . 12.1 mt -97.86 -15.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.516 -162.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -38.1 85.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 158.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.85 -33.57 76.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.022 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.85 -52.11 66.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.483 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.0 25.15 0.2 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.772 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -76.09 152.4 36.81 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 114.665 -0.768 . . . . 0.0 110.262 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 -42.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.194 169.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 113.56 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.421 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.714 HG13 ' HB ' ' B' ' 55' ' ' ILE . 22.4 t -137.3 161.93 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.393 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 81.8 p -88.42 133.93 33.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.414 169.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.99 -25.4 68.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.358 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.93 -36.38 79.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.421 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -63.17 -52.67 61.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.272 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.636 HH21 HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -68.82 -18.0 64.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.477 -168.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.25 -37.79 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.44 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 HG21 ' B' ' 60' ' ' ILE . 94.6 m -60.74 -32.29 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.457 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.947 HD22 HG13 ' B' ' 60' ' ' ILE . 10.9 tp -92.03 -33.74 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.024 -171.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 8' ' ' ILE . . . -61.02 -41.9 97.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.153 166.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -36.11 83.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.517 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.631 HG21 HG21 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.135 -167.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' B' ' 32' ' ' LEU . 2.8 mp -65.71 -57.61 7.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.507 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.808 ' HG2' HD13 ' B' ' 11' ' ' ILE . 9.5 tm-20 -61.47 -32.97 72.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.166 -166.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -40.25 95.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.93 170.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt -65.17 -38.02 89.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.581 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.653 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -76.98 -40.54 25.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -24.41 66.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.165 164.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -60.6 2.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.514 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.855 ' HB ' HD11 ' B' ' 28' ' ' LEU . 5.0 mt -61.37 -31.73 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.3 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.887 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.43 -61.36 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.347 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.516 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.6 -27.35 68.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.33 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 46' ' ' LEU . 43.3 mt-10 -61.13 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.011 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -72.28 -12.24 61.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.576 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.815 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -85.86 -56.67 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.268 -168.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD2' ' NH2' ' A' ' 48' ' ' ARG . 20.5 ttpp -66.52 -19.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.457 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -60.88 -44.05 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.294 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.6 -58.83 6.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.401 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' NH2' ' HD2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -71.07 -28.8 64.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.304 -165.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -60.54 -39.69 88.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.324 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -54.98 39.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.007 164.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.74 32.85 0.31 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.583 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 69.42 -87.89 0.03 OUTLIER 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.769 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt 58.44 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.055 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -157.8 168.47 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.129 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 47' ' ' ALA . 6.7 mm -82.44 137.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.214 165.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.22 155.87 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.418 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.33 -29.2 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.236 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 62' ' ' LEU . 7.9 mm-40 -61.54 -42.43 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 169.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.03 -43.12 79.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.487 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.731 HG23 HD13 ' B' ' 28' ' ' LEU . 44.7 mm -61.24 -45.72 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.499 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.74 -28.47 60.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.106 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 58' ' ' GLU . 6.4 mp -66.08 -43.3 87.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.31 169.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.49 -41.44 97.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.4 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -83.81 -55.08 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.143 -169.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -27.61 66.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.839 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -69.8 -36.29 75.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.377 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -27.95 68.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 170.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.22 169.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 165.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mttm . . . . . 0 C--O 1.238 0.499 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.368 168.939 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.8 ttm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 58.48 -164.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.67 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 3.9 mt -68.96 138.87 90.26 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.874 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -58.02 144.44 94.59 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.368 2.046 . . . . 0.0 113.509 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.595 HD13 ' NE ' ' B' ' 25' ' ' ARG . 1.4 pp -93.08 -24.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.375 -168.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.569 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -64.98 -56.39 21.12 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.8 Cg_endo -48.37 -53.83 6.2 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 122.507 2.138 . . . . 0.0 113.446 171.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.463 ' HA ' HD12 ' B' ' 11' ' ' ILE . 36.2 mt -61.1 -33.95 58.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.514 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -29.04 71.17 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 11.6 mtp-105 -87.88 -28.29 21.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.795 -0.703 . . . . 0.0 110.494 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 33' ' ' GLU . 65.5 mt -60.9 -53.07 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.419 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 40' ' ' ALA . 7.0 mm -63.87 -37.88 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.259 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 3.1 mtpm? -61.49 -35.78 78.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.265 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.82 -32.43 72.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.794 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.6 -53.58 56.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.506 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.92 21.61 0.29 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.956 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.815 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.21 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.275 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -167.69 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.048 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -130.8 98.98 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.459 168.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 58.3 t -106.22 145.21 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.322 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.7 p -70.06 155.99 39.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.321 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -32.09 72.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.353 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m-20 -61.56 -48.47 80.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.407 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.689 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.04 -52.35 64.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.274 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.595 ' NE ' HD13 ' B' ' 5' ' ' ILE . 0.4 OUTLIER -61.25 -38.36 86.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.274 -168.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -67.01 -37.61 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.47 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.645 HG22 HD11 ' B' ' 31' ' ' ILE . 84.5 m -61.08 -52.26 65.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.421 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 39' ' ' ILE . 4.1 tp -61.1 -42.3 98.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.335 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -60.76 -28.17 68.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.416 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -26.29 18.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.729 HG21 HG21 ' A' ' 64' ' ' VAL . 17.8 mt -60.87 -71.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.985 166.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.659 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.6 mp -59.44 -30.15 68.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.595 -168.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.535 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 7.1 tm-20 -75.83 -30.66 59.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.09 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.37 -44.79 96.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.065 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 12.6 mtt -62.37 -39.62 93.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.407 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -39.41 73.86 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -29.39 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 168.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.531 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.7 OUTLIER -82.31 -52.53 6.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.482 -169.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.672 HG12 HG23 ' B' ' 64' ' ' VAL . 5.6 mt -61.32 -34.28 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.185 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.945 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -77.6 -44.4 28.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.168 -164.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 4.4 t -70.62 -13.82 62.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.422 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.657 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 2.8 mm-40 -83.11 -44.76 14.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.993 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' B' ' 59' ' ' ASP . . . -80.59 -11.1 59.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.339 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ALA . 72.7 mt -93.85 -49.16 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -60.69 -24.1 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.344 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.945 HD22 HD23 ' B' ' 62' ' ' LEU . 2.9 mt -68.15 -54.13 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.367 170.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.639 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.13 -28.83 69.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.382 -167.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.46 -44.97 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.388 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -61.43 -37.36 83.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.327 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.5 75.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.197 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.92 47.86 4.33 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -165.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.67 -43.6 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.338 -166.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.58 118.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.473 -168.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 7.3 m 68.53 139.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.489 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.714 ' HB ' HG13 ' A' ' 20' ' ' VAL . 26.6 mt -105.19 163.21 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.374 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 mtmt -149.51 166.24 29.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 -169.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -12.96 26.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.256 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 26.9 mt-10 -86.44 -19.0 30.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.078 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.548 ' HB3' ' HB1' ' B' ' 43' ' ' ALA . 0.8 OUTLIER -82.53 -33.71 28.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.288 174.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.947 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.88 -56.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.67 161.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 3.0 mt-10 -61.31 -30.29 70.4 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.71 -168.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.945 HD23 HD22 ' B' ' 46' ' ' LEU . 12.0 tp -76.32 -46.69 26.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.639 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -61.27 -24.11 66.16 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.416 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.672 HG23 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -110.65 -55.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -160.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -10.7 2.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.668 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -92.9 -65.64 0.98 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.613 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -62.49 -23.67 67.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -155.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -96.22 87.07 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.417 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.565 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.35 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 mtt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.149 0.499 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -63.1 -158.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.196 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp -56.5 102.36 0.3 Allowed Pre-proline 0 C--O 1.251 1.134 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.598 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.577 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 3.5 Cg_exo -65.77 159.95 46.06 Favored 'Trans proline' 0 N--CA 1.484 0.967 0 C-N-CA 122.932 2.421 . . . . 0.0 113.542 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 2.6 pp -93.47 -26.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.394 -166.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.57 -56.49 9.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.698 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.0 Cg_endo -60.47 -47.65 13.5 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.121 1.881 . . . . 0.0 113.513 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.4 mt -60.87 -34.69 60.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.271 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.52 -26.82 65.02 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.541 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -84.35 -27.25 27.86 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.326 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.52 -58.44 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.454 169.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.705 HG23 ' CB ' ' B' ' 40' ' ' ALA . 8.7 mm -65.62 -42.64 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.198 -166.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -31.95 72.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.34 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.28 -33.71 75.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.756 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.27 -53.66 55.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.447 169.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.76 19.46 0.57 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.711 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.66 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.281 165.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.041 167.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.67 110.53 22.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.347 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' B' ' 55' ' ' ILE . 45.7 t -145.78 148.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.353 -169.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 p -87.45 154.78 20.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.383 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 9.5 p30 -61.14 -31.46 71.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.472 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.1 m-20 -83.87 -25.3 30.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.397 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -61.03 -40.08 92.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.252 168.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 5' ' ' ILE . 5.8 mtt180 -66.64 -47.53 72.27 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.476 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.715 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 tp -65.16 -35.99 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.356 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.785 ' O ' HD12 ' A' ' 31' ' ' ILE . 13.3 m -61.16 -53.68 53.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.293 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.889 HD22 HG13 ' B' ' 60' ' ' ILE . 6.0 tp -60.86 -9.82 4.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.251 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -84.52 -58.55 2.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.423 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -61.77 -26.12 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.22 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 27' ' ' THR . 2.3 mp -60.87 -74.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.961 161.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.765 ' O ' HD21 ' B' ' 32' ' ' LEU . 2.3 mm? -57.79 -30.1 65.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.617 -161.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.787 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.19 -44.18 47.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.262 178.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.58 -37.05 73.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.09 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 23.8 mmt -61.29 -40.48 94.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.38 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.32 -47.23 72.81 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -60.66 -17.72 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.458 171.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -86.83 -49.94 7.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.385 -173.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.818 ' HB ' HD11 ' B' ' 28' ' ' LEU . 4.8 mt -61.81 -23.84 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.081 171.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.674 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.87 -73.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.358 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.622 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 30.2 m -61.57 -13.05 18.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.312 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.67 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -78.47 -57.14 3.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.329 170.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.42 -11.9 12.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.529 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.862 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -96.81 -51.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.791 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -60.21 -15.6 25.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.459 167.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' ALA . 8.3 mt -79.17 -41.1 29.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.46 171.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.751 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -61.23 -17.98 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.24 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 -48.01 7.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.49 170.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.75 -14.6 33.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.395 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.63 -48.56 7.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.271 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 42.15 3.42 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -165.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.99 160.47 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.356 -165.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -117.27 145.81 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.307 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.884 HG23 ' HG3' ' B' ' 19' ' ' ARG . 3.8 m 69.83 158.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -168.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.751 HD13 ' HB2' ' A' ' 47' ' ' ALA . 11.0 mm -109.48 160.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.462 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -143.42 173.57 11.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.339 -168.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -72.83 -16.7 61.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.403 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 4.9 mm-40 -80.69 -14.35 58.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.264 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 73.9 m-20 -88.04 -40.4 13.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.307 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.817 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.5 -47.25 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.823 162.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 6.3 mt-10 -61.74 -42.22 98.68 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.983 -166.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.18 -28.71 27.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.433 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.67 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -60.26 -43.62 96.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.452 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.699 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.55 -55.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.009 -164.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -60.22 -24.61 64.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -14.96 23.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.462 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 46.0 t80 -60.77 -57.3 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.409 171.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.96 -76.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.484 -175.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 9.8 mtmt . . . . . 0 C--O 1.241 0.615 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.371 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 4.0 ptt? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.492 ' C ' HD23 ' B' ' 3' ' ' LEU . 9.6 mm-40 -68.54 -157.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 164.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.829 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -103.86 83.03 0.61 Allowed Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.546 177.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -61.33 149.6 88.69 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.599 2.199 . . . . 0.0 113.597 166.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.677 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -63.3 -13.14 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.786 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -72.89 -57.49 3.04 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.1 Cg_endo -54.94 -59.42 0.82 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.643 2.229 . . . . 0.0 113.596 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.829 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.7 mt -61.63 -49.05 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.371 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.71 -27.54 68.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 13.1 tpt180 -78.14 -26.55 47.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.509 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 3' ' ' LEU . 66.4 mt -69.88 -46.54 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.491 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.4 mm -64.41 -38.97 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.191 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.65 -35.32 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.376 168.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -62.16 -33.6 74.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.729 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -59.16 -53.5 57.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.358 169.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.2 14.65 0.62 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.256 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.862 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.59 147.54 41.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.318 162.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -55.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.114 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.884 ' HG3' HG23 ' A' ' 54' ' ' THR . 4.7 tpt180 -101.94 104.89 15.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.4 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -133.83 146.76 31.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.375 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 35.7 p -85.37 143.11 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.448 170.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -71.83 -28.46 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.31 -170.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -34.48 74.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.47 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -61.27 -54.04 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.258 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.512 ' HD3' ' HB ' ' B' ' 5' ' ' ILE . 5.7 mtt180 -64.96 -12.59 51.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.463 -170.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.752 HG22 ' HD2' ' B' ' 30' ' ' LYS . 86.4 mt -103.64 -25.63 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.447 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.811 ' O ' HD12 ' B' ' 31' ' ' ILE . 81.8 m -63.41 -44.06 95.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 39' ' ' ILE . 1.9 tp -59.92 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.295 172.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.13 -38.19 85.5 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.561 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.752 ' HD2' HG22 ' B' ' 26' ' ' ILE . 3.3 mtpt -80.41 -28.52 37.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.203 -173.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.811 HD12 ' O ' ' B' ' 27' ' ' THR . 2.7 mt -60.81 -70.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.996 160.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.75 -16.76 18.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.723 -166.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.18 -37.65 12.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.083 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 11.4 mt-10 -61.27 -57.64 11.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.254 171.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' B' ' 32' ' ' LEU . 19.0 ptp -62.33 -28.7 69.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.343 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.18 -46.24 51.52 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.566 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -14.54 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -89.97 -51.06 5.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.534 -173.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.685 HD13 ' CG2' ' B' ' 64' ' ' VAL . 6.8 mt -61.96 -26.3 39.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.053 171.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -62.14 -68.41 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.212 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.498 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 86.6 p -61.1 -10.65 6.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.534 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.0 OUTLIER -95.54 -36.04 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.035 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.515 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -75.52 -9.93 59.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.373 167.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 58.0 mt -98.6 -49.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.923 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' B' ' 48' ' ' ARG . 10.9 mttp -60.27 -27.79 67.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.453 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' B' ' 63' ' ' ALA . 10.0 mt -61.5 -55.44 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.346 166.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.715 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.33 -31.36 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.312 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.496 ' HG2' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -74.3 -38.13 63.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.408 178.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.444 ' N ' ' HG3' ' B' ' 48' ' ' ARG . 38.2 t-80 -60.55 -32.28 71.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.229 168.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.36 -53.97 51.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.28 170.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.94 23.96 0.75 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.775 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 56.0 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.1 0.476 . . . . 0.0 111.914 169.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -67.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.391 168.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.48 HG22 ' N ' ' B' ' 55' ' ' ILE . 93.6 m -146.28 166.47 26.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.364 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.941 HG23 ' HB3' ' B' ' 59' ' ' ASP . 65.7 mt -119.4 146.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.408 170.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -137.91 -172.92 3.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.424 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.45 -16.41 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.646 ' O ' HD13 ' B' ' 62' ' ' LEU . 0.1 OUTLIER -79.36 -25.32 42.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.102 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.941 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -85.94 -35.51 20.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.281 -176.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.889 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.77 -46.4 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.705 160.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -62.09 -40.29 95.34 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.823 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.646 HD13 ' O ' ' B' ' 58' ' ' GLU . 7.5 mp -74.76 -45.38 44.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.55 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.37 -31.81 71.71 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.387 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -95.16 -54.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.983 -165.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -16.68 34.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.697 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -11.81 15.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 3.2 t80 -61.1 -52.52 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.278 166.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.81 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.366 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.238 0.497 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.682 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.7 mt-10 58.84 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.714 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp -57.47 98.91 0.17 Allowed Pre-proline 0 C--O 1.251 1.178 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.499 -172.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 -60.56 -61.8 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 65.16 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.486 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.543 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.32 -168.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.09 0.472 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 1' ' ' MET . 4.1 mt-10 59.15 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.783 -174.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt -73.84 137.2 76.62 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.783 -168.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.93 -46.57 90.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.81 -76.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.382 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.353 -169.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptp . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 121.12 0.486 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 3' ' ' LEU . 45.8 tt0 -78.23 174.71 10.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.055 169.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 33' ' ' GLU . 11.5 mt -63.02 138.76 97.41 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.791 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 5.2 Cg_endo -58.96 148.93 82.46 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.392 2.061 . . . . 0.0 113.44 167.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 2.5 pp -85.1 -28.91 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -62.14 -62.22 6.21 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.779 -171.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -51.89 -46.24 33.46 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.48 2.12 . . . . 0.0 113.588 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' HA ' HD12 ' A' ' 11' ' ' ILE . 59.9 mt -61.18 -59.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.76 -26.76 67.35 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.0 -32.97 61.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.348 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.2 mt -60.76 -40.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.493 169.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' B' ' 40' ' ' ALA . 19.4 mm -66.51 -34.58 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.405 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -29.93 65.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.392 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -62.6 -35.52 79.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.811 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.49 -53.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.395 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.63 18.46 0.32 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.834 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.81 142.2 56.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.311 165.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.66 -33.58 3.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.117 -169.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 88.09 1.91 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.486 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.787 HG22 HD12 ' B' ' 55' ' ' ILE . 23.5 t -114.91 133.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.381 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -92.02 157.73 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.434 -169.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.02 -49.02 79.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.375 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -44.33 96.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.335 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 5.6 mtt180 -63.31 -47.21 83.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.434 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 mm -60.69 -32.79 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.506 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.3 m -67.66 -43.08 81.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.335 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.5 OUTLIER -61.32 -34.13 74.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.314 177.014 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.75 -47.92 23.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.203 -168.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.77 -32.8 72.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.32 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.87 HG21 HG21 ' B' ' 64' ' ' VAL . 13.0 mt -60.91 -77.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.935 164.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.89 -29.06 64.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.718 -160.318 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 3' ' ' LEU . 2.1 pp20? -75.51 -41.82 54.28 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.165 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -68.16 -25.15 65.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.02 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.45 -33.6 31.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.478 174.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.03 -39.47 84.59 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.97 -33.54 73.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.261 165.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 1.6 t0 -64.57 -60.88 2.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.432 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 64' ' ' VAL . 15.3 mt -61.17 -29.31 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.506 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.863 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.33 -63.45 1.28 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.261 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 88.5 p -61.66 -26.76 68.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.158 -175.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 46' ' ' LEU . 28.4 mm-40 -61.05 -45.74 93.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.029 163.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -76.14 -8.14 56.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.903 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -90.7 -55.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.999 -169.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -20.97 66.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.636 168.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.0 mp -61.16 -58.17 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.442 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -61.69 -22.04 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.19 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.472 HH12 HG23 ' A' ' 44' ' ' ILE . 21.4 ttp-105 -97.04 -31.44 12.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.267 -168.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -34.43 74.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.189 167.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -61.12 -49.99 75.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.034 164.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 41.06 59.76 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -166.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -129.19 -166.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.344 -164.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 118.41 36.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.28 -165.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' B' ' 21' ' ' SER . 95.0 m 67.79 161.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.383 165.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 47' ' ' ALA . 80.4 mt -100.93 147.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.54 173.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -145.85 -171.35 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.374 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.87 -42.48 99.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.322 -169.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.757 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -61.99 -23.53 66.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.094 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 10.6 m-20 -81.14 -55.78 4.53 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.862 HG23 HD13 ' B' ' 28' ' ' LEU . 44.8 mm -61.09 -37.64 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.366 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.49 -45.88 92.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.1 mm? -62.76 -45.72 91.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.467 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.64 -30.33 70.64 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.361 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.84 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -62.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.16 -164.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.5 mtt180 -60.4 -18.36 50.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.595 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.7 tpt85 -64.39 -76.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.274 168.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -64.8 -22.28 66.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.044 -159.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.732 ' HD2' ' HZ1' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -60.67 -35.29 75.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.473 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.558 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.724 171.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.502 ' HA ' ' HG3' ' B' ' 33' ' ' GLU . 2.7 ptt? . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.174 0.511 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 7' ' ' PRO . 10.2 tt0 -170.77 43.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.996 170.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -100.1 101.71 15.37 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.52 173.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.511 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.5 Cg_endo -59.41 140.32 93.74 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.623 2.216 . . . . 0.0 113.553 167.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' B' ' 25' ' ' ARG . 23.7 pt -77.04 -11.54 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.679 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.93 -64.03 0.81 Allowed Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.787 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -51.29 -45.78 35.14 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.104 1.87 . . . . 0.0 113.279 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' B' ' 3' ' ' LEU . 28.0 mt -60.03 -43.82 93.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.493 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.67 99.73 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.571 -172.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.6 -22.34 50.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.437 -174.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' B' ' 8' ' ' ILE . 55.0 mt -68.24 -41.41 83.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.328 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.863 HD13 ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm -61.46 -40.35 86.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.104 167.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 26.4 mtpp -62.21 -31.81 72.39 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.051 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -62.35 -31.91 72.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.683 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.62 -53.94 52.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.413 170.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 24.44 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.686 -172.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.847 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.3 -171.35 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.287 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -153.18 -38.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.953 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 104.0 4.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.763 HG21 HG21 ' B' ' 12' ' ' ILE . 11.4 t -101.16 102.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.179 167.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 54' ' ' THR . 45.9 t -62.13 177.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.399 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.8 OUTLIER -61.01 -34.58 75.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.315 -171.038 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 10.2 m-20 -60.99 -58.72 7.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.519 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.634 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.92 -45.16 93.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.654 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.0 ptp180 -61.91 -37.67 85.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.364 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.502 HG13 ' HG3' ' B' ' 25' ' ' ARG . 41.8 mt -75.78 -36.29 32.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.575 HG22 HD11 ' B' ' 31' ' ' ILE . 97.8 m -60.82 -52.36 65.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.392 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.862 HD13 HG23 ' A' ' 60' ' ' ILE . 4.8 tp -60.53 -47.14 87.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.447 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.1 70.41 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.31 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.69 -24.81 23.76 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.461 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 64' ' ' VAL . 46.5 mt -61.9 -75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.965 165.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.714 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.5 mp -59.66 -20.78 58.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.729 -165.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' B' ' 1' ' ' MET . 2.3 tt0 -66.81 -57.73 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.193 170.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -38.02 89.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.024 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 6.0 ttp -60.71 -28.59 68.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.436 169.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.7 -45.85 16.19 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.421 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.42 -14.28 18.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.137 -0.531 . . . . 0.0 110.459 167.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -91.32 -51.94 5.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.412 -171.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' B' ' 64' ' ' VAL . 5.4 mt -61.42 -22.35 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.308 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -63.1 -73.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.305 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 84.3 p -61.33 -13.79 22.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.536 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -78.2 -56.99 4.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.055 170.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.08 -12.6 12.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.392 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 17' ' ' ALA . 73.3 mt -94.97 -51.8 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.106 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -60.67 -31.66 70.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.42 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.744 HD22 ' HG ' ' B' ' 62' ' ' LEU . 28.7 mt -60.66 -52.7 64.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.503 170.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.58 -36.44 80.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.262 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.8 -40.71 98.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.378 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -61.09 -38.03 84.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.414 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.94 -51.52 68.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.131 167.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.6 36.92 0.7 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.453 -164.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 62.85 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.651 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.11 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.832 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.9 m -157.57 167.39 30.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.106 165.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.787 HD12 HG22 ' A' ' 20' ' ' VAL . 24.0 mt -106.89 132.38 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.35 166.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -142.65 -176.21 4.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.458 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -26.78 68.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.314 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.53 -52.71 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.026 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.26 -24.48 63.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.303 -170.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.795 ' CG2' HD22 ' A' ' 28' ' ' LEU . 38.0 mm -75.51 -48.37 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.465 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.83 -30.4 70.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.026 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.744 ' HG ' HD22 ' B' ' 46' ' ' LEU . 14.8 tp -64.05 -50.05 69.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.394 169.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.727 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.28 -41.09 96.37 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.365 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.87 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -89.1 -57.83 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.172 -162.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -59.89 -25.84 65.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.793 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -29.94 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.409 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.2 OUTLIER -60.35 -67.03 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.468 170.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 60.93 101.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.495 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.732 ' HZ1' ' HD2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.348 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.7 mt-10 58.84 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.714 175.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp -57.47 98.91 0.17 Allowed Pre-proline 0 C--O 1.251 1.178 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.499 -172.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 -60.56 -61.8 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 65.16 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.486 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.543 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.32 -168.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.09 0.472 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 1' ' ' MET . 4.1 mt-10 59.15 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.783 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt -73.84 137.2 76.62 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.783 -168.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.93 -46.57 90.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.81 -76.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.382 -171.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.353 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.75 156.49 42.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.077 -166.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.036 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 6.3 mp -56.9 138.98 78.51 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.587 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 10.7 Cg_endo -61.16 142.18 95.94 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.144 2.563 . . . . 0.0 113.656 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 1.3 pp -95.49 -25.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.448 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.739 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.82 -56.51 31.58 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.7 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 6.7 Cg_endo -58.32 -55.6 2.09 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.592 2.195 . . . . 0.0 113.565 175.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 11' ' ' ILE . 51.7 mt -61.48 -45.08 99.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.492 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.497 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.76 -38.07 95.33 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -21.94 39.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.406 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 8' ' ' ILE . 54.9 mt -62.63 -50.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.405 168.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.667 HG23 ' CB ' ' B' ' 40' ' ' ALA . 18.7 mm -63.47 -41.33 92.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.373 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -62.86 -34.29 77.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.298 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.46 -33.8 75.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.787 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.16 -53.02 63.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.488 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.55 18.84 0.38 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 136.9 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.515 -0.342 . . . . 0.0 110.189 164.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.29 -25.42 8.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -168.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 92.91 1.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HD12 ' B' ' 55' ' ' ILE . 16.8 t -117.82 134.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.395 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -93.03 155.77 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.376 -170.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.11 -17.66 53.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.373 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -63.41 -50.24 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.441 168.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.662 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -62.09 -44.55 96.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.277 -174.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.512 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 4.9 mtt180 -61.45 -50.5 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.73 -31.9 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.536 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.58 ' O ' HD12 ' A' ' 31' ' ' ILE . 85.9 m -66.23 -43.25 87.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.3 OUTLIER -61.22 -32.07 71.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.266 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.036 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -78.13 -46.36 20.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.189 -168.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -60.84 -32.79 72.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.285 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.04 HG21 HG21 ' B' ' 64' ' ' VAL . 11.0 mt -60.83 -75.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.956 164.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.73 -28.19 63.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.735 -162.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' HD13 ' A' ' 3' ' ' LEU . 1.9 pp20? -77.11 -46.12 24.62 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.017 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.39 -26.54 67.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.055 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -73.59 -36.52 65.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.537 171.011 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.72 -42.27 71.6 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 9.8 ttp180 -60.95 -25.73 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.35 -0.425 . . . . 0.0 110.399 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -73.46 -59.28 2.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.509 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.71 HD12 HD11 ' B' ' 32' ' ' LEU . 7.8 mt -62.64 -20.04 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.24 -71.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.355 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 44' ' ' ILE . 85.8 p -61.56 -25.38 67.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.236 -172.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.8 mm-40 -61.71 -54.24 45.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.081 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -67.85 -10.32 52.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.775 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -89.39 -57.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.225 -167.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -64.89 -19.06 65.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.577 169.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -61.34 -55.78 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.323 168.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.61 -23.11 65.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.265 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' NH2' ' HG3' ' A' ' 45' ' ' LYS . 23.3 ttp-105 -100.76 -30.24 11.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.308 -165.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -34.95 75.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.127 165.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -60.88 -50.74 72.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.977 163.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.46 43.25 78.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -165.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.723 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -134.03 -166.74 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.329 -161.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.469 -165.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -60.57 168.66 2.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.507 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.661 ' HB ' HG22 ' B' ' 20' ' ' VAL . 26.6 mt -71.57 137.07 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.405 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -145.05 -175.7 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.358 -167.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.41 -47.99 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.258 -169.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.749 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.41 -24.92 67.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.979 -176.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.96 -53.11 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.373 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.781 HG23 HD13 ' B' ' 28' ' ' LEU . 43.5 mm -65.82 -39.61 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -168.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.75 -41.96 98.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.05 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.4 mm? -62.56 -47.12 85.27 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.341 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.61 -31.45 71.52 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.379 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.81 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -61.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.812 0.815 . . . . 0.0 109.029 -162.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.49 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.9 mtt180 -60.16 -19.07 52.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.667 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -63.3 -77.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.146 168.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -64.96 -21.61 66.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.122 -159.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.749 ' HD2' ' HZ1' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -60.58 -35.77 76.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.54 175.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.616 171.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.494 ' HA ' ' HG3' ' B' ' 33' ' ' GLU . 2.6 ptt? . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 7' ' ' PRO . 6.3 tt0 -170.75 43.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.12 170.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.916 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -101.52 101.12 15.99 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.618 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.0 Cg_endo -59.87 140.01 90.98 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.544 2.163 . . . . 0.0 113.528 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' B' ' 25' ' ' ARG . 33.0 pt -78.52 -10.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.631 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.7 -61.19 1.41 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.8 Cg_endo -55.49 -45.95 35.86 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 122.443 2.096 . . . . 0.0 113.453 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.916 HD11 ' HB3' ' B' ' 3' ' ' LEU . 31.0 mt -60.32 -44.56 96.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.459 172.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.25 97.32 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.549 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' B' ' 7' ' ' PRO . 0.0 OUTLIER -77.19 -23.26 51.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 0.0 110.503 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' B' ' 8' ' ' ILE . 64.8 mt -67.85 -48.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.461 170.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -61.92 -33.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.037 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 27.0 mtpp -61.34 -33.88 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.209 171.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.6 -32.78 73.85 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.638 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.86 -53.32 59.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.429 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.11 21.34 0.78 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.974 -170.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.833 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -65.63 147.03 54.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.34 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -40.79 3.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.045 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -148.55 139.14 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.507 168.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 55' ' ' ILE . 88.8 t -129.45 113.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.205 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -62.28 174.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.381 -166.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.9 OUTLIER -61.67 -32.29 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.371 -177.153 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 4.3 m-20 -64.2 -55.55 20.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.468 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.666 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.12 -48.0 82.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.301 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.6 ptp180 -61.03 -37.85 84.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.394 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.443 HD12 ' O ' ' B' ' 22' ' ' ASP . 34.3 mt -72.05 -36.56 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.49 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.569 HG22 HD11 ' B' ' 31' ' ' ILE . 97.9 m -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.365 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.781 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.94 -47.04 88.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.383 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.98 70.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.384 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -87.15 -26.14 23.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.494 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.81 HG21 HG21 ' A' ' 64' ' ' VAL . 37.8 mt -61.83 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.015 165.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.774 ' HB3' HD23 ' A' ' 32' ' ' LEU . 6.0 mp -59.6 -17.45 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.494 ' HG3' ' HA ' ' B' ' 1' ' ' MET . 2.0 tt0 -73.61 -53.43 10.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.139 173.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 -40.43 88.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.045 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.526 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 10.0 ttp -60.82 -28.68 68.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.477 170.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.79 -46.23 18.63 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.44 -13.88 16.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.534 167.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -91.22 -51.28 5.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.418 -172.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.54 ' CG2' HG23 ' B' ' 64' ' ' VAL . 4.8 mt -61.6 -21.32 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.271 170.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.667 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -63.22 -73.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.315 172.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 81.8 p -61.45 -13.94 24.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.503 -173.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.489 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -77.92 -56.95 4.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 170.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.2 -13.18 16.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.323 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.812 HD11 ' HB2' ' A' ' 17' ' ' ALA . 81.4 mt -95.55 -51.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.96 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -60.67 -32.97 72.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.45 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' B' ' 62' ' ' LEU . 20.9 mt -60.47 -51.5 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.551 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.5 -36.04 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.257 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.86 -40.77 98.51 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.418 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -61.24 -38.1 85.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.326 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.97 -51.41 69.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.124 167.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 37.21 0.72 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.448 -164.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 62.34 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.536 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -79.5 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.754 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.494 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.1 m -157.55 167.55 29.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.153 165.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 20' ' ' VAL . 23.6 mt -108.16 132.7 55.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.439 166.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 5.2 mmmt -143.38 -177.14 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.387 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -27.03 68.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.52 -55.09 34.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.042 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.1 OUTLIER -65.79 -29.34 69.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.394 -170.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.836 ' CG2' HD22 ' A' ' 28' ' ' LEU . 37.1 mm -71.61 -48.7 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.402 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.6 -31.41 71.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.023 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' B' ' 46' ' ' LEU . 15.0 tp -62.11 -51.12 69.2 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.416 168.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.36 -41.08 96.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.376 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -88.75 -58.65 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.13 -162.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -59.74 -25.56 64.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.8 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 -30.4 43.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.388 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.4 OUTLIER -60.2 -65.14 0.73 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.511 171.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 61.07 101.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.749 ' HZ1' ' HD2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.519 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.361 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.531 ' HG3' ' H ' ' A' ' 2' ' ' GLU . 10.7 ptm . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 1' ' ' MET . 7.3 pt-20 -79.31 -157.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.89 165.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.2 mp -56.87 100.76 0.23 Allowed Pre-proline 0 C--O 1.251 1.173 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.53 -168.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 1.7 Cg_endo -53.95 142.87 63.17 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.07 2.513 . . . . 0.0 113.513 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 13.5 pt -92.24 -13.2 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.374 -165.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -79.65 -54.65 0.92 Allowed Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.719 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 16.1 Cg_exo -51.55 -55.17 4.23 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.499 2.133 . . . . 0.0 113.627 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 3' ' ' LEU . 45.0 mt -61.71 -44.23 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.248 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.14 -22.17 60.3 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.4 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -26.29 21.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.724 -0.738 . . . . 0.0 110.483 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' B' ' 3' ' ' LEU . 27.4 mt -63.44 -54.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.43 170.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.69 HG23 ' CB ' ' B' ' 40' ' ' ALA . 9.4 mm -65.32 -36.58 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.262 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -69.21 -32.58 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.331 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.41 -34.87 77.58 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.8 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -52.92 63.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.491 169.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.63 24.03 0.3 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.566 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.811 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.57 142.62 58.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.825 -0.688 . . . . 0.0 110.323 174.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.49 124.52 41.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.98 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.5 116.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.435 174.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.738 HG11 HH21 ' A' ' 25' ' ' ARG . 15.6 t -146.14 165.65 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.362 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 20' ' ' VAL . 15.7 p -99.99 159.81 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.442 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.746 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.4 m-20 -61.01 -33.78 73.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -37.24 86.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.354 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -60.93 -46.12 91.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.318 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.738 HH21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.95 -36.85 84.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.407 -170.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.2 mt -79.64 -43.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.457 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.816 ' O ' HD12 ' A' ' 31' ' ' ILE . 90.5 m -60.92 -47.89 84.35 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.285 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD22 HG13 ' B' ' 60' ' ' ILE . 4.5 tp -59.19 -45.77 90.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.412 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.67 -21.06 62.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.659 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.66 -24.41 14.43 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.357 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 27' ' ' THR . 1.8 mp -61.11 -68.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.884 162.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.26 -33.41 72.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.599 -169.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.809 ' HB2' HD13 ' A' ' 3' ' ' LEU . 2.3 tm-20 -65.03 -55.12 20.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.1 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -61.68 -26.13 67.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.909 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -46.92 77.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.358 164.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -40.2 96.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -60.75 -31.99 71.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.302 172.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -51.63 60.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.628 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.66 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mt -62.6 -32.74 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.694 -172.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -78.01 -52.15 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.342 -166.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.2 t -61.25 -14.37 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.273 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -87.61 -54.82 4.07 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.213 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.99 -33.59 74.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.176 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' B' ' 17' ' ' ALA . 55.7 mt -60.59 -46.21 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.175 164.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -60.33 -21.92 62.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.565 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 9.9 mt -89.08 -23.57 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.452 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.16 -28.4 65.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.301 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -61.31 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.37 170.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -61.12 -23.08 65.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.374 -168.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 -47.54 62.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.308 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.39 27.9 4.27 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.12 121.92 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.819 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -161.41 15.43 0.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.502 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 55' ' ' ILE . 90.4 m 63.14 151.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.392 -167.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' B' ' 20' ' ' VAL . 29.4 mt -78.22 138.09 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.5 mtmt -153.65 -178.17 6.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.455 -170.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.97 80.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.262 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -50.0 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.196 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -33.34 74.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.405 -173.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' B' ' 28' ' ' LEU . 11.5 mm -75.27 -58.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.342 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 39.8 mt-10 -61.64 -9.86 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.319 172.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 mt -85.95 -41.28 15.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.487 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.617 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.15 -36.49 79.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.098 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 ' HD3' ' A' ' 68' ' ' LYS . 55.9 t -61.85 -76.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.723 168.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -14.91 23.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.396 -167.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -61.52 -66.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 165.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 39' ' ' ILE . 8.3 p90 -77.5 -17.08 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.482 -168.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HD3' HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -61.18 130.94 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.404 -168.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.597 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.433 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 58.94 116.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.774 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.656 ' CD2' HD11 ' A' ' 11' ' ' ILE . 6.1 mt -61.47 141.38 94.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.814 -172.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.82 153.5 43.35 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.485 2.123 . . . . 0.0 113.317 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' B' ' 25' ' ' ARG . 16.5 pt -92.35 -25.13 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.42 -168.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.15 -62.56 3.55 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.754 -170.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 7.9 Cg_endo -50.11 -45.39 33.4 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.39 2.06 . . . . 0.0 113.417 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.746 HG22 HH12 ' B' ' 25' ' ' ARG . 21.5 mt -60.96 -38.2 78.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.407 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -61.65 -53.9 39.97 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.556 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -70.41 -15.09 62.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.432 -170.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 3' ' ' LEU . 66.1 mt -73.33 -34.47 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.534 168.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.877 HG23 ' HB1' ' A' ' 40' ' ' ALA . 2.6 mm -70.03 -46.26 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.894 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.3 mtpt -62.33 -41.33 98.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.045 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -60.79 -31.09 70.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.015 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.04 -52.43 65.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.575 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.72 31.61 0.4 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.597 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -80.76 -177.56 6.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -171.06 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.94 167.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.03 106.68 17.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.428 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 55' ' ' ILE . 14.7 t -141.48 171.9 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.395 171.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.556 ' H ' HG12 ' B' ' 20' ' ' VAL . 16.1 t -127.07 156.45 41.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.308 -176.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.71 -37.82 85.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.379 -170.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.92 71.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.391 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.649 ' O ' HG22 ' B' ' 27' ' ' THR . . . -65.83 -43.84 87.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.314 171.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.746 HH12 HG22 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -61.24 -47.66 85.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.339 -175.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 52.3 mt -61.44 -38.84 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.542 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 24' ' ' ALA . 1.5 t -69.77 -43.32 72.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.178 -167.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 60' ' ' ILE . 2.6 tp -59.44 -36.86 76.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.523 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.71 -40.0 93.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.207 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -27.14 23.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.491 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.64 HD12 ' C ' ' B' ' 27' ' ' THR . 24.8 mt -61.61 -67.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.04 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.693 ' HB3' HD23 ' A' ' 32' ' ' LEU . 3.0 mp -60.4 -34.71 74.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.57 -176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.553 ' HG3' HD13 ' A' ' 11' ' ' ILE . 34.6 tt0 -67.52 -37.9 83.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.933 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -35.16 77.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.891 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 3.3 mtp -65.06 -48.34 74.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.461 170.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.23 -40.22 97.77 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.555 ' HG3' HG23 ' A' ' 11' ' ' ILE . 12.2 mtp180 -60.93 -29.69 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.345 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -67.89 -55.27 13.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.503 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.73 HG21 HG23 ' B' ' 64' ' ' VAL . 2.2 mt -63.31 -26.28 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.821 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.69 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.49 -70.07 0.21 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.292 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.497 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.46 -17.01 52.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.388 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 3.3 mm-40 -84.61 -38.49 19.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.051 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -78.04 -8.28 57.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.832 172.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 17' ' ' ALA . 51.3 mt -96.99 -51.06 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.765 -175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -60.25 -22.24 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.375 166.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 43' ' ' ALA . 9.6 mt -69.62 -53.74 17.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.379 168.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.63 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.59 -23.54 66.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.307 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 -34.3 15.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.252 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -60.55 -36.77 79.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.434 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.02 74.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.17 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.17 46.94 7.85 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 4.1 tpm_? -121.23 -18.54 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.451 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.28 18.68 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -145.47 138.35 26.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.406 170.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' B' ' 47' ' ' ALA . 45.2 mt -93.76 148.5 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.341 170.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 6.1 mtpp -147.94 178.36 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.381 -169.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.33 -17.82 55.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.331 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.699 ' C ' HD12 ' B' ' 62' ' ' LEU . 5.6 mp0 -81.2 -41.27 22.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.069 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -75.28 -26.77 59.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.373 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.772 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -64.43 -59.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.339 174.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 11.6 mt-10 -74.41 -12.44 60.51 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.557 -176.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 58' ' ' GLU . 7.5 mt -81.67 -46.12 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 168.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' B' ' 39' ' ' ILE . . . -60.34 -41.62 93.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.398 172.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.73 HG23 HG21 ' B' ' 39' ' ' ILE . 37.9 t -62.72 -74.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.63 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -10.76 3.44 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.509 -164.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -85.77 -60.87 1.9 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.582 164.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.539 ' HB3' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -64.36 -8.82 14.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.42 -155.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.7 tptt -75.97 -33.31 59.77 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.371 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm . . . . . 0 C--O 1.239 0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 171.395 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mmm . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.178 0.513 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.46 28.29 16.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.841 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.817 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 28.8 mt 59.8 75.07 0.51 Allowed Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 121.763 0.792 . . . . 0.0 110.358 166.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 7.0 Cg_exo -48.3 150.99 4.84 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 122.388 2.058 . . . . 0.0 113.512 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -69.21 -11.55 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.591 -166.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.6 -58.93 1.32 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.772 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.12 -57.11 1.43 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.432 2.088 . . . . 0.0 113.437 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.8 mt -60.6 -32.66 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.378 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.59 -26.65 64.95 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.357 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -78.02 -36.4 48.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.373 -0.914 . . . . 0.0 110.483 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.739 HG23 ' HG3' ' B' ' 37' ' ' ARG . 25.1 mt -60.63 -64.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.48 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.3 mm -60.91 -33.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -166.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -65.36 -40.45 93.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.468 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.11 -32.41 72.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.777 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.99 -52.64 64.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.522 170.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.76 22.09 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.654 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.64 159.25 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.295 169.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.01 -63.34 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.054 -169.334 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.588 ' O ' HG23 ' B' ' 54' ' ' THR . 9.4 mtp180 -144.6 80.06 1.62 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.478 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.736 HG22 HG13 ' B' ' 55' ' ' ILE . 15.5 t -71.33 107.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.31 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -61.54 158.88 14.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.459 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.7 p30 -61.31 -18.66 59.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.269 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -66.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.773 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -60.69 -39.66 89.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.386 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.676 ' HB3' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -62.01 -37.78 86.17 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.448 -175.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -76.28 -29.45 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.357 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.588 HG22 ' CG2' ' B' ' 60' ' ' ILE . 97.1 m -61.06 -60.75 3.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.341 171.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.923 HD12 ' CG2' ' A' ' 31' ' ' ILE . 64.4 tp -68.33 -28.74 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.424 -171.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -71.35 -40.38 70.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.116 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -60.38 -35.59 76.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.379 166.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.923 ' CG2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -69.78 -38.96 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.378 -170.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.8 mm? -74.84 -67.74 0.61 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.479 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.806 ' O ' HD12 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -67.39 -17.85 64.89 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.811 -163.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.17 -49.57 64.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.108 164.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.577 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' N ' HD21 ' B' ' 32' ' ' LEU . . . -76.71 -36.15 38.27 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' N ' ' CG2' ' B' ' 11' ' ' ILE . 2.4 ttm-85 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.38 169.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.56 -51.7 33.05 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.429 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.719 HD13 HG22 ' A' ' 64' ' ' VAL . 25.1 mt -63.9 -33.75 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.395 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.41 -66.23 0.57 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.275 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.738 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.21 -15.47 34.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.373 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.78 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -71.38 -63.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.135 167.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -13.14 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.488 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.3 mt -97.2 -59.26 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -61.89 -17.43 56.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.333 174.062 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 42' ' ' GLU . 16.7 mt -69.84 -58.66 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.363 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -25.57 67.33 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.398 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.71 -55.85 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.448 -170.597 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -68.01 -24.95 65.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.389 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.02 62.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.347 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.22 26.42 2.04 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.61 165.6 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.416 -170.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -132.68 18.46 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.446 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.6 m -157.66 132.94 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.301 170.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 59' ' ' ASP . 4.4 mp -100.36 133.26 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.309 166.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 -172.62 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.454 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -61.35 -20.0 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.315 -171.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.18 -67.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.077 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.583 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -61.15 -32.27 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.366 -167.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 HD13 ' B' ' 28' ' ' LEU . 37.9 mm -61.2 -64.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.387 172.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 3.4 mt-10 -61.1 -10.07 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.41 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.98 -39.5 12.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.457 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.78 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -76.26 -27.56 56.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.113 175.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.081 HG21 HD13 ' B' ' 31' ' ' ILE . 15.3 t -62.48 -66.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.448 160.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -59.39 -11.19 3.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.002 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -30.65 15.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.31 -22.58 53.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.617 163.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.74 -176.72 0.08 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.331 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.544 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.389 -170.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.046 0.451 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 9.3 tt0 -106.07 -11.83 15.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.174 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 0.7 OUTLIER -98.48 103.02 16.25 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.642 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' B' ' 2' ' ' GLU . 12.4 Cg_endo -57.89 139.73 91.37 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.461 2.107 . . . . 0.0 113.407 165.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' B' ' 25' ' ' ARG . 22.7 pt -92.95 21.43 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.567 -167.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -83.57 -58.02 0.41 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.733 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.7 Cg_endo -55.91 -50.74 11.44 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' B' ' 5' ' ' ILE . 23.5 mt -60.85 -23.18 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.322 167.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.1 96.63 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.518 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -94.26 -18.03 22.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.986 -0.607 . . . . 0.0 110.347 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 33' ' ' GLU . 7.7 mm -60.83 -72.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.002 163.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.7 mm -63.38 -17.0 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.169 -171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -37.3 24.1 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.377 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -32.53 73.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.836 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.738 ' HB1' ' CA ' ' A' ' 41' ' ' SER . . . -58.82 -52.88 63.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.516 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.21 23.06 0.35 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.702 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.638 ' HB1' HG21 ' B' ' 20' ' ' VAL . . . -67.8 147.05 53.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.772 -0.714 . . . . 0.0 110.424 173.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.77 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.939 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 80.33 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.381 168.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.638 HG21 ' HB1' ' B' ' 17' ' ' ALA . 59.4 t -134.89 137.73 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.472 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 58.9 p -74.49 150.89 39.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.365 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.16 -17.92 55.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.302 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -44.65 63.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.422 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.672 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.45 -43.61 98.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.363 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' B' ' 5' ' ' ILE . 28.1 mtt-85 -62.23 -32.57 73.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.417 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -88.02 -30.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.445 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.442 ' CG2' ' HG3' ' A' ' 61' ' ' GLU . 97.8 m -61.1 -54.11 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.37 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.768 HD13 HG23 ' A' ' 60' ' ' ILE . 4.3 tp -59.83 -45.38 92.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.556 172.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -31.16 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.362 -171.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -91.94 -23.2 19.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 64' ' ' VAL . 64.4 mt -61.36 -70.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.135 166.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.717 ' O ' HD11 ' A' ' 32' ' ' LEU . 1.1 mp -60.47 -33.15 72.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.719 -170.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' B' ' 3' ' ' LEU . 18.5 tt0 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.12 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -32.11 72.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.945 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.675 ' HG2' HD11 ' B' ' 39' ' ' ILE . 2.1 ttt -60.46 -42.55 96.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.426 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.21 68.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -169.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.739 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.7 mtp180 -60.58 -28.51 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.49 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -70.18 -57.8 4.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.53 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.725 HG21 HG23 ' B' ' 64' ' ' VAL . 10.2 mt -61.04 -23.44 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.483 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.73 -70.05 0.21 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.504 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.7 OUTLIER -61.22 -11.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.479 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.525 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -78.62 -58.32 3.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.068 170.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.519 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.15 -17.44 52.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.47 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 90.0 mt -91.18 -50.17 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.983 -173.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -60.68 -27.91 68.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.377 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 15.4 mt -64.81 -54.72 26.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.354 167.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.27 -50.63 72.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.275 -169.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -42.63 99.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.12 -35.19 76.39 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.407 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.75 -47.34 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.302 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.29 30.1 7.99 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' B' ' 54' ' ' THR . 0.0 OUTLIER -134.48 104.11 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.352 169.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 6.6 mttt -61.13 -16.98 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.335 -169.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' ARG . 94.2 m -88.39 122.21 31.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.447 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 20' ' ' VAL . 11.8 mm -75.1 138.29 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.515 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 1.1 mmmt -130.2 158.55 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.324 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -62.86 -31.06 72.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.309 -167.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.95 -37.93 82.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.081 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.7 OUTLIER -64.88 -37.12 86.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.44 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.588 ' CG2' HG22 ' A' ' 27' ' ' THR . 48.8 mm -60.9 -55.9 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.432 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -70.64 -22.64 62.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.009 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.13 -36.17 40.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.449 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.99 -55.36 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.372 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.725 HG23 HG21 ' B' ' 39' ' ' ILE 0.256 0.4 OUTLIER -70.16 -50.71 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.978 -165.806 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' B' ' 65' ' ' ARG . 5.1 mmm180 -60.9 -43.06 99.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -20.73 64.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.4 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 50.5 t80 -80.16 -40.84 26.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.306 -172.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.545 ' HZ2' ' HB3' ' B' ' 68' ' ' LYS . 0.2 OUTLIER -85.06 96.66 9.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.381 170.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.554 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.429 -170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.98 170.93 6.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.966 171.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 33' ' ' GLU . 3.4 mt -63.36 134.49 95.86 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.746 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.97 144.16 94.84 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.172 1.915 . . . . 0.0 113.66 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.624 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -101.99 19.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.684 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.92 -58.81 0.31 Allowed Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 11.7 Cg_endo -59.46 -45.81 24.39 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.503 2.135 . . . . 0.0 113.557 168.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 27.9 mt -69.06 -32.93 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.438 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -30.31 71.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.8 ttp-105 -92.39 -18.73 22.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.315 -174.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.791 HD11 HD21 ' B' ' 3' ' ' LEU . 10.3 mm -61.01 -60.59 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.244 166.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.3 mm -72.32 -22.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.039 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -77.31 -34.27 55.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.296 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -61.45 -31.17 71.12 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.877 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.94 -52.23 66.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.492 170.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.89 34.31 0.56 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.53 -167.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -84.25 145.92 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.255 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.05 -38.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.026 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.824 ' NH2' HG23 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -122.9 85.0 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.48 170.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 55' ' ' ILE . 89.8 t -132.42 113.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.274 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -65.46 164.26 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.462 -167.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.775 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -65.42 -30.56 71.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.36 -173.007 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.853 ' HB2' ' HB2' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -60.97 -43.38 98.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.402 176.066 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.682 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.56 -41.2 97.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.347 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -61.73 -42.26 98.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.389 -176.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.3 mt -83.29 -28.42 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.447 -176.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.82 ' O ' HD12 ' A' ' 31' ' ' ILE . 97.3 m -60.89 -47.7 85.21 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.293 174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.74 HD13 HG23 ' B' ' 60' ' ' ILE . 4.4 tp -59.21 -45.54 90.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.453 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.12 -20.8 63.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.547 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -96.91 -28.86 14.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.323 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 27' ' ' THR . 1.9 mp -60.7 -70.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.929 162.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -58.32 -35.16 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.796 -166.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 3' ' ' LEU . 9.9 tt0 -69.52 -61.71 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.201 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 80.0 mt-10 -61.55 -34.09 74.97 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.797 -170.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.5 ttm -62.2 -46.9 86.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.46 165.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -63.39 -47.69 85.32 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -60.65 -23.0 64.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.368 170.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -75.6 -52.32 10.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.605 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.673 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.3 mt -61.49 -28.75 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.071 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.811 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.04 -74.09 0.09 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.191 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.521 ' HB3' ' HB1' ' B' ' 15' ' ' ALA . 1.9 p -60.94 -11.38 7.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.489 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.707 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.4 mm-40 -79.92 -55.84 4.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.089 171.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.16 -20.83 63.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.368 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' B' ' 17' ' ' ALA . 92.8 mt -88.82 -52.03 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.93 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -27.81 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.447 170.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -63.36 -61.02 2.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.375 171.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.817 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.78 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.241 -167.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' CD ' ' NH1' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -82.61 -41.1 19.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.411 -171.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -66.2 -21.27 66.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.247 167.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.16 -53.27 59.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.23 166.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.71 9.92 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.64 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.449 ' NH1' ' CD ' ' A' ' 48' ' ' ARG . 13.6 ttm-85 66.69 134.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.419 169.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.19 -65.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.303 169.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 55' ' ' ILE . 92.7 m -157.63 144.4 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.323 169.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' THR . 25.4 mm -66.22 136.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.322 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.833 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.3 tptt -131.83 165.21 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.404 -167.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -61.13 -17.72 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.246 169.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.55 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.4 tp10 -76.29 -44.83 35.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.092 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 3.1 m-20 -68.9 -35.05 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.278 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.89 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.89 -56.15 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.763 162.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -61.47 -33.22 73.39 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.909 -166.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.6 mp -75.91 -45.78 33.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.551 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.37 -27.05 68.24 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.434 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.791 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -96.09 -56.3 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.866 -164.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH1' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -60.13 -26.25 66.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.632 174.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' NH2' HD23 ' A' ' 62' ' ' LEU . 97.4 mtt180 -81.38 -23.86 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.411 171.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 5.5 t80 -61.12 -48.46 81.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.46 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' HD2' ' A' ' 69' ' ' LYS . 12.0 tppt? 179.28 128.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.449 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.394 166.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 121.171 0.51 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.15 -65.75 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.095 -170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 11' ' ' ILE . 1.5 mt -89.13 138.83 28.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.568 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.562 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 12.0 Cg_endo -62.56 147.97 94.03 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.514 2.143 . . . . 0.0 113.401 165.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.66 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -99.16 19.21 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.955 174.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -94.55 -59.35 0.2 Allowed Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.737 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.9 Cg_endo -57.89 -46.97 22.79 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.484 2.123 . . . . 0.0 113.454 169.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.73 -37.06 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.391 168.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.57 -21.35 60.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -103.61 -18.39 14.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.067 -0.567 . . . . 0.0 110.327 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.725 HG22 HD13 ' B' ' 12' ' ' ILE . 9.4 mm -60.78 -49.93 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.275 164.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' B' ' 17' ' ' ALA . 6.2 mm -85.46 -31.26 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.967 -168.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.385 170.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.32 -32.52 73.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.748 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.8 -53.47 57.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.521 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.82 24.04 0.48 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.618 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.833 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -61.02 144.2 53.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.73 -0.735 . . . . 0.0 110.409 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -146.01 122.02 10.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.036 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 64.28 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.367 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' HG3' ' B' ' 25' ' ' ARG . 25.8 t -101.4 123.65 54.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.337 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -61.25 154.35 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.419 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.48 -37.08 82.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.395 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.72 -48.6 81.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.511 170.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.833 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.95 -48.61 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.297 -172.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.444 ' HG3' ' CG1' ' B' ' 20' ' ' VAL . 9.2 mtp180 -61.61 -36.97 82.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.392 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -89.2 -32.99 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.42 -167.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.475 HG22 HD12 ' B' ' 31' ' ' ILE . 90.1 m -67.21 -41.05 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.449 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 60' ' ' ILE . 2.2 tp -62.97 -48.21 79.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.913 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.02 -25.78 67.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.553 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -95.96 -29.4 14.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.283 -175.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 64' ' ' VAL . 15.4 mt -61.4 -59.9 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.845 166.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.01 -22.05 47.82 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.77 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.513 ' OE1' HD21 ' B' ' 3' ' ' LEU . 8.9 tp10 -83.34 -65.05 1.06 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.011 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.68 -34.22 75.36 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.849 -174.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.46 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 8.2 ttm -62.15 -47.75 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.521 165.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -61.29 -49.53 76.72 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.59 -25.06 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.433 171.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -71.32 -49.91 37.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.61 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.527 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.0 mt -61.43 -34.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.261 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.8 -71.78 0.14 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.301 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 24.7 p -62.04 -17.88 58.79 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.557 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.543 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -81.51 -50.85 8.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.26 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.4 -12.89 24.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.099 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.824 HG23 ' NH2' ' A' ' 19' ' ' ARG . 96.6 mt -95.47 -49.31 12.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.817 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -67.84 -7.4 27.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.182 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.543 HD12 ' O ' ' B' ' 42' ' ' GLU . 3.9 mt -83.61 -43.05 16.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.26 169.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -60.49 -14.83 21.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.324 166.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -92.31 -35.29 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.498 168.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 46' ' ' LEU . 23.8 t-80 -61.66 -39.56 91.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.266 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.681 ' HB1' ' NZ ' ' B' ' 53' ' ' LYS . . . -61.05 -52.63 64.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.212 165.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.84 9.53 10.87 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.539 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 179.23 -166.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.931 -0.635 . . . . 0.0 110.323 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.681 ' NZ ' ' HB1' ' B' ' 50' ' ' ALA . 2.7 mppt? 65.73 162.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.41 167.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.621 HG22 ' O ' ' B' ' 55' ' ' ILE . 91.8 m -96.55 152.68 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.346 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 20' ' ' VAL . 3.6 mp -69.3 133.66 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 168.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' B' ' 58' ' ' GLU . 0.3 OUTLIER -135.63 -171.36 2.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.376 177.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.853 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -61.75 -27.15 68.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.247 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.538 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.0 pt-20 -73.99 -49.0 26.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.1 OUTLIER -61.89 -31.56 71.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.401 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.74 HG23 HD13 ' A' ' 28' ' ' LEU . 25.3 mm -61.89 -68.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.268 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt-10 -61.06 -14.61 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 3.6 mp -70.66 -55.2 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.403 169.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.483 ' HB1' ' CZ ' ' B' ' 67' ' ' PHE . . . -60.91 -37.03 80.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.484 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HG12 ' A' ' 31' ' ' ILE . 40.2 t -62.43 -69.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.796 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.19 -9.17 4.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.508 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -50.29 21.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.488 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -80.51 -48.89 12.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -174.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.494 ' HG3' ' HB2' ' B' ' 67' ' ' PHE . 4.9 mttm -150.31 -173.16 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 -166.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? . . . . . 0 C--O 1.241 0.639 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.42 -177.71 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 10.5 mtm . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 121.074 0.464 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER 59.05 146.64 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.749 -175.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 33' ' ' GLU . 3.3 mt -69.89 146.74 95.64 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.792 172.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.12 140.18 93.17 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.543 2.162 . . . . 0.0 113.533 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 pt -80.64 -31.23 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.366 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.75 -62.73 4.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.763 -173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -50.87 -42.85 50.06 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 C-N-CA 122.48 2.12 . . . . 0.0 113.524 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 3' ' ' LEU . 50.3 mt -60.81 -39.15 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.435 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 25' ' ' ARG . . . -61.58 -26.12 66.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -91.14 -25.33 19.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.169 -0.515 . . . . 0.0 110.36 -176.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' B' ' 3' ' ' LEU . 53.7 mt -60.83 -62.43 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.296 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.2 mm -61.21 -35.18 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.249 -175.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.4 mtmt -60.79 -37.09 80.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.498 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.56 -35.21 78.76 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.789 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.32 -53.08 62.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.41 167.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.57 16.58 0.21 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.051 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.809 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.16 170.57 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 163.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.09 -57.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.941 165.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' NH1' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -73.62 83.28 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.391 172.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HB ' ' B' ' 55' ' ' ILE . 24.6 t -129.03 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 -170.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.3 p -85.24 156.48 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.423 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.8 t0 -61.42 -23.19 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.318 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -90.65 -28.62 18.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.394 -170.066 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -61.69 -42.04 98.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.157 166.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HG3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.76 -51.17 68.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.445 -178.122 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.3 tt -62.68 -40.95 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.234 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.639 HG22 HD11 ' A' ' 31' ' ' ILE . 91.7 m -60.77 -59.06 5.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.369 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.3 tp -61.01 -10.5 5.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.344 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -82.37 -59.29 2.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.448 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -61.33 -25.14 66.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.434 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 28' ' ' LEU . 74.0 mt -61.65 -75.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.052 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 31' ' ' ILE . 7.1 mp -60.57 -36.92 79.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -166.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 3' ' ' LEU . 8.4 tt0 -67.46 -42.75 82.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.053 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.4 mt-10 -62.12 -41.15 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.056 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.9 mmm -60.76 -42.1 96.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.506 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.57 -46.27 90.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' B' ' 11' ' ' ILE . 3.1 mtp180 -60.73 -33.83 73.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.378 168.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -65.69 -50.2 65.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 -175.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.622 HG21 HG23 ' A' ' 64' ' ' VAL . 11.0 mt -65.1 -36.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.417 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -65.26 -54.08 34.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.32 -172.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 -34.33 75.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.298 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -60.91 -38.26 85.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.063 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -79.82 -13.67 59.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.794 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -82.79 -57.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.372 -168.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.29 -31.36 70.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.414 169.29 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 42' ' ' GLU . 11.4 mt -59.96 -43.84 94.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.584 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.831 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -67.86 -26.37 65.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.103 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -60.67 -61.61 2.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.332 168.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -61.31 -10.09 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.584 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -84.16 -57.86 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.953 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.64 9.93 0.04 OUTLIER Glycine 0 C--N 1.344 0.996 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.666 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 0.3 OUTLIER 73.6 -58.22 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.424 0.689 . . . . 0.0 111.47 158.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.53 -23.3 49.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 111.182 -157.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.524 HG22 ' N ' ' B' ' 21' ' ' SER . 0.2 OUTLIER -155.43 154.97 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.354 169.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.927 ' HB ' HG13 ' B' ' 20' ' ' VAL . 4.3 mm -72.44 150.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.015 159.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 156.33 40.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.413 -169.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.23 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.246 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -68.72 -38.99 80.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.902 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -48.0 83.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.618 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.781 ' CG2' HD22 ' B' ' 28' ' ' LEU . 22.8 mm -61.55 -46.2 97.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -36.86 69.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.054 -170.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mp -63.51 -43.28 97.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.414 167.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 46' ' ' LEU . . . -61.54 -57.42 12.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.41 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.802 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -68.26 -52.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.042 -168.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -41.35 92.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.731 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -69.51 -20.72 63.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.337 174.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 44.5 t80 -80.93 -28.9 35.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.206 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HD2' ' HG2' ' B' ' 69' ' ' LYS . 2.5 tppt? -118.7 86.81 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 168.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HD2' ' HG2' ' A' ' 66' ' ' ARG . 9.8 ptmt . . . . . 0 C--O 1.239 0.515 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.355 -169.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 58.56 171.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.73 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 11' ' ' ILE . 1.5 mt -80.46 161.83 63.16 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.625 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' B' ' 7' ' ' PRO . 12.6 Cg_endo -60.67 140.91 93.44 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.533 2.156 . . . . 0.0 113.405 164.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -99.47 -17.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.389 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -79.09 -62.0 0.46 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.754 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.48 -36.24 58.43 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 122.508 2.139 . . . . 0.0 113.522 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' B' ' 3' ' ' LEU . 54.0 mt -60.42 -42.22 90.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.362 168.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' B' ' 25' ' ' ARG . . . -61.54 -28.15 69.2 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.603 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HG3' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -86.55 -21.84 26.67 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.511 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.491 HG23 ' HD3' ' A' ' 37' ' ' ARG . 26.4 mt -69.02 -44.0 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.399 167.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.5 mm -62.65 -36.17 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.04 171.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' HA ' ' B' ' 10' ' ' ARG . 0.6 OUTLIER -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.387 172.107 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 37' ' ' ARG . 16.5 t70 -62.55 -32.78 73.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.75 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -52.57 65.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.443 169.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.41 18.88 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.051 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.842 ' HB1' ' CG2' ' B' ' 20' ' ' VAL . . . -64.43 165.76 9.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.311 168.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.21 -58.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.049 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 83.3 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.452 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.927 HG13 ' HB ' ' A' ' 55' ' ' ILE . 57.9 t -104.45 145.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.324 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 54' ' ' THR . 77.8 p -61.21 139.73 58.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.33 168.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.98 -24.25 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.261 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -53.17 56.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.454 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.336 -167.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.463 ' HG2' ' CA ' ' B' ' 9' ' ' GLY . 4.1 mpp_? -60.87 -49.03 79.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.417 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.11 -23.68 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.449 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.716 ' O ' HD12 ' B' ' 31' ' ' ILE . 97.7 m -77.83 -40.08 41.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.362 -170.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.839 HD12 HD11 ' B' ' 32' ' ' LEU . 0.8 OUTLIER -60.68 -37.37 81.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.409 169.226 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.61 96.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.245 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.2 mmmm -77.8 -31.41 51.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.369 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.802 HG21 HG21 ' A' ' 64' ' ' VAL . 5.5 mt -61.35 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.035 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.839 HD11 HD12 ' B' ' 28' ' ' LEU . 3.5 mp -59.42 -35.4 73.93 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.611 -165.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.537 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -71.17 -37.44 72.18 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.125 -177.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 17.1 mm-40 -65.24 -52.08 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.3 ptm -65.03 -28.27 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.343 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.96 -45.8 48.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 11' ' ' ILE . 1.7 mtt-85 -60.64 -18.29 52.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.452 169.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.9 OUTLIER -87.03 -54.7 4.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.454 -173.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 64' ' ' VAL . 7.1 mt -61.54 -19.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.443 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -65.7 -70.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.353 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.544 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 32.3 t -61.07 -10.14 5.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.61 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.485 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -90.45 -45.02 9.24 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.097 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.456 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -63.51 -24.38 67.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.272 169.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 17' ' ' ALA . 78.2 mt -86.31 -50.43 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.134 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -31.77 70.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.371 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.793 HD22 HD23 ' B' ' 62' ' ' LEU . 14.4 mt -60.78 -55.09 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.371 167.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.32 -30.42 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.292 -170.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.35 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -60.71 -35.05 75.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.371 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.61 -53.51 56.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.27 171.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.84 24.11 1.12 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.599 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HD3' ' NH1' ' A' ' 19' ' ' ARG . 1.3 ptp85 59.57 33.51 22.1 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.226 -0.573 . . . . 0.0 111.169 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 77.37 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.407 169.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.417 HG22 ' H ' ' B' ' 55' ' ' ILE . 1.5 m 68.49 175.93 0.27 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.528 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 20' ' ' VAL . 17.4 mm -118.41 137.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.235 166.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -142.94 166.34 24.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.429 -168.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' OE2' ' B' ' 61' ' ' GLU . . . -63.21 -25.17 68.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.253 -172.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 1.0 OUTLIER -64.18 -37.48 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.108 168.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HG2' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -79.5 -39.86 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.395 -176.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.473 HG13 ' CA ' ' A' ' 24' ' ' ALA . 38.2 mm -60.98 -54.4 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.421 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.768 ' OE2' ' HB1' ' B' ' 57' ' ' ALA . 4.5 mt-10 -68.59 -36.43 78.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.986 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.793 HD23 HD22 ' B' ' 46' ' ' LEU . 16.4 tp -61.13 -44.41 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.338 168.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.548 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.41 -42.82 99.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.413 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.929 HG23 HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -82.99 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.18 -167.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -11.89 8.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.565 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -94.61 -30.9 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.443 168.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 1.1 t80 -61.27 -14.08 23.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.761 171.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 125.34 23.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.689 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.525 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 7.2 mttm . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.382 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' HG2' ' NH1' ' B' ' 10' ' ' ARG . 44.3 mtp . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.141 0.495 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.39 137.04 49.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.201 -172.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.891 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.2 mp -57.34 100.2 0.21 Allowed Pre-proline 0 C--O 1.25 1.117 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.487 -168.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.9 Cg_endo -67.59 141.72 56.24 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.114 2.542 . . . . 0.0 113.67 -172.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.49 -9.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.023 -172.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.94 -60.33 1.23 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.727 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -56.92 -51.37 9.05 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.454 2.103 . . . . 0.0 113.497 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.2 mt -60.59 -45.91 96.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.45 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.58 -30.03 75.41 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.686 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.85 -20.57 27.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.493 -0.353 . . . . 0.0 110.329 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.635 HD11 ' HG3' ' B' ' 2' ' ' GLU . 30.1 mt -65.19 -49.7 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.446 166.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.656 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.9 mm -61.05 -46.61 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.418 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -62.32 -30.32 71.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.261 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.34 -35.39 78.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.77 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.54 -52.63 64.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.511 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.11 23.53 0.34 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.576 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.7 170.51 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.306 173.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.65 -58.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.952 167.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -125.76 104.57 8.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.36 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.882 HG22 HD12 ' B' ' 55' ' ' ILE . 59.6 t -112.26 103.8 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.345 168.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.44 167.88 3.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.403 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -26.07 67.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.363 -170.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.21 -63.03 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.518 172.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.79 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.03 -39.54 92.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.3 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.7 mtm180 -61.56 -38.62 88.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.291 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.9 mm -76.25 -25.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.51 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.044 HG22 HG22 ' B' ' 60' ' ' ILE . 71.3 m -74.4 -45.8 44.42 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.12 -168.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD13 HG12 ' B' ' 60' ' ' ILE . 5.6 tp -59.19 -47.76 84.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.36 164.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -61.1 -18.46 58.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.531 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -99.68 -27.18 13.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.316 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.836 HG21 HG21 ' B' ' 64' ' ' VAL . 2.0 mp -60.79 -69.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.85 162.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.1 mp -59.67 -34.68 73.16 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.555 -168.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.891 ' CG ' HD13 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.67 -59.3 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.55 -20.24 63.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.83 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -52.2 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.223 160.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.87 95.15 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -61.31 -39.91 92.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.377 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -63.19 -56.49 16.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.434 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.932 HG21 HG23 ' A' ' 64' ' ' VAL . 3.0 mt -61.57 -28.0 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.219 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -64.34 -61.33 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.231 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.3 OUTLIER -80.71 -15.24 57.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.517 -167.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -78.98 -48.6 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.125 168.322 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.71 -37.46 86.59 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.041 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' B' ' 17' ' ' ALA . 48.2 mt -61.19 -50.3 81.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.147 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.91 -14.88 25.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.3 mt -91.63 -34.38 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.161 -172.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.5 -47.2 87.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.428 168.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -62.01 -48.35 80.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.359 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -62.7 -35.28 79.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.37 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.99 -54.24 47.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.183 168.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 24.71 0.57 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.618 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.31 96.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.215 -0.492 . . . . 0.0 110.531 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -153.61 78.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.239 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 55' ' ' ILE . 16.4 m 69.3 168.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.532 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.656 HD12 HG22 ' B' ' 20' ' ' VAL . 86.2 mt -121.9 147.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.356 168.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -178.84 7.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.424 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -64.23 -22.75 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.258 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.65 -68.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.155 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -25.94 67.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -169.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.959 HG23 HD13 ' B' ' 28' ' ' LEU . 16.0 mm -76.14 -60.05 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.343 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.3 mt-10 -61.75 -18.7 60.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.413 177.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.88 -41.01 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.469 173.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.459 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -66.43 -37.07 84.36 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.12 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.954 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.02 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.713 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -60.27 -9.87 3.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.657 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.2 tpt180 -73.66 -48.52 31.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.408 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.7 m-85 -60.64 -52.32 65.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.365 168.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.43 -72.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.469 -164.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.167 0.508 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.635 ' HG3' HD11 ' A' ' 11' ' ' ILE . 9.4 tp10 -114.87 -78.9 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.903 -170.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' B' ' 33' ' ' GLU . 7.6 mt -68.98 123.19 87.57 Favored Pre-proline 0 C--O 1.244 0.786 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.58 168.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.91 146.51 94.91 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.722 2.281 . . . . 0.0 113.439 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 pt -93.78 21.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.49 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -88.58 -59.81 0.25 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.748 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.5 Cg_endo -56.48 -45.72 35.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.362 2.041 . . . . 0.0 113.506 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -61.15 -55.2 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.515 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.39 68.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -80.45 -25.75 38.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.456 -177.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 3' ' ' LEU . 80.6 mt -68.38 -46.84 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.411 167.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.1 mm -65.44 -40.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.212 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtpp -61.05 -36.88 80.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.453 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -62.0 -31.9 72.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.845 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -52.35 65.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.52 170.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.59 22.57 0.85 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.744 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -64.3 146.29 54.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.807 -0.696 . . . . 0.0 110.405 172.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.32 -58.21 0.18 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.989 168.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -80.76 81.4 7.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.351 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.656 HG22 HD12 ' A' ' 55' ' ' ILE . 21.6 t -139.86 153.37 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.37 -168.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 99.0 p -101.71 150.36 23.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.393 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -16.97 49.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.32 168.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.96 -49.02 79.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.411 169.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.565 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.59 -45.84 92.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.388 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -30.05 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.404 -171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 58.3 mt -94.81 -20.41 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.436 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.668 HG22 HD11 ' B' ' 31' ' ' ILE . 88.8 m -61.03 -56.77 17.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.254 167.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.959 HD13 HG23 ' A' ' 60' ' ' ILE . 3.0 tp -60.7 -40.24 91.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.529 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.12 -39.97 92.0 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.421 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -84.22 -21.12 31.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.399 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.954 HD13 HG21 ' A' ' 64' ' ' VAL . 58.8 mt -61.4 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.018 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.901 ' HB3' HD23 ' A' ' 32' ' ' LEU . 8.9 mp -60.79 -42.82 98.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.539 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 14.6 tm-20 -63.56 -36.67 84.55 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.065 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -61.48 -43.98 97.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.063 173.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.625 ' HB3' HD11 ' B' ' 39' ' ' ILE . 34.5 mtp -60.78 -37.91 83.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.562 174.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.91 99.72 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -44.73 95.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.476 172.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.1 t70 -77.61 -45.87 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.559 -165.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' B' ' 35' ' ' MET . 5.8 mt -61.21 -30.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.253 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -67.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.305 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.455 ' N ' HD12 ' B' ' 44' ' ' ILE . 2.4 t -61.24 -9.19 4.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.471 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.75 -38.15 11.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.171 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.602 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.32 -16.11 59.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.46 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -87.45 -49.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.836 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -30.03 68.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.414 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.94 -47.23 85.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.405 166.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.679 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.93 -18.6 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.333 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -41.39 67.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.277 168.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -60.3 -30.74 69.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.415 170.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.77 -51.56 68.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.418 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.22 41.84 1.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.477 -174.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.53 18.97 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.43 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 140.66 29.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.191 165.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -61.03 168.25 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.361 -167.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -92.96 141.22 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.559 -168.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.58 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -138.25 -169.14 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.363 -171.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.612 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -66.83 -45.87 76.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.037 -169.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.468 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.8 mt-10 -61.54 -31.0 71.0 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.26 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.55 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.54 -68.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.336 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.04 -32.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 -162.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -38.59 87.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.468 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.55 -47.12 87.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.468 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.96 25.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.615 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.64 -57.21 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -159.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -10.92 3.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.39 166.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -85.37 -69.67 0.64 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.632 166.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER -62.03 -28.45 69.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -154.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -146.99 109.48 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.491 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.274 169.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.272 0.558 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.79 -78.22 0.32 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.002 -170.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' B' ' 11' ' ' ILE . 0.9 OUTLIER -89.23 143.84 31.56 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.552 171.339 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 7' ' ' PRO . 18.0 Cg_endo -62.08 140.73 85.73 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.505 2.137 . . . . 0.0 113.444 163.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -96.89 -10.97 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.698 -170.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.06 -53.75 60.67 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.691 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.0 Cg_endo -51.01 -57.21 2.39 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.613 2.209 . . . . 0.0 113.549 171.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.67 -25.98 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.422 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.95 32.69 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.549 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -76.43 -16.6 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.419 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.992 HD11 HD21 ' B' ' 3' ' ' LEU . 31.8 mt -60.99 -73.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.262 166.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.678 HD13 HG22 ' A' ' 11' ' ' ILE . 7.4 mm -61.89 -23.42 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.852 -170.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -69.27 -38.69 78.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.457 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' B' ' 37' ' ' ARG . 57.6 t0 -62.31 -33.68 75.13 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.802 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.91 -53.23 60.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.454 169.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.59 15.88 0.32 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.277 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -64.37 -177.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.261 165.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -171.13 -52.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.991 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -92.0 99.03 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.409 170.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.67 117.88 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.486 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.5 t -61.6 159.34 13.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.38 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.0 -22.82 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.372 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.685 ' HA ' HG22 ' A' ' 26' ' ' ILE . 8.2 t70 -96.4 -35.25 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.291 -170.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -60.61 -38.49 84.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.065 164.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HD3' HG21 ' A' ' 5' ' ' ILE . 7.4 ttm180 -60.16 -52.37 65.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.514 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tp -72.65 -37.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' CG2' ' B' ' 60' ' ' ILE . 55.6 m -61.37 -51.86 67.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.262 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 ' N ' HG21 ' B' ' 60' ' ' ILE . 11.8 tp -61.44 -25.5 67.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.189 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -53.36 15.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.534 169.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.03 -28.84 65.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.363 -170.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.826 HD12 HG22 ' B' ' 60' ' ' ILE . 88.2 mt -61.42 -72.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.054 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.913 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -59.92 -19.08 49.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.771 -166.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 2.5 pp20? -91.43 -41.89 10.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.027 -171.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.58 -35.14 76.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.904 167.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 mmt -61.05 -54.05 49.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.476 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.79 95.23 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -167.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.704 ' NE ' HG23 ' B' ' 11' ' ' ILE . 0.1 OUTLIER -60.92 -33.9 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.315 170.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -53.88 48.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.541 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 64' ' ' VAL . 9.8 mt -61.37 -38.92 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.233 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.77 -57.11 10.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.384 -172.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.5 t -61.71 -30.62 70.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.254 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.7 mm-40 -60.76 -60.04 4.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.36 -11.93 12.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.535 -176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.76 -56.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.117 -169.107 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.4 65.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.439 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 42' ' ' GLU . 7.0 mp -61.15 -49.04 78.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.293 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.723 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.38 -27.84 68.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.327 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -53.28 40.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.455 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.423 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.93 -55.08 37.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.124 170.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.3 32.94 0.37 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.508 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.03 -59.93 0.5 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.79 -0.705 . . . . 0.0 111.009 164.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -60.13 98.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.583 -163.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m 70.14 123.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.371 166.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' B' ' 20' ' ' VAL . 15.9 mt -79.02 140.21 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.273 164.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD2' ' CB ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -144.47 -174.32 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -168.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.7 -31.18 71.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.34 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.45 -42.33 83.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.115 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -35.43 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.323 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.839 HG23 HD13 ' B' ' 28' ' ' LEU . 33.6 mm -61.09 -40.05 84.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.326 169.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 37.5 mt-10 -80.34 -34.07 36.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.002 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -45.08 95.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.436 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.17 -36.96 81.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.518 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 1.14 HG21 HG21 ' B' ' 31' ' ' ILE 0.257 0.4 OUTLIER -75.22 -52.67 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.989 -167.155 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.17 62.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.596 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.488 ' HE ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -104.27 -12.5 16.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.923 -163.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -101.23 -22.34 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 164.325 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 105.92 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.438 -170.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.595 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.334 -168.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpp . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.18 0.515 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.16 -76.96 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.03 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.992 HD21 HD11 ' A' ' 11' ' ' ILE . 16.0 mt -62.23 133.23 94.22 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.743 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.664 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.5 Cg_endo -60.05 147.75 91.87 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.324 2.016 . . . . 0.0 113.496 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.67 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -85.23 -30.84 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.541 -177.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.24 -59.8 4.73 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.69 -171.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.4 Cg_endo -52.58 -46.15 35.26 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 122.552 2.168 . . . . 0.0 113.533 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.9 mt -60.5 -36.23 68.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.394 172.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.55 -27.2 67.64 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.439 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 tpt85 -86.6 -27.38 23.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.395 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.704 HG23 ' NE ' ' A' ' 37' ' ' ARG . 16.2 mt -60.63 -46.36 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.47 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.0 mm -74.79 -31.62 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.922 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -60.71 -41.89 96.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.45 169.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.71 -31.9 72.09 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.853 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.93 -53.81 54.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.428 167.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.17 30.53 0.27 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.722 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.735 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -80.87 171.81 14.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.67 -0.765 . . . . 0.0 110.26 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -171.1 -25.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.956 166.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 82.0 1.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.533 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.745 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -113.79 129.4 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.165 167.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.6 p -61.0 165.94 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.256 166.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -10.82 5.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.353 167.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -75.83 -55.28 5.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.453 176.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -62.1 -41.13 97.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.25 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.514 HH21 HG23 ' B' ' 20' ' ' VAL . 3.3 ttm180 -62.29 -48.13 81.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.386 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.467 HD11 HG21 ' B' ' 5' ' ' ILE . 11.2 mm -76.25 -32.13 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.391 -174.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 57' ' ' ALA . 84.9 m -60.98 -52.02 66.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.461 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.839 HD13 HG23 ' A' ' 60' ' ' ILE . 4.1 tp -61.34 -45.65 93.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.264 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -60.89 -28.52 68.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.449 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -27.98 21.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.455 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 1.14 HG21 HG21 ' A' ' 64' ' ' VAL . 16.7 mt -61.77 -72.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.989 165.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.51 -12.8 10.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.565 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.3 -57.95 3.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.054 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.96 79.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.042 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 7.2 tpp -60.82 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.428 166.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.94 89.9 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -170.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -60.83 -26.82 67.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.317 170.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -48.09 38.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.522 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.913 HD12 HD11 ' A' ' 32' ' ' LEU . 1.2 mt -63.02 -28.83 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.474 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.668 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -65.34 -68.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.318 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 80.9 p -61.45 -16.06 43.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.629 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -69.06 -64.51 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.13 165.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.16 -10.92 7.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.624 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.0 mt -99.82 -50.42 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.769 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.27 -29.3 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.402 168.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.8 mt -60.82 -51.52 68.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.245 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.699 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -67.97 -38.19 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.293 -169.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -70.35 -39.9 74.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.403 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -60.78 -35.88 77.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.335 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.67 -54.38 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.195 167.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.96 22.37 0.74 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.725 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.52 -165.12 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.294 -0.533 . . . . 0.0 110.981 168.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 65.44 100.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.466 -167.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 21' ' ' SER . 2.0 m 70.14 124.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.377 167.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' B' ' 47' ' ' ALA . 5.6 mm -89.82 152.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.316 166.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.502 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -131.03 159.62 36.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.428 -168.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.93 -30.04 70.63 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.335 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -53.38 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.156 171.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -13.09 23.8 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.456 -174.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.826 HG22 HD12 ' A' ' 31' ' ' ILE . 33.0 mm -84.01 -63.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.393 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' A' ' 31' ' ' ILE . 31.1 mt-10 -61.72 -13.74 25.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.625 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.6 -30.78 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.332 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -63.9 -37.52 87.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.755 161.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 31' ' ' ILE . 41.0 t -61.45 -71.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.769 166.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' B' ' 68' ' ' LYS . 4.8 mtt-85 -59.2 -11.51 3.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.811 -170.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -71.72 -50.02 34.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.439 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.714 ' HE2' HG23 ' B' ' 39' ' ' ILE . 29.5 p90 -90.97 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.543 173.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.451 ' CB ' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -119.84 78.24 1.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.348 171.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mttm . . . . . 0 C--O 1.239 0.505 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.496 -175.318 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.35 37.97 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.972 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 33' ' ' GLU . 10.4 mp 58.83 92.62 0.06 OUTLIER Pre-proline 0 C--O 1.248 1.002 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.551 170.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 9.3 Cg_endo -49.13 138.49 28.28 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 C-N-CA 122.6 2.2 . . . . 0.0 113.348 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.68 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -91.53 19.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.898 -167.214 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.35 -58.24 0.45 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.699 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -54.41 -53.27 6.48 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.497 2.131 . . . . 0.0 113.537 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.2 mt -61.44 -59.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.522 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.6 -18.83 57.14 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -31.68 22.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.952 -0.624 . . . . 0.0 110.356 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' B' ' 3' ' ' LEU . 61.4 mt -60.53 -51.14 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.554 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.9 mm -61.27 -37.61 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.281 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -34.31 77.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.344 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -62.52 -34.42 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' B' ' 41' ' ' SER . . . -59.34 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.485 169.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.73 21.98 0.42 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.604 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.31 150.62 29.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.349 167.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.07 -51.81 2.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.036 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.52 132.12 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.37 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 45.5 t -124.73 123.1 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.333 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.441 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 21.4 t -66.29 156.73 33.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.454 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HA ' ' CG ' ' A' ' 25' ' ' ARG . 27.9 t0 -61.37 -24.07 66.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.346 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 0.7 OUTLIER -60.65 -53.69 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.513 172.386 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' B' ' 60' ' ' ILE . . . -62.18 -47.24 85.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.318 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HD3' HG13 ' A' ' 5' ' ' ILE . 1.4 ptp85 -70.96 -27.65 63.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 -168.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 78.5 mt -86.29 -27.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.421 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.505 HG22 HD12 ' A' ' 31' ' ' ILE . 99.3 m -60.95 -54.4 45.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.345 170.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.976 HD13 HG23 ' B' ' 60' ' ' ILE . 4.0 tp -60.14 -43.01 96.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.49 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.19 -32.19 71.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.501 -174.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.86 -24.1 15.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.236 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.067 HD13 HG21 ' B' ' 64' ' ' VAL . 84.4 mt -60.65 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.028 164.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -59.04 -33.89 71.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.699 -172.021 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.796 ' HB2' HD13 ' A' ' 3' ' ' LEU . 10.4 tm-20 -61.86 -59.33 5.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.047 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 2.3 tp10 -64.52 -30.57 71.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.838 -171.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.42 -41.14 93.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.292 164.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.62 -46.9 93.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.46 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -62.66 -24.75 67.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.049 -178.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.9 t0 -80.9 -45.25 17.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.504 -174.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 67' ' ' PHE . 9.6 mt -61.65 -30.28 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.144 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.652 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.54 -77.31 0.05 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.25 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.774 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.81 -11.0 10.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.384 -172.428 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.35 -56.46 4.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.114 170.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -60.5 -17.2 43.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.612 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' B' ' 17' ' ' ALA . 78.3 mt -85.58 -51.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.854 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -60.63 -39.73 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.383 168.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 63' ' ' ALA . 50.6 mt -60.76 -39.69 89.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.415 170.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.46 -24.75 66.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.295 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -82.34 -48.85 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.343 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.01 64.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.242 167.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -56.57 19.96 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.137 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.25 30.07 0.16 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.697 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.69 -60.96 0.49 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.923 161.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.05 93.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.306 0.574 . . . . 0.0 110.581 -161.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.532 HG21 ' HB2' ' B' ' 21' ' ' SER . 24.9 m 70.44 144.28 0.06 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HB ' HG13 ' B' ' 20' ' ' VAL . 15.3 mm -73.32 138.35 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.221 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -135.94 170.32 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.429 -170.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.45 55.91 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.48 -165.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.717 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.23 -26.81 68.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.946 -174.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.8 m-20 -65.18 -39.5 92.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.499 173.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.829 HD12 ' CD2' ' B' ' 28' ' ' LEU . 36.5 mm -62.75 -67.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.391 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.6 mt-10 -61.09 -11.21 7.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.278 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -73.1 -50.88 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.437 166.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -61.14 -42.82 99.23 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.304 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.854 HG21 HD13 ' B' ' 31' ' ' ILE . 21.8 t -62.02 -68.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.856 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.17 -9.79 3.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.682 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -35.32 39.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.355 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CE2' HG12 ' A' ' 39' ' ' ILE . 96.9 m-85 -59.72 -59.78 4.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.367 163.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tptp -65.09 140.78 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.416 -168.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.579 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.363 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.096 0.474 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -71.3 -179.29 2.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.022 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.642 ' CD2' HD11 ' A' ' 11' ' ' ILE . 3.2 mt -69.23 138.51 89.47 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -170.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 140.88 94.04 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.41 2.074 . . . . 0.0 113.481 167.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.671 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -88.61 -11.94 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.657 -173.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.45 -60.55 2.57 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.81 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.7 Cg_endo -55.64 -42.97 62.27 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.462 2.108 . . . . 0.0 113.546 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' B' ' 3' ' ' LEU . 57.4 mt -60.45 -39.76 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.472 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.72 -29.92 73.47 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.579 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.495 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 mtp180 -89.82 -23.13 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 110.383 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 3' ' ' LEU . 36.5 mt -60.93 -58.39 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.317 166.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.652 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.3 mm -61.87 -36.53 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.274 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.98 -36.31 79.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.362 169.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.3 -32.78 73.57 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.835 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.774 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.79 -53.41 58.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.425 169.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.59 20.85 0.76 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.725 -172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.24 120.08 9.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.35 166.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.41 -54.48 10.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.168 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 104.9 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.379 174.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.795 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.2 t -83.81 129.28 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.267 169.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 54' ' ' THR . 27.0 t -61.49 148.29 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.279 166.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 10.9 p30 -61.54 -22.78 65.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.417 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG22 ' B' ' 26' ' ' ILE . 10.1 t70 -88.73 -25.56 22.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.387 -172.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -66.41 -44.14 83.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.24 168.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.503 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 2.3 ptt-85 -83.09 -18.17 40.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.414 -167.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.675 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -78.19 -35.43 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.41 168.543 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.555 HG22 HG21 ' A' ' 60' ' ' ILE . 68.7 m -61.11 -37.93 84.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.265 175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.829 ' CD2' HD12 ' A' ' 60' ' ' ILE . 1.1 mm? -60.84 -40.54 93.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.322 166.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.67 -52.13 65.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.337 -176.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.479 ' NZ ' HD11 ' B' ' 26' ' ' ILE . 0.2 OUTLIER -68.55 -33.47 74.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.464 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 64' ' ' VAL . 41.1 mt -61.71 -71.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.16 170.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.724 ' CD1' HD12 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.8 -15.66 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.832 -169.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.417 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 2.7 tt0 -95.41 -24.03 16.88 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.054 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -61.43 -52.26 65.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.111 167.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -73.56 -27.41 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.327 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.32 91.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.86 69.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.334 168.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 2.2 t70 -70.26 -58.18 4.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.557 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.668 HG21 HG23 ' B' ' 64' ' ' VAL . 4.2 mt -61.44 -30.32 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.385 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.22 -73.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.296 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.921 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 24.5 p -62.13 -15.44 45.62 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.529 -170.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.53 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -89.67 -39.52 13.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.158 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.63 -9.07 56.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.486 168.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.786 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.6 mt -94.34 -53.24 8.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.873 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.43 -18.21 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.382 168.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.1 mt -72.96 -48.75 33.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.398 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -70.3 -31.94 69.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.218 -170.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.429 ' CZ ' ' HB2' ' B' ' 48' ' ' ARG . 22.8 ttm105 -65.83 -40.02 91.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.282 168.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.23 -38.58 87.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.31 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.88 -51.21 70.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.287 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.14 4.31 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 148.02 22.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.415 -170.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -82.63 171.98 13.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -170.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 93.9 m 61.54 119.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.421 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.761 HG23 ' HB3' ' B' ' 59' ' ' ASP . 82.4 mt -88.6 148.31 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.388 170.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 0.0 OUTLIER -135.75 179.69 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.45 -169.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -61.6 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.291 -171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 15.7 pt-20 -84.36 -43.86 14.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.063 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.761 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.4 OUTLIER -61.61 -23.52 66.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.44 179.278 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 28' ' ' LEU . 29.7 mm -88.61 -56.37 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.239 -171.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 36.5 mt-10 -62.09 -18.06 59.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 172.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' B' ' 62' ' ' LEU . 12.1 mt -67.17 -55.82 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.336 168.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.64 81.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.219 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 31' ' ' ILE . 49.2 t -62.1 -79.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.689 171.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -12.02 9.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.365 -168.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -53.68 48.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.36 167.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 5.0 m-85 -61.07 -56.59 19.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.375 173.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.64 26.89 13.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.349 -169.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.24 0.557 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.096 0.474 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -126.86 -29.7 2.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.074 -169.912 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 8' ' ' ILE . 17.2 mt -61.81 104.6 0.49 Allowed Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.989 -177.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 4.2 Cg_endo -46.52 140.45 11.94 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.4 2.067 . . . . 0.0 113.478 173.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.661 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -89.76 -13.41 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.755 -168.799 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.76 -55.86 8.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.665 173.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.5 Cg_exo -48.68 -59.33 1.29 Allowed 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.705 2.27 . . . . 0.0 113.555 169.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.7 mt -61.43 -35.87 69.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.458 -178.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 25' ' ' ARG . . . -61.61 -37.73 94.68 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.556 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 9.4 ptp180 -90.23 -14.35 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.465 -171.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.52 -56.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.305 165.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.699 HD11 HD23 ' A' ' 28' ' ' LEU . 9.1 mm -61.34 -37.31 77.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.149 -177.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 mttm -60.37 -39.45 87.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.429 167.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.34 -33.35 74.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.751 -177.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -59.11 -53.86 53.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.207 -1.361 . . . . 0.0 110.427 169.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.48 21.56 0.45 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.713 -175.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.56 137.95 58.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.409 168.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.9 -27.72 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.005 -170.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.82 117.99 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.445 169.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' CG1' ' B' ' 55' ' ' ILE . 89.5 t -141.41 132.24 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -172.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 p -83.34 151.23 25.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.406 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 p30 -62.03 -14.17 33.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 26' ' ' ILE . 11.7 m-20 -86.48 -27.9 23.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.394 -176.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -65.42 -39.28 91.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.109 165.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -61.66 -43.64 98.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.518 -178.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.605 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 tt -75.08 -40.45 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.269 -172.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD11 ' A' ' 31' ' ' ILE . 83.1 m -60.66 -44.42 96.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.396 -174.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.782 HD13 HG23 ' B' ' 60' ' ' ILE . 2.2 tp -61.0 -35.41 76.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.288 169.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -62.05 -42.07 98.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.405 178.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -29.42 40.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 28.9 mt -61.28 -72.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.029 171.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 31' ' ' ILE . 8.2 mp -60.11 -30.28 69.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 -167.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.4 tm-20 -81.53 -37.44 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.034 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -61.47 -39.79 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.955 166.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 95.3 mtp -61.36 -40.91 96.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.495 175.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.09 -38.21 63.7 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -166.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -61.02 -27.5 68.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.248 164.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -74.12 -51.47 15.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.53 -173.82 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 64' ' ' VAL . 12.5 mt -61.14 -38.86 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.204 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.878 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -60.97 -58.68 7.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.388 -170.016 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 23.3 p -61.49 -28.79 69.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.365 178.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.0 -43.38 98.94 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.071 169.575 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -76.9 -12.73 60.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.354 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.849 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -84.27 -56.59 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.306 -168.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -59.79 -28.89 67.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.488 170.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.79 HD22 HD23 ' A' ' 62' ' ' LEU . 13.5 mt -60.63 -47.02 88.09 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.457 174.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.73 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.23 -38.03 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.325 -176.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -44.94 75.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 -170.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -60.97 -31.48 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.336 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.27 -53.21 59.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.211 168.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.82 17.14 0.84 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 59.39 28.39 17.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.322 -0.516 . . . . 0.0 111.237 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 77.59 8.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.298 169.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.583 HG23 ' HG3' ' B' ' 19' ' ' ARG . 6.7 m 68.51 169.58 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.709 ' HB ' HG22 ' B' ' 20' ' ' VAL . 5.6 mm -106.08 137.29 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.195 164.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.737 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -128.26 159.77 34.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.417 -167.475 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -62.28 -13.04 24.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.126 -172.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 1.0 OUTLIER -81.69 -25.49 35.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 174.04 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -84.04 -36.43 23.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.27 -174.673 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.831 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.82 -48.72 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.489 161.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.4 mm-40 -61.44 -43.85 98.15 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.81 -174.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 HD22 ' A' ' 46' ' ' LEU . 39.9 tp -65.38 -44.74 86.6 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.542 173.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.39 -45.05 95.96 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.426 -175.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.887 HG21 HG21 ' B' ' 31' ' ' ILE 0.25 0.4 OUTLIER -78.51 -53.52 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.085 -166.554 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -36.26 77.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.631 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -21.06 59.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.374 174.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.9 t80 -68.89 -64.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.259 -173.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.96 -168.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.312 178.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 tttp . . . . . 0 C--O 1.24 0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.299 167.45 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttt . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 121.071 0.463 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -81.3 145.0 31.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.938 -168.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.671 ' CB ' HD11 ' B' ' 8' ' ' ILE . 4.6 mt -61.07 99.41 0.18 Allowed Pre-proline 0 C--O 1.243 0.716 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.71 166.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.3 Cg_endo -55.07 142.93 76.05 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 122.613 2.209 . . . . 0.0 113.628 -172.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.789 HG21 ' HE ' ' B' ' 25' ' ' ARG . 0.1 OUTLIER -66.42 -18.3 23.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.571 -165.198 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -74.62 -62.47 0.94 Allowed Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.776 -170.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.9 Cg_endo -52.72 -50.5 13.83 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.402 2.068 . . . . 0.0 113.444 175.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.671 HD11 ' CB ' ' B' ' 3' ' ' LEU . 27.2 mt -60.45 -31.74 49.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.393 168.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.99 67.97 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.484 -175.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 49.7 mmm-85 -91.66 -27.72 17.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.477 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.476 HD13 ' HG2' ' A' ' 33' ' ' GLU . 36.5 mt -60.92 -59.57 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.526 170.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.878 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.0 mm -61.37 -38.42 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -61.8 -34.01 75.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.349 175.739 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.22 -32.56 73.23 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.685 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.69 -54.0 51.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.45 169.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.45 28.62 0.26 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.67 -176.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.849 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.09 148.84 37.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.715 -0.743 . . . . 0.0 110.357 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.62 117.08 5.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.092 169.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.583 ' HG3' HG23 ' A' ' 54' ' ' THR . 3.1 tpp180 65.04 97.02 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.356 -173.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 55' ' ' ILE . 46.2 t -110.8 150.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.292 168.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -61.13 149.41 37.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.315 169.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.449 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 1.7 m-20 -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.309 170.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.78 -60.25 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.593 174.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -62.09 -47.66 83.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.318 -171.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.789 ' HE ' HG21 ' B' ' 5' ' ' ILE . 5.7 ptt180 -61.09 -34.81 75.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.344 -172.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.15 -33.89 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.499 175.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.81 ' O ' HD12 ' B' ' 31' ' ' ILE . 80.0 m -60.99 -44.93 96.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.407 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.831 HD22 HG13 ' A' ' 60' ' ' ILE . 3.9 tp -60.39 -54.47 45.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.268 173.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -61.54 -15.53 39.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.456 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' CG ' ' B' ' 33' ' ' GLU . 8.5 tmtt? -99.02 -25.46 14.55 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.266 -174.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mt -60.54 -69.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.951 162.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 28' ' ' LEU . 2.5 mp -59.92 -35.16 74.3 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.575 -167.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.515 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -70.35 -40.08 74.27 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.964 -176.771 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -44.17 97.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.122 173.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.511 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 63.1 mmm -61.01 -27.09 68.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.462 175.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.15 -43.47 13.45 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -60.34 -17.98 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.393 166.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -90.96 -52.13 5.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.358 -168.711 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.734 HD13 ' CG2' ' B' ' 64' ' ' VAL . 4.3 mt -61.11 -23.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.206 167.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.66 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.84 -72.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.28 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.828 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 11.8 m -61.67 -11.4 11.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.358 -175.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.432 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -80.22 -56.63 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.129 171.304 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.4 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -61.1 -14.65 25.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.326 176.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 17' ' ' ALA . 70.8 mt -90.62 -54.96 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.056 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.53 -11.62 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.414 170.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 6.4 mt -87.81 -42.47 12.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.443 176.448 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.47 -25.69 67.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.276 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -83.41 -50.75 8.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.45 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -61.31 -31.62 71.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.375 -178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.28 73.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.201 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.83 35.78 0.94 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -166.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 66.49 118.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.487 169.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.598 ' O ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -167.82 13.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.321 179.387 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.598 HG22 ' O ' ' B' ' 53' ' ' LYS . 0.7 OUTLIER 60.96 162.37 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.494 -175.947 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.895 ' CG1' HG22 ' A' ' 20' ' ' VAL . 14.0 mm -75.21 137.47 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.339 173.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 18.9 mtmt -154.32 -178.82 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.425 -169.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -24.69 66.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.34 172.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -26.48 21.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.123 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -35.5 13.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.317 -175.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 28' ' ' LEU . 46.9 mm -61.15 -47.37 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.196 167.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.492 ' HG2' ' NH2' ' B' ' 65' ' ' ARG . 20.9 mt-10 -62.02 -44.53 96.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.971 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -45.98 92.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.464 172.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' B' ' 46' ' ' LEU . . . -61.49 -46.04 91.69 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.421 -177.153 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.734 ' CG2' HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -80.02 -60.94 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.099 -165.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' B' ' 61' ' ' GLU . 4.6 mtm180 -60.22 -19.0 52.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.565 -175.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -89.54 -25.5 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.544 171.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.8 t80 -61.29 -41.64 97.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.46 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.69 129.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.3 -165.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.376 -170.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptt? . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.128 0.489 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.56 121.0 12.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.062 -168.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.3 mp -57.1 138.9 79.68 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.569 -172.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.665 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.3 Cg_endo -63.82 141.21 77.41 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 113.646 -178.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 HH21 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -100.24 -13.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.636 -166.859 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.44 -55.54 3.53 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.674 173.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.2 Cg_exo -49.43 -61.17 0.62 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.749 2.299 . . . . 0.0 113.557 168.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 3' ' ' LEU . 54.9 mt -61.39 -49.58 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.4 91.27 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -172.286 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -40.99 96.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.081 -0.56 . . . . 0.0 110.407 176.088 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 8' ' ' ILE . 68.1 mt -61.55 -36.11 71.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.538 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.673 HG23 ' HB1' ' B' ' 40' ' ' ALA . 8.3 mm -72.79 -44.97 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.192 -172.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -31.96 72.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.255 176.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -61.89 -33.3 73.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.807 177.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.26 -53.21 60.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.462 170.215 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.4 25.79 0.63 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.496 -174.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.21 119.79 9.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.718 -0.741 . . . . 0.0 110.363 176.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.59 -71.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.12 131.84 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.368 168.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.557 ' CG2' ' HB1' ' A' ' 17' ' ' ALA . 60.0 t -124.62 133.14 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.422 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.9 p -73.47 136.02 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.04 -12.88 13.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.398 -174.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -86.67 -21.93 26.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.35 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.719 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -70.72 -38.47 73.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.123 164.036 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.487 HH21 HD13 ' A' ' 5' ' ' ILE . 2.3 mtp180 -61.48 -31.48 71.46 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.502 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.5 tp -89.7 -34.61 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 -175.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.665 ' O ' HD12 ' A' ' 31' ' ' ILE . 80.5 m -61.52 -41.16 96.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.18 177.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.8 tp -59.19 -45.48 90.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.541 167.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.52 -43.09 99.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.504 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -76.62 -28.09 55.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.235 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.02 HG21 HG21 ' B' ' 64' ' ' VAL . 6.6 mt -59.59 -73.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.908 162.177 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.687 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -56.15 -23.79 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.819 -159.646 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.785 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.83 -60.76 2.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.038 166.558 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -28.66 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.109 -164.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.531 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.3 mmm -71.58 -38.96 70.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.436 167.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -66.49 -44.3 90.44 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -174.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.399 168.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -66.35 -53.75 32.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.434 -178.003 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.639 ' HB ' HD11 ' B' ' 28' ' ' LEU . 8.1 mt -61.39 -45.48 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.388 -175.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.29 -48.36 81.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 -172.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.2 t -62.15 -27.46 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.385 177.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -68.37 -43.15 78.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.181 168.978 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -73.06 -7.78 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.676 177.283 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.831 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.84 -52.07 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.275 -174.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -31.1 68.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.667 168.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 43' ' ' ALA . 12.7 mt -61.16 -51.13 70.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.405 175.009 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.99 67.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.348 -171.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -41.97 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.439 170.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -63.22 -31.6 72.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.389 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.261 169.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 35.01 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -170.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.15 133.68 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.375 169.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.4 mmpp? -61.35 -43.51 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.34 -169.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -66.41 126.21 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.412 -168.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 59' ' ' ASP . 7.0 mt -91.67 154.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.362 168.062 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HE3' ' H ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -158.84 173.53 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.377 -166.521 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' H ' ' HE3' ' A' ' 56' ' ' LYS . . . -61.97 -15.85 46.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.255 -177.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.718 ' O ' HD13 ' A' ' 62' ' ' LEU . 1.3 tt0 -83.76 -41.59 17.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.087 175.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -59.94 -49.38 77.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.608 170.985 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 28' ' ' LEU . 32.2 mm -60.77 -59.92 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.415 -171.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 30.3 mt-10 -61.83 -29.17 69.99 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.968 -174.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.1 mp -60.36 -45.6 92.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.469 168.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.14 -42.93 99.44 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.588 -176.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.76 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.14 -55.07 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.054 -165.569 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -21.87 64.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.738 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -92.92 -14.33 27.72 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.736 177.056 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CD2' ' HG2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.27 -75.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.92 161.248 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 59.13 15.93 4.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.767 158.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.241 0.611 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.207 -162.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.56 -172.55 0.1 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 169.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.578 ' CB ' HD11 ' B' ' 8' ' ' ILE . 12.1 mt -61.61 138.28 95.08 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.603 -166.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 5.1 Cg_endo -60.32 160.98 21.35 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.575 2.183 . . . . 0.0 113.407 164.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.412 HD13 ' OD1' ' B' ' 22' ' ' ASP . 2.4 pp -102.27 -20.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.517 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.14 -59.09 4.5 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.754 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 4.7 Cg_endo -48.66 -50.98 11.19 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.585 2.19 . . . . 0.0 113.467 171.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.853 ' HA ' HD12 ' B' ' 11' ' ' ILE . 66.9 mt -60.83 -27.91 42.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.317 174.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.44 -40.71 99.05 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.502 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.06 -21.68 39.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.495 -178.441 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' B' ' 8' ' ' ILE . 89.7 mt -67.19 -44.44 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.507 178.053 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.0 mm -69.17 -41.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.325 175.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 11.2 mtmt -61.51 -39.67 91.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.313 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.59 -31.31 71.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.908 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.07 -52.37 65.82 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.639 170.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.91 24.33 0.33 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.635 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.831 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -75.69 120.04 20.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.617 -0.791 . . . . 0.0 110.255 176.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 13.88 29.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.995 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 179.35 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.419 -174.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.8 HG22 ' HB1' ' B' ' 17' ' ' ALA . 10.7 t -99.85 125.58 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.338 -176.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -63.57 149.64 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.169 164.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' B' ' 5' ' ' ILE . 35.9 t70 -60.58 -12.23 9.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.502 169.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' B' ' 26' ' ' ILE . 0.5 OUTLIER -95.37 -32.67 12.83 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.428 -174.61 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -61.2 -41.33 96.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.182 169.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.15 -53.55 55.55 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.52 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.77 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -67.21 -33.44 62.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.316 -171.915 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.444 HG22 ' CG2' ' A' ' 60' ' ' ILE . 85.0 m -70.1 -34.45 73.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.318 -174.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.918 HD21 HD12 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -60.68 -40.76 93.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.21 166.591 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.57 -56.82 15.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.299 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -33.64 76.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.445 -174.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 64' ' ' VAL . 69.7 mt -61.05 -74.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.935 167.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.687 ' O ' HD11 ' A' ' 32' ' ' LEU . 3.7 mt -59.33 -28.67 67.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.57 -164.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.557 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.6 pp20? -75.72 -39.5 57.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -35.73 79.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.969 175.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.517 170.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.91 -38.35 95.88 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -33.89 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.276 167.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.1 t70 -64.29 -55.7 19.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.438 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.685 ' HB ' HD11 ' A' ' 28' ' ' LEU . 4.9 mt -61.8 -33.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.09 -177.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.93 -65.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.27 -173.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.51 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.03 -18.26 64.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.521 -175.373 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.3 OUTLIER -81.71 -44.65 16.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.168 175.796 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -68.27 -32.53 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.148 175.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.996 HD11 ' HB2' ' A' ' 17' ' ' ALA . 21.7 mt -60.71 -47.39 93.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.097 164.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -30.29 69.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.429 177.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.0 mt -72.31 -34.34 68.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.366 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -61.13 -35.84 78.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.294 176.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.64 -44.06 96.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 172.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.74 -36.84 79.89 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.438 174.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.81 -49.88 75.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 172.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 29.79 2.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -163.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.32 -169.58 0.14 Allowed 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.089 -0.654 . . . . 0.0 111.072 175.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.86 98.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.466 -169.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.94 122.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 165.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' B' ' 47' ' ' ALA . 4.1 mp -93.22 138.16 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.152 162.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -130.55 178.95 6.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.401 -167.825 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.34 -19.88 62.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.47 -28.67 21.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.043 -177.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.2 -34.94 21.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.338 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.719 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 46.7 mm -61.02 -50.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.403 168.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 5.5 mt-10 -69.1 -37.52 78.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -175.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.04 -45.45 94.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.397 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.435 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.29 -49.48 76.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.385 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 31' ' ' ILE 0.257 0.4 OUTLIER -74.87 -50.5 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.937 -160.89 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -30.19 71.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.439 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.55 84.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.377 -177.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.98 -65.12 0.74 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.398 172.203 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -154.92 173.54 16.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.464 -171.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mttt . . . . . 0 C--O 1.241 0.622 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.376 169.975 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmm . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 121.155 0.502 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -68.54 -178.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.994 -171.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 8' ' ' ILE . 13.2 mt -61.06 102.78 0.33 Allowed Pre-proline 0 C--O 1.243 0.731 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.975 175.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.21 141.55 58.83 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.85 1.7 . . . . 0.0 113.113 168.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -93.25 20.77 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.622 -164.319 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.56 -59.39 0.45 Allowed Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.716 172.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -58.0 -50.5 10.0 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.496 2.131 . . . . 0.0 113.498 173.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.846 ' HA ' HD12 ' A' ' 11' ' ' ILE . 57.4 mt -61.37 -44.03 97.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.499 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.41 98.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -170.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.53 -32.31 69.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.008 -0.596 . . . . 0.0 110.334 -178.244 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 8' ' ' ILE . 39.6 mt -61.76 -51.76 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.354 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mm -65.78 -48.44 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.439 -173.024 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -35.14 78.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.253 177.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.83 -32.19 72.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.85 177.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.83 -52.47 65.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.522 170.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.54 20.65 0.61 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.737 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.77 119.54 10.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.181 -0.509 . . . . 0.0 110.319 168.005 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -112.69 18.47 18.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.893 176.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' B' ' 54' ' ' THR . 0.0 OUTLIER 179.89 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.332 -164.396 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.868 HG22 HD12 ' B' ' 55' ' ' ILE . 12.3 t -136.81 118.11 18.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.38 172.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -74.39 159.74 31.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.393 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.13 -23.59 65.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.412 -171.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' ILE . 80.5 m-20 -90.67 -29.6 17.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -170.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.755 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.26 -42.81 99.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.143 162.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.543 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -77.31 -28.69 53.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 -167.519 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 23' ' ' ASP . 5.2 tp -72.94 -37.33 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.429 172.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 31' ' ' ILE . 57.8 m -60.69 -39.98 90.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.727 HD13 HG23 ' B' ' 60' ' ' ILE . 3.5 tp -64.55 -44.37 90.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.014 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.63 72.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.452 173.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -79.35 -33.21 43.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.478 179.207 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.737 HG21 HG21 ' B' ' 64' ' ' VAL . 11.6 mt -60.57 -69.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.003 169.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.739 ' O ' HD21 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -58.09 -27.64 63.86 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.672 -168.496 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -84.55 -19.92 32.36 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.149 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -63.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.008 165.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.419 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 11.0 mtp -61.99 -31.04 71.37 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 -174.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.45 -42.96 71.61 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -177.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -22.02 63.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.547 . . . . 0.0 110.435 169.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.4 m-20 -90.46 -47.74 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.608 -168.368 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.9 mt -61.27 -29.66 46.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.243 171.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.98 -66.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.237 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 29.7 p -63.61 -17.57 63.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.542 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.696 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -69.7 -60.84 2.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.909 167.896 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' CA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.69 -14.68 33.63 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.417 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.961 HD11 ' HB2' ' B' ' 17' ' ' ALA . 84.2 mt -96.93 -48.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.664 -172.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -59.85 -11.62 5.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.482 164.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.7 mp -87.17 -52.84 5.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.277 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -14.27 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.314 177.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.94 -70.27 0.7 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.414 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -67.87 -12.01 59.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.852 -170.078 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 52' ' ' ARG . . . -64.7 -45.96 84.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 163.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.08 4.31 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -166.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.516 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 14.6 mmm180 -126.09 172.54 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.448 -164.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 135.92 50.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.445 -170.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 55' ' ' ILE . 70.2 m 62.82 146.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.469 -178.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.972 HD12 HG22 ' B' ' 20' ' ' VAL . 64.3 mt -97.19 156.62 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.234 168.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 177.08 11.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.469 -171.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.87 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.3 173.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -65.34 -50.35 65.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.028 168.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.785 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -61.4 -51.93 66.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.334 179.41 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.813 HG23 HD13 ' B' ' 28' ' ' LEU . 47.6 mm -60.76 -44.13 96.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.342 -168.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -39.21 88.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.151 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.38 -48.31 81.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.328 176.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.37 -30.21 70.39 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.401 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.694 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -89.49 -56.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.129 -165.222 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -16.24 31.42 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.695 171.2 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -32.02 57.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.358 169.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.95 -35.24 74.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.465 171.828 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -60.7 99.95 0.1 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.45 172.378 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.535 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.327 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 7' ' ' PRO . 1.5 ttt . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.137 0.494 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 6.7 pt-20 -62.71 138.96 58.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.029 170.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.672 ' CB ' HD11 ' B' ' 8' ' ' ILE . 15.5 mt -61.87 107.89 1.34 Allowed Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.915 -177.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 4.4 Cg_endo -47.53 142.42 13.42 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.551 2.168 . . . . 0.0 113.424 168.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.66 -19.21 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.447 -167.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.99 -62.66 1.51 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.744 -168.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.3 Cg_endo -52.68 -42.86 59.77 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.5 2.133 . . . . 0.0 113.491 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.672 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -60.41 -47.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.537 172.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.03 -26.13 67.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -173.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.24 -33.42 32.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.402 -177.725 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' HD21 ' A' ' 3' ' ' LEU . 67.5 mt -60.76 -52.4 62.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.447 169.766 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.956 HG22 ' HB2' ' B' ' 17' ' ' ALA . 11.8 mm -61.1 -35.13 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.199 177.662 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.5 mttt -67.58 -37.05 82.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.504 178.074 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -61.7 -31.42 71.57 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.687 -178.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.81 -53.58 56.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.474 168.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.14 7.51 0.81 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.782 -166.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -63.7 -162.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.954 0.502 . . . . 0.0 110.691 168.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' HG2' ' B' ' 13' ' ' LYS . 4.0 tm-20 64.2 25.42 13.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -155.533 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 20.19 17.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.404 151.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.972 HG22 HD12 ' A' ' 55' ' ' ILE . 61.2 t -113.27 172.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.228 -161.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.671 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 24.6 p -108.63 169.21 8.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.587 175.104 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 1.8 p30 -78.54 -33.52 47.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.336 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.83 -30.81 70.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.334 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' B' ' 21' ' ' SER . . . -60.95 -69.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.269 169.295 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' B' ' 22' ' ' ASP . 1.3 ptt180 -61.06 -11.44 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.345 -166.558 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 29.7 mt -86.11 -35.3 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.424 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.652 HG22 HD11 ' B' ' 31' ' ' ILE . 73.1 m -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.419 176.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 60' ' ' ILE . 2.8 tp -60.74 -40.45 92.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.42 177.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.32 96.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.511 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 5.7 tttt -74.63 -31.33 61.95 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.393 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.694 HG21 HG21 ' A' ' 64' ' ' VAL . 54.0 mt -60.72 -75.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.964 170.559 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.93 -30.98 66.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 -162.439 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 2.5 tm-20 -85.81 -31.44 22.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.016 -173.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.6 mm-40 -61.49 -36.91 81.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.829 163.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 2.6 ttm -63.82 -43.52 95.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.446 176.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.72 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -71.49 -33.58 63.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -165.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -60.85 -33.22 72.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.27 164.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -51.07 54.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.712 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.72 HD12 ' HA2' ' B' ' 36' ' ' GLY . 1.1 mt -62.32 -35.59 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.758 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 12' ' ' ILE . . . -61.35 -65.75 0.64 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.9 -20.51 63.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.418 -179.165 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.714 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -70.16 -61.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.133 169.763 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.32 -5.88 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' A' ' 17' ' ' ALA . 77.6 mt -101.41 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.885 -176.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -15.77 32.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.387 171.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.714 HD12 ' C ' ' B' ' 42' ' ' GLU . 13.4 mt -79.86 -50.32 10.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.432 170.177 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.35 -17.57 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.252 -171.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -46.51 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.458 169.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -61.74 -37.97 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.335 -173.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.04 -47.65 85.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.24 169.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.19 33.07 5.57 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -166.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.15 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.439 -168.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -91.61 132.31 36.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.37 170.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER 66.24 142.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.344 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 20' ' ' VAL . 89.2 mt -89.52 132.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.213 166.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -118.12 171.7 7.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.332 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -14.35 20.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.366 172.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.443 ' OE1' HD11 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -71.41 -52.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.183 169.387 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -68.91 -36.06 77.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.38 -178.083 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.755 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 39.2 mm -61.49 -62.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.342 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.81 -26.35 68.06 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.885 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 11.6 mt -60.46 -50.72 72.45 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.423 170.324 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -62.02 -32.91 73.46 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.479 -172.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -86.95 -48.84 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -162.512 . . . . . . . . 4 4 . 1 . 023 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -66.69 -24.63 66.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.438 169.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.82 -37.08 80.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.415 173.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' B' ' 64' ' ' VAL . 10.5 p90 -108.34 -18.71 13.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.333 -168.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 110.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.365 -174.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 tttm . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.403 166.155 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.1 mtt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.543 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 20.7 mm-40 -126.64 -179.82 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.006 -164.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp 58.65 77.42 0.4 Allowed Pre-proline 0 C--O 1.248 1.0 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.626 178.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 2' ' ' GLU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 -60.3 -54.49 45.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? 64.53 -74.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.333 -165.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.319 168.178 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.085 0.469 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -51.8 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.093 -170.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt -62.49 138.81 96.6 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.778 -173.102 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 -61.15 -57.49 12.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 87.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.401 -168.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 tptm . . . . . 0 C--O 1.241 0.608 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.412 -170.133 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.099 0.476 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.25 137.4 46.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -171.137 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp -57.86 99.49 0.19 Allowed Pre-proline 0 C--O 1.25 1.082 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.43 -168.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 -60.48 -52.25 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.33 -74.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.351 -164.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.337 170.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -158.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.992 168.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.8 139.5 95.79 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.713 -173.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -62.01 -29.63 70.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -145.63 109.96 4.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.428 170.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.415 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.1 mtt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.543 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 20.7 mm-40 -126.64 -179.82 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.006 -164.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp 58.65 77.42 0.4 Allowed Pre-proline 0 C--O 1.248 1.0 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.626 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 2' ' ' GLU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 -60.3 -54.49 45.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? 64.53 -74.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.333 -165.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.319 168.178 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.085 0.469 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -51.8 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.093 -170.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt -62.49 138.81 96.6 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.778 -173.102 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 -61.15 -57.49 12.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 87.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.401 -168.72 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 tptm . . . . . 0 C--O 1.241 0.608 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.412 -170.133 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.099 0.476 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.25 137.4 46.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -171.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp -57.86 99.49 0.19 Allowed Pre-proline 0 C--O 1.25 1.082 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.43 -168.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 -60.48 -52.25 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.33 -74.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.351 -164.3 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.337 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -158.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.992 168.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.8 139.5 95.79 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.713 -173.152 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -62.01 -29.63 70.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -145.63 109.96 4.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.428 170.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.415 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.4 mt-10 58.82 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.73 174.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.681 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp -57.43 100.09 0.21 Allowed Pre-proline 0 C--O 1.251 1.147 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.564 -172.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -60.22 150.0 82.16 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 123.016 2.477 . . . . 0.0 113.479 -172.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -100.65 17.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.809 -164.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -89.87 -56.86 0.27 Allowed Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.703 175.538 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.3 Cg_exo -53.76 -58.83 1.17 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.596 2.198 . . . . 0.0 113.371 164.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 3' ' ' LEU . 25.7 mt -61.74 -47.93 91.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.478 -178.049 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.88 93.42 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -39.98 95.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.412 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 3' ' ' LEU . 75.0 mt -61.81 -48.08 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.438 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.8 mm -64.54 -36.78 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.426 -172.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -32.4 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.366 171.781 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.74 -34.99 78.33 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.827 -178.098 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.42 -53.71 54.99 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.376 169.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.68 21.06 0.38 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.715 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.23 135.3 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.153 -0.523 . . . . 0.0 110.385 166.489 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -157.65 31.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.024 174.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 81.24 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.268 168.061 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG22 HD12 ' B' ' 55' ' ' ILE . 14.2 t -131.16 142.33 43.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.387 -168.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.31 151.15 24.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.352 169.068 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -13.66 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.487 172.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.724 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -87.57 -30.55 20.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.324 -174.901 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.148 165.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -61.76 -34.39 75.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.424 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.27 -37.44 22.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.317 -179.368 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.553 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -63.4 -44.05 95.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.294 -171.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.938 HD11 ' HB ' ' B' ' 39' ' ' ILE . 4.0 tp -59.6 -42.32 92.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.464 167.559 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.78 -39.4 91.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.312 -176.377 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 -20.88 23.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.302 -175.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.77 HG21 HG21 ' B' ' 64' ' ' VAL . 32.3 mt -61.08 -71.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.92 162.448 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.0 mp -59.74 -20.22 55.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.745 -167.725 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.681 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.13 -55.3 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.115 170.925 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.74 -41.73 98.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.984 -172.364 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.433 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.2 mmm -61.16 -43.53 98.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.447 168.322 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.42 -48.24 45.95 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -167.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.72 -19.14 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.277 167.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -75.95 -58.93 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.499 179.533 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.771 HG21 HG23 ' A' ' 64' ' ' VAL . 4.0 mt -60.89 -22.92 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.576 178.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.64 -77.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.266 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.79 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.24 -10.98 7.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.477 -172.577 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.54 -52.93 6.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.186 172.772 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.91 -19.0 59.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.41 173.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.795 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.7 mt -86.29 -51.25 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.949 -177.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -60.16 -11.28 5.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.444 167.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.3 mp -85.21 -38.44 18.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.315 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.92 -30.93 70.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.37 170.739 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 29.5 mmt-85 -68.36 -53.31 24.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.409 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -19.98 60.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.375 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.07 -53.74 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.245 168.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.02 24.05 0.53 Allowed Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.482 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.5 ttp-105 66.4 122.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.446 166.144 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.43 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.4 167.363 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 30.0 m -162.05 141.81 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.447 -178.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.938 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.1 mm -71.77 148.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.393 170.432 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 10.2 mttp -153.12 -177.85 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.523 177.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.01 75.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -173.129 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.697 ' O ' HD12 ' A' ' 62' ' ' LEU . 24.9 tt0 -73.11 -27.56 61.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -178.715 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -36.64 42.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.413 178.309 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.708 ' CG2' HD22 ' B' ' 28' ' ' LEU . 38.5 mm -60.83 -57.25 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.417 170.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -61.47 -30.68 70.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.02 -176.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.46 -51.57 68.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.412 169.209 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -46.76 89.43 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.482 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.771 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.77 -51.47 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.892 -163.473 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.21 -21.71 66.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.708 176.345 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD2' HD11 ' A' ' 46' ' ' LEU . 6.4 ttt-85 -61.29 -39.99 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.268 174.116 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 83.6 m-85 -60.6 -62.27 1.99 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.279 166.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 64.95 -77.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.449 170.042 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.312 -167.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 109.959 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' B' ' 1' ' ' MET . 4.2 mt-10 59.16 121.39 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.746 -175.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 11' ' ' ILE . 3.5 mt -73.5 137.26 77.74 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.79 -168.225 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.96 153.5 50.93 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.394 2.063 . . . . 0.0 113.49 169.264 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.6 pt -100.62 16.98 3.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.696 -176.021 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.41 -59.61 0.28 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.712 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.4 Cg_endo -58.25 -50.06 10.8 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.437 2.091 . . . . 0.0 113.375 168.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.84 -28.99 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 175.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.4 77.8 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.526 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -82.4 -17.19 46.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.395 -170.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.0 mm -60.73 -66.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.439 168.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.72 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.5 -31.39 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.077 -174.291 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -66.1 -37.72 86.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.455 172.276 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -62.13 -32.25 72.81 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.884 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.79 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.73 -52.96 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.454 170.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.86 27.5 0.72 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.523 -170.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.795 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.73 119.99 9.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.775 -0.712 . . . . 0.0 110.373 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.52 -38.69 65.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.13 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.32 100.2 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.718 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.22 140.18 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.275 165.6 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 95.9 p -66.95 165.71 15.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.27 167.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.98 -18.68 58.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.284 168.104 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -58.37 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.441 169.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -62.07 -42.57 99.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.334 -169.396 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.572 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 41.2 mtm180 -61.77 -50.04 73.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.386 -178.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.457 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.5 mm -61.49 -25.04 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.445 179.348 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.566 HG21 ' HB ' ' A' ' 60' ' ' ILE . 85.3 m -73.91 -42.46 60.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.37 -172.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.744 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.76 -35.48 76.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.345 169.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -63.67 -43.54 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.297 -173.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -80.55 -27.83 37.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.376 -179.558 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 64' ' ' VAL . 52.4 mt -61.36 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.976 167.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.744 HD11 HD12 ' B' ' 28' ' ' LEU . 3.8 mp -59.11 -23.39 62.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.733 -164.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -85.0 -28.51 25.69 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.05 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.78 -31.76 71.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.862 163.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -34.21 32.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.413 -176.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.52 42.23 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -176.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.425 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.377 169.547 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.357 176.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.938 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.2 mt -60.89 -21.72 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.307 -170.238 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.72 -69.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.324 173.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.513 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.44 -11.03 8.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.554 -177.275 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.91 -40.46 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.068 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.473 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -69.93 -14.81 62.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 168.562 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.2 mt -97.3 -52.14 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.956 -173.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -19.71 56.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.368 169.229 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.6 mt -68.62 -53.49 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.344 166.042 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.37 -25.91 67.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.247 -173.45 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -38.73 75.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.328 168.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.57 -32.61 71.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.375 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.72 -48.52 81.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.35 173.298 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.26 38.14 1.05 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -167.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 65.27 102.53 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.392 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -171.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.451 177.148 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.2 m -78.41 130.22 35.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.416 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.809 HD12 HG22 ' A' ' 20' ' ' VAL . 28.8 mt -74.01 132.78 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.275 166.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -136.77 -170.13 2.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.391 -177.338 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.99 -22.02 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.251 178.095 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.4 -34.11 21.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -81.25 -35.17 31.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.36 -177.579 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 28' ' ' LEU . 38.8 mm -61.18 -57.67 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.381 167.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.4 mt-10 -62.22 -37.59 85.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.951 -173.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.51 ' CD2' HD22 ' B' ' 46' ' ' LEU . 34.5 tp -60.77 -43.86 97.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.38 172.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.12 -35.25 76.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.441 178.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.77 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -90.46 -59.92 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.271 -162.355 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -23.46 64.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.6 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -23.36 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 172.09 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -60.83 -46.62 89.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.495 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 -77.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.388 -171.344 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.389 -169.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 mmt . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.108 0.48 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 5.6 pt-20 -130.75 -179.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.048 -169.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.058 HD21 HD11 ' B' ' 11' ' ' ILE . 6.8 mt -71.21 112.68 14.44 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.741 -168.35 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 10.9 Cg_endo -55.45 164.55 3.97 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.52 2.147 . . . . 0.0 113.395 164.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 25' ' ' ARG . 21.5 pt -95.88 38.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.314 -173.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -95.01 -58.47 0.2 Allowed Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.73 173.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.7 Cg_endo -59.91 -32.82 95.74 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.53 2.154 . . . . 0.0 113.653 173.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HA ' HD12 ' A' ' 11' ' ' ILE . 72.8 mt -96.81 -13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.62 -169.245 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -43.72 98.89 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -97.39 19.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.472 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.724 HG22 HD13 ' A' ' 12' ' ' ILE . 22.9 mt -90.28 -49.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.208 166.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.792 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 3.9 mm -96.31 48.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.651 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HA ' ' H ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -156.11 -26.45 0.1 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.748 169.72 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.68 -40.59 66.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.276 163.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.793 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.73 -72.87 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.727 172.545 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.7 36.39 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.149 152.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.099 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -73.29 123.15 23.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.153 -165.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -135.58 31.83 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.088 -165.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.95 102.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.423 168.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t -125.15 162.46 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.369 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 47.1 t -101.84 13.48 34.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.375 -169.324 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p30 60.47 23.56 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -140.67 -30.07 0.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.358 179.144 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.12 -40.6 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.437 177.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HG3' HG21 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.39 -30.1 70.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.409 -178.907 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 5' ' ' ILE . 9.1 mm -83.86 -30.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.413 179.288 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD12 ' A' ' 31' ' ' ILE . 74.6 m -60.79 -46.36 90.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.377 168.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.929 HD13 HG23 ' B' ' 60' ' ' ILE . 4.9 tp -61.0 -45.46 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.336 172.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 3' ' ' LEU . . . -61.75 -12.69 18.09 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.548 -178.689 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -107.74 -37.51 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.24 -178.7 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.966 HD13 HG21 ' B' ' 64' ' ' VAL . 60.0 mt -60.88 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.078 168.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.02 -34.85 72.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 -166.329 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 3' ' ' LEU . 2.5 tm-20 -68.05 -43.82 77.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.236 176.607 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.59 -17.02 63.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.029 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.438 ' CE ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 mtm -81.84 -43.4 18.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.466 169.165 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -69.27 -45.87 59.47 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -169.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' N ' HG22 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -61.53 -16.62 49.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.316 169.25 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.1 -54.63 5.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.447 -179.543 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.703 ' HB ' HD11 ' B' ' 28' ' ' LEU . 15.2 mt -61.52 -28.62 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.343 -176.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.34 -65.67 0.66 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.22 -173.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.755 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 25.9 t -61.2 -10.49 6.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.524 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 46' ' ' LEU . 12.1 mm-40 -85.01 -57.57 3.04 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.05 173.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.92 -8.61 5.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.532 174.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' B' ' 17' ' ' ALA . 51.4 mt -95.93 -54.31 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.222 178.391 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -13.82 62.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.359 -178.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 42' ' ' GLU . 7.6 mt -88.39 -21.41 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.403 173.307 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -80.49 -29.97 37.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -165.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.47 -15.72 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.384 -168.574 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -9.92 59.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.42 164.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.73 -54.12 49.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.297 174.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.21 33.85 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.535 -169.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 67.17 121.25 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.638 -0.781 . . . . 0.0 110.587 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' H ' ' NH1' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 179.86 -79.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.362 171.631 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.586 HG21 ' OG ' ' B' ' 21' ' ' SER . 72.5 m -167.51 159.97 12.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.134 -164.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.564 HD13 ' CB ' ' A' ' 47' ' ' ALA . 7.2 mm -90.09 137.62 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.3 165.165 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 7.7 mttm -153.37 -174.9 5.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.487 -166.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -66.33 -21.42 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.148 -169.445 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -94.18 25.13 3.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.147 175.018 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.624 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . 14.5 m-20 -119.21 -39.57 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.153 174.163 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.714 HG22 HG22 ' B' ' 27' ' ' THR . 3.1 mp -91.15 14.78 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.631 163.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.0 mm-40 -121.65 36.91 4.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 164.192 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 62' ' ' LEU . 10.6 tp -169.42 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.378 -174.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HB2' ' CA ' ' A' ' 43' ' ' ALA . . . -84.86 -17.53 37.67 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.405 173.54 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.69 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -107.61 -67.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.265 -157.676 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -60.76 -23.89 65.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.39 177.187 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 69' ' ' LYS . 5.5 mmt180 -78.35 -60.68 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.102 164.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER 60.37 67.66 0.83 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.151 -157.653 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.21 112.21 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.449 -176.054 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.606 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.412 169.229 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.106 0.479 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.524 ' HB2' ' HG3' ' B' ' 33' ' ' GLU . 1.5 mt-10 -66.21 -35.8 81.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -97.42 101.79 11.05 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.66 175.747 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' B' ' 2' ' ' GLU . 5.7 Cg_endo -52.86 151.43 20.11 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.665 2.244 . . . . 0.0 113.527 172.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.519 HG21 ' CG1' ' B' ' 26' ' ' ILE . 1.1 pt -85.63 64.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.51 175.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -151.65 -57.97 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.619 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.8 Cg_endo -60.08 -38.23 78.88 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.181 . . . . 0.0 113.589 170.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.642 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -73.4 -18.26 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.515 172.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' B' ' 25' ' ' ARG . . . -61.04 -52.91 49.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -166.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 5.1 mtt-85 -75.25 -20.66 59.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.411 -176.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 3' ' ' LEU . 16.1 mt -63.58 -47.39 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.278 167.282 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 40' ' ' ALA . 6.3 mm -95.77 45.41 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.835 175.07 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -149.47 -31.7 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.873 170.872 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.78 -31.28 70.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.92 172.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.755 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -58.74 -51.6 69.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.545 170.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.57 23.23 1.23 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.702 -171.2 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -65.81 131.58 46.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.349 173.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.6 -77.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.111 -177.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -146.83 144.12 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.318 -169.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.593 HG12 ' H ' ' B' ' 21' ' ' SER . 11.0 t -113.06 168.73 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -168.058 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.593 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -127.83 -162.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.244 -164.828 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.67 89.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.451 167.663 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.41 125.2 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.541 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . . . -176.66 -48.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.977 163.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.467 ' CZ ' HG21 ' B' ' 20' ' ' VAL . 15.1 ttp180 -77.22 -30.55 54.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.329 167.246 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.519 ' CG1' HG21 ' B' ' 5' ' ' ILE . 59.0 mt -72.72 -36.32 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.416 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 60' ' ' ILE . 92.5 m -60.81 -43.27 98.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.325 169.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -60.85 -45.81 93.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.149 174.414 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -17.82 54.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.511 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.22 -32.6 11.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.412 -171.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mp -62.11 -72.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.587 159.273 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -58.82 -14.12 7.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.931 -162.663 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' B' ' 2' ' ' GLU . 1.9 tm-20 -91.41 -26.36 18.9 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.17 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.28 -19.49 28.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.141 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 8.1 mtt -93.69 12.37 25.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.412 171.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.69 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 -41.2 0.51 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.088 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 15' ' ' ALA . 1.4 tmt_? -61.17 -20.67 62.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.262 166.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.37 -35.3 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.436 -167.704 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.795 HG23 ' O ' ' B' ' 63' ' ' ALA . 7.6 mt -62.04 -33.97 61.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.288 171.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.19 -63.02 1.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.306 -169.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.793 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 15.3 m -61.9 -13.76 27.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.592 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 3.0 mm-40 -81.6 -45.33 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.104 176.08 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -73.25 -33.71 65.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.209 177.044 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 1.099 HD11 ' HB2' ' A' ' 17' ' ' ALA . 15.2 mt -60.5 -56.35 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.351 167.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.65 69.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 -176.715 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' B' ' 63' ' ' ALA . 4.3 mt -76.24 -36.91 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.494 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.86 -45.24 94.63 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.262 -177.141 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -89.72 -25.72 21.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.373 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -64.04 -44.9 91.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.266 168.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.0 98.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.268 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.32 43.55 15.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -175.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -135.3 -166.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.398 -168.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -169.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.423 -167.385 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 0.8 OUTLIER -68.26 172.29 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.926 -167.903 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' B' ' 47' ' ' ALA . 31.9 mm -60.62 135.94 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.465 175.312 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -159.24 -176.59 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.423 -169.413 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -62.48 -24.09 67.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 -170.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.701 ' C ' HD23 ' B' ' 62' ' ' LEU . 1.1 pp20? -103.52 23.1 13.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.104 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.56 -34.63 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.424 168.319 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.929 HG23 HD13 ' A' ' 28' ' ' LEU . 36.7 mm -61.02 -65.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.328 165.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.732 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.2 mt-10 -61.4 -10.92 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.245 -177.187 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.701 HD23 ' C ' ' B' ' 58' ' ' GLU . 4.1 mm? -99.51 -18.66 17.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.515 176.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.795 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -92.06 14.53 15.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.561 164.917 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 31' ' ' ILE . 40.1 t -115.7 -68.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.585 -176.356 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -60.18 -10.06 4.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.588 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -37.61 86.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.663 168.348 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CZ ' HG12 ' B' ' 39' ' ' ILE . 3.1 m-85 -61.13 -35.01 75.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.205 168.541 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt 65.0 -75.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 -165.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.6 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.377 -174.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.113 0.482 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' HB3' ' CD ' ' A' ' 33' ' ' GLU . 4.3 mt-10 -119.32 82.95 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -173.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.678 HD13 ' HB3' ' A' ' 33' ' ' GLU . 10.4 mp 58.59 69.81 1.34 Allowed Pre-proline 0 C--O 1.248 0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.682 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 10.8 Cg_exo -45.2 148.78 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.868 2.378 . . . . 0.0 113.466 177.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 26' ' ' ILE . 2.0 pt -70.96 58.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.373 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -160.28 -52.89 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.52 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.0 Cg_endo -55.71 -32.62 84.74 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 C-N-CA 122.781 2.321 . . . . 0.0 113.506 167.022 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 29' ' ' ALA . 9.4 mm -60.63 -39.66 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.485 168.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.4 98.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -166.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.14 18.63 13.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.41 -176.605 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' B' ' 37' ' ' ARG . 95.5 mt -103.32 -39.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.182 164.576 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.711 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.3 mm -81.08 -37.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 -179.094 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -41.41 95.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.428 169.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.89 -30.79 71.11 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.815 -175.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.63 -53.29 59.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.55 168.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.09 32.33 0.35 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.562 -171.439 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.054 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -80.47 -167.63 1.42 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.3 177.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.05 93.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.997 165.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.3 104.93 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.32 162.8 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.069 164.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 16.6 t -94.41 -84.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.411 -166.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 9.1 t70 -174.89 136.88 0.41 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 -171.305 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.914 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 0.4 OUTLIER 77.97 -51.69 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.014 -161.605 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.13 -39.37 89.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.304 -173.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.94 -40.52 97.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.412 -177.842 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 5' ' ' ILE . 1.6 mp -94.64 -23.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.404 -170.087 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.625 HG22 HD11 ' A' ' 31' ' ' ILE . 92.0 m -60.79 -39.79 90.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.491 173.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD23 ' CD1' ' A' ' 12' ' ' ILE . 13.1 tp -88.35 -14.31 38.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.493 -171.577 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . -79.03 -45.33 20.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.198 164.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -61.0 -36.97 80.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.484 175.554 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.726 HG21 HG21 ' B' ' 64' ' ' VAL . 23.0 mt -62.21 -78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.897 170.672 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD21 HD12 ' B' ' 39' ' ' ILE . 2.0 mm? -57.09 -26.62 60.74 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.543 -158.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.678 ' HB3' HD13 ' A' ' 3' ' ' LEU . 11.5 pt-20 -64.24 -36.12 83.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.025 176.411 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -62.33 -39.58 93.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.818 -164.492 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.467 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 21.6 mtt -81.69 -25.94 35.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -72.89 -39.83 53.7 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.515 -176.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -60.98 -17.06 49.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.395 168.902 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -99.83 -46.09 5.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.555 -164.664 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.677 HD13 ' CG2' ' A' ' 64' ' ' VAL . 7.2 mt -61.62 -26.28 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.183 172.123 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.33 -70.38 0.2 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.115 177.153 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.18 -18.17 56.82 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.525 179.472 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 46' ' ' LEU . 6.5 mm-40 -72.3 -61.65 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.034 169.311 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.13 -9.49 4.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.539 179.1 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' B' ' 17' ' ' ALA . 90.1 mt -100.77 -67.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.048 -178.366 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -17.4 53.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.349 -176.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.763 HD12 ' C ' ' A' ' 42' ' ' GLU . 14.5 mt -60.93 -48.18 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.206 163.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB1' ' HB3' ' A' ' 53' ' ' LYS . . . -87.49 -27.71 22.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.224 -168.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -21.65 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.33 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -60.98 -14.61 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.323 166.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -82.93 -43.95 15.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.305 175.535 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.1 15.54 23.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 172.175 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 178.93 84.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 169.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -108.91 151.94 25.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.462 -161.358 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.493 HG22 ' HB3' ' B' ' 21' ' ' SER . 98.3 m -140.55 114.42 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.158 163.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.776 ' HB ' HG13 ' B' ' 20' ' ' VAL . 13.6 mm -60.52 153.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.349 -166.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.7 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -140.88 173.33 11.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.416 -171.968 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.16 -11.94 10.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.3 168.226 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -113.64 30.72 7.02 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.06 179.759 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -120.83 -39.37 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.248 169.153 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.83 HG13 HD22 ' B' ' 28' ' ' LEU . 1.3 mp -62.12 -54.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.442 160.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.9 mm-40 -61.6 -9.23 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.19 -174.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 61' ' ' GLU . 72.0 mt -138.32 35.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.454 175.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -130.62 10.41 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.907 163.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.677 ' CG2' HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -134.09 -63.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.533 0.683 . . . . 0.0 109.237 -156.222 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.449 ' H ' HG12 ' A' ' 64' ' ' VAL . 10.3 ttp180 -78.41 -27.26 46.64 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.232 162.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 6.7 mmt180 -75.49 -11.25 59.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.768 167.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.546 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -60.98 -48.68 80.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.179 -176.889 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.528 165.426 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttt . . . . . 0 C--O 1.24 0.584 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.326 -168.131 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpt . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 1.0 OUTLIER -94.91 -164.71 1.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.972 -170.927 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.61 HD21 ' HG3' ' B' ' 33' ' ' GLU . 17.2 mt -61.67 107.68 1.23 Allowed Pre-proline 0 C--O 1.243 0.748 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.889 -178.576 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 8.0 Cg_endo -49.11 143.62 18.13 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.466 2.11 . . . . 0.0 113.367 166.797 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.472 ' CG2' ' HG3' ' B' ' 25' ' ' ARG . 1.3 pp -95.19 26.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.383 -168.343 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -82.67 -58.14 0.44 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.694 169.427 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -58.89 -46.95 20.06 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.543 2.162 . . . . 0.0 113.568 171.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 mt -68.33 -18.83 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.411 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.434 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -60.95 -47.38 91.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -170.534 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.9 ttt180 -85.59 -17.51 36.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.371 -170.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 3' ' ' LEU . 26.7 mt -60.97 -59.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.405 171.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 14.8 mm -63.89 -36.38 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.458 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 6.8 mmtp -64.59 -33.31 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.298 176.493 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 25.0 t0 -61.72 -31.5 71.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.834 177.407 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -51.17 71.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.558 170.65 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 34.42 0.68 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.545 -168.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.697 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -70.97 157.93 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.02 99.61 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.136 179.439 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 63.14 132.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -176.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.776 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t -119.46 160.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.369 170.251 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' THR . 21.6 p -84.43 -10.11 57.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.436 178.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.404 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.2 OUTLIER 71.02 164.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.983 -161.342 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 74.32 -50.94 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 -162.375 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 55' ' ' ILE . . . -60.42 -44.29 95.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.418 174.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.676 ' HE ' HG21 ' B' ' 20' ' ' VAL . 13.9 tpp85 -68.89 -16.82 63.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.524 -173.3 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.68 -30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.415 -168.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.648 ' O ' HD12 ' B' ' 31' ' ' ILE . 89.1 m -61.12 -40.68 94.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.269 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.83 HD22 HG13 ' A' ' 60' ' ' ILE . 2.0 tp -59.97 -43.78 94.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.322 172.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -12.91 13.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.662 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.9 mmtp -105.57 -30.36 9.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.393 -175.552 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.796 HD13 ' CG2' ' A' ' 60' ' ' ILE . 3.3 mp -61.85 -74.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.655 161.093 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.826 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.71 -40.93 85.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.649 -163.572 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' B' ' 3' ' ' LEU . 4.7 tt0 -66.86 -20.43 65.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.044 -174.743 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 4.7 tt0 -77.06 -53.53 7.68 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.077 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.03 -29.87 67.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.352 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.11 -30.54 78.07 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 169.182 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 11' ' ' ILE . 3.0 mtp85 -81.79 -19.44 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.467 175.052 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -37.5 12.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.403 -169.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.916 HD12 HD21 ' A' ' 32' ' ' LEU . 12.0 mt -61.08 -27.9 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.296 168.173 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -68.29 -60.35 2.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.305 -177.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.656 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 48.9 m -61.68 -13.7 25.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.33 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.588 ' O ' ' HG ' ' B' ' 46' ' ' LEU . 4.9 mm-40 -75.6 -53.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.091 171.439 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.9 -31.95 68.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.141 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 1.054 HD11 ' HB2' ' A' ' 17' ' ' ALA . 49.1 mt -60.81 -49.55 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.212 165.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.547 176.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' B' ' 43' ' ' ALA . 28.8 mt -65.32 -48.82 71.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.418 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.75 65.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.34 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -19.07 36.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.341 176.562 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -61.24 -37.41 82.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.244 166.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.1 -46.26 35.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.056 165.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.63 -7.03 24.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.81 168.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.11 98.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.354 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.5 160.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 166.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 95.1 m -69.31 159.27 33.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.457 168.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.631 ' CG2' ' HB1' ' B' ' 43' ' ' ALA . 55.5 mt -87.0 133.9 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 -170.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -118.39 -178.34 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.391 -178.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . . . -74.8 -32.07 61.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.269 -169.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.67 -13.44 22.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.097 168.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -94.2 -43.54 8.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.356 -179.368 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 24' ' ' ALA . 42.0 mm -61.1 -33.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.457 177.681 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.78 -22.17 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.849 -171.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.652 ' O ' HD11 ' B' ' 46' ' ' LEU . 24.7 tp -106.4 18.19 22.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.579 167.189 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.551 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -106.92 -14.8 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.273 166.17 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -121.2 -65.29 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.282 -165.569 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG12 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -60.43 -11.84 7.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.501 172.21 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -82.34 -24.42 34.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.409 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.4 -72.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.305 168.232 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 -172.07 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.285 170.183 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.321 168.785 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.181 0.515 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' OE2' HG23 ' A' ' 26' ' ' ILE . 9.2 pt-20 -170.75 -164.77 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.059 -171.15 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 33' ' ' GLU . 1.1 mt -96.61 104.81 19.36 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.706 177.366 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 2' ' ' GLU . 2.2 Cg_endo -51.83 154.47 9.72 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.673 2.249 . . . . 0.0 113.619 177.392 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -92.93 19.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.683 -170.45 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -80.74 -58.15 0.55 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.625 170.286 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.7 Cg_endo -59.19 -61.88 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.585 2.19 . . . . 0.0 113.55 170.329 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 62.7 mt -61.19 -14.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.452 177.672 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.63 99.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.97 25.44 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.386 -173.862 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.82 -40.06 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.508 169.817 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 40' ' ' ALA . 17.4 mm -83.97 -39.94 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.423 -174.488 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -26.75 67.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.3 173.187 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.05 -34.1 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.814 177.756 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.09 -53.16 61.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.314 168.27 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.97 21.6 0.78 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.772 -172.125 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.837 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -65.26 127.02 30.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.415 170.448 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -102.25 -17.45 15.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.013 -171.791 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 163.16 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.33 168.855 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG21 ' CD ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -118.0 163.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.305 168.594 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.532 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 24.7 p -75.5 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.44 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.94 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.34 171.798 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.46 -18.45 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.408 -165.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.36 -40.44 94.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.304 -167.015 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.791 ' CD ' HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -65.42 -60.08 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.446 176.198 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG23 ' OE2' ' A' ' 2' ' ' GLU . 3.0 mt -65.23 -27.77 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.449 -171.603 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 31' ' ' ILE . 79.8 m -61.02 -61.67 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.395 166.869 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 HG23 ' B' ' 60' ' ' ILE . 10.5 tp -61.51 -10.3 7.58 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.482 -171.441 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.66 -63.53 1.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.435 171.271 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 5.6 mtpm? -61.46 -21.27 64.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.993 HD13 HG21 ' B' ' 64' ' ' VAL . 32.5 mt -61.89 -76.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.893 162.562 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.39 -30.71 68.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.697 -162.958 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -77.73 -18.61 56.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.018 -178.635 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -90.03 -17.82 27.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.037 169.312 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 9.8 mtp -99.58 18.83 17.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 170.768 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.674 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -119.4 -41.74 0.57 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 170.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -13.24 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.199 163.888 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.06 -55.01 4.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.385 -178.342 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 63' ' ' ALA . 7.3 mt -61.24 -19.74 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.463 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -72.57 -63.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.255 -169.176 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 35.1 t -60.64 -13.4 14.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.439 177.059 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -72.71 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.095 166.785 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 60' ' ' ILE . . . -61.41 -15.52 37.69 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.502 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.1 mt -92.78 -51.9 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.894 -175.35 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.35 -11.81 7.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.477 166.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.3 mp -82.85 -42.83 17.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.244 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 52' ' ' ARG . . . -61.33 -23.68 65.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.403 -176.684 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -27.52 38.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.438 -177.474 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -61.13 -27.75 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.347 169.683 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.94 -47.15 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.288 178.795 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.0 13.17 25.89 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -169.235 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 mtp85 -143.0 116.98 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.404 -179.5 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -62.72 -24.68 67.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.351 -167.937 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.625 HG22 ' HB3' ' B' ' 21' ' ' SER . 1.0 OUTLIER -60.96 116.12 4.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.42 -168.538 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.53 149.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.414 177.56 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' OD2' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -139.09 164.21 30.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -169.867 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -66.73 -18.26 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.316 168.74 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 62' ' ' LEU . 74.3 mm-40 -96.83 29.26 3.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.083 169.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 56' ' ' LYS . 76.5 m-20 -117.52 -34.88 4.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.423 168.638 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.711 HG12 HD21 ' B' ' 28' ' ' LEU . 4.1 mp -102.65 -12.32 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.383 -175.324 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 62' ' ' LEU . 12.5 mt-10 -70.97 -10.8 60.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 161.712 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -145.07 25.04 1.43 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.468 -179.55 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.827 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -111.21 15.25 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.31 163.58 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -144.41 -65.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -155.359 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.1 mtp180 -62.13 -29.19 70.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.316 164.744 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -84.75 -21.0 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 172.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 42' ' ' GLU . 4.4 t80 -60.96 -16.03 38.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.429 176.774 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -69.05 -69.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.348 167.542 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? . . . . . 0 C--O 1.241 0.647 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.407 -178.864 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.185 0.517 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -91.84 116.71 29.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.086 -171.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.792 HD21 ' CG ' ' B' ' 33' ' ' GLU . 4.4 mt -63.57 140.14 97.72 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.805 171.199 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -58.99 147.7 88.78 Favored 'Trans proline' 0 N--CA 1.484 0.942 0 C-N-CA 122.493 2.128 . . . . 0.0 113.617 172.845 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -82.39 76.36 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.525 177.611 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -153.53 -54.76 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.599 171.414 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -62.23 -11.34 21.83 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.658 2.238 . . . . 0.0 113.65 171.179 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' B' ' 3' ' ' LEU . 40.0 mt -114.92 -37.61 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.482 -179.101 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.83 -48.33 86.78 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.849 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 1.1 ptt180 -93.83 19.21 9.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.511 -179.285 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mm -83.62 -60.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.126 164.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.71 HD11 ' HG ' ' B' ' 28' ' ' LEU . 9.7 mm -66.43 -36.05 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.218 -176.384 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 12.1 mttm -64.93 -39.07 92.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.425 178.217 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -62.11 -31.46 71.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.793 -177.738 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.68 -52.76 64.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.603 170.621 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.24 19.54 0.53 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.609 -179.098 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.882 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.67 125.9 25.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.332 165.494 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.78 -64.41 1.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.071 -170.036 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -110.02 111.32 22.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.411 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.665 HG21 ' HG3' ' B' ' 25' ' ' ARG . 11.3 t -90.24 152.05 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.294 172.126 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 54' ' ' THR . 24.7 p -98.47 16.6 21.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.345 -176.616 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.55 163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.09 -162.332 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 75.33 -58.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.898 -166.699 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' B' ' 20' ' ' VAL . . . -60.22 -38.2 82.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.345 -165.004 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.665 ' HG3' HG21 ' B' ' 20' ' ' VAL . 7.7 mtp180 -64.21 -13.51 49.34 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.555 -179.417 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 2.9 mp -122.56 -5.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -177.852 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.621 HG22 HD13 ' B' ' 31' ' ' ILE . 98.9 m -60.64 -43.16 97.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.451 173.404 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 60' ' ' ILE . 2.9 mm? -61.21 -23.43 65.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.443 177.284 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -74.88 -11.12 60.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.436 -178.502 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.48 -32.6 6.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.482 -177.65 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.985 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 mp -61.72 -75.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.821 163.803 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.1 -21.03 44.42 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.797 -160.494 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.792 ' CG ' HD21 ' B' ' 3' ' ' LEU . 4.3 tm-20 -89.2 -18.15 27.67 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -39.8 28.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.093 168.359 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.473 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -93.34 19.56 8.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.422 178.838 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.68 -33.85 1.5 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 165.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.7 -20.78 59.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.191 165.25 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' B' ' 35' ' ' MET . 27.3 t0 -61.13 -60.88 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.346 171.337 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 64' ' ' VAL . 22.0 mt -61.04 -33.95 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.46 -169.022 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.62 -53.48 55.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.315 -172.749 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -17.29 64.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.785 -173.487 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.453 ' C ' HD12 ' B' ' 46' ' ' LEU . 2.6 mp0 -89.21 -42.4 11.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.085 173.645 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.601 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -60.86 -12.43 10.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.479 172.106 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.837 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.2 -61.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.611 -169.979 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' B' ' 44' ' ' ILE . 0.6 OUTLIER -67.64 -16.85 64.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.488 175.739 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.816 HD22 HD23 ' B' ' 62' ' ' LEU . 4.0 mt -61.09 -32.03 71.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.287 166.924 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' B' ' 55' ' ' ILE . . . -73.42 -40.5 64.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.341 177.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -90.07 -33.73 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.374 -167.526 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -61.1 -37.57 83.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.377 171.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.7 94.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.339 168.657 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.87 27.19 17.33 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -179.007 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 179.11 4.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.415 -169.306 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 161.29 14.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.447 171.645 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 21' ' ' SER . 88.6 m 69.92 134.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.4 168.154 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' B' ' 47' ' ' ALA . 13.3 mm -90.82 135.52 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.384 168.209 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.532 ' HG3' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -135.73 177.13 8.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.464 179.262 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.93 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.347 -167.723 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.16 -16.61 27.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.129 -178.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.8 OUTLIER -86.88 -18.53 30.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.413 168.455 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 28' ' ' LEU . 46.7 mm -92.43 -42.11 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 -170.956 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.505 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 31.6 mt-10 -91.05 22.03 3.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.635 172.477 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.816 HD23 HD22 ' B' ' 46' ' ' LEU . 19.8 tp -126.53 -15.67 5.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.679 169.428 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.601 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -89.55 -35.72 15.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.827 163.649 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.993 HG21 HD13 ' A' ' 31' ' ' ILE . 53.9 t -62.32 -79.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.618 162.847 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -59.48 -12.68 6.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.718 -159.322 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -81.87 -17.99 45.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.5 -177.215 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.498 ' HE2' HG12 ' B' ' 39' ' ' ILE . 13.2 m-85 -70.7 -65.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.305 168.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 105.8 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.379 -176.142 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.38 -169.434 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 mtp . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 19.1 mt-10 -108.38 163.14 13.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.029 -169.238 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' A' ' 8' ' ' ILE . 1.1 mt -93.33 100.07 3.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.595 -172.492 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 5.0 Cg_endo -47.95 148.13 6.91 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.588 2.192 . . . . 0.0 113.589 172.486 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -63.89 -26.67 41.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.352 -175.32 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.26 -62.37 3.19 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.684 -170.21 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.5 Cg_endo -50.82 -22.67 10.27 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 122.594 2.196 . . . . 0.0 113.595 -177.088 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 3' ' ' LEU . 85.9 mt -107.23 -30.18 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.493 -169.691 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.72 80.51 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -169.597 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -79.62 -21.7 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.364 -174.558 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' B' ' 37' ' ' ARG . 26.8 mt -63.7 -52.27 59.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.417 170.907 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.704 HD12 ' HB2' ' B' ' 40' ' ' ALA . 14.7 mm -67.12 -35.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.428 -168.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -28.34 69.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.2 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.93 -33.45 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.874 177.027 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.08 -51.32 70.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.496 169.515 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.92 10.89 0.44 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.69 -174.301 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -73.18 170.2 15.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.025 -0.587 . . . . 0.0 110.316 175.458 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.74 -46.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -168.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.34 170.94 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.459 171.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.687 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 96.9 t -151.85 161.01 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.359 -169.128 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 27.4 t -77.32 -167.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.398 175.863 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -17.18 51.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.352 -173.029 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -170.57 124.74 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 168.347 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -146.75 -61.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.164 166.601 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.665 ' NH1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -65.86 -14.94 62.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.361 -178.326 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.6 mt -86.43 -34.82 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.396 175.182 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.472 HG22 HD12 ' A' ' 31' ' ' ILE . 98.7 m -61.14 -53.98 50.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.228 165.409 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.705 HD12 ' CG2' ' A' ' 31' ' ' ILE . 16.7 tp -62.08 -23.52 66.55 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.347 -174.102 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 3' ' ' LEU . . . -82.16 -36.44 27.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.232 178.76 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.2 -16.13 60.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.51 172.529 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.999 HG12 HG11 ' B' ' 64' ' ' VAL . 0.7 OUTLIER -83.07 -29.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.889 -165.33 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -89.39 -34.85 16.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -173.612 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.89 -34.91 76.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.982 -179.031 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 8.3 mm-40 -73.87 -26.62 60.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.05 168.994 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -95.25 22.75 6.44 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.428 178.758 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.26 -41.63 0.09 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -173.362 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -65.88 -26.01 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.417 -0.392 . . . . 0.0 110.177 167.507 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -87.44 -35.83 18.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.354 -168.512 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.737 HD13 HG22 ' A' ' 64' ' ' VAL . 6.6 mt -61.24 -32.1 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.423 174.149 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.933 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.48 -61.43 2.45 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.212 171.792 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.524 -175.563 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.756 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.66 -53.67 4.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.169 171.238 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.94 -11.55 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.7 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.87 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -78.4 -60.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.402 -169.349 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mtmt -69.08 -18.56 64.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.468 173.108 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 42' ' ' GLU . 4.1 mp -61.1 -18.38 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 166.462 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -91.45 -18.39 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.381 177.754 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -81.44 -33.32 32.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -170.71 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -61.11 -24.56 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.356 169.81 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.26 -52.66 63.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.226 166.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.18 28.66 0.58 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.467 -177.334 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.49 93.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.465 175.911 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.86 -76.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.467 179.372 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 55' ' ' ILE . 96.7 m -160.04 140.28 11.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.423 -169.666 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.2 mm -61.58 165.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.267 167.209 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -170.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.397 168.868 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.37 -19.52 65.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.304 -166.525 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.36 23.64 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.255 170.654 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -121.22 -26.6 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.317 168.33 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HD13 ' B' ' 28' ' ' LEU . 36.6 mm -95.99 -47.82 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.001 -163.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -75.92 -12.76 60.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.167 174.442 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -48.14 7.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.43 177.747 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.98 -31.21 70.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.228 172.115 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.737 HG22 HD13 ' A' ' 39' ' ' ILE . 25.3 t -61.33 -70.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.756 164.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -9.82 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.806 -170.099 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HD3' ' HG2' ' A' ' 42' ' ' GLU . 8.9 ttt85 -77.66 -34.14 53.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.904 172.628 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.498 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 5.6 m-85 -59.98 -37.16 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.437 178.598 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 13.5 tptp -60.78 -14.5 21.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.523 -168.854 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 tttm . . . . . 0 C--O 1.24 0.565 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.427 165.8 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptm . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.104 0.478 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 2' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' B' ' 29' ' ' ALA . 0.9 OUTLIER -160.82 134.9 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.102 170.139 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.594 ' HB2' HD11 ' B' ' 8' ' ' ILE . 5.6 mt -61.33 99.63 0.19 Allowed Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.839 -173.037 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -46.93 157.54 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.229 1.953 . . . . 0.0 113.454 -179.07 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.04 23.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.378 -167.157 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.732 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -84.23 -58.19 0.38 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 169.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.2 Cg_endo -57.75 -65.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 122.505 2.137 . . . . 0.0 113.612 173.667 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' B' ' 3' ' ' LEU . 74.3 mt -60.8 -11.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.532 -170.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.82 55.53 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -178.707 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -94.96 17.36 14.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.588 . . . . 0.0 110.642 -178.895 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.49 HG22 HD13 ' B' ' 12' ' ' ILE . 23.1 mt -95.27 -45.05 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.025 163.146 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.933 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm -94.29 46.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.849 171.551 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 19.8 mtpt -149.59 -30.56 0.23 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.945 171.52 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 27.9 t0 -60.05 -30.49 69.23 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.065 171.264 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.96 74.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.638 170.907 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.64 22.33 2.28 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.552 -165.876 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.87 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.76 123.45 22.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.092 179.375 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -77.15 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.007 -164.667 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -109.84 -52.54 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.429 -177.841 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.766 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t 62.84 132.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.331 -175.172 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -65.75 175.16 2.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.249 178.785 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -93.81 20.33 7.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.59 -44.86 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.446 169.02 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.0 -45.88 91.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.326 -170.347 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -66.97 -25.47 66.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.315 -171.446 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.92 -32.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.381 171.762 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.829 ' O ' HD12 ' B' ' 31' ' ' ILE . 90.0 m -70.39 -45.69 65.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.276 -169.821 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.79 HD13 HG23 ' A' ' 60' ' ' ILE . 4.7 tp -59.78 -44.67 93.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.437 171.873 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.539 ' HB3' ' OE2' ' B' ' 2' ' ' GLU . . . -61.03 -10.07 5.39 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.541 177.636 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -109.71 -29.51 8.3 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.475 -176.134 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.829 HD12 ' O ' ' B' ' 27' ' ' THR . 2.8 mp -62.22 -74.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.854 164.108 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' A' ' 32' ' ' LEU . 1.4 mp -59.36 -11.4 4.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 -160.632 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -92.17 -52.82 4.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.206 -176.401 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -29.43 70.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 170.387 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 35' ' ' MET . . . . . 0.551 ' HE3' HG23 ' B' ' 31' ' ' ILE . 4.4 mtt -64.28 -45.52 87.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.356 168.376 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.62 78.43 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.84 ' HG2' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -67.08 -33.52 75.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.248 167.124 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 38' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 3.2 m-20 -72.41 -54.5 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.432 -171.836 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.826 HG23 ' O ' ' B' ' 63' ' ' ALA . 51.8 mt -60.83 -35.53 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.382 -174.797 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.704 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.89 -57.77 11.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.167 -173.008 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.456 ' HA ' ' CG2' ' B' ' 44' ' ' ILE . 43.2 p -66.18 -14.61 62.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.76 176.796 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' B' ' 68' ' ' LYS . 0.0 OUTLIER -87.56 -35.5 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.974 179.501 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -77.36 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.286 170.322 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.79 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -85.57 -61.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.56 -172.508 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HA ' ' HG3' ' B' ' 48' ' ' ARG . 2.2 mptm? -60.6 -17.57 47.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.573 172.083 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.784 HD22 ' OD1' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -61.63 -27.73 68.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.233 167.895 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.714 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -73.55 -44.34 57.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.505 ' HB2' ' NE ' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -81.07 -31.28 34.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.346 -177.906 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 49' ' ' HIS . . . . . 0.482 ' N ' ' HD2' ' B' ' 48' ' ' ARG . 6.2 t60 -60.98 -36.64 79.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 168.674 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.99 -52.83 63.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.152 165.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.87 28.37 0.74 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.533 -173.825 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.505 ' NE ' ' HB2' ' B' ' 48' ' ' ARG . 6.1 mpt_? 65.11 96.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.521 169.371 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -152.36 -73.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.433 -177.019 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.465 HG22 ' O ' ' B' ' 55' ' ' ILE . 90.5 m -165.14 148.26 8.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.298 -173.731 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.465 ' O ' HG22 ' B' ' 54' ' ' THR . 31.8 mt -94.25 147.82 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.42 168.282 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.61 -174.61 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.4 -169.602 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.4 77.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.217 -168.25 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.69 ' O ' HD22 ' B' ' 62' ' ' LEU . 2.0 tm-20 -93.97 23.49 4.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.076 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.784 ' OD1' HD22 ' B' ' 46' ' ' LEU . 0.8 OUTLIER -117.8 -17.26 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.511 166.664 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 64' ' ' VAL . 32.9 mm -92.27 -59.92 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.292 -175.58 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.645 ' HG2' HD11 ' A' ' 31' ' ' ILE . 71.2 mt-10 -60.48 -10.44 4.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.228 168.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.69 HD22 ' O ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -100.47 -14.94 18.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.876 177.952 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.826 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -102.22 5.85 40.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.553 165.184 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.999 HG11 HG12 ' A' ' 31' ' ' ILE . 55.7 t -113.83 -84.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.572 -177.576 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' NH1' ' B' ' 65' ' ' ARG . 0.4 OUTLIER -60.8 -22.36 64.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.187 -178.73 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 66' ' ' ARG . . . . . 0.465 ' HD2' ' CG ' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -82.18 -46.7 13.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 160.504 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.17 31.71 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.335 -163.947 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.554 ' HD3' ' HG ' ' B' ' 46' ' ' LEU . 4.1 tptt 62.85 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.583 178.683 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.465 ' CG ' ' HD2' ' B' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.598 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.354 166.483 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 121.067 0.461 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 15.5 mm-40 58.45 172.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.704 170.228 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -98.64 104.35 23.96 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.514 -175.908 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 2' ' ' GLU . 8.1 Cg_exo -50.45 156.19 4.36 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.503 2.135 . . . . 0.0 113.537 168.056 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -87.69 62.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.38 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -153.25 -57.42 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.696 -177.388 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.8 Cg_endo -59.35 -41.37 59.18 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.548 2.165 . . . . 0.0 113.657 170.654 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.908 HD11 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -61.41 -23.67 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.43 170.913 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.8 -57.54 18.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -167.524 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -20.92 64.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.402 -170.507 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.856 HG22 HD13 ' A' ' 12' ' ' ILE . 28.0 mt -61.65 -49.75 83.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.183 167.115 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.867 HD12 ' HB2' ' B' ' 40' ' ' ALA . 1.8 mm -96.61 45.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 -35.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.779 173.883 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.37 -31.47 70.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.929 170.419 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.04 62.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.502 170.103 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.88 33.09 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.552 -169.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -82.83 138.46 33.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.82 -50.34 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.001 -170.6 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.83 171.25 15.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.412 -168.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.797 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 17.1 m -115.24 -173.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 167.295 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.734 ' HA ' HG21 ' B' ' 54' ' ' THR . 54.0 p -90.33 -65.38 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.125 175.248 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -141.52 -34.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.71 161.761 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 47.7 m-20 -107.76 -106.15 0.34 Allowed 'General case' 0 C--O 1.253 1.277 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.657 165.048 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.797 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . 88.98 -56.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.026 1.331 . . . . 0.0 109.695 -168.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.504 ' NH1' ' HB ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.11 -21.45 46.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.647 -179.067 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -64.07 -43.26 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.806 173.618 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.637 HG22 ' CD1' ' A' ' 31' ' ' ILE . 51.2 m -60.66 -46.05 91.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.205 172.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 2.1 tp -60.82 -33.89 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.269 173.445 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.91 -26.25 62.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.384 175.279 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 28.87 2.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.528 176.373 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.977 HD13 HG21 ' B' ' 64' ' ' VAL . 66.8 mt -145.15 -64.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.109 -170.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.06 -38.64 83.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.69 177.21 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 5.0 tm-20 -86.35 -23.57 26.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.101 -169.681 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.57 19.26 6.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 173.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpp -126.21 -32.4 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.11 164.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.678 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -60.9 -40.9 98.98 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -18.77 65.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.481 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 33.0 m-20 -101.73 -18.85 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.369 -167.476 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.645 ' CG2' HG23 ' A' ' 64' ' ' VAL . 14.9 mt -80.75 -24.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.377 171.422 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -72.85 -70.04 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.396 -166.916 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -60.74 -10.0 4.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.503 -176.753 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 54.2 mm-40 -88.13 -47.66 8.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.216 177.094 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.45 -27.17 68.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.187 170.355 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.9 mt -77.95 -52.1 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.18 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -26.69 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.494 174.33 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 43' ' ' ALA . 4.6 mt -62.27 -40.5 96.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.319 176.533 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.711 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . . . -61.21 -25.56 67.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.272 -167.756 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -103.95 -25.72 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.35 -176.176 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -64.33 -37.8 88.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.339 169.473 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.33 97.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.334 168.61 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.83 18.95 14.01 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 169.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 179.18 -167.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.274 170.339 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 137.08 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.562 170.013 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' B' ' 21' ' ' SER . 86.6 m -60.82 171.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.386 167.51 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.711 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 18.8 mm -60.6 136.9 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.481 175.391 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.866 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -159.97 -178.27 6.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.366 -167.092 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -18.68 61.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.245 -171.057 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.34 -17.79 23.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.057 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 m-20 -78.23 -43.54 28.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.373 168.283 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.809 HG23 HD22 ' B' ' 28' ' ' LEU . 37.7 mm -72.22 -57.64 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.404 -170.371 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.77 -40.4 84.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.074 -166.521 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -37.47 82.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.442 170.049 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 59' ' ' ASP . . . -61.56 -16.41 47.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.438 -175.752 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.645 HG23 ' CG2' ' A' ' 39' ' ' ILE 0.256 0.4 OUTLIER -104.57 -50.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.042 -160.582 . . . . . . . . 4 4 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.69 23.8 4.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.526 -178.077 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -122.05 -55.71 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.481 -176.74 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 38' ' ' ASP . 1.5 p90 -61.26 -46.88 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.3 -163.443 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.98 158.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.415 -168.451 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.556 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.393 -169.331 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.162 0.506 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.88 161.0 40.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 -173.594 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.785 ' CD2' HD11 ' A' ' 11' ' ' ILE . 4.0 mt -74.05 138.56 75.91 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.799 -168.091 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.96 157.15 30.15 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.357 2.038 . . . . 0.0 113.221 164.703 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 5' ' ' ILE . . . . . 0.404 ' CG2' HD13 ' B' ' 26' ' ' ILE . 49.6 pt -93.02 23.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.519 178.7 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -90.87 -57.81 0.25 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.763 170.063 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.2 Cg_endo -60.7 -54.62 1.87 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.532 2.155 . . . . 0.0 113.57 173.325 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 HD12 ' B' ' 3' ' ' LEU . 28.7 mt -60.5 -13.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.498 169.901 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.41 -61.49 1.98 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -93.82 17.06 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.593 -167.13 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 3' ' ' LEU . 29.0 mt -96.73 -49.62 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 162.79 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -68.04 -38.28 79.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.211 178.557 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.8 mttt -61.57 -35.25 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.355 174.574 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.54 -34.02 76.09 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.862 -177.774 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -59.26 -52.39 65.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.433 169.385 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.79 15.82 0.3 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.221 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.83 125.72 24.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.219 164.777 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.36 -53.96 2.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.039 -167.808 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -130.55 93.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.412 171.653 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 55' ' ' ILE . 27.8 t -67.94 166.0 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.282 168.367 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 21' ' ' SER . . . . . 0.622 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 26.5 t -102.32 -166.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.388 170.39 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.31 167.36 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.284 166.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.65 -61.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.498 171.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.866 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.88 -47.07 86.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.388 -167.212 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -60.83 -12.11 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.601 178.99 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.9 mm -114.03 -15.88 9.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.645 -175.906 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.834 ' O ' HD12 ' B' ' 31' ' ' ILE . 41.4 m -73.77 -33.82 64.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.436 -171.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.809 HD22 HG23 ' A' ' 60' ' ' ILE . 2.7 mm? -62.71 -21.76 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.407 168.399 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -79.07 -12.79 60.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.382 175.032 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 4.6 mttm -95.75 -29.1 14.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.493 172.229 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 31' ' ' ILE . . . . . 0.834 HD12 ' O ' ' B' ' 27' ' ' THR . 2.9 mp -78.73 -79.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.184 170.683 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.91 -12.89 8.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.649 -161.918 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 33' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -93.39 -31.52 14.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.102 178.212 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.5 mt-10 -72.25 -29.74 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.148 169.022 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -99.45 36.24 1.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.278 172.78 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.644 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -144.94 -40.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 170.658 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -43.48 98.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.179 165.527 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.82 -38.81 92.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.438 -171.245 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 28' ' ' LEU . 9.8 mt -70.6 -37.86 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 -175.583 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.77 -64.39 0.97 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.355 -168.767 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 1.2 t -61.69 -11.21 10.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.419 -176.588 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 42' ' ' GLU . . . . . 0.754 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -88.03 -51.9 5.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.183 174.408 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.661 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -60.79 -9.63 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.364 171.23 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 17' ' ' ALA . 57.9 mt -99.11 -54.37 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.127 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -23.67 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.343 -177.658 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.928 HD22 HD23 ' B' ' 62' ' ' LEU . 12.1 mt -60.71 -48.36 82.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.373 170.791 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.9 -60.32 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.371 171.303 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -20.64 62.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.365 -169.612 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.5 -44.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 169.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 -51.7 59.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 29.6 5.37 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 169.347 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.62 -171.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.3 169.854 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 64.34 163.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.439 -178.056 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.734 HG21 ' HA ' ' A' ' 21' ' ' SER . 6.1 t -88.52 -167.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.382 -169.399 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.661 HD12 ' O ' ' B' ' 43' ' ' ALA . 10.6 mm -100.63 142.6 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.327 173.146 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.528 ' HE2' ' H ' ' B' ' 57' ' ' ALA . 1.9 tmtt? -160.56 172.52 17.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.312 -165.132 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.528 ' H ' ' HE2' ' B' ' 56' ' ' LYS . . . -61.72 -33.23 73.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.369 -168.444 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 56' ' ' LYS . 1.8 pt-20 -83.62 15.7 3.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 177.705 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -130.65 -20.79 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.54 167.303 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 60' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 28' ' ' LEU . 10.1 mm -79.49 -50.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 20.4 mt-10 -61.31 -39.46 90.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.027 166.212 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.928 HD23 HD22 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -62.22 -32.2 72.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.508 178.351 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.577 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -81.03 -35.68 31.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.207 175.054 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.977 HG21 HD13 ' A' ' 31' ' ' ILE . 19.9 t -62.39 -79.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.637 175.652 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -58.99 -12.73 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.664 -164.239 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -60.42 -26.0 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.512 171.501 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG3' ' B' ' 42' ' ' GLU . 17.4 m-85 -88.01 -50.41 6.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.409 -175.404 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -134.27 119.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.39 -172.315 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.587 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.306 170.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.252 1.187 0 CA-C-O 122.016 0.912 . . . . 0.0 112.553 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.642 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.5 Cg_endo -56.74 140.3 90.59 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.751 2.301 . . . . 0.0 113.49 171.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.2 -14.11 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.456 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.23 -55.37 3.78 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.653 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 15.5 Cg_exo -49.77 -49.59 15.51 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.655 2.237 . . . . 0.0 113.644 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 3' ' ' LEU . 63.0 mt -61.25 -45.74 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.521 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.05 59.23 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.37 -29.44 18.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.475 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.595 HD13 ' HG2' ' B' ' 33' ' ' GLU . 27.8 mt -61.5 -57.63 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.309 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' B' ' 40' ' ' ALA . 10.9 mm -61.21 -36.19 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.331 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mttm -62.98 -36.68 84.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.444 170.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.63 -34.02 76.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.753 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.376 169.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.42 20.61 0.34 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.691 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.21 149.34 33.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.401 166.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.23 -55.17 2.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 111.59 10.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' B' ' 55' ' ' ILE . 94.3 t -133.04 132.15 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.384 -169.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.4 p -65.92 157.17 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.351 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.92 -18.56 63.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.428 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.629 ' HA ' HG22 ' A' ' 26' ' ' ILE . 24.2 m-20 -81.0 -34.57 32.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.455 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' B' ' 60' ' ' ILE . . . -61.52 -40.36 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.192 166.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -40.51 90.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.333 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 23' ' ' ASP . 7.3 tt -81.39 -34.88 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.375 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.477 HG22 HG22 ' B' ' 60' ' ' ILE . 84.9 m -63.58 -45.96 88.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.091 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HG13 ' B' ' 60' ' ' ILE . 3.3 tp -60.36 -42.84 96.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.289 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.53 -42.93 99.54 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.268 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -78.62 -27.15 45.43 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.384 -176.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.735 HG21 HG21 ' B' ' 64' ' ' VAL . 23.3 mt -61.42 -73.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 166.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -59.53 -26.66 65.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.848 -166.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.894 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.52 -48.14 14.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.081 -176.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 2.5 mt-10 -63.98 -26.41 68.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.017 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.532 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 13.5 ttm -71.92 -43.49 65.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.452 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -65.06 -45.33 92.39 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -60.69 -22.16 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.39 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.07 -54.83 5.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.489 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 64' ' ' VAL . 10.1 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.208 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -61.24 -54.24 46.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.309 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 44' ' ' ILE . 84.3 p -61.48 -28.17 69.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.393 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 46' ' ' LEU . 1.2 mm-40 -62.06 -56.37 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.061 165.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -65.18 -4.52 5.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.023 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.839 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -94.1 -56.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.248 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -62.49 -17.12 58.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.74 167.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 42' ' ' GLU . 5.1 mp -67.18 -61.03 2.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.112 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.53 -14.21 18.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.462 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . 18.4 ttt-85 -97.41 -23.21 16.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.016 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -36.1 76.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.051 163.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -67.3 -56.76 8.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 161.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.96 -14.05 21.79 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.358 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 172.47 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.785 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.66 28.81 0.0 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.991 164.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.784 HG23 ' O ' ' B' ' 19' ' ' ARG . 100.0 m 63.45 150.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.407 177.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.793 ' HB ' HG13 ' B' ' 20' ' ' VAL . 9.6 mm -69.73 134.25 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.014 169.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.802 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 41.1 mtmt -142.38 175.31 9.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.504 -164.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -63.86 -55.13 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.289 -173.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 3.4 mt-10 -68.5 -16.05 63.75 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.992 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -72.05 -39.3 69.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.325 172.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.823 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.83 -56.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.501 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 22.1 mt-10 -60.6 -43.22 97.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.877 -161.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.03 -45.45 94.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.468 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.54 -29.09 69.79 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.452 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.748 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -86.22 -52.2 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.62 -168.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -18.73 60.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.589 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -76.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.316 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.184 -162.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 8' ' ' ILE . 18.9 mt . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.481 0.658 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.496 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 7.9 Cg_endo -48.81 138.09 26.62 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.16 1.907 . . . . 0.0 113.353 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.655 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -80.91 -11.33 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.627 -165.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.45 -56.47 6.54 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.764 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 3.7 Cg_endo -58.74 -48.83 13.35 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 122.504 2.136 . . . . 0.0 113.499 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.93 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.8 mt -60.89 -21.11 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.321 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.82 -53.55 44.31 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.6 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 10.7 mtp-105 -79.28 -21.56 45.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.372 -172.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 3' ' ' LEU . 64.0 mt -61.36 -57.6 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.153 165.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.956 HG23 ' HB1' ' A' ' 40' ' ' ALA . 5.6 mt -78.55 -12.93 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.944 -172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtmm -68.47 -40.38 81.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 162.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.35 -32.98 73.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.876 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.48 -52.06 66.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.554 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.9 25.61 0.26 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.732 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.839 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -77.94 145.48 36.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.289 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.725 162.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 66.53 100.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.423 -163.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.793 HG13 ' HB ' ' A' ' 55' ' ' ILE . 12.7 t -100.91 169.27 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 20' ' ' VAL . 15.1 t -117.14 141.52 48.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.393 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.602 ' O ' HD12 ' B' ' 26' ' ' ILE . 0.3 OUTLIER -60.87 -27.48 68.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.332 -167.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -60.89 -40.12 91.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.464 172.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -63.84 -57.97 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.466 ' HB3' ' CG2' ' B' ' 5' ' ' ILE . 0.0 OUTLIER -61.06 -33.25 73.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.388 -167.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 22' ' ' ASP . 21.7 mt -82.18 -38.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.449 -173.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.436 ' C ' HD12 ' B' ' 31' ' ' ILE . 85.3 m -61.26 -47.07 87.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.887 HD23 HD11 ' B' ' 12' ' ' ILE . 4.4 tp -60.49 -47.83 84.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.382 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 3' ' ' LEU . . . -61.31 -27.1 68.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.373 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -36.18 40.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.389 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.748 HG21 HG21 ' A' ' 64' ' ' VAL . 4.9 mt -61.14 -72.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.051 172.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 28' ' ' LEU . 3.0 mp -60.06 -31.99 70.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 -165.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' A' ' 11' ' ' ILE . 3.3 tm-20 -76.82 -33.61 57.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.061 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.2 89.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.064 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.64 -43.5 80.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.527 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.61 -40.33 97.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.5 -32.9 71.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.429 171.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -63.73 -56.88 12.23 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.539 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.88 HD13 HG23 ' B' ' 64' ' ' VAL . 5.0 mt -62.52 -26.38 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.787 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.648 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.88 -70.53 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.317 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.9 OUTLIER -62.14 -17.29 57.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.371 -173.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.646 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -73.36 -59.04 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.067 170.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.8 -14.45 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.679 HD11 ' HB2' ' A' ' 17' ' ' ALA . 62.8 mt -94.3 -54.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.97 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -60.46 -14.88 21.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.373 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.726 HD21 ' NH2' ' B' ' 66' ' ' ARG . 16.8 mt -75.83 -53.81 7.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.465 169.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.23 -16.43 61.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.27 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -34.57 14.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.373 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.65 -34.26 74.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.12 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.336 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.3 12.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.31 -176.34 2.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.009 -0.595 . . . . 0.0 110.431 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -115.07 -46.29 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.336 -170.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -87.45 117.54 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.42 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.771 HG23 ' HB2' ' B' ' 59' ' ' ASP . 9.8 mt -78.72 143.55 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.327 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.476 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 2.1 mtmp? -125.92 177.33 6.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.455 -167.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.57 -21.37 64.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.273 170.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 30.2 tt0 -69.08 -48.61 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.044 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' B' ' 55' ' ' ILE . 7.6 m-20 -63.51 -37.49 87.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.4 -168.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.829 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -62.7 -39.13 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.777 163.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -62.28 -39.46 93.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -170.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 62' ' ' LEU . 22.9 mt -84.53 -39.26 19.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.479 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.49 -49.18 78.59 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.393 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.88 HG23 HD13 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -72.66 -52.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.015 -170.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -60.3 -31.45 70.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . 0.726 ' NH2' HD21 ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.31 -40.36 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.325 178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 14.8 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.336 169.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 8' ' ' ILE . 4.9 mt . . . . . 0 C--O 1.243 0.739 0 CA-C-O 121.241 0.543 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -46.66 141.34 11.34 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.387 2.058 . . . . 0.0 113.438 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.3 pt -89.83 17.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.975 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.0 -55.98 0.65 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.627 166.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.6 Cg_endo -60.05 -54.64 2.12 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.659 2.239 . . . . 0.0 113.575 171.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 11' ' ' ILE . 23.8 mt -65.02 -45.25 95.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.361 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.58 62.3 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -88.02 -27.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.8 mt -62.07 -55.27 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 169.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' B' ' 40' ' ' ALA . 10.0 mm -67.89 -36.21 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.33 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -33.27 72.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.286 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -62.43 -34.66 77.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.824 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.779 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.56 -52.35 65.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.435 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.79 23.88 0.35 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.544 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 150.57 32.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.436 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -122.55 -75.32 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.033 -167.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -121.92 104.97 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.434 -174.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' NH2' ' A' ' 25' ' ' ARG . 19.8 t -116.13 150.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.323 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -87.79 148.84 24.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.365 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -60.95 -20.14 61.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.375 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -60.8 -54.73 41.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.441 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.913 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -62.22 -42.61 99.47 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.385 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.978 ' NH2' HG21 ' A' ' 20' ' ' VAL . 4.6 mmt85 -61.71 -46.12 91.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.354 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.31 -32.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.451 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.696 HG22 HG21 ' B' ' 60' ' ' ILE . 97.1 m -60.95 -44.33 97.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.497 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.892 HD22 HG13 ' B' ' 60' ' ' ILE . 7.4 tp -83.43 -14.07 53.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.078 -172.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -81.73 -21.76 37.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.407 163.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 33' ' ' GLU . 6.3 tttt -88.57 -31.14 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.37 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.017 HG21 HG21 ' B' ' 64' ' ' VAL . 3.1 mp -61.08 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.658 159.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 32' ' ' LEU . 4.3 mm? -59.04 -14.86 10.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.634 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HG3' HD12 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -71.02 -69.11 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.699 163.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.8 -32.3 71.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.097 -167.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.466 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -66.42 -34.92 79.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.433 166.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.23 -53.96 12.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' B' ' 15' ' ' ALA . 0.0 OUTLIER -64.31 -26.09 68.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.458 173.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 15.0 m-20 -60.89 -62.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.477 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.697 HG21 HG23 ' A' ' 64' ' ' VAL . 3.2 mt -62.59 -17.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.583 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -80.78 -69.17 0.62 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.254 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -61.04 -13.57 17.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.459 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -73.2 -63.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.077 166.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -60.93 -11.26 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.556 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -93.28 -49.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.803 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -60.28 -33.12 71.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.395 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 43' ' ' ALA . 15.6 mt -60.34 -42.72 96.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.334 166.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -61.23 -54.36 45.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.277 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -68.09 -14.94 63.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.431 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -71.27 -56.54 5.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.219 172.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.34 24.08 0.23 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.909 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' NE ' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 55.21 -162.71 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 O-C-N 122.184 -0.598 . . . . 0.0 111.428 158.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.602 ' H ' ' NE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER 70.23 -81.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.559 -165.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 m -115.45 137.87 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.379 -160.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 47' ' ' ALA . 8.3 mm -94.28 137.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.164 161.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 167.42 23.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.547 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.261 -167.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.1 -42.86 99.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.942 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.8 -45.42 94.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.5 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.818 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.0 mm -66.86 -47.2 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.401 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.68 -33.89 74.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HB3' HD13 ' A' ' 46' ' ' LEU . 1.7 mp -61.23 -53.85 51.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.384 175.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.02 -49.46 77.3 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.328 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -67.37 -53.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.931 -164.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -20.26 66.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.818 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -43.87 98.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.255 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 43.0 m-85 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.465 168.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.846 HD22 HD11 ' A' ' 11' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HG2' ' B' ' 7' ' ' PRO . 19.3 Cg_endo -62.09 143.37 94.71 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.397 2.064 . . . . 0.0 113.463 164.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.451 HD12 ' NH2' ' B' ' 25' ' ' ARG . 12.2 pt -108.23 -14.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.444 -167.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -77.0 -54.76 1.51 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.682 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 17.2 Cg_exo -50.23 -46.48 28.49 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.722 2.281 . . . . 0.0 113.617 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.6 -47.61 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.459 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.84 -29.07 71.28 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.552 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -89.19 -19.99 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.332 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 33' ' ' GLU . 46.1 mm -61.61 -48.39 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.106 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.8 mm -70.22 -39.27 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.711 -174.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.1 OUTLIER -60.44 -43.11 97.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.442 169.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.96 -31.99 72.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.857 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -53.62 56.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.492 169.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.48 20.83 0.61 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.45 119.88 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.272 167.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.94 -61.18 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.057 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 108.83 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.468 167.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' B' ' 12' ' ' ILE . 11.6 t -75.17 114.47 15.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.232 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -60.73 151.59 29.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.409 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.467 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 60.2 m-20 -61.59 -19.23 61.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.363 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 26' ' ' ILE . 2.3 t0 -89.42 -26.08 21.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.32 -175.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -63.78 -47.74 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.251 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 12.6 ptt180 -71.4 -29.14 64.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.402 -169.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.724 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -73.13 -42.21 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.443 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.779 ' O ' HD12 ' B' ' 31' ' ' ILE . 67.1 m -60.93 -37.57 82.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.242 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.818 HD22 ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.106 167.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -62.86 -32.57 73.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.27 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -69.94 -45.14 68.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.587 174.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.779 HD12 ' O ' ' B' ' 27' ' ' THR . 3.2 mt -61.15 -73.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.211 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -55.55 -28.51 55.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.32 -167.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.605 ' HB2' HD11 ' B' ' 3' ' ' LEU . 8.0 tp10 -65.24 -57.8 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.88 -38.2 87.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.986 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 22.1 mmm -72.0 -38.24 69.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.54 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.11 -40.71 95.14 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.5 mtp85 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.388 170.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.3 OUTLIER -65.26 -58.86 4.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.511 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.637 HG12 HG23 ' B' ' 64' ' ' VAL . 4.1 mt -61.51 -31.71 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.339 -173.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.92 -70.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.244 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.779 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 16.1 t -62.27 -12.42 20.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.444 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.511 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 1.2 mp0 -93.84 -48.24 6.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.175 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.55 -10.89 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.378 167.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 17' ' ' ALA . 56.7 mt -100.74 -49.15 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.793 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.01 -11.38 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.454 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.76 HD22 HD23 ' B' ' 62' ' ' LEU . 8.1 mt -84.1 -59.52 2.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.422 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -60.69 -18.21 52.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.523 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.11 -28.48 20.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.052 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -60.23 -35.7 76.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.174 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -65.48 -55.59 17.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.998 162.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 2.98 44.76 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.762 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 178.71 -163.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.638 -166.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt 76.02 -93.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.535 HG22 ' O ' ' B' ' 55' ' ' ILE . 99.7 m -172.08 168.81 5.74 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.824 -0.548 . . . . 0.0 109.955 -160.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' B' ' 47' ' ' ALA . 7.3 mm -114.74 135.41 54.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.903 155.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -147.22 -177.46 5.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 -165.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -61.74 -15.49 41.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.346 -176.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 1.8 tp10 -100.76 -30.15 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.047 -170.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -36.36 79.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.136 167.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.892 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.39 -64.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.814 162.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -61.08 -22.46 64.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 -163.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.76 HD23 HD22 ' B' ' 46' ' ' LEU . 5.2 tp -86.67 -39.67 15.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.458 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.84 -36.17 78.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.355 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -88.15 -45.1 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.876 -166.167 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.38 -27.17 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.53 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.5 95.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.107 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 18.3 m-85 . . . . . 0 N--CA 1.455 -0.195 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 162.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' B' ' 11' ' ' ILE . 2.5 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.267 0.556 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.29 144.31 95.14 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.484 2.123 . . . . 0.0 113.52 164.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.852 HG21 HG12 ' A' ' 26' ' ' ILE . 2.2 pp -107.84 16.54 7.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.879 -169.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.84 -55.87 0.51 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.699 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -61.09 -42.49 35.9 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.555 2.17 . . . . 0.0 113.561 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' HD12 ' A' ' 11' ' ' ILE . 25.7 mt -60.63 -35.04 60.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.472 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -46.82 93.46 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.585 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -18.57 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.347 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 8' ' ' ILE . 93.6 mt -60.91 -40.22 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.162 163.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.933 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.8 mt -93.22 -25.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.51 -162.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -64.02 -36.88 85.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.05 -32.97 74.71 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.088 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.02 -52.36 65.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.509 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' C ' HG21 ' B' ' 44' ' ' ILE . . . 138.7 28.51 0.25 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.978 -1.464 . . . . 0.0 110.713 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -75.18 127.77 33.96 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.531 -175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.22 -25.47 11.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.96 107.71 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.462 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' HB1' ' A' ' 17' ' ' ALA . 18.7 t -120.14 133.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.418 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 p -70.64 157.18 38.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.351 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.3 m-20 -60.64 -33.3 72.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.406 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -44.61 96.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.429 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' B' ' 55' ' ' ILE . . . -62.98 -52.66 62.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.24 -174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.717 ' NH1' HD13 ' A' ' 5' ' ' ILE . 8.9 ptt180 -79.17 -14.23 59.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.38 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.852 HG12 HG21 ' A' ' 5' ' ' ILE . 37.3 mt -96.81 -32.16 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.4 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.877 HG22 HG22 ' B' ' 60' ' ' ILE . 58.6 m -60.43 -35.4 75.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 168.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 12' ' ' ILE . 3.5 tp -60.01 -48.44 81.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.294 165.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.8 69.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.386 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.57 -40.75 15.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.444 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.498 HD12 ' CG2' ' B' ' 60' ' ' ILE . 18.4 mt -59.79 -69.37 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.982 171.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.529 HD11 ' N ' ' B' ' 36' ' ' GLY . 2.7 tt -59.38 -31.2 69.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.846 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.05 -53.74 51.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.007 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 58.4 tt0 -64.59 -20.95 66.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.958 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.47 ' HB3' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -63.06 -44.59 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 160.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -61.28 -51.96 54.74 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.699 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 8.3 ptm180 -61.46 -27.41 68.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.208 -0.496 . . . . 0.0 109.904 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t70 -59.83 -54.44 46.21 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.669 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.804 ' HB ' HD11 ' B' ' 28' ' ' LEU . 1.7 mt -62.44 -37.49 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.776 -174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.12 -68.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.401 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.7 t -62.52 -31.75 72.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.152 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.13 -53.6 54.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.227 171.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -69.66 -13.25 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.528 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -83.77 -55.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.197 -168.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -16.74 59.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.574 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 66' ' ' ARG . 11.4 mt -61.3 -45.11 95.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.16 166.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.696 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -79.85 -24.36 41.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.253 -167.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -79.32 -52.5 8.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.494 178.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.05 66.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.71 -55.96 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.178 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 6.95 0.08 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.755 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.21 80.05 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.616 0.722 . . . . 0.0 112.182 162.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 -68.36 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.143 165.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.619 HG21 ' HB2' ' B' ' 21' ' ' SER . 6.0 t -138.13 -169.37 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.049 164.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.98 HG13 HG22 ' B' ' 20' ' ' VAL . 9.0 mm -100.93 135.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.738 161.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' NZ ' HG22 ' A' ' 54' ' ' THR . 3.4 mttt -136.29 159.78 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.527 -164.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.89 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.26 -20.42 62.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.307 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.29 -59.23 4.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.979 165.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 1.3 m-20 -66.51 -40.47 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.392 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.883 HG23 HD13 ' B' ' 28' ' ' LEU . 16.8 mm -61.93 -56.56 16.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.396 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' B' ' 31' ' ' ILE . 14.6 mt-10 -61.67 -19.48 62.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -64.26 -53.94 41.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.322 167.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -61.06 -31.35 71.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.353 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 50.2 t -62.45 -67.72 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.6 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -60.52 -12.84 10.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.749 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.57 ' CD ' HD21 ' A' ' 46' ' ' LEU . 1.1 tpm_? -79.47 -36.95 37.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.14 -170.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' CZ ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.452 158.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.924 ' HB3' HD12 ' B' ' 8' ' ' ILE . 17.8 mt . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.474 0.654 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 7.3 Cg_exo -46.33 148.78 3.01 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.612 2.208 . . . . 0.0 113.389 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' B' ' 8' ' ' ILE . 1.8 pp -66.89 -10.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.467 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -87.86 -56.9 0.31 Allowed Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.868 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.3 Cg_endo -60.3 -39.96 62.97 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.609 2.206 . . . . 0.0 113.463 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.924 HD12 ' HB3' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.72 -55.78 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.829 167.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.05 -17.11 50.9 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.894 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HE3' ' B' ' 13' ' ' LYS . 6.1 ttm105 -82.06 -37.93 25.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.295 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 3' ' ' LEU . 64.6 mt -58.31 -50.36 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.9 164.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.958 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.6 mm -68.72 -30.18 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.322 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' B' ' 10' ' ' ARG . 17.5 mtmt -61.98 -38.45 88.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.181 170.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -61.16 -30.56 70.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.884 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.83 -52.04 67.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.508 169.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.38 34.74 0.6 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.59 -164.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 44' ' ' ILE . . . -83.32 149.21 26.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.278 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.05 -25.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.984 169.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -106.21 34.24 3.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.307 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 55' ' ' ILE . 22.6 t -82.34 138.15 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.253 167.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.619 ' HB2' HG21 ' A' ' 54' ' ' THR . 31.2 t -80.05 152.31 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.386 163.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.2 -15.25 32.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.5 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.481 ' O ' HG22 ' B' ' 26' ' ' ILE . 9.2 t70 -90.31 -29.3 18.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.389 -171.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.704 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -68.28 -44.27 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.207 167.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -61.82 -43.98 97.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.279 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.482 ' CD1' ' HD3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -62.9 -49.5 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.256 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -62.27 -29.13 70.2 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.949 -170.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.883 HD13 HG23 ' A' ' 60' ' ' ILE . 3.8 tp -61.82 -42.73 99.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.943 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -64.12 -34.76 78.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.446 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -83.94 -41.51 17.28 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.687 -175.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.538 HD12 ' O ' ' B' ' 27' ' ' THR . 21.8 mt -60.45 -65.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.048 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.97 HD11 ' HA2' ' A' ' 36' ' ' GLY . 5.2 mt -55.81 -23.01 27.65 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.234 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.1 OUTLIER -61.6 -62.63 1.68 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.663 169.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.35 -20.95 63.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.888 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.5 mmt -66.32 -48.82 69.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.176 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -61.01 -46.04 95.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.911 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -33.93 74.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.255 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -59.74 -61.69 2.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.974 173.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.742 ' HB ' HD11 ' A' ' 28' ' ' LEU . 3.1 mt -61.14 -41.35 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.241 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.933 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -67.2 -53.44 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.308 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.581 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 30.6 t -63.82 -30.36 71.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.53 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.687 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 1.4 tm-20 -62.03 -62.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.904 170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -60.92 -9.88 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.601 HD12 ' C ' ' B' ' 40' ' ' ALA . 39.1 mt -95.07 -48.23 12.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.783 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.05 -16.29 30.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.336 166.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.7 mt -82.84 -46.64 12.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -76.53 -32.66 58.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.247 -173.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -80.45 -32.67 37.2 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.367 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -60.4 -35.89 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.268 168.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.82 -50.39 73.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.18 165.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 41.26 23.55 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -130.61 -173.76 3.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.405 -167.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.513 ' O ' HG22 ' B' ' 54' ' ' THR . 5.0 mtmm -75.04 98.06 3.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.48 -165.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.8 t 60.34 -176.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.952 166.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.3 mt -112.05 142.24 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.428 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.546 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 3.3 mmmt -125.11 -176.68 3.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.384 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.3 93.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.289 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -31.43 71.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.256 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.546 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 3.1 m-20 -80.22 -36.38 34.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.409 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 27' ' ' THR . 1.0 OUTLIER -64.2 -47.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.607 174.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 7.9 mt-10 -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.138 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 8.6 tp -64.47 -51.93 60.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.378 171.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -66.88 -32.95 74.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 60' ' ' ILE . 41.5 t -61.54 -67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.715 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.59 4.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.772 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -73.97 -39.45 63.7 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.069 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' HG12 ' B' ' 39' ' ' ILE . 12.3 m-85 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.493 164.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HG2' ' HG3' ' A' ' 7' ' ' PRO . 7.5 Cg_endo -46.22 139.13 12.49 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.444 2.096 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.28 -8.26 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.915 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.25 -57.8 6.85 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.663 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -51.87 -60.39 0.79 Allowed 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.615 2.21 . . . . 0.0 113.584 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 3' ' ' LEU . 26.4 mt -61.02 -49.09 86.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.521 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.05 -22.88 63.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -171.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -82.74 -35.34 26.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.364 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.942 HG23 ' HG3' ' B' ' 37' ' ' ARG . 62.6 mt -59.69 -58.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.648 166.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.037 HG22 ' HB2' ' A' ' 17' ' ' ALA . 5.5 mm -61.94 -20.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.063 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 18' ' ' GLU . 3.6 mmmt -74.63 -36.77 62.91 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.299 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.85 -32.76 73.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.821 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.1 -53.41 58.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.383 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.51 17.62 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.316 -167.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -66.51 -163.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.678 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 61.6 24.2 14.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.612 -158.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -110.78 22.63 15.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 154.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.781 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 14.6 t -117.35 176.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.192 -162.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.605 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.6 t -125.08 168.37 13.47 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.526 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 65.6 m-20 -61.8 -25.75 67.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 3.4 t0 -61.19 -55.96 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.447 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -62.12 -52.73 62.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.329 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -61.07 -37.37 82.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.263 -168.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.38 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.422 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 31' ' ' ILE . 82.9 m -61.05 -44.7 97.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.245 -168.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.615 HD22 HG12 ' B' ' 60' ' ' ILE . 4.5 tp -59.79 -45.66 91.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.34 171.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -16.82 44.68 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.494 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 1.3 tptp -101.32 -26.15 13.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.326 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 27' ' ' THR . 1.6 mp -60.6 -68.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.792 161.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' B' ' 32' ' ' LEU . 3.7 mm? -58.48 -34.72 71.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.743 -168.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -74.24 -50.2 20.1 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.001 -175.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.0 tt0 -61.7 -44.09 97.59 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.952 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -35.16 75.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.574 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.37 -49.32 32.69 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -60.3 -14.28 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.417 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.4 t0 -88.8 -47.13 8.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.52 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.757 HD12 HD11 ' B' ' 32' ' ' LEU . 20.5 mt -60.64 -30.73 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.285 170.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.72 -74.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.304 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.94 -18.9 61.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.462 -174.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.9 mm-40 -69.22 -61.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.013 167.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -9.96 5.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.587 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.8 mt -94.26 -52.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.946 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -60.32 -10.65 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.487 167.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.8 mp -82.96 -47.05 12.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.217 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.19 96.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.355 167.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -54.53 27.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.375 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.48 -28.78 68.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.332 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.07 92.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.317 169.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.66 17.83 2.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HD3' ' NZ ' ' A' ' 56' ' ' LYS . 4.4 mmp_? -98.77 -167.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.4 -171.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -127.23 -37.05 2.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.398 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 ' O ' ' B' ' 19' ' ' ARG . 31.1 m -101.41 149.55 23.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.424 -168.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 44' ' ' ILE . 13.9 mm -91.44 137.8 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.365 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' NZ ' ' HD3' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -138.74 175.46 9.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.66 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.227 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.58 -40.47 69.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.111 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -33.67 71.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.399 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.652 ' CG1' ' HB1' ' B' ' 24' ' ' ALA . 44.5 mm -61.15 -69.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.29 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -61.66 -12.09 14.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.269 -170.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mt -75.47 -48.93 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.391 168.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -64.24 -35.72 81.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.361 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.001 HG21 HD13 ' B' ' 31' ' ' ILE . 25.0 t -66.09 -72.01 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.65 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -59.66 -11.16 4.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -169.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -29.36 14.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.367 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.514 ' CE2' HG12 ' A' ' 39' ' ' ILE . 1.5 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.445 163.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.661 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 2.4 Cg_endo -57.88 163.26 9.65 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.476 2.117 . . . . 0.0 113.509 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 pt -86.21 -25.25 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.4 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.64 -59.88 4.32 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.781 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 1.2 Cg_endo -54.48 -48.72 19.9 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 C-N-CA 122.498 2.132 . . . . 0.0 113.517 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' B' ' 3' ' ' LEU . 38.9 mt -61.03 -43.73 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.369 169.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -16.18 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.7 OUTLIER -96.38 -26.76 15.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.359 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -61.27 -56.02 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.325 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 40' ' ' ALA . 9.8 mm -64.04 -36.11 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.168 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.8 OUTLIER -62.68 -36.9 84.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.435 171.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.57 -34.2 76.5 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.777 -1.102 . . . . 0.0 109.817 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -59.26 -53.34 59.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.488 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.58 19.93 0.35 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.806 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.2 120.9 10.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.311 -0.445 . . . . 0.0 110.335 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.27 -74.65 0.34 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.048 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.669 ' O ' HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -122.19 109.25 14.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.407 -169.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.66 HG21 HH21 ' B' ' 25' ' ' ARG . 47.5 t -112.14 150.27 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.74 150.04 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.311 169.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.454 ' O ' HD12 ' B' ' 26' ' ' ILE . 2.4 p30 -60.85 -12.97 12.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.357 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -55.35 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -61.98 -40.69 96.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.304 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.66 HH21 HG21 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -61.61 -45.39 94.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.456 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.454 HD12 ' O ' ' B' ' 22' ' ' ASP . 51.8 mt -77.73 -21.56 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.422 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.754 HG22 HD11 ' B' ' 31' ' ' ILE . 88.3 m -72.79 -50.58 23.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.312 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' B' ' 31' ' ' ILE . 3.2 tp -59.19 -37.86 78.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.561 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.09 75.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.32 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -26.42 23.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.43 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 1.001 HD13 HG21 ' A' ' 64' ' ' VAL . 67.5 mt -61.04 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.033 170.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD12 ' A' ' 32' ' ' LEU . 7.2 mp -60.03 -38.34 82.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.715 -170.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.574 ' HG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.37 -30.09 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.929 -170.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.02 -45.45 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.122 167.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 33.9 mtt -61.43 -42.33 98.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.517 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.07 99.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -170.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.942 ' HG3' HG23 ' A' ' 11' ' ' ILE . 2.4 mtp180 -60.43 -35.35 75.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.552 171.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -77.95 -45.7 23.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.499 -167.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.614 HD13 ' CG2' ' B' ' 64' ' ' VAL . 11.9 mt -60.85 -35.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.099 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.905 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.65 -59.55 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.341 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.501 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 72.0 p -68.79 -24.33 64.39 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.224 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.588 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.5 OUTLIER -61.19 -55.93 26.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.041 165.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.468 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -65.82 -13.68 59.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.602 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.825 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -87.62 -56.46 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.309 -164.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -72.26 -17.29 61.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.467 172.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.507 HD12 ' C ' ' B' ' 42' ' ' GLU . 8.3 mt -60.83 -44.16 97.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.369 167.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.859 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.15 -44.02 97.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.362 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -50.99 25.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.43 -171.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -61.54 -34.29 75.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.32 91.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.335 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.1 29.99 5.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -110.46 135.63 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.404 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.88 -42.95 47.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.382 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 7.0 m -111.07 119.8 40.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.399 -168.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.859 HG12 ' HB2' ' B' ' 47' ' ' ALA . 79.9 mt -76.74 139.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.291 168.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.904 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 5.5 mtmt -141.8 -170.33 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.463 -169.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.76 -33.36 73.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.241 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -30.43 69.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.064 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.73 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.6 OUTLIER -84.19 -39.14 19.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.415 -166.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -65.2 -42.19 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.216 162.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 3.8 mt-10 -61.53 -31.15 71.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.977 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.7 -33.27 18.8 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.357 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.54 -42.9 97.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.436 172.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.44 -52.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -164.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.28 78.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.799 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.98 -17.93 54.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.9 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.327 173.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.84 ' CB ' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.4 Cg_endo -57.68 162.66 10.21 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.614 2.21 . . . . 0.0 113.545 170.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -84.82 -15.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.526 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.42 -58.59 14.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.762 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.5 Cg_endo -59.3 -57.65 0.85 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.595 2.197 . . . . 0.0 113.619 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.5 mt -61.71 -43.33 97.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.372 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' A' ' 25' ' ' ARG . . . -61.74 -41.06 99.56 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -72.82 -18.47 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.455 -174.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG23 ' HD2' ' B' ' 37' ' ' ARG . 69.7 mt -77.67 -41.18 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.53 172.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.5 mm -63.99 -43.96 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.149 171.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.8 mttt -62.07 -35.68 79.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.244 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.49 -31.15 71.12 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.845 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.63 -52.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.521 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.1 24.6 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.493 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -60.91 120.27 9.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.314 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -90.35 -48.02 7.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.189 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.52 90.43 2.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.501 168.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' B' ' 55' ' ' ILE . 97.8 t -96.41 129.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.126 166.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 p -60.84 146.2 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.546 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -61.16 -21.97 64.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.34 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.14 -27.17 64.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.42 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.797 ' O ' HG22 ' A' ' 27' ' ' THR . . . -78.06 -41.76 34.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.288 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -60.7 -45.7 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.503 172.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 19.9 mt -66.55 -27.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.437 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 24' ' ' ALA . 1.3 t -76.5 -33.19 58.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.228 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.771 HD22 HG21 ' B' ' 60' ' ' ILE . 1.1 mm? -59.9 -39.13 84.34 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.434 170.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -61.49 -42.05 98.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.396 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -25.69 24.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.415 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 27' ' ' THR . 17.4 mt -61.42 -72.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.925 165.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.816 -167.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HG3' HD11 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.29 -55.69 22.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 170.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.77 -32.82 73.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.966 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.521 ' HB3' HD21 ' B' ' 32' ' ' LEU . 3.0 tpp -66.36 -44.83 82.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.414 167.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.24 99.14 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -35.17 75.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.195 -0.503 . . . . 0.0 110.427 169.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -61.42 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.533 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 HG22 ' A' ' 64' ' ' VAL . 8.7 mt -61.79 -31.78 51.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.353 -171.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -66.86 -61.18 2.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.253 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.519 ' CB ' ' HB1' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -60.87 -10.52 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.412 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -81.37 -57.94 3.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.412 169.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 59' ' ' ASP . . . -66.01 -5.47 9.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.818 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.94 HD11 ' HB2' ' B' ' 17' ' ' ALA . 77.5 mt -85.95 -65.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.906 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -21.96 64.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.951 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 42' ' ' GLU . 8.4 mp -60.01 -57.18 13.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.21 158.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.746 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.87 -42.76 99.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.236 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -56.57 13.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.472 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -64.45 -23.7 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.419 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.11 -55.71 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.016 164.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.27 19.67 0.26 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 113.85 -1.523 . . . . 0.0 111.035 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.64 -167.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.358 -0.495 . . . . 0.0 111.012 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 98.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 -164.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.4 m 71.65 117.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.622 165.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.913 HD11 HG12 ' A' ' 44' ' ' ILE . 14.6 mt -71.76 147.72 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.614 157.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 27.9 mttt -141.97 160.63 39.83 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.323 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.99 -28.0 69.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.704 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -61.38 -41.02 96.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.977 166.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.842 ' CG ' ' HB1' ' A' ' 43' ' ' ALA 0.268 0.0 OUTLIER -67.6 -40.41 84.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.352 -173.865 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.903 HG23 HD13 ' B' ' 28' ' ' LEU . 45.7 mm -73.14 -36.12 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.288 -169.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -87.48 -17.56 31.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.157 177.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 58' ' ' GLU . 3.8 mm? -72.16 -47.17 52.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.104 164.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -64.84 -42.65 94.76 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.063 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.036 HG21 HD13 ' B' ' 31' ' ' ILE . 23.9 t -61.22 -73.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.616 171.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.85 -11.05 6.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.387 -167.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HD2' HD21 ' A' ' 46' ' ' LEU . 7.4 mtt180 -70.4 -47.58 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.314 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.311 167.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.815 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.547 0.842 0 CA-C-O 121.486 0.66 . . . . 0.0 109.545 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -50.48 152.86 8.29 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 122.617 2.211 . . . . 0.0 113.622 170.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 pt -85.28 -10.61 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.858 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.752 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.05 -62.69 1.76 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.781 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -53.93 -52.3 8.74 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.337 2.025 . . . . 0.0 113.505 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.815 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.3 mt -60.26 -38.43 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.461 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.77 95.17 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.622 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -80.7 -16.52 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.361 -0.42 . . . . 0.0 110.443 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' B' ' 8' ' ' ILE . 17.7 mt -80.15 -39.1 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.772 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 40' ' ' ALA . 20.1 mm -61.18 -46.99 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.243 168.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 5.7 mtpt -63.65 -36.93 85.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.225 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.4 -30.82 70.79 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.878 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.28 -53.4 58.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.681 169.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.06 30.4 0.27 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.707 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.94 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -88.44 -175.5 5.0 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 114.763 -0.718 . . . . 0.0 110.296 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.25 -72.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.047 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -99.11 122.01 41.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.354 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.838 HG11 ' CZ ' ' B' ' 25' ' ' ARG . 14.0 t -145.52 155.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.303 -166.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -93.2 149.51 21.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 167.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.85 -13.07 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.267 167.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m-20 -60.4 -59.64 5.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.529 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.688 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -63.8 -43.97 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.315 -175.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.924 ' NH2' HG21 ' B' ' 12' ' ' ILE . 5.3 mmt-85 -67.62 -33.32 74.74 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.486 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.25 -19.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.403 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 60' ' ' ILE . 89.5 m -71.77 -48.83 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.426 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.53 -46.86 88.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.404 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -61.99 -29.69 70.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.467 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -26.02 15.03 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.319 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 1.036 HD13 HG21 ' A' ' 64' ' ' VAL . 79.4 mt -60.87 -70.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.961 163.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.654 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.32 -27.23 67.17 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.551 -170.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.5 ' HG3' ' HG ' ' B' ' 3' ' ' LEU . 6.5 mt-10 -61.27 -47.2 87.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.203 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.8 -29.24 70.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.005 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -49.8 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.427 166.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.0 98.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.6 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.62 -32.4 71.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.393 170.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.2 t0 -64.47 -58.73 5.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.427 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.63 HG21 HG23 ' B' ' 64' ' ' VAL . 2.9 mt -65.61 -24.88 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.157 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.771 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -64.2 -75.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.312 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.513 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 p -61.43 -16.81 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.583 -171.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.512 ' HG3' ' CZ ' ' B' ' 67' ' ' PHE . 0.0 OUTLIER -72.45 -59.46 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.082 168.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.89 -12.72 11.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.41 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.689 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.6 mt -94.45 -50.34 11.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.724 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.27 -21.37 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.547 168.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -71.61 -46.67 58.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.391 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -45.09 14.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.387 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -61.55 -35.93 79.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.356 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.85 -46.83 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.35 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 29.46 6.91 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 174.04 7.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.343 170.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.18 151.29 48.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.389 -168.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 99.1 m 70.1 127.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.463 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.878 ' HB ' HG22 ' A' ' 20' ' ' VAL . 4.6 mp -87.58 140.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.265 166.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 ptpp? -137.65 -171.25 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 166.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.13 -16.91 49.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 1.3 tm-20 -90.15 -20.73 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.042 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.842 ' HB2' HG23 ' B' ' 55' ' ' ILE . 18.2 m-20 -81.06 -34.08 32.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.389 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.771 HG21 HD22 ' A' ' 28' ' ' LEU . 35.9 mm -60.53 -68.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.348 167.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.408 ' HA ' HG12 ' B' ' 64' ' ' VAL . 41.4 mt-10 -61.38 -15.29 34.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.772 -170.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 11.5 mt -68.31 -50.82 50.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.284 165.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.439 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -75.52 -56.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.861 -162.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -21.31 59.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.875 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -48.85 79.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.281 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' B' ' 39' ' ' ILE . 4.5 m-85 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.301 164.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.953 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.761 0 CA-C-O 121.647 0.737 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 20.4 Cg_endo -60.89 148.1 93.43 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.099 1.866 . . . . 0.0 113.469 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -115.87 -12.48 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.846 -175.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -70.14 -56.3 7.25 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.701 173.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -63.22 -51.8 2.49 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.586 2.191 . . . . 0.0 113.542 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.536 ' HA ' HD12 ' A' ' 11' ' ' ILE . 45.9 mt -60.88 -55.45 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.39 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -30.04 74.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -68.49 -36.33 78.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.397 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 8' ' ' ILE . 23.9 mt -60.63 -40.6 85.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.509 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.8 mm -68.09 -41.03 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.277 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.62 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.275 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -62.25 -35.11 77.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.855 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.842 ' HB1' ' CB ' ' B' ' 41' ' ' SER . . . -59.75 -53.09 62.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.428 169.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.74 24.99 0.28 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.583 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.87 129.15 40.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.393 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.64 -37.64 6.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.115 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 109.64 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.37 169.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 t -107.51 127.69 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.308 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 26.6 t -62.5 146.45 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.352 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -30.28 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.347 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.8 -45.83 92.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.432 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.783 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -65.73 -59.06 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.297 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 25' ' ' ARG . 11.5 ptm180 -62.55 -23.72 67.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -82.49 -32.72 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.564 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 60' ' ' ILE . 72.4 m -61.21 -39.36 89.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.397 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.883 HD22 HG13 ' B' ' 60' ' ' ILE . 0.4 OUTLIER -60.79 -45.03 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.135 170.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.953 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -61.35 -42.95 99.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.461 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.15 -25.29 55.15 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.224 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.738 HG21 HG21 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -61.82 -50.42 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.402 162.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.882 HD13 ' HG ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -58.63 -36.4 74.03 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.608 -172.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB2' HD21 ' A' ' 3' ' ' LEU . 22.3 tp10 -81.26 -41.37 22.31 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.978 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -86.34 -18.99 30.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.889 -170.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -44.35 48.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.9 160.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.29 99.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.696 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.38 -35.66 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.023 175.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -49.89 75.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.507 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 HG23 ' A' ' 64' ' ' VAL . 28.2 mt -61.62 -53.03 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.272 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.87 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -63.33 -47.83 80.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.28 -167.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.409 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 7.1 t -64.68 -19.93 66.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.156 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -78.67 -50.05 12.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.124 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.793 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -71.67 -32.05 67.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.987 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.5 mt -60.58 -44.06 95.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.935 161.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.57 -31.05 70.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.477 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 6.5 mt -80.47 -43.44 20.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.279 -169.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -60.75 -38.87 86.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.221 165.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.71 -47.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.37 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -34.47 74.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.446 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.72 83.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.242 168.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.61 43.66 5.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -168.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HG3' ' H ' ' A' ' 53' ' ' LYS . 4.3 tpt85 -119.45 160.8 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.334 -168.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -93.65 147.37 23.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.393 -177.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.503 ' N ' ' HG2' ' A' ' 53' ' ' LYS . 98.8 m 68.16 128.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.475 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 44' ' ' ILE . 41.1 mm -91.61 138.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.375 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -144.3 -171.76 3.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.316 -166.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -74.13 -38.94 63.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.21 -167.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.737 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.9 mp0 -61.34 -36.34 79.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.11 169.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -42.76 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.405 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.707 ' CG2' HD13 ' B' ' 28' ' ' LEU . 29.2 mm -61.11 -56.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.345 168.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.6 mt-10 -62.06 -22.8 66.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.931 -172.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -60.54 -52.6 64.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.312 165.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -60.25 -44.81 94.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.588 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.829 HG23 HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.91 -55.52 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.043 -160.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -29.18 68.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.74 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.381 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 11.0 m-85 . . . . . 0 N--CA 1.454 -0.264 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.419 170.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' B' ' 8' ' ' ILE . 14.5 mt . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.652 0.739 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.03 151.9 11.13 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.328 2.019 . . . . 0.0 113.547 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' B' ' 25' ' ' ARG . 1.1 pt -92.42 18.31 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.685 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -80.04 -58.67 0.59 Allowed Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.673 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.2 Cg_endo -58.65 -54.57 2.76 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.18 . . . . 0.0 113.496 168.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.787 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.4 mt -67.83 -23.84 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.386 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.11 97.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -86.9 -14.2 42.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.477 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mt -60.97 -49.57 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 163.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.982 HD11 HD23 ' B' ' 28' ' ' LEU . 5.7 mt -92.03 -19.69 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.484 -166.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 9.3 mttm -62.48 -41.63 98.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.459 159.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.62 -33.01 73.18 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.09 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.397 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.78 38.35 0.54 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.565 -163.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.917 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -79.8 164.09 23.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.767 -0.717 . . . . 0.0 110.26 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -132.0 -39.04 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.78 100.2 2.05 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.345 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.511 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -92.53 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.055 160.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.7 t -68.51 171.19 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.2 165.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 25' ' ' ARG . 0.5 OUTLIER -60.58 -22.34 63.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.407 172.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.8 m-20 -61.17 -61.67 2.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.48 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.4 -51.2 68.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.243 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.568 ' CZ ' HD13 ' B' ' 5' ' ' ILE . 1.4 ptm180 -60.89 -48.0 83.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.361 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 86.0 mt -62.08 -43.59 97.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.457 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.566 ' C ' HD12 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -63.18 -45.84 89.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 -167.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.982 HD23 HD11 ' B' ' 12' ' ' ILE . 1.9 tp -59.51 -33.69 71.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.665 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.669 ' O ' HD12 ' B' ' 3' ' ' LEU . . . -61.42 -41.55 97.34 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.311 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 -18.97 19.47 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.331 -174.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.736 HG21 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -60.22 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.891 161.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.882 ' HG ' HD13 ' A' ' 32' ' ' LEU . 1.1 mp -58.49 -25.9 62.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.705 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.627 ' OE1' HD11 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.22 -56.97 14.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.011 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -30.6 70.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.935 -168.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.626 ' CG ' HD11 ' B' ' 39' ' ' ILE . 3.4 tpp -61.98 -45.08 95.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.297 164.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.51 -41.44 94.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.422 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 1.8 t70 -65.41 -57.46 8.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.493 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.713 ' CG1' HG23 ' B' ' 64' ' ' VAL . 1.9 mt -62.16 -29.42 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.872 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.28 -75.14 0.08 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.842 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -62.13 -12.71 21.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.454 -170.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -88.27 -44.52 10.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.23 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -66.64 -10.76 49.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.344 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.0 mt -95.39 -53.98 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.113 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -60.69 -21.36 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.468 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.9 mt -66.72 -63.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.429 168.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.05 75.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.22 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -38.23 51.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.419 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.63 -35.96 77.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.331 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' B' ' 52' ' ' ARG . . . -60.75 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.301 167.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 52.39 5.96 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -130.22 21.94 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.341 -169.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt 65.31 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.472 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 1.7 m -89.09 140.54 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.366 -167.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.615 HG23 ' HB3' ' B' ' 59' ' ' ASP . 3.6 mt -92.83 140.85 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.391 168.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.783 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.61 178.71 5.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.45 -169.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -22.48 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.376 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 4.4 tp10 -71.37 -22.44 61.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.166 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.3 OUTLIER -93.59 -35.4 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.297 -172.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.883 HG13 HD22 ' A' ' 28' ' ' LEU . 1.3 mp -64.2 -36.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.487 160.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 1.1 mt-10 -62.06 -46.23 90.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.84 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.42 -50.35 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.525 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.65 -56.61 19.22 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.521 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.738 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -64.2 -52.62 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.227 -170.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -60.49 -37.23 80.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.742 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' B' ' 66' ' ' ARG . 1.4 tpt180 -61.6 -40.57 95.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -171.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 1.2 m-85 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.398 170.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.866 HD21 HD11 ' B' ' 11' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 8.0 Cg_endo -61.31 144.14 98.41 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.472 2.115 . . . . 0.0 113.525 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.888 HD13 ' NH2' ' A' ' 25' ' ' ARG . 2.5 pp -64.96 -7.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.911 -169.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.19 -55.17 0.67 Allowed Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.81 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.5 Cg_endo -59.7 -49.8 9.36 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.469 2.112 . . . . 0.0 113.599 176.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.8 mt -60.83 -37.77 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.232 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.79 -16.03 44.27 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.564 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 3.8 tpp85 -96.3 -26.66 15.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' B' ' 3' ' ' LEU . 8.6 mm -60.28 -54.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.394 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 17' ' ' ALA . 8.1 mm -76.73 -35.88 25.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.271 -164.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -65.1 -34.62 78.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.338 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.33 -33.39 74.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.77 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.64 -54.18 50.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.461 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.19 30.4 0.31 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.613 -173.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.789 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -75.99 147.3 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.727 -0.737 . . . . 0.0 110.344 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' NH1' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -171.13 47.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.013 166.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -164.88 24.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.42 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 24' ' ' ALA . 37.3 t -85.85 119.65 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.31 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' ' CG2' ' B' ' 54' ' ' THR . 25.1 p -62.2 164.23 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.297 168.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 11.7 t70 -60.65 -21.89 63.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.535 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.594 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -90.04 -31.94 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.448 -168.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -69.39 -44.03 72.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.22 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.888 ' NH2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -73.99 -21.99 59.78 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.383 -173.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.743 ' O ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -83.45 -42.81 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.361 178.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.479 HG22 ' CG2' ' B' ' 60' ' ' ILE . 57.3 m -61.34 -38.49 87.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.447 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 3.6 tp -62.02 -41.37 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.131 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.58 98.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.354 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 2.4 tppt? -83.32 -29.05 28.62 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.396 -172.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.922 HD13 HG21 ' B' ' 64' ' ' VAL . 45.4 mt -60.53 -66.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.011 165.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.914 HD12 HD23 ' B' ' 32' ' ' LEU . 0.7 OUTLIER -58.15 -32.96 68.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.787 -169.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.448 ' CG ' ' HA ' ' A' ' 30' ' ' LYS . 1.8 pp20? -82.67 -30.96 28.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.081 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.5 mt-10 -61.64 -33.92 74.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -55.58 8.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.509 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -61.15 -45.11 97.2 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.2 ttp180 -60.69 -33.92 73.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.419 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.7 m-20 -66.76 -56.78 8.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.481 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 64' ' ' VAL . 4.5 mt -61.51 -26.1 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.289 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.664 ' CB ' HG23 ' B' ' 12' ' ' ILE . . . -61.82 -74.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.211 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.431 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 15.5 t -62.2 -12.88 22.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.351 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.55 -57.88 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.07 171.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.78 -10.49 5.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.595 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -98.89 -51.42 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.662 -174.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 12.2 ttpt -60.04 -10.58 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.348 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.738 HD22 ' HB2' ' A' ' 63' ' ' ALA . 3.8 mp -82.73 -42.6 17.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.246 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -68.74 -36.09 77.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -82.71 -43.93 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.415 -168.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.43 ' N ' ' HD3' ' A' ' 48' ' ' ARG . 7.1 m-70 -61.22 -23.86 65.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.191 168.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.94 -54.34 46.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.082 165.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.12 29.85 0.38 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.532 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.64 99.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.782 -0.709 . . . . 0.0 110.446 169.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.69 -169.08 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.297 168.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -65.22 125.53 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.378 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.623 HD12 HG22 ' B' ' 20' ' ' VAL . 44.6 mt -62.53 147.8 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.301 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -145.95 164.02 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.509 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.06 64.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.247 -168.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -58.14 9.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.034 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.89 -21.79 65.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.434 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.812 HG23 HD13 ' B' ' 28' ' ' LEU . 29.8 mm -72.68 -76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.224 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.546 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -62.74 -8.44 6.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.454 -176.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.12 -27.56 19.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.586 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.738 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -81.53 -31.98 32.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.005 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.786 HG21 HD13 ' B' ' 31' ' ' ILE . 25.7 t -60.64 -69.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.637 160.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -14.3 19.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.565 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -62.09 -51.12 69.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.358 167.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 54.0 m-85 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.537 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 11' ' ' ILE . 2.8 mt . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 121.325 0.584 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.412 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.1 Cg_endo -61.12 142.63 97.52 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 122.471 2.114 . . . . 0.0 113.558 167.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.703 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -67.78 -20.19 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.381 -170.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -61.35 -62.2 6.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.736 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.07 -50.56 13.52 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.455 2.103 . . . . 0.0 113.623 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' B' ' 3' ' ' LEU . 7.5 mt -62.22 -21.7 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.449 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.86 97.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.624 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -86.44 -15.32 40.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.522 -173.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 3' ' ' LEU . 11.1 mm -60.85 -73.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.234 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.812 HD13 HG22 ' B' ' 11' ' ' ILE . 8.0 mm -63.27 -20.96 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.936 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB3' ' NZ ' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -73.51 -36.35 65.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.391 172.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.92 -31.88 72.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.825 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.18 -52.64 64.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.455 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.96 33.5 0.51 Allowed Glycine 0 CA--C 1.527 0.783 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.607 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -77.45 147.1 36.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.28 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -106.48 -67.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.977 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 112.14 9.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.418 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.678 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 80.6 t -103.62 137.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.31 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 54.0 p -61.11 146.55 47.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.427 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH1' ' B' ' 25' ' ' ARG . 2.3 p30 -61.69 -24.4 66.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.412 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.575 ' HA ' HG22 ' B' ' 26' ' ' ILE . 4.9 t0 -84.04 -26.0 29.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.382 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.678 ' HB3' ' CG1' ' B' ' 20' ' ' VAL . . . -62.7 -45.05 94.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.171 168.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptt-85 -85.88 -13.27 48.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.554 -166.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.76 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -84.12 -38.33 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.444 168.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.472 HG22 HD11 ' B' ' 31' ' ' ILE . 59.4 m -61.33 -43.15 99.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.218 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.812 HD13 HG23 ' A' ' 60' ' ' ILE . 2.6 tp -60.22 -37.59 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.272 166.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.33 -43.04 99.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -82.2 -26.13 33.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.448 -177.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.786 HD13 HG21 ' A' ' 64' ' ' VAL . 34.7 mt -60.95 -71.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.99 -32.19 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.681 -166.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.7 pp20? -80.85 -39.68 26.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.175 -170.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 3.2 mm-40 -61.59 -39.23 90.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.007 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 4.8 mtp -61.0 -54.86 39.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.535 168.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.3 -45.81 95.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -165.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.845 ' HG3' HG23 ' A' ' 11' ' ' ILE . 9.2 mtp-105 -61.21 -32.33 72.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.235 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -61.5 -49.58 76.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.604 175.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.852 HD13 HG22 ' B' ' 64' ' ' VAL . 2.8 mt -62.06 -37.17 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.59 -69.0 0.27 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.315 -175.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 1.4 p -62.17 -10.27 10.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.498 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.4 OUTLIER -93.84 -50.78 5.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.279 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.72 -10.57 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.376 170.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 17' ' ' ALA . 87.4 mt -101.24 -50.77 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.752 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -60.42 -11.71 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.463 168.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.498 HD12 ' C ' ' B' ' 42' ' ' GLU . 6.0 mt -83.97 -54.05 5.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.395 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.22 -21.15 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.386 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -44.91 15.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.311 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -60.41 -30.51 69.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.398 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.64 -49.78 76.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.423 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.26 37.6 0.79 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -168.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mtt85 66.05 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.492 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -130.77 -177.65 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.351 167.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 21' ' ' SER . 87.7 m -78.16 130.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.468 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.678 HG22 ' HB1' ' A' ' 24' ' ' ALA . 13.5 mm -69.97 134.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.249 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.516 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -139.73 175.51 9.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.527 -171.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -25.37 67.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.279 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.441 ' C ' HD12 ' B' ' 62' ' ' LEU . 0.6 OUTLIER -62.17 -63.59 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.11 169.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -61.06 -12.44 11.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.468 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 31' ' ' ILE . 41.4 mm -88.39 -57.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.178 -177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 9.6 mt-10 -61.48 -16.89 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.177 170.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -67.56 -59.73 3.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.324 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.77 71.75 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.119 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.922 HG21 HD13 ' A' ' 31' ' ' ILE . 43.4 t -61.61 -71.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.693 169.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -61.16 -9.17 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.497 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.51 48.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.296 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 38.1 m-85 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.34 171.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 mt . . . . . 0 C--O 1.242 0.688 0 CA-C-O 121.511 0.672 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.29 148.8 13.62 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.341 2.027 . . . . 0.0 113.285 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.559 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.1 pp -93.03 20.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.628 -167.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.53 -59.54 0.31 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.68 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.7 Cg_endo -53.05 -50.46 14.0 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.493 2.129 . . . . 0.0 113.522 172.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 29' ' ' ALA . 86.3 mt -69.05 -30.36 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.382 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.04 99.66 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.47 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -78.25 -31.91 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.353 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' ILE . 85.5 mt -60.81 -40.05 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.379 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.945 HG23 ' HB1' ' B' ' 40' ' ' ALA . 12.1 mt -97.86 -15.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.516 -162.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -38.1 85.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 158.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.85 -33.57 76.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.022 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.85 -52.11 66.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.483 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.0 25.15 0.2 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.772 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -76.09 152.4 36.81 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 114.665 -0.768 . . . . 0.0 110.262 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 -42.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.194 169.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 113.56 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.421 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.714 HG13 ' HB ' ' B' ' 55' ' ' ILE . 22.4 t -137.3 161.93 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.393 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 81.8 p -88.42 133.93 33.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.414 169.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.99 -25.4 68.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.358 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.93 -36.38 79.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.421 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -63.17 -52.67 61.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.272 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.636 HH21 HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -68.82 -18.0 64.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.477 -168.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.25 -37.79 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.44 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 HG21 ' B' ' 60' ' ' ILE . 94.6 m -60.74 -32.29 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.457 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.947 HD22 HG13 ' B' ' 60' ' ' ILE . 10.9 tp -92.03 -33.74 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.024 -171.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 8' ' ' ILE . . . -61.02 -41.9 97.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.153 166.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -36.11 83.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.517 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.631 HG21 HG21 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.135 -167.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' B' ' 32' ' ' LEU . 2.8 mp -65.71 -57.61 7.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.507 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.808 ' HG2' HD13 ' B' ' 11' ' ' ILE . 9.5 tm-20 -61.47 -32.97 72.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.166 -166.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -40.25 95.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.93 170.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt -65.17 -38.02 89.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.581 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.653 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -76.98 -40.54 25.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -24.41 66.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.165 164.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -60.6 2.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.514 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.855 ' HB ' HD11 ' B' ' 28' ' ' LEU . 5.0 mt -61.37 -31.73 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.3 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.887 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.43 -61.36 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.347 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.516 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.6 -27.35 68.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.33 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 46' ' ' LEU . 43.3 mt-10 -61.13 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.011 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -72.28 -12.24 61.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.576 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.815 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -85.86 -56.67 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.268 -168.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD2' ' NH2' ' A' ' 48' ' ' ARG . 20.5 ttpp -66.52 -19.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.457 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -60.88 -44.05 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.294 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.6 -58.83 6.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.401 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' NH2' ' HD2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -71.07 -28.8 64.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.304 -165.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -60.54 -39.69 88.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.324 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -54.98 39.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.007 164.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.74 32.85 0.31 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.583 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 69.42 -87.89 0.03 OUTLIER 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.769 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt 58.44 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.055 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -157.8 168.47 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.129 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 47' ' ' ALA . 6.7 mm -82.44 137.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.214 165.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.22 155.87 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.418 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.33 -29.2 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.236 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 62' ' ' LEU . 7.9 mm-40 -61.54 -42.43 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 169.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.03 -43.12 79.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.487 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.731 HG23 HD13 ' B' ' 28' ' ' LEU . 44.7 mm -61.24 -45.72 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.499 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.74 -28.47 60.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.106 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 58' ' ' GLU . 6.4 mp -66.08 -43.3 87.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.31 169.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.49 -41.44 97.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.4 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -83.81 -55.08 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.143 -169.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -27.61 66.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.839 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -69.8 -36.29 75.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.377 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 3.9 mt . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 121.47 0.652 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -58.02 144.44 94.59 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.368 2.046 . . . . 0.0 113.509 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.595 HD13 ' NE ' ' B' ' 25' ' ' ARG . 1.4 pp -93.08 -24.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.375 -168.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.569 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -64.98 -56.39 21.12 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.8 Cg_endo -48.37 -53.83 6.2 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 122.507 2.138 . . . . 0.0 113.446 171.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.463 ' HA ' HD12 ' B' ' 11' ' ' ILE . 36.2 mt -61.1 -33.95 58.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.514 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -29.04 71.17 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 11.6 mtp-105 -87.88 -28.29 21.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.795 -0.703 . . . . 0.0 110.494 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 33' ' ' GLU . 65.5 mt -60.9 -53.07 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.419 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 40' ' ' ALA . 7.0 mm -63.87 -37.88 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.259 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 3.1 mtpm? -61.49 -35.78 78.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.265 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.82 -32.43 72.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.794 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.6 -53.58 56.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.506 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.92 21.61 0.29 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.956 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.815 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.21 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.275 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -167.69 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.048 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -130.8 98.98 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.459 168.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 58.3 t -106.22 145.21 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.322 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.7 p -70.06 155.99 39.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.321 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -32.09 72.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.353 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m-20 -61.56 -48.47 80.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.407 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.689 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.04 -52.35 64.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.274 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.595 ' NE ' HD13 ' B' ' 5' ' ' ILE . 0.4 OUTLIER -61.25 -38.36 86.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.274 -168.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -67.01 -37.61 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.47 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.645 HG22 HD11 ' B' ' 31' ' ' ILE . 84.5 m -61.08 -52.26 65.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.421 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 39' ' ' ILE . 4.1 tp -61.1 -42.3 98.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.335 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -60.76 -28.17 68.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.416 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -26.29 18.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.729 HG21 HG21 ' A' ' 64' ' ' VAL . 17.8 mt -60.87 -71.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.985 166.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.659 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.6 mp -59.44 -30.15 68.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.595 -168.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.535 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 7.1 tm-20 -75.83 -30.66 59.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.09 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.37 -44.79 96.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.065 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 12.6 mtt -62.37 -39.62 93.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.407 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -39.41 73.86 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -29.39 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 168.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.531 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.7 OUTLIER -82.31 -52.53 6.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.482 -169.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.672 HG12 HG23 ' B' ' 64' ' ' VAL . 5.6 mt -61.32 -34.28 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.185 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.945 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -77.6 -44.4 28.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.168 -164.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 4.4 t -70.62 -13.82 62.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.422 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.657 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 2.8 mm-40 -83.11 -44.76 14.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.993 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' B' ' 59' ' ' ASP . . . -80.59 -11.1 59.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.339 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ALA . 72.7 mt -93.85 -49.16 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -60.69 -24.1 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.344 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.945 HD22 HD23 ' B' ' 62' ' ' LEU . 2.9 mt -68.15 -54.13 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.367 170.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.639 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.13 -28.83 69.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.382 -167.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.46 -44.97 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.388 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -61.43 -37.36 83.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.327 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.5 75.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.197 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.92 47.86 4.33 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -165.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.67 -43.6 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.338 -166.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.58 118.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.473 -168.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 7.3 m 68.53 139.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.489 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.714 ' HB ' HG13 ' A' ' 20' ' ' VAL . 26.6 mt -105.19 163.21 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.374 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 mtmt -149.51 166.24 29.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 -169.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -12.96 26.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.256 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 26.9 mt-10 -86.44 -19.0 30.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.078 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.548 ' HB3' ' HB1' ' B' ' 43' ' ' ALA . 0.8 OUTLIER -82.53 -33.71 28.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.288 174.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.947 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.88 -56.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.67 161.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 3.0 mt-10 -61.31 -30.29 70.4 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.71 -168.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.945 HD23 HD22 ' B' ' 46' ' ' LEU . 12.0 tp -76.32 -46.69 26.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.639 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -61.27 -24.11 66.16 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.416 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.672 HG23 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -110.65 -55.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -160.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -10.7 2.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.668 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -92.9 -65.64 0.98 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.613 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.716 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -155.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.251 1.134 0 CA-C-O 122.097 0.951 . . . . 0.0 112.598 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.577 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 3.5 Cg_exo -65.77 159.95 46.06 Favored 'Trans proline' 0 N--CA 1.484 0.967 0 C-N-CA 122.932 2.421 . . . . 0.0 113.542 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 2.6 pp -93.47 -26.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.394 -166.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.57 -56.49 9.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.698 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.0 Cg_endo -60.47 -47.65 13.5 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.121 1.881 . . . . 0.0 113.513 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.4 mt -60.87 -34.69 60.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.271 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.52 -26.82 65.02 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.541 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -84.35 -27.25 27.86 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.326 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.52 -58.44 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.454 169.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.705 HG23 ' CB ' ' B' ' 40' ' ' ALA . 8.7 mm -65.62 -42.64 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.198 -166.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -31.95 72.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.34 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.28 -33.71 75.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.756 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.27 -53.66 55.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.447 169.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.76 19.46 0.57 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.711 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.66 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.281 165.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.041 167.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.67 110.53 22.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.347 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' B' ' 55' ' ' ILE . 45.7 t -145.78 148.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.353 -169.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 p -87.45 154.78 20.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.383 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 9.5 p30 -61.14 -31.46 71.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.472 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.1 m-20 -83.87 -25.3 30.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.397 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -61.03 -40.08 92.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.252 168.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 5' ' ' ILE . 5.8 mtt180 -66.64 -47.53 72.27 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.476 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.715 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 tp -65.16 -35.99 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.356 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.785 ' O ' HD12 ' A' ' 31' ' ' ILE . 13.3 m -61.16 -53.68 53.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.293 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.889 HD22 HG13 ' B' ' 60' ' ' ILE . 6.0 tp -60.86 -9.82 4.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.251 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -84.52 -58.55 2.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.423 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -61.77 -26.12 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.22 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 27' ' ' THR . 2.3 mp -60.87 -74.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.961 161.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.765 ' O ' HD21 ' B' ' 32' ' ' LEU . 2.3 mm? -57.79 -30.1 65.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.617 -161.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.787 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.19 -44.18 47.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.262 178.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.58 -37.05 73.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.09 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 23.8 mmt -61.29 -40.48 94.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.38 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.32 -47.23 72.81 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -60.66 -17.72 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.458 171.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -86.83 -49.94 7.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.385 -173.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.818 ' HB ' HD11 ' B' ' 28' ' ' LEU . 4.8 mt -61.81 -23.84 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.081 171.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.674 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.87 -73.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.358 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.622 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 30.2 m -61.57 -13.05 18.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.312 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.67 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -78.47 -57.14 3.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.329 170.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.42 -11.9 12.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.529 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.862 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -96.81 -51.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.791 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -60.21 -15.6 25.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.459 167.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' ALA . 8.3 mt -79.17 -41.1 29.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.46 171.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.751 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -61.23 -17.98 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.24 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 -48.01 7.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.49 170.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.75 -14.6 33.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.395 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.63 -48.56 7.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.271 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 42.15 3.42 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -165.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.99 160.47 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.356 -165.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -117.27 145.81 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.307 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.884 HG23 ' HG3' ' B' ' 19' ' ' ARG . 3.8 m 69.83 158.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -168.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.751 HD13 ' HB2' ' A' ' 47' ' ' ALA . 11.0 mm -109.48 160.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.462 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -143.42 173.57 11.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.339 -168.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -72.83 -16.7 61.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.403 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 4.9 mm-40 -80.69 -14.35 58.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.264 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 73.9 m-20 -88.04 -40.4 13.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.307 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.817 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.5 -47.25 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.823 162.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 6.3 mt-10 -61.74 -42.22 98.68 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.983 -166.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.18 -28.71 27.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.433 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.67 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -60.26 -43.62 96.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.452 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.699 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.55 -55.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.009 -164.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -60.22 -24.61 64.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -14.96 23.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.462 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 46.0 t80 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.409 171.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.829 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -61.33 149.6 88.69 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.599 2.199 . . . . 0.0 113.597 166.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.677 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -63.3 -13.14 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.786 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -72.89 -57.49 3.04 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.1 Cg_endo -54.94 -59.42 0.82 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.643 2.229 . . . . 0.0 113.596 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.829 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.7 mt -61.63 -49.05 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.371 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.71 -27.54 68.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 13.1 tpt180 -78.14 -26.55 47.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.509 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 3' ' ' LEU . 66.4 mt -69.88 -46.54 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.491 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.4 mm -64.41 -38.97 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.191 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.65 -35.32 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.376 168.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -62.16 -33.6 74.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.729 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -59.16 -53.5 57.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.358 169.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.2 14.65 0.62 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.256 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.862 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.59 147.54 41.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.318 162.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -55.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.114 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.884 ' HG3' HG23 ' A' ' 54' ' ' THR . 4.7 tpt180 -101.94 104.89 15.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.4 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -133.83 146.76 31.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.375 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 35.7 p -85.37 143.11 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.448 170.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -71.83 -28.46 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.31 -170.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -34.48 74.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.47 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -61.27 -54.04 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.258 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.512 ' HD3' ' HB ' ' B' ' 5' ' ' ILE . 5.7 mtt180 -64.96 -12.59 51.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.463 -170.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.752 HG22 ' HD2' ' B' ' 30' ' ' LYS . 86.4 mt -103.64 -25.63 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.447 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.811 ' O ' HD12 ' B' ' 31' ' ' ILE . 81.8 m -63.41 -44.06 95.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 39' ' ' ILE . 1.9 tp -59.92 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.295 172.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.13 -38.19 85.5 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.561 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.752 ' HD2' HG22 ' B' ' 26' ' ' ILE . 3.3 mtpt -80.41 -28.52 37.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.203 -173.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.811 HD12 ' O ' ' B' ' 27' ' ' THR . 2.7 mt -60.81 -70.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.996 160.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.75 -16.76 18.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.723 -166.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.18 -37.65 12.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.083 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 11.4 mt-10 -61.27 -57.64 11.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.254 171.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' B' ' 32' ' ' LEU . 19.0 ptp -62.33 -28.7 69.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.343 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.18 -46.24 51.52 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.566 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -14.54 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -89.97 -51.06 5.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.534 -173.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.685 HD13 ' CG2' ' B' ' 64' ' ' VAL . 6.8 mt -61.96 -26.3 39.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.053 171.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -62.14 -68.41 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.212 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.498 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 86.6 p -61.1 -10.65 6.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.534 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.0 OUTLIER -95.54 -36.04 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.035 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.515 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -75.52 -9.93 59.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.373 167.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 58.0 mt -98.6 -49.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.923 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' B' ' 48' ' ' ARG . 10.9 mttp -60.27 -27.79 67.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.453 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' B' ' 63' ' ' ALA . 10.0 mt -61.5 -55.44 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.346 166.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.715 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.33 -31.36 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.312 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.496 ' HG2' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -74.3 -38.13 63.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.408 178.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.444 ' N ' ' HG3' ' B' ' 48' ' ' ARG . 38.2 t-80 -60.55 -32.28 71.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.229 168.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.36 -53.97 51.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.28 170.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.94 23.96 0.75 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.775 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 56.0 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.1 0.476 . . . . 0.0 111.914 169.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -67.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.391 168.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.48 HG22 ' N ' ' B' ' 55' ' ' ILE . 93.6 m -146.28 166.47 26.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.364 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.941 HG23 ' HB3' ' B' ' 59' ' ' ASP . 65.7 mt -119.4 146.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.408 170.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -137.91 -172.92 3.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.424 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.45 -16.41 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.646 ' O ' HD13 ' B' ' 62' ' ' LEU . 0.1 OUTLIER -79.36 -25.32 42.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.102 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.941 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -85.94 -35.51 20.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.281 -176.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.889 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.77 -46.4 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.705 160.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -62.09 -40.29 95.34 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.823 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.646 HD13 ' O ' ' B' ' 58' ' ' GLU . 7.5 mp -74.76 -45.38 44.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.55 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.37 -31.81 71.71 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.387 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -95.16 -54.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.983 -165.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -16.68 34.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.697 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -11.81 15.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 3.2 t80 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.278 166.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 121.991 0.9 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.485 0.659 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 33' ' ' GLU . 11.5 mt . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 5.2 Cg_endo -58.96 148.93 82.46 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.392 2.061 . . . . 0.0 113.44 167.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 2.5 pp -85.1 -28.91 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -62.14 -62.22 6.21 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.779 -171.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -51.89 -46.24 33.46 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.48 2.12 . . . . 0.0 113.588 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.45 ' HA ' HD12 ' A' ' 11' ' ' ILE . 59.9 mt -61.18 -59.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.76 -26.76 67.35 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.0 -32.97 61.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.348 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.2 mt -60.76 -40.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.493 169.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' B' ' 40' ' ' ALA . 19.4 mm -66.51 -34.58 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.405 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -29.93 65.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.392 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -62.6 -35.52 79.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.811 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.49 -53.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.395 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.63 18.46 0.32 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.834 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.81 142.2 56.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.311 165.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.66 -33.58 3.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.117 -169.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 88.09 1.91 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.486 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.787 HG22 HD12 ' B' ' 55' ' ' ILE . 23.5 t -114.91 133.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.381 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -92.02 157.73 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.434 -169.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.02 -49.02 79.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.375 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -44.33 96.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.335 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 5.6 mtt180 -63.31 -47.21 83.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.434 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 mm -60.69 -32.79 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.506 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.3 m -67.66 -43.08 81.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.335 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.5 OUTLIER -61.32 -34.13 74.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.314 177.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.75 -47.92 23.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.203 -168.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.77 -32.8 72.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.32 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.87 HG21 HG21 ' B' ' 64' ' ' VAL . 13.0 mt -60.91 -77.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.935 164.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.89 -29.06 64.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.718 -160.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 3' ' ' LEU . 2.1 pp20? -75.51 -41.82 54.28 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.165 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -68.16 -25.15 65.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.02 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.45 -33.6 31.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.478 174.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.03 -39.47 84.59 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.97 -33.54 73.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.261 165.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 1.6 t0 -64.57 -60.88 2.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.432 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 64' ' ' VAL . 15.3 mt -61.17 -29.31 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.506 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.863 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.33 -63.45 1.28 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.261 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 88.5 p -61.66 -26.76 68.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.158 -175.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 46' ' ' LEU . 28.4 mm-40 -61.05 -45.74 93.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.029 163.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -76.14 -8.14 56.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.903 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -90.7 -55.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.999 -169.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -20.97 66.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.636 168.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.0 mp -61.16 -58.17 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.442 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -61.69 -22.04 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.19 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.472 HH12 HG23 ' A' ' 44' ' ' ILE . 21.4 ttp-105 -97.04 -31.44 12.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.267 -168.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -34.43 74.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.189 167.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -61.12 -49.99 75.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.034 164.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 41.06 59.76 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -166.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -129.19 -166.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.344 -164.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 118.41 36.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.28 -165.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' B' ' 21' ' ' SER . 95.0 m 67.79 161.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.383 165.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 47' ' ' ALA . 80.4 mt -100.93 147.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.54 173.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.479 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -145.85 -171.35 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.374 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.87 -42.48 99.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.322 -169.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.757 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -61.99 -23.53 66.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.094 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 10.6 m-20 -81.14 -55.78 4.53 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.862 HG23 HD13 ' B' ' 28' ' ' LEU . 44.8 mm -61.09 -37.64 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.366 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.49 -45.88 92.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.1 mm? -62.76 -45.72 91.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.467 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.64 -30.33 70.64 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.361 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.84 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -62.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.16 -164.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -60.4 -18.36 50.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.595 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.7 tpt85 -64.39 -76.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.274 168.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.044 -159.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.547 0.845 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.511 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.5 Cg_endo -59.41 140.32 93.74 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.623 2.216 . . . . 0.0 113.553 167.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' B' ' 25' ' ' ARG . 23.7 pt -77.04 -11.54 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.679 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.93 -64.03 0.81 Allowed Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.787 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -51.29 -45.78 35.14 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.104 1.87 . . . . 0.0 113.279 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' B' ' 3' ' ' LEU . 28.0 mt -60.03 -43.82 93.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.493 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.67 99.73 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.571 -172.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.6 -22.34 50.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.437 -174.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' B' ' 8' ' ' ILE . 55.0 mt -68.24 -41.41 83.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.328 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.863 HD13 ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm -61.46 -40.35 86.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.104 167.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 26.4 mtpp -62.21 -31.81 72.39 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.051 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -62.35 -31.91 72.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.683 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.62 -53.94 52.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.413 170.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 24.44 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.686 -172.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.847 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.3 -171.35 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.287 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -153.18 -38.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.953 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 104.0 4.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.763 HG21 HG21 ' B' ' 12' ' ' ILE . 11.4 t -101.16 102.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.179 167.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 54' ' ' THR . 45.9 t -62.13 177.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.399 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.8 OUTLIER -61.01 -34.58 75.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.315 -171.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 10.2 m-20 -60.99 -58.72 7.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.519 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.634 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.92 -45.16 93.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.654 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.0 ptp180 -61.91 -37.67 85.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.364 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.502 HG13 ' HG3' ' B' ' 25' ' ' ARG . 41.8 mt -75.78 -36.29 32.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.575 HG22 HD11 ' B' ' 31' ' ' ILE . 97.8 m -60.82 -52.36 65.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.392 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.862 HD13 HG23 ' A' ' 60' ' ' ILE . 4.8 tp -60.53 -47.14 87.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.447 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.1 70.41 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.31 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.69 -24.81 23.76 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.461 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 64' ' ' VAL . 46.5 mt -61.9 -75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.965 165.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.714 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.5 mp -59.66 -20.78 58.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.729 -165.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -66.81 -57.73 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.193 170.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -38.02 89.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.024 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 6.0 ttp -60.71 -28.59 68.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.436 169.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.7 -45.85 16.19 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.421 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.42 -14.28 18.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.137 -0.531 . . . . 0.0 110.459 167.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -91.32 -51.94 5.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.412 -171.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' B' ' 64' ' ' VAL . 5.4 mt -61.42 -22.35 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.308 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -63.1 -73.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.305 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 84.3 p -61.33 -13.79 22.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.536 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -78.2 -56.99 4.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.055 170.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.08 -12.6 12.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.392 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 17' ' ' ALA . 73.3 mt -94.97 -51.8 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.106 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -60.67 -31.66 70.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.42 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.744 HD22 ' HG ' ' B' ' 62' ' ' LEU . 28.7 mt -60.66 -52.7 64.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.503 170.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.58 -36.44 80.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.262 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.8 -40.71 98.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.378 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -61.09 -38.03 84.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.414 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.94 -51.52 68.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.131 167.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.6 36.92 0.7 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.453 -164.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 62.85 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.651 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.11 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.832 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.9 m -157.57 167.39 30.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.106 165.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.787 HD12 HG22 ' A' ' 20' ' ' VAL . 24.0 mt -106.89 132.38 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.35 166.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -142.65 -176.21 4.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.458 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -26.78 68.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.314 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.53 -52.71 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.026 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.26 -24.48 63.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.303 -170.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.795 ' CG2' HD22 ' A' ' 28' ' ' LEU . 38.0 mm -75.51 -48.37 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.465 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.83 -30.4 70.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.026 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.744 ' HG ' HD22 ' B' ' 46' ' ' LEU . 14.8 tp -64.05 -50.05 69.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.394 169.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.727 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.28 -41.09 96.37 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.365 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.87 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -89.1 -57.83 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.172 -162.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -59.89 -25.84 65.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.793 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -29.94 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.409 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.468 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 121.991 0.9 . . . . 0.0 112.499 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 121.485 0.659 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 . . . . . 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.036 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 6.3 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 121.936 0.874 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 10.7 Cg_endo -61.16 142.18 95.94 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.144 2.563 . . . . 0.0 113.656 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 1.3 pp -95.49 -25.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.448 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.739 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.82 -56.51 31.58 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.7 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 6.7 Cg_endo -58.32 -55.6 2.09 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.592 2.195 . . . . 0.0 113.565 175.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 11' ' ' ILE . 51.7 mt -61.48 -45.08 99.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.492 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.497 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.76 -38.07 95.33 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -21.94 39.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.406 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 8' ' ' ILE . 54.9 mt -62.63 -50.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.405 168.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.667 HG23 ' CB ' ' B' ' 40' ' ' ALA . 18.7 mm -63.47 -41.33 92.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.373 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -62.86 -34.29 77.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.298 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.46 -33.8 75.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.787 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.16 -53.02 63.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.488 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.55 18.84 0.38 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 136.9 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.515 -0.342 . . . . 0.0 110.189 164.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.29 -25.42 8.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -168.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 92.91 1.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HD12 ' B' ' 55' ' ' ILE . 16.8 t -117.82 134.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.395 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -93.03 155.77 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.376 -170.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.11 -17.66 53.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.373 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -63.41 -50.24 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.441 168.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.662 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -62.09 -44.55 96.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.277 -174.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.512 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 4.9 mtt180 -61.45 -50.5 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.73 -31.9 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.536 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.58 ' O ' HD12 ' A' ' 31' ' ' ILE . 85.9 m -66.23 -43.25 87.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.3 OUTLIER -61.22 -32.07 71.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.266 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.036 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -78.13 -46.36 20.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.189 -168.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -60.84 -32.79 72.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.285 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.04 HG21 HG21 ' B' ' 64' ' ' VAL . 11.0 mt -60.83 -75.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.956 164.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.73 -28.19 63.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.735 -162.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' HD13 ' A' ' 3' ' ' LEU . 1.9 pp20? -77.11 -46.12 24.62 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.017 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.39 -26.54 67.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.055 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -73.59 -36.52 65.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.537 171.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.72 -42.27 71.6 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 9.8 ttp180 -60.95 -25.73 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.35 -0.425 . . . . 0.0 110.399 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -73.46 -59.28 2.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.509 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.71 HD12 HD11 ' B' ' 32' ' ' LEU . 7.8 mt -62.64 -20.04 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.24 -71.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.355 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 44' ' ' ILE . 85.8 p -61.56 -25.38 67.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.236 -172.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.8 mm-40 -61.71 -54.24 45.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.081 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -67.85 -10.32 52.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.775 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -89.39 -57.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.225 -167.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -64.89 -19.06 65.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.577 169.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -61.34 -55.78 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.323 168.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.61 -23.11 65.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.265 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.433 ' NH2' ' HG3' ' A' ' 45' ' ' LYS . 23.3 ttp-105 -100.76 -30.24 11.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.308 -165.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -34.95 75.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.127 165.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -60.88 -50.74 72.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.977 163.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.46 43.25 78.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -165.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.723 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -134.03 -166.74 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.329 -161.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.469 -165.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -60.57 168.66 2.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.507 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.661 ' HB ' HG22 ' B' ' 20' ' ' VAL . 26.6 mt -71.57 137.07 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.405 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -145.05 -175.7 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.358 -167.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.41 -47.99 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.258 -169.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.749 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.41 -24.92 67.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.979 -176.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.96 -53.11 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.373 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.781 HG23 HD13 ' B' ' 28' ' ' LEU . 43.5 mm -65.82 -39.61 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -168.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.75 -41.96 98.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.05 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.4 mm? -62.56 -47.12 85.27 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.341 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.61 -31.45 71.52 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.379 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.81 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -61.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.812 0.815 . . . . 0.0 109.029 -162.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -60.16 -19.07 52.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.667 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -63.3 -77.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.146 168.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.122 -159.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.916 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.0 Cg_endo -59.87 140.01 90.98 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.544 2.163 . . . . 0.0 113.528 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' B' ' 25' ' ' ARG . 33.0 pt -78.52 -10.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.631 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.7 -61.19 1.41 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.8 Cg_endo -55.49 -45.95 35.86 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 122.443 2.096 . . . . 0.0 113.453 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.916 HD11 ' HB3' ' B' ' 3' ' ' LEU . 31.0 mt -60.32 -44.56 96.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.459 172.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.25 97.32 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.549 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' B' ' 7' ' ' PRO . 0.0 OUTLIER -77.19 -23.26 51.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 0.0 110.503 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' B' ' 8' ' ' ILE . 64.8 mt -67.85 -48.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.461 170.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -61.92 -33.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.037 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 27.0 mtpp -61.34 -33.88 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.209 171.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.6 -32.78 73.85 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.638 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.86 -53.32 59.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.429 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.11 21.34 0.78 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.974 -170.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.833 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -65.63 147.03 54.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.34 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -40.79 3.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.045 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -148.55 139.14 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.507 168.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 55' ' ' ILE . 88.8 t -129.45 113.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.205 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -62.28 174.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.381 -166.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.9 OUTLIER -61.67 -32.29 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.371 -177.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 4.3 m-20 -64.2 -55.55 20.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.468 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.666 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.12 -48.0 82.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.301 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.6 ptp180 -61.03 -37.85 84.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.394 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.443 HD12 ' O ' ' B' ' 22' ' ' ASP . 34.3 mt -72.05 -36.56 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.49 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.569 HG22 HD11 ' B' ' 31' ' ' ILE . 97.9 m -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.365 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.781 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.94 -47.04 88.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.383 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.98 70.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.384 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -87.15 -26.14 23.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.494 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.81 HG21 HG21 ' A' ' 64' ' ' VAL . 37.8 mt -61.83 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.015 165.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.774 ' HB3' HD23 ' A' ' 32' ' ' LEU . 6.0 mp -59.6 -17.45 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.61 -53.43 10.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.139 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 -40.43 88.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.045 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.526 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 10.0 ttp -60.82 -28.68 68.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.477 170.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.79 -46.23 18.63 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.44 -13.88 16.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.534 167.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -91.22 -51.28 5.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.418 -172.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.54 ' CG2' HG23 ' B' ' 64' ' ' VAL . 4.8 mt -61.6 -21.32 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.271 170.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.667 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -63.22 -73.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.315 172.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 81.8 p -61.45 -13.94 24.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.503 -173.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.489 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -77.92 -56.95 4.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 170.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.2 -13.18 16.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.323 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.812 HD11 ' HB2' ' A' ' 17' ' ' ALA . 81.4 mt -95.55 -51.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.96 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -60.67 -32.97 72.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.45 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' B' ' 62' ' ' LEU . 20.9 mt -60.47 -51.5 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.551 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.5 -36.04 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.257 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.86 -40.77 98.51 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.418 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -61.24 -38.1 85.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.326 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.97 -51.41 69.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.124 167.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 37.21 0.72 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.448 -164.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 62.34 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.536 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -79.5 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.754 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.494 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.1 m -157.55 167.55 29.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.153 165.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 20' ' ' VAL . 23.6 mt -108.16 132.7 55.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.439 166.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 5.2 mmmt -143.38 -177.14 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.387 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -27.03 68.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.52 -55.09 34.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.042 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.1 OUTLIER -65.79 -29.34 69.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.394 -170.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.836 ' CG2' HD22 ' A' ' 28' ' ' LEU . 37.1 mm -71.61 -48.7 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.402 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.6 -31.41 71.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.023 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' B' ' 46' ' ' LEU . 15.0 tp -62.11 -51.12 69.2 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.416 168.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.36 -41.08 96.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.376 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -88.75 -58.65 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.13 -162.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -59.74 -25.56 64.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.8 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 -30.4 43.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.388 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.511 171.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.251 1.173 0 CA-C-O 122.064 0.935 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 1.7 Cg_endo -53.95 142.87 63.17 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.07 2.513 . . . . 0.0 113.513 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.514 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 13.5 pt -92.24 -13.2 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.374 -165.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -79.65 -54.65 0.92 Allowed Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.719 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 16.1 Cg_exo -51.55 -55.17 4.23 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.499 2.133 . . . . 0.0 113.627 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 3' ' ' LEU . 45.0 mt -61.71 -44.23 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.248 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.14 -22.17 60.3 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.4 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -26.29 21.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.724 -0.738 . . . . 0.0 110.483 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' B' ' 3' ' ' LEU . 27.4 mt -63.44 -54.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.43 170.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.69 HG23 ' CB ' ' B' ' 40' ' ' ALA . 9.4 mm -65.32 -36.58 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.262 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -69.21 -32.58 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.331 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.41 -34.87 77.58 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.8 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -52.92 63.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.491 169.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.63 24.03 0.3 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.566 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.811 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.57 142.62 58.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.825 -0.688 . . . . 0.0 110.323 174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.49 124.52 41.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.98 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.5 116.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.435 174.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.738 HG11 HH21 ' A' ' 25' ' ' ARG . 15.6 t -146.14 165.65 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.362 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 20' ' ' VAL . 15.7 p -99.99 159.81 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.442 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.746 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.4 m-20 -61.01 -33.78 73.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -37.24 86.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.354 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -60.93 -46.12 91.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.318 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.738 HH21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.95 -36.85 84.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.407 -170.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.2 mt -79.64 -43.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.457 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.816 ' O ' HD12 ' A' ' 31' ' ' ILE . 90.5 m -60.92 -47.89 84.35 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.285 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD22 HG13 ' B' ' 60' ' ' ILE . 4.5 tp -59.19 -45.77 90.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.412 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.67 -21.06 62.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.659 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.66 -24.41 14.43 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.357 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 27' ' ' THR . 1.8 mp -61.11 -68.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.884 162.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.26 -33.41 72.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.599 -169.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.809 ' HB2' HD13 ' A' ' 3' ' ' LEU . 2.3 tm-20 -65.03 -55.12 20.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.1 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -61.68 -26.13 67.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.909 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -46.92 77.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.358 164.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -40.2 96.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -60.75 -31.99 71.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.302 172.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -51.63 60.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.628 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.66 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mt -62.6 -32.74 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.694 -172.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -78.01 -52.15 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.342 -166.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.2 t -61.25 -14.37 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.273 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -87.61 -54.82 4.07 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.213 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.99 -33.59 74.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.176 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' B' ' 17' ' ' ALA . 55.7 mt -60.59 -46.21 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.175 164.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -60.33 -21.92 62.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.565 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 9.9 mt -89.08 -23.57 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.452 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.16 -28.4 65.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.301 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -61.31 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.37 170.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -61.12 -23.08 65.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.374 -168.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 -47.54 62.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.308 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.39 27.9 4.27 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.12 121.92 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.819 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -161.41 15.43 0.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.502 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 55' ' ' ILE . 90.4 m 63.14 151.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.392 -167.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' B' ' 20' ' ' VAL . 29.4 mt -78.22 138.09 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.5 mtmt -153.65 -178.17 6.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.455 -170.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.97 80.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.262 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -50.0 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.196 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -33.34 74.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.405 -173.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' B' ' 28' ' ' LEU . 11.5 mm -75.27 -58.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.342 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 39.8 mt-10 -61.64 -9.86 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.319 172.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 mt -85.95 -41.28 15.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.487 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.617 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.15 -36.49 79.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.098 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 61' ' ' GLU . 55.9 t -61.85 -76.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.723 168.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -14.91 23.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.396 -167.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -61.52 -66.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 165.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 39' ' ' ILE . 8.3 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.482 -168.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.656 ' CD2' HD11 ' A' ' 11' ' ' ILE . 6.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.326 0.584 . . . . 0.0 109.814 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.82 153.5 43.35 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.485 2.123 . . . . 0.0 113.317 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' B' ' 25' ' ' ARG . 16.5 pt -92.35 -25.13 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.42 -168.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.15 -62.56 3.55 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.754 -170.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 7.9 Cg_endo -50.11 -45.39 33.4 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.39 2.06 . . . . 0.0 113.417 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.746 HG22 HH12 ' B' ' 25' ' ' ARG . 21.5 mt -60.96 -38.2 78.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.407 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -61.65 -53.9 39.97 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.556 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -70.41 -15.09 62.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.432 -170.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 3' ' ' LEU . 66.1 mt -73.33 -34.47 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.534 168.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.877 HG23 ' HB1' ' A' ' 40' ' ' ALA . 2.6 mm -70.03 -46.26 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.894 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.3 mtpt -62.33 -41.33 98.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.045 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -60.79 -31.09 70.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.015 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.04 -52.43 65.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.575 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.72 31.61 0.4 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.597 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -80.76 -177.56 6.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -171.06 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.94 167.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.03 106.68 17.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.428 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 55' ' ' ILE . 14.7 t -141.48 171.9 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.395 171.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.556 ' H ' HG12 ' B' ' 20' ' ' VAL . 16.1 t -127.07 156.45 41.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.308 -176.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.71 -37.82 85.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.379 -170.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.92 71.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.391 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.649 ' O ' HG22 ' B' ' 27' ' ' THR . . . -65.83 -43.84 87.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.314 171.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.746 HH12 HG22 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -61.24 -47.66 85.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.339 -175.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 52.3 mt -61.44 -38.84 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.542 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 24' ' ' ALA . 1.5 t -69.77 -43.32 72.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.178 -167.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 60' ' ' ILE . 2.6 tp -59.44 -36.86 76.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.523 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.71 -40.0 93.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.207 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -27.14 23.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.491 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.64 HD12 ' C ' ' B' ' 27' ' ' THR . 24.8 mt -61.61 -67.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.04 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.693 ' HB3' HD23 ' A' ' 32' ' ' LEU . 3.0 mp -60.4 -34.71 74.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.57 -176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.553 ' HG3' HD13 ' A' ' 11' ' ' ILE . 34.6 tt0 -67.52 -37.9 83.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.933 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -35.16 77.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.891 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 3.3 mtp -65.06 -48.34 74.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.461 170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.23 -40.22 97.77 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.555 ' HG3' HG23 ' A' ' 11' ' ' ILE . 12.2 mtp180 -60.93 -29.69 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.345 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -67.89 -55.27 13.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.503 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.73 HG21 HG23 ' B' ' 64' ' ' VAL . 2.2 mt -63.31 -26.28 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.821 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.69 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.49 -70.07 0.21 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.292 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.497 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.46 -17.01 52.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.388 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 3.3 mm-40 -84.61 -38.49 19.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.051 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -78.04 -8.28 57.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.832 172.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 17' ' ' ALA . 51.3 mt -96.99 -51.06 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.765 -175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -60.25 -22.24 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.375 166.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 43' ' ' ALA . 9.6 mt -69.62 -53.74 17.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.379 168.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.63 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.59 -23.54 66.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.307 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 -34.3 15.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.252 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -60.55 -36.77 79.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.434 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.02 74.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.17 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.17 46.94 7.85 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 4.1 tpm_? -121.23 -18.54 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.451 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.28 18.68 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -145.47 138.35 26.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.406 170.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' B' ' 47' ' ' ALA . 45.2 mt -93.76 148.5 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.341 170.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 6.1 mtpp -147.94 178.36 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.381 -169.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.33 -17.82 55.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.331 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.699 ' C ' HD12 ' B' ' 62' ' ' LEU . 5.6 mp0 -81.2 -41.27 22.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.069 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -75.28 -26.77 59.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.373 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.772 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -64.43 -59.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.339 174.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 11.6 mt-10 -74.41 -12.44 60.51 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.557 -176.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 58' ' ' GLU . 7.5 mt -81.67 -46.12 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 168.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' B' ' 39' ' ' ILE . . . -60.34 -41.62 93.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.398 172.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.73 HG23 HG21 ' B' ' 39' ' ' ILE . 37.9 t -62.72 -74.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.63 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -10.76 3.44 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.509 -164.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -85.77 -60.87 1.9 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.582 164.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.539 ' HB3' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.42 -155.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.817 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 28.8 mt . . . . . 0 C--O 1.24 0.563 0 CA-C-O 121.763 0.792 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 7.0 Cg_exo -48.3 150.99 4.84 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 122.388 2.058 . . . . 0.0 113.512 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -69.21 -11.55 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.591 -166.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.6 -58.93 1.32 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.772 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.12 -57.11 1.43 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.432 2.088 . . . . 0.0 113.437 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.8 mt -60.6 -32.66 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.378 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.59 -26.65 64.95 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.357 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -78.02 -36.4 48.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.373 -0.914 . . . . 0.0 110.483 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.739 HG23 ' HG3' ' B' ' 37' ' ' ARG . 25.1 mt -60.63 -64.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.48 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.3 mm -60.91 -33.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -166.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -65.36 -40.45 93.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.468 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.11 -32.41 72.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.777 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.99 -52.64 64.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.522 170.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.76 22.09 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.654 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.64 159.25 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.295 169.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.01 -63.34 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.054 -169.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.588 ' O ' HG23 ' B' ' 54' ' ' THR . 9.4 mtp180 -144.6 80.06 1.62 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.478 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.736 HG22 HG13 ' B' ' 55' ' ' ILE . 15.5 t -71.33 107.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.31 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -61.54 158.88 14.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.459 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.7 p30 -61.31 -18.66 59.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.269 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -66.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.773 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -60.69 -39.66 89.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.386 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.676 ' HB3' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -62.01 -37.78 86.17 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.448 -175.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -76.28 -29.45 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.357 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.588 HG22 ' CG2' ' B' ' 60' ' ' ILE . 97.1 m -61.06 -60.75 3.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.341 171.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.923 HD12 ' CG2' ' A' ' 31' ' ' ILE . 64.4 tp -68.33 -28.74 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.424 -171.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -71.35 -40.38 70.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.116 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -60.38 -35.59 76.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.379 166.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.923 ' CG2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -69.78 -38.96 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.378 -170.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.8 mm? -74.84 -67.74 0.61 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.479 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.806 ' O ' HD12 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -67.39 -17.85 64.89 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.811 -163.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.17 -49.57 64.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.108 164.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.577 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.488 ' N ' HD21 ' B' ' 32' ' ' LEU . . . -76.71 -36.15 38.27 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' N ' ' CG2' ' B' ' 11' ' ' ILE . 2.4 ttm-85 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.38 169.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.56 -51.7 33.05 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.429 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.719 HD13 HG22 ' A' ' 64' ' ' VAL . 25.1 mt -63.9 -33.75 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.395 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.41 -66.23 0.57 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.275 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.738 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.21 -15.47 34.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.373 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.78 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -71.38 -63.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.135 167.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -13.14 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.488 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.3 mt -97.2 -59.26 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -61.89 -17.43 56.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.333 174.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 42' ' ' GLU . 16.7 mt -69.84 -58.66 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.363 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -25.57 67.33 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.398 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.71 -55.85 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.448 -170.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 2.4 p-80 -68.01 -24.95 65.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.389 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.02 62.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.347 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.22 26.42 2.04 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.61 165.6 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.416 -170.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -132.68 18.46 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.446 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.6 m -157.66 132.94 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.301 170.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 59' ' ' ASP . 4.4 mp -100.36 133.26 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.309 166.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 -172.62 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.454 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -61.35 -20.0 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.315 -171.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.18 -67.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.077 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.583 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -61.15 -32.27 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.366 -167.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 HD13 ' B' ' 28' ' ' LEU . 37.9 mm -61.2 -64.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.387 172.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 3.4 mt-10 -61.1 -10.07 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.41 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.98 -39.5 12.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.457 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.78 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -76.26 -27.56 56.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.113 175.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.081 HG21 HD13 ' B' ' 31' ' ' ILE . 15.3 t -62.48 -66.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.448 160.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -59.39 -11.19 3.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.002 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -30.65 15.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.236 0.357 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.617 163.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.802 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 12.4 Cg_endo -57.89 139.73 91.37 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.461 2.107 . . . . 0.0 113.407 165.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' B' ' 25' ' ' ARG . 22.7 pt -92.95 21.43 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.567 -167.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -83.57 -58.02 0.41 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.733 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.7 Cg_endo -55.91 -50.74 11.44 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' B' ' 5' ' ' ILE . 23.5 mt -60.85 -23.18 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.322 167.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.1 96.63 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.518 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -94.26 -18.03 22.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.986 -0.607 . . . . 0.0 110.347 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 33' ' ' GLU . 7.7 mm -60.83 -72.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.002 163.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.7 mm -63.38 -17.0 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.169 -171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -37.3 24.1 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.377 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -32.53 73.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.836 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.738 ' HB1' ' CA ' ' A' ' 41' ' ' SER . . . -58.82 -52.88 63.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.516 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.21 23.06 0.35 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.702 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.638 ' HB1' HG21 ' B' ' 20' ' ' VAL . . . -67.8 147.05 53.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.772 -0.714 . . . . 0.0 110.424 173.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.77 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.939 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 80.33 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.381 168.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.638 HG21 ' HB1' ' B' ' 17' ' ' ALA . 59.4 t -134.89 137.73 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.472 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 58.9 p -74.49 150.89 39.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.365 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.16 -17.92 55.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.302 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -44.65 63.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.422 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.672 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.45 -43.61 98.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.363 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' B' ' 5' ' ' ILE . 28.1 mtt-85 -62.23 -32.57 73.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.417 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -88.02 -30.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.445 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.442 ' CG2' ' HG3' ' A' ' 61' ' ' GLU . 97.8 m -61.1 -54.11 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.37 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.768 HD13 HG23 ' A' ' 60' ' ' ILE . 4.3 tp -59.83 -45.38 92.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.556 172.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -31.16 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.362 -171.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -91.94 -23.2 19.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 64' ' ' VAL . 64.4 mt -61.36 -70.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.135 166.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.717 ' O ' HD11 ' A' ' 32' ' ' LEU . 1.1 mp -60.47 -33.15 72.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.719 -170.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' B' ' 3' ' ' LEU . 18.5 tt0 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.12 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -32.11 72.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.945 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.675 ' HG2' HD11 ' B' ' 39' ' ' ILE . 2.1 ttt -60.46 -42.55 96.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.426 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.21 68.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -169.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.739 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.7 mtp180 -60.58 -28.51 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.49 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -70.18 -57.8 4.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.53 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.725 HG21 HG23 ' B' ' 64' ' ' VAL . 10.2 mt -61.04 -23.44 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.483 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.73 -70.05 0.21 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.504 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.7 OUTLIER -61.22 -11.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.479 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.525 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -78.62 -58.32 3.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.068 170.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.519 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.15 -17.44 52.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.47 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 90.0 mt -91.18 -50.17 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.983 -173.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -60.68 -27.91 68.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.377 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 15.4 mt -64.81 -54.72 26.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.354 167.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.27 -50.63 72.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.275 -169.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -42.63 99.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.12 -35.19 76.39 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.407 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.75 -47.34 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.302 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.29 30.1 7.99 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' B' ' 54' ' ' THR . 0.0 OUTLIER -134.48 104.11 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.352 169.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 6.6 mttt -61.13 -16.98 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.335 -169.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' ARG . 94.2 m -88.39 122.21 31.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.447 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 20' ' ' VAL . 11.8 mm -75.1 138.29 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.515 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 1.1 mmmt -130.2 158.55 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.324 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -62.86 -31.06 72.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.309 -167.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.95 -37.93 82.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.081 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.7 OUTLIER -64.88 -37.12 86.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.44 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.588 ' CG2' HG22 ' A' ' 27' ' ' THR . 48.8 mm -60.9 -55.9 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.432 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -70.64 -22.64 62.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.009 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.13 -36.17 40.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.449 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.99 -55.36 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.372 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.725 HG23 HG21 ' B' ' 39' ' ' ILE 0.256 0.4 OUTLIER -70.16 -50.71 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.978 -165.806 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' B' ' 65' ' ' ARG . 5.1 mmm180 -60.9 -43.06 99.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -20.73 64.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.4 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 50.5 t80 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.306 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 33' ' ' GLU . 3.4 mt . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.609 0.719 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.97 144.16 94.84 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.172 1.915 . . . . 0.0 113.66 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.624 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -101.99 19.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.684 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.92 -58.81 0.31 Allowed Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 11.7 Cg_endo -59.46 -45.81 24.39 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.503 2.135 . . . . 0.0 113.557 168.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 27.9 mt -69.06 -32.93 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.438 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -30.31 71.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.8 ttp-105 -92.39 -18.73 22.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.315 -174.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.791 HD11 HD21 ' B' ' 3' ' ' LEU . 10.3 mm -61.01 -60.59 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.244 166.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.3 mm -72.32 -22.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.039 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -77.31 -34.27 55.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.296 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -61.45 -31.17 71.12 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.877 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.94 -52.23 66.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.492 170.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.89 34.31 0.56 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.53 -167.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -84.25 145.92 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.255 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.05 -38.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.026 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.824 ' NH2' HG23 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -122.9 85.0 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.48 170.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 55' ' ' ILE . 89.8 t -132.42 113.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.274 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -65.46 164.26 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.462 -167.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.775 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -65.42 -30.56 71.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.36 -173.007 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.853 ' HB2' ' HB2' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -60.97 -43.38 98.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.402 176.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.682 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.56 -41.2 97.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.347 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -61.73 -42.26 98.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.389 -176.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.3 mt -83.29 -28.42 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.447 -176.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.82 ' O ' HD12 ' A' ' 31' ' ' ILE . 97.3 m -60.89 -47.7 85.21 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.293 174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.74 HD13 HG23 ' B' ' 60' ' ' ILE . 4.4 tp -59.21 -45.54 90.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.453 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.12 -20.8 63.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.547 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -96.91 -28.86 14.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.323 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 27' ' ' THR . 1.9 mp -60.7 -70.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.929 162.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -58.32 -35.16 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.796 -166.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 3' ' ' LEU . 9.9 tt0 -69.52 -61.71 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.201 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 80.0 mt-10 -61.55 -34.09 74.97 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.797 -170.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.5 ttm -62.2 -46.9 86.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.46 165.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -63.39 -47.69 85.32 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -60.65 -23.0 64.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.368 170.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -75.6 -52.32 10.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.605 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.673 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.3 mt -61.49 -28.75 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.071 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.811 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.04 -74.09 0.09 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.191 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.521 ' HB3' ' HB1' ' B' ' 15' ' ' ALA . 1.9 p -60.94 -11.38 7.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.489 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.707 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.4 mm-40 -79.92 -55.84 4.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.089 171.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.16 -20.83 63.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.368 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' B' ' 17' ' ' ALA . 92.8 mt -88.82 -52.03 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.93 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -27.81 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.447 170.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -63.36 -61.02 2.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.375 171.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.817 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.78 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.241 -167.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.449 ' CD ' ' NH1' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -82.61 -41.1 19.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.411 -171.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -66.2 -21.27 66.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.247 167.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.16 -53.27 59.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.23 166.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.71 9.92 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.64 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.449 ' NH1' ' CD ' ' A' ' 48' ' ' ARG . 13.6 ttm-85 66.69 134.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.419 169.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.19 -65.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.303 169.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 55' ' ' ILE . 92.7 m -157.63 144.4 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.323 169.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' THR . 25.4 mm -66.22 136.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.322 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.833 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.3 tptt -131.83 165.21 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.404 -167.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -61.13 -17.72 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.246 169.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.55 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.4 tp10 -76.29 -44.83 35.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.092 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 3.1 m-20 -68.9 -35.05 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.278 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.89 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.89 -56.15 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.763 162.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -61.47 -33.22 73.39 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.909 -166.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.6 mp -75.91 -45.78 33.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.551 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.37 -27.05 68.24 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.434 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.791 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -96.09 -56.3 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.866 -164.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH1' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -60.13 -26.25 66.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.632 174.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' NH2' HD23 ' A' ' 62' ' ' LEU . 97.4 mtt180 -81.38 -23.86 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.411 171.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 5.5 t80 . . . . . 0 N--CA 1.455 -0.205 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.46 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 11' ' ' ILE . 1.5 mt . . . . . 0 CA--C 1.545 0.765 0 CA-C-O 121.264 0.554 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.562 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 12.0 Cg_endo -62.56 147.97 94.03 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.514 2.143 . . . . 0.0 113.401 165.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.66 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -99.16 19.21 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.955 174.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -94.55 -59.35 0.2 Allowed Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.737 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.9 Cg_endo -57.89 -46.97 22.79 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.484 2.123 . . . . 0.0 113.454 169.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.73 -37.06 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.391 168.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.57 -21.35 60.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -103.61 -18.39 14.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.067 -0.567 . . . . 0.0 110.327 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.725 HG22 HD13 ' B' ' 12' ' ' ILE . 9.4 mm -60.78 -49.93 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.275 164.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' B' ' 17' ' ' ALA . 6.2 mm -85.46 -31.26 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.967 -168.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.385 170.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.32 -32.52 73.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.748 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.8 -53.47 57.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.521 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.82 24.04 0.48 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.618 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.833 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -61.02 144.2 53.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.73 -0.735 . . . . 0.0 110.409 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -146.01 122.02 10.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.036 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 64.28 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.367 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' HG3' ' B' ' 25' ' ' ARG . 25.8 t -101.4 123.65 54.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.337 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -61.25 154.35 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.419 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.48 -37.08 82.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.395 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.72 -48.6 81.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.511 170.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.833 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.95 -48.61 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.297 -172.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.444 ' HG3' ' CG1' ' B' ' 20' ' ' VAL . 9.2 mtp180 -61.61 -36.97 82.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.392 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -89.2 -32.99 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.42 -167.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.475 HG22 HD12 ' B' ' 31' ' ' ILE . 90.1 m -67.21 -41.05 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.449 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 60' ' ' ILE . 2.2 tp -62.97 -48.21 79.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.913 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.02 -25.78 67.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.553 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -95.96 -29.4 14.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.283 -175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 64' ' ' VAL . 15.4 mt -61.4 -59.9 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.845 166.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.01 -22.05 47.82 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.77 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.513 ' OE1' HD21 ' B' ' 3' ' ' LEU . 8.9 tp10 -83.34 -65.05 1.06 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.011 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.68 -34.22 75.36 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.849 -174.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.46 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 8.2 ttm -62.15 -47.75 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.521 165.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -61.29 -49.53 76.72 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.59 -25.06 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.433 171.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -71.32 -49.91 37.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.61 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.527 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.0 mt -61.43 -34.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.261 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.8 -71.78 0.14 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.301 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 24.7 p -62.04 -17.88 58.79 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.557 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.543 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -81.51 -50.85 8.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.26 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.4 -12.89 24.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.099 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.824 HG23 ' NH2' ' A' ' 19' ' ' ARG . 96.6 mt -95.47 -49.31 12.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.817 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -67.84 -7.4 27.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.182 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.543 HD12 ' O ' ' B' ' 42' ' ' GLU . 3.9 mt -83.61 -43.05 16.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.26 169.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -60.49 -14.83 21.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.324 166.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -92.31 -35.29 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.498 168.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 46' ' ' LEU . 23.8 t-80 -61.66 -39.56 91.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.266 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.681 ' HB1' ' NZ ' ' B' ' 53' ' ' LYS . . . -61.05 -52.63 64.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.212 165.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.84 9.53 10.87 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.539 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 179.23 -166.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.931 -0.635 . . . . 0.0 110.323 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.681 ' NZ ' ' HB1' ' B' ' 50' ' ' ALA . 2.7 mppt? 65.73 162.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.41 167.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.621 HG22 ' O ' ' B' ' 55' ' ' ILE . 91.8 m -96.55 152.68 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.346 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 20' ' ' VAL . 3.6 mp -69.3 133.66 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 168.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' B' ' 58' ' ' GLU . 0.3 OUTLIER -135.63 -171.36 2.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.376 177.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.853 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -61.75 -27.15 68.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.247 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.538 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.0 pt-20 -73.99 -49.0 26.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.1 OUTLIER -61.89 -31.56 71.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.401 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.74 HG23 HD13 ' A' ' 28' ' ' LEU . 25.3 mm -61.89 -68.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.268 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt-10 -61.06 -14.61 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 3.6 mp -70.66 -55.2 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.403 169.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.483 ' HB1' ' CZ ' ' B' ' 67' ' ' PHE . . . -60.91 -37.03 80.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.484 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HG12 ' A' ' 31' ' ' ILE . 40.2 t -62.43 -69.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.796 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.19 -9.17 4.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.508 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -50.29 21.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.488 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.166 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -174.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 33' ' ' GLU . 3.3 mt . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 121.507 0.67 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.12 140.18 93.17 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.543 2.162 . . . . 0.0 113.533 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 pt -80.64 -31.23 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.366 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.75 -62.73 4.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.763 -173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -50.87 -42.85 50.06 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 C-N-CA 122.48 2.12 . . . . 0.0 113.524 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 3' ' ' LEU . 50.3 mt -60.81 -39.15 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.435 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 25' ' ' ARG . . . -61.58 -26.12 66.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -91.14 -25.33 19.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.169 -0.515 . . . . 0.0 110.36 -176.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' B' ' 3' ' ' LEU . 53.7 mt -60.83 -62.43 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.296 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.2 mm -61.21 -35.18 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.249 -175.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.4 mtmt -60.79 -37.09 80.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.498 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.56 -35.21 78.76 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.789 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.32 -53.08 62.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.41 167.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.57 16.58 0.21 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.051 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.809 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.16 170.57 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 163.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.09 -57.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.941 165.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.486 ' NH1' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -73.62 83.28 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.391 172.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HB ' ' B' ' 55' ' ' ILE . 24.6 t -129.03 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 -170.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.3 p -85.24 156.48 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.423 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.8 t0 -61.42 -23.19 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.318 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -90.65 -28.62 18.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.394 -170.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.473 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -61.69 -42.04 98.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.157 166.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HG3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.76 -51.17 68.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.445 -178.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.3 tt -62.68 -40.95 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.234 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.639 HG22 HD11 ' A' ' 31' ' ' ILE . 91.7 m -60.77 -59.06 5.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.369 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.3 tp -61.01 -10.5 5.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.344 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -82.37 -59.29 2.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.448 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -61.33 -25.14 66.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.434 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 28' ' ' LEU . 74.0 mt -61.65 -75.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.052 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 31' ' ' ILE . 7.1 mp -60.57 -36.92 79.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -166.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 3' ' ' LEU . 8.4 tt0 -67.46 -42.75 82.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.053 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.4 mt-10 -62.12 -41.15 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.056 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.9 mmm -60.76 -42.1 96.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.506 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.57 -46.27 90.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' B' ' 11' ' ' ILE . 3.1 mtp180 -60.73 -33.83 73.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.378 168.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -65.69 -50.2 65.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 -175.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.622 HG21 HG23 ' A' ' 64' ' ' VAL . 11.0 mt -65.1 -36.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.417 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -65.26 -54.08 34.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.32 -172.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 -34.33 75.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.298 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -60.91 -38.26 85.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.063 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -79.82 -13.67 59.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.794 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -82.79 -57.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.372 -168.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.29 -31.36 70.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.414 169.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 42' ' ' GLU . 11.4 mt -59.96 -43.84 94.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.584 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.831 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -67.86 -26.37 65.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.103 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -60.67 -61.61 2.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.332 168.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -61.31 -10.09 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.584 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -84.16 -57.86 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.953 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.64 9.93 0.04 OUTLIER Glycine 0 C--N 1.344 0.996 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.666 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 0.3 OUTLIER 73.6 -58.22 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.424 0.689 . . . . 0.0 111.47 158.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.53 -23.3 49.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 111.182 -157.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.524 HG22 ' N ' ' B' ' 21' ' ' SER . 0.2 OUTLIER -155.43 154.97 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.354 169.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.927 ' HB ' HG13 ' B' ' 20' ' ' VAL . 4.3 mm -72.44 150.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.015 159.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 156.33 40.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.413 -169.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.23 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.246 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -68.72 -38.99 80.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.902 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -48.0 83.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.618 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.781 ' CG2' HD22 ' B' ' 28' ' ' LEU . 22.8 mm -61.55 -46.2 97.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -36.86 69.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.054 -170.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mp -63.51 -43.28 97.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.414 167.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 46' ' ' LEU . . . -61.54 -57.42 12.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.41 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.802 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -68.26 -52.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.042 -168.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -41.35 92.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.731 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -20.72 63.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.337 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 44.5 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.206 -171.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 11' ' ' ILE . 1.5 mt . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' B' ' 7' ' ' PRO . 12.6 Cg_endo -60.67 140.91 93.44 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.533 2.156 . . . . 0.0 113.405 164.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -99.47 -17.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.389 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -79.09 -62.0 0.46 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.754 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.48 -36.24 58.43 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 122.508 2.139 . . . . 0.0 113.522 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' B' ' 3' ' ' LEU . 54.0 mt -60.42 -42.22 90.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.362 168.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' B' ' 25' ' ' ARG . . . -61.54 -28.15 69.2 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.603 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HG3' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -86.55 -21.84 26.67 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.511 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.491 HG23 ' HD3' ' A' ' 37' ' ' ARG . 26.4 mt -69.02 -44.0 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.399 167.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.5 mm -62.65 -36.17 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.04 171.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' HA ' ' B' ' 10' ' ' ARG . 0.6 OUTLIER -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.387 172.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 37' ' ' ARG . 16.5 t70 -62.55 -32.78 73.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.75 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -52.57 65.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.443 169.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.41 18.88 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.051 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.842 ' HB1' ' CG2' ' B' ' 20' ' ' VAL . . . -64.43 165.76 9.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.311 168.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.21 -58.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.049 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 83.3 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.452 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.927 HG13 ' HB ' ' A' ' 55' ' ' ILE . 57.9 t -104.45 145.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.324 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 54' ' ' THR . 77.8 p -61.21 139.73 58.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.33 168.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.98 -24.25 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.261 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -53.17 56.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.454 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.336 -167.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.463 ' HG2' ' CA ' ' B' ' 9' ' ' GLY . 4.1 mpp_? -60.87 -49.03 79.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.417 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.11 -23.68 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.449 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.716 ' O ' HD12 ' B' ' 31' ' ' ILE . 97.7 m -77.83 -40.08 41.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.362 -170.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.839 HD12 HD11 ' B' ' 32' ' ' LEU . 0.8 OUTLIER -60.68 -37.37 81.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.409 169.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.61 96.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.245 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.2 mmmm -77.8 -31.41 51.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.369 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.802 HG21 HG21 ' A' ' 64' ' ' VAL . 5.5 mt -61.35 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.035 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.839 HD11 HD12 ' B' ' 28' ' ' LEU . 3.5 mp -59.42 -35.4 73.93 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.611 -165.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.537 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -71.17 -37.44 72.18 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.125 -177.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 17.1 mm-40 -65.24 -52.08 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.3 ptm -65.03 -28.27 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.343 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.96 -45.8 48.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 11' ' ' ILE . 1.7 mtt-85 -60.64 -18.29 52.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.452 169.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.9 OUTLIER -87.03 -54.7 4.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.454 -173.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 64' ' ' VAL . 7.1 mt -61.54 -19.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.443 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -65.7 -70.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.353 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.544 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 32.3 t -61.07 -10.14 5.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.61 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.485 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -90.45 -45.02 9.24 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.097 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.456 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -63.51 -24.38 67.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.272 169.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 17' ' ' ALA . 78.2 mt -86.31 -50.43 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.134 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -31.77 70.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.371 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.793 HD22 HD23 ' B' ' 62' ' ' LEU . 14.4 mt -60.78 -55.09 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.371 167.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.32 -30.42 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.292 -170.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.35 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -60.71 -35.05 75.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.371 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.61 -53.51 56.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.27 171.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.84 24.11 1.12 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.599 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HD3' ' NH1' ' A' ' 19' ' ' ARG . 1.3 ptp85 59.57 33.51 22.1 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.226 -0.573 . . . . 0.0 111.169 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 77.37 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.407 169.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.417 HG22 ' H ' ' B' ' 55' ' ' ILE . 1.5 m 68.49 175.93 0.27 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.528 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 20' ' ' VAL . 17.4 mm -118.41 137.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.235 166.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -142.94 166.34 24.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.429 -168.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' OE2' ' B' ' 61' ' ' GLU . . . -63.21 -25.17 68.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.253 -172.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 1.0 OUTLIER -64.18 -37.48 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.108 168.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HG2' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -79.5 -39.86 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.395 -176.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.473 HG13 ' CA ' ' A' ' 24' ' ' ALA . 38.2 mm -60.98 -54.4 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.421 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.768 ' OE2' ' HB1' ' B' ' 57' ' ' ALA . 4.5 mt-10 -68.59 -36.43 78.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.986 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.793 HD23 HD22 ' B' ' 46' ' ' LEU . 16.4 tp -61.13 -44.41 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.338 168.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.548 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.41 -42.82 99.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.413 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.929 HG23 HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -82.99 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.18 -167.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -11.89 8.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.565 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -94.61 -30.9 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.443 168.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 1.1 t80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.761 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.891 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.2 mp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 122.294 1.045 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.9 Cg_endo -67.59 141.72 56.24 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.114 2.542 . . . . 0.0 113.67 -172.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.49 -9.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.023 -172.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.94 -60.33 1.23 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.727 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -56.92 -51.37 9.05 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.454 2.103 . . . . 0.0 113.497 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.2 mt -60.59 -45.91 96.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.45 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.58 -30.03 75.41 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.686 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.85 -20.57 27.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.493 -0.353 . . . . 0.0 110.329 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.1 mt -65.19 -49.7 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.446 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.656 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.9 mm -61.05 -46.61 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.418 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -62.32 -30.32 71.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.261 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.34 -35.39 78.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.77 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.54 -52.63 64.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.511 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.11 23.53 0.34 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.576 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.7 170.51 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.306 173.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.65 -58.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.952 167.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -125.76 104.57 8.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.36 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.882 HG22 HD12 ' B' ' 55' ' ' ILE . 59.6 t -112.26 103.8 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.345 168.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.44 167.88 3.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.403 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -26.07 67.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.363 -170.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.21 -63.03 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.518 172.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.79 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.03 -39.54 92.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.3 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.7 mtm180 -61.56 -38.62 88.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.291 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.9 mm -76.25 -25.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.51 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.044 HG22 HG22 ' B' ' 60' ' ' ILE . 71.3 m -74.4 -45.8 44.42 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.12 -168.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD13 HG12 ' B' ' 60' ' ' ILE . 5.6 tp -59.19 -47.76 84.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.36 164.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -61.1 -18.46 58.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.531 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -99.68 -27.18 13.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.316 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.836 HG21 HG21 ' B' ' 64' ' ' VAL . 2.0 mp -60.79 -69.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.85 162.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.1 mp -59.67 -34.68 73.16 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.555 -168.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.891 ' CG ' HD13 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.67 -59.3 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.55 -20.24 63.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.83 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -52.2 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.223 160.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.87 95.15 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -61.31 -39.91 92.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.377 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -63.19 -56.49 16.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.434 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.932 HG21 HG23 ' A' ' 64' ' ' VAL . 3.0 mt -61.57 -28.0 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.219 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -64.34 -61.33 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.231 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.3 OUTLIER -80.71 -15.24 57.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.517 -167.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -78.98 -48.6 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.125 168.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.71 -37.46 86.59 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.041 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' B' ' 17' ' ' ALA . 48.2 mt -61.19 -50.3 81.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.147 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.91 -14.88 25.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.3 mt -91.63 -34.38 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.161 -172.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.5 -47.2 87.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.428 168.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -62.01 -48.35 80.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.359 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -62.7 -35.28 79.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.37 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.99 -54.24 47.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.183 168.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 24.71 0.57 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.618 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.31 96.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.215 -0.492 . . . . 0.0 110.531 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -153.61 78.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.239 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 55' ' ' ILE . 16.4 m 69.3 168.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.532 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.656 HD12 HG22 ' B' ' 20' ' ' VAL . 86.2 mt -121.9 147.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.356 168.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -178.84 7.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.424 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -64.23 -22.75 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.258 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.65 -68.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.155 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -25.94 67.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -169.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.959 HG23 HD13 ' B' ' 28' ' ' LEU . 16.0 mm -76.14 -60.05 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.343 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.3 mt-10 -61.75 -18.7 60.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.413 177.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.88 -41.01 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.469 173.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.459 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -66.43 -37.07 84.36 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.12 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.954 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.02 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.713 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -60.27 -9.87 3.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.657 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.2 tpt180 -73.66 -48.52 31.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.408 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.7 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.365 168.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' B' ' 33' ' ' GLU . 7.6 mt . . . . . 0 C--O 1.244 0.786 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.91 146.51 94.91 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.722 2.281 . . . . 0.0 113.439 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 pt -93.78 21.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.49 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -88.58 -59.81 0.25 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.748 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.5 Cg_endo -56.48 -45.72 35.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.362 2.041 . . . . 0.0 113.506 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -61.15 -55.2 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.515 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.39 68.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -80.45 -25.75 38.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.456 -177.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 3' ' ' LEU . 80.6 mt -68.38 -46.84 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.411 167.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.1 mm -65.44 -40.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.212 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtpp -61.05 -36.88 80.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.453 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -62.0 -31.9 72.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.845 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -52.35 65.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.52 170.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.59 22.57 0.85 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.744 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -64.3 146.29 54.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.807 -0.696 . . . . 0.0 110.405 172.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.32 -58.21 0.18 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.989 168.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -80.76 81.4 7.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.351 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.656 HG22 HD12 ' A' ' 55' ' ' ILE . 21.6 t -139.86 153.37 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.37 -168.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 99.0 p -101.71 150.36 23.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.393 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -16.97 49.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.32 168.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.96 -49.02 79.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.411 169.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.565 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.59 -45.84 92.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.388 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -30.05 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.404 -171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 58.3 mt -94.81 -20.41 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.436 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.668 HG22 HD11 ' B' ' 31' ' ' ILE . 88.8 m -61.03 -56.77 17.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.254 167.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.959 HD13 HG23 ' A' ' 60' ' ' ILE . 3.0 tp -60.7 -40.24 91.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.529 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.12 -39.97 92.0 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.421 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -84.22 -21.12 31.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.399 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.954 HD13 HG21 ' A' ' 64' ' ' VAL . 58.8 mt -61.4 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.018 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.901 ' HB3' HD23 ' A' ' 32' ' ' LEU . 8.9 mp -60.79 -42.82 98.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.539 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 14.6 tm-20 -63.56 -36.67 84.55 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.065 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -61.48 -43.98 97.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.063 173.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.625 ' HB3' HD11 ' B' ' 39' ' ' ILE . 34.5 mtp -60.78 -37.91 83.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.562 174.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.91 99.72 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -44.73 95.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.476 172.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.1 t70 -77.61 -45.87 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.559 -165.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' B' ' 35' ' ' MET . 5.8 mt -61.21 -30.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.253 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -67.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.305 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.455 ' N ' HD12 ' B' ' 44' ' ' ILE . 2.4 t -61.24 -9.19 4.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.471 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.75 -38.15 11.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.171 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.602 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.32 -16.11 59.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.46 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -87.45 -49.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.836 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -30.03 68.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.414 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.94 -47.23 85.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.405 166.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.679 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.93 -18.6 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.333 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -41.39 67.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.277 168.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -60.3 -30.74 69.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.415 170.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.77 -51.56 68.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.418 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.22 41.84 1.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.477 -174.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.53 18.97 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.43 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 140.66 29.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.191 165.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -61.03 168.25 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.361 -167.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -92.96 141.22 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.559 -168.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.58 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -138.25 -169.14 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.363 -171.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.612 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -66.83 -45.87 76.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.037 -169.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.468 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.8 mt-10 -61.54 -31.0 71.0 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.26 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.55 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.54 -68.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.336 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.04 -32.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 -162.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -38.59 87.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.468 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.55 -47.12 87.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.468 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.96 25.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.615 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.64 -57.21 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -159.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -10.92 3.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.39 166.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -85.37 -69.67 0.64 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.632 166.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -154.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' B' ' 11' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.548 0.872 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 7' ' ' PRO . 18.0 Cg_endo -62.08 140.73 85.73 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.505 2.137 . . . . 0.0 113.444 163.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -96.89 -10.97 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.698 -170.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.06 -53.75 60.67 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.691 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.0 Cg_endo -51.01 -57.21 2.39 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.613 2.209 . . . . 0.0 113.549 171.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.67 -25.98 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.422 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.95 32.69 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.549 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -76.43 -16.6 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.419 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.992 HD11 HD21 ' B' ' 3' ' ' LEU . 31.8 mt -60.99 -73.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.262 166.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.678 HD13 HG22 ' A' ' 11' ' ' ILE . 7.4 mm -61.89 -23.42 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.852 -170.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -69.27 -38.69 78.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.457 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' B' ' 37' ' ' ARG . 57.6 t0 -62.31 -33.68 75.13 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.802 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.91 -53.23 60.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.454 169.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.59 15.88 0.32 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.277 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -64.37 -177.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.261 165.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -171.13 -52.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.991 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -92.0 99.03 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.409 170.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.67 117.88 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.486 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.5 t -61.6 159.34 13.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.38 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.0 -22.82 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.372 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.685 ' HA ' HG22 ' A' ' 26' ' ' ILE . 8.2 t70 -96.4 -35.25 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.291 -170.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -60.61 -38.49 84.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.065 164.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HD3' HG21 ' A' ' 5' ' ' ILE . 7.4 ttm180 -60.16 -52.37 65.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.514 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tp -72.65 -37.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' CG2' ' B' ' 60' ' ' ILE . 55.6 m -61.37 -51.86 67.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.262 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 ' N ' HG21 ' B' ' 60' ' ' ILE . 11.8 tp -61.44 -25.5 67.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.189 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -53.36 15.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.534 169.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.03 -28.84 65.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.363 -170.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.826 HD12 HG22 ' B' ' 60' ' ' ILE . 88.2 mt -61.42 -72.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.054 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.913 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -59.92 -19.08 49.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.771 -166.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 2.5 pp20? -91.43 -41.89 10.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.027 -171.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.58 -35.14 76.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.904 167.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 mmt -61.05 -54.05 49.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.476 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.79 95.23 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -167.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.704 ' NE ' HG23 ' B' ' 11' ' ' ILE . 0.1 OUTLIER -60.92 -33.9 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.315 170.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -53.88 48.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.541 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 64' ' ' VAL . 9.8 mt -61.37 -38.92 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.233 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.77 -57.11 10.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.384 -172.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.5 t -61.71 -30.62 70.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.254 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.7 mm-40 -60.76 -60.04 4.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.36 -11.93 12.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.535 -176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.76 -56.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.117 -169.107 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.4 65.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.439 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 42' ' ' GLU . 7.0 mp -61.15 -49.04 78.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.293 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.723 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.38 -27.84 68.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.327 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -53.28 40.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.455 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.423 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.93 -55.08 37.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.124 170.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.3 32.94 0.37 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.508 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.03 -59.93 0.5 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.79 -0.705 . . . . 0.0 111.009 164.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -60.13 98.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.583 -163.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m 70.14 123.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.371 166.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' B' ' 20' ' ' VAL . 15.9 mt -79.02 140.21 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.273 164.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD2' ' CB ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -144.47 -174.32 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -168.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.7 -31.18 71.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.34 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.45 -42.33 83.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.115 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -35.43 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.323 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.839 HG23 HD13 ' B' ' 28' ' ' LEU . 33.6 mm -61.09 -40.05 84.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.326 169.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 37.5 mt-10 -80.34 -34.07 36.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.002 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -45.08 95.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.436 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.17 -36.96 81.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.518 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 1.14 HG21 HG21 ' B' ' 31' ' ' ILE 0.257 0.4 OUTLIER -75.22 -52.67 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.989 -167.155 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.17 62.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.596 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.488 ' HE ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -104.27 -12.5 16.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.923 -163.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 164.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.992 HD21 HD11 ' A' ' 11' ' ' ILE . 16.0 mt . . . . . 0 C--O 1.241 0.636 0 CA-C-O 121.534 0.683 . . . . 0.0 109.743 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.664 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.5 Cg_endo -60.05 147.75 91.87 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.324 2.016 . . . . 0.0 113.496 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.67 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -85.23 -30.84 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.541 -177.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.24 -59.8 4.73 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.69 -171.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.4 Cg_endo -52.58 -46.15 35.26 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 122.552 2.168 . . . . 0.0 113.533 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.9 mt -60.5 -36.23 68.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.394 172.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.55 -27.2 67.64 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.439 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 tpt85 -86.6 -27.38 23.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.395 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.704 HG23 ' NE ' ' A' ' 37' ' ' ARG . 16.2 mt -60.63 -46.36 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.47 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.0 mm -74.79 -31.62 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.922 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -60.71 -41.89 96.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.45 169.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.71 -31.9 72.09 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.853 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.93 -53.81 54.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.428 167.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.17 30.53 0.27 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.722 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.735 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -80.87 171.81 14.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.67 -0.765 . . . . 0.0 110.26 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -171.1 -25.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.956 166.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 82.0 1.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.533 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.745 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -113.79 129.4 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.165 167.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.6 p -61.0 165.94 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.256 166.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -10.82 5.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.353 167.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -75.83 -55.28 5.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.453 176.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -62.1 -41.13 97.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.25 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.514 HH21 HG23 ' B' ' 20' ' ' VAL . 3.3 ttm180 -62.29 -48.13 81.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.386 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.467 HD11 HG21 ' B' ' 5' ' ' ILE . 11.2 mm -76.25 -32.13 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.391 -174.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 57' ' ' ALA . 84.9 m -60.98 -52.02 66.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.461 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.839 HD13 HG23 ' A' ' 60' ' ' ILE . 4.1 tp -61.34 -45.65 93.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.264 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -60.89 -28.52 68.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.449 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -27.98 21.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.455 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 1.14 HG21 HG21 ' A' ' 64' ' ' VAL . 16.7 mt -61.77 -72.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.989 165.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.51 -12.8 10.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.565 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.3 -57.95 3.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.054 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.96 79.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.042 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 7.2 tpp -60.82 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.428 166.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.94 89.9 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -170.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -60.83 -26.82 67.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.317 170.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -48.09 38.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.522 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.913 HD12 HD11 ' A' ' 32' ' ' LEU . 1.2 mt -63.02 -28.83 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.474 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.668 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -65.34 -68.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.318 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 80.9 p -61.45 -16.06 43.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.629 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -69.06 -64.51 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.13 165.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.16 -10.92 7.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.624 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.0 mt -99.82 -50.42 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.769 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.27 -29.3 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.402 168.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.8 mt -60.82 -51.52 68.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.245 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.699 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -67.97 -38.19 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.293 -169.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -70.35 -39.9 74.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.403 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -60.78 -35.88 77.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.335 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.67 -54.38 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.195 167.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.96 22.37 0.74 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.725 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.52 -165.12 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.294 -0.533 . . . . 0.0 110.981 168.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 65.44 100.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.466 -167.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 21' ' ' SER . 2.0 m 70.14 124.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.377 167.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' B' ' 47' ' ' ALA . 5.6 mm -89.82 152.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.316 166.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.502 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -131.03 159.62 36.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.428 -168.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.93 -30.04 70.63 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.335 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -53.38 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.156 171.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -13.09 23.8 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.456 -174.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.826 HG22 HD12 ' A' ' 31' ' ' ILE . 33.0 mm -84.01 -63.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.393 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' A' ' 31' ' ' ILE . 31.1 mt-10 -61.72 -13.74 25.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.625 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.6 -30.78 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.332 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -63.9 -37.52 87.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.755 161.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 31' ' ' ILE . 41.0 t -61.45 -71.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.769 166.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 -59.2 -11.51 3.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.811 -170.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -71.72 -50.02 34.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.439 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.714 ' HE2' HG23 ' B' ' 39' ' ' ILE . 29.5 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.543 173.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 33' ' ' GLU . 10.4 mp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 121.898 0.856 . . . . 0.0 111.551 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 9.3 Cg_endo -49.13 138.49 28.28 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 C-N-CA 122.6 2.2 . . . . 0.0 113.348 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.68 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -91.53 19.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.898 -167.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.35 -58.24 0.45 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.699 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -54.41 -53.27 6.48 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.497 2.131 . . . . 0.0 113.537 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.2 mt -61.44 -59.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.522 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.6 -18.83 57.14 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -31.68 22.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.952 -0.624 . . . . 0.0 110.356 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' B' ' 3' ' ' LEU . 61.4 mt -60.53 -51.14 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.554 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.9 mm -61.27 -37.61 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.281 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -34.31 77.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.344 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -62.52 -34.42 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' B' ' 41' ' ' SER . . . -59.34 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.485 169.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.73 21.98 0.42 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.604 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.31 150.62 29.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.349 167.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.07 -51.81 2.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.036 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.52 132.12 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.37 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 45.5 t -124.73 123.1 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.333 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.441 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 21.4 t -66.29 156.73 33.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.454 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HA ' ' CG ' ' A' ' 25' ' ' ARG . 27.9 t0 -61.37 -24.07 66.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.346 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 0.7 OUTLIER -60.65 -53.69 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.513 172.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' B' ' 60' ' ' ILE . . . -62.18 -47.24 85.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.318 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HD3' HG13 ' A' ' 5' ' ' ILE . 1.4 ptp85 -70.96 -27.65 63.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 -168.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 78.5 mt -86.29 -27.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.421 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.505 HG22 HD12 ' A' ' 31' ' ' ILE . 99.3 m -60.95 -54.4 45.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.345 170.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.976 HD13 HG23 ' B' ' 60' ' ' ILE . 4.0 tp -60.14 -43.01 96.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.49 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.19 -32.19 71.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.501 -174.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.86 -24.1 15.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.236 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.067 HD13 HG21 ' B' ' 64' ' ' VAL . 84.4 mt -60.65 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.028 164.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -59.04 -33.89 71.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.699 -172.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.796 ' HB2' HD13 ' A' ' 3' ' ' LEU . 10.4 tm-20 -61.86 -59.33 5.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.047 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 2.3 tp10 -64.52 -30.57 71.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.838 -171.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.42 -41.14 93.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.292 164.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.62 -46.9 93.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.46 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -62.66 -24.75 67.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.049 -178.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.9 t0 -80.9 -45.25 17.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.504 -174.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 67' ' ' PHE . 9.6 mt -61.65 -30.28 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.144 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.652 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.54 -77.31 0.05 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.25 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.774 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.81 -11.0 10.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.384 -172.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.35 -56.46 4.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.114 170.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -60.5 -17.2 43.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.612 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' B' ' 17' ' ' ALA . 78.3 mt -85.58 -51.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.854 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -60.63 -39.73 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.383 168.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 63' ' ' ALA . 50.6 mt -60.76 -39.69 89.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.415 170.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.46 -24.75 66.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.295 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -82.34 -48.85 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.343 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.01 64.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.242 167.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -56.57 19.96 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.137 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.25 30.07 0.16 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.697 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.69 -60.96 0.49 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.923 161.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.05 93.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.306 0.574 . . . . 0.0 110.581 -161.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.532 HG21 ' HB2' ' B' ' 21' ' ' SER . 24.9 m 70.44 144.28 0.06 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HB ' HG13 ' B' ' 20' ' ' VAL . 15.3 mm -73.32 138.35 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.221 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -135.94 170.32 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.429 -170.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.45 55.91 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.48 -165.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.717 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.23 -26.81 68.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.946 -174.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.8 m-20 -65.18 -39.5 92.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.499 173.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.829 HD12 ' CD2' ' B' ' 28' ' ' LEU . 36.5 mm -62.75 -67.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.391 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.6 mt-10 -61.09 -11.21 7.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.278 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -73.1 -50.88 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.437 166.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -61.14 -42.82 99.23 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.304 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.854 HG21 HD13 ' B' ' 31' ' ' ILE . 21.8 t -62.02 -68.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.856 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.17 -9.79 3.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.682 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -35.32 39.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.355 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CE2' HG12 ' A' ' 39' ' ' ILE . 96.9 m-85 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.367 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.642 ' CD2' HD11 ' A' ' 11' ' ' ILE . 3.2 mt . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 140.88 94.04 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.41 2.074 . . . . 0.0 113.481 167.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.671 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -88.61 -11.94 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.657 -173.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.45 -60.55 2.57 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.81 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.7 Cg_endo -55.64 -42.97 62.27 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.462 2.108 . . . . 0.0 113.546 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' B' ' 3' ' ' LEU . 57.4 mt -60.45 -39.76 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.472 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.72 -29.92 73.47 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.579 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.495 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 mtp180 -89.82 -23.13 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 110.383 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 3' ' ' LEU . 36.5 mt -60.93 -58.39 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.317 166.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.652 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.3 mm -61.87 -36.53 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.274 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.98 -36.31 79.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.362 169.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.3 -32.78 73.57 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.835 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.774 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.79 -53.41 58.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.425 169.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.59 20.85 0.76 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.725 -172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.24 120.08 9.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.35 166.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.41 -54.48 10.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.168 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 104.9 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.379 174.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.795 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.2 t -83.81 129.28 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.267 169.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 54' ' ' THR . 27.0 t -61.49 148.29 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.279 166.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 10.9 p30 -61.54 -22.78 65.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.417 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG22 ' B' ' 26' ' ' ILE . 10.1 t70 -88.73 -25.56 22.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.387 -172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -66.41 -44.14 83.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.24 168.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.503 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 2.3 ptt-85 -83.09 -18.17 40.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.414 -167.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.675 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -78.19 -35.43 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.41 168.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.555 HG22 HG21 ' A' ' 60' ' ' ILE . 68.7 m -61.11 -37.93 84.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.265 175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.829 ' CD2' HD12 ' A' ' 60' ' ' ILE . 1.1 mm? -60.84 -40.54 93.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.322 166.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.67 -52.13 65.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.337 -176.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.479 ' NZ ' HD11 ' B' ' 26' ' ' ILE . 0.2 OUTLIER -68.55 -33.47 74.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.464 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 64' ' ' VAL . 41.1 mt -61.71 -71.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.16 170.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.724 ' CD1' HD12 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.8 -15.66 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.832 -169.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.417 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 2.7 tt0 -95.41 -24.03 16.88 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.054 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -61.43 -52.26 65.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.111 167.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -73.56 -27.41 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.327 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.32 91.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.86 69.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.334 168.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 2.2 t70 -70.26 -58.18 4.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.557 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.668 HG21 HG23 ' B' ' 64' ' ' VAL . 4.2 mt -61.44 -30.32 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.385 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.22 -73.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.296 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.921 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 24.5 p -62.13 -15.44 45.62 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.529 -170.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.53 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -89.67 -39.52 13.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.158 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.63 -9.07 56.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.486 168.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.786 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.6 mt -94.34 -53.24 8.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.873 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.43 -18.21 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.382 168.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.1 mt -72.96 -48.75 33.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.398 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -70.3 -31.94 69.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.218 -170.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.429 ' CZ ' ' HB2' ' B' ' 48' ' ' ARG . 22.8 ttm105 -65.83 -40.02 91.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.282 168.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.23 -38.58 87.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.31 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.88 -51.21 70.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.287 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.14 4.31 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 148.02 22.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.415 -170.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -82.63 171.98 13.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -170.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 93.9 m 61.54 119.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.421 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.761 HG23 ' HB3' ' B' ' 59' ' ' ASP . 82.4 mt -88.6 148.31 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.388 170.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 0.0 OUTLIER -135.75 179.69 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.45 -169.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -61.6 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.291 -171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 15.7 pt-20 -84.36 -43.86 14.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.063 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.761 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.4 OUTLIER -61.61 -23.52 66.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.44 179.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 28' ' ' LEU . 29.7 mm -88.61 -56.37 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.239 -171.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 36.5 mt-10 -62.09 -18.06 59.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 172.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' B' ' 62' ' ' LEU . 12.1 mt -67.17 -55.82 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.336 168.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.64 81.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.219 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 31' ' ' ILE . 49.2 t -62.1 -79.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.689 171.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -12.02 9.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.365 -168.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -53.68 48.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.36 167.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 5.0 m-85 . . . . . 0 N--CA 1.454 -0.245 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.375 173.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 8' ' ' ILE . 17.2 mt . . . . . 0 C--O 1.242 0.665 0 CA-C-O 121.599 0.714 . . . . 0.0 109.989 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 4.2 Cg_endo -46.52 140.45 11.94 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.4 2.067 . . . . 0.0 113.478 173.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.661 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -89.76 -13.41 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.755 -168.799 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.76 -55.86 8.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.665 173.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.5 Cg_exo -48.68 -59.33 1.29 Allowed 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.705 2.27 . . . . 0.0 113.555 169.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.7 mt -61.43 -35.87 69.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.458 -178.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 25' ' ' ARG . . . -61.61 -37.73 94.68 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.556 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 9.4 ptp180 -90.23 -14.35 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.465 -171.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.52 -56.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.305 165.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.699 HD11 HD23 ' A' ' 28' ' ' LEU . 9.1 mm -61.34 -37.31 77.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.149 -177.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 mttm -60.37 -39.45 87.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.429 167.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.34 -33.35 74.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.751 -177.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -59.11 -53.86 53.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.207 -1.361 . . . . 0.0 110.427 169.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.48 21.56 0.45 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.713 -175.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.56 137.95 58.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.409 168.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.9 -27.72 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.005 -170.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.82 117.99 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.445 169.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' CG1' ' B' ' 55' ' ' ILE . 89.5 t -141.41 132.24 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -172.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 p -83.34 151.23 25.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.406 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 p30 -62.03 -14.17 33.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 26' ' ' ILE . 11.7 m-20 -86.48 -27.9 23.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.394 -176.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -65.42 -39.28 91.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.109 165.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -61.66 -43.64 98.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.518 -178.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.605 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 tt -75.08 -40.45 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.269 -172.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD11 ' A' ' 31' ' ' ILE . 83.1 m -60.66 -44.42 96.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.396 -174.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.782 HD13 HG23 ' B' ' 60' ' ' ILE . 2.2 tp -61.0 -35.41 76.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.288 169.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -62.05 -42.07 98.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.405 178.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -29.42 40.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 28.9 mt -61.28 -72.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.029 171.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 31' ' ' ILE . 8.2 mp -60.11 -30.28 69.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 -167.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.4 tm-20 -81.53 -37.44 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.034 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -61.47 -39.79 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.955 166.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.427 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 95.3 mtp -61.36 -40.91 96.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.495 175.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.09 -38.21 63.7 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -166.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -61.02 -27.5 68.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.248 164.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -74.12 -51.47 15.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.53 -173.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 64' ' ' VAL . 12.5 mt -61.14 -38.86 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.204 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.878 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -60.97 -58.68 7.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.388 -170.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 23.3 p -61.49 -28.79 69.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.365 178.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.0 -43.38 98.94 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.071 169.575 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -76.9 -12.73 60.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.354 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.849 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -84.27 -56.59 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.306 -168.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -59.79 -28.89 67.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.488 170.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.79 HD22 HD23 ' A' ' 62' ' ' LEU . 13.5 mt -60.63 -47.02 88.09 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.457 174.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.73 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.23 -38.03 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.325 -176.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -44.94 75.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 -170.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -60.97 -31.48 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.336 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.27 -53.21 59.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.211 168.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.82 17.14 0.84 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 59.39 28.39 17.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.322 -0.516 . . . . 0.0 111.237 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 77.59 8.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.298 169.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.583 HG23 ' HG3' ' B' ' 19' ' ' ARG . 6.7 m 68.51 169.58 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.709 ' HB ' HG22 ' B' ' 20' ' ' VAL . 5.6 mm -106.08 137.29 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.195 164.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.737 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -128.26 159.77 34.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.417 -167.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -62.28 -13.04 24.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.126 -172.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 1.0 OUTLIER -81.69 -25.49 35.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 174.04 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -84.04 -36.43 23.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.27 -174.673 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.831 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.82 -48.72 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.489 161.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.4 mm-40 -61.44 -43.85 98.15 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.81 -174.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 HD22 ' A' ' 46' ' ' LEU . 39.9 tp -65.38 -44.74 86.6 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.542 173.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.39 -45.05 95.96 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.426 -175.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.887 HG21 HG21 ' B' ' 31' ' ' ILE 0.25 0.4 OUTLIER -78.51 -53.52 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.085 -166.554 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -36.26 77.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.631 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -21.06 59.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.374 174.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.9 t80 . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.259 -173.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.671 ' CB ' HD11 ' B' ' 8' ' ' ILE . 4.6 mt . . . . . 0 C--O 1.243 0.716 0 CA-C-O 121.324 0.583 . . . . 0.0 109.71 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.3 Cg_endo -55.07 142.93 76.05 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 122.613 2.209 . . . . 0.0 113.628 -172.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.789 HG21 ' HE ' ' B' ' 25' ' ' ARG . 0.1 OUTLIER -66.42 -18.3 23.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.571 -165.198 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -74.62 -62.47 0.94 Allowed Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.776 -170.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.9 Cg_endo -52.72 -50.5 13.83 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.402 2.068 . . . . 0.0 113.444 175.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.671 HD11 ' CB ' ' B' ' 3' ' ' LEU . 27.2 mt -60.45 -31.74 49.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.393 168.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.99 67.97 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.484 -175.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 49.7 mmm-85 -91.66 -27.72 17.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.477 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.476 HD13 ' HG2' ' A' ' 33' ' ' GLU . 36.5 mt -60.92 -59.57 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.526 170.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.878 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.0 mm -61.37 -38.42 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -61.8 -34.01 75.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.349 175.739 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.22 -32.56 73.23 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.685 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.69 -54.0 51.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.45 169.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.45 28.62 0.26 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.67 -176.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.849 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.09 148.84 37.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.715 -0.743 . . . . 0.0 110.357 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.62 117.08 5.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.092 169.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.583 ' HG3' HG23 ' A' ' 54' ' ' THR . 3.1 tpp180 65.04 97.02 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.356 -173.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 55' ' ' ILE . 46.2 t -110.8 150.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.292 168.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -61.13 149.41 37.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.315 169.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.449 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 1.7 m-20 -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.309 170.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.78 -60.25 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.593 174.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -62.09 -47.66 83.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.318 -171.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.789 ' HE ' HG21 ' B' ' 5' ' ' ILE . 5.7 ptt180 -61.09 -34.81 75.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.344 -172.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.15 -33.89 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.499 175.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.81 ' O ' HD12 ' B' ' 31' ' ' ILE . 80.0 m -60.99 -44.93 96.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.407 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.831 HD22 HG13 ' A' ' 60' ' ' ILE . 3.9 tp -60.39 -54.47 45.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.268 173.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -61.54 -15.53 39.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.456 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' CG ' ' B' ' 33' ' ' GLU . 8.5 tmtt? -99.02 -25.46 14.55 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.266 -174.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mt -60.54 -69.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.951 162.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 28' ' ' LEU . 2.5 mp -59.92 -35.16 74.3 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.575 -167.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.515 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -70.35 -40.08 74.27 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.964 -176.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -44.17 97.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.122 173.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.511 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 63.1 mmm -61.01 -27.09 68.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.462 175.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.15 -43.47 13.45 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -60.34 -17.98 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.393 166.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -90.96 -52.13 5.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.358 -168.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.734 HD13 ' CG2' ' B' ' 64' ' ' VAL . 4.3 mt -61.11 -23.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.206 167.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.66 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.84 -72.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.28 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.828 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 11.8 m -61.67 -11.4 11.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.358 -175.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.432 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -80.22 -56.63 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.129 171.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.4 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -61.1 -14.65 25.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.326 176.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 17' ' ' ALA . 70.8 mt -90.62 -54.96 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.056 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.53 -11.62 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.414 170.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 6.4 mt -87.81 -42.47 12.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.443 176.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.47 -25.69 67.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.276 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -83.41 -50.75 8.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.45 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -61.31 -31.62 71.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.375 -178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.28 73.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.201 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.83 35.78 0.94 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -166.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 66.49 118.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.487 169.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.598 ' O ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -167.82 13.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.321 179.387 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.598 HG22 ' O ' ' B' ' 53' ' ' LYS . 0.7 OUTLIER 60.96 162.37 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.494 -175.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.895 ' CG1' HG22 ' A' ' 20' ' ' VAL . 14.0 mm -75.21 137.47 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.339 173.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 18.9 mtmt -154.32 -178.82 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.425 -169.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -24.69 66.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.34 172.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -26.48 21.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.123 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -35.5 13.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.317 -175.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 28' ' ' LEU . 46.9 mm -61.15 -47.37 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.196 167.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.492 ' HG2' ' NH2' ' B' ' 65' ' ' ARG . 20.9 mt-10 -62.02 -44.53 96.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.971 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -45.98 92.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.464 172.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' B' ' 46' ' ' LEU . . . -61.49 -46.04 91.69 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.421 -177.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.734 ' CG2' HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -80.02 -60.94 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.099 -165.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' B' ' 61' ' ' GLU . 4.6 mtm180 -60.22 -19.0 52.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.565 -175.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -89.54 -25.5 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.544 171.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.8 t80 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.46 -179.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 122.086 0.946 . . . . 0.0 112.569 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.665 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.3 Cg_endo -63.82 141.21 77.41 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 113.646 -178.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 HH21 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -100.24 -13.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.636 -166.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.44 -55.54 3.53 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.674 173.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.2 Cg_exo -49.43 -61.17 0.62 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.749 2.299 . . . . 0.0 113.557 168.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 3' ' ' LEU . 54.9 mt -61.39 -49.58 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.4 91.27 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -172.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -40.99 96.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.081 -0.56 . . . . 0.0 110.407 176.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 8' ' ' ILE . 68.1 mt -61.55 -36.11 71.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.538 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.673 HG23 ' HB1' ' B' ' 40' ' ' ALA . 8.3 mm -72.79 -44.97 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.192 -172.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -31.96 72.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.255 176.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -61.89 -33.3 73.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.807 177.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.26 -53.21 60.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.462 170.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.4 25.79 0.63 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.496 -174.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.21 119.79 9.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.718 -0.741 . . . . 0.0 110.363 176.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.59 -71.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.12 131.84 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.368 168.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.557 ' CG2' ' HB1' ' A' ' 17' ' ' ALA . 60.0 t -124.62 133.14 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.422 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.9 p -73.47 136.02 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.04 -12.88 13.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.398 -174.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -86.67 -21.93 26.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.35 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.719 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -70.72 -38.47 73.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.123 164.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.487 HH21 HD13 ' A' ' 5' ' ' ILE . 2.3 mtp180 -61.48 -31.48 71.46 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.502 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.5 tp -89.7 -34.61 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 -175.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.665 ' O ' HD12 ' A' ' 31' ' ' ILE . 80.5 m -61.52 -41.16 96.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.18 177.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.8 tp -59.19 -45.48 90.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.541 167.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.52 -43.09 99.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.504 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -76.62 -28.09 55.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.235 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.02 HG21 HG21 ' B' ' 64' ' ' VAL . 6.6 mt -59.59 -73.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.908 162.177 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.687 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -56.15 -23.79 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.819 -159.646 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.785 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.83 -60.76 2.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.038 166.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -28.66 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.109 -164.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.531 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.3 mmm -71.58 -38.96 70.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.436 167.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -66.49 -44.3 90.44 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -174.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.399 168.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -66.35 -53.75 32.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.434 -178.003 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.639 ' HB ' HD11 ' B' ' 28' ' ' LEU . 8.1 mt -61.39 -45.48 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.388 -175.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.29 -48.36 81.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 -172.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.2 t -62.15 -27.46 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.385 177.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -68.37 -43.15 78.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.181 168.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -73.06 -7.78 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.676 177.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.831 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.84 -52.07 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.275 -174.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -31.1 68.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.667 168.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 43' ' ' ALA . 12.7 mt -61.16 -51.13 70.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.405 175.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.99 67.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.348 -171.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -41.97 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.439 170.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -63.22 -31.6 72.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.389 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.261 169.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 35.01 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -170.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.15 133.68 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.375 169.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.4 mmpp? -61.35 -43.51 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.34 -169.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -66.41 126.21 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.412 -168.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 59' ' ' ASP . 7.0 mt -91.67 154.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.362 168.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HE3' ' H ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -158.84 173.53 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.377 -166.521 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' H ' ' HE3' ' A' ' 56' ' ' LYS . . . -61.97 -15.85 46.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.255 -177.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.718 ' O ' HD13 ' A' ' 62' ' ' LEU . 1.3 tt0 -83.76 -41.59 17.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.087 175.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -59.94 -49.38 77.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.608 170.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 28' ' ' LEU . 32.2 mm -60.77 -59.92 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.415 -171.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 30.3 mt-10 -61.83 -29.17 69.99 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.968 -174.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.1 mp -60.36 -45.6 92.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.469 168.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.14 -42.93 99.44 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.588 -176.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.76 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.14 -55.07 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.054 -165.569 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -21.87 64.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.738 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -92.92 -14.33 27.72 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.736 177.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CD2' ' HG2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.92 161.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.578 ' CB ' HD11 ' B' ' 8' ' ' ILE . 12.1 mt . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.311 0.577 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 5.1 Cg_endo -60.32 160.98 21.35 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.575 2.183 . . . . 0.0 113.407 164.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.412 HD13 ' OD1' ' B' ' 22' ' ' ASP . 2.4 pp -102.27 -20.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.517 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.14 -59.09 4.5 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.754 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 4.7 Cg_endo -48.66 -50.98 11.19 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.585 2.19 . . . . 0.0 113.467 171.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.853 ' HA ' HD12 ' B' ' 11' ' ' ILE . 66.9 mt -60.83 -27.91 42.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.317 174.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.44 -40.71 99.05 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.502 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.06 -21.68 39.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.495 -178.441 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' B' ' 8' ' ' ILE . 89.7 mt -67.19 -44.44 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.507 178.053 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.0 mm -69.17 -41.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.325 175.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 11.2 mtmt -61.51 -39.67 91.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.313 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.59 -31.31 71.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.908 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.07 -52.37 65.82 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.639 170.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.91 24.33 0.33 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.635 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.831 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -75.69 120.04 20.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.617 -0.791 . . . . 0.0 110.255 176.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 13.88 29.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.995 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 179.35 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.419 -174.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.8 HG22 ' HB1' ' B' ' 17' ' ' ALA . 10.7 t -99.85 125.58 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.338 -176.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -63.57 149.64 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.169 164.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' B' ' 5' ' ' ILE . 35.9 t70 -60.58 -12.23 9.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.502 169.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' B' ' 26' ' ' ILE . 0.5 OUTLIER -95.37 -32.67 12.83 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.428 -174.61 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -61.2 -41.33 96.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.182 169.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.15 -53.55 55.55 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.52 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.77 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -67.21 -33.44 62.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.316 -171.915 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.444 HG22 ' CG2' ' A' ' 60' ' ' ILE . 85.0 m -70.1 -34.45 73.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.318 -174.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.918 HD21 HD12 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -60.68 -40.76 93.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.21 166.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.57 -56.82 15.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.299 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -33.64 76.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.445 -174.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 64' ' ' VAL . 69.7 mt -61.05 -74.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.935 167.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.687 ' O ' HD11 ' A' ' 32' ' ' LEU . 3.7 mt -59.33 -28.67 67.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.57 -164.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.557 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.6 pp20? -75.72 -39.5 57.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -35.73 79.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.969 175.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.517 170.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.91 -38.35 95.88 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -33.89 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.276 167.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.1 t70 -64.29 -55.7 19.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.438 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.685 ' HB ' HD11 ' A' ' 28' ' ' LEU . 4.9 mt -61.8 -33.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.09 -177.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.93 -65.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.27 -173.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.51 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.03 -18.26 64.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.521 -175.373 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.3 OUTLIER -81.71 -44.65 16.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.168 175.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -68.27 -32.53 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.148 175.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.996 HD11 ' HB2' ' A' ' 17' ' ' ALA . 21.7 mt -60.71 -47.39 93.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.097 164.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -30.29 69.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.429 177.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.0 mt -72.31 -34.34 68.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.366 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -61.13 -35.84 78.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.294 176.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.64 -44.06 96.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 172.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.74 -36.84 79.89 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.438 174.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.81 -49.88 75.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 172.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 29.79 2.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -163.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.32 -169.58 0.14 Allowed 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.089 -0.654 . . . . 0.0 111.072 175.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.86 98.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.466 -169.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.94 122.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 165.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' B' ' 47' ' ' ALA . 4.1 mp -93.22 138.16 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.152 162.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -130.55 178.95 6.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.401 -167.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.34 -19.88 62.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.47 -28.67 21.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.043 -177.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.2 -34.94 21.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.338 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.719 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 46.7 mm -61.02 -50.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.403 168.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 5.5 mt-10 -69.1 -37.52 78.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -175.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.04 -45.45 94.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.397 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.435 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.29 -49.48 76.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.385 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 31' ' ' ILE 0.257 0.4 OUTLIER -74.87 -50.5 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.937 -160.89 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -30.19 71.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.439 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.55 84.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.377 -177.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.398 172.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 8' ' ' ILE . 13.2 mt . . . . . 0 C--O 1.243 0.731 0 CA-C-O 121.394 0.616 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.21 141.55 58.83 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.85 1.7 . . . . 0.0 113.113 168.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -93.25 20.77 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.622 -164.319 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.56 -59.39 0.45 Allowed Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.716 172.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -58.0 -50.5 10.0 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.496 2.131 . . . . 0.0 113.498 173.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.846 ' HA ' HD12 ' A' ' 11' ' ' ILE . 57.4 mt -61.37 -44.03 97.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.499 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.41 98.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -170.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.53 -32.31 69.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.008 -0.596 . . . . 0.0 110.334 -178.244 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 8' ' ' ILE . 39.6 mt -61.76 -51.76 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.354 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mm -65.78 -48.44 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.439 -173.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -35.14 78.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.253 177.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.83 -32.19 72.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.85 177.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.83 -52.47 65.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.522 170.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.54 20.65 0.61 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.737 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.77 119.54 10.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.181 -0.509 . . . . 0.0 110.319 168.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -112.69 18.47 18.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.893 176.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' B' ' 54' ' ' THR . 0.0 OUTLIER 179.89 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.332 -164.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.868 HG22 HD12 ' B' ' 55' ' ' ILE . 12.3 t -136.81 118.11 18.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.38 172.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -74.39 159.74 31.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.393 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.13 -23.59 65.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.412 -171.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' ILE . 80.5 m-20 -90.67 -29.6 17.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -170.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.755 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.26 -42.81 99.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.143 162.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.543 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -77.31 -28.69 53.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 -167.519 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 23' ' ' ASP . 5.2 tp -72.94 -37.33 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.429 172.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 31' ' ' ILE . 57.8 m -60.69 -39.98 90.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.727 HD13 HG23 ' B' ' 60' ' ' ILE . 3.5 tp -64.55 -44.37 90.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.014 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.63 72.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.452 173.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -79.35 -33.21 43.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.478 179.207 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.737 HG21 HG21 ' B' ' 64' ' ' VAL . 11.6 mt -60.57 -69.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.003 169.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.739 ' O ' HD21 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -58.09 -27.64 63.86 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.672 -168.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -84.55 -19.92 32.36 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.149 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -63.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.008 165.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.419 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 11.0 mtp -61.99 -31.04 71.37 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 -174.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.45 -42.96 71.61 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -177.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -22.02 63.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.547 . . . . 0.0 110.435 169.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.4 m-20 -90.46 -47.74 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.608 -168.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.9 mt -61.27 -29.66 46.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.243 171.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.98 -66.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.237 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 29.7 p -63.61 -17.57 63.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.542 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.696 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -69.7 -60.84 2.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.909 167.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.425 ' CA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.69 -14.68 33.63 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.417 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.961 HD11 ' HB2' ' B' ' 17' ' ' ALA . 84.2 mt -96.93 -48.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.664 -172.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -59.85 -11.62 5.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.482 164.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.7 mp -87.17 -52.84 5.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.277 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -14.27 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.314 177.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.94 -70.27 0.7 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.414 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -67.87 -12.01 59.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.852 -170.078 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 52' ' ' ARG . . . -64.7 -45.96 84.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 163.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.08 4.31 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -166.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.516 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 14.6 mmm180 -126.09 172.54 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.448 -164.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 135.92 50.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.445 -170.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 55' ' ' ILE . 70.2 m 62.82 146.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.469 -178.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.972 HD12 HG22 ' B' ' 20' ' ' VAL . 64.3 mt -97.19 156.62 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.234 168.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 177.08 11.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.469 -171.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.87 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.3 173.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -65.34 -50.35 65.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.028 168.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.785 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -61.4 -51.93 66.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.334 179.41 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.813 HG23 HD13 ' B' ' 28' ' ' LEU . 47.6 mm -60.76 -44.13 96.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.342 -168.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -39.21 88.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.151 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.38 -48.31 81.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.328 176.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.37 -30.21 70.39 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.401 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.694 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -89.49 -56.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.129 -165.222 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -16.24 31.42 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.695 171.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -32.02 57.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.358 169.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.465 171.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.672 ' CB ' HD11 ' B' ' 8' ' ' ILE . 15.5 mt . . . . . 0 C--O 1.242 0.697 0 CA-C-O 121.507 0.67 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 4.4 Cg_endo -47.53 142.42 13.42 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.551 2.168 . . . . 0.0 113.424 168.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.66 -19.21 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.447 -167.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.99 -62.66 1.51 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.744 -168.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.3 Cg_endo -52.68 -42.86 59.77 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.5 2.133 . . . . 0.0 113.491 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.672 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -60.41 -47.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.537 172.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.03 -26.13 67.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -173.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.24 -33.42 32.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.402 -177.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' HD21 ' A' ' 3' ' ' LEU . 67.5 mt -60.76 -52.4 62.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.447 169.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.956 HG22 ' HB2' ' B' ' 17' ' ' ALA . 11.8 mm -61.1 -35.13 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.199 177.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.5 mttt -67.58 -37.05 82.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.504 178.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -61.7 -31.42 71.57 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.687 -178.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.81 -53.58 56.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.474 168.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.14 7.51 0.81 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.782 -166.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -63.7 -162.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.954 0.502 . . . . 0.0 110.691 168.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' HG2' ' B' ' 13' ' ' LYS . 4.0 tm-20 64.2 25.42 13.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -155.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 20.19 17.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.404 151.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.972 HG22 HD12 ' A' ' 55' ' ' ILE . 61.2 t -113.27 172.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.228 -161.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.671 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 24.6 p -108.63 169.21 8.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.587 175.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 1.8 p30 -78.54 -33.52 47.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.336 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.83 -30.81 70.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.334 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' B' ' 21' ' ' SER . . . -60.95 -69.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.269 169.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' B' ' 22' ' ' ASP . 1.3 ptt180 -61.06 -11.44 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.345 -166.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 29.7 mt -86.11 -35.3 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.424 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.652 HG22 HD11 ' B' ' 31' ' ' ILE . 73.1 m -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.419 176.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 60' ' ' ILE . 2.8 tp -60.74 -40.45 92.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.42 177.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.32 96.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.511 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 5.7 tttt -74.63 -31.33 61.95 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.393 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.694 HG21 HG21 ' A' ' 64' ' ' VAL . 54.0 mt -60.72 -75.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.964 170.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.93 -30.98 66.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 -162.439 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 2.5 tm-20 -85.81 -31.44 22.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.016 -173.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.6 mm-40 -61.49 -36.91 81.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.829 163.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 2.6 ttm -63.82 -43.52 95.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.446 176.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.72 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -71.49 -33.58 63.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -165.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -60.85 -33.22 72.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.27 164.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -51.07 54.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.712 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.72 HD12 ' HA2' ' B' ' 36' ' ' GLY . 1.1 mt -62.32 -35.59 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.758 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 12' ' ' ILE . . . -61.35 -65.75 0.64 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.9 -20.51 63.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.418 -179.165 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.714 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -70.16 -61.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.133 169.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.32 -5.88 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' A' ' 17' ' ' ALA . 77.6 mt -101.41 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.885 -176.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -15.77 32.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.387 171.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.714 HD12 ' C ' ' B' ' 42' ' ' GLU . 13.4 mt -79.86 -50.32 10.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.432 170.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.35 -17.57 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.252 -171.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -46.51 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.458 169.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -61.74 -37.97 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.335 -173.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.04 -47.65 85.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.24 169.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.19 33.07 5.57 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -166.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.15 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.439 -168.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -91.61 132.31 36.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.37 170.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER 66.24 142.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.344 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 20' ' ' VAL . 89.2 mt -89.52 132.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.213 166.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -118.12 171.7 7.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.332 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -14.35 20.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.366 172.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.443 ' OE1' HD11 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -71.41 -52.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.183 169.387 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -68.91 -36.06 77.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.38 -178.083 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.755 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 39.2 mm -61.49 -62.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.342 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.81 -26.35 68.06 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.885 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 11.6 mt -60.46 -50.72 72.45 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.423 170.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -62.02 -32.91 73.46 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.479 -172.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -86.95 -48.84 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -162.512 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -66.69 -24.63 66.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.438 169.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.82 -37.08 80.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.415 173.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' B' ' 64' ' ' VAL . 10.5 p90 . . . . . 0 N--CA 1.464 0.256 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.333 -168.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 121.917 0.865 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 3' ' ' LEU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 122.217 1.008 . . . . 0.0 112.43 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 121.917 0.865 . . . . 0.0 111.626 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 3' ' ' LEU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 109.778 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.25 1.082 0 CA-C-O 122.217 1.008 . . . . 0.0 112.43 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 121.212 0.53 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.681 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 122.099 0.952 . . . . 0.0 112.564 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -60.22 150.0 82.16 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 123.016 2.477 . . . . 0.0 113.479 -172.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -100.65 17.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.809 -164.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -89.87 -56.86 0.27 Allowed Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.703 175.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.3 Cg_exo -53.76 -58.83 1.17 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.596 2.198 . . . . 0.0 113.371 164.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 3' ' ' LEU . 25.7 mt -61.74 -47.93 91.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.478 -178.049 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.88 93.42 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -39.98 95.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.412 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 3' ' ' LEU . 75.0 mt -61.81 -48.08 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.438 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.8 mm -64.54 -36.78 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.426 -172.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -32.4 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.366 171.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.74 -34.99 78.33 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.827 -178.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.42 -53.71 54.99 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.376 169.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.68 21.06 0.38 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.715 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.23 135.3 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.153 -0.523 . . . . 0.0 110.385 166.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -157.65 31.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.024 174.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 81.24 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.268 168.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG22 HD12 ' B' ' 55' ' ' ILE . 14.2 t -131.16 142.33 43.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.387 -168.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.31 151.15 24.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.352 169.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -13.66 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.487 172.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.724 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -87.57 -30.55 20.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.324 -174.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.148 165.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -61.76 -34.39 75.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.424 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.27 -37.44 22.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.317 -179.368 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.553 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -63.4 -44.05 95.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.294 -171.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.938 HD11 ' HB ' ' B' ' 39' ' ' ILE . 4.0 tp -59.6 -42.32 92.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.464 167.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.78 -39.4 91.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.312 -176.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 -20.88 23.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.302 -175.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.77 HG21 HG21 ' B' ' 64' ' ' VAL . 32.3 mt -61.08 -71.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.92 162.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.0 mp -59.74 -20.22 55.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.745 -167.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.681 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.13 -55.3 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.115 170.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.74 -41.73 98.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.984 -172.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.433 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.2 mmm -61.16 -43.53 98.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.447 168.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.42 -48.24 45.95 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -167.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.72 -19.14 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.277 167.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -75.95 -58.93 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.499 179.533 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.771 HG21 HG23 ' A' ' 64' ' ' VAL . 4.0 mt -60.89 -22.92 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.576 178.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.64 -77.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.266 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.79 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.24 -10.98 7.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.477 -172.577 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.54 -52.93 6.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.186 172.772 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.91 -19.0 59.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.41 173.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.795 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.7 mt -86.29 -51.25 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.949 -177.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -60.16 -11.28 5.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.444 167.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.3 mp -85.21 -38.44 18.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.315 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.92 -30.93 70.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.37 170.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 29.5 mmt-85 -68.36 -53.31 24.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.409 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -19.98 60.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.375 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.07 -53.74 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.245 168.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.02 24.05 0.53 Allowed Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.482 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.5 ttp-105 66.4 122.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.446 166.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.43 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.4 167.363 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 30.0 m -162.05 141.81 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.447 -178.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.938 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.1 mm -71.77 148.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.393 170.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 10.2 mttp -153.12 -177.85 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.523 177.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.01 75.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -173.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.697 ' O ' HD12 ' A' ' 62' ' ' LEU . 24.9 tt0 -73.11 -27.56 61.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -178.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -36.64 42.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.413 178.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.708 ' CG2' HD22 ' B' ' 28' ' ' LEU . 38.5 mm -60.83 -57.25 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.417 170.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -61.47 -30.68 70.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.02 -176.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.46 -51.57 68.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.412 169.209 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -46.76 89.43 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.482 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.771 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.77 -51.47 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.892 -163.473 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.21 -21.71 66.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.708 176.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD2' HD11 ' A' ' 46' ' ' LEU . 6.4 ttt-85 -61.29 -39.99 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.268 174.116 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 83.6 m-85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.279 166.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 11' ' ' ILE . 3.5 mt . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.96 153.5 50.93 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.394 2.063 . . . . 0.0 113.49 169.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.6 pt -100.62 16.98 3.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.696 -176.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.41 -59.61 0.28 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.712 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.4 Cg_endo -58.25 -50.06 10.8 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.437 2.091 . . . . 0.0 113.375 168.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.84 -28.99 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 175.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.4 77.8 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.526 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -82.4 -17.19 46.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.395 -170.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.0 mm -60.73 -66.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.439 168.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.72 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.5 -31.39 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.077 -174.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -66.1 -37.72 86.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.455 172.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -62.13 -32.25 72.81 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.884 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.79 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.73 -52.96 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.454 170.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.86 27.5 0.72 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.523 -170.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.795 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.73 119.99 9.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.775 -0.712 . . . . 0.0 110.373 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.52 -38.69 65.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.13 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.32 100.2 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.718 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.22 140.18 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.275 165.6 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 95.9 p -66.95 165.71 15.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.27 167.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.98 -18.68 58.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.284 168.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -58.37 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.441 169.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -62.07 -42.57 99.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.334 -169.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.572 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 41.2 mtm180 -61.77 -50.04 73.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.386 -178.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.457 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.5 mm -61.49 -25.04 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.445 179.348 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.566 HG21 ' HB ' ' A' ' 60' ' ' ILE . 85.3 m -73.91 -42.46 60.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.37 -172.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.744 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.76 -35.48 76.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.345 169.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -63.67 -43.54 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.297 -173.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -80.55 -27.83 37.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.376 -179.558 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 64' ' ' VAL . 52.4 mt -61.36 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.976 167.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.744 HD11 HD12 ' B' ' 28' ' ' LEU . 3.8 mp -59.11 -23.39 62.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.733 -164.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -85.0 -28.51 25.69 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.05 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.78 -31.76 71.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.862 163.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -34.21 32.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.413 -176.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.52 42.23 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -176.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.425 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.377 169.547 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.357 176.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.938 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.2 mt -60.89 -21.72 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.307 -170.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.72 -69.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.324 173.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.513 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.44 -11.03 8.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.554 -177.275 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.91 -40.46 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.068 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.473 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -69.93 -14.81 62.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 168.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.2 mt -97.3 -52.14 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.956 -173.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -19.71 56.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.368 169.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.6 mt -68.62 -53.49 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.344 166.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.37 -25.91 67.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.247 -173.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -38.73 75.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.328 168.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.57 -32.61 71.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.375 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.72 -48.52 81.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.35 173.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.26 38.14 1.05 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -167.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 65.27 102.53 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.392 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -171.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.451 177.148 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.2 m -78.41 130.22 35.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.416 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.809 HD12 HG22 ' A' ' 20' ' ' VAL . 28.8 mt -74.01 132.78 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.275 166.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -136.77 -170.13 2.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.391 -177.338 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.99 -22.02 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.251 178.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.4 -34.11 21.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -81.25 -35.17 31.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.36 -177.579 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 28' ' ' LEU . 38.8 mm -61.18 -57.67 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.381 167.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.4 mt-10 -62.22 -37.59 85.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.951 -173.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.51 ' CD2' HD22 ' B' ' 46' ' ' LEU . 34.5 tp -60.77 -43.86 97.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.38 172.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.12 -35.25 76.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.441 178.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.77 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -90.46 -59.92 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.271 -162.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -23.46 64.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.6 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -23.36 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 172.09 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.495 177.093 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.058 HD21 HD11 ' B' ' 11' ' ' ILE . 6.8 mt . . . . . 0 C--O 1.242 0.692 0 CA-C-O 121.338 0.59 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 10.9 Cg_endo -55.45 164.55 3.97 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.52 2.147 . . . . 0.0 113.395 164.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 25' ' ' ARG . 21.5 pt -95.88 38.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.314 -173.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -95.01 -58.47 0.2 Allowed Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.73 173.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.7 Cg_endo -59.91 -32.82 95.74 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.53 2.154 . . . . 0.0 113.653 173.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HA ' HD12 ' A' ' 11' ' ' ILE . 72.8 mt -96.81 -13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.62 -169.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -43.72 98.89 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -97.39 19.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.472 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.724 HG22 HD13 ' A' ' 12' ' ' ILE . 22.9 mt -90.28 -49.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.208 166.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.792 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 3.9 mm -96.31 48.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.651 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HA ' ' H ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -156.11 -26.45 0.1 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.748 169.72 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.68 -40.59 66.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.276 163.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.793 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.73 -72.87 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.727 172.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.7 36.39 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.149 152.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.099 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -73.29 123.15 23.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.153 -165.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -135.58 31.83 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.088 -165.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.95 102.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.423 168.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t -125.15 162.46 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.369 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 47.1 t -101.84 13.48 34.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.375 -169.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p30 60.47 23.56 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -140.67 -30.07 0.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.358 179.144 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.12 -40.6 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.437 177.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HG3' HG21 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.39 -30.1 70.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.409 -178.907 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 5' ' ' ILE . 9.1 mm -83.86 -30.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.413 179.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD12 ' A' ' 31' ' ' ILE . 74.6 m -60.79 -46.36 90.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.377 168.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.929 HD13 HG23 ' B' ' 60' ' ' ILE . 4.9 tp -61.0 -45.46 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.336 172.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 3' ' ' LEU . . . -61.75 -12.69 18.09 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.548 -178.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -107.74 -37.51 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.24 -178.7 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.966 HD13 HG21 ' B' ' 64' ' ' VAL . 60.0 mt -60.88 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.078 168.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.02 -34.85 72.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 -166.329 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 3' ' ' LEU . 2.5 tm-20 -68.05 -43.82 77.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.236 176.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.59 -17.02 63.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.029 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.438 ' CE ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 mtm -81.84 -43.4 18.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.466 169.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -69.27 -45.87 59.47 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -169.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.485 ' N ' HG22 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -61.53 -16.62 49.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.316 169.25 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.1 -54.63 5.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.447 -179.543 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.703 ' HB ' HD11 ' B' ' 28' ' ' LEU . 15.2 mt -61.52 -28.62 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.343 -176.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.34 -65.67 0.66 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.22 -173.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.755 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 25.9 t -61.2 -10.49 6.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.524 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 46' ' ' LEU . 12.1 mm-40 -85.01 -57.57 3.04 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.05 173.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.92 -8.61 5.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.532 174.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' B' ' 17' ' ' ALA . 51.4 mt -95.93 -54.31 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.222 178.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -13.82 62.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.359 -178.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 42' ' ' GLU . 7.6 mt -88.39 -21.41 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.403 173.307 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -80.49 -29.97 37.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -165.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.47 -15.72 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.384 -168.574 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -9.92 59.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.42 164.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.73 -54.12 49.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.297 174.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.21 33.85 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.535 -169.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 67.17 121.25 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.638 -0.781 . . . . 0.0 110.587 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' H ' ' NH1' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 179.86 -79.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.362 171.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.586 HG21 ' OG ' ' B' ' 21' ' ' SER . 72.5 m -167.51 159.97 12.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.134 -164.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.564 HD13 ' CB ' ' A' ' 47' ' ' ALA . 7.2 mm -90.09 137.62 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.3 165.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 7.7 mttm -153.37 -174.9 5.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.487 -166.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -66.33 -21.42 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.148 -169.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -94.18 25.13 3.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.147 175.018 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.624 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . 14.5 m-20 -119.21 -39.57 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.153 174.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.714 HG22 HG22 ' B' ' 27' ' ' THR . 3.1 mp -91.15 14.78 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.631 163.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.0 mm-40 -121.65 36.91 4.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 164.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 62' ' ' LEU . 10.6 tp -169.42 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.378 -174.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HB2' ' CA ' ' A' ' 43' ' ' ALA . . . -84.86 -17.53 37.67 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.405 173.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.69 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -107.61 -67.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.265 -157.676 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -60.76 -23.89 65.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.39 177.187 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -78.35 -60.68 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.102 164.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.237 0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.151 -157.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 121.315 0.578 . . . . 0.0 109.66 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 5.7 Cg_endo -52.86 151.43 20.11 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.665 2.244 . . . . 0.0 113.527 172.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.519 HG21 ' CG1' ' B' ' 26' ' ' ILE . 1.1 pt -85.63 64.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.51 175.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -151.65 -57.97 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.619 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.8 Cg_endo -60.08 -38.23 78.88 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.181 . . . . 0.0 113.589 170.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.642 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -73.4 -18.26 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.515 172.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' B' ' 25' ' ' ARG . . . -61.04 -52.91 49.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -166.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 5.1 mtt-85 -75.25 -20.66 59.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.411 -176.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 3' ' ' LEU . 16.1 mt -63.58 -47.39 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.278 167.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 40' ' ' ALA . 6.3 mm -95.77 45.41 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.835 175.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -149.47 -31.7 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.873 170.872 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.78 -31.28 70.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.92 172.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.755 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -58.74 -51.6 69.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.545 170.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.57 23.23 1.23 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.702 -171.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -65.81 131.58 46.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.349 173.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.6 -77.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.111 -177.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -146.83 144.12 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.318 -169.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.593 HG12 ' H ' ' B' ' 21' ' ' SER . 11.0 t -113.06 168.73 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -168.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.593 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -127.83 -162.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.244 -164.828 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.67 89.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.451 167.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.41 125.2 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.541 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . . . -176.66 -48.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.977 163.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.467 ' CZ ' HG21 ' B' ' 20' ' ' VAL . 15.1 ttp180 -77.22 -30.55 54.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.329 167.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.519 ' CG1' HG21 ' B' ' 5' ' ' ILE . 59.0 mt -72.72 -36.32 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.416 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 60' ' ' ILE . 92.5 m -60.81 -43.27 98.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.325 169.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -60.85 -45.81 93.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.149 174.414 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -17.82 54.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.511 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.22 -32.6 11.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.412 -171.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mp -62.11 -72.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.587 159.273 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -58.82 -14.12 7.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.931 -162.663 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.402 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 1.9 tm-20 -91.41 -26.36 18.9 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.17 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.28 -19.49 28.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.141 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 8.1 mtt -93.69 12.37 25.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.412 171.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.69 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 -41.2 0.51 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.088 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 15' ' ' ALA . 1.4 tmt_? -61.17 -20.67 62.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.262 166.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.37 -35.3 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.436 -167.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.795 HG23 ' O ' ' B' ' 63' ' ' ALA . 7.6 mt -62.04 -33.97 61.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.288 171.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.19 -63.02 1.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.306 -169.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.793 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 15.3 m -61.9 -13.76 27.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.592 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 3.0 mm-40 -81.6 -45.33 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.104 176.08 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -73.25 -33.71 65.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.209 177.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 1.099 HD11 ' HB2' ' A' ' 17' ' ' ALA . 15.2 mt -60.5 -56.35 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.351 167.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.65 69.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 -176.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' B' ' 63' ' ' ALA . 4.3 mt -76.24 -36.91 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.494 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.86 -45.24 94.63 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.262 -177.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -89.72 -25.72 21.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.373 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -64.04 -44.9 91.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.266 168.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.0 98.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.268 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.32 43.55 15.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -175.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -135.3 -166.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.398 -168.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -169.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.423 -167.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 0.8 OUTLIER -68.26 172.29 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.926 -167.903 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' B' ' 47' ' ' ALA . 31.9 mm -60.62 135.94 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.465 175.312 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -159.24 -176.59 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.423 -169.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -62.48 -24.09 67.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 -170.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.701 ' C ' HD23 ' B' ' 62' ' ' LEU . 1.1 pp20? -103.52 23.1 13.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.104 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.56 -34.63 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.424 168.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.929 HG23 HD13 ' A' ' 28' ' ' LEU . 36.7 mm -61.02 -65.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.328 165.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.732 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.2 mt-10 -61.4 -10.92 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.245 -177.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.701 HD23 ' C ' ' B' ' 58' ' ' GLU . 4.1 mm? -99.51 -18.66 17.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.515 176.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.795 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -92.06 14.53 15.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.561 164.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 31' ' ' ILE . 40.1 t -115.7 -68.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.585 -176.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -60.18 -10.06 4.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.588 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -37.61 86.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.663 168.348 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CZ ' HG12 ' B' ' 39' ' ' ILE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.205 168.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.678 HD13 ' HB3' ' A' ' 33' ' ' GLU . 10.4 mp . . . . . 0 C--O 1.248 0.988 0 CA-C-O 121.983 0.897 . . . . 0.0 111.682 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 10.8 Cg_exo -45.2 148.78 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.868 2.378 . . . . 0.0 113.466 177.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 26' ' ' ILE . 2.0 pt -70.96 58.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.373 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -160.28 -52.89 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.52 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.0 Cg_endo -55.71 -32.62 84.74 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 C-N-CA 122.781 2.321 . . . . 0.0 113.506 167.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 29' ' ' ALA . 9.4 mm -60.63 -39.66 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.485 168.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.4 98.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -166.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.14 18.63 13.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.41 -176.605 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' B' ' 37' ' ' ARG . 95.5 mt -103.32 -39.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.182 164.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.711 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.3 mm -81.08 -37.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 -179.094 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -41.41 95.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.428 169.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.89 -30.79 71.11 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.815 -175.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.63 -53.29 59.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.55 168.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.09 32.33 0.35 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.562 -171.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.054 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -80.47 -167.63 1.42 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.3 177.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.05 93.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.997 165.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.3 104.93 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.32 162.8 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.069 164.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 16.6 t -94.41 -84.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.411 -166.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 9.1 t70 -174.89 136.88 0.41 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 -171.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.914 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 0.4 OUTLIER 77.97 -51.69 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.014 -161.605 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.13 -39.37 89.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.304 -173.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.94 -40.52 97.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.412 -177.842 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 5' ' ' ILE . 1.6 mp -94.64 -23.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.404 -170.087 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.625 HG22 HD11 ' A' ' 31' ' ' ILE . 92.0 m -60.79 -39.79 90.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.491 173.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.666 HD23 ' CD1' ' A' ' 12' ' ' ILE . 13.1 tp -88.35 -14.31 38.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.493 -171.577 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . -79.03 -45.33 20.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.198 164.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -61.0 -36.97 80.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.484 175.554 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.726 HG21 HG21 ' B' ' 64' ' ' VAL . 23.0 mt -62.21 -78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.897 170.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD21 HD12 ' B' ' 39' ' ' ILE . 2.0 mm? -57.09 -26.62 60.74 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.543 -158.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.678 ' HB3' HD13 ' A' ' 3' ' ' LEU . 11.5 pt-20 -64.24 -36.12 83.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.025 176.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -62.33 -39.58 93.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.818 -164.492 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.467 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 21.6 mtt -81.69 -25.94 35.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -72.89 -39.83 53.7 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.515 -176.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -60.98 -17.06 49.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.395 168.902 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -99.83 -46.09 5.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.555 -164.664 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.677 HD13 ' CG2' ' A' ' 64' ' ' VAL . 7.2 mt -61.62 -26.28 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.183 172.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.33 -70.38 0.2 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.115 177.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.18 -18.17 56.82 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.525 179.472 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 46' ' ' LEU . 6.5 mm-40 -72.3 -61.65 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.034 169.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.13 -9.49 4.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.539 179.1 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' B' ' 17' ' ' ALA . 90.1 mt -100.77 -67.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.048 -178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -17.4 53.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.349 -176.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.763 HD12 ' C ' ' A' ' 42' ' ' GLU . 14.5 mt -60.93 -48.18 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.206 163.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB1' ' HB3' ' A' ' 53' ' ' LYS . . . -87.49 -27.71 22.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.224 -168.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -21.65 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.33 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -60.98 -14.61 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.323 166.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -82.93 -43.95 15.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.305 175.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.1 15.54 23.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 172.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 178.93 84.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 169.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -108.91 151.94 25.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.462 -161.358 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.493 HG22 ' HB3' ' B' ' 21' ' ' SER . 98.3 m -140.55 114.42 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.158 163.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.776 ' HB ' HG13 ' B' ' 20' ' ' VAL . 13.6 mm -60.52 153.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.349 -166.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.7 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -140.88 173.33 11.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.416 -171.968 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.16 -11.94 10.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.3 168.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -113.64 30.72 7.02 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.06 179.759 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -120.83 -39.37 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.248 169.153 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.83 HG13 HD22 ' B' ' 28' ' ' LEU . 1.3 mp -62.12 -54.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.442 160.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.9 mm-40 -61.6 -9.23 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.19 -174.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 61' ' ' GLU . 72.0 mt -138.32 35.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.454 175.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -130.62 10.41 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.907 163.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.677 ' CG2' HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -134.09 -63.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.533 0.683 . . . . 0.0 109.237 -156.222 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.449 ' H ' HG12 ' A' ' 64' ' ' VAL . 10.3 ttp180 -78.41 -27.26 46.64 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.232 162.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 6.7 mmt180 -75.49 -11.25 59.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.768 167.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.546 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.179 -176.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.61 HD21 ' HG3' ' B' ' 33' ' ' GLU . 17.2 mt . . . . . 0 C--O 1.243 0.748 0 CA-C-O 121.343 0.592 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 8.0 Cg_endo -49.11 143.62 18.13 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.466 2.11 . . . . 0.0 113.367 166.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.472 ' CG2' ' HG3' ' B' ' 25' ' ' ARG . 1.3 pp -95.19 26.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.383 -168.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -82.67 -58.14 0.44 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.694 169.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -58.89 -46.95 20.06 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.543 2.162 . . . . 0.0 113.568 171.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 mt -68.33 -18.83 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.411 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.434 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -60.95 -47.38 91.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -170.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.9 ttt180 -85.59 -17.51 36.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.371 -170.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 3' ' ' LEU . 26.7 mt -60.97 -59.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.405 171.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 14.8 mm -63.89 -36.38 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.458 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 6.8 mmtp -64.59 -33.31 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.298 176.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 25.0 t0 -61.72 -31.5 71.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.834 177.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -51.17 71.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.558 170.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 34.42 0.68 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.545 -168.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.697 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -70.97 157.93 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.02 99.61 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.136 179.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 63.14 132.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -176.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.776 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t -119.46 160.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.369 170.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' THR . 21.6 p -84.43 -10.11 57.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.436 178.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.404 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.2 OUTLIER 71.02 164.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.983 -161.342 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 74.32 -50.94 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 -162.375 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 55' ' ' ILE . . . -60.42 -44.29 95.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.418 174.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.676 ' HE ' HG21 ' B' ' 20' ' ' VAL . 13.9 tpp85 -68.89 -16.82 63.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.524 -173.3 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.68 -30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.415 -168.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.648 ' O ' HD12 ' B' ' 31' ' ' ILE . 89.1 m -61.12 -40.68 94.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.269 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.83 HD22 HG13 ' A' ' 60' ' ' ILE . 2.0 tp -59.97 -43.78 94.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.322 172.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -12.91 13.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.662 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.9 mmtp -105.57 -30.36 9.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.393 -175.552 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.796 HD13 ' CG2' ' A' ' 60' ' ' ILE . 3.3 mp -61.85 -74.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.655 161.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.826 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.71 -40.93 85.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.649 -163.572 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' B' ' 3' ' ' LEU . 4.7 tt0 -66.86 -20.43 65.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.044 -174.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 4.7 tt0 -77.06 -53.53 7.68 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.077 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.03 -29.87 67.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.352 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.11 -30.54 78.07 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 169.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 11' ' ' ILE . 3.0 mtp85 -81.79 -19.44 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.467 175.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -37.5 12.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.403 -169.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.916 HD12 HD21 ' A' ' 32' ' ' LEU . 12.0 mt -61.08 -27.9 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.296 168.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -68.29 -60.35 2.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.305 -177.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.656 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 48.9 m -61.68 -13.7 25.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.33 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.588 ' O ' ' HG ' ' B' ' 46' ' ' LEU . 4.9 mm-40 -75.6 -53.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.091 171.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.9 -31.95 68.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.141 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 1.054 HD11 ' HB2' ' A' ' 17' ' ' ALA . 49.1 mt -60.81 -49.55 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.212 165.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.547 176.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' B' ' 43' ' ' ALA . 28.8 mt -65.32 -48.82 71.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.418 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.75 65.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.34 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -19.07 36.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.341 176.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -61.24 -37.41 82.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.244 166.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.1 -46.26 35.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.056 165.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.63 -7.03 24.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.81 168.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.11 98.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.354 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.5 160.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 166.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 95.1 m -69.31 159.27 33.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.457 168.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.631 ' CG2' ' HB1' ' B' ' 43' ' ' ALA . 55.5 mt -87.0 133.9 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 -170.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -118.39 -178.34 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.391 -178.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . . . -74.8 -32.07 61.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.269 -169.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.67 -13.44 22.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.097 168.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -94.2 -43.54 8.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.356 -179.368 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 24' ' ' ALA . 42.0 mm -61.1 -33.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.457 177.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.78 -22.17 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.849 -171.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.652 ' O ' HD11 ' B' ' 46' ' ' LEU . 24.7 tp -106.4 18.19 22.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.579 167.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.551 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -106.92 -14.8 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.273 166.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -121.2 -65.29 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.282 -165.569 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG12 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -60.43 -11.84 7.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.501 172.21 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -82.34 -24.42 34.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.409 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.305 168.232 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 33' ' ' GLU . 1.1 mt . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 121.482 0.658 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 2.2 Cg_endo -51.83 154.47 9.72 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.673 2.249 . . . . 0.0 113.619 177.392 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -92.93 19.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.683 -170.45 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -80.74 -58.15 0.55 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.625 170.286 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.7 Cg_endo -59.19 -61.88 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.585 2.19 . . . . 0.0 113.55 170.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 62.7 mt -61.19 -14.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.452 177.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.63 99.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.97 25.44 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.386 -173.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.82 -40.06 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.508 169.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 40' ' ' ALA . 17.4 mm -83.97 -39.94 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.423 -174.488 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -26.75 67.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.3 173.187 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.05 -34.1 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.814 177.756 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.09 -53.16 61.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.314 168.27 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.97 21.6 0.78 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.772 -172.125 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.837 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -65.26 127.02 30.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.415 170.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -102.25 -17.45 15.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.013 -171.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 163.16 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.33 168.855 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG21 ' CD ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -118.0 163.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.305 168.594 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.532 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 24.7 p -75.5 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.44 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.94 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.34 171.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.46 -18.45 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.408 -165.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.36 -40.44 94.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.304 -167.015 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.791 ' CD ' HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -65.42 -60.08 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.446 176.198 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.0 mt -65.23 -27.77 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.449 -171.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 31' ' ' ILE . 79.8 m -61.02 -61.67 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.395 166.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 HG23 ' B' ' 60' ' ' ILE . 10.5 tp -61.51 -10.3 7.58 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.482 -171.441 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.66 -63.53 1.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.435 171.271 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 5.6 mtpm? -61.46 -21.27 64.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.993 HD13 HG21 ' B' ' 64' ' ' VAL . 32.5 mt -61.89 -76.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.893 162.562 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.39 -30.71 68.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.697 -162.958 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -77.73 -18.61 56.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.018 -178.635 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -90.03 -17.82 27.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.037 169.312 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 9.8 mtp -99.58 18.83 17.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 170.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.674 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -119.4 -41.74 0.57 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 170.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -13.24 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.199 163.888 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.06 -55.01 4.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.385 -178.342 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 63' ' ' ALA . 7.3 mt -61.24 -19.74 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.463 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -72.57 -63.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.255 -169.176 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 35.1 t -60.64 -13.4 14.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.439 177.059 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -72.71 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.095 166.785 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 60' ' ' ILE . . . -61.41 -15.52 37.69 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.502 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.1 mt -92.78 -51.9 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.894 -175.35 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.35 -11.81 7.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.477 166.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.3 mp -82.85 -42.83 17.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.244 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 52' ' ' ARG . . . -61.33 -23.68 65.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.403 -176.684 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -27.52 38.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.438 -177.474 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -61.13 -27.75 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.347 169.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.94 -47.15 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.288 178.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.0 13.17 25.89 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -169.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 mtp85 -143.0 116.98 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.404 -179.5 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -62.72 -24.68 67.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.351 -167.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.625 HG22 ' HB3' ' B' ' 21' ' ' SER . 1.0 OUTLIER -60.96 116.12 4.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.42 -168.538 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.53 149.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.414 177.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' OD2' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -139.09 164.21 30.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -169.867 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -66.73 -18.26 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.316 168.74 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 62' ' ' LEU . 74.3 mm-40 -96.83 29.26 3.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.083 169.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 56' ' ' LYS . 76.5 m-20 -117.52 -34.88 4.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.423 168.638 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.711 HG12 HD21 ' B' ' 28' ' ' LEU . 4.1 mp -102.65 -12.32 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.383 -175.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 62' ' ' LEU . 12.5 mt-10 -70.97 -10.8 60.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 161.712 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -145.07 25.04 1.43 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.468 -179.55 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.827 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -111.21 15.25 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.31 163.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -144.41 -65.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -155.359 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.1 mtp180 -62.13 -29.19 70.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.316 164.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -84.75 -21.0 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 172.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 42' ' ' GLU . 4.4 t80 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.429 176.774 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.792 HD21 ' CG ' ' B' ' 33' ' ' GLU . 4.4 mt . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 121.461 0.648 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -58.99 147.7 88.78 Favored 'Trans proline' 0 N--CA 1.484 0.942 0 C-N-CA 122.493 2.128 . . . . 0.0 113.617 172.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -82.39 76.36 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.525 177.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -153.53 -54.76 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.599 171.414 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -62.23 -11.34 21.83 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.658 2.238 . . . . 0.0 113.65 171.179 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' B' ' 3' ' ' LEU . 40.0 mt -114.92 -37.61 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.482 -179.101 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.83 -48.33 86.78 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 1.1 ptt180 -93.83 19.21 9.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.511 -179.285 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mm -83.62 -60.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.126 164.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.71 HD11 ' HG ' ' B' ' 28' ' ' LEU . 9.7 mm -66.43 -36.05 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.218 -176.384 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 12.1 mttm -64.93 -39.07 92.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.425 178.217 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -62.11 -31.46 71.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.793 -177.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.68 -52.76 64.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.603 170.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.24 19.54 0.53 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.609 -179.098 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.882 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.67 125.9 25.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.332 165.494 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.78 -64.41 1.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.071 -170.036 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -110.02 111.32 22.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.411 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.665 HG21 ' HG3' ' B' ' 25' ' ' ARG . 11.3 t -90.24 152.05 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.294 172.126 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 54' ' ' THR . 24.7 p -98.47 16.6 21.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.345 -176.616 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.55 163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.09 -162.332 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 75.33 -58.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.898 -166.699 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' B' ' 20' ' ' VAL . . . -60.22 -38.2 82.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.345 -165.004 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.665 ' HG3' HG21 ' B' ' 20' ' ' VAL . 7.7 mtp180 -64.21 -13.51 49.34 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.555 -179.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 2.9 mp -122.56 -5.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -177.852 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.621 HG22 HD13 ' B' ' 31' ' ' ILE . 98.9 m -60.64 -43.16 97.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.451 173.404 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 60' ' ' ILE . 2.9 mm? -61.21 -23.43 65.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.443 177.284 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -74.88 -11.12 60.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.436 -178.502 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.48 -32.6 6.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.482 -177.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.985 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 mp -61.72 -75.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.821 163.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.1 -21.03 44.42 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.797 -160.494 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.792 ' CG ' HD21 ' B' ' 3' ' ' LEU . 4.3 tm-20 -89.2 -18.15 27.67 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -39.8 28.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.093 168.359 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.473 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -93.34 19.56 8.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.422 178.838 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.68 -33.85 1.5 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 165.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.7 -20.78 59.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.191 165.25 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' B' ' 35' ' ' MET . 27.3 t0 -61.13 -60.88 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.346 171.337 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 64' ' ' VAL . 22.0 mt -61.04 -33.95 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.46 -169.022 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.62 -53.48 55.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.315 -172.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -17.29 64.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.785 -173.487 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.453 ' C ' HD12 ' B' ' 46' ' ' LEU . 2.6 mp0 -89.21 -42.4 11.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.085 173.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.601 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -60.86 -12.43 10.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.479 172.106 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.837 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.2 -61.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.611 -169.979 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' B' ' 44' ' ' ILE . 0.6 OUTLIER -67.64 -16.85 64.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.488 175.739 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.816 HD22 HD23 ' B' ' 62' ' ' LEU . 4.0 mt -61.09 -32.03 71.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.287 166.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' B' ' 55' ' ' ILE . . . -73.42 -40.5 64.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.341 177.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -90.07 -33.73 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.374 -167.526 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -61.1 -37.57 83.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.377 171.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.7 94.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.339 168.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.87 27.19 17.33 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -179.007 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 179.11 4.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.415 -169.306 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 161.29 14.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.447 171.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 21' ' ' SER . 88.6 m 69.92 134.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.4 168.154 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' B' ' 47' ' ' ALA . 13.3 mm -90.82 135.52 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.384 168.209 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.532 ' HG3' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -135.73 177.13 8.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.464 179.262 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.93 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.347 -167.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.16 -16.61 27.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.129 -178.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.8 OUTLIER -86.88 -18.53 30.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.413 168.455 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 28' ' ' LEU . 46.7 mm -92.43 -42.11 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 -170.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.505 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 31.6 mt-10 -91.05 22.03 3.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.635 172.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.816 HD23 HD22 ' B' ' 46' ' ' LEU . 19.8 tp -126.53 -15.67 5.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.679 169.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.601 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -89.55 -35.72 15.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.827 163.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.993 HG21 HD13 ' A' ' 31' ' ' ILE . 53.9 t -62.32 -79.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.618 162.847 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -59.48 -12.68 6.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.718 -159.322 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -81.87 -17.99 45.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.5 -177.215 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.498 ' HE2' HG12 ' B' ' 39' ' ' ILE . 13.2 m-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.305 168.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' A' ' 8' ' ' ILE . 1.1 mt . . . . . 0 CA--C 1.544 0.727 0 CA-C-O 121.472 0.654 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 5.0 Cg_endo -47.95 148.13 6.91 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.588 2.192 . . . . 0.0 113.589 172.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -63.89 -26.67 41.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.352 -175.32 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.26 -62.37 3.19 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.684 -170.21 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.5 Cg_endo -50.82 -22.67 10.27 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 122.594 2.196 . . . . 0.0 113.595 -177.088 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 3' ' ' LEU . 85.9 mt -107.23 -30.18 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.493 -169.691 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.72 80.51 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -169.597 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -79.62 -21.7 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.364 -174.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' B' ' 37' ' ' ARG . 26.8 mt -63.7 -52.27 59.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.417 170.907 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.704 HD12 ' HB2' ' B' ' 40' ' ' ALA . 14.7 mm -67.12 -35.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.428 -168.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -28.34 69.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.2 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.93 -33.45 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.874 177.027 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.08 -51.32 70.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.496 169.515 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.92 10.89 0.44 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.69 -174.301 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.79 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -73.18 170.2 15.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.025 -0.587 . . . . 0.0 110.316 175.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.74 -46.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -168.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.34 170.94 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.459 171.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.687 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 96.9 t -151.85 161.01 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.359 -169.128 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 27.4 t -77.32 -167.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.398 175.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -17.18 51.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.352 -173.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -170.57 124.74 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 168.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -146.75 -61.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.164 166.601 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.665 ' NH1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -65.86 -14.94 62.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.361 -178.326 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.6 mt -86.43 -34.82 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.396 175.182 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.472 HG22 HD12 ' A' ' 31' ' ' ILE . 98.7 m -61.14 -53.98 50.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.228 165.409 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.705 HD12 ' CG2' ' A' ' 31' ' ' ILE . 16.7 tp -62.08 -23.52 66.55 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.347 -174.102 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 3' ' ' LEU . . . -82.16 -36.44 27.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.232 178.76 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.2 -16.13 60.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.51 172.529 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.999 HG12 HG11 ' B' ' 64' ' ' VAL . 0.7 OUTLIER -83.07 -29.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.889 -165.33 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -89.39 -34.85 16.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -173.612 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.89 -34.91 76.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.982 -179.031 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 8.3 mm-40 -73.87 -26.62 60.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.05 168.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -95.25 22.75 6.44 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.428 178.758 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.26 -41.63 0.09 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -173.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -65.88 -26.01 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.417 -0.392 . . . . 0.0 110.177 167.507 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -87.44 -35.83 18.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.354 -168.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.737 HD13 HG22 ' A' ' 64' ' ' VAL . 6.6 mt -61.24 -32.1 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.423 174.149 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.933 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.48 -61.43 2.45 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.212 171.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.524 -175.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.756 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.66 -53.67 4.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.169 171.238 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.94 -11.55 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.7 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.87 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -78.4 -60.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.402 -169.349 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mtmt -69.08 -18.56 64.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.468 173.108 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 42' ' ' GLU . 4.1 mp -61.1 -18.38 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 166.462 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -91.45 -18.39 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.381 177.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -81.44 -33.32 32.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -170.71 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -61.11 -24.56 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.356 169.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.26 -52.66 63.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.226 166.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.18 28.66 0.58 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.467 -177.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.49 93.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.465 175.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.86 -76.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.467 179.372 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 55' ' ' ILE . 96.7 m -160.04 140.28 11.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.423 -169.666 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.2 mm -61.58 165.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.267 167.209 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -170.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.397 168.868 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.37 -19.52 65.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.304 -166.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.36 23.64 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.255 170.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -121.22 -26.6 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.317 168.33 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HD13 ' B' ' 28' ' ' LEU . 36.6 mm -95.99 -47.82 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.001 -163.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -75.92 -12.76 60.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.167 174.442 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -48.14 7.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.43 177.747 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.98 -31.21 70.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.228 172.115 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.737 HG22 HD13 ' A' ' 39' ' ' ILE . 25.3 t -61.33 -70.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.756 164.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -9.82 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.806 -170.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HD3' ' HG2' ' A' ' 42' ' ' GLU . 8.9 ttt85 -77.66 -34.14 53.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.904 172.628 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.498 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 5.6 m-85 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.437 178.598 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.594 ' HB2' HD11 ' B' ' 8' ' ' ILE . 5.6 mt . . . . . 0 C--O 1.242 0.67 0 CA-C-O 121.327 0.584 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -46.93 157.54 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.229 1.953 . . . . 0.0 113.454 -179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.04 23.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.378 -167.157 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.732 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -84.23 -58.19 0.38 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 169.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.2 Cg_endo -57.75 -65.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 122.505 2.137 . . . . 0.0 113.612 173.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' B' ' 3' ' ' LEU . 74.3 mt -60.8 -11.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.532 -170.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.82 55.53 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -178.707 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -94.96 17.36 14.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.588 . . . . 0.0 110.642 -178.895 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.49 HG22 HD13 ' B' ' 12' ' ' ILE . 23.1 mt -95.27 -45.05 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.025 163.146 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.933 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm -94.29 46.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.849 171.551 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 19.8 mtpt -149.59 -30.56 0.23 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.945 171.52 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 27.9 t0 -60.05 -30.49 69.23 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.065 171.264 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.96 74.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.638 170.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.64 22.33 2.28 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.552 -165.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.87 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.76 123.45 22.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.092 179.375 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -77.15 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.007 -164.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -109.84 -52.54 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.429 -177.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.766 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t 62.84 132.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.331 -175.172 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -65.75 175.16 2.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.249 178.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -93.81 20.33 7.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.59 -44.86 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.446 169.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.0 -45.88 91.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.326 -170.347 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -66.97 -25.47 66.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.315 -171.446 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.92 -32.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.381 171.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.829 ' O ' HD12 ' B' ' 31' ' ' ILE . 90.0 m -70.39 -45.69 65.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.276 -169.821 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.79 HD13 HG23 ' A' ' 60' ' ' ILE . 4.7 tp -59.78 -44.67 93.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.437 171.873 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -61.03 -10.07 5.39 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.541 177.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -109.71 -29.51 8.3 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.475 -176.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.829 HD12 ' O ' ' B' ' 27' ' ' THR . 2.8 mp -62.22 -74.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.854 164.108 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' A' ' 32' ' ' LEU . 1.4 mp -59.36 -11.4 4.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 -160.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -92.17 -52.82 4.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.206 -176.401 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -29.43 70.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 170.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . 0.551 ' HE3' HG23 ' B' ' 31' ' ' ILE . 4.4 mtt -64.28 -45.52 87.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.356 168.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.62 78.43 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . 0.84 ' HG2' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -67.08 -33.52 75.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.248 167.124 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 3.2 m-20 -72.41 -54.5 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.432 -171.836 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.826 HG23 ' O ' ' B' ' 63' ' ' ALA . 51.8 mt -60.83 -35.53 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.382 -174.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.704 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.89 -57.77 11.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.167 -173.008 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.456 ' HA ' ' CG2' ' B' ' 44' ' ' ILE . 43.2 p -66.18 -14.61 62.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.76 176.796 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -35.5 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.974 179.501 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -77.36 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.286 170.322 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.79 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -85.57 -61.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.56 -172.508 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HA ' ' HG3' ' B' ' 48' ' ' ARG . 2.2 mptm? -60.6 -17.57 47.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.573 172.083 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.784 HD22 ' OD1' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -61.63 -27.73 68.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.233 167.895 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.714 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -73.55 -44.34 57.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.505 ' HB2' ' NE ' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -81.07 -31.28 34.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.346 -177.906 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . 0.482 ' N ' ' HD2' ' B' ' 48' ' ' ARG . 6.2 t60 -60.98 -36.64 79.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 168.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.99 -52.83 63.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.152 165.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.87 28.37 0.74 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.533 -173.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . 0.505 ' NE ' ' HB2' ' B' ' 48' ' ' ARG . 6.1 mpt_? 65.11 96.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.521 169.371 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -152.36 -73.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.433 -177.019 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.465 HG22 ' O ' ' B' ' 55' ' ' ILE . 90.5 m -165.14 148.26 8.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.298 -173.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.465 ' O ' HG22 ' B' ' 54' ' ' THR . 31.8 mt -94.25 147.82 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.42 168.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.61 -174.61 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.4 -169.602 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.4 77.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.217 -168.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.69 ' O ' HD22 ' B' ' 62' ' ' LEU . 2.0 tm-20 -93.97 23.49 4.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.076 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.784 ' OD1' HD22 ' B' ' 46' ' ' LEU . 0.8 OUTLIER -117.8 -17.26 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.511 166.664 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 64' ' ' VAL . 32.9 mm -92.27 -59.92 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.292 -175.58 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.645 ' HG2' HD11 ' A' ' 31' ' ' ILE . 71.2 mt-10 -60.48 -10.44 4.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.228 168.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.69 HD22 ' O ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -100.47 -14.94 18.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.876 177.952 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.826 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -102.22 5.85 40.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.553 165.184 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.999 HG11 HG12 ' A' ' 31' ' ' ILE . 55.7 t -113.83 -84.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.572 -177.576 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' NH1' ' B' ' 65' ' ' ARG . 0.4 OUTLIER -60.8 -22.36 64.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.187 -178.73 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -46.7 13.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 160.504 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.335 -163.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 121.331 0.586 . . . . 0.0 109.514 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.425 ' O ' ' HD2' ' A' ' 7' ' ' PRO . 8.1 Cg_exo -50.45 156.19 4.36 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.503 2.135 . . . . 0.0 113.537 168.056 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -87.69 62.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.38 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -153.25 -57.42 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.696 -177.388 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.8 Cg_endo -59.35 -41.37 59.18 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.548 2.165 . . . . 0.0 113.657 170.654 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.908 HD11 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -61.41 -23.67 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.43 170.913 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.8 -57.54 18.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -167.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -20.92 64.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.402 -170.507 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.856 HG22 HD13 ' A' ' 12' ' ' ILE . 28.0 mt -61.65 -49.75 83.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.183 167.115 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.867 HD12 ' HB2' ' B' ' 40' ' ' ALA . 1.8 mm -96.61 45.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 -35.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.779 173.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.37 -31.47 70.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.929 170.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.04 62.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.502 170.103 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.88 33.09 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.552 -169.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -82.83 138.46 33.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.82 -50.34 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.001 -170.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.83 171.25 15.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.412 -168.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.797 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 17.1 m -115.24 -173.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 167.295 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.734 ' HA ' HG21 ' B' ' 54' ' ' THR . 54.0 p -90.33 -65.38 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.125 175.248 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -141.52 -34.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.71 161.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 47.7 m-20 -107.76 -106.15 0.34 Allowed 'General case' 0 C--O 1.253 1.277 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.657 165.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.797 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . 88.98 -56.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.026 1.331 . . . . 0.0 109.695 -168.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.504 ' NH1' ' HB ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.11 -21.45 46.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.647 -179.067 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -64.07 -43.26 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.806 173.618 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.637 HG22 ' CD1' ' A' ' 31' ' ' ILE . 51.2 m -60.66 -46.05 91.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.205 172.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 2.1 tp -60.82 -33.89 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.269 173.445 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.91 -26.25 62.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.384 175.279 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 28.87 2.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.528 176.373 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.977 HD13 HG21 ' B' ' 64' ' ' VAL . 66.8 mt -145.15 -64.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.109 -170.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.06 -38.64 83.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.69 177.21 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 5.0 tm-20 -86.35 -23.57 26.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.101 -169.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.57 19.26 6.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 173.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpp -126.21 -32.4 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.11 164.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.678 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -60.9 -40.9 98.98 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -18.77 65.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.481 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 33.0 m-20 -101.73 -18.85 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.369 -167.476 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.645 ' CG2' HG23 ' A' ' 64' ' ' VAL . 14.9 mt -80.75 -24.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.377 171.422 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -72.85 -70.04 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.396 -166.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -60.74 -10.0 4.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.503 -176.753 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 54.2 mm-40 -88.13 -47.66 8.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.216 177.094 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.45 -27.17 68.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.187 170.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.9 mt -77.95 -52.1 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.18 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -26.69 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.494 174.33 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 43' ' ' ALA . 4.6 mt -62.27 -40.5 96.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.319 176.533 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.711 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . . . -61.21 -25.56 67.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.272 -167.756 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -103.95 -25.72 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.35 -176.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -64.33 -37.8 88.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.339 169.473 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.33 97.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.334 168.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.83 18.95 14.01 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 169.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 179.18 -167.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.274 170.339 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 137.08 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.562 170.013 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' B' ' 21' ' ' SER . 86.6 m -60.82 171.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.386 167.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.711 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 18.8 mm -60.6 136.9 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.481 175.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.866 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -159.97 -178.27 6.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.366 -167.092 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -18.68 61.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.245 -171.057 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.34 -17.79 23.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.057 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 m-20 -78.23 -43.54 28.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.373 168.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.809 HG23 HD22 ' B' ' 28' ' ' LEU . 37.7 mm -72.22 -57.64 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.404 -170.371 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.77 -40.4 84.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.074 -166.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -37.47 82.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.442 170.049 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 59' ' ' ASP . . . -61.56 -16.41 47.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.438 -175.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.645 HG23 ' CG2' ' A' ' 39' ' ' ILE 0.256 0.4 OUTLIER -104.57 -50.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.042 -160.582 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.69 23.8 4.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.526 -178.077 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -122.05 -55.71 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.481 -176.74 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 38' ' ' ASP . 1.5 p90 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.3 -163.443 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 3' ' ' LEU . . . . . 0.785 ' CD2' HD11 ' A' ' 11' ' ' ILE . 4.0 mt . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 121.316 0.579 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.96 157.15 30.15 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.357 2.038 . . . . 0.0 113.221 164.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 5' ' ' ILE . . . . . 0.404 ' CG2' HD13 ' B' ' 26' ' ' ILE . 49.6 pt -93.02 23.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.519 178.7 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -90.87 -57.81 0.25 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.763 170.063 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.2 Cg_endo -60.7 -54.62 1.87 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.532 2.155 . . . . 0.0 113.57 173.325 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 HD12 ' B' ' 3' ' ' LEU . 28.7 mt -60.5 -13.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.498 169.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.41 -61.49 1.98 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -93.82 17.06 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.593 -167.13 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 11' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 3' ' ' LEU . 29.0 mt -96.73 -49.62 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 162.79 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -68.04 -38.28 79.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.211 178.557 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.8 mttt -61.57 -35.25 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.355 174.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.54 -34.02 76.09 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.862 -177.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -59.26 -52.39 65.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.433 169.385 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.79 15.82 0.3 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.221 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.83 125.72 24.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.219 164.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.36 -53.96 2.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.039 -167.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -130.55 93.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.412 171.653 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 55' ' ' ILE . 27.8 t -67.94 166.0 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.282 168.367 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 21' ' ' SER . . . . . 0.622 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 26.5 t -102.32 -166.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.388 170.39 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.31 167.36 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.284 166.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.65 -61.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.498 171.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.866 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.88 -47.07 86.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.388 -167.212 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -60.83 -12.11 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.601 178.99 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.9 mm -114.03 -15.88 9.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.645 -175.906 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.834 ' O ' HD12 ' B' ' 31' ' ' ILE . 41.4 m -73.77 -33.82 64.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.436 -171.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.809 HD22 HG23 ' A' ' 60' ' ' ILE . 2.7 mm? -62.71 -21.76 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.407 168.399 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -79.07 -12.79 60.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.382 175.032 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 4.6 mttm -95.75 -29.1 14.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.493 172.229 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 31' ' ' ILE . . . . . 0.834 HD12 ' O ' ' B' ' 27' ' ' THR . 2.9 mp -78.73 -79.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.184 170.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.91 -12.89 8.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.649 -161.918 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -93.39 -31.52 14.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.102 178.212 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.5 mt-10 -72.25 -29.74 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.148 169.022 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -99.45 36.24 1.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.278 172.78 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.644 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -144.94 -40.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 170.658 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -43.48 98.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.179 165.527 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.82 -38.81 92.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.438 -171.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 28' ' ' LEU . 9.8 mt -70.6 -37.86 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 -175.583 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.77 -64.39 0.97 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.355 -168.767 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 1.2 t -61.69 -11.21 10.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.419 -176.588 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 42' ' ' GLU . . . . . 0.754 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -88.03 -51.9 5.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.183 174.408 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.661 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -60.79 -9.63 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.364 171.23 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 17' ' ' ALA . 57.9 mt -99.11 -54.37 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.127 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -23.67 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.343 -177.658 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.928 HD22 HD23 ' B' ' 62' ' ' LEU . 12.1 mt -60.71 -48.36 82.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.373 170.791 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.9 -60.32 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.371 171.303 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -20.64 62.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.365 -169.612 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.5 -44.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 169.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 -51.7 59.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 29.6 5.37 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 169.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.62 -171.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.3 169.854 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 64.34 163.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.439 -178.056 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.734 HG21 ' HA ' ' A' ' 21' ' ' SER . 6.1 t -88.52 -167.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.382 -169.399 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.661 HD12 ' O ' ' B' ' 43' ' ' ALA . 10.6 mm -100.63 142.6 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.327 173.146 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 56' ' ' LYS . . . . . 0.528 ' HE2' ' H ' ' B' ' 57' ' ' ALA . 1.9 tmtt? -160.56 172.52 17.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.312 -165.132 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.528 ' H ' ' HE2' ' B' ' 56' ' ' LYS . . . -61.72 -33.23 73.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.369 -168.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 56' ' ' LYS . 1.8 pt-20 -83.62 15.7 3.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 177.705 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -130.65 -20.79 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.54 167.303 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 60' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 28' ' ' LEU . 10.1 mm -79.49 -50.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 20.4 mt-10 -61.31 -39.46 90.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.027 166.212 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.928 HD23 HD22 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -62.22 -32.2 72.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.508 178.351 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.577 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -81.03 -35.68 31.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.207 175.054 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.977 HG21 HD13 ' A' ' 31' ' ' ILE . 19.9 t -62.39 -79.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.637 175.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -58.99 -12.73 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.664 -164.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -60.42 -26.0 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.512 171.501 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG3' ' B' ' 42' ' ' GLU . 17.4 m-85 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.409 -175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mtt . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 121.19 0.519 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.04 -162.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.173 -170.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.894 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp -57.22 102.29 0.3 Allowed Pre-proline 0 C--O 1.252 1.187 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.553 -169.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.642 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.5 Cg_endo -56.74 140.3 90.59 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 122.751 2.301 . . . . 0.0 113.49 171.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 pt -85.2 -14.11 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.456 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.23 -55.37 3.78 Favored Pre-proline 0 CA--C 1.544 0.737 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.653 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 15.5 Cg_exo -49.77 -49.59 15.51 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 C-N-CA 122.655 2.237 . . . . 0.0 113.644 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.698 HD11 ' HB3' ' A' ' 3' ' ' LEU . 63.0 mt -61.25 -45.74 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.521 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.05 59.23 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -90.37 -29.44 18.04 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.475 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.595 HD13 ' HG2' ' B' ' 33' ' ' GLU . 27.8 mt -61.5 -57.63 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.309 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.648 HG23 ' CB ' ' B' ' 40' ' ' ALA . 10.9 mm -61.21 -36.19 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.331 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 2.7 mttm -62.98 -36.68 84.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.444 170.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -62.63 -34.02 76.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.753 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.376 169.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.42 20.61 0.34 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.691 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.679 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.21 149.34 33.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.401 166.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -117.23 -55.17 2.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.079 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 111.59 10.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.357 -169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.6 HG22 ' HB ' ' B' ' 55' ' ' ILE . 94.3 t -133.04 132.15 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.384 -169.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.4 p -65.92 157.17 31.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.351 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -69.92 -18.56 63.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.428 171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.629 ' HA ' HG22 ' A' ' 26' ' ' ILE . 24.2 m-20 -81.0 -34.57 32.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.455 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' B' ' 60' ' ' ILE . . . -61.52 -40.36 94.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.192 166.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -40.51 90.91 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.333 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.629 HG22 ' HA ' ' A' ' 23' ' ' ASP . 7.3 tt -81.39 -34.88 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.375 -166.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.477 HG22 HG22 ' B' ' 60' ' ' ILE . 84.9 m -63.58 -45.96 88.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.091 174.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.829 HD22 HG13 ' B' ' 60' ' ' ILE . 3.3 tp -60.36 -42.84 96.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.289 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.53 -42.93 99.54 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.268 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -78.62 -27.15 45.43 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.384 -176.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.735 HG21 HG21 ' B' ' 64' ' ' VAL . 23.3 mt -61.42 -73.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.082 166.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -59.53 -26.66 65.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.848 -166.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.894 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.52 -48.14 14.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.081 -176.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 2.5 mt-10 -63.98 -26.41 68.57 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.017 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.532 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 13.5 ttm -71.92 -43.49 65.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.452 170.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -65.06 -45.33 92.39 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -60.69 -22.16 63.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.39 169.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -78.07 -54.83 5.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.489 -177.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 64' ' ' VAL . 10.1 mt -61.56 -45.05 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.208 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -61.24 -54.24 46.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.309 -171.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.47 ' O ' HG22 ' A' ' 44' ' ' ILE . 84.3 p -61.48 -28.17 69.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.393 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.735 ' O ' HD13 ' A' ' 46' ' ' LEU . 1.2 mm-40 -62.06 -56.37 19.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.061 165.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.673 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -65.18 -4.52 5.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.023 -178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.839 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -94.1 -56.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.248 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -62.49 -17.12 58.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.74 167.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 42' ' ' GLU . 5.1 mp -67.18 -61.03 2.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.112 170.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.53 -14.21 18.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.462 173.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . 18.4 ttt-85 -97.41 -23.21 16.18 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.016 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -36.1 76.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.051 163.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -67.3 -56.76 8.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.979 161.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.96 -14.05 21.79 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.358 -177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 172.47 114.93 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.641 -0.779 . . . . 0.0 109.785 -172.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.66 28.81 0.0 OUTLIER 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.991 164.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.784 HG23 ' O ' ' B' ' 19' ' ' ARG . 100.0 m 63.45 150.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.407 177.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.793 ' HB ' HG13 ' B' ' 20' ' ' VAL . 9.6 mm -69.73 134.25 30.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.014 169.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.802 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 41.1 mtmt -142.38 175.31 9.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.504 -164.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -63.86 -55.13 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.289 -173.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 3.4 mt-10 -68.5 -16.05 63.75 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.992 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -72.05 -39.3 69.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.325 172.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.823 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.83 -56.04 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.501 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.64 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 22.1 mt-10 -60.6 -43.22 97.68 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.877 -161.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.03 -45.45 94.75 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.468 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.545 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.54 -29.09 69.79 Favored 'General case' 0 C--N 1.334 -0.066 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.452 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.748 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -86.22 -52.2 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.62 -168.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -18.73 60.53 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.589 171.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -76.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.316 171.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -67.04 -29.39 69.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.184 -162.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -70.1 146.88 50.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.341 -173.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp . . . . . 0 C--O 1.241 0.633 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.362 -170.852 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -97.67 47.42 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.808 0.813 . . . . 0.0 109.815 167.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 8' ' ' ILE . 18.9 mt 58.56 86.28 0.16 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.312 -172.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.496 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 7.9 Cg_endo -48.81 138.09 26.62 Favored 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.16 1.907 . . . . 0.0 113.353 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.655 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -80.91 -11.33 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.627 -165.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.45 -56.47 6.54 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.764 172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 3.7 Cg_endo -58.74 -48.83 13.35 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 C-N-CA 122.504 2.136 . . . . 0.0 113.499 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.93 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.8 mt -60.89 -21.11 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.321 169.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.82 -53.55 44.31 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.6 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 10.7 mtp-105 -79.28 -21.56 45.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.372 -172.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.582 HD11 HD12 ' A' ' 3' ' ' LEU . 64.0 mt -61.36 -57.6 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.153 165.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.956 HG23 ' HB1' ' A' ' 40' ' ' ALA . 5.6 mt -78.55 -12.93 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.944 -172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtmm -68.47 -40.38 81.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 162.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.35 -32.98 73.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 113.841 -1.527 . . . . 0.0 109.876 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.48 -52.06 66.93 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.554 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.9 25.61 0.26 Allowed Glycine 0 C--N 1.338 0.677 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.732 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.839 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -77.94 145.48 36.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.165 -0.518 . . . . 0.0 110.289 -173.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.99 117.58 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.725 162.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.784 ' O ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER 66.53 100.01 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.423 -163.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.793 HG13 ' HB ' ' A' ' 55' ' ' ILE . 12.7 t -100.91 169.27 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.192 166.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.445 ' N ' HG12 ' B' ' 20' ' ' VAL . 15.1 t -117.14 141.52 48.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.393 174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.602 ' O ' HD12 ' B' ' 26' ' ' ILE . 0.3 OUTLIER -60.87 -27.48 68.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.332 -167.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -60.89 -40.12 91.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.464 172.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.802 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -63.84 -57.97 8.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.281 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.466 ' HB3' ' CG2' ' B' ' 5' ' ' ILE . 0.0 OUTLIER -61.06 -33.25 73.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.388 -167.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.602 HD12 ' O ' ' B' ' 22' ' ' ASP . 21.7 mt -82.18 -38.53 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.449 -173.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.436 ' C ' HD12 ' B' ' 31' ' ' ILE . 85.3 m -61.26 -47.07 87.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.168 -0.923 . . . . 0.0 110.343 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.887 HD23 HD11 ' B' ' 12' ' ' ILE . 4.4 tp -60.49 -47.83 84.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.382 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.709 ' HB1' ' HB2' ' B' ' 3' ' ' LEU . . . -61.31 -27.1 68.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.373 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.14 -36.18 40.93 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.389 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.748 HG21 HG21 ' A' ' 64' ' ' VAL . 4.9 mt -61.14 -72.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.051 172.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.631 HD12 ' O ' ' B' ' 28' ' ' LEU . 3.0 mp -60.06 -31.99 70.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.666 -165.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.595 ' HG2' HD13 ' A' ' 11' ' ' ILE . 3.3 tm-20 -76.82 -33.61 57.95 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.061 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -39.2 89.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.064 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 18.6 mtt -67.64 -43.5 80.17 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.527 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.61 -40.33 97.46 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.5 -32.9 71.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.429 171.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -63.73 -56.88 12.23 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.539 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.88 HD13 HG23 ' B' ' 64' ' ' VAL . 5.0 mt -62.52 -26.38 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.787 -176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.648 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.88 -70.53 0.19 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.317 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.502 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.9 OUTLIER -62.14 -17.29 57.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.371 -173.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.646 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.1 OUTLIER -73.36 -59.04 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.067 170.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.718 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.8 -14.45 21.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.662 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.679 HD11 ' HB2' ' A' ' 17' ' ' ALA . 62.8 mt -94.3 -54.17 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.97 -173.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -60.46 -14.88 21.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.373 167.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.726 HD21 ' NH2' ' B' ' 66' ' ' ARG . 16.8 mt -75.83 -53.81 7.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.465 169.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.23 -16.43 61.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.27 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.35 -34.57 14.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.373 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -60.65 -34.26 74.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.407 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.57 -46.12 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.336 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 24.3 12.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 ttt85 -114.31 -176.34 2.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.009 -0.595 . . . . 0.0 110.431 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -115.07 -46.29 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.336 -170.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 9.7 m -87.45 117.54 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.42 -170.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.771 HG23 ' HB2' ' B' ' 59' ' ' ASP . 9.8 mt -78.72 143.55 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.327 169.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.476 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 2.1 mtmp? -125.92 177.33 6.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.455 -167.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.57 -21.37 64.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.273 170.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 30.2 tt0 -69.08 -48.61 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.044 170.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.771 ' HB2' HG23 ' B' ' 55' ' ' ILE . 7.6 m-20 -63.51 -37.49 87.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.4 -168.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.829 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -62.7 -39.13 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.777 163.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -62.28 -39.46 93.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -170.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 62' ' ' LEU . 22.9 mt -84.53 -39.26 19.02 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.479 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.49 -49.18 78.59 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.393 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.88 HG23 HD13 ' B' ' 39' ' ' ILE . 0.4 OUTLIER -72.66 -52.78 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.015 -170.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -60.3 -31.45 70.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.796 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . 0.726 ' NH2' HD21 ' B' ' 46' ' ' LEU . 1.0 OUTLIER -61.31 -40.36 93.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.325 178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 14.8 m-85 -60.85 -73.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.336 169.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt 178.43 -62.72 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.402 -177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.414 -168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.825 ' OE2' HD12 ' A' ' 26' ' ' ILE . 5.4 pt-20 58.88 45.24 15.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.262 169.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.725 ' HB3' HD11 ' A' ' 8' ' ' ILE . 4.9 mt 60.3 81.16 0.25 Allowed Pre-proline 0 C--O 1.243 0.739 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.035 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -46.66 141.34 11.34 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 122.387 2.058 . . . . 0.0 113.438 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.3 pt -89.83 17.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.975 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.0 -55.98 0.65 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.627 166.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.6 Cg_endo -60.05 -54.64 2.12 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.659 2.239 . . . . 0.0 113.575 171.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.942 ' HA ' HD12 ' A' ' 11' ' ' ILE . 23.8 mt -65.02 -45.25 95.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.361 -179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -22.58 62.3 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -88.02 -27.47 22.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.942 -0.629 . . . . 0.0 110.369 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.942 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.8 mt -62.07 -55.27 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 169.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' B' ' 40' ' ' ALA . 10.0 mm -67.89 -36.21 74.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.33 -168.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.79 -33.27 72.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.286 176.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -62.43 -34.66 77.2 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.824 178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.779 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.56 -52.35 65.91 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.435 169.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.79 23.88 0.35 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.544 177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.752 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 150.57 32.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.436 173.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -122.55 -75.32 0.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.033 -167.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -121.92 104.97 9.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.434 -174.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' NH2' ' A' ' 25' ' ' ARG . 19.8 t -116.13 150.85 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.323 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.5 t -87.79 148.84 24.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.365 168.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -60.95 -20.14 61.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.375 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -60.8 -54.73 41.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.441 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.913 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -62.22 -42.61 99.47 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.385 -172.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.978 ' NH2' HG21 ' A' ' 20' ' ' VAL . 4.6 mmt85 -61.71 -46.12 91.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.354 -175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.825 HD12 ' OE2' ' A' ' 2' ' ' GLU . 40.3 mm -73.31 -32.13 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.451 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.696 HG22 HG21 ' B' ' 60' ' ' ILE . 97.1 m -60.95 -44.33 97.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.497 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.892 HD22 HG13 ' B' ' 60' ' ' ILE . 7.4 tp -83.43 -14.07 53.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.078 -172.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' A' ' 2' ' ' GLU . . . -81.73 -21.76 37.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.407 163.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 33' ' ' GLU . 6.3 tttt -88.57 -31.14 18.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.37 -174.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.017 HG21 HG21 ' B' ' 64' ' ' VAL . 3.1 mp -61.08 -63.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.658 159.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.903 HD12 ' HB3' ' B' ' 32' ' ' LEU . 4.3 mm? -59.04 -14.86 10.87 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.634 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HG3' HD12 ' B' ' 11' ' ' ILE . 0.4 OUTLIER -71.02 -69.11 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.699 163.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -60.8 -32.3 71.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.097 -167.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.466 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -66.42 -34.92 79.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.433 166.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.23 -53.96 12.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 -174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' B' ' 15' ' ' ALA . 0.0 OUTLIER -64.31 -26.09 68.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.458 173.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 15.0 m-20 -60.89 -62.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.477 172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.697 HG21 HG23 ' A' ' 64' ' ' VAL . 3.2 mt -62.59 -17.57 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.583 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.725 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -80.78 -69.17 0.62 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.254 -173.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -61.04 -13.57 17.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.459 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -73.2 -63.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.077 166.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -60.93 -11.26 7.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.556 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -93.28 -49.69 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.803 -176.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -60.28 -33.12 71.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.395 167.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 43' ' ' ALA . 15.6 mt -60.34 -42.72 96.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.334 166.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.717 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -61.23 -54.36 45.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.277 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -68.09 -14.94 63.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.431 174.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -71.27 -56.54 5.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.219 172.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.34 24.08 0.23 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.909 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' NE ' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 55.21 -162.71 0.14 Allowed 'General case' 0 C--O 1.237 0.409 0 O-C-N 122.184 -0.598 . . . . 0.0 111.428 158.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.602 ' H ' ' NE ' ' A' ' 52' ' ' ARG . 0.4 OUTLIER 70.23 -81.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.559 -165.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.3 m -115.45 137.87 51.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.379 -160.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.588 HD13 ' HB2' ' A' ' 47' ' ' ALA . 8.3 mm -94.28 137.14 23.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.164 161.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.46 167.42 23.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.547 -173.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.42 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.261 -167.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -62.1 -42.86 99.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.942 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -60.8 -45.42 94.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.5 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.818 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.0 mm -66.86 -47.2 83.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.401 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.68 -33.89 74.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.012 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HB3' HD13 ' A' ' 46' ' ' LEU . 1.7 mp -61.23 -53.85 51.56 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.384 175.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.02 -49.46 77.3 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.328 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -67.37 -53.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.931 -164.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -20.26 66.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 113.989 -1.459 . . . . 0.0 110.818 175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -43.87 98.04 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.255 176.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 43.0 m-85 -60.41 -46.49 89.81 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.465 168.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.97 -170.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.372 -168.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 pttp . . . . . 0 C--O 1.239 0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.383 -169.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.308 0.575 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -91.6 22.47 4.04 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.471 -168.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.846 HD22 HD11 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -91.68 150.81 41.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.317 164.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HG2' ' B' ' 7' ' ' PRO . 19.3 Cg_endo -62.09 143.37 94.71 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.397 2.064 . . . . 0.0 113.463 164.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.451 HD12 ' NH2' ' B' ' 25' ' ' ARG . 12.2 pt -108.23 -14.51 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.444 -167.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.806 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -77.0 -54.76 1.51 Allowed Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.682 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 17.2 Cg_exo -50.23 -46.48 28.49 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 122.722 2.281 . . . . 0.0 113.617 173.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.6 -47.61 92.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.459 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.84 -29.07 71.28 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.552 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -89.19 -19.99 24.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.332 -171.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 33' ' ' GLU . 46.1 mm -61.61 -48.39 88.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.106 162.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.8 mm -70.22 -39.27 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.711 -174.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.1 OUTLIER -60.44 -43.11 97.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.442 169.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.96 -31.99 72.39 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.857 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -53.62 56.27 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.492 169.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.48 20.83 0.61 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 113.979 -1.464 . . . . 0.0 110.546 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.45 119.88 8.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.253 -0.473 . . . . 0.0 110.272 167.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.94 -61.18 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.057 -175.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.88 108.83 6.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.468 167.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.598 HG21 ' HB ' ' B' ' 12' ' ' ILE . 11.6 t -75.17 114.47 15.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.232 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -60.73 151.59 29.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.409 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.467 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 60.2 m-20 -61.59 -19.23 61.97 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.363 -176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 26' ' ' ILE . 2.3 t0 -89.42 -26.08 21.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.32 -175.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.504 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -63.78 -47.74 79.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.251 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.467 ' NE ' ' HA ' ' B' ' 22' ' ' ASP . 12.6 ptt180 -71.4 -29.14 64.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.402 -169.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.724 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -73.13 -42.21 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.443 176.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.779 ' O ' HD12 ' B' ' 31' ' ' ILE . 67.1 m -60.93 -37.57 82.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.242 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.818 HD22 ' CG2' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -60.58 -41.96 95.71 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.106 167.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -62.86 -32.57 73.82 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.27 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.449 ' HE3' HD12 ' B' ' 26' ' ' ILE . 0.0 OUTLIER -69.94 -45.14 68.13 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.587 174.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.779 HD12 ' O ' ' B' ' 27' ' ' THR . 3.2 mt -61.15 -73.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.211 176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD12 ' A' ' 32' ' ' LEU . 6.5 mp -55.55 -28.51 55.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.32 -167.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.605 ' HB2' HD11 ' B' ' 3' ' ' LEU . 8.0 tp10 -65.24 -57.8 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.126 174.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -61.88 -38.2 87.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.986 -174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 22.1 mmm -72.0 -38.24 69.67 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.54 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.11 -40.71 95.14 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.505 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.5 mtp85 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.388 170.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.3 OUTLIER -65.26 -58.86 4.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.511 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.637 HG12 HG23 ' B' ' 64' ' ' VAL . 4.1 mt -61.51 -31.71 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.339 -173.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.758 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.92 -70.9 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.244 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.779 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 16.1 t -62.27 -12.42 20.47 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.444 -172.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.511 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 1.2 mp0 -93.84 -48.24 6.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.175 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.679 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.55 -10.89 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.378 167.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 17' ' ' ALA . 56.7 mt -100.74 -49.15 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.793 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.01 -11.38 5.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.454 168.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.76 HD22 HD23 ' B' ' 62' ' ' LEU . 8.1 mt -84.1 -59.52 2.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.422 176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -60.69 -18.21 52.64 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.523 175.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -89.11 -28.48 20.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.052 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -60.23 -35.7 76.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.174 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -65.48 -55.59 17.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.998 162.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.26 2.98 44.76 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.762 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 ttp180 178.71 -163.8 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.638 -166.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt 76.02 -93.58 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.314 0.645 . . . . 0.0 111.469 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.535 HG22 ' O ' ' B' ' 55' ' ' ILE . 99.7 m -172.08 168.81 5.74 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.824 -0.548 . . . . 0.0 109.955 -160.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.543 HD13 ' HB2' ' B' ' 47' ' ' ALA . 7.3 mm -114.74 135.41 54.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.903 155.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.913 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -147.22 -177.46 5.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.522 -165.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.619 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -61.74 -15.49 41.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.346 -176.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.532 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 1.8 tp10 -100.76 -30.15 11.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.047 -170.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -36.36 79.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.136 167.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.892 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.39 -64.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.814 162.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.6 OUTLIER -61.08 -22.46 64.65 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.932 -163.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.76 HD23 HD22 ' B' ' 46' ' ' LEU . 5.2 tp -86.67 -39.67 15.83 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.458 175.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.84 -36.17 78.43 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.355 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 1.017 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -88.15 -45.1 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.876 -166.167 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.38 -27.17 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.53 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -40.5 95.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.107 176.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 18.3 m-85 -60.37 -61.96 2.22 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.217 162.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -70.84 101.69 2.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.386 -169.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.578 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.425 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mtt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.67 112.33 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.6 171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' B' ' 11' ' ' ILE . 2.5 mt -66.87 139.99 95.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.638 171.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -62.29 144.31 95.14 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.484 2.123 . . . . 0.0 113.52 164.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.852 HG21 HG12 ' A' ' 26' ' ' ILE . 2.2 pp -107.84 16.54 7.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.879 -169.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.84 -55.87 0.51 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.699 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -61.09 -42.49 35.9 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.555 2.17 . . . . 0.0 113.561 173.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HA ' HD12 ' A' ' 11' ' ' ILE . 25.7 mt -60.63 -35.04 60.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.472 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -46.82 93.46 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.585 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.37 -18.57 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.482 -0.359 . . . . 0.0 110.347 -168.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' B' ' 2' ' ' GLU . 93.6 mt -60.91 -40.22 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.162 163.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.933 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.8 mt -93.22 -25.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.51 -162.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -64.02 -36.88 85.44 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 163.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.05 -32.97 74.71 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 113.419 -1.719 . . . . 0.0 110.088 174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.02 -52.36 65.85 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.509 174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' C ' HG21 ' B' ' 44' ' ' ILE . . . 138.7 28.51 0.25 Allowed Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.978 -1.464 . . . . 0.0 110.713 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -75.18 127.77 33.96 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.531 -175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -108.22 -25.47 11.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.037 174.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.96 107.71 1.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.462 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' HB1' ' A' ' 17' ' ' ALA . 18.7 t -120.14 133.74 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.418 172.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 p -70.64 157.18 38.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.351 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.538 ' O ' HD12 ' A' ' 26' ' ' ILE . 2.3 m-20 -60.64 -33.3 72.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.406 171.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -44.61 96.96 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.429 176.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' B' ' 55' ' ' ILE . . . -62.98 -52.66 62.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.24 -174.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.717 ' NH1' HD13 ' A' ' 5' ' ' ILE . 8.9 ptt180 -79.17 -14.23 59.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.38 -167.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.852 HG12 HG21 ' A' ' 5' ' ' ILE . 37.3 mt -96.81 -32.16 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.4 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.877 HG22 HG22 ' B' ' 60' ' ' ILE . 58.6 m -60.43 -35.4 75.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 168.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 12' ' ' ILE . 3.5 tp -60.01 -48.44 81.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.294 165.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.0 -29.8 69.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.386 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -85.57 -40.75 15.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.444 -177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.498 HD12 ' CG2' ' B' ' 60' ' ' ILE . 18.4 mt -59.79 -69.37 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.982 171.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.529 HD11 ' N ' ' B' ' 36' ' ' GLY . 2.7 tt -59.38 -31.2 69.02 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.846 -166.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.742 ' HB2' HD11 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -62.05 -53.74 51.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.007 177.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 58.4 tt0 -64.59 -20.95 66.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.958 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.47 ' HB3' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -63.06 -44.59 95.41 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.917 160.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.97 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -61.28 -51.96 54.74 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.699 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 8.3 ptm180 -61.46 -27.41 68.55 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.208 -0.496 . . . . 0.0 109.904 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.5 t70 -59.83 -54.44 46.21 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.669 169.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.804 ' HB ' HD11 ' B' ' 28' ' ' LEU . 1.7 mt -62.44 -37.49 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.776 -174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.958 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.12 -68.37 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.401 -174.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 44' ' ' ILE . 4.7 t -62.52 -31.75 72.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.152 -174.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -61.13 -53.6 54.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.227 171.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -69.66 -13.25 62.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.528 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HA ' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -83.77 -55.74 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.197 -168.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -16.74 59.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.398 -1.273 . . . . 0.0 110.574 173.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.57 HD21 ' CD ' ' A' ' 66' ' ' ARG . 11.4 mt -61.3 -45.11 95.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.16 166.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.696 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -79.85 -24.36 41.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.253 -167.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.429 ' NH1' ' HG3' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -79.32 -52.5 8.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.494 178.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -20.05 66.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 172.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.71 -55.96 26.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.178 169.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.84 6.95 0.08 OUTLIER Glycine 0 C--N 1.339 0.735 0 CA-C-N 114.119 -1.401 . . . . 0.0 111.755 -176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.21 80.05 0.12 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.616 0.722 . . . . 0.0 112.182 162.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.12 -68.36 0.92 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.143 165.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.619 HG21 ' HB2' ' B' ' 21' ' ' SER . 6.0 t -138.13 -169.37 2.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.049 164.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.98 HG13 HG22 ' B' ' 20' ' ' VAL . 9.0 mm -100.93 135.36 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.738 161.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' NZ ' HG22 ' A' ' 54' ' ' THR . 3.4 mttt -136.29 159.78 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.527 -164.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.89 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.26 -20.42 62.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.307 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.29 -59.23 4.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.979 165.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 62' ' ' LEU . 1.3 m-20 -66.51 -40.47 89.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.392 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.883 HG23 HD13 ' B' ' 28' ' ' LEU . 16.8 mm -61.93 -56.56 16.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.396 -177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.504 ' HG3' HD11 ' B' ' 31' ' ' ILE . 14.6 mt-10 -61.67 -19.48 62.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.033 174.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -64.26 -53.94 41.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.322 167.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 43' ' ' ALA . . . -61.06 -31.35 71.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.353 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 67' ' ' PHE . 50.2 t -62.45 -67.72 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.6 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' NH2' ' HG2' ' A' ' 69' ' ' LYS . 1.9 mtp85 -60.52 -12.84 10.92 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.749 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.57 ' CD ' HD21 ' A' ' 46' ' ' LEU . 1.1 tpm_? -79.47 -36.95 37.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.14 -170.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' CZ ' HG12 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -62.41 -67.6 0.4 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.452 158.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.69 -169.63 0.1 Allowed 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.077 -1.419 . . . . 0.0 110.298 -175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HG2' ' NH2' ' A' ' 65' ' ' ARG . 17.5 tptp . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.402 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 CA-C-O 121.143 0.497 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 1.6 pm0 -90.12 122.41 33.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.908 175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.924 ' HB3' HD12 ' B' ' 8' ' ' ILE . 17.8 mt 58.68 57.98 5.95 Favored Pre-proline 0 C--O 1.241 0.608 0 CA-C-N 113.684 -1.598 . . . . 0.0 110.65 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.618 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 7.3 Cg_exo -46.33 148.78 3.01 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.612 2.208 . . . . 0.0 113.389 -174.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' B' ' 8' ' ' ILE . 1.8 pp -66.89 -10.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.467 -165.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -87.86 -56.9 0.31 Allowed Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.868 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.3 Cg_endo -60.3 -39.96 62.97 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.609 2.206 . . . . 0.0 113.463 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.924 HD12 ' HB3' ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.72 -55.78 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.829 167.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.05 -17.11 50.9 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.894 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HE3' ' B' ' 13' ' ' LYS . 6.1 ttm105 -82.06 -37.93 25.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.295 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' A' ' 3' ' ' LEU . 64.6 mt -58.31 -50.36 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.9 164.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.958 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.6 mm -68.72 -30.18 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.322 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' B' ' 10' ' ' ARG . 17.5 mtmt -61.98 -38.45 88.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.181 170.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -61.16 -30.56 70.47 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.884 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.83 -52.04 67.09 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 113.852 -1.522 . . . . 0.0 110.508 169.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.38 34.74 0.6 Allowed Glycine 0 CA--C 1.524 0.65 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.59 -164.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 44' ' ' ILE . . . -83.32 149.21 26.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.112 -0.544 . . . . 0.0 110.278 -174.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.05 -25.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.984 169.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -106.21 34.24 3.45 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.307 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 55' ' ' ILE . 22.6 t -82.34 138.15 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.253 167.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.619 ' HB2' HG21 ' A' ' 54' ' ' THR . 31.2 t -80.05 152.31 29.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.386 163.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.2 -15.25 32.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.5 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.481 ' O ' HG22 ' B' ' 26' ' ' ILE . 9.2 t70 -90.31 -29.3 18.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.389 -171.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.704 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -68.28 -44.27 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.207 167.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -61.82 -43.98 97.76 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.279 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.482 ' CD1' ' HD3' ' B' ' 30' ' ' LYS . 0.1 OUTLIER -62.9 -49.5 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.256 176.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.89 HG21 ' HA ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -62.27 -29.13 70.2 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.949 -170.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.883 HD13 HG23 ' A' ' 60' ' ' ILE . 3.8 tp -61.82 -42.73 99.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.943 168.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -64.12 -34.76 78.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.446 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -83.94 -41.51 17.28 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.687 -175.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.538 HD12 ' O ' ' B' ' 27' ' ' THR . 21.8 mt -60.45 -65.86 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.048 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.97 HD11 ' HA2' ' A' ' 36' ' ' GLY . 5.2 mt -55.81 -23.01 27.65 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.234 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -61.6 -62.63 1.68 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.663 169.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.35 -20.95 63.57 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.084 -1.416 . . . . 0.0 109.888 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.5 mmt -66.32 -48.82 69.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.176 161.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.529 ' N ' HD11 ' A' ' 32' ' ' LEU . . . -61.01 -46.04 95.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.911 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -33.93 74.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.255 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.4 OUTLIER -59.74 -61.69 2.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.974 173.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.742 ' HB ' HD11 ' A' ' 28' ' ' LEU . 3.1 mt -61.14 -41.35 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.241 -171.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.933 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -67.2 -53.44 30.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.308 -167.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.581 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 30.6 t -63.82 -30.36 71.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.53 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.687 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 1.4 tm-20 -62.03 -62.65 1.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.904 170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -60.92 -9.88 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.601 HD12 ' C ' ' B' ' 40' ' ' ALA . 39.1 mt -95.07 -48.23 12.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.783 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -60.05 -16.29 30.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.336 166.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.7 mt -82.84 -46.64 12.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.414 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -76.53 -32.66 58.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.247 -173.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -80.45 -32.67 37.2 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.367 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -60.4 -35.89 76.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.268 168.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.82 -50.39 73.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.18 165.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 41.26 23.55 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -130.61 -173.76 3.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.405 -167.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.513 ' O ' HG22 ' B' ' 54' ' ' THR . 5.0 mtmm -75.04 98.06 3.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.48 -165.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.513 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.8 t 60.34 -176.59 0.11 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.952 166.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.3 mt -112.05 142.24 25.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.428 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.546 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 3.3 mmmt -125.11 -176.68 3.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.384 -167.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.2 -40.3 93.45 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.289 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -31.43 71.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.256 176.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.546 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 3.1 m-20 -80.22 -36.38 34.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.409 -168.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 27' ' ' THR . 1.0 OUTLIER -64.2 -47.1 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.607 174.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 7.9 mt-10 -63.3 -24.74 67.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.138 173.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.519 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 8.6 tp -64.47 -51.93 60.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.378 171.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.687 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -66.88 -32.95 74.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.394 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.664 HG23 ' O ' ' B' ' 60' ' ' ILE . 41.5 t -61.54 -67.33 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.715 173.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -10.59 4.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.772 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -73.97 -39.45 63.7 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.069 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' HG12 ' B' ' 39' ' ' ILE . 12.3 m-85 -59.63 -41.9 91.49 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.493 164.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt 61.59 -169.15 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.335 -172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tptm . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.395 169.444 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 mt-10 58.48 103.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.54 167.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -89.27 97.33 0.91 Allowed Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.54 164.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HG2' ' HG3' ' A' ' 7' ' ' PRO . 7.5 Cg_endo -46.22 139.13 12.49 Favored 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.444 2.096 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.28 -8.26 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.915 -167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.68 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.25 -57.8 6.85 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.663 169.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -51.87 -60.39 0.79 Allowed 'Trans proline' 0 N--CA 1.484 0.925 0 C-N-CA 122.615 2.21 . . . . 0.0 113.584 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 3' ' ' LEU . 26.4 mt -61.02 -49.09 86.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.521 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.05 -22.88 63.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -171.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -82.74 -35.34 26.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.364 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.942 HG23 ' HG3' ' B' ' 37' ' ' ARG . 62.6 mt -59.69 -58.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.648 166.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.037 HG22 ' HB2' ' A' ' 17' ' ' ALA . 5.5 mm -61.94 -20.6 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.063 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.621 ' HD3' ' HB2' ' A' ' 18' ' ' GLU . 3.6 mmmt -74.63 -36.77 62.91 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.299 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.85 -32.76 73.13 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.41 -1.268 . . . . 0.0 109.821 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.1 -53.41 58.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.383 169.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.51 17.62 0.84 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.316 -167.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -66.51 -163.85 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.678 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.621 ' HB2' ' HD3' ' A' ' 13' ' ' LYS . 0.5 OUTLIER 61.6 24.2 14.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.612 -158.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -110.78 22.63 15.16 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.538 154.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.781 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 14.6 t -117.35 176.11 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.192 -162.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.605 ' H ' HG12 ' A' ' 20' ' ' VAL . 16.6 t -125.08 168.37 13.47 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.526 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH2' ' A' ' 25' ' ' ARG . 65.6 m-20 -61.8 -25.75 67.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.4 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 3.4 t0 -61.19 -55.96 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.447 177.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.904 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -62.12 -52.73 62.69 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.329 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -61.07 -37.37 82.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.263 -168.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.38 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.422 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 31' ' ' ILE . 82.9 m -61.05 -44.7 97.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.245 -168.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.615 HD22 HG12 ' B' ' 60' ' ' ILE . 4.5 tp -59.79 -45.66 91.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.34 171.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -16.82 44.68 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.494 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 1.3 tptp -101.32 -26.15 13.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.326 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.791 HD12 ' O ' ' A' ' 27' ' ' THR . 1.6 mp -60.6 -68.08 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.792 161.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.896 HD12 ' HB3' ' B' ' 32' ' ' LEU . 3.7 mm? -58.48 -34.72 71.2 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.743 -168.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.493 ' HG3' ' H ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -74.24 -50.2 20.1 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.001 -175.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 12.0 tt0 -61.7 -44.09 97.59 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.952 -177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -35.16 75.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.574 172.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.37 -49.32 32.69 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -60.3 -14.28 17.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.121 -0.54 . . . . 0.0 110.417 169.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 8.4 t0 -88.8 -47.13 8.42 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.52 -173.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD12 HD11 ' B' ' 32' ' ' LEU . 20.5 mt -60.64 -30.73 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.285 170.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.72 -74.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.304 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.497 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.94 -18.9 61.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.462 -174.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.9 mm-40 -69.22 -61.06 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.013 167.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -9.96 5.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.587 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.8 mt -94.26 -52.78 9.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.946 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -60.32 -10.65 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.487 167.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.709 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.8 mp -82.96 -47.05 12.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.217 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.19 96.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.355 167.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -54.53 27.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.375 -170.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.48 -28.78 68.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.332 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.07 92.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.317 169.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 124.66 17.83 2.8 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.402 ' HD3' ' NZ ' ' A' ' 56' ' ' LYS . 4.4 mmp_? -98.77 -167.86 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.4 -171.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -127.23 -37.05 2.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.398 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 ' O ' ' B' ' 19' ' ' ARG . 31.1 m -101.41 149.55 23.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.424 -168.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' CD1' ' HA ' ' A' ' 44' ' ' ILE . 13.9 mm -91.44 137.8 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.365 169.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' NZ ' ' HD3' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -138.74 175.46 9.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.31 -30.66 70.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.227 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -71.58 -40.47 69.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.111 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.47 -33.67 71.53 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.399 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.652 ' CG1' ' HB1' ' B' ' 24' ' ' ALA . 44.5 mm -61.15 -69.82 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.29 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -61.66 -12.09 14.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.269 -170.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mt -75.47 -48.93 20.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.391 168.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.703 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -64.24 -35.72 81.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.361 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.001 HG21 HD13 ' B' ' 31' ' ' ILE . 25.0 t -66.09 -72.01 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.65 170.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' NH1' ' HB3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -59.66 -11.16 4.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.708 -169.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -29.36 14.58 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.367 170.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.514 ' CE2' HG12 ' A' ' 39' ' ' ILE . 1.5 m-85 -59.5 -22.97 62.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.445 163.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.64 82.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.443 172.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.631 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.369 176.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.444 ' HB3' ' CB ' ' A' ' 7' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.077 0.465 . . . . 0.0 109.921 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.537 ' C ' HD23 ' B' ' 3' ' ' LEU . 98.3 mt-10 -134.24 -159.2 0.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.039 171.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.713 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -107.9 97.79 22.59 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.529 177.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.661 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 2.4 Cg_endo -57.88 163.26 9.65 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.476 2.117 . . . . 0.0 113.509 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.8 pt -86.21 -25.25 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.4 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.64 -59.88 4.32 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.781 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 1.2 Cg_endo -54.48 -48.72 19.9 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 C-N-CA 122.498 2.132 . . . . 0.0 113.517 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.713 HD11 ' CB ' ' B' ' 3' ' ' LEU . 38.9 mt -61.03 -43.73 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.369 169.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -16.18 49.02 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.499 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.7 OUTLIER -96.38 -26.76 15.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.359 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -61.27 -56.02 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.325 165.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.686 HD12 ' HB2' ' A' ' 40' ' ' ALA . 9.8 mm -64.04 -36.11 75.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.168 -177.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.8 OUTLIER -62.68 -36.9 84.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.435 171.205 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.57 -34.2 76.5 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.777 -1.102 . . . . 0.0 109.817 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -59.26 -53.34 59.37 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.488 169.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.58 19.93 0.35 Allowed Glycine 0 CA--C 1.525 0.712 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.806 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.772 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.2 120.9 10.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.311 -0.445 . . . . 0.0 110.335 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -82.27 -74.65 0.34 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.048 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.669 ' O ' HG23 ' A' ' 54' ' ' THR . 0.5 OUTLIER -122.19 109.25 14.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.407 -169.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.66 HG21 HH21 ' B' ' 25' ' ' ARG . 47.5 t -112.14 150.27 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.74 150.04 28.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.311 169.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.454 ' O ' HD12 ' B' ' 26' ' ' ILE . 2.4 p30 -60.85 -12.97 12.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.357 170.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -55.35 7.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.652 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -61.98 -40.69 96.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.304 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.66 HH21 HG21 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -61.61 -45.39 94.28 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.456 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.454 HD12 ' O ' ' B' ' 22' ' ' ASP . 51.8 mt -77.73 -21.56 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.422 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.754 HG22 HD11 ' B' ' 31' ' ' ILE . 88.3 m -72.79 -50.58 23.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.312 -176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' B' ' 31' ' ' ILE . 3.2 tp -59.19 -37.86 78.45 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.561 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.09 75.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.32 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 -26.42 23.13 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.43 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 1.001 HD13 HG21 ' A' ' 64' ' ' VAL . 67.5 mt -61.04 -72.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.033 170.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD12 ' A' ' 32' ' ' LEU . 7.2 mp -60.03 -38.34 82.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.715 -170.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.574 ' HG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -73.37 -30.09 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.929 -170.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.02 -45.45 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.122 167.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 33.9 mtt -61.43 -42.33 98.58 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.517 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.07 99.57 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -170.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.942 ' HG3' HG23 ' A' ' 11' ' ' ILE . 2.4 mtp180 -60.43 -35.35 75.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.552 171.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -77.95 -45.7 23.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.499 -167.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.614 HD13 ' CG2' ' B' ' 64' ' ' VAL . 11.9 mt -60.85 -35.85 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.099 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.905 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.65 -59.55 5.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.341 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.501 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 72.0 p -68.79 -24.33 64.39 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.224 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.588 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.5 OUTLIER -61.19 -55.93 26.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.041 165.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.468 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -65.82 -13.68 59.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.602 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.825 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -87.62 -56.46 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.309 -164.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -72.26 -17.29 61.9 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.467 172.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.507 HD12 ' C ' ' B' ' 42' ' ' GLU . 8.3 mt -60.83 -44.16 97.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.369 167.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.859 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.15 -44.02 97.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.362 174.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -50.99 25.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.43 -171.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -61.54 -34.29 75.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.355 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.83 -46.32 91.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.335 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.1 29.99 5.26 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -110.46 135.63 50.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.332 -0.434 . . . . 0.0 110.404 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.88 -42.95 47.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.382 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 7.0 m -111.07 119.8 40.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.399 -168.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.859 HG12 ' HB2' ' B' ' 47' ' ' ALA . 79.9 mt -76.74 139.28 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.291 168.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.904 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 5.5 mtmt -141.8 -170.33 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.463 -169.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.76 -33.36 73.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.241 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.58 -30.43 69.18 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.064 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.73 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.6 OUTLIER -84.19 -39.14 19.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.415 -166.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -65.2 -42.19 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.216 162.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 3.8 mt-10 -61.53 -31.15 71.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.977 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.7 -33.27 18.8 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.357 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -60.54 -42.9 97.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.436 172.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.765 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.44 -52.97 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.013 -164.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.6 -37.28 78.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.799 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.98 -17.93 54.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.9 t80 -60.97 -60.41 3.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.327 173.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.17 -76.58 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.441 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.585 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.373 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HE2' ' HG2' ' B' ' 4' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.299 0.571 . . . . 0.0 110.16 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.604 ' N ' ' HB3' ' B' ' 7' ' ' PRO . 4.2 mt-10 58.44 -161.48 0.24 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.727 177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.84 ' CB ' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -102.77 96.83 8.19 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.589 174.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 7.4 Cg_endo -57.68 162.66 10.21 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.614 2.21 . . . . 0.0 113.545 170.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -84.82 -15.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.526 -179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.756 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.42 -58.59 14.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.762 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.5 Cg_endo -59.3 -57.65 0.85 Allowed 'Trans proline' 0 N--CA 1.484 0.947 0 C-N-CA 122.595 2.197 . . . . 0.0 113.619 172.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.84 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.5 mt -61.71 -43.33 97.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.372 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.563 ' HA2' ' HG2' ' A' ' 25' ' ' ARG . . . -61.74 -41.06 99.56 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.505 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.8 OUTLIER -72.82 -18.47 61.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.234 -0.483 . . . . 0.0 110.455 -174.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG23 ' HD2' ' B' ' 37' ' ' ARG . 69.7 mt -77.67 -41.18 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.53 172.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.5 mm -63.99 -43.96 97.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.149 171.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.8 mttt -62.07 -35.68 79.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.244 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -61.49 -31.15 71.12 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.845 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.63 -52.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.521 171.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.1 24.6 1.04 Allowed Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.493 -170.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.724 ' HB1' HG23 ' A' ' 20' ' ' VAL . . . -60.91 120.27 9.87 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.723 -0.738 . . . . 0.0 110.314 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -90.35 -48.02 7.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.189 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.52 90.43 2.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.501 168.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' B' ' 55' ' ' ILE . 97.8 t -96.41 129.94 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.126 166.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 p -60.84 146.2 47.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.546 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 0.9 OUTLIER -61.16 -21.97 64.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.34 177.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.14 -27.17 64.33 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.42 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.797 ' O ' HG22 ' A' ' 27' ' ' THR . . . -78.06 -41.76 34.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.288 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.563 ' HG2' ' HA2' ' A' ' 9' ' ' GLY . 0.7 OUTLIER -60.7 -45.7 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.503 172.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 19.9 mt -66.55 -27.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.437 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 24' ' ' ALA . 1.3 t -76.5 -33.19 58.65 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.228 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.771 HD22 HG21 ' B' ' 60' ' ' ILE . 1.1 mm? -59.9 -39.13 84.34 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.434 170.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -61.49 -42.05 98.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.396 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -25.69 24.41 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.415 -176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' C ' ' A' ' 27' ' ' THR . 17.4 mt -61.42 -72.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.925 165.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.3 OUTLIER -60.01 -26.11 65.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.816 -167.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HG3' HD11 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.29 -55.69 22.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.959 170.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.77 -32.82 73.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.966 -170.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.521 ' HB3' HD21 ' B' ' 32' ' ' LEU . 3.0 tpp -66.36 -44.83 82.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.414 167.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.41 -42.24 99.14 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -35.17 75.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.195 -0.503 . . . . 0.0 110.427 169.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -61.42 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.533 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.726 HD13 HG22 ' A' ' 64' ' ' VAL . 8.7 mt -61.79 -31.78 51.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.353 -171.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.035 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -66.86 -61.18 2.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.253 -175.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.519 ' CB ' ' HB1' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -60.87 -10.52 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.412 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -81.37 -57.94 3.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.412 169.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB1' ' CG ' ' A' ' 59' ' ' ASP . . . -66.01 -5.47 9.67 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.818 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.94 HD11 ' HB2' ' B' ' 17' ' ' ALA . 77.5 mt -85.95 -65.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.906 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -21.96 64.16 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.951 176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 42' ' ' GLU . 8.4 mp -60.01 -57.18 13.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.21 158.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.746 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.87 -42.76 99.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.236 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.53 -56.57 13.21 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.472 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -64.45 -23.7 67.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.419 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.11 -55.71 29.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.016 164.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.27 19.67 0.26 Allowed Glycine 0 C--N 1.337 0.624 0 CA-C-N 113.85 -1.523 . . . . 0.0 111.035 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.64 -167.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.358 -0.495 . . . . 0.0 111.012 164.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.82 98.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.331 -164.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.4 m 71.65 117.47 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.622 165.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.913 HD11 HG12 ' A' ' 44' ' ' ILE . 14.6 mt -71.76 147.72 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.614 157.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.477 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 27.9 mttt -141.97 160.63 39.83 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.323 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.99 -28.0 69.26 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.704 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -61.38 -41.02 96.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.977 166.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.842 ' CG ' ' HB1' ' A' ' 43' ' ' ALA 0.268 0.0 OUTLIER -67.6 -40.41 84.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.352 -173.865 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.903 HG23 HD13 ' B' ' 28' ' ' LEU . 45.7 mm -73.14 -36.12 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.288 -169.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.512 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -87.48 -17.56 31.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.157 177.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 58' ' ' GLU . 3.8 mm? -72.16 -47.17 52.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.104 164.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -64.84 -42.65 94.76 Favored 'General case' 0 C--O 1.249 1.053 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.063 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.036 HG21 HD13 ' B' ' 31' ' ' ILE . 23.9 t -61.22 -73.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.616 171.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.85 -11.05 6.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.387 -167.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.441 ' HD2' HD21 ' A' ' 46' ' ' LEU . 7.4 mtt180 -70.4 -47.58 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.314 169.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -61.52 -58.31 8.63 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.311 167.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 105.14 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.405 -160.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HE3' ' HA ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.589 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.363 166.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttp . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.008 0.432 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.559 ' C ' HD23 ' B' ' 3' ' ' LEU . 0.7 OUTLIER 58.57 -166.44 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.693 171.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.815 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -108.25 90.82 7.31 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.545 173.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.558 ' HG2' ' HE2' ' A' ' 1' ' ' MET . 15.7 Cg_exo -50.48 152.86 8.29 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 122.617 2.211 . . . . 0.0 113.622 170.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 17.4 pt -85.28 -10.61 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.858 -170.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.752 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.05 -62.69 1.76 Allowed Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.781 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -53.93 -52.3 8.74 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.337 2.025 . . . . 0.0 113.505 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.815 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.3 mt -60.26 -38.43 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.461 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.77 95.17 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.622 -174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.504 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -80.7 -16.52 53.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.361 -0.42 . . . . 0.0 110.443 -178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.709 HD12 ' HA ' ' B' ' 8' ' ' ILE . 17.7 mt -80.15 -39.1 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.772 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 40' ' ' ALA . 20.1 mm -61.18 -46.99 95.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.243 168.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 5.7 mtpt -63.65 -36.93 85.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.225 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.4 -30.82 70.79 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.878 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.28 -53.4 58.58 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.681 169.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.06 30.4 0.27 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 113.759 -1.564 . . . . 0.0 110.707 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.94 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -88.44 -175.5 5.0 Favored 'General case' 0 N--CA 1.46 0.069 0 CA-C-N 114.763 -0.718 . . . . 0.0 110.296 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.25 -72.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.047 169.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -99.11 122.01 41.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.354 -171.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.838 HG11 ' CZ ' ' B' ' 25' ' ' ARG . 14.0 t -145.52 155.52 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.303 -166.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 46.5 t -93.2 149.51 21.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.321 167.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.85 -13.07 13.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.267 167.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.2 m-20 -60.4 -59.64 5.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.529 169.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.688 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -63.8 -43.97 94.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.315 -175.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.924 ' NH2' HG21 ' B' ' 12' ' ' ILE . 5.3 mmt-85 -67.62 -33.32 74.74 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.486 -172.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm -84.25 -19.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.403 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.505 HG22 HG22 ' A' ' 60' ' ' ILE . 89.5 m -71.77 -48.83 44.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.426 175.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.53 -46.86 88.63 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.404 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 33' ' ' GLU . . . -61.99 -29.69 70.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.467 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 -26.02 15.03 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.319 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 1.036 HD13 HG21 ' A' ' 64' ' ' VAL . 79.4 mt -60.87 -70.05 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.961 163.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.654 ' HB3' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -60.32 -27.23 67.17 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.551 -170.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.5 ' HG3' ' HG ' ' B' ' 3' ' ' LEU . 6.5 mt-10 -61.27 -47.2 87.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.203 173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -61.8 -29.24 70.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.005 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -49.8 69.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.427 166.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.0 98.59 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -168.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.6 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.62 -32.4 71.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.393 170.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.2 t0 -64.47 -58.73 5.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.427 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.63 HG21 HG23 ' B' ' 64' ' ' VAL . 2.9 mt -65.61 -24.88 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.157 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.771 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -64.2 -75.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.312 174.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.513 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 p -61.43 -16.81 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.583 -171.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.512 ' HG3' ' CZ ' ' B' ' 67' ' ' PHE . 0.0 OUTLIER -72.45 -59.46 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.082 168.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.89 -12.72 11.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.41 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.689 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.6 mt -94.45 -50.34 11.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.724 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -60.27 -21.37 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.547 168.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' B' ' 43' ' ' ALA . 4.0 mt -71.61 -46.67 58.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.391 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.63 -38.09 86.38 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.384 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.67 -45.09 14.94 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.387 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -61.55 -35.93 79.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.356 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.85 -46.83 89.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.35 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.78 29.46 6.91 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.83 174.04 7.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.343 170.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.18 151.29 48.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.389 -168.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 99.1 m 70.1 127.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.463 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.878 ' HB ' HG22 ' A' ' 20' ' ' VAL . 4.6 mp -87.58 140.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.265 166.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 10.0 ptpp? -137.65 -171.25 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 166.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.13 -16.91 49.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.281 -166.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 1.3 tm-20 -90.15 -20.73 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.042 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.842 ' HB2' HG23 ' B' ' 55' ' ' ILE . 18.2 m-20 -81.06 -34.08 32.99 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.389 176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.771 HG21 HD22 ' A' ' 28' ' ' LEU . 35.9 mm -60.53 -68.27 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.348 167.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.408 ' HA ' HG12 ' B' ' 64' ' ' VAL . 41.4 mt-10 -61.38 -15.29 34.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.772 -170.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 11.5 mt -68.31 -50.82 50.86 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.284 165.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.15 -39.43 86.35 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.439 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -75.52 -56.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.166 -0.925 . . . . 0.0 108.861 -162.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -21.31 59.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.875 171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -48.85 79.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.281 176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' B' ' 39' ' ' ILE . 4.5 m-85 -60.67 -64.09 1.07 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.301 164.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' B' ' 68' ' ' LYS . 4.7 ttmm 178.69 169.17 0.87 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.343 -170.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.614 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.311 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 121.14 0.495 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HB2' HD23 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -109.95 -40.12 4.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.993 169.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.953 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -87.67 126.06 63.02 Favored Pre-proline 0 C--O 1.243 0.761 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.224 -172.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 20.4 Cg_endo -60.89 148.1 93.43 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.099 1.866 . . . . 0.0 113.469 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.513 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -115.87 -12.48 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.188 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.846 -175.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -70.14 -56.3 7.25 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.701 173.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -63.22 -51.8 2.49 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.586 2.191 . . . . 0.0 113.542 175.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.536 ' HA ' HD12 ' A' ' 11' ' ' ILE . 45.9 mt -60.88 -55.45 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.39 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -30.04 74.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -174.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -68.49 -36.33 78.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.229 -0.485 . . . . 0.0 110.397 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 8' ' ' ILE . 23.9 mt -60.63 -40.6 85.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.509 171.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.709 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.8 mm -68.09 -41.03 83.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.277 -174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.96 -34.62 76.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.275 174.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -62.25 -35.11 77.94 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.855 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.842 ' HB1' ' CB ' ' B' ' 41' ' ' SER . . . -59.75 -53.09 62.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.428 169.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.74 24.99 0.28 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.583 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.87 129.15 40.03 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.614 -0.793 . . . . 0.0 110.393 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.64 -37.64 6.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.115 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.84 109.64 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.37 169.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 t -107.51 127.69 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.308 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 26.6 t -62.5 146.45 51.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.352 169.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -30.28 70.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.347 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -60.8 -45.83 92.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.432 173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.783 ' HB2' ' CA ' ' B' ' 56' ' ' LYS . . . -65.73 -59.06 4.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.297 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' H ' ' HG2' ' A' ' 25' ' ' ARG . 11.5 ptm180 -62.55 -23.72 67.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 -168.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -82.49 -32.72 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.564 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.586 HG22 ' CG2' ' B' ' 60' ' ' ILE . 72.4 m -61.21 -39.36 89.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.397 176.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.883 HD22 HG13 ' B' ' 60' ' ' ILE . 0.4 OUTLIER -60.79 -45.03 95.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.135 170.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.953 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -61.35 -42.95 99.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.461 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -76.15 -25.29 55.15 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.224 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.738 HG21 HG21 ' B' ' 64' ' ' VAL . 0.1 OUTLIER -61.82 -50.42 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.402 162.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.882 HD13 ' HG ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -58.63 -36.4 74.03 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.608 -172.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB2' HD21 ' A' ' 3' ' ' LEU . 22.3 tp10 -81.26 -41.37 22.31 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.978 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -86.34 -18.99 30.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.889 -170.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -44.35 48.88 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.9 160.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.29 99.74 Favored Glycine 0 C--N 1.337 0.6 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.696 -178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.531 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -68.38 -35.66 78.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.385 -0.408 . . . . 0.0 110.023 175.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.12 -49.89 75.44 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.507 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.829 HD13 HG23 ' A' ' 64' ' ' VAL . 28.2 mt -61.62 -53.03 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.272 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.87 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -63.33 -47.83 80.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.28 -167.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.409 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 7.1 t -64.68 -19.93 66.02 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.156 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -78.67 -50.05 12.11 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.124 173.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.793 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -71.67 -32.05 67.46 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.987 -176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' B' ' 17' ' ' ALA . 65.5 mt -60.58 -44.06 95.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.935 161.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.57 -31.05 70.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.477 175.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 43' ' ' ALA . 6.5 mt -80.47 -43.44 20.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.279 -169.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 55' ' ' ILE . . . -60.75 -38.87 86.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.221 165.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -71.71 -47.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.37 -169.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -34.47 74.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.446 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.72 83.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.242 168.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.61 43.66 5.43 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -168.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' HG3' ' H ' ' A' ' 53' ' ' LYS . 4.3 tpt85 -119.45 160.8 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.334 -168.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -93.65 147.37 23.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.393 -177.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.503 ' N ' ' HG2' ' A' ' 53' ' ' LYS . 98.8 m 68.16 128.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.475 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.517 HD11 ' HA ' ' A' ' 44' ' ' ILE . 41.1 mm -91.61 138.87 18.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.375 167.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -144.3 -171.76 3.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.316 -166.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -74.13 -38.94 63.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.21 -167.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.737 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.9 mp0 -61.34 -36.34 79.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.11 169.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -42.76 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.405 -167.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.707 ' CG2' HD13 ' B' ' 28' ' ' LEU . 29.2 mm -61.11 -56.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.345 168.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.6 mt-10 -62.06 -22.8 66.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.931 -172.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -60.54 -52.6 64.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.312 165.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -60.25 -44.81 94.95 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.588 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.829 HG23 HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.91 -55.52 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.043 -160.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -29.18 68.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.74 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.381 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 11.0 m-85 -60.73 -54.71 41.91 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.419 170.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -66.68 115.37 6.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.444 -168.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.629 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.324 170.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtm . . . . . 0 N--CA 1.473 0.719 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.787 ' O ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 58.48 27.64 15.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.701 169.147 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' B' ' 8' ' ' ILE . 14.5 mt 60.24 86.25 0.16 Allowed Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.154 -175.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.03 151.9 11.13 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.328 2.019 . . . . 0.0 113.547 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.568 HD13 ' CZ ' ' B' ' 25' ' ' ARG . 1.1 pt -92.42 18.31 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.685 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -80.04 -58.67 0.59 Allowed Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.673 169.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.2 Cg_endo -58.65 -54.57 2.76 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.18 . . . . 0.0 113.496 168.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.787 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.4 mt -67.83 -23.84 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.386 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.37 -44.11 97.93 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.6 OUTLIER -86.9 -14.2 42.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.477 -173.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 24.8 mt -60.97 -49.57 84.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.131 163.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.982 HD11 HD23 ' B' ' 28' ' ' LEU . 5.7 mt -92.03 -19.69 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.484 -166.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 9.3 mttm -62.48 -41.63 98.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.459 159.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -61.62 -33.01 73.18 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 113.796 -1.547 . . . . 0.0 110.09 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -49.89 75.53 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.397 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.78 38.35 0.54 Allowed Glycine 0 CA--C 1.527 0.795 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.565 -163.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.917 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -79.8 164.09 23.91 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.767 -0.717 . . . . 0.0 110.26 -177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -132.0 -39.04 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 163.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.78 100.2 2.05 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.345 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.511 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -92.53 135.23 28.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.055 160.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 15.7 t -68.51 171.19 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.2 165.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' B' ' 25' ' ' ARG . 0.5 OUTLIER -60.58 -22.34 63.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.407 172.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.8 m-20 -61.17 -61.67 2.4 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.48 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.589 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.4 -51.2 68.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.243 -172.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.568 ' CZ ' HD13 ' B' ' 5' ' ' ILE . 1.4 ptm180 -60.89 -48.0 83.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.361 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 86.0 mt -62.08 -43.59 97.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.457 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.566 ' C ' HD12 ' B' ' 31' ' ' ILE . 0.7 OUTLIER -63.18 -45.84 89.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.932 -167.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.982 HD23 HD11 ' B' ' 12' ' ' ILE . 1.9 tp -59.51 -33.69 71.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.665 173.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' B' ' 2' ' ' GLU . . . -61.42 -41.55 97.34 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.311 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.522 ' HG3' ' HG3' ' B' ' 2' ' ' GLU . 0.1 OUTLIER -96.49 -18.97 19.47 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.331 -174.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.736 HG21 HG21 ' A' ' 64' ' ' VAL . 42.7 mt -60.22 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.891 161.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.882 ' HG ' HD13 ' A' ' 32' ' ' LEU . 1.1 mp -58.49 -25.9 62.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.705 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.627 ' OE1' HD11 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -61.22 -56.97 14.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.011 171.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.41 -30.6 70.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.935 -168.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.626 ' CG ' HD11 ' B' ' 39' ' ' ILE . 3.4 tpp -61.98 -45.08 95.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.297 164.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.43 99.75 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -60.51 -41.44 94.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.422 172.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 1.8 t70 -65.41 -57.46 8.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.493 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.713 ' CG1' HG23 ' B' ' 64' ' ' VAL . 1.9 mt -62.16 -29.42 46.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.872 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.709 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.28 -75.14 0.08 Allowed 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.325 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.842 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -62.13 -12.71 21.05 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.454 -170.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.521 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -88.27 -44.52 10.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.23 176.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -66.64 -10.76 49.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.344 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.0 mt -95.39 -53.98 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.113 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -60.69 -21.36 62.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.468 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.9 mt -66.72 -63.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.429 168.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.26 -34.05 75.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.22 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -38.23 51.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.419 -175.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.63 -35.96 77.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.331 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.524 ' HB1' ' HG3' ' B' ' 52' ' ' ARG . . . -60.75 -48.66 80.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.301 167.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 52.39 5.96 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -169.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.524 ' HG3' ' HB1' ' B' ' 50' ' ' ALA . 0.8 OUTLIER -130.22 21.94 5.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.341 -169.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt 65.31 -77.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.472 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 1.7 m -89.09 140.54 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.366 -167.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.615 HG23 ' HB3' ' B' ' 59' ' ' ASP . 3.6 mt -92.83 140.85 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.391 168.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.783 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -127.61 178.71 5.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.45 -169.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -22.48 64.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.376 174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.541 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 4.4 tp10 -71.37 -22.44 61.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.166 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.615 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.3 OUTLIER -93.59 -35.4 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.297 -172.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.883 HG13 HD22 ' A' ' 28' ' ' LEU . 1.3 mp -64.2 -36.89 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.487 160.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 1.1 mt-10 -62.06 -46.23 90.03 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.84 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -72.42 -50.35 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.525 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.65 -56.61 19.22 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.521 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.738 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -64.2 -52.62 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.227 -170.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -60.49 -37.23 80.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.742 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' B' ' 66' ' ' ARG . 1.4 tpt180 -61.6 -40.57 95.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -171.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.525 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 1.2 m-85 -60.86 -61.82 2.31 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.398 170.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -86.47 93.63 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.403 -169.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? . . . . . 0 C--O 1.24 0.588 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.336 171.774 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' N ' ' HB2' ' A' ' 33' ' ' GLU . 7.1 tpt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.563 ' C ' HD23 ' A' ' 3' ' ' LEU . 1.2 tp10 59.44 28.32 17.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.515 174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.866 HD21 HD11 ' B' ' 11' ' ' ILE . 0.2 OUTLIER -106.51 84.87 1.56 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.458 160.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 7' ' ' PRO . 8.0 Cg_endo -61.31 144.14 98.41 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 122.472 2.115 . . . . 0.0 113.525 174.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.888 HD13 ' NH2' ' A' ' 25' ' ' ARG . 2.5 pp -64.96 -7.7 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.911 -169.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.703 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.19 -55.17 0.67 Allowed Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.81 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.703 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.5 Cg_endo -59.7 -49.8 9.36 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.469 2.112 . . . . 0.0 113.599 176.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.749 HD11 ' CB ' ' A' ' 3' ' ' LEU . 27.8 mt -60.83 -37.77 77.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.232 167.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.79 -16.03 44.27 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 114.405 -1.271 . . . . 0.0 110.564 175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.419 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 3.8 tpp85 -96.3 -26.66 15.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.682 -0.759 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.885 HD11 HD21 ' B' ' 3' ' ' LEU . 8.6 mm -60.28 -54.83 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.394 165.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 17' ' ' ALA . 8.1 mm -76.73 -35.88 25.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.271 -164.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -65.1 -34.62 78.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.338 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.33 -33.39 74.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.77 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.64 -54.18 50.01 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.461 168.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.19 30.4 0.31 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.613 -173.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.789 ' HB2' HG22 ' A' ' 12' ' ' ILE . . . -75.99 147.3 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 114.727 -0.737 . . . . 0.0 110.344 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' NH1' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -171.13 47.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.013 166.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.502 ' NH1' ' HB2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -164.88 24.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.42 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 24' ' ' ALA . 37.3 t -85.85 119.65 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.31 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' ' CG2' ' B' ' 54' ' ' THR . 25.1 p -62.2 164.23 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.297 168.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 11.7 t70 -60.65 -21.89 63.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.535 173.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.594 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -90.04 -31.94 16.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.448 -168.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.678 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -69.39 -44.03 72.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.22 172.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.888 ' NH2' HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -73.99 -21.99 59.78 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.383 -173.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.743 ' O ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -83.45 -42.81 17.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.361 178.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.479 HG22 ' CG2' ' B' ' 60' ' ' ILE . 57.3 m -61.34 -38.49 87.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.447 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 3.6 tp -62.02 -41.37 98.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.131 171.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.47 -42.58 98.99 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.354 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 2.4 tppt? -83.32 -29.05 28.62 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.396 -172.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.922 HD13 HG21 ' B' ' 64' ' ' VAL . 45.4 mt -60.53 -66.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.011 165.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.914 HD12 HD23 ' B' ' 32' ' ' LEU . 0.7 OUTLIER -58.15 -32.96 68.68 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.787 -169.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.575 ' HB2' ' N ' ' A' ' 1' ' ' MET . 1.8 pp20? -82.67 -30.96 28.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.081 -176.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 4.5 mt-10 -61.64 -33.92 74.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.902 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -55.58 8.11 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.509 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -61.15 -45.11 97.2 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 24.2 ttp180 -60.69 -33.92 73.57 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.832 -0.684 . . . . 0.0 110.419 171.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.7 m-20 -66.76 -56.78 8.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.481 -177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.72 HG21 HG23 ' A' ' 64' ' ' VAL . 4.5 mt -61.51 -26.1 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.289 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.664 ' CB ' HG23 ' B' ' 12' ' ' ILE . . . -61.82 -74.06 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.211 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.431 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 15.5 t -62.2 -12.88 22.51 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.351 -174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -80.55 -57.88 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.07 171.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.502 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -60.78 -10.49 5.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.595 177.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -98.89 -51.42 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.662 -174.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 48' ' ' ARG . 12.2 ttpt -60.04 -10.58 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.348 166.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.738 HD22 ' HB2' ' A' ' 63' ' ' ALA . 3.8 mp -82.73 -42.6 17.82 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.246 175.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.82 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -68.74 -36.09 77.94 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.353 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' CG ' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -82.71 -43.93 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.415 -168.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.43 ' N ' ' HD3' ' A' ' 48' ' ' ARG . 7.1 m-70 -61.22 -23.86 65.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.191 168.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.94 -54.34 46.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.082 165.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.12 29.85 0.38 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.532 -174.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 66.64 99.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.782 -0.709 . . . . 0.0 110.446 169.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.69 -169.08 3.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.297 168.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 m -65.22 125.53 25.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.378 169.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.623 HD12 HG22 ' B' ' 20' ' ' VAL . 44.6 mt -62.53 147.8 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.301 170.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -145.95 164.02 33.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.509 -169.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.06 64.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.247 -168.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -58.14 9.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.034 169.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.89 -21.79 65.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.434 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.812 HG23 HD13 ' B' ' 28' ' ' LEU . 29.8 mm -72.68 -76.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.224 178.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.546 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -62.74 -8.44 6.76 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.454 -176.011 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tt -90.12 -27.56 19.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.586 172.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.738 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -81.53 -31.98 32.5 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.005 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.786 HG21 HD13 ' B' ' 31' ' ' ILE . 25.7 t -60.64 -69.1 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.637 160.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.61 -14.3 19.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.565 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -62.09 -51.12 69.2 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.358 167.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 54.0 m-85 -60.58 -52.27 65.9 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.537 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.513 ' HD3' ' HE2' ' B' ' 69' ' ' LYS . 5.8 ttmt 62.74 14.9 7.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.429 -169.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm . . . . . 0 C--O 1.24 0.568 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.485 -174.32 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 121.175 0.512 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -161.12 113.12 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.971 170.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.885 HD21 HD11 ' A' ' 11' ' ' ILE . 2.8 mt -69.42 139.8 89.65 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.699 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.412 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.1 Cg_endo -61.12 142.63 97.52 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 C-N-CA 122.471 2.114 . . . . 0.0 113.558 167.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.703 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -67.78 -20.19 25.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.381 -170.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -61.35 -62.2 6.41 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.736 -170.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.07 -50.56 13.52 Favored 'Trans proline' 0 N--CA 1.483 0.884 0 C-N-CA 122.455 2.103 . . . . 0.0 113.623 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' B' ' 3' ' ' LEU . 7.5 mt -62.22 -21.7 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.449 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.47 -44.86 97.23 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.624 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -86.44 -15.32 40.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.522 -173.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.866 HD11 HD21 ' A' ' 3' ' ' LEU . 11.1 mm -60.85 -73.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.234 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.812 HD13 HG22 ' B' ' 11' ' ' ILE . 8.0 mm -63.27 -20.96 27.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.936 -170.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.494 ' HB3' ' NZ ' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -73.51 -36.35 65.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.391 172.016 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.92 -31.88 72.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.825 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.18 -52.64 64.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.455 170.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.96 33.5 0.51 Allowed Glycine 0 CA--C 1.527 0.783 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.607 -168.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.703 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -77.45 147.1 36.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.28 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -106.48 -67.3 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.977 -169.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.85 112.14 9.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.418 169.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.678 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 80.6 t -103.62 137.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.31 168.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 54.0 p -61.11 146.55 47.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.427 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.49 ' HA ' ' NH1' ' B' ' 25' ' ' ARG . 2.3 p30 -61.69 -24.4 66.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.412 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.575 ' HA ' HG22 ' B' ' 26' ' ' ILE . 4.9 t0 -84.04 -26.0 29.42 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.382 -176.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.678 ' HB3' ' CG1' ' B' ' 20' ' ' VAL . . . -62.7 -45.05 94.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.171 168.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.49 ' NH1' ' HA ' ' B' ' 22' ' ' ASP . 6.0 ptt-85 -85.88 -13.27 48.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.554 -166.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.76 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -84.12 -38.33 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.444 168.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.472 HG22 HD11 ' B' ' 31' ' ' ILE . 59.4 m -61.33 -43.15 99.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.218 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.812 HD13 HG23 ' A' ' 60' ' ' ILE . 2.6 tp -60.22 -37.59 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.272 166.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.33 -43.04 99.54 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.213 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.1 OUTLIER -82.2 -26.13 33.6 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.448 -177.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.786 HD13 HG21 ' A' ' 64' ' ' VAL . 34.7 mt -60.95 -71.88 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.092 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.914 HD23 HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -59.99 -32.19 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.681 -166.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.607 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.7 pp20? -80.85 -39.68 26.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.175 -170.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 3.2 mm-40 -61.59 -39.23 90.46 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.007 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 4.8 mtp -61.0 -54.86 39.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.535 168.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.3 -45.81 95.72 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -165.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.845 ' HG3' HG23 ' A' ' 11' ' ' ILE . 9.2 mtp-105 -61.21 -32.33 72.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.235 175.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -61.5 -49.58 76.17 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.604 175.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.852 HD13 HG22 ' B' ' 64' ' ' VAL . 2.8 mt -62.06 -37.17 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.012 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.59 -69.0 0.27 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.315 -175.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 1.4 p -62.17 -10.27 10.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -175.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.498 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.4 OUTLIER -93.84 -50.78 5.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.279 178.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -60.72 -10.57 5.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.376 170.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 17' ' ' ALA . 87.4 mt -101.24 -50.77 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 114.486 -1.234 . . . . 0.0 109.752 -176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -60.42 -11.71 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.463 168.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.498 HD12 ' C ' ' B' ' 42' ' ' GLU . 6.0 mt -83.97 -54.05 5.14 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.395 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.22 -21.15 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.386 175.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.12 -44.91 15.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.311 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -60.41 -30.51 69.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.398 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.64 -49.78 76.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.423 174.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.26 37.6 0.79 Allowed Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -168.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 8.2 mtt85 66.05 99.34 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.666 -0.767 . . . . 0.0 110.492 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -130.77 -177.65 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.351 167.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 21' ' ' SER . 87.7 m -78.16 130.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.468 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.678 HG22 ' HB1' ' A' ' 24' ' ' ALA . 13.5 mm -69.97 134.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.249 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.516 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -139.73 175.51 9.51 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.527 -171.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -25.37 67.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.279 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.441 ' C ' HD12 ' B' ' 62' ' ' LEU . 0.6 OUTLIER -62.17 -63.59 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.11 169.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -61.06 -12.44 11.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.468 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.803 HG22 HD12 ' A' ' 31' ' ' ILE . 41.4 mm -88.39 -57.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.178 -177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.446 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 9.6 mt-10 -61.48 -16.89 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.177 170.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 0.3 OUTLIER -67.56 -59.73 3.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.324 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.77 71.75 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.119 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.922 HG21 HD13 ' A' ' 31' ' ' ILE . 43.4 t -61.61 -71.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.693 169.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -61.16 -9.17 4.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.497 -171.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.51 48.71 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.296 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.529 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 38.1 m-85 -60.67 -53.62 55.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.34 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 2.3 tttm 64.46 -76.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.359 -167.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.513 ' HE2' ' HD3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.548 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.358 168.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mtt . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.101 0.477 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -105.9 167.27 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.962 -170.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.584 ' HG ' ' HB2' ' A' ' 33' ' ' GLU . 13.6 mt -61.36 107.89 1.3 Allowed Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.916 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -50.29 148.8 13.62 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.341 2.027 . . . . 0.0 113.285 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.559 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 2.1 pp -93.03 20.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.628 -167.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.709 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.53 -59.54 0.31 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.68 174.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.7 Cg_endo -53.05 -50.46 14.0 Favored 'Trans proline' 0 N--CA 1.485 0.996 0 C-N-CA 122.493 2.129 . . . . 0.0 113.522 172.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 29' ' ' ALA . 86.3 mt -69.05 -30.36 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.382 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.06 -42.04 99.66 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.47 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -78.25 -31.91 49.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.353 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 8' ' ' ILE . 85.5 mt -60.81 -40.05 83.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.379 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.945 HG23 ' HB1' ' B' ' 40' ' ' ALA . 12.1 mt -97.86 -15.62 7.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.516 -162.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 -38.1 85.71 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 158.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -65.85 -33.57 76.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 113.536 -1.665 . . . . 0.0 110.022 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.85 -52.11 66.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.483 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.0 25.15 0.2 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.772 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -76.09 152.4 36.81 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 114.665 -0.768 . . . . 0.0 110.262 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 -42.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.194 169.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.6 113.56 4.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.421 -168.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.714 HG13 ' HB ' ' B' ' 55' ' ' ILE . 22.4 t -137.3 161.93 34.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.393 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 81.8 p -88.42 133.93 33.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.414 169.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.99 -25.4 68.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.358 -172.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -60.93 -36.38 79.18 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.421 174.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -63.17 -52.67 61.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.272 169.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.636 HH21 HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -68.82 -18.0 64.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.477 -168.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mt -82.25 -37.79 14.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.44 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 HG21 ' B' ' 60' ' ' ILE . 94.6 m -60.74 -32.29 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.457 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.947 HD22 HG13 ' B' ' 60' ' ' ILE . 10.9 tp -92.03 -33.74 14.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.024 -171.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HA ' HD13 ' A' ' 8' ' ' ILE . . . -61.02 -41.9 97.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.153 166.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -36.11 83.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.517 176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.631 HG21 HG21 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -68.0 -43.32 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.135 -167.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.659 HD23 ' HB3' ' B' ' 32' ' ' LEU . 2.8 mp -65.71 -57.61 7.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.507 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.808 ' HG2' HD13 ' B' ' 11' ' ' ILE . 9.5 tm-20 -61.47 -32.97 72.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.166 -166.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.25 -40.25 95.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.93 170.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 5.3 mtt -65.17 -38.02 89.22 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.542 -1.208 . . . . 0.0 110.581 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.653 ' CA ' HD21 ' B' ' 32' ' ' LEU . . . -76.98 -40.54 25.0 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -168.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -24.41 66.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.165 164.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.73 -60.6 2.28 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.514 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.855 ' HB ' HD11 ' B' ' 28' ' ' LEU . 5.0 mt -61.37 -31.73 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.3 -175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.887 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.43 -61.36 2.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.347 -176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.516 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.6 -27.35 68.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.33 -178.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.75 ' O ' HD13 ' A' ' 46' ' ' LEU . 43.3 mt-10 -61.13 -48.41 81.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.011 166.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -72.28 -12.24 61.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.576 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.815 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -85.86 -56.67 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.268 -168.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HD2' ' NH2' ' A' ' 48' ' ' ARG . 20.5 ttpp -66.52 -19.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.457 171.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.2 mp -60.88 -44.05 97.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.294 166.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.712 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.6 -58.83 6.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.401 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' NH2' ' HD2' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -71.07 -28.8 64.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.304 -165.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -60.54 -39.69 88.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.324 171.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -54.98 39.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.007 164.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.74 32.85 0.31 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 113.869 -1.514 . . . . 0.0 110.583 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 69.42 -87.89 0.03 OUTLIER 'General case' 0 C--O 1.24 0.557 0 CA-C-N 114.855 -0.672 . . . . 0.0 110.769 170.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt 58.44 -80.86 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.055 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m -157.8 168.47 27.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.129 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 47' ' ' ALA . 6.7 mm -82.44 137.08 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.214 165.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.22 155.87 43.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.418 -167.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.64 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.33 -29.2 69.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.236 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.659 ' O ' HD13 ' A' ' 62' ' ' LEU . 7.9 mm-40 -61.54 -42.43 98.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 169.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.03 -43.12 79.47 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.487 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.731 HG23 HD13 ' B' ' 28' ' ' LEU . 44.7 mm -61.24 -45.72 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.499 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.74 -28.47 60.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.106 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 58' ' ' GLU . 6.4 mp -66.08 -43.3 87.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.31 169.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.49 -41.44 97.27 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.4 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.84 HG23 HG12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -83.81 -55.08 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.143 -169.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -27.61 66.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.839 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm-85 -69.8 -36.29 75.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.377 169.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -27.95 68.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.382 170.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.22 169.02 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.421 165.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mttm . . . . . 0 C--O 1.238 0.499 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.368 168.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 29.8 ttm . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 58.48 -164.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.67 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 33' ' ' GLU . 3.9 mt -68.96 138.87 90.26 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.874 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -58.02 144.44 94.59 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.368 2.046 . . . . 0.0 113.509 170.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.595 HD13 ' NE ' ' B' ' 25' ' ' ARG . 1.4 pp -93.08 -24.76 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.375 -168.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.569 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -64.98 -56.39 21.12 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.759 -177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.8 Cg_endo -48.37 -53.83 6.2 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 C-N-CA 122.507 2.138 . . . . 0.0 113.446 171.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.463 ' HA ' HD12 ' B' ' 11' ' ' ILE . 36.2 mt -61.1 -33.95 58.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.514 176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -29.04 71.17 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 11.6 mtp-105 -87.88 -28.29 21.67 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.795 -0.703 . . . . 0.0 110.494 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.808 HD13 ' HG2' ' A' ' 33' ' ' GLU . 65.5 mt -60.9 -53.07 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.419 173.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.887 HD12 ' HB2' ' A' ' 40' ' ' ALA . 7.0 mm -63.87 -37.88 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.259 177.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 3.1 mtpm? -61.49 -35.78 78.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.265 177.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.82 -32.43 72.74 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.794 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.6 -53.58 56.68 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.506 170.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.92 21.61 0.29 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.956 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.815 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.21 171.66 14.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.743 -0.728 . . . . 0.0 110.275 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -167.69 -31.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.048 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.452 ' NH1' ' HA ' ' B' ' 19' ' ' ARG . 0.3 OUTLIER -130.8 98.98 4.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.459 168.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' B' ' 24' ' ' ALA . 58.3 t -106.22 145.21 14.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.322 172.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.7 p -70.06 155.99 39.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.321 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -32.09 72.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.353 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 1.4 m-20 -61.56 -48.47 80.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.407 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.689 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.04 -52.35 64.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.274 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.595 ' NE ' HD13 ' B' ' 5' ' ' ILE . 0.4 OUTLIER -61.25 -38.36 86.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.274 -168.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 37.6 mm -67.01 -37.61 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.47 173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.645 HG22 HD11 ' B' ' 31' ' ' ILE . 84.5 m -61.08 -52.26 65.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.421 -172.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 39' ' ' ILE . 4.1 tp -61.1 -42.3 98.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.335 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' B' ' 3' ' ' LEU . . . -60.76 -28.17 68.52 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.416 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.88 -26.29 18.54 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.729 HG21 HG21 ' A' ' 64' ' ' VAL . 17.8 mt -60.87 -71.8 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.985 166.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.659 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.6 mp -59.44 -30.15 68.29 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.595 -168.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.535 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 7.1 tm-20 -75.83 -30.66 59.04 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.09 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.37 -44.79 96.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.065 167.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 12.6 mtt -62.37 -39.62 93.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.407 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -39.41 73.86 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -29.39 69.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.113 0.482 . . . . 0.0 110.471 168.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.531 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.7 OUTLIER -82.31 -52.53 6.84 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.482 -169.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.672 HG12 HG23 ' B' ' 64' ' ' VAL . 5.6 mt -61.32 -34.28 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.185 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.945 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -77.6 -44.4 28.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.168 -164.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 4.4 t -70.62 -13.82 62.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.422 169.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.657 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 2.8 mm-40 -83.11 -44.76 14.76 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.993 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' B' ' 59' ' ' ASP . . . -80.59 -11.1 59.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.339 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ALA . 72.7 mt -93.85 -49.16 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.704 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -60.69 -24.1 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.344 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.945 HD22 HD23 ' B' ' 62' ' ' LEU . 2.9 mt -68.15 -54.13 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.367 170.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.639 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.13 -28.83 69.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.382 -167.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.46 -44.97 10.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.388 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -61.43 -37.36 83.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.327 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.29 -49.5 75.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.197 168.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.92 47.86 4.33 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 -165.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.67 -43.6 10.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.338 -166.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 63.58 118.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.473 -168.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 7.3 m 68.53 139.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.489 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.714 ' HB ' HG13 ' A' ' 20' ' ' VAL . 26.6 mt -105.19 163.21 4.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.374 -174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 mtmt -149.51 166.24 29.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 -169.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.61 -12.96 26.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.256 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' B' ' 61' ' ' GLU . 26.9 mt-10 -86.44 -19.0 30.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.078 177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.548 ' HB3' ' HB1' ' B' ' 43' ' ' ALA . 0.8 OUTLIER -82.53 -33.71 28.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.288 174.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.947 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.88 -56.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.67 161.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 3.0 mt-10 -61.31 -30.29 70.4 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.71 -168.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.945 HD23 HD22 ' B' ' 46' ' ' LEU . 12.0 tp -76.32 -46.69 26.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.639 170.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.657 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -61.27 -24.11 66.16 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.416 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.672 HG23 HG12 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -110.65 -55.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -160.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.16 -10.7 2.98 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.668 172.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -92.9 -65.64 0.98 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.613 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -62.49 -23.67 67.05 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.895 -155.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -96.22 87.07 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.417 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.565 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.35 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.7 mtt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.149 0.499 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -63.1 -158.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.196 171.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 33' ' ' GLU . 6.2 mp -56.5 102.36 0.3 Allowed Pre-proline 0 C--O 1.251 1.134 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.598 -169.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.577 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 3.5 Cg_exo -65.77 159.95 46.06 Favored 'Trans proline' 0 N--CA 1.484 0.967 0 C-N-CA 122.932 2.421 . . . . 0.0 113.542 -172.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.532 ' HA ' ' HB3' ' A' ' 25' ' ' ARG . 2.6 pp -93.47 -26.78 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.394 -166.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.57 -56.49 9.86 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.698 175.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.0 Cg_endo -60.47 -47.65 13.5 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.121 1.881 . . . . 0.0 113.513 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.4 mt -60.87 -34.69 60.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.271 169.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.52 -26.82 65.02 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 114.618 -1.173 . . . . 0.0 110.541 173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -84.35 -27.25 27.86 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.038 -0.581 . . . . 0.0 110.326 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.2 mm -60.52 -58.44 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.454 169.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.705 HG23 ' CB ' ' B' ' 40' ' ' ALA . 8.7 mm -65.62 -42.64 93.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.198 -166.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.78 -31.95 72.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.34 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -62.28 -33.71 75.17 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.756 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.27 -53.66 55.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.271 -1.332 . . . . 0.0 110.447 169.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.76 19.46 0.57 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.711 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.66 -169.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.281 165.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.89 -62.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.041 167.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.67 110.53 22.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.347 -168.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.637 HG22 ' HB ' ' B' ' 55' ' ' ILE . 45.7 t -145.78 148.99 16.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.353 -169.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.1 p -87.45 154.78 20.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.383 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' HA ' ' HD2' ' A' ' 25' ' ' ARG . 9.5 p30 -61.14 -31.46 71.17 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.472 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 26' ' ' ILE . 1.1 m-20 -83.87 -25.3 30.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.397 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.684 ' HB2' ' HA ' ' B' ' 56' ' ' LYS . . . -61.03 -40.08 92.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.252 168.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.532 ' HB3' ' HA ' ' A' ' 5' ' ' ILE . 5.8 mtt180 -66.64 -47.53 72.27 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.476 -176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.715 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 2.3 tp -65.16 -35.99 76.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.356 -174.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.785 ' O ' HD12 ' A' ' 31' ' ' ILE . 13.3 m -61.16 -53.68 53.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.293 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.889 HD22 HG13 ' B' ' 60' ' ' ILE . 6.0 tp -60.86 -9.82 4.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.251 174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -84.52 -58.55 2.69 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.423 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -61.77 -26.12 67.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.22 -174.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 27' ' ' THR . 2.3 mp -60.87 -74.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.961 161.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.765 ' O ' HD21 ' B' ' 32' ' ' LEU . 2.3 mm? -57.79 -30.1 65.39 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.617 -161.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.787 ' HB3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -75.19 -44.18 47.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.262 178.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -70.58 -37.05 73.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.09 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 23.8 mmt -61.29 -40.48 94.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.38 167.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.32 -47.23 72.81 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -60.66 -17.72 49.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.458 171.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -86.83 -49.94 7.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.385 -173.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.818 ' HB ' HD11 ' B' ' 28' ' ' LEU . 4.8 mt -61.81 -23.84 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.081 171.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.674 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.87 -73.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.358 176.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.622 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 30.2 m -61.57 -13.05 18.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.312 -171.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.67 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -78.47 -57.14 3.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.329 170.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.42 -11.9 12.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.529 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.862 HD11 ' HB2' ' B' ' 17' ' ' ALA . 96.9 mt -96.81 -51.24 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.791 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -60.21 -15.6 25.81 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.459 167.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' ALA . 8.3 mt -79.17 -41.1 29.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.46 171.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.751 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -61.23 -17.98 56.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.24 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.26 -48.01 7.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.49 170.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -61.75 -14.6 33.72 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.395 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.63 -48.56 7.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.271 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 42.15 3.42 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -165.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.99 160.47 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.356 -165.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -117.27 145.81 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.307 168.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.884 HG23 ' HG3' ' B' ' 19' ' ' ARG . 3.8 m 69.83 158.92 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -168.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.751 HD13 ' HB2' ' A' ' 47' ' ' ALA . 11.0 mm -109.48 160.36 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.462 174.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -143.42 173.57 11.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.339 -168.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -72.83 -16.7 61.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.403 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 4.9 mm-40 -80.69 -14.35 58.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.264 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.44 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 73.9 m-20 -88.04 -40.4 13.87 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.307 -177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.817 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.5 -47.25 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.823 162.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 6.3 mt-10 -61.74 -42.22 98.68 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.983 -166.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tp -84.18 -28.71 27.17 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.433 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.67 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -60.26 -43.62 96.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.452 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.699 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.55 -55.46 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.009 -164.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -60.22 -24.61 64.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.671 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -14.96 23.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.462 177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 38' ' ' ASP . 46.0 t80 -60.77 -57.3 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.409 171.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.96 -76.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.484 -175.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 69' ' ' LYS . 9.8 mtmt . . . . . 0 C--O 1.241 0.615 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.371 176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 7' ' ' PRO . 4.0 ptt? . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.492 ' C ' HD23 ' B' ' 3' ' ' LEU . 9.6 mm-40 -68.54 -157.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.926 164.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.829 ' CB ' HD11 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -103.86 83.03 0.61 Allowed Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.546 177.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -61.33 149.6 88.69 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 C-N-CA 122.599 2.199 . . . . 0.0 113.597 166.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.677 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -63.3 -13.14 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.786 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.649 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -72.89 -57.49 3.04 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.649 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.1 Cg_endo -54.94 -59.42 0.82 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 122.643 2.229 . . . . 0.0 113.596 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.829 HD11 ' CB ' ' B' ' 3' ' ' LEU . 26.7 mt -61.63 -49.05 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.371 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.71 -27.54 68.45 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 13.1 tpt180 -78.14 -26.55 47.9 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.209 -0.496 . . . . 0.0 110.509 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.566 HD11 HD11 ' A' ' 3' ' ' LEU . 66.4 mt -69.88 -46.54 73.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.491 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.4 mm -64.41 -38.97 83.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.191 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.65 -35.32 75.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.376 168.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -62.16 -33.6 74.82 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.729 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.622 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -59.16 -53.5 57.66 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.358 169.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.2 14.65 0.62 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.256 -173.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.862 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.59 147.54 41.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.318 162.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 -55.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.114 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.884 ' HG3' HG23 ' A' ' 54' ' ' THR . 4.7 tpt180 -101.94 104.89 15.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.4 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 55' ' ' ILE . 22.6 t -133.83 146.76 31.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.375 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 35.7 p -85.37 143.11 28.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.448 170.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -71.83 -28.46 63.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.31 -170.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.8 -34.48 74.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.47 171.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -61.27 -54.04 49.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.258 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.512 ' HD3' ' HB ' ' B' ' 5' ' ' ILE . 5.7 mtt180 -64.96 -12.59 51.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.463 -170.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.752 HG22 ' HD2' ' B' ' 30' ' ' LYS . 86.4 mt -103.64 -25.63 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.447 -176.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.811 ' O ' HD12 ' B' ' 31' ' ' ILE . 81.8 m -63.41 -44.06 95.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 166.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.818 HD11 ' HB ' ' A' ' 39' ' ' ILE . 1.9 tp -59.92 -42.77 94.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.295 172.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.13 -38.19 85.5 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.198 -1.364 . . . . 0.0 110.561 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.752 ' HD2' HG22 ' B' ' 26' ' ' ILE . 3.3 mtpt -80.41 -28.52 37.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.203 -173.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.811 HD12 ' O ' ' B' ' 27' ' ' THR . 2.7 mt -60.81 -70.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.996 160.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.75 -16.76 18.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.723 -166.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.18 -37.65 12.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.083 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 11.4 mt-10 -61.27 -57.64 11.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.254 171.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.473 ' HG2' ' HA ' ' B' ' 32' ' ' LEU . 19.0 ptp -62.33 -28.7 69.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.343 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.18 -46.24 51.52 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.566 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -14.54 24.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.383 169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.52 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.4 OUTLIER -89.97 -51.06 5.67 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.534 -173.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.685 HD13 ' CG2' ' B' ' 64' ' ' VAL . 6.8 mt -61.96 -26.3 39.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.053 171.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -62.14 -68.41 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.212 177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.498 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 86.6 p -61.1 -10.65 6.57 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.534 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.0 OUTLIER -95.54 -36.04 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.035 -178.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.515 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -75.52 -9.93 59.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.373 167.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 58.0 mt -98.6 -49.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.923 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.496 ' HA ' ' HG2' ' B' ' 48' ' ' ARG . 10.9 mttp -60.27 -27.79 67.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.453 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.552 HD12 ' HB2' ' B' ' 63' ' ' ALA . 10.0 mt -61.5 -55.44 31.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.346 166.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.715 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.33 -31.36 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.312 -168.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.496 ' HG2' ' HA ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -74.3 -38.13 63.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.408 178.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.444 ' N ' ' HG3' ' B' ' 48' ' ' ARG . 38.2 t-80 -60.55 -32.28 71.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.229 168.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.36 -53.97 51.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.28 170.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.94 23.96 0.75 Allowed Glycine 0 CA--C 1.521 0.468 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.775 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 56.0 95.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.1 0.476 . . . . 0.0 111.914 169.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.15 -67.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.391 168.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.48 HG22 ' N ' ' B' ' 55' ' ' ILE . 93.6 m -146.28 166.47 26.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.364 -175.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.941 HG23 ' HB3' ' B' ' 59' ' ' ASP . 65.7 mt -119.4 146.54 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.408 170.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.684 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -137.91 -172.92 3.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.424 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.45 -16.41 46.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.236 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.646 ' O ' HD13 ' B' ' 62' ' ' LEU . 0.1 OUTLIER -79.36 -25.32 42.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.102 178.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.941 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -85.94 -35.51 20.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.281 -176.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.889 HG13 HD22 ' A' ' 28' ' ' LEU . 1.2 mp -61.77 -46.4 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.705 160.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -62.09 -40.29 95.34 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.823 -172.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.646 HD13 ' O ' ' B' ' 58' ' ' GLU . 7.5 mp -74.76 -45.38 44.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.55 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.37 -31.81 71.71 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.387 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.707 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -95.16 -54.94 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.983 -165.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -16.68 34.88 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.697 176.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.56 -11.81 15.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.608 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 3.2 t80 -61.1 -52.52 64.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.278 166.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.81 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.366 172.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.238 0.497 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.682 171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.7 mt-10 58.84 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.714 175.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp -57.47 98.91 0.17 Allowed Pre-proline 0 C--O 1.251 1.178 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.499 -172.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 -60.56 -61.8 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 65.16 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.486 169.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.543 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.32 -168.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.09 0.472 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 1' ' ' MET . 4.1 mt-10 59.15 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.783 -174.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt -73.84 137.2 76.62 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.783 -168.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.93 -46.57 90.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.81 -76.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.382 -171.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.353 -169.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptp . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 121.12 0.486 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' HG2' ' N ' ' A' ' 3' ' ' LEU . 45.8 tt0 -78.23 174.71 10.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.055 169.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 33' ' ' GLU . 11.5 mt -63.02 138.76 97.41 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.791 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 5.2 Cg_endo -58.96 148.93 82.46 Favored 'Trans proline' 0 N--CA 1.489 1.227 0 C-N-CA 122.392 2.061 . . . . 0.0 113.44 167.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 2.5 pp -85.1 -28.91 6.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.386 -176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -62.14 -62.22 6.21 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.779 -171.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -51.89 -46.24 33.46 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.48 2.12 . . . . 0.0 113.588 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' HA ' HD12 ' A' ' 11' ' ' ILE . 59.9 mt -61.18 -59.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.445 177.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.76 -26.76 67.35 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.0 -32.97 61.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.16 -0.52 . . . . 0.0 110.348 -177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 8' ' ' ILE . 44.2 mt -60.76 -40.92 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.493 169.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' B' ' 40' ' ' ALA . 19.4 mm -66.51 -34.58 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.405 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.25 -29.93 65.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.392 176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -62.6 -35.52 79.81 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.31 -1.314 . . . . 0.0 109.811 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.49 -53.42 58.31 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.395 168.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.63 18.46 0.32 Allowed Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.834 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.814 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.81 142.2 56.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.311 165.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.66 -33.58 3.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.117 -169.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.51 88.09 1.91 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.486 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.787 HG22 HD12 ' B' ' 55' ' ' ILE . 23.5 t -114.91 133.54 60.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.381 177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -92.02 157.73 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.434 -169.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.94 -20.94 66.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -61.02 -49.02 79.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.375 169.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -61.95 -44.33 96.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.335 -175.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 5.6 mtt180 -63.31 -47.21 83.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.434 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 mm -60.69 -32.79 52.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.506 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 31' ' ' ILE . 83.3 m -67.66 -43.08 81.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.335 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.5 OUTLIER -61.32 -34.13 74.74 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.314 177.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.75 -47.92 23.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.203 -168.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.77 -32.8 72.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.32 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.87 HG21 HG21 ' B' ' 64' ' ' VAL . 13.0 mt -60.91 -77.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.935 164.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.89 -29.06 64.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.718 -160.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HB3' HD11 ' A' ' 3' ' ' LEU . 2.1 pp20? -75.51 -41.82 54.28 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.165 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -68.16 -25.15 65.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.02 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.45 -33.6 31.96 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.478 174.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.03 -39.47 84.59 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -60.97 -33.54 73.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.261 165.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 1.6 t0 -64.57 -60.88 2.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.432 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.743 HD13 HG23 ' A' ' 64' ' ' VAL . 15.3 mt -61.17 -29.31 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.506 -175.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.863 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.33 -63.45 1.28 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.261 -178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 88.5 p -61.66 -26.76 68.21 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.158 -175.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.742 ' O ' HD13 ' A' ' 46' ' ' LEU . 28.4 mm-40 -61.05 -45.74 93.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.029 163.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.548 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -76.14 -8.14 56.35 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.903 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.847 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -90.7 -55.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.999 -169.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -20.97 66.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.636 168.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.742 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.0 mp -61.16 -58.17 9.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.442 168.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 55' ' ' ILE . . . -61.69 -22.04 64.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.19 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.472 HH12 HG23 ' A' ' 44' ' ' ILE . 21.4 ttp-105 -97.04 -31.44 12.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.267 -168.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.79 -34.43 74.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.189 167.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -61.12 -49.99 75.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.034 164.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.33 41.06 59.76 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -166.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -129.19 -166.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.373 -0.413 . . . . 0.0 110.344 -164.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.62 118.41 36.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.28 -165.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.663 HG21 ' HB2' ' B' ' 21' ' ' SER . 95.0 m 67.79 161.42 0.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.383 165.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' HB2' ' A' ' 47' ' ' ALA . 80.4 mt -100.93 147.43 8.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.54 173.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.479 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -145.85 -171.35 3.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.374 -175.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.87 -42.48 99.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.322 -169.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.757 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -61.99 -23.53 66.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.094 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 10.6 m-20 -81.14 -55.78 4.53 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.344 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.862 HG23 HD13 ' B' ' 28' ' ' LEU . 44.8 mm -61.09 -37.64 77.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.366 -173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.49 -45.88 92.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 172.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.1 mm? -62.76 -45.72 91.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.467 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.64 -30.33 70.64 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.361 -175.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.84 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -62.19 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.16 -164.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.5 mtt180 -60.4 -18.36 50.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.595 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.7 tpt85 -64.39 -76.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.274 168.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -64.8 -22.28 66.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.044 -159.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.732 ' HD2' ' HZ1' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -60.67 -35.29 75.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.473 176.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.558 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.724 171.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.502 ' HA ' ' HG3' ' B' ' 33' ' ' GLU . 2.7 ptt? . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.174 0.511 . . . . 0.0 109.808 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 7' ' ' PRO . 10.2 tt0 -170.77 43.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.996 170.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -100.1 101.71 15.37 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.52 173.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.511 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.5 Cg_endo -59.41 140.32 93.74 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.623 2.216 . . . . 0.0 113.553 167.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.654 HD12 ' HD3' ' B' ' 25' ' ' ARG . 23.7 pt -77.04 -11.54 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.679 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.93 -64.03 0.81 Allowed Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.787 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -51.29 -45.78 35.14 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.104 1.87 . . . . 0.0 113.279 174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' B' ' 3' ' ' LEU . 28.0 mt -60.03 -43.82 93.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 114.493 -1.23 . . . . 0.0 110.493 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.31 -41.67 99.73 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.571 -172.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.481 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -77.6 -22.34 50.97 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.437 -174.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' B' ' 8' ' ' ILE . 55.0 mt -68.24 -41.41 83.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.328 170.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.863 HD13 ' HB2' ' A' ' 40' ' ' ALA . 1.9 mm -61.46 -40.35 86.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.104 167.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 26.4 mtpp -62.21 -31.81 72.39 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.051 177.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -62.35 -31.91 72.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.683 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.62 -53.94 52.69 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.413 170.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 24.44 0.54 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 114.033 -1.44 . . . . 0.0 110.686 -172.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.847 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.3 -171.35 0.59 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.802 -0.699 . . . . 0.0 110.287 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -153.18 -38.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.953 164.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.1 104.0 4.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.763 HG21 HG21 ' B' ' 12' ' ' ILE . 11.4 t -101.16 102.73 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.179 167.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.663 ' HB2' HG21 ' A' ' 54' ' ' THR . 45.9 t -62.13 177.62 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.399 -167.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.8 OUTLIER -61.01 -34.58 75.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.315 -171.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 10.2 m-20 -60.99 -58.72 7.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.519 175.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.634 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.92 -45.16 93.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.654 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.0 ptp180 -61.91 -37.67 85.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.364 -173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.502 HG13 ' HG3' ' B' ' 25' ' ' ARG . 41.8 mt -75.78 -36.29 32.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.407 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.575 HG22 HD11 ' B' ' 31' ' ' ILE . 97.8 m -60.82 -52.36 65.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.392 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.862 HD13 HG23 ' A' ' 60' ' ' ILE . 4.8 tp -60.53 -47.14 87.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.447 176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.72 -31.1 70.41 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.31 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -87.69 -24.81 23.76 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.461 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 64' ' ' VAL . 46.5 mt -61.9 -75.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.965 165.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.714 ' HB3' HD23 ' A' ' 32' ' ' LEU . 5.5 mp -59.66 -20.78 58.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.729 -165.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' B' ' 1' ' ' MET . 2.3 tt0 -66.81 -57.73 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.193 170.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.11 -38.02 89.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.024 -177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.534 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 6.0 ttp -60.71 -28.59 68.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.436 169.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.7 -45.85 16.19 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.421 ' HD2' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -60.42 -14.28 18.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.137 -0.531 . . . . 0.0 110.459 167.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.5 OUTLIER -91.32 -51.94 5.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.412 -171.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.536 ' CG2' HG23 ' B' ' 64' ' ' VAL . 5.4 mt -61.42 -22.35 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.308 169.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.663 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -63.1 -73.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.305 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 84.3 p -61.33 -13.79 22.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.536 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.1 OUTLIER -78.2 -56.99 4.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.055 170.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.08 -12.6 12.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.392 176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.814 HD11 ' HB2' ' A' ' 17' ' ' ALA . 73.3 mt -94.97 -51.8 10.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.106 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -60.67 -31.66 70.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.42 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.744 HD22 ' HG ' ' B' ' 62' ' ' LEU . 28.7 mt -60.66 -52.7 64.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.503 170.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.58 -36.44 80.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.262 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.8 -40.71 98.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.378 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -61.09 -38.03 84.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.414 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.94 -51.52 68.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.131 167.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.6 36.92 0.7 Allowed Glycine 0 CA--C 1.526 0.775 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.453 -164.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 62.85 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.886 -0.657 . . . . 0.0 110.651 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.11 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.832 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.9 m -157.57 167.39 30.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.106 165.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.787 HD12 HG22 ' A' ' 20' ' ' VAL . 24.0 mt -106.89 132.38 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.35 166.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -142.65 -176.21 4.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.458 -174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -26.78 68.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.314 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -61.53 -52.71 63.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.026 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.26 -24.48 63.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.303 -170.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.795 ' CG2' HD22 ' A' ' 28' ' ' LEU . 38.0 mm -75.51 -48.37 30.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.465 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -61.83 -30.4 70.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.026 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.744 ' HG ' HD22 ' B' ' 46' ' ' LEU . 14.8 tp -64.05 -50.05 69.95 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.394 169.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.727 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.28 -41.09 96.37 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.365 -178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.87 HG21 HG21 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -89.1 -57.83 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.172 -162.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 -59.89 -25.84 65.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.793 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -29.94 42.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.409 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.2 OUTLIER -60.35 -67.03 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.468 170.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 60.93 101.86 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.495 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.732 ' HZ1' ' HD2' ' A' ' 68' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.561 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.348 -175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.7 mt-10 58.84 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.714 175.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp -57.47 98.91 0.17 Allowed Pre-proline 0 C--O 1.251 1.178 0 CA-C-N 114.238 -1.346 . . . . 0.0 112.499 -172.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.78 150.59 44.37 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 123.08 2.52 . . . . 0.0 113.496 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.62 17.68 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.794 -166.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -90.11 -56.76 0.27 Allowed Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.652 176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.2 Cg_exo -53.86 -58.54 1.31 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.644 2.229 . . . . 0.0 113.412 164.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.8 mt -61.71 -48.34 89.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.516 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.81 -36.49 92.83 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -173.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -39.75 95.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.432 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.723 HD11 HD21 ' B' ' 3' ' ' LEU . 76.0 mt -61.62 -49.18 85.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.424 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.9 mm -63.56 -37.08 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.409 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -32.37 74.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.417 171.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -62.74 -35.11 78.72 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.752 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.31 -53.54 57.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.446 169.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.54 21.27 0.39 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.64 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.806 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.24 135.5 57.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.385 166.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -157.34 31.57 0.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.013 174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.79 81.11 0.3 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.308 168.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.825 HG22 HD12 ' B' ' 55' ' ' ILE . 13.8 t -131.11 143.0 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.35 -168.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -84.99 151.37 24.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.362 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.82 -13.64 16.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.471 172.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.729 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -86.86 -31.16 20.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.328 -175.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.599 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.66 94.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.17 166.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -61.71 -34.48 75.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.413 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.51 -36.64 20.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.322 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -64.23 -44.26 92.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.26 -172.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.937 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.9 tp -59.65 -41.99 91.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.431 167.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.79 -39.94 93.45 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.228 -176.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.15 -21.55 24.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.357 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.777 HG21 HG21 ' B' ' 64' ' ' VAL . 32.0 mt -61.1 -71.28 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.965 163.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.653 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.2 mp -59.56 -21.1 59.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.748 -167.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.651 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.31 -55.12 17.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.058 170.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -61.75 -42.42 98.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.976 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.434 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.3 mmm -60.91 -42.74 98.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.459 168.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.91 -48.27 42.06 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -167.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.67 -18.77 55.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.182 -0.509 . . . . 0.0 110.345 167.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -76.44 -58.8 3.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.488 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 HG23 ' A' ' 64' ' ' VAL . 4.1 mt -60.94 -23.13 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.492 178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.68 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.45 -77.73 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.249 175.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.796 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.29 -11.07 8.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.444 -172.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.695 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.31 -53.27 6.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.11 172.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.77 -19.0 58.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.856 -1.066 . . . . 0.0 110.429 173.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.793 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.8 mt -86.19 -51.25 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.975 -177.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -60.15 -11.53 6.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.438 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.2 mp -84.94 -38.54 19.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.285 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.937 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.93 -30.86 70.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.387 170.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 28.3 mmt-85 -68.03 -53.68 24.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.421 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -20.2 60.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.351 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.12 -53.83 52.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.182 168.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.6 23.86 0.5 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.635 -1.166 . . . . 0.0 110.433 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.4 ttp-105 66.37 124.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.241 -0.479 . . . . 0.0 110.446 166.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 178.93 -68.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.41 168.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 29.9 m -162.14 141.91 9.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.419 -178.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.937 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.0 mm -72.14 149.09 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.402 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 9.1 mttp -153.63 -177.41 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.461 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.93 -34.12 75.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.264 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.699 ' O ' HD12 ' A' ' 62' ' ' LEU . 25.4 tt0 -73.5 -27.34 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.039 -178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -36.63 41.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.386 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.711 ' CG2' HD22 ' B' ' 28' ' ' LEU . 37.8 mm -60.98 -57.07 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.361 170.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -61.44 -30.63 70.7 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.011 -176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.699 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.63 -51.7 68.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.394 169.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.664 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.05 -46.06 92.22 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.447 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.756 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -69.35 -51.39 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.895 -163.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.24 -21.59 66.76 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.783 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HD2' HD11 ' A' ' 46' ' ' LEU . 7.0 ttt-85 -61.2 -40.73 95.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.268 173.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 84.7 m-85 -60.56 -61.8 2.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.263 166.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 65.16 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.486 169.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.543 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.32 -168.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 121.09 0.472 . . . . 0.0 110.007 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 1' ' ' MET . 4.1 mt-10 59.15 122.21 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.783 -174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 11' ' ' ILE . 3.4 mt -73.84 137.2 76.62 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.783 -168.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -58.34 153.68 45.66 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.374 2.049 . . . . 0.0 113.446 169.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.5 pt -101.05 16.83 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.742 -176.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.16 -59.46 0.29 Allowed Pre-proline 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.703 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.3 Cg_endo -58.18 -50.29 10.3 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 C-N-CA 122.493 2.128 . . . . 0.0 113.365 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' B' ' 3' ' ' LEU . 65.1 mt -60.86 -29.24 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.482 175.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.46 -48.73 83.27 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.547 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -82.47 -17.54 44.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.352 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.2 mm -60.62 -66.24 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.44 168.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.728 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.53 -32.0 52.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.092 -174.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -65.09 -37.98 89.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.477 171.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -62.23 -32.25 72.9 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.829 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.796 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.77 -52.72 64.5 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.433 170.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.92 28.09 0.75 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.563 -170.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.793 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.65 119.8 8.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.703 -0.748 . . . . 0.0 110.376 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -73.11 -38.72 66.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.119 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.44 100.4 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.391 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.716 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.92 140.04 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.218 166.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 96.3 p -67.39 165.82 15.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.3 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.86 -19.07 59.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.294 168.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.44 -58.29 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.476 169.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -61.98 -42.12 98.78 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.347 -169.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 40.7 mtm180 -62.46 -50.03 73.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.432 -178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.3 mm -61.69 -24.73 34.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.501 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.556 HG21 ' HB ' ' A' ' 60' ' ' ILE . 89.2 m -74.47 -41.97 59.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.396 -172.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.746 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.79 -35.15 75.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.378 169.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -64.23 -42.98 96.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.331 -172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -81.09 -27.68 35.52 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.348 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.585 HG21 HG21 ' A' ' 64' ' ' VAL . 51.1 mt -61.34 -74.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.002 167.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.746 HD11 HD12 ' B' ' 28' ' ' LEU . 3.9 mp -59.02 -23.67 62.15 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.75 -164.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -84.56 -29.43 25.87 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.073 -178.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.74 -32.07 72.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.855 164.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -34.41 39.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.361 -177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.88 -39.94 37.46 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.72 -33.9 73.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.175 -0.513 . . . . 0.0 110.392 169.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -72.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.37 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.937 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.5 mt -60.72 -21.72 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.297 -170.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.639 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.9 -69.74 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.255 173.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.511 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.47 -10.94 8.76 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.517 -177.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -40.17 10.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.059 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.29 -14.92 62.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.339 168.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -97.02 -52.06 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.0 -173.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -19.86 57.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.338 169.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.5 mt -68.4 -53.48 23.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.371 166.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.691 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.34 -26.26 67.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.24 -173.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.94 -38.79 76.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 168.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -60.51 -32.58 71.59 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.416 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.68 -48.38 82.03 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.348 173.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.17 38.05 1.06 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -167.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 102.79 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.91 -0.645 . . . . 0.0 110.406 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.86 -171.36 1.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.413 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.7 m -79.2 130.12 35.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.399 -169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.825 HD12 HG22 ' A' ' 20' ' ' VAL . 30.0 mt -74.07 133.06 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 167.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.513 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -137.36 -170.92 2.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.38 -176.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.63 -21.77 64.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.32 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.67 -34.15 21.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.092 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.3 OUTLIER -80.62 -35.83 33.5 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.38 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.713 HG23 HD13 ' A' ' 28' ' ' LEU . 37.8 mm -61.15 -57.15 13.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.383 168.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.6 mt-10 -62.38 -37.8 87.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.93 -174.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.505 ' CD2' HD22 ' B' ' 46' ' ' LEU . 32.6 tp -60.76 -43.73 97.65 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.403 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.566 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.21 -36.3 79.55 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.338 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -89.3 -59.6 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.264 -162.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -24.18 64.6 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.649 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -23.42 32.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.423 172.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -60.93 -46.57 90.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.503 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.81 -76.98 0.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.382 -171.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.353 -169.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 mtp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.75 156.49 42.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.077 -166.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.036 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 6.3 mp -56.9 138.98 78.51 Favored Pre-proline 0 C--O 1.251 1.14 0 CA-C-N 114.253 -1.34 . . . . 0.0 112.587 -172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HB2' ' CG ' ' A' ' 7' ' ' PRO . 10.7 Cg_endo -61.16 142.18 95.94 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 123.144 2.563 . . . . 0.0 113.656 -178.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HB ' ' HD2' ' A' ' 25' ' ' ARG . 1.3 pp -95.49 -25.31 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.448 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.739 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.82 -56.51 31.58 Favored Pre-proline 0 CA--C 1.543 0.701 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.7 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.739 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 6.7 Cg_endo -58.32 -55.6 2.09 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.592 2.195 . . . . 0.0 113.565 175.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.711 ' HA ' HD12 ' A' ' 11' ' ' ILE . 51.7 mt -61.48 -45.08 99.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.492 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.497 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.76 -38.07 95.33 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.97 -21.94 39.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.437 -0.381 . . . . 0.0 110.406 -171.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 8' ' ' ILE . 54.9 mt -62.63 -50.38 79.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.405 168.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.667 HG23 ' CB ' ' B' ' 40' ' ' ALA . 18.7 mm -63.47 -41.33 92.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.373 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -62.86 -34.29 77.06 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.298 174.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.46 -33.8 75.55 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.787 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.16 -53.02 63.02 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.488 170.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.55 18.84 0.38 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.812 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.86 136.9 58.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.515 -0.342 . . . . 0.0 110.189 164.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.29 -25.42 8.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.069 -168.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.79 92.91 1.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.446 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG22 HD12 ' B' ' 55' ' ' ILE . 16.8 t -117.82 134.82 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.395 176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -93.03 155.77 17.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.376 -170.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.11 -17.66 53.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.373 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -63.41 -50.24 70.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.441 168.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.662 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -62.09 -44.55 96.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.277 -174.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.512 ' HD2' ' HB ' ' A' ' 5' ' ' ILE . 4.9 mtt180 -61.45 -50.5 72.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.294 -176.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -60.73 -31.9 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.536 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.58 ' O ' HD12 ' A' ' 31' ' ' ILE . 85.9 m -66.23 -43.25 87.18 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.393 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' B' ' 60' ' ' ILE . 0.3 OUTLIER -61.22 -32.07 71.84 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.266 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.036 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -78.13 -46.36 20.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.189 -168.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -60.84 -32.79 72.17 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.285 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.04 HG21 HG21 ' B' ' 64' ' ' VAL . 11.0 mt -60.83 -75.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.956 164.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' B' ' 32' ' ' LEU . 0.2 OUTLIER -57.73 -28.19 63.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.735 -162.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' HD13 ' A' ' 3' ' ' LEU . 1.9 pp20? -77.11 -46.12 24.62 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.017 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -66.39 -26.54 67.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.055 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.485 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -73.59 -36.52 65.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.537 171.011 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.72 -42.27 71.6 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 9.8 ttp180 -60.95 -25.73 67.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.35 -0.425 . . . . 0.0 110.399 167.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -73.46 -59.28 2.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.509 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.71 HD12 HD11 ' B' ' 32' ' ' LEU . 7.8 mt -62.64 -20.04 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.24 -71.16 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.355 173.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 44' ' ' ILE . 85.8 p -61.56 -25.38 67.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.236 -172.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.747 ' O ' HD13 ' A' ' 46' ' ' LEU . 37.8 mm-40 -61.71 -54.24 45.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.081 165.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -67.85 -10.32 52.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.775 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.833 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -89.39 -57.66 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.225 -167.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HG3' ' NH2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -64.89 -19.06 65.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.577 169.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.0 mp -61.34 -55.78 27.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.323 168.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.61 -23.11 65.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.265 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.433 ' NH2' ' HG3' ' A' ' 45' ' ' LYS . 23.3 ttp-105 -100.76 -30.24 11.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.308 -165.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.91 -34.95 75.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.127 165.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB1' ' HB2' ' A' ' 52' ' ' ARG . . . -60.88 -50.74 72.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.977 163.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.46 43.25 78.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -165.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.723 ' HB2' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -134.03 -166.74 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.418 -0.391 . . . . 0.0 110.329 -161.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -168.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.469 -165.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.2 t -60.57 168.66 2.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.507 -170.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.661 ' HB ' HG22 ' B' ' 20' ' ' VAL . 26.6 mt -71.57 137.07 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.405 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -145.05 -175.7 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.358 -167.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.666 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.41 -47.99 83.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.258 -169.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.749 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.41 -24.92 67.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.979 -176.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.96 -53.11 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.373 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.781 HG23 HD13 ' B' ' 28' ' ' LEU . 43.5 mm -65.82 -39.61 85.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.389 -168.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -61.75 -41.96 98.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.05 172.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 58' ' ' GLU . 2.4 mm? -62.56 -47.12 85.27 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.341 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.61 -31.45 71.52 Favored 'General case' 0 C--N 1.334 -0.072 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.379 -175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.81 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -89.97 -61.94 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 121.812 0.815 . . . . 0.0 109.029 -162.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.49 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.9 mtt180 -60.16 -19.07 52.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.667 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 27.0 tpt85 -63.3 -77.43 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.146 168.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -64.96 -21.61 66.86 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.122 -159.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.749 ' HD2' ' HZ1' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -60.58 -35.77 76.89 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.54 175.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.56 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.616 171.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.494 ' HA ' ' HG3' ' B' ' 33' ' ' GLU . 2.6 ptt? . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 7' ' ' PRO . 6.3 tt0 -170.75 43.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.12 170.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.916 ' HB3' HD11 ' B' ' 8' ' ' ILE . 0.4 OUTLIER -101.52 101.12 15.99 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.618 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' B' ' 7' ' ' PRO . 11.0 Cg_endo -59.87 140.01 90.98 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.544 2.163 . . . . 0.0 113.528 169.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.666 HD12 ' HD3' ' B' ' 25' ' ' ARG . 33.0 pt -78.52 -10.73 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.631 -169.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -73.7 -61.19 1.41 Allowed Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.813 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.8 Cg_endo -55.49 -45.95 35.86 Favored 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 122.443 2.096 . . . . 0.0 113.453 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.916 HD11 ' HB3' ' B' ' 3' ' ' LEU . 31.0 mt -60.32 -44.56 96.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.459 172.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.98 -39.25 97.32 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.549 -175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.536 ' HG2' ' HA ' ' B' ' 7' ' ' PRO . 0.0 OUTLIER -77.19 -23.26 51.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 0.0 110.503 -174.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' B' ' 8' ' ' ILE . 64.8 mt -67.85 -48.75 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.461 170.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -61.92 -33.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.037 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 27.0 mtpp -61.34 -33.88 74.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.209 171.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -62.6 -32.78 73.85 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.638 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.86 -53.32 59.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.429 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.11 21.34 0.78 Allowed Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.974 -170.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.833 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -65.63 147.03 54.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.764 -0.718 . . . . 0.0 110.34 171.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -40.79 3.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.045 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -148.55 139.14 22.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.507 168.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 55' ' ' ILE . 88.8 t -129.45 113.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.205 171.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -62.28 174.85 0.84 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.381 -166.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.492 ' HA ' ' NE ' ' B' ' 25' ' ' ARG . 0.9 OUTLIER -61.67 -32.29 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.371 -177.153 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 4.3 m-20 -64.2 -55.55 20.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.468 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.666 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.12 -48.0 82.08 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.301 -175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.666 ' HD3' HD12 ' B' ' 5' ' ' ILE . 6.6 ptp180 -61.03 -37.85 84.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.394 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.443 HD12 ' O ' ' B' ' 22' ' ' ASP . 34.3 mt -72.05 -36.56 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.49 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.569 HG22 HD11 ' B' ' 31' ' ' ILE . 97.9 m -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.365 -173.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.781 HD13 HG23 ' A' ' 60' ' ' ILE . 4.4 tp -60.94 -47.04 88.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.383 176.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.98 70.37 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.384 -175.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -87.15 -26.14 23.74 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.494 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.81 HG21 HG21 ' A' ' 64' ' ' VAL . 37.8 mt -61.83 -74.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.015 165.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.774 ' HB3' HD23 ' A' ' 32' ' ' LEU . 6.0 mp -59.6 -17.45 33.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.627 -166.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.494 ' HG3' ' HA ' ' B' ' 1' ' ' MET . 2.0 tt0 -73.61 -53.43 10.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.139 173.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 -40.43 88.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.045 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.526 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 10.0 ttp -60.82 -28.68 68.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.477 170.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.79 -46.23 18.63 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.434 ' O ' ' HB3' ' B' ' 40' ' ' ALA . 0.0 OUTLIER -60.44 -13.88 16.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.206 -0.497 . . . . 0.0 110.534 167.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.526 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -91.22 -51.28 5.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.418 -172.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.54 ' CG2' HG23 ' B' ' 64' ' ' VAL . 4.8 mt -61.6 -21.32 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.271 170.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.667 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -63.22 -73.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.315 172.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 81.8 p -61.45 -13.94 24.57 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.503 -173.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.489 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -77.92 -56.95 4.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.076 170.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.2 -13.18 16.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.323 176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.812 HD11 ' HB2' ' A' ' 17' ' ' ALA . 81.4 mt -95.55 -51.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.96 -176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.7 tptp -60.67 -32.97 72.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.45 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.715 HD22 ' HG ' ' B' ' 62' ' ' LEU . 20.9 mt -60.47 -51.5 69.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.551 170.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.5 -36.04 79.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.257 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -62.86 -40.77 98.51 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.418 178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -61.24 -38.1 85.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.326 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.97 -51.41 69.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.124 167.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 37.21 0.72 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.448 -164.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 62.34 -84.02 0.02 OUTLIER 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.856 -0.672 . . . . 0.0 110.536 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -79.5 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.754 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.494 HG22 ' N ' ' B' ' 55' ' ' ILE . 88.1 m -157.55 167.55 29.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.153 165.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.791 HD12 HG22 ' A' ' 20' ' ' VAL . 23.6 mt -108.16 132.7 55.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.439 166.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.409 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 5.2 mmmt -143.38 -177.14 5.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.387 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.72 -27.03 68.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -61.52 -55.09 34.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.042 170.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.1 OUTLIER -65.79 -29.34 69.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.394 -170.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.836 ' CG2' HD22 ' A' ' 28' ' ' LEU . 37.1 mm -71.61 -48.7 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.402 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -61.6 -31.41 71.48 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.023 -177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.715 ' HG ' HD22 ' B' ' 46' ' ' LEU . 15.0 tp -62.11 -51.12 69.2 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.416 168.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.669 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.36 -41.08 96.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.376 -177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 1.04 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -88.75 -58.65 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.13 -162.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -59.74 -25.56 64.95 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.8 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.25 -30.4 43.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.388 170.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 0.4 OUTLIER -60.2 -65.14 0.73 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.511 171.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? 61.07 101.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.528 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.749 ' HZ1' ' HD2' ' A' ' 68' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.519 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.361 -175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' HG3' ' H ' ' A' ' 2' ' ' GLU . 10.7 ptm . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 1' ' ' MET . 7.3 pt-20 -79.31 -157.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.89 165.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.2 mp -56.87 100.76 0.23 Allowed Pre-proline 0 C--O 1.251 1.173 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.53 -168.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 1.7 Cg_endo -53.95 142.87 63.17 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 123.07 2.513 . . . . 0.0 113.513 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' HB ' ' HG2' ' A' ' 25' ' ' ARG . 13.5 pt -92.24 -13.2 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.374 -165.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -79.65 -54.65 0.92 Allowed Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.719 176.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 16.1 Cg_exo -51.55 -55.17 4.23 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.499 2.133 . . . . 0.0 113.627 174.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.694 HD11 ' HB3' ' A' ' 3' ' ' LEU . 45.0 mt -61.71 -44.23 98.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.248 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 25' ' ' ARG . . . -61.14 -22.17 60.3 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.4 178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 -26.29 21.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.724 -0.738 . . . . 0.0 110.483 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.656 HD11 ' CD2' ' B' ' 3' ' ' LEU . 27.4 mt -63.44 -54.12 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.43 170.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.69 HG23 ' CB ' ' B' ' 40' ' ' ALA . 9.4 mm -65.32 -36.58 78.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.262 -172.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -69.21 -32.58 71.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.331 175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -62.41 -34.87 77.58 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.8 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.24 -52.92 63.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.491 169.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.63 24.03 0.3 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.566 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.811 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.57 142.62 58.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.825 -0.688 . . . . 0.0 110.323 174.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -125.49 124.52 41.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.98 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.5 116.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.435 174.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.738 HG11 HH21 ' A' ' 25' ' ' ARG . 15.6 t -146.14 165.65 8.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.362 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.415 ' N ' HG12 ' A' ' 20' ' ' VAL . 15.7 p -99.99 159.81 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.909 -1.042 . . . . 0.0 110.442 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.746 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.4 m-20 -61.01 -33.78 73.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 169.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -37.24 86.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.354 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.596 ' HB3' HG12 ' A' ' 20' ' ' VAL . . . -60.93 -46.12 91.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.318 171.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.738 HH21 HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -62.95 -36.85 84.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.407 -170.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.746 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.2 mt -79.64 -43.17 23.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.457 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.816 ' O ' HD12 ' A' ' 31' ' ' ILE . 90.5 m -60.92 -47.89 84.35 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.285 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD22 HG13 ' B' ' 60' ' ' ILE . 4.5 tp -59.19 -45.77 90.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.412 171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.67 -21.06 62.41 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 113.978 -1.465 . . . . 0.0 110.659 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.66 -24.41 14.43 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.357 -173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 27' ' ' THR . 1.8 mp -61.11 -68.2 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.884 162.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.26 -33.41 72.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.599 -169.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.809 ' HB2' HD13 ' A' ' 3' ' ' LEU . 2.3 tm-20 -65.03 -55.12 20.77 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.1 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -61.68 -26.13 67.83 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.909 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -46.92 77.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.358 164.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -40.2 96.27 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -60.75 -31.99 71.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.302 172.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -51.63 60.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.628 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.66 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mt -62.6 -32.74 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.694 -172.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB1' HG23 ' B' ' 12' ' ' ILE . . . -78.01 -52.15 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.342 -166.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.2 t -61.25 -14.37 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.273 170.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -87.61 -54.82 4.07 Favored 'General case' 0 CA--C 1.526 0.038 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.213 179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -61.99 -33.59 74.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.176 176.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' B' ' 17' ' ' ALA . 55.7 mt -60.59 -46.21 95.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.175 164.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -60.33 -21.92 62.61 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.565 176.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 43' ' ' ALA . 9.9 mt -89.08 -23.57 22.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.452 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.16 -28.4 65.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.301 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -61.31 2.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.37 170.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -61.12 -23.08 65.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.374 -168.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.86 -47.54 62.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.308 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.39 27.9 4.27 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -167.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 73.12 121.92 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.534 0.683 . . . . 0.0 111.819 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.9 mmtm -161.41 15.43 0.1 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.502 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 55' ' ' ILE . 90.4 m 63.14 151.82 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.392 -167.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.839 ' CG2' HG13 ' B' ' 20' ' ' VAL . 29.4 mt -78.22 138.09 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 170.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.5 mtmt -153.65 -178.17 6.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.455 -170.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.97 80.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.262 -174.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -50.0 66.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.196 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -33.34 74.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.405 -173.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' B' ' 28' ' ' LEU . 11.5 mm -75.27 -58.56 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.342 -172.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 39.8 mt-10 -61.64 -9.86 7.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.319 172.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.1 mt -85.95 -41.28 15.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.487 172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.617 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.15 -36.49 79.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.098 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 ' HD3' ' A' ' 68' ' ' LYS . 55.9 t -61.85 -76.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.723 168.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.64 -14.91 23.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.396 -167.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 tpt180 -61.52 -66.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.344 165.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CE2' HG12 ' A' ' 39' ' ' ILE . 8.3 p90 -77.5 -17.08 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.482 -168.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HD3' HG12 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -61.18 130.94 48.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.404 -168.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.597 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.433 172.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 58.94 116.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.774 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.656 ' CD2' HD11 ' A' ' 11' ' ' ILE . 6.1 mt -61.47 141.38 94.57 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.814 -172.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -57.82 153.5 43.35 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.485 2.123 . . . . 0.0 113.317 166.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' B' ' 25' ' ' ARG . 16.5 pt -92.35 -25.13 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.42 -168.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.727 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.15 -62.56 3.55 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.754 -170.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.727 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 7.9 Cg_endo -50.11 -45.39 33.4 Favored 'Trans proline' 0 N--CA 1.485 1.023 0 C-N-CA 122.39 2.06 . . . . 0.0 113.417 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.746 HG22 HH12 ' B' ' 25' ' ' ARG . 21.5 mt -60.96 -38.2 78.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.407 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -61.65 -53.9 39.97 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.556 -178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.497 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -70.41 -15.09 62.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.432 -170.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 3' ' ' LEU . 66.1 mt -73.33 -34.47 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.534 168.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.877 HG23 ' HB1' ' A' ' 40' ' ' ALA . 2.6 mm -70.03 -46.26 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.894 173.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.3 mtpt -62.33 -41.33 98.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.045 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -60.79 -31.09 70.48 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 113.841 -1.527 . . . . 0.0 110.015 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.04 -52.43 65.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.575 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.72 31.61 0.4 Allowed Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.974 -1.467 . . . . 0.0 110.597 -172.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.974 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -80.76 -177.56 6.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -171.06 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.94 167.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.03 106.68 17.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.428 175.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.839 HG13 ' CG2' ' A' ' 55' ' ' ILE . 14.7 t -141.48 171.9 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.395 171.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.556 ' H ' HG12 ' B' ' 20' ' ' VAL . 16.1 t -127.07 156.45 41.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.308 -176.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.71 -37.82 85.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.379 -170.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -31.92 71.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.391 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.649 ' O ' HG22 ' B' ' 27' ' ' THR . . . -65.83 -43.84 87.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.314 171.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.746 HH12 HG22 ' B' ' 8' ' ' ILE . 0.0 OUTLIER -61.24 -47.66 85.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.339 -175.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 52.3 mt -61.44 -38.84 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.542 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.649 HG22 ' O ' ' B' ' 24' ' ' ALA . 1.5 t -69.77 -43.32 72.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.178 -167.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 60' ' ' ILE . 2.6 tp -59.44 -36.86 76.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.523 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.71 -40.0 93.48 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.207 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -27.14 23.72 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.491 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.64 HD12 ' C ' ' B' ' 27' ' ' THR . 24.8 mt -61.61 -67.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.04 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.693 ' HB3' HD23 ' A' ' 32' ' ' LEU . 3.0 mp -60.4 -34.71 74.32 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.57 -176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.553 ' HG3' HD13 ' A' ' 11' ' ' ILE . 34.6 tt0 -67.52 -37.9 83.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.933 -176.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -35.16 77.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.891 175.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 3.3 mtp -65.06 -48.34 74.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.673 -1.148 . . . . 0.0 110.461 170.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.23 -40.22 97.77 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.555 ' HG3' HG23 ' A' ' 11' ' ' ILE . 12.2 mtp180 -60.93 -29.69 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.345 169.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CD2' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -67.89 -55.27 13.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.503 -179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.73 HG21 HG23 ' B' ' 64' ' ' VAL . 2.2 mt -63.31 -26.28 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.821 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.69 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.49 -70.07 0.21 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.292 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.497 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.46 -17.01 52.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.388 -178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.539 ' HG3' ' HB3' ' B' ' 67' ' ' PHE . 3.3 mm-40 -84.61 -38.49 19.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.051 178.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.559 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -78.04 -8.28 57.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.832 172.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.811 HD11 ' HB2' ' A' ' 17' ' ' ALA . 51.3 mt -96.99 -51.06 10.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.765 -175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -60.25 -22.24 62.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.375 166.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' B' ' 43' ' ' ALA . 9.6 mt -69.62 -53.74 17.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.379 168.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.63 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.59 -23.54 66.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.307 -167.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.22 -34.3 15.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.252 178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -60.55 -36.77 79.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.434 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.12 -50.02 74.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.17 166.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.17 46.94 7.85 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HA ' ' NE ' ' B' ' 52' ' ' ARG . 4.1 tpm_? -121.23 -18.54 7.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.451 -167.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.28 18.68 11.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.441 173.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -145.47 138.35 26.1 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.406 170.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.63 HG12 ' HB2' ' B' ' 47' ' ' ALA . 45.2 mt -93.76 148.5 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.341 170.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . 6.1 mtpp -147.94 178.36 8.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.381 -169.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.33 -17.82 55.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.331 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.699 ' C ' HD12 ' B' ' 62' ' ' LEU . 5.6 mp0 -81.2 -41.27 22.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.069 -178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.515 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 1.0 OUTLIER -75.28 -26.77 59.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.373 -179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.772 HG13 HD22 ' A' ' 28' ' ' LEU . 1.4 mp -64.43 -59.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.691 -1.141 . . . . 0.0 109.339 174.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 11.6 mt-10 -74.41 -12.44 60.51 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.557 -176.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 58' ' ' GLU . 7.5 mt -81.67 -46.12 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 168.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' B' ' 39' ' ' ILE . . . -60.34 -41.62 93.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.398 172.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.73 HG23 HG21 ' B' ' 39' ' ' ILE . 37.9 t -62.72 -74.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.63 169.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -10.76 3.44 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.509 -164.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 4.9 ttm-85 -85.77 -60.87 1.9 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.582 164.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.539 ' HB3' ' HG3' ' B' ' 42' ' ' GLU . 0.0 OUTLIER -64.36 -8.82 14.5 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.42 -155.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.416 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.7 tptt -75.97 -33.31 59.77 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.371 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 16.5 mmtm . . . . . 0 C--O 1.239 0.532 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.394 171.395 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mmm . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 121.178 0.513 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 58.46 28.29 16.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.841 -175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.817 ' HB2' ' HB1' ' A' ' 29' ' ' ALA . 28.8 mt 59.8 75.07 0.51 Allowed Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 121.763 0.792 . . . . 0.0 110.358 166.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 7.0 Cg_exo -48.3 150.99 4.84 Favored 'Trans proline' 0 N--CA 1.483 0.892 0 C-N-CA 122.388 2.058 . . . . 0.0 113.512 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.701 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -69.21 -11.55 14.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.591 -166.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.768 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.6 -58.93 1.32 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.772 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.12 -57.11 1.43 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.432 2.088 . . . . 0.0 113.437 -175.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.8 mt -60.6 -32.66 52.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.378 170.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.59 -26.65 64.95 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.357 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -78.02 -36.4 48.74 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.373 -0.914 . . . . 0.0 110.483 176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.739 HG23 ' HG3' ' B' ' 37' ' ' ARG . 25.1 mt -60.63 -64.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.48 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.3 mm -60.91 -33.29 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.414 -166.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -65.36 -40.45 93.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.468 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.11 -32.41 72.97 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.777 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.99 -52.64 64.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.522 170.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.76 22.09 0.35 Allowed Glycine 0 CA--C 1.525 0.662 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.654 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.824 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.64 159.25 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.124 -0.538 . . . . 0.0 110.295 169.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' HG2' ' HB3' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.01 -63.34 1.41 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.054 -169.334 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.588 ' O ' HG23 ' B' ' 54' ' ' THR . 9.4 mtp180 -144.6 80.06 1.62 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.478 176.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.736 HG22 HG13 ' B' ' 55' ' ' ILE . 15.5 t -71.33 107.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.31 175.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 t -61.54 158.88 14.08 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.459 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' O ' HD12 ' A' ' 26' ' ' ILE . 1.7 p30 -61.31 -18.66 59.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.269 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -66.37 0.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.773 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -60.69 -39.66 89.34 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.386 -170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.676 ' HB3' HG22 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -62.01 -37.78 86.17 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.448 -175.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -76.28 -29.45 19.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.357 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.588 HG22 ' CG2' ' B' ' 60' ' ' ILE . 97.1 m -61.06 -60.75 3.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.341 171.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.923 HD12 ' CG2' ' A' ' 31' ' ' ILE . 64.4 tp -68.33 -28.74 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.424 -171.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -71.35 -40.38 70.71 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.116 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -60.38 -35.59 76.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.379 166.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.923 ' CG2' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -69.78 -38.96 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.378 -170.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.717 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.8 mm? -74.84 -67.74 0.61 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.479 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.806 ' O ' HD12 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -67.39 -17.85 64.89 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.811 -163.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.17 -49.57 64.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.108 164.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -32.87 72.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.577 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' N ' HD21 ' B' ' 32' ' ' LEU . . . -76.71 -36.15 38.27 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.324 -1.111 . . . . 0.0 110.324 -171.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' N ' ' CG2' ' B' ' 11' ' ' ILE . 2.4 ttm-85 -60.72 -30.2 69.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.069 -0.565 . . . . 0.0 110.38 169.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -69.56 -51.7 33.05 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.429 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.719 HD13 HG22 ' A' ' 64' ' ' VAL . 25.1 mt -63.9 -33.75 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.395 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.773 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -61.41 -66.23 0.57 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.275 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.738 ' CA ' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -61.21 -15.47 34.66 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.373 178.209 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.78 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -71.38 -63.21 1.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.135 167.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.99 -13.14 14.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.488 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.3 mt -97.2 -59.26 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 -173.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -61.89 -17.43 56.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.333 174.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.639 HD12 ' C ' ' A' ' 42' ' ' GLU . 16.7 mt -69.84 -58.66 3.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.363 171.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.47 -25.57 67.33 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.398 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -72.71 -55.85 6.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.448 -170.597 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 2.4 p-80 -68.01 -24.95 65.18 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.389 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.91 -53.02 62.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.347 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.22 26.42 2.04 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.61 165.6 11.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.349 -0.426 . . . . 0.0 110.416 -170.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -132.68 18.46 4.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.446 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.6 m -157.66 132.94 8.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.301 170.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 59' ' ' ASP . 4.4 mp -100.36 133.26 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.309 166.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.42 -172.62 3.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.454 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -61.35 -20.0 62.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.315 -171.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.18 -67.42 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.077 168.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.583 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -61.15 -32.27 71.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.366 -167.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.768 HG23 HD13 ' B' ' 28' ' ' LEU . 37.9 mm -61.2 -64.41 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.387 172.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 3.4 mt-10 -61.1 -10.07 5.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.41 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 tt -89.98 -39.5 12.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.457 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.78 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -76.26 -27.56 56.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.113 175.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.081 HG21 HD13 ' B' ' 31' ' ' ILE . 15.3 t -62.48 -66.57 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.448 160.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -59.39 -11.19 3.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.002 -176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.32 -30.65 15.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.203 169.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -58.31 -22.58 53.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.617 163.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.74 -176.72 0.08 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.331 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.544 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.389 -170.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.046 0.451 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.446 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 9.3 tt0 -106.07 -11.83 15.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.174 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.418 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 0.7 OUTLIER -98.48 103.02 16.25 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.642 178.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' B' ' 2' ' ' GLU . 12.4 Cg_endo -57.89 139.73 91.37 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 C-N-CA 122.461 2.107 . . . . 0.0 113.407 165.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' B' ' 25' ' ' ARG . 22.7 pt -92.95 21.43 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.567 -167.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -83.57 -58.02 0.41 Allowed Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.733 170.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.7 Cg_endo -55.91 -50.74 11.44 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.544 2.163 . . . . 0.0 113.466 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' B' ' 5' ' ' ILE . 23.5 mt -60.85 -23.18 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.322 167.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.07 -39.1 96.63 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.518 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -94.26 -18.03 22.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.986 -0.607 . . . . 0.0 110.347 -175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.806 HD12 ' O ' ' A' ' 33' ' ' GLU . 7.7 mm -60.83 -72.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.002 163.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.773 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.7 mm -63.38 -17.0 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.169 -171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.04 -37.3 24.1 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.377 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -32.53 73.19 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.836 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.738 ' HB1' ' CA ' ' A' ' 41' ' ' SER . . . -58.82 -52.88 63.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.516 170.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.21 23.06 0.35 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.702 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.638 ' HB1' HG21 ' B' ' 20' ' ' VAL . . . -67.8 147.05 53.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.772 -0.714 . . . . 0.0 110.424 173.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.77 -30.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.939 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 80.33 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.381 168.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.638 HG21 ' HB1' ' B' ' 17' ' ' ALA . 59.4 t -134.89 137.73 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.472 -172.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 58.9 p -74.49 150.89 39.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.365 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -61.16 -17.92 55.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.302 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 -44.65 63.4 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.422 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.672 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.45 -43.61 98.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.363 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' B' ' 5' ' ' ILE . 28.1 mtt-85 -62.23 -32.57 73.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.417 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 10.9 mm -88.02 -30.58 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.445 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.442 ' CG2' ' HG3' ' A' ' 61' ' ' GLU . 97.8 m -61.1 -54.11 48.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.37 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.768 HD13 HG23 ' A' ' 60' ' ' ILE . 4.3 tp -59.83 -45.38 92.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.706 -1.133 . . . . 0.0 110.556 172.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -31.16 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.362 -171.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -91.94 -23.2 19.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 1.081 HD13 HG21 ' A' ' 64' ' ' VAL . 64.4 mt -61.36 -70.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.135 166.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.717 ' O ' HD11 ' A' ' 32' ' ' LEU . 1.1 mp -60.47 -33.15 72.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.719 -170.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' B' ' 3' ' ' LEU . 18.5 tt0 -61.57 -47.37 85.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.12 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -32.11 72.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.945 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.675 ' HG2' HD11 ' B' ' 39' ' ' ILE . 2.1 ttt -60.46 -42.55 96.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.426 166.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.56 -50.21 68.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -169.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.739 ' HG3' HG23 ' A' ' 11' ' ' ILE . 5.7 mtp180 -60.58 -28.51 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.179 -0.511 . . . . 0.0 110.49 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.3 OUTLIER -70.18 -57.8 4.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.53 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.725 HG21 HG23 ' B' ' 64' ' ' VAL . 10.2 mt -61.04 -23.44 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.483 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.685 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.73 -70.05 0.21 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.245 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.504 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.7 OUTLIER -61.22 -11.69 10.25 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.479 179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.525 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -78.62 -58.32 3.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.068 170.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.519 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.15 -17.44 52.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.47 177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 17' ' ' ALA . 90.0 mt -91.18 -50.17 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.983 -173.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -60.68 -27.91 68.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.377 173.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 15.4 mt -64.81 -54.72 26.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.354 167.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.627 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.27 -50.63 72.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.275 -169.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -42.63 99.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.356 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.12 -35.19 76.39 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.407 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.75 -47.34 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.302 171.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.29 30.1 7.99 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.448 ' HD3' ' HB ' ' B' ' 54' ' ' THR . 0.0 OUTLIER -134.48 104.11 5.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.352 169.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 6.6 mttt -61.13 -16.98 50.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.335 -169.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 19' ' ' ARG . 94.2 m -88.39 122.21 31.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.447 -177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 20' ' ' VAL . 11.8 mm -75.1 138.29 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.515 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.439 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 1.1 mmmt -130.2 158.55 39.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.324 -170.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -62.86 -31.06 72.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.309 -167.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.95 -37.93 82.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.081 170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.7 OUTLIER -64.88 -37.12 86.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.44 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.588 ' CG2' HG22 ' A' ' 27' ' ' THR . 48.8 mm -60.9 -55.9 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.432 173.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -70.64 -22.64 62.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.009 -170.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -79.13 -36.17 40.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.449 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.602 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -60.99 -55.36 33.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.372 172.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.725 HG23 HG21 ' B' ' 39' ' ' ILE 0.256 0.4 OUTLIER -70.16 -50.71 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.978 -165.806 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.45 ' HB3' ' CZ ' ' B' ' 65' ' ' ARG . 5.1 mmm180 -60.9 -43.06 99.06 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.54 -178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -20.73 64.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.4 175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 50.5 t80 -80.16 -40.84 26.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.306 -172.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.545 ' HZ2' ' HB3' ' B' ' 68' ' ' LYS . 0.2 OUTLIER -85.06 96.66 9.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.381 170.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.554 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.429 -170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.175 0.512 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.98 170.93 6.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.966 171.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 33' ' ' GLU . 3.4 mt -63.36 134.49 95.86 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.746 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.97 144.16 94.84 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.172 1.915 . . . . 0.0 113.66 175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.624 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -101.99 19.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.684 -174.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -85.92 -58.81 0.31 Allowed Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.715 172.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 11.7 Cg_endo -59.46 -45.81 24.39 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.503 2.135 . . . . 0.0 113.557 168.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 27.9 mt -69.06 -32.93 56.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.438 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -30.31 71.91 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 8.8 ttp-105 -92.39 -18.73 22.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.315 -174.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.791 HD11 HD21 ' B' ' 3' ' ' LEU . 10.3 mm -61.01 -60.59 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.244 166.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' B' ' 40' ' ' ALA . 7.3 mm -72.32 -22.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.039 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -77.31 -34.27 55.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.607 -1.178 . . . . 0.0 110.296 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -61.45 -31.17 71.12 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.877 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -57.94 -52.23 66.34 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.492 170.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.89 34.31 0.56 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.53 -167.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -84.25 145.92 28.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.255 -176.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -145.05 -38.74 0.26 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.026 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.824 ' NH2' HG23 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -122.9 85.0 2.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.48 170.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 55' ' ' ILE . 89.8 t -132.42 113.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.274 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.7 p -65.46 164.26 14.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.462 -167.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.775 ' O ' HD12 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -65.42 -30.56 71.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.36 -173.007 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.853 ' HB2' ' HB2' ' B' ' 57' ' ' ALA . 0.5 OUTLIER -60.97 -43.38 98.88 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.402 176.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.682 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.56 -41.2 97.04 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.347 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -61.73 -42.26 98.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.389 -176.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.775 HD12 ' O ' ' A' ' 22' ' ' ASP . 3.3 mt -83.29 -28.42 7.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.447 -176.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.82 ' O ' HD12 ' A' ' 31' ' ' ILE . 97.3 m -60.89 -47.7 85.21 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.293 174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.74 HD13 HG23 ' B' ' 60' ' ' ILE . 4.4 tp -59.21 -45.54 90.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.453 172.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.12 -20.8 63.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.108 -1.406 . . . . 0.0 110.547 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -96.91 -28.86 14.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.323 -177.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.82 HD12 ' O ' ' A' ' 27' ' ' THR . 1.9 mp -60.7 -70.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.929 162.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -58.32 -35.16 71.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.796 -166.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 3' ' ' LEU . 9.9 tt0 -69.52 -61.71 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.201 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 80.0 mt-10 -61.55 -34.09 74.97 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.797 -170.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 2.5 ttm -62.2 -46.9 86.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.46 165.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -63.39 -47.69 85.32 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -168.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -60.65 -23.0 64.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.368 170.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -75.6 -52.32 10.84 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.605 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.673 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.3 mt -61.49 -28.75 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.071 176.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.811 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.04 -74.09 0.09 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.191 -176.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.521 ' HB3' ' HB1' ' B' ' 15' ' ' ALA . 1.9 p -60.94 -11.38 7.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.489 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.707 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.4 mm-40 -79.92 -55.84 4.69 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.089 171.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.16 -20.83 63.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.368 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' B' ' 17' ' ' ALA . 92.8 mt -88.82 -52.03 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.93 -172.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -27.81 67.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.447 170.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.707 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -63.36 -61.02 2.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.375 171.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.817 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.78 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.241 -167.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.449 ' CD ' ' NH1' ' A' ' 52' ' ' ARG . 0.9 OUTLIER -82.61 -41.1 19.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.411 -171.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -66.2 -21.27 66.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.247 167.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.16 -53.27 59.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.23 166.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.71 9.92 0.14 Allowed Glycine 0 CA--C 1.523 0.535 0 CA-C-N 114.691 -1.141 . . . . 0.0 111.64 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.449 ' NH1' ' CD ' ' A' ' 48' ' ' ARG . 13.6 ttm-85 66.69 134.12 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.419 169.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.19 -65.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.303 169.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 55' ' ' ILE . 92.7 m -157.63 144.4 18.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.323 169.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' THR . 25.4 mm -66.22 136.37 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.322 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.833 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 13.3 tptt -131.83 165.21 24.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.404 -167.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' HB2' ' CB ' ' B' ' 23' ' ' ASP . . . -61.13 -17.72 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.246 169.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.55 ' O ' HD13 ' A' ' 62' ' ' LEU . 3.4 tp10 -76.29 -44.83 35.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.092 170.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 3.1 m-20 -68.9 -35.05 76.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.278 -173.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.89 HG13 HD22 ' B' ' 28' ' ' LEU . 1.4 mp -61.89 -56.15 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.763 162.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -61.47 -33.22 73.39 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.909 -166.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.6 mp -75.91 -45.78 33.45 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.551 173.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.552 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -61.37 -27.05 68.24 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.434 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.791 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -96.09 -56.3 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.866 -164.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH1' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -60.13 -26.25 66.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.632 174.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' NH2' HD23 ' A' ' 62' ' ' LEU . 97.4 mtt180 -81.38 -23.86 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.411 171.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 5.5 t80 -61.12 -48.46 81.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.46 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.436 ' HG3' ' HD2' ' A' ' 69' ' ' LYS . 12.0 tppt? 179.28 128.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.449 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.394 166.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmm . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 121.171 0.51 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.15 -65.75 0.98 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.095 -170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.791 HD21 HD11 ' A' ' 11' ' ' ILE . 1.5 mt -89.13 138.83 28.78 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.568 177.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.562 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 12.0 Cg_endo -62.56 147.97 94.03 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 122.514 2.143 . . . . 0.0 113.401 165.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.66 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -99.16 19.21 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.955 174.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -94.55 -59.35 0.2 Allowed Pre-proline 0 CA--C 1.544 0.713 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.737 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.9 Cg_endo -57.89 -46.97 22.79 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 C-N-CA 122.484 2.123 . . . . 0.0 113.454 169.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.73 -37.06 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.391 168.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.57 -21.35 60.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -103.61 -18.39 14.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.067 -0.567 . . . . 0.0 110.327 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.725 HG22 HD13 ' B' ' 12' ' ' ILE . 9.4 mm -60.78 -49.93 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.275 164.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' B' ' 17' ' ' ALA . 6.2 mm -85.46 -31.26 6.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.967 -168.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.385 170.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.32 -32.52 73.29 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.748 -178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.8 -53.47 57.98 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.028 -1.442 . . . . 0.0 110.521 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.82 24.04 0.48 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.618 -175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.833 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -61.02 144.2 53.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.73 -0.735 . . . . 0.0 110.409 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -146.01 122.02 10.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.036 167.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 64.28 82.69 0.18 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.367 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' HG3' ' B' ' 25' ' ' ARG . 25.8 t -101.4 123.65 54.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.337 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 31.3 t -61.25 154.35 23.83 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.419 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -61.48 -37.08 82.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.395 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -60.72 -48.6 81.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.511 170.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.833 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.95 -48.61 79.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.297 -172.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.444 ' HG3' ' CG1' ' B' ' 20' ' ' VAL . 9.2 mtp180 -61.61 -36.97 82.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.392 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -89.2 -32.99 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.42 -167.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.475 HG22 HD12 ' B' ' 31' ' ' ILE . 90.1 m -67.21 -41.05 86.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.449 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 60' ' ' ILE . 2.2 tp -62.97 -48.21 79.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.913 170.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.02 -25.78 67.15 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.553 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -95.96 -29.4 14.18 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.283 -175.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 64' ' ' VAL . 15.4 mt -61.4 -59.9 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.845 166.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.879 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.01 -22.05 47.82 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.77 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.513 ' OE1' HD21 ' B' ' 3' ' ' LEU . 8.9 tp10 -83.34 -65.05 1.06 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.011 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.68 -34.22 75.36 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.849 -174.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.46 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 8.2 ttm -62.15 -47.75 83.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.521 165.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -61.29 -49.53 76.72 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -173.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.59 -25.06 65.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.433 171.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 0.5 OUTLIER -71.32 -49.91 37.78 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.61 -179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.527 ' HB ' HD11 ' A' ' 28' ' ' LEU . 6.0 mt -61.43 -34.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.261 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.8 -71.78 0.14 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.301 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 24.7 p -62.04 -17.88 58.79 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.557 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.543 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -81.51 -50.85 8.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.26 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.4 -12.89 24.12 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.099 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.824 HG23 ' NH2' ' A' ' 19' ' ' ARG . 96.6 mt -95.47 -49.31 12.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.817 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -67.84 -7.4 27.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.182 170.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.543 HD12 ' O ' ' B' ' 42' ' ' GLU . 3.9 mt -83.61 -43.05 16.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.26 169.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.55 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -60.49 -14.83 21.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.324 166.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -92.31 -35.29 13.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.498 168.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' B' ' 46' ' ' LEU . 23.8 t-80 -61.66 -39.56 91.79 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.266 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.681 ' HB1' ' NZ ' ' B' ' 53' ' ' LYS . . . -61.05 -52.63 64.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.212 165.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.84 9.53 10.87 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.539 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 179.23 -166.8 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.931 -0.635 . . . . 0.0 110.323 -175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.681 ' NZ ' ' HB1' ' B' ' 50' ' ' ALA . 2.7 mppt? 65.73 162.72 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.41 167.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.621 HG22 ' O ' ' B' ' 55' ' ' ILE . 91.8 m -96.55 152.68 18.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.346 -168.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.899 ' HB ' HG22 ' A' ' 20' ' ' VAL . 3.6 mp -69.3 133.66 31.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.303 168.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.531 ' HB2' ' HG2' ' B' ' 58' ' ' GLU . 0.3 OUTLIER -135.63 -171.36 2.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.376 177.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.853 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . . . -61.75 -27.15 68.53 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.247 -178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.538 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.0 pt-20 -73.99 -49.0 26.47 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.06 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.1 OUTLIER -61.89 -31.56 71.86 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.401 -178.165 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.74 HG23 HD13 ' A' ' 28' ' ' LEU . 25.3 mm -61.89 -68.47 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.268 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 10.2 mt-10 -61.06 -14.61 24.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 3.6 mp -70.66 -55.2 9.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.403 169.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.483 ' HB1' ' CZ ' ' B' ' 67' ' ' PHE . . . -60.91 -37.03 80.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.484 177.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HG12 ' A' ' 31' ' ' ILE . 40.2 t -62.43 -69.02 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.796 176.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -61.19 -9.17 4.38 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.508 -176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -73.84 -50.29 21.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.488 178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.4 OUTLIER -80.51 -48.89 12.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.205 -174.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.494 ' HG3' ' HB2' ' B' ' 67' ' ' PHE . 4.9 mttm -150.31 -173.16 4.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.356 -166.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? . . . . . 0 C--O 1.241 0.639 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.42 -177.71 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 10.5 mtm . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 121.074 0.464 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.5 OUTLIER 59.05 146.64 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.749 -175.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.759 HD21 ' HG3' ' A' ' 33' ' ' GLU . 3.3 mt -69.89 146.74 95.64 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.792 172.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.12 140.18 93.17 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.543 2.162 . . . . 0.0 113.533 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 pt -80.64 -31.23 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.366 -169.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -63.75 -62.73 4.85 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.763 -173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 5.7 Cg_endo -50.87 -42.85 50.06 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 C-N-CA 122.48 2.12 . . . . 0.0 113.524 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.576 HD11 ' HB2' ' A' ' 3' ' ' LEU . 50.3 mt -60.81 -39.15 80.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.435 170.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.455 ' HA2' ' CZ ' ' A' ' 25' ' ' ARG . . . -61.58 -26.12 66.19 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -91.14 -25.33 19.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.169 -0.515 . . . . 0.0 110.36 -176.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.658 HD11 ' CD2' ' B' ' 3' ' ' LEU . 53.7 mt -60.83 -62.43 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.296 166.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.2 mm -61.21 -35.18 64.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.249 -175.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 4.4 mtmt -60.79 -37.09 80.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.498 169.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.56 -35.21 78.76 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.789 -175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' B' ' 41' ' ' SER . . . -59.32 -53.08 62.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.41 167.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.57 16.58 0.21 Allowed Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.051 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.809 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.16 170.57 1.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 163.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.09 -57.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.941 165.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.486 ' NH1' ' HD3' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -73.62 83.28 1.55 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.391 172.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.739 HG13 ' HB ' ' B' ' 55' ' ' ILE . 24.6 t -129.03 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 -170.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.3 p -85.24 156.48 20.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.423 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HG3' ' A' ' 25' ' ' ARG . 5.8 t0 -61.42 -23.19 65.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.318 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -90.65 -28.62 18.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.394 -170.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' CA ' HG13 ' B' ' 60' ' ' ILE . . . -61.69 -42.04 98.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.157 166.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HG3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.76 -51.17 68.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.445 -178.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.621 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 3.3 tt -62.68 -40.95 90.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.234 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.639 HG22 HD11 ' A' ' 31' ' ' ILE . 91.7 m -60.77 -59.06 5.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.369 -174.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.815 ' HA ' HD12 ' A' ' 31' ' ' ILE . 9.3 tp -61.01 -10.5 5.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.344 175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -82.37 -59.29 2.59 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.448 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -61.33 -25.14 66.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.434 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 28' ' ' LEU . 74.0 mt -61.65 -75.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.052 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.536 HD12 HG22 ' A' ' 31' ' ' ILE . 7.1 mp -60.57 -36.92 79.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.467 -166.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.759 ' HG3' HD21 ' A' ' 3' ' ' LEU . 8.4 tt0 -67.46 -42.75 82.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.053 -176.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 6.4 mt-10 -62.12 -41.15 97.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.056 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.9 mmm -60.76 -42.1 96.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.506 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.57 -46.27 90.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -167.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' HD3' HG23 ' B' ' 11' ' ' ILE . 3.1 mtp180 -60.73 -33.83 73.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.378 168.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -65.69 -50.2 65.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.43 -175.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.622 HG21 HG23 ' A' ' 64' ' ' VAL . 11.0 mt -65.1 -36.04 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.417 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.795 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -65.26 -54.08 34.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.32 -172.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.538 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -61.49 -34.33 75.29 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.298 178.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -60.91 -38.26 85.13 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.063 169.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -79.82 -13.67 59.24 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.794 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -82.79 -57.95 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.372 -168.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -60.29 -31.36 70.18 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.414 169.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 42' ' ' GLU . 11.4 mt -59.96 -43.84 94.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.584 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.831 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -67.86 -26.37 65.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.103 -173.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -60.67 -61.61 2.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.332 168.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -61.31 -10.09 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.584 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -84.16 -57.86 3.0 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.953 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.64 9.93 0.04 OUTLIER Glycine 0 C--N 1.344 0.996 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.666 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 0.3 OUTLIER 73.6 -58.22 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.424 0.689 . . . . 0.0 111.47 158.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.53 -23.3 49.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 111.182 -157.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.524 HG22 ' N ' ' B' ' 21' ' ' SER . 0.2 OUTLIER -155.43 154.97 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.354 169.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.927 ' HB ' HG13 ' B' ' 20' ' ' VAL . 4.3 mm -72.44 150.24 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.015 159.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.99 156.33 40.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.413 -169.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.23 -19.97 65.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.246 -170.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -68.72 -38.99 80.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.902 166.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -48.0 83.63 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.618 171.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.781 ' CG2' HD22 ' B' ' 28' ' ' LEU . 22.8 mm -61.55 -46.2 97.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.28 -36.86 69.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.054 -170.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.8 mp -63.51 -43.28 97.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.414 167.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 46' ' ' LEU . . . -61.54 -57.42 12.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.41 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.802 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -68.26 -52.84 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.042 -168.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.16 -41.35 92.62 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.731 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' HG2' ' HD2' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -69.51 -20.72 63.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.337 174.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 44.5 t80 -80.93 -28.9 35.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.206 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HD2' ' HG2' ' B' ' 69' ' ' LYS . 2.5 tppt? -118.7 86.81 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.333 168.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.516 ' HD2' ' HG2' ' A' ' 66' ' ' ARG . 9.8 ptmt . . . . . 0 C--O 1.239 0.515 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.355 -169.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptt? . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 58.56 171.71 0.06 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.73 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 11' ' ' ILE . 1.5 mt -80.46 161.83 63.16 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.625 176.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' B' ' 7' ' ' PRO . 12.6 Cg_endo -60.67 140.91 93.44 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 122.533 2.156 . . . . 0.0 113.405 164.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -99.47 -17.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.389 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -79.09 -62.0 0.46 Allowed Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.754 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 6.0 Cg_endo -51.48 -36.24 58.43 Favored 'Trans proline' 0 N--CA 1.482 0.85 0 C-N-CA 122.508 2.139 . . . . 0.0 113.522 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' B' ' 3' ' ' LEU . 54.0 mt -60.42 -42.22 90.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.362 168.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.463 ' CA ' ' HG2' ' B' ' 25' ' ' ARG . . . -61.54 -28.15 69.2 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.603 -177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HG3' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -86.55 -21.84 26.67 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 114.947 -0.627 . . . . 0.0 110.511 -178.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.491 HG23 ' HD3' ' A' ' 37' ' ' ARG . 26.4 mt -69.02 -44.0 81.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.399 167.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.795 HD13 ' HB2' ' A' ' 40' ' ' ALA . 3.5 mm -62.65 -36.17 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.04 171.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' HA ' ' B' ' 10' ' ' ARG . 0.6 OUTLIER -60.97 -34.16 74.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.387 172.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HG2' ' A' ' 37' ' ' ARG . 16.5 t70 -62.55 -32.78 73.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.75 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -52.57 65.13 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.443 169.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.41 18.88 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.051 -171.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.842 ' HB1' ' CG2' ' B' ' 20' ' ' VAL . . . -64.43 165.76 9.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.311 168.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.21 -58.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.049 169.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.32 83.3 4.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.452 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.927 HG13 ' HB ' ' A' ' 55' ' ' ILE . 57.9 t -104.45 145.41 13.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.324 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 54' ' ' THR . 77.8 p -61.21 139.73 58.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.33 168.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -60.98 -24.25 65.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.261 169.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.48 -53.17 56.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.454 169.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.336 -167.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.463 ' HG2' ' CA ' ' B' ' 9' ' ' GLY . 4.1 mpp_? -60.87 -49.03 79.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.417 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 58.4 mt -61.11 -23.68 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.449 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.716 ' O ' HD12 ' B' ' 31' ' ' ILE . 97.7 m -77.83 -40.08 41.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.362 -170.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.839 HD12 HD11 ' B' ' 32' ' ' LEU . 0.8 OUTLIER -60.68 -37.37 81.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.409 169.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.18 -40.61 96.6 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.245 -175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.2 mmmm -77.8 -31.41 51.79 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.369 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.802 HG21 HG21 ' A' ' 64' ' ' VAL . 5.5 mt -61.35 -74.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.035 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.839 HD11 HD12 ' B' ' 28' ' ' LEU . 3.5 mp -59.42 -35.4 73.93 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.611 -165.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.537 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -71.17 -37.44 72.18 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.125 -177.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 17.1 mm-40 -65.24 -52.08 56.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.097 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.3 ptm -65.03 -28.27 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.343 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.96 -45.8 48.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 11' ' ' ILE . 1.7 mtt-85 -60.64 -18.29 52.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.256 -0.472 . . . . 0.0 110.452 169.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' B' ' 67' ' ' PHE . 0.9 OUTLIER -87.03 -54.7 4.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.454 -173.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 64' ' ' VAL . 7.1 mt -61.54 -19.01 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.443 173.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -65.7 -70.88 0.21 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.353 172.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.544 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 32.3 t -61.07 -10.14 5.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.61 -177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.485 ' O ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -90.45 -45.02 9.24 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.097 179.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.456 ' CA ' ' HB2' ' B' ' 63' ' ' ALA . . . -63.51 -24.38 67.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.272 169.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 17' ' ' ALA . 78.2 mt -86.31 -50.43 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.134 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -31.77 70.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.371 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.793 HD22 HD23 ' B' ' 62' ' ' LEU . 14.4 mt -60.78 -55.09 37.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.371 167.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.689 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.32 -30.42 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.292 -170.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -61.05 -44.36 97.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.35 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -60.71 -35.05 75.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.371 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.61 -53.51 56.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.27 171.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 128.84 24.11 1.12 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.599 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.486 ' HD3' ' NH1' ' A' ' 19' ' ' ARG . 1.3 ptp85 59.57 33.51 22.1 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.226 -0.573 . . . . 0.0 111.169 169.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.55 77.37 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.407 169.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.417 HG22 ' H ' ' B' ' 55' ' ' ILE . 1.5 m 68.49 175.93 0.27 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.528 173.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.739 ' HB ' HG13 ' A' ' 20' ' ' VAL . 17.4 mm -118.41 137.16 53.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.235 166.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -142.94 166.34 24.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.429 -168.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' OE2' ' B' ' 61' ' ' GLU . . . -63.21 -25.17 68.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.253 -172.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 1.0 OUTLIER -64.18 -37.48 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.108 168.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HG2' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -79.5 -39.86 31.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.395 -176.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.473 HG13 ' CA ' ' A' ' 24' ' ' ALA . 38.2 mm -60.98 -54.4 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.421 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.768 ' OE2' ' HB1' ' B' ' 57' ' ' ALA . 4.5 mt-10 -68.59 -36.43 78.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.986 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.793 HD23 HD22 ' B' ' 46' ' ' LEU . 16.4 tp -61.13 -44.41 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.338 168.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.548 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.41 -42.82 99.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.413 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.929 HG23 HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -82.99 -60.78 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.18 -167.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -11.89 8.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.565 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -94.61 -30.9 14.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.443 168.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 1.1 t80 -61.27 -14.08 23.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.761 171.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.46 125.34 23.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.689 -165.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.525 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 7.2 mttm . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.382 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' HG2' ' NH1' ' B' ' 10' ' ' ARG . 44.3 mtp . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.141 0.495 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.39 137.04 49.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.201 -172.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.891 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.2 mp -57.34 100.2 0.21 Allowed Pre-proline 0 C--O 1.25 1.117 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.487 -168.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.9 Cg_endo -67.59 141.72 56.24 Favored 'Trans proline' 0 N--CA 1.484 0.926 0 C-N-CA 123.114 2.542 . . . . 0.0 113.67 -172.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -80.49 -9.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.023 -172.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -74.94 -60.33 1.23 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.727 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -56.92 -51.37 9.05 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 122.454 2.103 . . . . 0.0 113.497 173.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.2 mt -60.59 -45.91 96.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.45 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.58 -30.03 75.41 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.686 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.85 -20.57 27.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.493 -0.353 . . . . 0.0 110.329 -172.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.635 HD11 ' HG3' ' B' ' 2' ' ' GLU . 30.1 mt -65.19 -49.7 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.446 166.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.656 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.9 mm -61.05 -46.61 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.418 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -62.32 -30.32 71.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.261 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.34 -35.39 78.96 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.77 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.54 -52.63 64.73 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.511 169.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.11 23.53 0.34 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.576 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.761 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.7 170.51 1.94 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.893 -0.654 . . . . 0.0 110.306 173.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.65 -58.86 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.952 167.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -125.76 104.57 8.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.36 -169.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.882 HG22 HD12 ' B' ' 55' ' ' ILE . 59.6 t -112.26 103.8 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.345 168.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.44 167.88 3.09 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.403 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -26.07 67.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.363 -170.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.21 -63.03 1.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.518 172.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.79 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.03 -39.54 92.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.3 -168.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.7 mtm180 -61.56 -38.62 88.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.291 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.9 mm -76.25 -25.64 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.51 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.044 HG22 HG22 ' B' ' 60' ' ' ILE . 71.3 m -74.4 -45.8 44.42 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.12 -168.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD13 HG12 ' B' ' 60' ' ' ILE . 5.6 tp -59.19 -47.76 84.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.36 164.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -61.1 -18.46 58.08 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.531 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -99.68 -27.18 13.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.316 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.836 HG21 HG21 ' B' ' 64' ' ' VAL . 2.0 mp -60.79 -69.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.85 162.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.901 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.1 mp -59.67 -34.68 73.16 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.555 -168.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.891 ' CG ' HD13 ' A' ' 3' ' ' LEU . 9.8 mt-10 -63.67 -59.3 4.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.064 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -61.55 -20.24 63.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.83 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -52.2 48.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.223 160.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.16 -45.87 95.15 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -168.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -61.31 -39.91 92.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.377 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -63.19 -56.49 16.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.434 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.932 HG21 HG23 ' A' ' 64' ' ' VAL . 3.0 mt -61.57 -28.0 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.219 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -64.34 -61.33 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.231 -177.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.3 OUTLIER -80.71 -15.24 57.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.517 -167.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -78.98 -48.6 14.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.125 168.322 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -62.71 -37.46 86.59 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.041 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' B' ' 17' ' ' ALA . 48.2 mt -61.19 -50.3 81.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.147 165.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.91 -14.88 25.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.51 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 2.3 mt -91.63 -34.38 14.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.161 -172.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.5 -47.2 87.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.428 168.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -62.01 -48.35 80.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.359 -174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -62.7 -35.28 79.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.37 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.99 -54.24 47.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.183 168.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.91 24.71 0.57 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.618 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.31 96.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.215 -0.492 . . . . 0.0 110.531 166.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -153.61 78.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.239 165.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 55' ' ' ILE . 16.4 m 69.3 168.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.532 175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.656 HD12 HG22 ' B' ' 20' ' ' VAL . 86.2 mt -121.9 147.77 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.356 168.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.33 -178.84 7.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.424 -169.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -64.23 -22.75 67.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.258 -169.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.65 -68.07 0.35 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.155 169.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -25.94 67.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.41 -169.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.959 HG23 HD13 ' B' ' 28' ' ' LEU . 16.0 mm -76.14 -60.05 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.343 -178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 14.3 mt-10 -61.75 -18.7 60.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.413 177.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.88 -41.01 30.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.469 173.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.459 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -66.43 -37.07 84.36 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.12 173.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.954 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.02 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.713 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -60.27 -9.87 3.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.657 -169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.2 tpt180 -73.66 -48.52 31.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.408 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.7 m-85 -60.64 -52.32 65.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.365 168.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.43 -72.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.469 -164.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.61 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.375 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.167 0.508 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.635 ' HG3' HD11 ' A' ' 11' ' ' ILE . 9.4 tp10 -114.87 -78.9 0.58 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.903 -170.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' B' ' 33' ' ' GLU . 7.6 mt -68.98 123.19 87.57 Favored Pre-proline 0 C--O 1.244 0.786 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.58 168.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -62.91 146.51 94.91 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.722 2.281 . . . . 0.0 113.439 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 pt -93.78 21.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.49 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -88.58 -59.81 0.25 Allowed Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.748 178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.5 Cg_endo -56.48 -45.72 35.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 122.362 2.041 . . . . 0.0 113.506 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 36.1 mt -61.15 -55.2 26.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.515 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.39 68.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.1 OUTLIER -80.45 -25.75 38.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.456 -177.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 3' ' ' LEU . 80.6 mt -68.38 -46.84 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.411 167.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.1 mm -65.44 -40.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.212 177.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.1 mtpp -61.05 -36.88 80.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.453 171.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -62.0 -31.9 72.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.845 -178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.28 -52.35 65.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.987 -1.46 . . . . 0.0 110.52 170.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.59 22.57 0.85 Allowed Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.744 -171.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -64.3 146.29 54.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.807 -0.696 . . . . 0.0 110.405 172.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.32 -58.21 0.18 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.989 168.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -80.76 81.4 7.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.351 -178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.656 HG22 HD12 ' A' ' 55' ' ' ILE . 21.6 t -139.86 153.37 22.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.37 -168.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 99.0 p -101.71 150.36 23.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.393 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -16.97 49.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.32 168.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -60.96 -49.02 79.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.411 169.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.565 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.59 -45.84 92.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.388 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -30.05 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.404 -171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.412 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 58.3 mt -94.81 -20.41 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.436 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.668 HG22 HD11 ' B' ' 31' ' ' ILE . 88.8 m -61.03 -56.77 17.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.254 167.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.959 HD13 HG23 ' A' ' 60' ' ' ILE . 3.0 tp -60.7 -40.24 91.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.529 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.12 -39.97 92.0 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.421 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.9 OUTLIER -84.22 -21.12 31.32 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.399 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.954 HD13 HG21 ' A' ' 64' ' ' VAL . 58.8 mt -61.4 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.018 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.901 ' HB3' HD23 ' A' ' 32' ' ' LEU . 8.9 mp -60.79 -42.82 98.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.539 -174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.531 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 14.6 tm-20 -63.56 -36.67 84.55 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.065 -171.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -61.48 -43.98 97.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.063 173.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.625 ' HB3' HD11 ' B' ' 39' ' ' ILE . 34.5 mtp -60.78 -37.91 83.49 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.562 174.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.19 -41.91 99.72 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.54 -44.73 95.8 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.476 172.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.1 t70 -77.61 -45.87 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.559 -165.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' B' ' 35' ' ' MET . 5.8 mt -61.21 -30.35 47.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.253 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -67.14 0.44 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.305 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.455 ' N ' HD12 ' B' ' 44' ' ' ILE . 2.4 t -61.24 -9.19 4.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.471 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.75 -38.15 11.95 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.171 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.602 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.32 -16.11 59.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.46 171.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.3 mt -87.45 -49.19 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.836 -173.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -30.03 68.96 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.414 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.94 -47.23 85.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.405 166.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.679 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.93 -18.6 64.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.333 -173.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -41.39 67.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.277 168.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -60.3 -30.74 69.68 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.415 170.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.77 -51.56 68.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.418 174.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.22 41.84 1.23 Allowed Glycine 0 CA--C 1.526 0.774 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.477 -174.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.53 18.97 11.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.43 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.94 140.66 29.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.191 165.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -61.03 168.25 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.361 -167.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.882 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -92.96 141.22 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.559 -168.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.58 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.2 mtpt -138.25 -169.14 2.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.363 -171.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.612 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -66.83 -45.87 76.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.037 -169.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.468 ' O ' HD13 ' B' ' 62' ' ' LEU . 5.8 mt-10 -61.54 -31.0 71.0 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.26 177.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.55 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.54 -68.78 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.336 179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.04 -32.9 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 -162.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -38.59 87.1 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.086 175.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.468 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.55 -47.12 87.6 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.468 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.56 -13.96 25.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.615 -175.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.64 -57.21 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -159.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -10.92 3.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.39 166.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -85.37 -69.67 0.64 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.632 166.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' HG12 ' B' ' 39' ' ' ILE . 0.1 OUTLIER -62.03 -28.45 69.6 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.952 -154.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -146.99 109.48 4.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.491 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.274 169.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.272 0.558 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.79 -78.22 0.32 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.002 -170.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' B' ' 11' ' ' ILE . 0.9 OUTLIER -89.23 143.84 31.56 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.552 171.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 7' ' ' PRO . 18.0 Cg_endo -62.08 140.73 85.73 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 122.505 2.137 . . . . 0.0 113.444 163.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -96.89 -10.97 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.698 -170.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -61.06 -53.75 60.67 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.691 171.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 4.0 Cg_endo -51.01 -57.21 2.39 Favored 'Trans proline' 0 N--CA 1.484 0.948 0 C-N-CA 122.613 2.209 . . . . 0.0 113.549 171.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 54.3 mt -61.67 -25.98 38.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.422 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.95 32.69 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.549 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -76.43 -16.6 59.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.419 -170.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.992 HD11 HD21 ' B' ' 3' ' ' LEU . 31.8 mt -60.99 -73.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.262 166.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.678 HD13 HG22 ' A' ' 11' ' ' ILE . 7.4 mm -61.89 -23.42 31.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.852 -170.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -69.27 -38.69 78.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.457 170.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' B' ' 37' ' ' ARG . 57.6 t0 -62.31 -33.68 75.13 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.802 -176.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.91 -53.23 60.72 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.454 169.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.59 15.88 0.32 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.277 -176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.849 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -64.37 -177.02 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.261 165.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -171.13 -52.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.991 167.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -92.0 99.03 11.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.409 170.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.67 117.88 56.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 169.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.486 ' HB2' HG22 ' B' ' 54' ' ' THR . 35.5 t -61.6 159.34 13.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.38 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.0 -22.82 64.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.372 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.685 ' HA ' HG22 ' A' ' 26' ' ' ILE . 8.2 t70 -96.4 -35.25 11.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.291 -170.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.551 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -60.61 -38.49 84.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.065 164.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.583 ' HD3' HG21 ' A' ' 5' ' ' ILE . 7.4 ttm180 -60.16 -52.37 65.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.514 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.3 tp -72.65 -37.47 56.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.302 -173.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' CG2' ' B' ' 60' ' ' ILE . 55.6 m -61.37 -51.86 67.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.262 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 ' N ' HG21 ' B' ' 60' ' ' ILE . 11.8 tp -61.44 -25.5 67.26 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.189 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.99 -53.36 15.11 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.534 169.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.03 -28.84 65.81 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.363 -170.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.826 HD12 HG22 ' B' ' 60' ' ' ILE . 88.2 mt -61.42 -72.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.054 167.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.913 HD11 HD12 ' B' ' 39' ' ' ILE . 0.7 OUTLIER -59.92 -19.08 49.76 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.771 -166.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB2' ' NH2' ' A' ' 37' ' ' ARG . 2.5 pp20? -91.43 -41.89 10.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.027 -171.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -61.58 -35.14 76.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.904 167.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 4.3 mmt -61.05 -54.05 49.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.476 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.43 -37.79 95.23 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -167.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.704 ' NE ' HG23 ' B' ' 11' ' ' ILE . 0.1 OUTLIER -60.92 -33.9 73.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.422 -0.389 . . . . 0.0 110.315 170.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -53.88 48.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.541 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 64' ' ' VAL . 9.8 mt -61.37 -38.92 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.233 -174.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.877 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.77 -57.11 10.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.384 -172.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 44' ' ' ILE . 1.5 t -61.71 -30.62 70.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.254 -179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.729 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.7 mm-40 -60.76 -60.04 4.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.168 167.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.36 -11.93 12.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.535 -176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.76 -56.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.117 -169.107 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -23.4 65.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.439 170.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.729 HD13 ' O ' ' A' ' 42' ' ' GLU . 7.0 mp -61.15 -49.04 78.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.293 168.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.723 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.38 -27.84 68.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.327 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 -53.28 40.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.455 176.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.423 177.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.93 -55.08 37.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.124 170.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.3 32.94 0.37 Allowed Glycine 0 CA--C 1.53 0.99 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.508 -170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.03 -59.93 0.5 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.79 -0.705 . . . . 0.0 111.009 164.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -60.13 98.59 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.583 -163.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.6 m 70.14 123.28 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.371 166.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.745 ' HB ' HG12 ' B' ' 20' ' ' VAL . 15.9 mt -79.02 140.21 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.273 164.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HD2' ' CB ' ' B' ' 23' ' ' ASP . 0.2 OUTLIER -144.47 -174.32 4.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -168.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -61.7 -31.18 71.31 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.34 -178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.45 -42.33 83.28 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.115 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -35.43 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.323 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.839 HG23 HD13 ' B' ' 28' ' ' LEU . 33.6 mm -61.09 -40.05 84.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.326 169.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 37.5 mt-10 -80.34 -34.07 36.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.002 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.8 -45.08 95.82 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.436 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.17 -36.96 81.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.518 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 1.14 HG21 HG21 ' B' ' 31' ' ' ILE 0.257 0.4 OUTLIER -75.22 -52.67 18.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.989 -167.155 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -17.17 62.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.596 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.488 ' HE ' HD11 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -104.27 -12.5 16.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.923 -163.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -101.23 -22.34 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.639 164.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.09 105.92 0.54 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.438 -170.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.595 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.334 -168.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpp . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 121.18 0.515 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -92.16 -76.96 0.44 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.03 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.992 HD21 HD11 ' A' ' 11' ' ' ILE . 16.0 mt -62.23 133.23 94.22 Favored Pre-proline 0 C--O 1.241 0.636 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.743 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.664 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.5 Cg_endo -60.05 147.75 91.87 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.324 2.016 . . . . 0.0 113.496 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.67 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -85.23 -30.84 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.541 -177.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.725 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -69.24 -59.8 4.73 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.69 -171.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.725 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 5.4 Cg_endo -52.58 -46.15 35.26 Favored 'Trans proline' 0 N--CA 1.484 0.962 0 C-N-CA 122.552 2.168 . . . . 0.0 113.533 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' B' ' 3' ' ' LEU . 26.9 mt -60.5 -36.23 68.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.394 172.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.55 -27.2 67.64 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.439 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 tpt85 -86.6 -27.38 23.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.395 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.704 HG23 ' NE ' ' A' ' 37' ' ' ARG . 16.2 mt -60.63 -46.36 95.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.47 169.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 40' ' ' ALA . 4.0 mm -74.79 -31.62 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.922 -176.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -60.71 -41.89 96.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.45 169.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.71 -31.9 72.09 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.853 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -57.93 -53.81 54.02 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.428 167.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.17 30.53 0.27 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-N 113.726 -1.579 . . . . 0.0 110.722 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.735 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -80.87 171.81 14.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.67 -0.765 . . . . 0.0 110.26 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -171.1 -25.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.956 166.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 82.0 1.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.533 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.745 HG12 ' HB ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -113.79 129.4 69.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.165 167.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 25.6 p -61.0 165.94 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.256 166.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.65 -10.82 5.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.353 167.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.426 ' CB ' ' HD2' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -75.83 -55.28 5.77 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.453 176.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -62.1 -41.13 97.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.25 -176.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.514 HH21 HG23 ' B' ' 20' ' ' VAL . 3.3 ttm180 -62.29 -48.13 81.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.386 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.467 HD11 HG21 ' B' ' 5' ' ' ILE . 11.2 mm -76.25 -32.13 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.391 -174.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 57' ' ' ALA . 84.9 m -60.98 -52.02 66.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.461 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.839 HD13 HG23 ' A' ' 60' ' ' ILE . 4.1 tp -61.34 -45.65 93.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.264 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.447 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -60.89 -28.52 68.96 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.449 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -27.98 21.36 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.455 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 1.14 HG21 HG21 ' A' ' 64' ' ' VAL . 16.7 mt -61.77 -72.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.989 165.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mt -60.51 -12.8 10.81 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.565 -168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -78.3 -57.95 3.51 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.054 172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -35.96 79.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.042 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 7.2 tpp -60.82 -47.14 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.428 166.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.73 -40.94 89.9 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -170.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.471 ' HD2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -60.83 -26.82 67.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.317 170.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.16 -48.09 38.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.522 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.913 HD12 HD11 ' A' ' 32' ' ' LEU . 1.2 mt -63.02 -28.83 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.474 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.668 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -65.34 -68.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.318 -175.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.488 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 80.9 p -61.45 -16.06 43.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.331 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.629 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 0.0 OUTLIER -69.06 -64.51 0.86 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.13 165.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.442 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -61.16 -10.92 7.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.624 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.0 mt -99.82 -50.42 10.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.769 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -60.27 -29.3 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.402 168.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.8 mt -60.82 -51.52 68.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.245 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.699 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -67.97 -38.19 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.293 -169.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -70.35 -39.9 74.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.403 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -60.78 -35.88 77.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.335 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.67 -54.38 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.195 167.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.96 22.37 0.74 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.725 -173.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.52 -165.12 0.2 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 122.294 -0.533 . . . . 0.0 110.981 168.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 65.44 100.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.466 -167.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 21' ' ' SER . 2.0 m 70.14 124.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.377 167.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' B' ' 47' ' ' ALA . 5.6 mm -89.82 152.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.316 166.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.502 ' C ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -131.03 159.62 36.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.428 -168.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 24' ' ' ALA . . . -61.93 -30.04 70.63 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.335 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -53.38 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.156 171.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.16 -13.09 23.8 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.456 -174.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.826 HG22 HD12 ' A' ' 31' ' ' ILE . 33.0 mm -84.01 -63.28 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.393 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.524 ' HG3' HD11 ' A' ' 31' ' ' ILE . 31.1 mt-10 -61.72 -13.74 25.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.625 173.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 tp -94.6 -30.78 14.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.332 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -63.9 -37.52 87.69 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.755 161.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.757 HG21 HD13 ' A' ' 31' ' ' ILE . 41.0 t -61.45 -71.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.769 166.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.451 ' HA ' ' CB ' ' B' ' 68' ' ' LYS . 4.8 mtt-85 -59.2 -11.51 3.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.811 -170.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -71.72 -50.02 34.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.439 167.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.714 ' HE2' HG23 ' B' ' 39' ' ' ILE . 29.5 p90 -90.97 25.35 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.543 173.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.451 ' CB ' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -119.84 78.24 1.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 114.351 -1.295 . . . . 0.0 110.348 171.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.8 mttm . . . . . 0 C--O 1.239 0.505 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.496 -175.318 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.203 0.525 . . . . 0.0 109.79 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -154.35 37.97 0.44 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.972 -170.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 33' ' ' GLU . 10.4 mp 58.83 92.62 0.06 OUTLIER Pre-proline 0 C--O 1.248 1.002 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.551 170.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 9.3 Cg_endo -49.13 138.49 28.28 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 C-N-CA 122.6 2.2 . . . . 0.0 113.348 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.68 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -91.53 19.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.898 -167.214 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -82.35 -58.24 0.45 Allowed Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.699 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 7.7 Cg_endo -54.41 -53.27 6.48 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.497 2.131 . . . . 0.0 113.537 171.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 3' ' ' LEU . 26.2 mt -61.44 -59.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.522 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.6 -18.83 57.14 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -31.68 22.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.952 -0.624 . . . . 0.0 110.356 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.642 HD11 ' CD2' ' B' ' 3' ' ' LEU . 61.4 mt -60.53 -51.14 76.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.554 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.707 HD12 ' HB2' ' B' ' 40' ' ' ALA . 9.9 mm -61.27 -37.61 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.281 -173.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -34.31 77.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.344 172.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -62.52 -34.42 76.87 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.755 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.921 ' HB1' ' HB3' ' B' ' 41' ' ' SER . . . -59.34 -53.6 56.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.485 169.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.73 21.98 0.42 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.604 -178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.786 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.31 150.62 29.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.349 167.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.07 -51.81 2.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.036 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.52 132.12 23.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.37 168.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 45.5 t -124.73 123.1 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.333 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.441 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 21.4 t -66.29 156.73 33.51 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.454 -176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' HA ' ' CG ' ' A' ' 25' ' ' ARG . 27.9 t0 -61.37 -24.07 66.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.346 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' B' ' 57' ' ' ALA . 0.7 OUTLIER -60.65 -53.69 54.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.513 172.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB1' HG13 ' B' ' 60' ' ' ILE . . . -62.18 -47.24 85.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.318 -172.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.539 ' HD3' HG13 ' A' ' 5' ' ' ILE . 1.4 ptp85 -70.96 -27.65 63.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.393 -168.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 78.5 mt -86.29 -27.42 6.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.421 174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.505 HG22 HD12 ' A' ' 31' ' ' ILE . 99.3 m -60.95 -54.4 45.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.345 170.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.976 HD13 HG23 ' B' ' 60' ' ' ILE . 4.0 tp -60.14 -43.01 96.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.49 174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 26' ' ' ILE . . . -61.19 -32.19 71.95 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.501 -174.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mtpp -97.86 -24.1 15.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.236 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.067 HD13 HG21 ' B' ' 64' ' ' VAL . 84.4 mt -60.65 -69.37 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.028 164.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -59.04 -33.89 71.29 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.699 -172.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.796 ' HB2' HD13 ' A' ' 3' ' ' LEU . 10.4 tm-20 -61.86 -59.33 5.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.047 177.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 2.3 tp10 -64.52 -30.57 71.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.838 -171.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 19.2 ttt -60.42 -41.14 93.34 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.292 164.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.62 -46.9 93.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.46 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -62.66 -24.75 67.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 114.853 -0.673 . . . . 0.0 110.049 -178.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 6.9 t0 -80.9 -45.25 17.07 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.504 -174.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 67' ' ' PHE . 9.6 mt -61.65 -30.28 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.144 174.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.652 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.54 -77.31 0.05 Allowed 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.25 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.774 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.81 -11.0 10.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.384 -172.428 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -81.35 -56.46 4.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.114 170.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 47' ' ' ALA . . . -60.5 -17.2 43.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.612 177.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.74 HD11 ' HB2' ' B' ' 17' ' ' ALA . 78.3 mt -85.58 -51.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.854 -173.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -60.63 -39.73 89.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.383 168.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 63' ' ' ALA . 50.6 mt -60.76 -39.69 89.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.415 170.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -61.46 -24.75 66.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.295 178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -82.34 -48.85 10.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.343 -171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -16.01 64.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.242 167.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.28 -56.57 19.96 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.137 167.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.25 30.07 0.16 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.697 -171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.69 -60.96 0.49 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.833 -0.684 . . . . 0.0 110.923 161.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.05 93.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.306 0.574 . . . . 0.0 110.581 -161.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.532 HG21 ' HB2' ' B' ' 21' ' ' SER . 24.9 m 70.44 144.28 0.06 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 172.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.795 ' HB ' HG13 ' B' ' 20' ' ' VAL . 15.3 mm -73.32 138.35 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.221 169.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -135.94 170.32 16.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.429 -170.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.7 -53.45 55.91 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.48 -165.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.717 ' O ' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -62.23 -26.81 68.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.946 -174.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.8 m-20 -65.18 -39.5 92.98 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.499 173.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.829 HD12 ' CD2' ' B' ' 28' ' ' LEU . 36.5 mm -62.75 -67.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.391 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.6 mt-10 -61.09 -11.21 7.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.278 -174.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.717 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.2 OUTLIER -73.1 -50.88 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.437 166.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.515 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -61.14 -42.82 99.23 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.304 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.854 HG21 HD13 ' B' ' 31' ' ' ILE . 21.8 t -62.02 -68.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.856 174.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -60.17 -9.79 3.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.682 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -35.32 39.29 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.355 174.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.529 ' CE2' HG12 ' A' ' 39' ' ' ILE . 96.9 m-85 -59.72 -59.78 4.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.367 163.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 tptp -65.09 140.78 58.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.416 -168.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.24 0.579 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.363 -169.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.096 0.474 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -71.3 -179.29 2.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.022 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.642 ' CD2' HD11 ' A' ' 11' ' ' ILE . 3.2 mt -69.23 138.51 89.47 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -170.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 140.88 94.04 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 122.41 2.074 . . . . 0.0 113.481 167.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.671 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -88.61 -11.94 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.657 -173.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.45 -60.55 2.57 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.81 178.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.7 Cg_endo -55.64 -42.97 62.27 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.462 2.108 . . . . 0.0 113.546 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' B' ' 3' ' ' LEU . 57.4 mt -60.45 -39.76 82.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.472 172.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.72 -29.92 73.47 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.579 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.495 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 3.2 mtp180 -89.82 -23.13 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.339 -0.43 . . . . 0.0 110.383 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.755 HD11 HD11 ' A' ' 3' ' ' LEU . 36.5 mt -60.93 -58.39 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.317 166.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.652 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.3 mm -61.87 -36.53 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.274 -177.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.4 OUTLIER -60.98 -36.31 79.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.362 169.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -62.3 -32.78 73.57 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.835 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.774 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.79 -53.41 58.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.425 169.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.59 20.85 0.76 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.725 -172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.74 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.24 120.08 9.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.35 166.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.41 -54.48 10.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.168 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.44 104.9 3.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.379 174.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.795 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.2 t -83.81 129.28 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.267 169.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.532 ' HB2' HG21 ' A' ' 54' ' ' THR . 27.0 t -61.49 148.29 42.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.279 166.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.503 ' HB3' ' NH1' ' B' ' 25' ' ' ARG . 10.9 p30 -61.54 -22.78 65.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.417 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.512 ' HA ' HG22 ' B' ' 26' ' ' ILE . 10.1 t70 -88.73 -25.56 22.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.387 -172.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 60' ' ' ILE . . . -66.41 -44.14 83.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.24 168.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.503 ' NH1' ' HB3' ' B' ' 22' ' ' ASP . 2.3 ptt-85 -83.09 -18.17 40.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.414 -167.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.675 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.2 OUTLIER -78.19 -35.43 19.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.41 168.543 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.555 HG22 HG21 ' A' ' 60' ' ' ILE . 68.7 m -61.11 -37.93 84.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.265 175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.829 ' CD2' HD12 ' A' ' 60' ' ' ILE . 1.1 mm? -60.84 -40.54 93.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.322 166.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.67 -52.13 65.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.337 -176.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.479 ' NZ ' HD11 ' B' ' 26' ' ' ILE . 0.2 OUTLIER -68.55 -33.47 74.15 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.464 -177.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.854 HD13 HG21 ' A' ' 64' ' ' VAL . 41.1 mt -61.71 -71.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.16 170.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.724 ' CD1' HD12 ' B' ' 28' ' ' LEU . 0.5 OUTLIER -59.8 -15.66 22.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.832 -169.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.417 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 2.7 tt0 -95.41 -24.03 16.88 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.054 -177.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -61.43 -52.26 65.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.111 167.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 1.3 ttp -73.56 -27.41 61.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.327 -172.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.21 -42.32 91.14 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -28.86 69.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.334 168.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 2.2 t70 -70.26 -58.18 4.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.557 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.668 HG21 HG23 ' B' ' 64' ' ' VAL . 4.2 mt -61.44 -30.32 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.385 -177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.707 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -62.22 -73.87 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.296 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.921 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 24.5 p -62.13 -15.44 45.62 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.529 -170.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.53 ' HG2' ' CE1' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -89.67 -39.52 13.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.158 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.63 -9.07 56.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.486 168.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.786 HD11 ' HB2' ' A' ' 17' ' ' ALA . 74.6 mt -94.34 -53.24 8.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.873 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.43 -18.21 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.382 168.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' B' ' 43' ' ' ALA . 5.1 mt -72.96 -48.75 33.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.398 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.436 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -70.3 -31.94 69.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.218 -170.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.429 ' CZ ' ' HB2' ' B' ' 48' ' ' ARG . 22.8 ttm105 -65.83 -40.02 91.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.282 168.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -61.23 -38.58 87.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.31 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.88 -51.21 70.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.287 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.67 37.14 4.31 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.32 148.02 22.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.415 -170.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -82.63 171.98 13.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -170.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.441 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 93.9 m 61.54 119.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.421 -178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.761 HG23 ' HB3' ' B' ' 59' ' ' ASP . 82.4 mt -88.6 148.31 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.388 170.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.404 ' H ' ' HB2' ' B' ' 59' ' ' ASP . 0.0 OUTLIER -135.75 179.69 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.45 -169.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . . . -61.6 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.291 -171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 15.7 pt-20 -84.36 -43.86 14.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.063 -179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.761 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.4 OUTLIER -61.61 -23.52 66.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.44 179.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 28' ' ' LEU . 29.7 mm -88.61 -56.37 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.239 -171.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.516 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 36.5 mt-10 -62.09 -18.06 59.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.115 172.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.45 HD23 ' HA ' ' B' ' 62' ' ' LEU . 12.1 mt -67.17 -55.82 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.336 168.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.35 -35.64 81.53 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.219 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 1.067 HG21 HD13 ' A' ' 31' ' ' ILE . 49.2 t -62.1 -79.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.689 171.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.88 -12.02 9.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.365 -168.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.48 -53.68 48.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.36 167.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.53 ' CE1' ' HG2' ' B' ' 42' ' ' GLU . 5.0 m-85 -61.07 -56.59 19.17 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.375 173.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.64 26.89 13.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.349 -169.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.24 0.557 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.371 168.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.096 0.474 . . . . 0.0 109.984 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -126.86 -29.7 2.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.074 -169.912 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 8' ' ' ILE . 17.2 mt -61.81 104.6 0.49 Allowed Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.989 -177.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 4.2 Cg_endo -46.52 140.45 11.94 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 C-N-CA 122.4 2.067 . . . . 0.0 113.478 173.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.661 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -89.76 -13.41 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.755 -168.799 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.802 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -69.76 -55.86 8.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.665 173.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.802 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.5 Cg_exo -48.68 -59.33 1.29 Allowed 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.705 2.27 . . . . 0.0 113.555 169.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 3' ' ' LEU . 30.7 mt -61.43 -35.87 69.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.458 -178.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' HA3' ' NH1' ' A' ' 25' ' ' ARG . . . -61.61 -37.73 94.68 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.556 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.518 ' HA ' ' HB2' ' A' ' 13' ' ' LYS . 9.4 ptp180 -90.23 -14.35 33.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.465 -171.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.52 -56.08 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.305 165.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.699 HD11 HD23 ' A' ' 28' ' ' LEU . 9.1 mm -61.34 -37.31 77.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.149 -177.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 10' ' ' ARG . 22.7 mttm -60.37 -39.45 87.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.429 167.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.34 -33.35 74.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.751 -177.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.828 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -59.11 -53.86 53.58 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.207 -1.361 . . . . 0.0 110.427 169.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.48 21.56 0.45 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.713 -175.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.56 137.95 58.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.042 -0.579 . . . . 0.0 110.409 168.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -120.9 -27.72 4.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.005 -170.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -145.82 117.99 8.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.445 169.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.895 HG22 ' CG1' ' B' ' 55' ' ' ILE . 89.5 t -141.41 132.24 26.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.275 -172.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.6 p -83.34 151.23 25.65 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.406 176.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 3.1 p30 -62.03 -14.17 33.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.409 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 26' ' ' ILE . 11.7 m-20 -86.48 -27.9 23.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.394 -176.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.822 ' HB1' HG22 ' B' ' 55' ' ' ILE . . . -65.42 -39.28 91.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.109 165.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.513 ' NH1' ' HA3' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -61.66 -43.64 98.48 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.518 -178.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.605 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 6.4 tt -75.08 -40.45 44.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.269 -172.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD11 ' A' ' 31' ' ' ILE . 83.1 m -60.66 -44.42 96.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.396 -174.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.782 HD13 HG23 ' B' ' 60' ' ' ILE . 2.2 tp -61.0 -35.41 76.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.288 169.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 26' ' ' ILE . . . -62.05 -42.07 98.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.405 178.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -29.42 40.33 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.45 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 28.9 mt -61.28 -72.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.029 171.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HG22 ' A' ' 31' ' ' ILE . 8.2 mp -60.11 -30.28 69.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.739 -167.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' A' ' 3' ' ' LEU . 3.4 tm-20 -81.53 -37.44 27.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.034 -168.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -61.47 -39.79 92.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.955 166.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.427 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 95.3 mtp -61.36 -40.91 96.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.495 175.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.09 -38.21 63.7 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -166.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.5 ttt-85 -61.02 -27.5 68.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.248 164.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -74.12 -51.47 15.55 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.53 -173.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.611 ' CG2' HG23 ' A' ' 64' ' ' VAL . 12.5 mt -61.14 -38.86 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.204 177.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.878 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -60.97 -58.68 7.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.388 -170.016 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.53 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 23.3 p -61.49 -28.79 69.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.365 178.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -63.0 -43.38 98.94 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.071 169.575 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -76.9 -12.73 60.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.354 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.849 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -84.27 -56.59 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.063 -0.972 . . . . 0.0 109.306 -168.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.4 mttp -59.79 -28.89 67.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.488 170.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.79 HD22 HD23 ' A' ' 62' ' ' LEU . 13.5 mt -60.63 -47.02 88.09 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.457 174.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.73 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.23 -38.03 89.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.325 -176.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -44.94 75.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.388 -170.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -60.97 -31.48 71.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.336 171.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.27 -53.21 59.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.211 168.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 135.82 17.14 0.84 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.5 ptt180 59.39 28.39 17.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 O-C-N 122.322 -0.516 . . . . 0.0 111.237 169.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 77.59 8.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.298 169.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.583 HG23 ' HG3' ' B' ' 19' ' ' ARG . 6.7 m 68.51 169.58 0.28 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.409 -179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.709 ' HB ' HG22 ' B' ' 20' ' ' VAL . 5.6 mm -106.08 137.29 36.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.195 164.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.737 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -128.26 159.77 34.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.417 -167.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' B' ' 24' ' ' ALA . . . -62.28 -13.04 24.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.126 -172.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 1.0 OUTLIER -81.69 -25.49 35.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.148 174.04 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 56' ' ' LYS . 0.7 OUTLIER -84.04 -36.43 23.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.27 -174.673 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.831 HG13 HD22 ' B' ' 28' ' ' LEU . 1.5 mp -62.82 -48.72 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.489 161.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.4 mm-40 -61.44 -43.85 98.15 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.81 -174.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.79 HD23 HD22 ' A' ' 46' ' ' LEU . 39.9 tp -65.38 -44.74 86.6 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.542 173.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.536 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.39 -45.05 95.96 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.426 -175.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.887 HG21 HG21 ' B' ' 31' ' ' ILE 0.25 0.4 OUTLIER -78.51 -53.52 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.085 -166.554 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -36.26 77.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.631 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.96 -21.06 59.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.374 174.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 29.9 t80 -68.89 -64.65 0.83 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.259 -173.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.96 -168.47 0.19 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.312 178.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.9 tttp . . . . . 0 C--O 1.24 0.558 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.299 167.45 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttt . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 121.071 0.463 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -81.3 145.0 31.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.938 -168.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.671 ' CB ' HD11 ' B' ' 8' ' ' ILE . 4.6 mt -61.07 99.41 0.18 Allowed Pre-proline 0 C--O 1.243 0.716 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.71 166.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.407 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 12.3 Cg_endo -55.07 142.93 76.05 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 122.613 2.209 . . . . 0.0 113.628 -172.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.789 HG21 ' HE ' ' B' ' 25' ' ' ARG . 0.1 OUTLIER -66.42 -18.3 23.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.571 -165.198 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.753 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -74.62 -62.47 0.94 Allowed Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.776 -170.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.753 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.9 Cg_endo -52.72 -50.5 13.83 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.402 2.068 . . . . 0.0 113.444 175.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.671 HD11 ' CB ' ' B' ' 3' ' ' LEU . 27.2 mt -60.45 -31.74 49.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.393 168.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.99 67.97 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.484 -175.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 49.7 mmm-85 -91.66 -27.72 17.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.477 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.476 HD13 ' HG2' ' A' ' 33' ' ' GLU . 36.5 mt -60.92 -59.57 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.526 170.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.878 HD12 ' HB2' ' A' ' 40' ' ' ALA . 10.0 mm -61.37 -38.42 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.0 OUTLIER -61.8 -34.01 75.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.349 175.739 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -62.22 -32.56 73.23 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.685 178.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.69 -54.0 51.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.45 169.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.45 28.62 0.26 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.67 -176.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.849 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -76.09 148.84 37.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 114.715 -0.743 . . . . 0.0 110.357 179.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.62 117.08 5.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.092 169.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.583 ' HG3' HG23 ' A' ' 54' ' ' THR . 3.1 tpp180 65.04 97.02 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.356 -173.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.709 HG22 ' HB ' ' A' ' 55' ' ' ILE . 46.2 t -110.8 150.2 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.292 168.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 52.4 p -61.13 149.41 37.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.315 169.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.449 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 1.7 m-20 -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.309 170.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -60.78 -60.25 4.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.593 174.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.737 ' HB2' ' C ' ' A' ' 56' ' ' LYS . . . -62.09 -47.66 83.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.318 -171.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.789 ' HE ' HG21 ' B' ' 5' ' ' ILE . 5.7 ptt180 -61.09 -34.81 75.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.344 -172.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.15 -33.89 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.499 175.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.81 ' O ' HD12 ' B' ' 31' ' ' ILE . 80.0 m -60.99 -44.93 96.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.407 -179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.831 HD22 HG13 ' A' ' 60' ' ' ILE . 3.9 tp -60.39 -54.47 45.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.268 173.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' B' ' 8' ' ' ILE . . . -61.54 -15.53 39.3 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.456 -179.36 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.447 ' HA ' ' CG ' ' B' ' 33' ' ' GLU . 8.5 tmtt? -99.02 -25.46 14.55 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.266 -174.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mt -60.54 -69.55 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.951 162.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.83 HD12 ' O ' ' B' ' 28' ' ' LEU . 2.5 mp -59.92 -35.16 74.3 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.575 -167.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.515 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -70.35 -40.08 74.27 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.964 -176.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.35 -44.17 97.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.122 173.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.511 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 63.1 mmm -61.01 -27.09 68.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.462 175.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.15 -43.47 13.45 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -174.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -60.34 -17.98 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.949 -0.625 . . . . 0.0 110.393 166.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.511 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 0.4 OUTLIER -90.96 -52.13 5.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.358 -168.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.734 HD13 ' CG2' ' B' ' 64' ' ' VAL . 4.3 mt -61.11 -23.53 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.206 167.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.66 ' CB ' HG23 ' A' ' 12' ' ' ILE . . . -61.84 -72.48 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.28 176.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.828 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 11.8 m -61.67 -11.4 11.58 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.358 -175.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.432 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -80.22 -56.63 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.129 171.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.4 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -61.1 -14.65 25.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.326 176.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 17' ' ' ALA . 70.8 mt -90.62 -54.96 6.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.056 -177.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -60.53 -11.62 7.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.414 170.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' B' ' 63' ' ' ALA . 6.4 mt -87.81 -42.47 12.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.443 176.448 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.47 -25.69 67.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.276 -179.066 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -83.41 -50.75 8.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.45 175.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -61.31 -31.62 71.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.375 -178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.28 73.71 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.201 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.83 35.78 0.94 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -166.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 66.49 118.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.487 169.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.598 ' O ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -167.82 13.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.321 179.387 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.598 HG22 ' O ' ' B' ' 53' ' ' LYS . 0.7 OUTLIER 60.96 162.37 0.06 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.494 -175.947 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.895 ' CG1' HG22 ' A' ' 20' ' ' VAL . 14.0 mm -75.21 137.47 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.339 173.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 18.9 mtmt -154.32 -178.82 7.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.425 -169.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -60.92 -24.69 66.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.34 172.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.03 -26.48 21.41 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.123 -176.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -35.5 13.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.317 -175.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.782 HG23 HD13 ' A' ' 28' ' ' LEU . 46.9 mm -61.15 -47.37 93.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.196 167.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.492 ' HG2' ' NH2' ' B' ' 65' ' ' ARG . 20.9 mt-10 -62.02 -44.53 96.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.971 -172.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -45.98 92.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.464 172.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' B' ' 46' ' ' LEU . . . -61.49 -46.04 91.69 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 114.768 -1.106 . . . . 0.0 110.421 -177.153 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.734 ' CG2' HD13 ' B' ' 39' ' ' ILE . 0.3 OUTLIER -80.02 -60.94 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.099 -165.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.492 ' NH2' ' HG2' ' B' ' 61' ' ' GLU . 4.6 mtm180 -60.22 -19.0 52.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.565 -175.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -89.54 -25.5 21.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.544 171.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' B' ' 38' ' ' ASP . 2.8 t80 -61.29 -41.64 97.31 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.46 -179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.69 129.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.3 -165.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.376 -170.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ptt? . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.128 0.489 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.56 121.0 12.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.062 -168.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.785 HD13 ' HB2' ' A' ' 33' ' ' GLU . 6.3 mp -57.1 138.9 79.68 Favored Pre-proline 0 C--O 1.251 1.132 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.569 -172.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.665 ' HG2' ' HG2' ' A' ' 7' ' ' PRO . 11.3 Cg_endo -63.82 141.21 77.41 Favored 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 123.204 2.603 . . . . 0.0 113.646 -178.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 HH21 ' A' ' 25' ' ' ARG . 1.0 OUTLIER -100.24 -13.41 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.636 -166.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.44 -55.54 3.53 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.674 173.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 13.2 Cg_exo -49.43 -61.17 0.62 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.749 2.299 . . . . 0.0 113.557 168.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 3' ' ' LEU . 54.9 mt -61.39 -49.58 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.512 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.4 91.27 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -172.286 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -40.99 96.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.081 -0.56 . . . . 0.0 110.407 176.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 8' ' ' ILE . 68.1 mt -61.55 -36.11 71.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.538 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.673 HG23 ' HB1' ' B' ' 40' ' ' ALA . 8.3 mm -72.79 -44.97 58.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.192 -172.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -31.96 72.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.255 176.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -61.89 -33.3 73.97 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.807 177.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.26 -53.21 60.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.462 170.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.4 25.79 0.63 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.496 -174.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.996 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.21 119.79 9.11 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.718 -0.741 . . . . 0.0 110.363 176.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.59 -71.96 0.27 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.062 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.12 131.84 48.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.368 168.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.557 ' CG2' ' HB1' ' A' ' 17' ' ' ALA . 60.0 t -124.62 133.14 70.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.422 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.9 p -73.47 136.02 44.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.04 -12.88 13.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.398 -174.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.9 OUTLIER -86.67 -21.93 26.4 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.35 -179.398 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.719 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -70.72 -38.47 73.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.123 164.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.487 HH21 HD13 ' A' ' 5' ' ' ILE . 2.3 mtp180 -61.48 -31.48 71.46 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.502 -178.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 23' ' ' ASP . 3.5 tp -89.7 -34.61 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 -175.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.665 ' O ' HD12 ' A' ' 31' ' ' ILE . 80.5 m -61.52 -41.16 96.91 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.18 177.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD11 ' HB ' ' B' ' 39' ' ' ILE . 3.8 tp -59.19 -45.48 90.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.541 167.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.52 -43.09 99.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.504 -177.056 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 mttp -76.62 -28.09 55.98 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.235 -175.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.02 HG21 HG21 ' B' ' 64' ' ' VAL . 6.6 mt -59.59 -73.84 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.908 162.177 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.687 HD11 ' O ' ' B' ' 32' ' ' LEU . 1.0 OUTLIER -56.15 -23.79 37.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.819 -159.646 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.785 ' HB2' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -66.83 -60.76 2.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.038 166.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.02 -28.66 69.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.109 -164.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.531 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 32.3 mmm -71.58 -38.96 70.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.436 167.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -66.49 -44.3 90.44 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -174.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -61.03 -31.16 70.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.456 -0.372 . . . . 0.0 110.399 168.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -66.35 -53.75 32.49 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.434 -178.003 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.639 ' HB ' HD11 ' B' ' 28' ' ' LEU . 8.1 mt -61.39 -45.48 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.388 -175.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.998 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.29 -48.36 81.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.339 -172.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.536 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 1.2 t -62.15 -27.46 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.385 177.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HG2' ' CD2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -68.37 -43.15 78.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.181 168.978 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -73.06 -7.78 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.676 177.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.831 HD11 ' N ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -86.84 -52.07 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.275 -174.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.3 -31.1 68.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.667 168.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 43' ' ' ALA . 12.7 mt -61.16 -51.13 70.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.405 175.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.99 67.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.348 -171.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.91 -41.97 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.439 170.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -63.22 -31.6 72.79 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.389 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.77 -48.7 79.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.261 169.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.72 35.01 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -170.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.15 133.68 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.375 169.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.4 mmpp? -61.35 -43.51 98.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.34 -169.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 m -66.41 126.21 28.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.412 -168.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.66 HG23 ' HB2' ' A' ' 59' ' ' ASP . 7.0 mt -91.67 154.51 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.362 168.062 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.518 ' HE3' ' H ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -158.84 173.53 16.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.377 -166.521 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' H ' ' HE3' ' A' ' 56' ' ' LYS . . . -61.97 -15.85 46.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.255 -177.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.718 ' O ' HD13 ' A' ' 62' ' ' LEU . 1.3 tt0 -83.76 -41.59 17.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.087 175.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.66 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -59.94 -49.38 77.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.608 170.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 28' ' ' LEU . 32.2 mm -60.77 -59.92 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.415 -171.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG3' ' CG2' ' B' ' 27' ' ' THR . 30.3 mt-10 -61.83 -29.17 69.99 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.968 -174.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 58' ' ' GLU . 7.1 mp -60.36 -45.6 92.92 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.469 168.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -61.14 -42.93 99.44 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.588 -176.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.76 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -82.14 -55.07 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.054 -165.569 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -21.87 64.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.738 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -92.92 -14.33 27.72 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.736 177.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.505 ' CD2' ' HG2' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.27 -75.98 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.92 161.248 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 59.13 15.93 4.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.767 158.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.241 0.611 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.207 -162.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 58.56 -172.55 0.1 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 169.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.578 ' CB ' HD11 ' B' ' 8' ' ' ILE . 12.1 mt -61.61 138.28 95.08 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.603 -166.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.634 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 5.1 Cg_endo -60.32 160.98 21.35 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.575 2.183 . . . . 0.0 113.407 164.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.412 HD13 ' OD1' ' B' ' 22' ' ' ASP . 2.4 pp -102.27 -20.61 5.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.517 -175.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.643 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -70.14 -59.09 4.5 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.754 -179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.643 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 4.7 Cg_endo -48.66 -50.98 11.19 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 C-N-CA 122.585 2.19 . . . . 0.0 113.467 171.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.853 ' HA ' HD12 ' B' ' 11' ' ' ILE . 66.9 mt -60.83 -27.91 42.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.317 174.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.44 -40.71 99.05 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.502 -179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.06 -21.68 39.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.03 -0.585 . . . . 0.0 110.495 -178.441 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.853 HD12 ' HA ' ' B' ' 8' ' ' ILE . 89.7 mt -67.19 -44.44 87.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.507 178.053 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.998 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.0 mm -69.17 -41.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.325 175.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 11.2 mtmt -61.51 -39.67 91.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.313 177.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -61.59 -31.31 71.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.908 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.07 -52.37 65.82 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.639 170.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.91 24.33 0.33 Allowed Glycine 0 CA--C 1.528 0.845 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.635 -177.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.831 ' N ' HD11 ' A' ' 44' ' ' ILE . . . -75.69 120.04 20.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.617 -0.791 . . . . 0.0 110.255 176.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.49 13.88 29.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.995 -178.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 179.35 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.419 -174.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.8 HG22 ' HB1' ' B' ' 17' ' ' ALA . 10.7 t -99.85 125.58 53.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.338 -176.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -63.57 149.64 45.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.169 164.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' B' ' 5' ' ' ILE . 35.9 t70 -60.58 -12.23 9.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.502 169.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.689 ' HA ' HG22 ' B' ' 26' ' ' ILE . 0.5 OUTLIER -95.37 -32.67 12.83 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.428 -174.61 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.531 ' HA ' HG13 ' A' ' 60' ' ' ILE . . . -61.2 -41.33 96.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.182 169.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -61.15 -53.55 55.55 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.52 176.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.77 HD13 ' O ' ' B' ' 26' ' ' ILE . 0.1 OUTLIER -67.21 -33.44 62.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.316 -171.915 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.444 HG22 ' CG2' ' A' ' 60' ' ' ILE . 85.0 m -70.1 -34.45 73.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.318 -174.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.918 HD21 HD12 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -60.68 -40.76 93.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.21 166.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -61.57 -56.82 15.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.299 -179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -33.64 76.45 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.445 -174.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.76 HG21 HG21 ' A' ' 64' ' ' VAL . 69.7 mt -61.05 -74.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.935 167.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.687 ' O ' HD11 ' A' ' 32' ' ' LEU . 3.7 mt -59.33 -28.67 67.03 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.57 -164.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.557 ' HB3' ' HG ' ' B' ' 3' ' ' LEU . 1.6 pp20? -75.72 -39.5 57.19 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.84 -35.73 79.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.969 175.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -45.05 95.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.517 170.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.91 -38.35 95.88 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -33.89 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.357 -0.422 . . . . 0.0 110.276 167.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' B' ' 42' ' ' GLU . 4.1 t70 -64.29 -55.7 19.58 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.438 -178.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.685 ' HB ' HD11 ' A' ' 28' ' ' LEU . 4.9 mt -61.8 -33.3 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.09 -177.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.93 -65.64 0.66 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.27 -173.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.51 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -68.03 -18.26 64.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.521 -175.373 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' B' ' 38' ' ' ASP . 0.3 OUTLIER -81.71 -44.65 16.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.168 175.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -68.27 -32.53 72.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.148 175.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.996 HD11 ' HB2' ' A' ' 17' ' ' ALA . 21.7 mt -60.71 -47.39 93.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.097 164.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -30.29 69.91 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.429 177.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.478 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.0 mt -72.31 -34.34 68.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.366 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.668 ' HB2' HG13 ' B' ' 55' ' ' ILE . . . -61.13 -35.84 78.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.294 176.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -60.64 -44.06 96.83 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.393 172.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -60.74 -36.84 79.89 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.438 174.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.81 -49.88 75.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.271 172.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.68 29.79 2.36 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -163.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.32 -169.58 0.14 Allowed 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.089 -0.654 . . . . 0.0 111.072 175.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.86 98.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.466 -169.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 69.94 122.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.367 165.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' B' ' 47' ' ' ALA . 4.1 mp -93.22 138.16 20.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.152 162.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -130.55 178.95 6.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.401 -167.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.34 -19.88 62.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.267 -172.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.47 -28.67 21.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.043 -177.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -85.2 -34.94 21.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.338 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.719 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 46.7 mm -61.02 -50.02 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.403 168.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 5.5 mt-10 -69.1 -37.52 78.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -175.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.04 -45.45 94.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.397 175.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.435 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -61.29 -49.48 76.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.385 178.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 31' ' ' ILE 0.257 0.4 OUTLIER -74.87 -50.5 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.937 -160.89 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -30.19 71.31 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.439 178.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -47.55 84.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.377 -177.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER -60.98 -65.12 0.74 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.398 172.203 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -154.92 173.54 16.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.464 -171.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mttt . . . . . 0 C--O 1.241 0.622 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.376 169.975 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mmm . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 121.155 0.502 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -68.54 -178.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.994 -171.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.735 ' HB3' HD11 ' A' ' 8' ' ' ILE . 13.2 mt -61.06 102.78 0.33 Allowed Pre-proline 0 C--O 1.243 0.731 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.975 175.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -53.21 141.55 58.83 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.85 1.7 . . . . 0.0 113.113 168.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -93.25 20.77 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.622 -164.319 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -81.56 -59.39 0.45 Allowed Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.716 172.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.5 Cg_endo -58.0 -50.5 10.0 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 122.496 2.131 . . . . 0.0 113.498 173.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.846 ' HA ' HD12 ' A' ' 11' ' ' ILE . 57.4 mt -61.37 -44.03 97.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.499 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.91 -40.41 98.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -170.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -70.53 -32.31 69.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.008 -0.596 . . . . 0.0 110.334 -178.244 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 8' ' ' ILE . 39.6 mt -61.76 -51.76 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.354 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 6.4 mm -65.78 -48.44 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.439 -173.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -35.14 78.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.253 177.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -61.83 -32.19 72.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.125 -1.398 . . . . 0.0 109.85 177.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.83 -52.47 65.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.073 -1.421 . . . . 0.0 110.522 170.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.54 20.65 0.61 Allowed Glycine 0 CA--C 1.526 0.756 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.737 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -63.77 119.54 10.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.181 -0.509 . . . . 0.0 110.319 168.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -112.69 18.47 18.27 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.893 176.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' B' ' 54' ' ' THR . 0.0 OUTLIER 179.89 84.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.332 -164.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.868 HG22 HD12 ' B' ' 55' ' ' ILE . 12.3 t -136.81 118.11 18.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.38 172.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -74.39 159.74 31.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.393 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.13 -23.59 65.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.412 -171.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' HG22 ' A' ' 26' ' ' ILE . 80.5 m-20 -90.67 -29.6 17.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.32 -170.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.755 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.26 -42.81 99.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.143 162.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.543 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 0.6 OUTLIER -77.31 -28.69 53.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.48 -167.519 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 23' ' ' ASP . 5.2 tp -72.94 -37.33 53.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.429 172.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.465 HG22 ' CD1' ' A' ' 31' ' ' ILE . 57.8 m -60.69 -39.98 90.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.727 HD13 HG23 ' B' ' 60' ' ' ILE . 3.5 tp -64.55 -44.37 90.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.014 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -32.63 72.3 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.452 173.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -79.35 -33.21 43.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.478 179.207 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.737 HG21 HG21 ' B' ' 64' ' ' VAL . 11.6 mt -60.57 -69.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.003 169.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.739 ' O ' HD21 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -58.09 -27.64 63.86 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.672 -168.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -84.55 -19.92 32.36 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 114.121 -1.399 . . . . 0.0 110.149 -179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -63.06 1.15 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.008 165.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.419 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 11.0 mtp -61.99 -31.04 71.37 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.417 -174.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.45 -42.96 71.61 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 -177.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.53 -22.02 63.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.547 . . . . 0.0 110.435 169.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.4 m-20 -90.46 -47.74 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.608 -168.368 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.642 HD13 ' CG2' ' A' ' 64' ' ' VAL . 5.9 mt -61.27 -29.66 46.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.243 171.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.653 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.98 -66.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.237 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.51 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 29.7 p -63.61 -17.57 63.02 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.542 177.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.696 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -69.7 -60.84 2.06 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.909 167.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.425 ' CA ' ' HB2' ' A' ' 63' ' ' ALA . . . -61.69 -14.68 33.63 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.417 -178.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.961 HD11 ' HB2' ' B' ' 17' ' ' ALA . 84.2 mt -96.93 -48.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.664 -172.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -59.85 -11.62 5.81 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.482 164.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.696 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.7 mp -87.17 -52.84 5.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.277 -178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.33 -14.27 25.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.314 177.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.6 mmm-85 -91.94 -70.27 0.7 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.414 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -67.87 -12.01 59.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.852 -170.078 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 52' ' ' ARG . . . -64.7 -45.96 84.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 163.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.37 40.08 4.31 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -166.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.516 ' HG2' ' HB1' ' A' ' 50' ' ' ALA . 14.6 mmm180 -126.09 172.54 9.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.317 -0.442 . . . . 0.0 110.448 -164.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.99 135.92 50.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.445 -170.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 55' ' ' ILE . 70.2 m 62.82 146.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.469 -178.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.972 HD12 HG22 ' B' ' 20' ' ' VAL . 64.3 mt -97.19 156.62 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.234 168.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.35 177.08 11.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.469 -171.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.94 -22.87 64.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.3 173.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -65.34 -50.35 65.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.028 168.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.785 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -61.4 -51.93 66.73 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.334 179.41 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.813 HG23 HD13 ' B' ' 28' ' ' LEU . 47.6 mm -60.76 -44.13 96.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.342 -168.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -39.21 88.96 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.151 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.38 -48.31 81.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.328 176.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.629 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -61.37 -30.21 70.39 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.401 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.694 HG21 HG21 ' B' ' 31' ' ' ILE . 0.4 OUTLIER -89.49 -56.73 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.129 -165.222 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -16.24 31.42 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.695 171.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -32.02 57.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.358 169.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -59.95 -35.24 74.53 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.465 171.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -60.7 99.95 0.1 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.45 172.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.535 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.327 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.526 ' N ' ' HA ' ' A' ' 7' ' ' PRO . 1.5 ttt . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.137 0.494 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 6.7 pt-20 -62.71 138.96 58.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.029 170.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.672 ' CB ' HD11 ' B' ' 8' ' ' ILE . 15.5 mt -61.87 107.89 1.34 Allowed Pre-proline 0 C--O 1.242 0.697 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.915 -177.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 4.4 Cg_endo -47.53 142.42 13.42 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 122.551 2.168 . . . . 0.0 113.424 168.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -72.66 -19.21 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.447 -167.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -71.99 -62.66 1.51 Allowed Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.744 -168.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.3 Cg_endo -52.68 -42.86 59.77 Favored 'Trans proline' 0 N--CA 1.484 0.95 0 C-N-CA 122.5 2.133 . . . . 0.0 113.491 178.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.672 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -60.41 -47.06 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.537 172.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.03 -26.13 67.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -173.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.51 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -81.24 -33.42 32.81 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.402 -177.725 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.593 ' CD1' HD21 ' A' ' 3' ' ' LEU . 67.5 mt -60.76 -52.4 62.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.447 169.766 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.956 HG22 ' HB2' ' B' ' 17' ' ' ALA . 11.8 mm -61.1 -35.13 63.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.199 177.662 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 1.5 mttt -67.58 -37.05 82.05 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.504 178.074 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -61.7 -31.42 71.57 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.687 -178.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.81 -53.58 56.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.942 -1.481 . . . . 0.0 110.474 168.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.14 7.51 0.81 Allowed Glycine 0 CA--C 1.522 0.519 0 CA-C-N 114.204 -1.362 . . . . 0.0 111.782 -166.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.961 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -63.7 -162.53 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.954 0.502 . . . . 0.0 110.691 168.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.458 ' HB2' ' HG2' ' B' ' 13' ' ' LYS . 4.0 tm-20 64.2 25.42 13.61 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -155.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 20.19 17.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.404 151.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.972 HG22 HD12 ' A' ' 55' ' ' ILE . 61.2 t -113.27 172.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.228 -161.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.671 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 24.6 p -108.63 169.21 8.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.587 175.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.535 ' HA ' ' HG2' ' B' ' 25' ' ' ARG . 1.8 p30 -78.54 -33.52 47.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.336 -175.333 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -60.83 -30.81 70.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.334 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' B' ' 21' ' ' SER . . . -60.95 -69.71 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.269 169.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' B' ' 22' ' ' ASP . 1.3 ptt180 -61.06 -11.44 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.345 -166.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 29.7 mt -86.11 -35.3 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.424 176.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.652 HG22 HD11 ' B' ' 31' ' ' ILE . 73.1 m -60.86 -48.73 80.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.419 176.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.813 HD13 HG23 ' A' ' 60' ' ' ILE . 2.8 tp -60.74 -40.45 92.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.42 177.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -41.32 96.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.511 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 5.7 tttt -74.63 -31.33 61.95 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.393 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.694 HG21 HG21 ' A' ' 64' ' ' VAL . 54.0 mt -60.72 -75.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.964 170.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.739 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.93 -30.98 66.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.83 -162.439 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' B' ' 3' ' ' LEU . 2.5 tm-20 -85.81 -31.44 22.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.016 -173.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.6 mm-40 -61.49 -36.91 81.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.829 163.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 2.6 ttm -63.82 -43.52 95.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.446 176.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.72 ' HA2' HD12 ' B' ' 39' ' ' ILE . . . -71.49 -33.58 63.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -165.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 -60.85 -33.22 72.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.423 . . . . 0.0 110.27 164.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -51.07 54.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.712 -177.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.72 HD12 ' HA2' ' B' ' 36' ' ' GLY . 1.1 mt -62.32 -35.59 70.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.758 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 12' ' ' ILE . . . -61.35 -65.75 0.64 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.444 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.5 OUTLIER -61.9 -20.51 63.84 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.418 -179.165 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.714 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.0 OUTLIER -70.16 -61.51 1.75 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.133 169.763 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.32 -5.88 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.824 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' A' ' 17' ' ' ALA . 77.6 mt -101.41 -56.86 4.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.885 -176.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -15.77 32.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.387 171.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.714 HD12 ' C ' ' B' ' 42' ' ' GLU . 13.4 mt -79.86 -50.32 10.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.432 170.177 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.575 ' HB2' HG12 ' B' ' 55' ' ' ILE . . . -61.35 -17.57 54.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.252 -171.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -46.51 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.458 169.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -61.74 -37.97 86.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.335 -173.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.04 -47.65 85.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.24 169.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.19 33.07 5.57 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -166.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.15 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.439 -168.628 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 3.0 pttm -91.61 132.31 36.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.37 170.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER 66.24 142.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.344 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 20' ' ' VAL . 89.2 mt -89.52 132.91 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.213 166.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -118.12 171.7 7.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.332 -176.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.68 -14.35 20.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.366 172.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.443 ' OE1' HD11 ' B' ' 62' ' ' LEU . 0.0 OUTLIER -71.41 -52.29 19.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.183 169.387 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -68.91 -36.06 77.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.38 -178.083 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.755 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 39.2 mm -61.49 -62.36 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.342 178.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.81 -26.35 68.06 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.885 179.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' B' ' 59' ' ' ASP . 11.6 mt -60.46 -50.72 72.45 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.423 170.324 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' B' ' 42' ' ' GLU . . . -62.02 -32.91 73.46 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.479 -172.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 31' ' ' ILE 0.274 0.5 OUTLIER -86.95 -48.84 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -162.512 . . . . . . . . 4 4 . 1 . 023 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -66.69 -24.63 66.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.438 169.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -60.82 -37.08 80.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.415 173.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' B' ' 64' ' ' VAL . 10.5 p90 -108.34 -18.71 13.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.333 -168.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.81 110.13 0.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.365 -174.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 tttm . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.403 166.155 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.1 mtt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.543 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 20.7 mm-40 -126.64 -179.82 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.006 -164.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp 58.65 77.42 0.4 Allowed Pre-proline 0 C--O 1.248 1.0 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.626 178.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 2' ' ' GLU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 -60.3 -54.49 45.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? 64.53 -74.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.333 -165.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.319 168.178 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.085 0.469 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -51.8 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.093 -170.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt -62.49 138.81 96.6 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.778 -173.102 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 -61.15 -57.49 12.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 87.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.401 -168.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 tptm . . . . . 0 C--O 1.241 0.608 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.412 -170.133 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.099 0.476 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.25 137.4 46.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -171.137 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp -57.86 99.49 0.19 Allowed Pre-proline 0 C--O 1.25 1.082 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.43 -168.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 -60.48 -52.25 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.33 -74.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.351 -164.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.337 170.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -158.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.992 168.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.8 139.5 95.79 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.713 -173.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -62.01 -29.63 70.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -145.63 109.96 4.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.428 170.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.415 169.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.1 mtt . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.543 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 20.7 mm-40 -126.64 -179.82 4.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.006 -164.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.61 ' CB ' ' HB1' ' A' ' 29' ' ' ALA . 10.4 mp 58.65 77.42 0.4 Allowed Pre-proline 0 C--O 1.248 1.0 0 CA-C-N 114.171 -1.377 . . . . 0.0 111.626 178.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 5.6 Cg_exo -49.16 145.98 13.66 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.297 1.998 . . . . 0.0 113.235 169.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.613 HD13 HH21 ' A' ' 25' ' ' ARG . 2.7 pp -70.13 -11.2 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.553 -166.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.687 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -73.78 -55.01 3.48 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.786 178.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 1.7 Cg_endo -57.15 -34.76 98.35 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.493 2.129 . . . . 0.0 113.483 178.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.598 HD11 ' HA ' ' A' ' 29' ' ' ALA . 7.2 mm -60.43 -72.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.515 171.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' HA3' ' HD2' ' A' ' 25' ' ' ARG . . . -61.45 -15.8 47.45 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -168.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.86 -37.88 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.391 176.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.91 HD11 HD21 ' B' ' 3' ' ' LEU . 10.7 mm -60.87 -58.85 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.401 165.405 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.667 HD12 ' HB2' ' B' ' 40' ' ' ALA . 8.6 mm -63.89 -24.87 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.143 -170.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -28.97 60.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.328 172.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -62.07 -33.04 73.67 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.775 175.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -58.72 -53.48 57.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.428 168.342 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.51 30.83 0.54 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.644 -169.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.92 ' CA ' HD11 ' B' ' 44' ' ' ILE . . . -74.55 137.38 42.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.246 -0.477 . . . . 0.0 110.235 -173.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -101.56 79.19 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.125 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 66.45 130.69 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.592 -169.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.744 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 90.4 t -113.63 120.85 64.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.36 167.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.6 t -61.44 149.32 38.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.367 178.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' O ' HD12 ' A' ' 26' ' ' ILE . 6.2 p-10 -60.88 -16.54 42.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.357 -168.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -57.28 8.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.425 169.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.744 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -61.95 -41.86 98.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.311 -174.101 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.613 HH21 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -61.51 -48.42 81.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.459 -177.756 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 22' ' ' ASP . 42.2 mt -77.95 -24.82 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.422 -175.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.643 HG22 HD11 ' A' ' 31' ' ' ILE . 89.9 m -61.16 -56.31 22.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.322 171.069 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.819 ' HA ' HD12 ' A' ' 31' ' ' ILE . 14.8 tp -76.83 -16.77 59.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.311 -168.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 3' ' ' LEU . . . -74.09 -44.27 54.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.133 166.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HE2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -67.85 -32.62 73.27 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.367 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.819 HD12 ' HA ' ' A' ' 28' ' ' LEU . 28.3 mt -62.03 -76.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.042 169.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.11 -16.66 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.645 -165.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 2' ' ' GLU . 25.4 tt0 -78.29 -47.11 18.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.107 178.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.0 -35.99 80.19 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.865 178.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 39' ' ' ILE . 19.2 ttt -60.26 -55.52 32.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.489 165.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.68 -46.16 94.8 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -166.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -61.3 -33.12 73.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.414 -0.393 . . . . 0.0 110.205 176.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -60.38 -55.42 33.75 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.733 174.881 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.739 HD12 HD11 ' B' ' 32' ' ' LEU . 2.5 mt -62.11 -30.8 49.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.815 -176.076 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.02 -70.22 0.21 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.287 -1.324 . . . . 0.0 110.31 -176.309 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -67.46 -16.69 64.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.405 -173.864 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.751 ' O ' HD13 ' A' ' 46' ' ' LEU . 3.2 mm-40 -70.72 -61.6 1.71 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.894 165.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 46' ' ' LEU . . . -61.46 -8.81 4.53 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.435 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.892 HD11 ' HB2' ' B' ' 17' ' ' ALA . 40.6 mt -93.59 -47.65 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.555 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -59.8 -11.82 6.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.416 166.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.751 HD13 ' O ' ' A' ' 42' ' ' GLU . 6.3 mp -85.94 -49.11 8.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.355 -179.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.9 -18.88 59.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.379 171.375 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -35.68 56.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.325 173.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -60.63 -33.75 73.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.21 167.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -62.16 -51.52 67.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.119 163.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.28 9.45 47.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 175.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.16 -169.77 0.11 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.913 -0.643 . . . . 0.0 110.335 -179.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.73 -178.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.369 165.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.56 HG23 ' HB2' ' B' ' 19' ' ' ARG . 0.2 OUTLIER -89.44 166.26 13.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.386 -169.431 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' B' ' 20' ' ' VAL . 12.9 mm -68.9 137.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.266 166.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG3' ' HB2' ' A' ' 59' ' ' ASP . 0.0 OUTLIER -130.53 -176.34 3.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.338 -168.401 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' B' ' 27' ' ' THR . . . -78.59 -54.44 6.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.144 -166.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 62' ' ' LEU . 4.0 tt0 -60.89 -23.1 64.94 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.038 172.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB2' ' HG3' ' A' ' 56' ' ' LYS . 0.5 OUTLIER -60.81 -56.04 25.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.494 172.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.068 HG22 HG22 ' B' ' 27' ' ' THR . 0.3 OUTLIER -71.83 -42.89 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.741 -164.81 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.861 ' HG2' HD11 ' B' ' 31' ' ' ILE . 14.7 mt-10 -66.37 -27.55 67.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.232 176.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD11 ' OE2' ' A' ' 58' ' ' GLU . 14.0 mt -68.68 -42.24 78.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.282 172.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.748 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -63.01 -34.51 77.71 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.162 170.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 60' ' ' ILE . 53.2 t -61.57 -74.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.693 170.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -60.66 -13.46 14.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.662 -170.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -66.93 -43.87 82.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.256 170.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 39' ' ' ILE . 31.5 m-85 -60.3 -54.49 45.08 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.538 170.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? 64.53 -74.82 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.333 -165.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 C--O 1.24 0.566 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.319 168.178 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 121.085 0.469 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.0 -51.8 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.093 -170.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.91 HD21 HD11 ' A' ' 11' ' ' ILE . 3.1 mt -62.49 138.81 96.6 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.778 -173.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.509 ' HB2' ' HD2' ' B' ' 7' ' ' PRO . 9.7 Cg_endo -60.35 142.81 99.03 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.457 2.104 . . . . 0.0 113.543 166.219 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.41 HG21 ' CD1' ' B' ' 26' ' ' ILE . 2.4 pp -96.67 -12.67 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.411 -170.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.744 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -67.44 -61.79 4.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.844 173.518 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 8.5 Cg_endo -53.56 -44.16 51.48 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.455 2.103 . . . . 0.0 113.532 177.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' B' ' 3' ' ' LEU . 60.7 mt -60.68 -50.2 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.52 172.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -17.17 53.97 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -174.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.511 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -92.12 -28.63 16.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.308 -0.446 . . . . 0.0 110.372 -179.839 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 3' ' ' LEU . 28.9 mt -61.15 -53.78 44.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.226 165.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 40' ' ' ALA . 8.6 mm -65.2 -36.24 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.178 -177.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 2.0 mttp -60.55 -36.67 79.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.43 168.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -62.21 -33.57 74.83 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.821 -1.082 . . . . 0.0 109.846 -176.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.94 -53.72 55.17 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.395 169.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.12 18.07 0.59 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.944 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.892 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.26 128.07 34.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.316 165.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -101.0 -25.13 14.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.979 -1.009 . . . . 0.0 110.105 178.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 54' ' ' THR . 0.4 OUTLIER -154.24 120.17 5.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.497 174.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.467 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.7 t -111.39 112.46 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.354 168.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 54' ' ' THR . 15.9 t -63.11 163.47 10.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.456 -178.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.437 ' O ' HD13 ' B' ' 26' ' ' ILE . 9.8 p-10 -61.38 -30.85 70.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.303 -172.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -57.05 14.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.452 176.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' B' ' 27' ' ' THR . . . -62.75 -41.98 99.46 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.469 -170.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HG3' ' CD1' ' B' ' 26' ' ' ILE . 0.0 OUTLIER -67.64 -40.13 84.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.431 -171.119 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.475 HD12 ' N ' ' B' ' 26' ' ' ILE . 1.3 mp -67.11 -36.43 76.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.627 167.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 1.068 HG22 HG22 ' A' ' 60' ' ' ILE . 33.2 m -68.91 -44.29 73.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.965 -168.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.833 HD13 HG12 ' A' ' 60' ' ' ILE . 6.1 tp -59.59 -52.52 65.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.455 165.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.39 -24.54 66.57 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.429 -170.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' B' ' 30' ' ' LYS . 0.0 OUTLIER -86.03 -34.33 20.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.515 -1.221 . . . . 0.0 110.354 177.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.861 HD11 ' HG2' ' A' ' 61' ' ' GLU . 6.6 mt -60.9 -70.29 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.027 170.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.744 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.42 -35.93 74.92 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.687 -167.265 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -38.96 93.03 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.987 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.07 -34.27 75.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.991 178.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.469 ' HA ' ' HB2' ' B' ' 38' ' ' ASP . 23.6 mmt -74.38 -40.56 61.99 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.548 175.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.03 -43.18 65.92 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -172.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -27.24 68.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.324 167.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.502 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 0.2 OUTLIER -74.1 -51.92 14.2 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.402 -175.036 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.669 HD13 HG23 ' B' ' 64' ' ' VAL . 8.0 mt -69.82 -23.96 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.483 -176.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.667 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.0 -53.55 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.321 171.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.561 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 11.9 p -76.07 -35.13 59.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.357 -167.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.513 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.5 OUTLIER -61.55 -34.05 74.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.856 167.058 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' B' ' 46' ' ' LEU . . . -82.56 -10.54 58.94 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.547 179.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.92 HD11 ' CA ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.17 -57.9 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.482 -172.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 4.2 tptt -61.05 -26.09 67.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.478 170.282 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 6.5 mt -60.45 -40.11 89.98 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.48 171.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.77 -36.07 65.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.281 -173.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' B' ' 45' ' ' LYS . 0.3 OUTLIER -64.46 -46.46 82.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.589 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.41 -34.53 75.53 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.299 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.87 -52.97 62.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.347 174.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.92 24.22 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.494 -178.165 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.9 101.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.406 168.14 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.522 ' O ' HG22 ' B' ' 54' ' ' THR . 1.0 OUTLIER -172.72 76.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.186 168.28 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.522 HG22 ' O ' ' B' ' 53' ' ' LYS . 3.2 t 58.65 -177.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.484 -1.234 . . . . 0.0 111.1 -173.247 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 20' ' ' VAL . 25.5 mt -110.13 137.08 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.308 169.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.463 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -133.14 178.16 7.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.46 -166.716 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -43.82 98.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.29 -172.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.615 ' O ' ' HG ' ' B' ' 62' ' ' LEU . 0.8 OUTLIER -66.44 -26.59 67.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.061 -177.299 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.45 -46.0 35.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.419 175.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.643 ' CG1' ' HB1' ' A' ' 24' ' ' ALA . 35.0 mm -61.17 -37.87 78.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.458 177.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.78 -35.1 29.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.013 -170.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' B' ' 58' ' ' GLU . 46.3 mt -61.27 -44.24 97.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.272 168.293 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.76 88.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.377 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.758 HG21 HG21 ' A' ' 31' ' ' ILE 0.254 0.4 OUTLIER -76.35 -50.47 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.961 -170.799 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 mtp-105 -62.1 -30.05 70.75 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.446 -179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -42.15 98.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.362 176.256 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' B' ' 38' ' ' ASP . 7.3 m-85 -61.15 -57.49 12.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.429 175.158 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.91 87.76 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.401 -168.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 13.4 tptm . . . . . 0 C--O 1.241 0.608 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.412 -170.133 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 mtp . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.099 0.476 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.25 137.4 46.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.075 -171.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.866 HD13 ' CG ' ' A' ' 33' ' ' GLU . 6.3 mp -57.86 99.49 0.19 Allowed Pre-proline 0 C--O 1.25 1.082 0 CA-C-N 114.72 -1.127 . . . . 0.0 112.43 -168.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.645 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 1.2 Cg_endo -67.05 144.65 70.56 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.136 2.557 . . . . 0.0 113.642 -172.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.658 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -82.26 -8.56 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.986 -173.801 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -75.65 -60.24 1.1 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.841 177.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.9 Cg_endo -57.22 -51.74 8.02 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.54 2.16 . . . . 0.0 113.489 173.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' A' ' 3' ' ' LEU . 27.1 mt -60.62 -45.93 96.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.418 175.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.49 -29.53 73.74 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.67 -173.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.85 -19.51 27.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.448 -0.376 . . . . 0.0 110.314 -173.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.4 mt -66.48 -49.14 77.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.434 166.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.651 HG23 ' HB1' ' B' ' 40' ' ' ALA . 13.7 mm -61.11 -45.81 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.49 -178.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -63.23 -30.62 71.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.284 176.49 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.25 -35.36 78.72 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.182 -1.372 . . . . 0.0 109.819 177.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.56 -52.51 65.22 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.463 169.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.09 23.55 0.34 Allowed Glycine 0 CA--C 1.525 0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 110.672 177.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.746 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -61.76 170.48 1.99 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.804 -0.698 . . . . 0.0 110.354 173.412 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.27 -59.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.017 167.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -124.77 104.79 8.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.379 -169.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.873 HG22 HD12 ' B' ' 55' ' ' ILE . 57.7 t -112.29 104.28 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.24 168.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HB2' HG23 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.59 168.04 3.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.345 -179.101 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.97 -26.41 67.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.31 -170.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -62.63 1.72 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.528 173.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.781 ' CB ' HG22 ' B' ' 55' ' ' ILE . . . -62.04 -39.42 92.28 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.415 -168.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' HG3' HG12 ' A' ' 20' ' ' VAL . 21.8 mtm180 -61.59 -38.5 87.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.392 -178.489 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.417 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.8 mm -76.84 -25.32 15.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.363 174.012 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 1.027 HG22 HG22 ' B' ' 60' ' ' ILE . 70.7 m -74.51 -46.06 41.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.075 -169.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.686 HD13 HG12 ' B' ' 60' ' ' ILE . 5.7 tp -59.22 -47.98 83.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.346 165.096 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 33' ' ' GLU . . . -60.97 -18.67 58.61 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.595 -178.421 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 30' ' ' LYS . 8.8 tptt -98.82 -27.87 13.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.359 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.818 HG21 HG21 ' B' ' 64' ' ' VAL . 2.1 mt -60.53 -69.4 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.883 162.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.796 HD23 ' HB3' ' B' ' 32' ' ' LEU . 6.5 mp -59.88 -35.4 74.75 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.592 -167.533 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.866 ' CG ' HD13 ' A' ' 3' ' ' LEU . 11.0 mt-10 -62.55 -58.88 5.99 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.008 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.31 -20.87 63.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.961 -175.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -52.02 51.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.254 160.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.09 -45.72 95.5 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -168.429 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.3 ttp85 -61.12 -40.76 94.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.392 173.73 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 2.5 m-20 -62.78 -55.8 23.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.437 -177.204 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.954 HG21 HG23 ' A' ' 64' ' ' VAL . 2.9 mt -61.65 -28.98 45.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.169 -175.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.23 -62.66 1.54 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.184 -177.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.613 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -79.42 -15.59 57.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.578 -167.057 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -79.2 -48.32 14.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.09 168.6 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.67 -36.86 84.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.039 177.182 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.947 HD11 ' HB2' ' B' ' 17' ' ' ALA . 59.6 mt -61.17 -50.76 79.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.063 164.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 42' ' ' GLU . 1.4 tptt -60.7 -13.99 18.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.56 177.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 43' ' ' ALA . 2.6 mt -92.58 -35.43 13.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.144 -172.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -60.56 -46.22 91.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.394 168.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -48.15 81.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.432 -175.157 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.7 -34.83 77.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.399 -179.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.03 -54.48 44.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.18 169.109 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 134.7 23.4 0.64 Allowed Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.573 -174.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.58 97.05 0.05 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.472 167.051 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.8 mtmm -154.06 78.91 1.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.31 164.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 55' ' ' ILE . 12.3 m 69.27 167.95 0.29 Allowed 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.653 174.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.741 HD12 HG22 ' B' ' 20' ' ' VAL . 73.2 mt -122.28 148.97 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.327 168.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.24 -177.85 6.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.442 -169.312 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -64.81 -22.81 67.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.25 -169.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -61.8 -68.66 0.3 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.088 169.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -26.15 67.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.393 -169.202 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.942 HG23 HD13 ' B' ' 28' ' ' LEU . 15.2 mm -75.85 -60.35 2.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.365 -179.052 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.483 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 13.3 mt-10 -61.78 -17.94 57.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.342 177.328 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.15 -46.11 24.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.452 172.166 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.439 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -63.11 -36.36 83.35 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.05 175.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.988 HG21 HD13 ' B' ' 31' ' ' ILE . 41.2 t -61.13 -71.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.677 165.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -60.12 -10.34 4.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.734 -169.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' HA ' ' HD2' ' A' ' 66' ' ' ARG . 11.4 tpt180 -72.65 -48.89 35.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.398 170.336 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 31.0 m-85 -60.48 -52.25 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.435 168.705 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp 65.33 -74.05 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.351 -164.3 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.241 0.63 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.337 170.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -158.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.992 168.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.8 139.5 95.79 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.713 -173.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -61.5 145.95 97.46 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.42 2.08 . . . . 0.0 113.274 163.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.665 ' H ' HD13 ' B' ' 5' ' ' ILE . 0.2 OUTLIER -96.98 20.67 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.962 179.281 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.723 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -92.32 -59.49 0.22 Allowed Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.679 176.351 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.723 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -54.11 -45.7 39.07 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.491 2.127 . . . . 0.0 113.307 169.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 mt -60.94 -54.72 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.5 176.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.05 65.75 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -171.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.522 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 7.2 mtt-85 -79.37 -30.34 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.258 -0.471 . . . . 0.0 110.47 -179.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.08 -39.2 84.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.379 168.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.732 HD12 ' HB2' ' A' ' 40' ' ' ALA . 5.7 mm -72.56 -43.08 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.051 177.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -61.65 -37.67 84.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.324 177.053 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.48 -31.0 70.96 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.95 179.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.45 -52.68 64.59 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.56 171.047 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.86 23.49 0.62 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 114.179 -1.373 . . . . 0.0 110.763 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.947 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -68.62 145.26 54.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.674 -0.763 . . . . 0.0 110.343 174.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' B' ' 19' ' ' ARG . 9.7 pt-20 -147.05 -43.28 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.091 168.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' B' ' 18' ' ' GLU . 16.1 mtt180 -98.62 81.36 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.403 -174.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.741 HG22 HD12 ' A' ' 55' ' ' ILE . 21.4 t -138.49 152.56 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.383 -168.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 91.0 p -100.57 150.92 22.2 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.419 177.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.01 -16.89 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.341 168.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.89 -49.12 78.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.395 169.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.562 ' HB1' HG13 ' A' ' 60' ' ' ILE . . . -61.72 -46.25 90.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' B' ' 5' ' ' ILE . 0.3 OUTLIER -63.38 -30.04 71.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.394 -171.526 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.483 ' HA ' ' HB3' ' B' ' 29' ' ' ALA . 59.8 mt -94.4 -20.99 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.663 HG22 HD11 ' B' ' 31' ' ' ILE . 89.8 m -61.03 -56.79 16.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.231 167.449 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.942 HD13 HG23 ' A' ' 60' ' ' ILE . 3.2 tp -60.5 -40.35 91.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.502 177.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' B' ' 26' ' ' ILE . . . -61.31 -38.16 85.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.398 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.7 OUTLIER -87.33 -20.19 27.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.487 -176.473 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.988 HD13 HG21 ' A' ' 64' ' ' VAL . 57.3 mt -61.29 -71.33 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.021 169.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.808 HD12 HG22 ' B' ' 31' ' ' ILE . 9.1 mp -60.72 -43.09 98.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.521 -174.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -63.96 -36.68 84.77 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.026 -171.086 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 0.4 OUTLIER -61.36 -44.26 97.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.997 173.627 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.602 ' HB3' HD11 ' B' ' 39' ' ' ILE . 35.5 mtp -61.01 -36.88 80.66 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.53 175.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -41.98 99.72 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.326 -1.109 . . . . 0.0 110.326 -172.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -45.0 95.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.806 -0.697 . . . . 0.0 110.431 172.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' CE2' ' B' ' 67' ' ' PHE . 1.3 t70 -77.14 -45.93 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.442 -165.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' B' ' 35' ' ' MET . 6.4 mt -61.14 -30.57 48.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.247 173.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.651 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -61.37 -66.85 0.47 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.303 -178.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 2.2 t -61.41 -9.23 5.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.351 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' B' ' 67' ' ' PHE . 0.1 OUTLIER -92.09 -38.16 12.35 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.135 178.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.568 ' HB2' HG13 ' B' ' 60' ' ' ILE . . . -76.94 -15.86 59.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.468 172.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.4 mt -87.64 -49.29 14.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.803 -173.077 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -29.86 69.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.281 167.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.49 ' HB2' ' HA ' ' B' ' 43' ' ' ALA . 2.6 mt -61.7 -47.83 83.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.318 166.214 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -68.54 -18.47 64.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.287 -172.918 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 -41.55 67.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.232 168.207 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -60.33 -30.66 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.367 170.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.92 -51.42 69.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.417 175.023 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.15 41.81 1.25 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -174.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? 65.65 18.77 11.31 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.845 -0.678 . . . . 0.0 110.501 175.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.81 140.83 29.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.261 165.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 21' ' ' SER . 5.8 t -60.94 168.24 2.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.341 -167.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.873 HD12 HG22 ' A' ' 20' ' ' VAL . 61.2 mt -93.01 141.3 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.527 -169.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.573 ' N ' ' HB2' ' A' ' 24' ' ' ALA . 2.7 mtpt -138.84 -169.24 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.382 -171.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' A' ' 27' ' ' THR . . . -64.4 -48.07 76.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.253 -170.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.453 ' O ' HD13 ' B' ' 62' ' ' LEU . 6.4 mt-10 -61.85 -30.08 70.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.132 179.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.8 OUTLIER -61.38 -68.19 0.34 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.419 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 1.027 HG22 HG22 ' A' ' 27' ' ' THR . 0.0 OUTLIER -70.27 -33.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.449 -163.087 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -38.33 86.17 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.066 176.371 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 58' ' ' GLU . 0.5 OUTLIER -60.73 -46.47 90.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.314 168.78 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.45 -14.32 27.61 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.589 -176.407 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.818 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -113.59 -57.22 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 121.926 0.869 . . . . 0.0 108.778 -159.567 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.27 -10.84 3.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.365 166.145 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -85.13 -70.01 0.61 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.635 166.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.552 ' HB3' ' HG2' ' B' ' 42' ' ' GLU . 0.1 OUTLIER -62.01 -29.63 70.4 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.034 -154.523 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -145.63 109.96 4.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.428 170.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.563 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.415 169.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 1' ' ' MET . 5.4 mt-10 58.82 127.42 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.73 174.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.681 HD13 ' HG3' ' A' ' 33' ' ' GLU . 6.3 mp -57.43 100.09 0.21 Allowed Pre-proline 0 C--O 1.251 1.147 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.564 -172.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -60.22 150.0 82.16 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 C-N-CA 123.016 2.477 . . . . 0.0 113.479 -172.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -100.65 17.82 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.809 -164.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.785 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -89.87 -56.86 0.27 Allowed Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.703 175.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.785 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 3.3 Cg_exo -53.76 -58.83 1.17 Allowed 'Trans proline' 0 N--CA 1.486 1.032 0 C-N-CA 122.596 2.198 . . . . 0.0 113.371 164.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 3' ' ' LEU . 25.7 mt -61.74 -47.93 91.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.478 -178.049 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.83 -36.88 93.42 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -173.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -39.98 95.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.028 -0.586 . . . . 0.0 110.412 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.721 HD11 HD21 ' B' ' 3' ' ' LEU . 75.0 mt -61.81 -48.08 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.438 -178.115 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.644 HD12 ' HB2' ' B' ' 40' ' ' ALA . 12.8 mm -64.54 -36.78 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.426 -172.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -32.4 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.366 171.781 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.74 -34.99 78.33 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.827 -178.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HA ' ' NH2' ' B' ' 37' ' ' ARG . . . -59.42 -53.71 54.99 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.376 169.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 139.68 21.06 0.38 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.715 -178.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.804 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -60.23 135.3 57.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.153 -0.523 . . . . 0.0 110.385 166.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -157.65 31.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.024 174.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.32 81.24 0.34 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.268 168.061 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG22 HD12 ' B' ' 55' ' ' ILE . 14.2 t -131.16 142.33 43.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.387 -168.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -84.31 151.15 24.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.352 169.068 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -13.66 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.487 172.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.724 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -87.57 -30.55 20.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.324 -174.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.148 165.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -61.76 -34.39 75.78 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.424 -176.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 23' ' ' ASP . 0.7 OUTLIER -78.27 -37.44 22.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.317 -179.368 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.553 HG22 HD11 ' A' ' 31' ' ' ILE . 88.8 m -63.4 -44.05 95.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.294 -171.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.938 HD11 ' HB ' ' B' ' 39' ' ' ILE . 4.0 tp -59.6 -42.32 92.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.464 167.559 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 3' ' ' LEU . . . -61.78 -39.4 91.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.312 -176.377 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.2 -20.88 23.63 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.302 -175.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.77 HG21 HG21 ' B' ' 64' ' ' VAL . 32.3 mt -61.08 -71.26 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.92 162.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HB3' HD23 ' B' ' 32' ' ' LEU . 6.0 mp -59.74 -20.22 55.11 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.745 -167.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.681 ' HG3' HD13 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -67.13 -55.3 14.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.115 170.925 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -61.74 -41.73 98.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.984 -172.364 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.433 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.2 mmm -61.16 -43.53 98.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.447 168.322 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.42 -48.24 45.95 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -167.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -60.72 -19.14 58.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.159 -0.521 . . . . 0.0 110.277 167.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -75.95 -58.93 2.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.499 179.533 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.771 HG21 HG23 ' A' ' 64' ' ' VAL . 4.0 mt -60.89 -22.92 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.576 178.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.681 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -63.64 -77.81 0.05 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.266 175.353 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.79 ' OG ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -61.24 -10.98 7.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.477 -172.577 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -82.54 -52.93 6.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.186 172.772 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.516 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -60.91 -19.0 59.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.41 173.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.795 HD11 ' HB2' ' B' ' 17' ' ' ALA . 95.7 mt -86.29 -51.25 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.949 -177.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -60.16 -11.28 5.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.444 167.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 42' ' ' GLU . 2.3 mp -85.21 -38.44 18.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.315 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -60.92 -30.93 70.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.37 170.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 48' ' ' ARG . 29.5 mmt-85 -68.36 -53.31 24.87 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.409 -179.391 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -19.98 60.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.375 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.07 -53.74 53.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.245 168.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 136.02 24.05 0.53 Allowed Glycine 0 CA--C 1.527 0.841 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.482 -178.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 52' ' ' ARG . 21.5 ttp-105 66.4 122.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.235 -0.482 . . . . 0.0 110.446 166.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -179.43 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.4 167.363 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HB ' ' NZ ' ' A' ' 56' ' ' LYS . 30.0 m -162.05 141.81 9.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.447 -178.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.938 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.1 mm -71.77 148.53 9.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.393 170.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' NZ ' ' HB ' ' A' ' 54' ' ' THR . 10.2 mttp -153.12 -177.85 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.523 177.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.97 -34.01 75.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -173.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.697 ' O ' HD12 ' A' ' 62' ' ' LEU . 24.9 tt0 -73.11 -27.56 61.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.046 -178.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.83 -36.64 42.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.413 178.309 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.708 ' CG2' HD22 ' B' ' 28' ' ' LEU . 38.5 mm -60.83 -57.25 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.417 170.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -61.47 -30.68 70.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.02 -176.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -60.46 -51.57 68.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.412 169.209 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.97 -46.76 89.43 Favored 'General case' 0 N--CA 1.457 -0.103 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.482 -179.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.771 HG23 HG21 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -68.77 -51.47 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.892 -163.473 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -65.21 -21.71 66.79 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.708 176.345 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' HD2' HD11 ' A' ' 46' ' ' LEU . 6.4 ttt-85 -61.29 -39.99 92.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.268 174.116 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.538 ' CZ ' ' HG2' ' A' ' 42' ' ' GLU . 83.6 m-85 -60.6 -62.27 1.99 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.279 166.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? 64.95 -77.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.449 170.042 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.24 0.577 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.312 -167.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.427 ' O ' ' HB2' ' B' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.0 109.959 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' B' ' 1' ' ' MET . 4.2 mt-10 59.16 121.39 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.746 -175.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.721 HD21 HD11 ' A' ' 11' ' ' ILE . 3.5 mt -73.5 137.26 77.74 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.79 -168.225 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -58.96 153.5 50.93 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 C-N-CA 122.394 2.063 . . . . 0.0 113.49 169.264 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' B' ' 25' ' ' ARG . 1.6 pt -100.62 16.98 3.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.696 -176.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -86.41 -59.61 0.28 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.712 179.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 11.4 Cg_endo -58.25 -50.06 10.8 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.437 2.091 . . . . 0.0 113.375 168.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.84 -28.99 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.447 175.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.4 77.8 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.526 -179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -82.4 -17.19 46.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.395 -170.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.577 HD12 ' HG2' ' A' ' 33' ' ' GLU . 11.0 mm -60.73 -66.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.439 168.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.72 HG22 ' HB2' ' B' ' 17' ' ' ALA . 9.1 mm -61.5 -31.39 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.077 -174.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -66.1 -37.72 86.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.455 172.276 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -62.13 -32.25 72.81 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.884 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.79 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -58.73 -52.96 63.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.079 -1.419 . . . . 0.0 110.454 170.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.86 27.5 0.72 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.523 -170.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.795 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.73 119.99 9.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.775 -0.712 . . . . 0.0 110.373 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.52 -38.69 65.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.13 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.32 100.2 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.395 178.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.718 HG12 ' CG2' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -86.22 140.18 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.275 165.6 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 95.9 p -66.95 165.71 15.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.27 167.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.98 -18.68 58.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.284 168.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.62 -58.37 7.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.441 169.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' B' ' 20' ' ' VAL . . . -62.07 -42.57 99.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.334 -169.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.572 ' HB3' ' HB ' ' B' ' 5' ' ' ILE . 41.2 mtm180 -61.77 -50.04 73.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.386 -178.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.457 HD13 ' CG2' ' B' ' 5' ' ' ILE . 11.5 mm -61.49 -25.04 35.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.445 179.348 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.566 HG21 ' HB ' ' A' ' 60' ' ' ILE . 85.3 m -73.91 -42.46 60.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.37 -172.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.744 HD12 HD11 ' B' ' 32' ' ' LEU . 2.0 mm? -60.76 -35.48 76.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.345 169.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -63.67 -43.54 96.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.297 -173.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -80.55 -27.83 37.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.376 -179.558 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 64' ' ' VAL . 52.4 mt -61.36 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.976 167.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.744 HD11 HD12 ' B' ' 28' ' ' LEU . 3.8 mp -59.11 -23.39 62.06 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.733 -164.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -85.0 -28.51 25.69 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.05 -178.846 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 2.6 mm-40 -61.78 -31.76 71.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.862 163.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.23 -34.21 32.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.413 -176.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.11 -40.52 42.23 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -176.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.425 ' NH2' ' HA ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -60.75 -33.7 73.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.15 -0.525 . . . . 0.0 110.377 169.547 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -72.55 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.357 176.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.938 ' HB ' HD11 ' A' ' 28' ' ' LEU . 7.2 mt -60.89 -21.72 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.307 -170.238 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.644 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.72 -69.79 0.23 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.324 173.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.513 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 0.2 OUTLIER -61.44 -11.03 8.87 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.554 -177.275 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.91 -40.46 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.068 -179.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.473 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -69.93 -14.81 62.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.347 168.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 17' ' ' ALA . 55.2 mt -97.3 -52.14 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.956 -173.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -19.71 56.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.368 169.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' B' ' 63' ' ' ALA . 9.6 mt -68.62 -53.49 22.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.344 166.042 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.672 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -61.37 -25.91 67.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.247 -173.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -38.73 75.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.328 168.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -60.57 -32.61 71.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.375 172.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.672 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.72 -48.52 81.43 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.35 173.298 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.26 38.14 1.05 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -167.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 65.27 102.53 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.822 -0.689 . . . . 0.0 110.392 178.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -171.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.451 177.148 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 96.2 m -78.41 130.22 35.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.416 -169.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.809 HD12 HG22 ' A' ' 20' ' ' VAL . 28.8 mt -74.01 132.78 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.275 166.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 24' ' ' ALA . 0.7 OUTLIER -136.77 -170.13 2.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.391 -177.338 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -61.99 -22.02 65.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.251 178.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.4 -34.11 21.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.104 -178.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' B' ' 56' ' ' LYS . 0.4 OUTLIER -81.25 -35.17 31.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.36 -177.579 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.711 HG23 HD13 ' A' ' 28' ' ' LEU . 38.8 mm -61.18 -57.67 11.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.381 167.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' B' ' 57' ' ' ALA . 4.4 mt-10 -62.22 -37.59 85.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.951 -173.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.51 ' CD2' HD22 ' B' ' 46' ' ' LEU . 34.5 tp -60.77 -43.86 97.51 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.38 172.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' B' ' 46' ' ' LEU . . . -61.12 -35.25 76.53 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.441 178.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.77 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -90.46 -59.92 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.271 -162.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -23.46 64.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.6 179.578 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -23.36 31.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.409 172.09 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -60.83 -46.62 89.84 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.495 177.093 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 -77.17 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.388 -171.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.599 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.389 -169.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 mmt . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 121.108 0.48 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 5.6 pt-20 -130.75 -179.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.048 -169.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.058 HD21 HD11 ' B' ' 11' ' ' ILE . 6.8 mt -71.21 112.68 14.44 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.741 -168.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 10.9 Cg_endo -55.45 164.55 3.97 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.52 2.147 . . . . 0.0 113.395 164.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 25' ' ' ARG . 21.5 pt -95.88 38.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.314 -173.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -95.01 -58.47 0.2 Allowed Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.73 173.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.7 Cg_endo -59.91 -32.82 95.74 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.53 2.154 . . . . 0.0 113.653 173.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 ' HA ' HD12 ' A' ' 11' ' ' ILE . 72.8 mt -96.81 -13.73 8.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.62 -169.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.66 -43.72 98.89 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 -173.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -97.39 19.19 13.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.472 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.724 HG22 HD13 ' A' ' 12' ' ' ILE . 22.9 mt -90.28 -49.34 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.208 166.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.792 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 3.9 mm -96.31 48.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 114.207 -1.36 . . . . 0.0 109.651 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HA ' ' H ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -156.11 -26.45 0.1 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.748 169.72 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -53.68 -40.59 66.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.276 163.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.793 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.73 -72.87 0.08 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.727 172.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.7 36.39 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.149 152.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.099 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -73.29 123.15 23.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.352 . . . . 0.0 110.153 -165.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -135.58 31.83 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.088 -165.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.95 102.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.423 168.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t -125.15 162.46 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.369 179.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 47.1 t -101.84 13.48 34.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.375 -169.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.5 p30 60.47 23.56 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -140.67 -30.07 0.66 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.358 179.144 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.839 ' HB1' ' CG1' ' B' ' 60' ' ' ILE . . . -61.12 -40.6 94.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.437 177.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.632 ' HG3' HG21 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -62.39 -30.1 70.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.409 -178.907 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.617 ' CD1' HG23 ' A' ' 5' ' ' ILE . 9.1 mm -83.86 -30.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.413 179.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.585 HG22 HD12 ' A' ' 31' ' ' ILE . 74.6 m -60.79 -46.36 90.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.377 168.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.929 HD13 HG23 ' B' ' 60' ' ' ILE . 4.9 tp -61.0 -45.46 94.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.336 172.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 3' ' ' LEU . . . -61.75 -12.69 18.09 Favored 'General case' 0 N--CA 1.457 -0.078 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.548 -178.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -107.74 -37.51 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.24 -178.7 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.966 HD13 HG21 ' B' ' 64' ' ' VAL . 60.0 mt -60.88 -70.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.078 168.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.02 -34.85 72.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.586 -166.329 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 3' ' ' LEU . 2.5 tm-20 -68.05 -43.82 77.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.236 176.607 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.59 -17.02 63.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.029 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.438 ' CE ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 mtm -81.84 -43.4 18.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.466 169.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.608 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -69.27 -45.87 59.47 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -169.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.485 ' N ' HG22 ' B' ' 11' ' ' ILE . 0.0 OUTLIER -61.53 -16.62 49.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.396 -0.402 . . . . 0.0 110.316 169.25 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.1 -54.63 5.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.447 -179.543 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.703 ' HB ' HD11 ' B' ' 28' ' ' LEU . 15.2 mt -61.52 -28.62 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.343 -176.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.037 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -61.34 -65.67 0.66 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.22 -173.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.755 ' HB2' ' HB1' ' B' ' 15' ' ' ALA . 25.9 t -61.2 -10.49 6.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.524 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HD12 ' A' ' 46' ' ' LEU . 12.1 mm-40 -85.01 -57.57 3.04 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.05 173.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.92 -8.61 5.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.532 174.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.893 HD11 ' HB2' ' B' ' 17' ' ' ALA . 51.4 mt -95.93 -54.31 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.222 178.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -13.82 62.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.359 -178.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 42' ' ' GLU . 7.6 mt -88.39 -21.41 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.403 173.307 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.564 ' CB ' HD13 ' A' ' 55' ' ' ILE . . . -80.49 -29.97 37.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.251 -165.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' NH1' ' H ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -94.47 -15.72 23.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.384 -168.574 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -9.92 59.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.42 164.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -60.73 -54.12 49.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.297 174.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 130.21 33.85 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.535 -169.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 ttp-105 67.17 121.25 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.638 -0.781 . . . . 0.0 110.587 169.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' H ' ' NH1' ' A' ' 48' ' ' ARG . 0.0 OUTLIER 179.86 -79.19 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.362 171.631 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.586 HG21 ' OG ' ' B' ' 21' ' ' SER . 72.5 m -167.51 159.97 12.69 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.134 -164.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.564 HD13 ' CB ' ' A' ' 47' ' ' ALA . 7.2 mm -90.09 137.62 21.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.3 165.165 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 7.7 mttm -153.37 -174.9 5.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.487 -166.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -66.33 -21.42 66.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.148 -169.445 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -94.18 25.13 3.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.147 175.018 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.624 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . 14.5 m-20 -119.21 -39.57 2.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.153 174.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.714 HG22 HG22 ' B' ' 27' ' ' THR . 3.1 mp -91.15 14.78 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.631 163.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 58' ' ' GLU . 2.0 mm-40 -121.65 36.91 4.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.887 164.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 62' ' ' LEU . 10.6 tp -169.42 -25.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.378 -174.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' HB2' ' CA ' ' A' ' 43' ' ' ALA . . . -84.86 -17.53 37.67 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.405 173.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.69 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -107.61 -67.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.265 -157.676 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' N ' ' CG1' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -60.76 -23.89 65.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.39 177.187 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 69' ' ' LYS . 5.5 mmt180 -78.35 -60.68 2.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.102 164.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 38' ' ' ASP . 0.2 OUTLIER 60.37 67.66 0.83 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.151 -157.653 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.21 112.21 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.449 -176.054 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.606 0 CA-C-N 115.173 -0.922 . . . . 0.0 110.412 169.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.106 0.479 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.524 ' HB2' ' HG3' ' B' ' 33' ' ' GLU . 1.5 mt-10 -66.21 -35.8 81.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 -170.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -97.42 101.79 11.05 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.66 175.747 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' B' ' 2' ' ' GLU . 5.7 Cg_endo -52.86 151.43 20.11 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.665 2.244 . . . . 0.0 113.527 172.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.519 HG21 ' CG1' ' B' ' 26' ' ' ILE . 1.1 pt -85.63 64.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.51 175.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.75 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -151.65 -57.97 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.619 177.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.8 Cg_endo -60.08 -38.23 78.88 Favored 'Trans proline' 0 N--CA 1.485 1.028 0 C-N-CA 122.571 2.181 . . . . 0.0 113.589 170.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.642 HD11 ' CB ' ' B' ' 3' ' ' LEU . 44.5 mt -73.4 -18.26 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.515 172.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.414 ' HA2' ' HD2' ' B' ' 25' ' ' ARG . . . -61.04 -52.91 49.24 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -166.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 5.1 mtt-85 -75.25 -20.66 59.08 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.098 -0.551 . . . . 0.0 110.411 -176.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 1.058 HD11 HD21 ' A' ' 3' ' ' LEU . 16.1 mt -63.58 -47.39 91.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.278 167.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 1.037 HD12 ' HB2' ' A' ' 40' ' ' ALA . 6.3 mm -95.77 45.41 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.835 175.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 0.2 OUTLIER -149.47 -31.7 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.873 170.872 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.78 -31.28 70.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 113.588 -1.642 . . . . 0.0 109.92 172.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.755 ' HB1' ' HB2' ' A' ' 41' ' ' SER . . . -58.74 -51.6 69.28 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.85 -1.523 . . . . 0.0 110.545 170.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.57 23.23 1.23 Allowed Glycine 0 CA--C 1.527 0.786 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.702 -171.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.893 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -65.81 131.58 46.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.349 173.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.6 -77.2 0.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.111 -177.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 16.6 mtt-85 -146.83 144.12 29.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.318 -169.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.593 HG12 ' H ' ' B' ' 21' ' ' SER . 11.0 t -113.06 168.73 5.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.356 -168.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.593 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.1 OUTLIER -127.83 -162.33 1.16 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.244 -164.828 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.67 89.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.451 167.663 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.41 125.2 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.541 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 56' ' ' LYS . . . -176.66 -48.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.977 163.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.467 ' CZ ' HG21 ' B' ' 20' ' ' VAL . 15.1 ttp180 -77.22 -30.55 54.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.329 167.246 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.519 ' CG1' HG21 ' B' ' 5' ' ' ILE . 59.0 mt -72.72 -36.32 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.416 169.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 60' ' ' ILE . 92.5 m -60.81 -43.27 98.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.325 169.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.703 HD11 ' HB ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -60.85 -45.81 93.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.149 174.414 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.16 -17.82 54.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.511 176.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.22 -32.6 11.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.412 -171.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.69 HG21 HG21 ' A' ' 64' ' ' VAL . 2.1 mp -62.11 -72.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.587 159.273 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -58.82 -14.12 7.99 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.931 -162.663 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' B' ' 2' ' ' GLU . 1.9 tm-20 -91.41 -26.36 18.9 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.17 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.28 -19.49 28.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.141 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 8.1 mtt -93.69 12.37 25.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.412 171.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.69 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -121.36 -41.2 0.51 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 177.088 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 15' ' ' ALA . 1.4 tmt_? -61.17 -20.67 62.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.262 166.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.37 -35.3 12.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.436 -167.704 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.795 HG23 ' O ' ' B' ' 63' ' ' ALA . 7.6 mt -62.04 -33.97 61.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.288 171.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.752 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.19 -63.02 1.43 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.306 -169.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.793 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 15.3 m -61.9 -13.76 27.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.592 ' HB3' ' HB1' ' B' ' 63' ' ' ALA . 3.0 mm-40 -81.6 -45.33 15.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.104 176.08 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.461 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -73.25 -33.71 65.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 110.209 177.044 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 1.099 HD11 ' HB2' ' A' ' 17' ' ' ALA . 15.2 mt -60.5 -56.35 18.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.351 167.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -28.65 69.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.353 -176.715 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' B' ' 63' ' ' ALA . 4.3 mt -76.24 -36.91 58.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.494 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' B' ' 55' ' ' ILE . . . -61.86 -45.24 94.63 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.262 -177.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -89.72 -25.72 21.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.373 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -64.04 -44.9 91.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.266 168.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.0 98.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.268 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.32 43.55 15.74 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -175.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -135.3 -166.81 1.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.398 -168.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.62 -169.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.423 -167.385 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.421 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 0.8 OUTLIER -68.26 172.29 6.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.926 -167.903 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' B' ' 47' ' ' ALA . 31.9 mm -60.62 135.94 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.465 175.312 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -159.24 -176.59 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.423 -169.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' B' ' 61' ' ' GLU . . . -62.48 -24.09 67.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 -170.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.701 ' C ' HD23 ' B' ' 62' ' ' LEU . 1.1 pp20? -103.52 23.1 13.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.104 179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -129.56 -34.63 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.424 168.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.929 HG23 HD13 ' A' ' 28' ' ' LEU . 36.7 mm -61.02 -65.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.328 165.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.732 ' HG2' HD11 ' A' ' 31' ' ' ILE . 37.2 mt-10 -61.4 -10.92 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.245 -177.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.701 HD23 ' C ' ' B' ' 58' ' ' GLU . 4.1 mm? -99.51 -18.66 17.29 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.515 176.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.795 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -92.06 14.53 15.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.561 164.917 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.966 HG21 HD13 ' A' ' 31' ' ' ILE . 40.1 t -115.7 -68.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.585 -176.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 18.8 ttt-85 -60.18 -10.06 4.05 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.588 173.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -37.61 86.65 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.663 168.348 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.518 ' CZ ' HG12 ' B' ' 39' ' ' ILE . 3.1 m-85 -61.13 -35.01 75.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.205 168.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt 65.0 -75.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 -165.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.24 0.6 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.377 -174.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttt . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 121.113 0.482 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.415 ' HB3' ' CD ' ' A' ' 33' ' ' GLU . 4.3 mt-10 -119.32 82.95 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.915 -173.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.678 HD13 ' HB3' ' A' ' 33' ' ' GLU . 10.4 mp 58.59 69.81 1.34 Allowed Pre-proline 0 C--O 1.248 0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 111.682 179.709 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' C ' ' HD2' ' A' ' 7' ' ' PRO . 10.8 Cg_exo -45.2 148.78 1.67 Allowed 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.868 2.378 . . . . 0.0 113.466 177.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.482 ' CG2' HG12 ' A' ' 26' ' ' ILE . 2.0 pt -70.96 58.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.373 -178.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -160.28 -52.89 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.52 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 8.0 Cg_endo -55.71 -32.62 84.74 Favored 'Trans proline' 0 N--CA 1.485 1.01 0 C-N-CA 122.781 2.321 . . . . 0.0 113.506 167.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.69 HD11 ' HA ' ' A' ' 29' ' ' ALA . 9.4 mm -60.63 -39.66 82.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.485 168.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.4 98.5 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -166.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.14 18.63 13.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.266 -0.467 . . . . 0.0 110.41 -176.605 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.534 HG23 ' HG3' ' B' ' 37' ' ' ARG . 95.5 mt -103.32 -39.38 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.182 164.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.711 HG23 ' HB1' ' B' ' 40' ' ' ALA . 7.3 mm -81.08 -37.93 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.192 -179.094 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -41.41 95.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.428 169.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -61.89 -30.79 71.11 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.815 -175.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.656 ' HB1' ' OG ' ' B' ' 41' ' ' SER . . . -57.63 -53.29 59.82 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.55 168.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.09 32.33 0.35 Allowed Glycine 0 CA--C 1.528 0.856 0 CA-C-N 113.888 -1.506 . . . . 0.0 110.562 -171.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.054 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -80.47 -167.63 1.42 Allowed 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.671 -0.764 . . . . 0.0 110.3 177.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.05 93.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.997 165.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.3 104.93 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.394 179.572 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.32 162.8 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.069 164.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 16.6 t -94.41 -84.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.411 -166.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.503 ' HA ' ' HD3' ' A' ' 25' ' ' ARG . 9.1 t70 -174.89 136.88 0.41 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.028 -171.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.914 ' HB3' ' HB2' ' B' ' 57' ' ' ALA . 0.4 OUTLIER 77.97 -51.69 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.014 -161.605 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.13 -39.37 89.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.304 -173.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -62.94 -40.52 97.9 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.412 -177.842 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 5' ' ' ILE . 1.6 mp -94.64 -23.77 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.404 -170.087 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.625 HG22 HD11 ' A' ' 31' ' ' ILE . 92.0 m -60.79 -39.79 90.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.491 173.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.666 HD23 ' CD1' ' A' ' 12' ' ' ILE . 13.1 tp -88.35 -14.31 38.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.493 -171.577 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 8' ' ' ILE . . . -79.03 -45.33 20.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.198 164.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -61.0 -36.97 80.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.484 175.554 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.726 HG21 HG21 ' B' ' 64' ' ' VAL . 23.0 mt -62.21 -78.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.897 170.672 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD21 HD12 ' B' ' 39' ' ' ILE . 2.0 mm? -57.09 -26.62 60.74 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.543 -158.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.678 ' HB3' HD13 ' A' ' 3' ' ' LEU . 11.5 pt-20 -64.24 -36.12 83.04 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.025 176.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG3' ' HG3' ' A' ' 35' ' ' MET . 0.3 OUTLIER -62.33 -39.58 93.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.818 -164.492 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.467 ' HG3' ' HG3' ' A' ' 34' ' ' GLU . 21.6 mtt -81.69 -25.94 35.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.466 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' B' ' 32' ' ' LEU . . . -72.89 -39.83 53.7 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.515 -176.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -60.98 -17.06 49.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.395 168.902 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -99.83 -46.09 5.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.555 -164.664 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.677 HD13 ' CG2' ' A' ' 64' ' ' VAL . 7.2 mt -61.62 -26.28 39.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.183 172.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.745 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.33 -70.38 0.2 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.115 177.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.5 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -61.18 -18.17 56.82 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.525 179.472 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.763 ' C ' HD12 ' A' ' 46' ' ' LEU . 6.5 mm-40 -72.3 -61.65 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.034 169.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 59' ' ' ASP . . . -61.13 -9.49 4.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.539 179.1 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' B' ' 17' ' ' ALA . 90.1 mt -100.77 -67.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.048 -178.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.39 -17.4 53.95 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.349 -176.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.763 HD12 ' C ' ' A' ' 42' ' ' GLU . 14.5 mt -60.93 -48.18 82.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.206 163.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.697 ' HB1' ' HB3' ' A' ' 53' ' ' LYS . . . -87.49 -27.71 22.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.224 -168.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -21.65 59.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.33 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -60.98 -14.61 24.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.323 166.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -82.93 -43.95 15.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.305 175.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.1 15.54 23.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 172.175 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 178.93 84.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 169.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.697 ' HB3' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -108.91 151.94 25.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.462 -161.358 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.493 HG22 ' HB3' ' B' ' 21' ' ' SER . 98.3 m -140.55 114.42 8.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.158 163.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.776 ' HB ' HG13 ' B' ' 20' ' ' VAL . 13.6 mm -60.52 153.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.349 -166.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.7 ' C ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -140.88 173.33 11.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.416 -171.968 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.644 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -61.16 -11.94 10.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.3 168.226 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -113.64 30.72 7.02 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.06 179.759 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' HG23 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -120.83 -39.37 2.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.248 169.153 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.83 HG13 HD22 ' B' ' 28' ' ' LEU . 1.3 mp -62.12 -54.22 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.12 -0.946 . . . . 0.0 109.442 160.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 7.9 mm-40 -61.6 -9.23 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.19 -174.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 61' ' ' GLU . 72.0 mt -138.32 35.87 2.29 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.454 175.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 42' ' ' GLU . . . -130.62 10.41 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.907 163.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.677 ' CG2' HD13 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -134.09 -63.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.533 0.683 . . . . 0.0 109.237 -156.222 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.449 ' H ' HG12 ' A' ' 64' ' ' VAL . 10.3 ttp180 -78.41 -27.26 46.64 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.232 162.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 6.7 mmt180 -75.49 -11.25 59.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.768 167.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.546 ' CE2' ' HG3' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -60.98 -48.68 80.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.179 -176.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 65.78 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.528 165.426 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mttt . . . . . 0 C--O 1.24 0.584 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.326 -168.131 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.1 tpt . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.205 0.526 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.409 ' O ' ' HD3' ' B' ' 4' ' ' PRO . 1.0 OUTLIER -94.91 -164.71 1.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.972 -170.927 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.61 HD21 ' HG3' ' B' ' 33' ' ' GLU . 17.2 mt -61.67 107.68 1.23 Allowed Pre-proline 0 C--O 1.243 0.748 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.889 -178.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' B' ' 3' ' ' LEU . 8.0 Cg_endo -49.11 143.62 18.13 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 C-N-CA 122.466 2.11 . . . . 0.0 113.367 166.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.472 ' CG2' ' HG3' ' B' ' 25' ' ' ARG . 1.3 pp -95.19 26.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.383 -168.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.746 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -82.67 -58.14 0.44 Allowed Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.694 169.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.0 Cg_endo -58.89 -46.95 20.06 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.543 2.162 . . . . 0.0 113.568 171.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 29.7 mt -68.33 -18.83 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.411 -179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.434 ' HA2' ' NH1' ' B' ' 25' ' ' ARG . . . -60.95 -47.38 91.57 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -170.534 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.514 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 6.9 ttt180 -85.59 -17.51 36.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.371 -170.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 3' ' ' LEU . 26.7 mt -60.97 -59.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.405 171.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.745 HD12 ' HB2' ' A' ' 40' ' ' ALA . 14.8 mm -63.89 -36.38 76.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.458 -179.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 6.8 mmtp -64.59 -33.31 75.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.298 176.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.475 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 25.0 t0 -61.72 -31.5 71.67 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.242 -1.345 . . . . 0.0 109.834 177.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.67 -51.17 71.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 113.907 -1.497 . . . . 0.0 110.558 170.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.97 34.42 0.68 Allowed Glycine 0 CA--C 1.525 0.713 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.545 -168.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.697 ' HB2' HG22 ' B' ' 12' ' ' ILE . . . -70.97 157.93 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.928 -0.636 . . . . 0.0 110.244 -179.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -153.02 99.61 2.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.136 179.439 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 63.14 132.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -176.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.776 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t -119.46 160.91 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.369 170.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 54' ' ' THR . 21.6 p -84.43 -10.11 57.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.436 178.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.404 ' H ' HG12 ' B' ' 20' ' ' VAL . 0.2 OUTLIER 71.02 164.95 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.983 -161.342 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 74.32 -50.94 0.68 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.545 -162.375 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.768 ' HB1' HG22 ' A' ' 55' ' ' ILE . . . -60.42 -44.29 95.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.418 174.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.676 ' HE ' HG21 ' B' ' 20' ' ' VAL . 13.9 tpp85 -68.89 -16.82 63.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.524 -173.3 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 mt -114.68 -30.69 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.415 -168.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.648 ' O ' HD12 ' B' ' 31' ' ' ILE . 89.1 m -61.12 -40.68 94.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.269 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.83 HD22 HG13 ' A' ' 60' ' ' ILE . 2.0 tp -59.97 -43.78 94.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.322 172.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.05 -12.91 13.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.662 176.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 1.9 mmtp -105.57 -30.36 9.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.393 -175.552 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.796 HD13 ' CG2' ' A' ' 60' ' ' ILE . 3.3 mp -61.85 -74.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.655 161.093 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.826 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.71 -40.93 85.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.649 -163.572 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.61 ' HG3' HD21 ' B' ' 3' ' ' LEU . 4.7 tt0 -66.86 -20.43 65.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.044 -174.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 4.7 tt0 -77.06 -53.53 7.68 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.077 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 6.6 ttt -70.03 -29.87 67.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.352 179.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.11 -30.54 78.07 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 169.182 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.534 ' HG3' HG23 ' A' ' 11' ' ' ILE . 3.0 mtp85 -81.79 -19.44 41.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.04 -0.58 . . . . 0.0 110.467 175.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -37.5 12.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.403 -169.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.916 HD12 HD21 ' A' ' 32' ' ' LEU . 12.0 mt -61.08 -27.9 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.296 168.173 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.711 ' HB1' HG23 ' A' ' 12' ' ' ILE . . . -68.29 -60.35 2.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.305 -177.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.656 ' OG ' ' HB1' ' A' ' 15' ' ' ALA . 48.9 m -61.68 -13.7 25.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.33 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.588 ' O ' ' HG ' ' B' ' 46' ' ' LEU . 4.9 mm-40 -75.6 -53.29 8.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.091 171.439 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -70.9 -31.95 68.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.141 -178.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 1.054 HD11 ' HB2' ' A' ' 17' ' ' ALA . 49.1 mt -60.81 -49.55 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.212 165.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -33.44 72.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.547 176.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.845 HD12 ' HA ' ' B' ' 43' ' ' ALA . 28.8 mt -65.32 -48.82 71.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.418 -179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.75 65.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.34 -174.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -19.07 36.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.341 176.562 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -61.24 -37.41 82.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.244 166.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.1 -46.26 35.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.056 165.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.63 -7.03 24.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.81 168.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 179.11 98.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.354 -177.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.5 160.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.378 166.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.461 ' CG2' ' HB2' ' A' ' 21' ' ' SER . 95.1 m -69.31 159.27 33.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.457 168.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.631 ' CG2' ' HB1' ' B' ' 43' ' ' ALA . 55.5 mt -87.0 133.9 28.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 -170.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -118.39 -178.34 3.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.391 -178.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.914 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . . . -74.8 -32.07 61.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.269 -169.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -61.67 -13.44 22.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.097 168.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.2 OUTLIER -94.2 -43.54 8.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.356 -179.368 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.546 HG13 ' HA ' ' A' ' 24' ' ' ALA . 42.0 mm -61.1 -33.51 56.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.457 177.681 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.78 -22.17 34.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.849 -171.426 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.652 ' O ' HD11 ' B' ' 46' ' ' LEU . 24.7 tp -106.4 18.19 22.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.579 167.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.551 ' HB2' HD12 ' B' ' 46' ' ' LEU . . . -106.92 -14.8 14.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.273 166.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -121.2 -65.29 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.282 -165.569 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.431 ' H ' HG12 ' B' ' 64' ' ' VAL . 0.0 OUTLIER -60.43 -11.84 7.89 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.501 172.21 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -82.34 -24.42 34.58 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.409 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -61.4 -72.58 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.305 168.232 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 -172.07 0.13 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.285 170.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.576 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.321 168.785 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.181 0.515 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' OE2' HG23 ' A' ' 26' ' ' ILE . 9.2 pt-20 -170.75 -164.77 0.39 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.059 -171.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 33' ' ' GLU . 1.1 mt -96.61 104.81 19.36 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.706 177.366 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 2' ' ' GLU . 2.2 Cg_endo -51.83 154.47 9.72 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.673 2.249 . . . . 0.0 113.619 177.392 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.668 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -92.93 19.28 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.683 -170.45 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.765 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -80.74 -58.15 0.55 Allowed Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.625 170.286 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 10.7 Cg_endo -59.19 -61.88 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.585 2.19 . . . . 0.0 113.55 170.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 3' ' ' LEU . 62.7 mt -61.19 -14.31 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.452 177.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.68 -41.63 99.8 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.97 25.44 11.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.386 -173.862 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.82 -40.06 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.508 169.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' B' ' 40' ' ' ALA . 17.4 mm -83.97 -39.94 15.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.423 -174.488 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -26.75 67.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.3 173.187 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.05 -34.1 75.61 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.814 177.756 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.09 -53.16 61.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.314 168.27 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.97 21.6 0.78 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.772 -172.125 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.837 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -65.26 127.02 30.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.915 -0.642 . . . . 0.0 110.415 170.448 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -102.25 -17.45 15.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.013 -171.791 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.38 163.16 5.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.33 168.855 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG21 ' CD ' ' A' ' 25' ' ' ARG . 1.0 OUTLIER -118.0 163.72 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.305 168.594 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.532 ' HB3' ' HG3' ' B' ' 56' ' ' LYS . 24.7 p -75.5 -61.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.44 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.94 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.34 171.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -103.46 -18.45 14.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.408 -165.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HA ' HG13 ' B' ' 60' ' ' ILE . . . -61.36 -40.44 94.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.304 -167.015 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.791 ' CD ' HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -65.42 -60.08 3.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.446 176.198 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.492 HG23 ' OE2' ' A' ' 2' ' ' GLU . 3.0 mt -65.23 -27.77 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.449 -171.603 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.493 HG22 ' CD1' ' A' ' 31' ' ' ILE . 79.8 m -61.02 -61.67 2.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.395 166.869 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD13 HG23 ' B' ' 60' ' ' ILE . 10.5 tp -61.51 -10.3 7.58 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.482 -171.441 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.66 -63.53 1.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.435 171.271 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' NZ ' ' HB3' ' A' ' 30' ' ' LYS . 5.6 mtpm? -61.46 -21.27 64.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.335 -179.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.993 HD13 HG21 ' B' ' 64' ' ' VAL . 32.5 mt -61.89 -76.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.893 162.562 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -59.39 -30.71 68.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.697 -162.958 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -77.73 -18.61 56.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.018 -178.635 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -90.03 -17.82 27.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.037 169.312 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.51 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 9.8 mtp -99.58 18.83 17.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.433 170.768 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.674 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -119.4 -41.74 0.57 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 170.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -13.24 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.199 163.888 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.51 ' HB2' ' HA ' ' A' ' 35' ' ' MET . 0.2 OUTLIER -84.06 -55.01 4.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.385 -178.342 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.827 HG23 ' O ' ' A' ' 63' ' ' ALA . 7.3 mt -61.24 -19.74 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.463 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -72.57 -63.89 1.07 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.255 -169.176 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 35.1 t -60.64 -13.4 14.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.439 177.059 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.699 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -72.71 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.095 166.785 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.662 ' HB2' HG13 ' A' ' 60' ' ' ILE . . . -61.41 -15.52 37.69 Favored 'General case' 0 N--CA 1.458 -0.064 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.502 -178.681 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.882 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.1 mt -92.78 -51.9 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.894 -175.35 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.35 -11.81 7.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.477 166.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.699 HD13 ' O ' ' A' ' 42' ' ' GLU . 3.3 mp -82.85 -42.83 17.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.244 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 52' ' ' ARG . . . -61.33 -23.68 65.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.403 -176.684 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -27.52 38.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.438 -177.474 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -61.13 -27.75 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.347 169.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.94 -47.15 16.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.288 178.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.0 13.17 25.89 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 -169.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 mtp85 -143.0 116.98 9.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.031 -0.585 . . . . 0.0 110.404 -179.5 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -62.72 -24.68 67.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.351 -167.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.625 HG22 ' HB3' ' B' ' 21' ' ' SER . 1.0 OUTLIER -60.96 116.12 4.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.42 -168.538 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.53 149.03 7.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.414 177.56 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HG3' ' OD2' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -139.09 164.21 30.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.416 -169.867 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.543 ' HB2' ' HB3' ' B' ' 23' ' ' ASP . . . -66.73 -18.26 65.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.316 168.74 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 62' ' ' LEU . 74.3 mm-40 -96.83 29.26 3.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.083 169.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.402 ' OD2' ' HG3' ' A' ' 56' ' ' LYS . 76.5 m-20 -117.52 -34.88 4.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.423 168.638 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.711 HG12 HD21 ' B' ' 28' ' ' LEU . 4.1 mp -102.65 -12.32 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.383 -175.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.675 ' C ' HD23 ' A' ' 62' ' ' LEU . 12.5 mt-10 -70.97 -10.8 60.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.056 161.712 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.678 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -145.07 25.04 1.43 Allowed 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.468 -179.55 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.827 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -111.21 15.25 21.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.31 163.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.985 HG21 HG21 ' B' ' 31' ' ' ILE . 0.3 OUTLIER -144.41 -65.22 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -155.359 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' H ' HG12 ' A' ' 64' ' ' VAL . 1.1 mtp180 -62.13 -29.19 70.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.316 164.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -84.75 -21.0 30.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.434 172.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.438 ' CD1' ' HG2' ' A' ' 42' ' ' GLU . 4.4 t80 -60.96 -16.03 38.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.429 176.774 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -69.05 -69.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.348 167.542 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? . . . . . 0 C--O 1.241 0.647 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.407 -178.864 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.185 0.517 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -91.84 116.71 29.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.086 -171.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.792 HD21 ' CG ' ' B' ' 33' ' ' GLU . 4.4 mt -63.57 140.14 97.72 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.805 171.199 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' B' ' 7' ' ' PRO . 10.9 Cg_endo -58.99 147.7 88.78 Favored 'Trans proline' 0 N--CA 1.484 0.942 0 C-N-CA 122.493 2.128 . . . . 0.0 113.617 172.845 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 pt -82.39 76.36 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.525 177.611 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.728 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -153.53 -54.76 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.599 171.414 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.3 Cg_endo -62.23 -11.34 21.83 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.658 2.238 . . . . 0.0 113.65 171.179 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' B' ' 3' ' ' LEU . 40.0 mt -114.92 -37.61 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.482 -179.101 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.83 -48.33 86.78 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -165.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 1.1 ptt180 -93.83 19.21 9.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.511 -179.285 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 mm -83.62 -60.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.126 164.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.71 HD11 ' HG ' ' B' ' 28' ' ' LEU . 9.7 mm -66.43 -36.05 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.218 -176.384 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 12.1 mttm -64.93 -39.07 92.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.425 178.217 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -62.11 -31.46 71.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.793 -177.738 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -58.68 -52.76 64.31 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 113.929 -1.487 . . . . 0.0 110.603 170.621 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.24 19.54 0.53 Allowed Glycine 0 CA--C 1.527 0.84 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.609 -179.098 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.882 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -60.67 125.9 25.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.332 165.494 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.78 -64.41 1.26 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.071 -170.036 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -110.02 111.32 22.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.411 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.665 HG21 ' HG3' ' B' ' 25' ' ' ARG . 11.3 t -90.24 152.05 3.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.294 172.126 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.625 ' HB3' HG22 ' A' ' 54' ' ' THR . 24.7 p -98.47 16.6 21.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.345 -176.616 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 61.55 163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.09 -162.332 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 0.1 OUTLIER 75.33 -58.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.898 -166.699 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' B' ' 20' ' ' VAL . . . -60.22 -38.2 82.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.345 -165.004 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.665 ' HG3' HG21 ' B' ' 20' ' ' VAL . 7.7 mtp180 -64.21 -13.51 49.34 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.555 -179.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.567 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 2.9 mp -122.56 -5.22 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.887 -177.852 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.621 HG22 HD13 ' B' ' 31' ' ' ILE . 98.9 m -60.64 -43.16 97.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.451 173.404 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.711 HD21 HG12 ' A' ' 60' ' ' ILE . 2.9 mm? -61.21 -23.43 65.6 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.443 177.284 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -74.88 -11.12 60.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.436 -178.502 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.48 -32.6 6.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.482 -177.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.985 HG21 HG21 ' A' ' 64' ' ' VAL . 2.6 mp -61.72 -75.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.821 163.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.946 HD23 HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -58.1 -21.03 44.42 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.797 -160.494 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.792 ' CG ' HD21 ' B' ' 3' ' ' LEU . 4.3 tm-20 -89.2 -18.15 27.67 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.185 -178.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -39.8 28.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.093 168.359 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.473 ' O ' HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -93.34 19.56 8.1 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.422 178.838 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.68 -33.85 1.5 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 165.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.7 -20.78 59.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.191 165.25 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' B' ' 35' ' ' MET . 27.3 t0 -61.13 -60.88 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.346 171.337 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 64' ' ' VAL . 22.0 mt -61.04 -33.95 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.46 -169.022 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -61.62 -53.48 55.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.315 -172.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -17.29 64.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.785 -173.487 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.453 ' C ' HD12 ' B' ' 46' ' ' LEU . 2.6 mp0 -89.21 -42.4 11.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.085 173.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.601 ' N ' ' HB2' ' B' ' 63' ' ' ALA . . . -60.86 -12.43 10.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.479 172.106 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.837 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -86.2 -61.95 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.611 -169.979 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.402 ' N ' ' CG2' ' B' ' 44' ' ' ILE . 0.6 OUTLIER -67.64 -16.85 64.37 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.488 175.739 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.816 HD22 HD23 ' B' ' 62' ' ' LEU . 4.0 mt -61.09 -32.03 71.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.287 166.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.764 ' HB2' ' CD1' ' B' ' 55' ' ' ILE . . . -73.42 -40.5 64.22 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.341 177.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -90.07 -33.73 16.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.374 -167.526 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -61.1 -37.57 83.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.377 171.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.02 -40.7 94.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.339 168.657 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.87 27.19 17.33 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -179.007 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.09 179.11 4.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.415 -169.306 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 161.29 14.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.447 171.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 21' ' ' SER . 88.6 m 69.92 134.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.4 168.154 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.764 ' CD1' ' HB2' ' B' ' 47' ' ' ALA . 13.3 mm -90.82 135.52 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.384 168.209 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.532 ' HG3' ' HB3' ' A' ' 21' ' ' SER . 0.0 OUTLIER -135.73 177.13 8.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.464 179.262 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.47 -12.93 16.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.347 -167.723 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -91.16 -16.61 27.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.129 -178.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' B' ' 55' ' ' ILE . 0.8 OUTLIER -86.88 -18.53 30.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.413 168.455 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.772 HG23 HD13 ' A' ' 28' ' ' LEU . 46.7 mm -92.43 -42.11 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.221 -170.956 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.505 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 31.6 mt-10 -91.05 22.03 3.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.635 172.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.816 HD23 HD22 ' B' ' 46' ' ' LEU . 19.8 tp -126.53 -15.67 5.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.679 169.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.601 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -89.55 -35.72 15.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.827 163.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.993 HG21 HD13 ' A' ' 31' ' ' ILE . 53.9 t -62.32 -79.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.618 162.847 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -59.48 -12.68 6.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.718 -159.322 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -81.87 -17.99 45.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.5 -177.215 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.498 ' HE2' HG12 ' B' ' 39' ' ' ILE . 13.2 m-85 -70.7 -65.09 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.305 168.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.28 105.8 2.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.379 -176.142 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.573 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.38 -169.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 mtp . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.437 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 19.1 mt-10 -108.38 163.14 13.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.029 -169.238 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.87 ' HB3' HD11 ' A' ' 8' ' ' ILE . 1.1 mt -93.33 100.07 3.93 Favored Pre-proline 0 CA--C 1.544 0.727 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.595 -172.492 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 3' ' ' LEU . 5.0 Cg_endo -47.95 148.13 6.91 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.588 2.192 . . . . 0.0 113.589 172.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -63.89 -26.67 41.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.352 -175.32 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.762 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -68.26 -62.37 3.19 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.684 -170.21 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 2.5 Cg_endo -50.82 -22.67 10.27 Favored 'Trans proline' 0 N--CA 1.484 0.915 0 C-N-CA 122.594 2.196 . . . . 0.0 113.595 -177.088 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.87 HD11 ' HB3' ' A' ' 3' ' ' LEU . 85.9 mt -107.23 -30.18 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.493 -169.691 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.85 -32.72 80.51 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -169.597 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 32.9 ttp85 -79.62 -21.7 44.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.364 -174.558 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.84 HG23 ' HG2' ' B' ' 37' ' ' ARG . 26.8 mt -63.7 -52.27 59.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.417 170.907 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.704 HD12 ' HB2' ' B' ' 40' ' ' ALA . 14.7 mm -67.12 -35.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.428 -168.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -28.34 69.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.2 177.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -61.93 -33.45 74.29 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.108 -1.406 . . . . 0.0 109.874 177.027 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 12' ' ' ILE . . . -59.08 -51.32 70.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.496 169.515 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.92 10.89 0.44 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.69 -174.301 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.79 ' N ' HD11 ' B' ' 44' ' ' ILE . . . -73.18 170.2 15.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.025 -0.587 . . . . 0.0 110.316 175.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -169.74 -46.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.036 -168.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.34 170.94 15.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.459 171.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.687 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 96.9 t -151.85 161.01 3.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.359 -169.128 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB2' ' CG2' ' B' ' 54' ' ' THR . 27.4 t -77.32 -167.78 0.99 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.398 175.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.09 -17.18 51.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.352 -173.029 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -170.57 124.74 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.386 168.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -146.75 -61.82 0.3 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.164 166.601 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.665 ' NH1' HG22 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -65.86 -14.94 62.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.361 -178.326 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.6 mt -86.43 -34.82 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.396 175.182 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.472 HG22 HD12 ' A' ' 31' ' ' ILE . 98.7 m -61.14 -53.98 50.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.228 165.409 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.705 HD12 ' CG2' ' A' ' 31' ' ' ILE . 16.7 tp -62.08 -23.52 66.55 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.347 -174.102 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 3' ' ' LEU . . . -82.16 -36.44 27.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.232 178.76 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -74.2 -16.13 60.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.51 172.529 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.999 HG12 HG11 ' B' ' 64' ' ' VAL . 0.7 OUTLIER -83.07 -29.46 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.889 -165.33 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' B' ' 32' ' ' LEU . 0.2 OUTLIER -89.39 -34.85 16.35 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.413 -173.612 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' HG ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -61.89 -34.91 76.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.982 -179.031 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' H ' ' HG3' ' A' ' 33' ' ' GLU . 8.3 mm-40 -73.87 -26.62 60.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.05 168.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -95.25 22.75 6.44 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.428 178.758 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.26 -41.63 0.09 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -173.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HD3' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -65.88 -26.01 67.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.417 -0.392 . . . . 0.0 110.177 167.507 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -87.44 -35.83 18.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.354 -168.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.737 HD13 HG22 ' A' ' 64' ' ' VAL . 6.6 mt -61.24 -32.1 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.423 174.149 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.933 ' HB2' HD12 ' B' ' 12' ' ' ILE . . . -62.48 -61.43 2.45 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.212 171.792 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 m -61.92 -13.65 26.94 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.524 -175.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.756 ' O ' HD13 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -89.66 -53.67 4.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.169 171.238 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . . . -61.94 -11.55 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.7 -179.275 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.87 HD11 ' CA ' ' B' ' 17' ' ' ALA . 0.0 OUTLIER -78.4 -60.93 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.402 -169.349 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 48' ' ' ARG . 9.2 mtmt -69.08 -18.56 64.01 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.468 173.108 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 42' ' ' GLU . 4.1 mp -61.1 -18.38 57.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.201 166.462 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 55' ' ' ILE . . . -91.45 -18.39 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.381 177.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -81.44 -33.32 32.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.372 -170.71 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -61.11 -24.56 66.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.356 169.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 47' ' ' ALA . . . -61.26 -52.66 63.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.226 166.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.18 28.66 0.58 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.467 -177.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.49 93.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.793 -0.704 . . . . 0.0 110.465 175.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.86 -76.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.467 179.372 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 55' ' ' ILE . 96.7 m -160.04 140.28 11.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.423 -169.666 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 47' ' ' ALA . 17.2 mm -61.58 165.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.267 167.209 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.92 -170.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.397 168.868 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.37 -19.52 65.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.304 -166.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -94.36 23.64 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.255 170.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' HB2' HG23 ' A' ' 55' ' ' ILE . 0.7 OUTLIER -121.22 -26.6 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.317 168.33 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.79 HG23 HD13 ' B' ' 28' ' ' LEU . 36.6 mm -95.99 -47.82 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.001 -163.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HG2' HD11 ' B' ' 31' ' ' ILE . 0.5 OUTLIER -75.92 -12.76 60.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.167 174.442 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.74 -48.14 7.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.43 177.747 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.581 ' HB2' HD22 ' A' ' 46' ' ' LEU . . . -60.98 -31.21 70.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.228 172.115 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.737 HG22 HD13 ' A' ' 39' ' ' ILE . 25.3 t -61.33 -70.18 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.756 164.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -9.82 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.806 -170.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HD3' ' HG2' ' A' ' 42' ' ' GLU . 8.9 ttt85 -77.66 -34.14 53.19 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.904 172.628 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.498 ' CE2' ' HG3' ' A' ' 35' ' ' MET . 5.6 m-85 -59.98 -37.16 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.437 178.598 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 68' ' ' LYS . 13.5 tptp -60.78 -14.5 21.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.523 -168.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.9 tttm . . . . . 0 C--O 1.24 0.565 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.427 165.8 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptm . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.104 0.478 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . 0.539 ' OE2' ' HB3' ' B' ' 29' ' ' ALA . 0.9 OUTLIER -160.82 134.9 7.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.102 170.139 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.594 ' HB2' HD11 ' B' ' 8' ' ' ILE . 5.6 mt -61.33 99.63 0.19 Allowed Pre-proline 0 C--O 1.242 0.67 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.839 -173.037 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -46.93 157.54 0.53 Allowed 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.229 1.953 . . . . 0.0 113.454 -179.07 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.04 23.04 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.378 -167.157 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.732 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -84.23 -58.19 0.38 Allowed Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.703 169.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 10.2 Cg_endo -57.75 -65.38 0.1 OUTLIER 'Trans proline' 0 N--CA 1.485 0.977 0 C-N-CA 122.505 2.137 . . . . 0.0 113.612 173.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' B' ' 3' ' ' LEU . 74.3 mt -60.8 -11.61 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.532 -170.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.34 -51.82 55.53 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -178.707 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -94.96 17.36 14.01 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.588 . . . . 0.0 110.642 -178.895 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.49 HG22 HD13 ' B' ' 12' ' ' ILE . 23.1 mt -95.27 -45.05 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.025 163.146 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.933 HD12 ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm -94.29 46.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.095 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.849 171.551 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 19.8 mtpt -149.59 -30.56 0.23 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.945 171.52 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.53 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 27.9 t0 -60.05 -30.49 69.23 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.065 171.264 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.96 74.53 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.638 170.907 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.64 22.33 2.28 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.552 -165.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.87 ' CA ' HD11 ' A' ' 44' ' ' ILE . . . -71.76 123.45 22.62 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 114.838 -0.681 . . . . 0.0 110.092 179.375 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -77.15 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.007 -164.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -109.84 -52.54 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.429 -177.841 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.766 HG13 ' HB ' ' A' ' 55' ' ' ILE . 11.5 t 62.84 132.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.331 -175.172 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -65.75 175.16 2.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.249 178.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -93.81 20.33 7.76 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.434 177.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.59 -44.86 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.446 169.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 60' ' ' ILE . . . -62.0 -45.88 91.66 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.326 -170.347 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -66.97 -25.47 66.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.315 -171.446 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mm -81.92 -32.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.381 171.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.829 ' O ' HD12 ' B' ' 31' ' ' ILE . 90.0 m -70.39 -45.69 65.49 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.276 -169.821 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.79 HD13 HG23 ' A' ' 60' ' ' ILE . 4.7 tp -59.78 -44.67 93.79 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.437 171.873 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.539 ' HB3' ' OE2' ' B' ' 2' ' ' GLU . . . -61.03 -10.07 5.39 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.541 177.636 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -109.71 -29.51 8.3 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.475 -176.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.829 HD12 ' O ' ' B' ' 27' ' ' THR . 2.8 mp -62.22 -74.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.854 164.108 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.657 HD23 HD23 ' A' ' 32' ' ' LEU . 1.4 mp -59.36 -11.4 4.2 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 -160.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.538 ' HB2' ' HG ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -92.17 -52.82 4.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.206 -176.401 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -29.43 70.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.944 170.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . 0.551 ' HE3' HG23 ' B' ' 31' ' ' ILE . 4.4 mtt -64.28 -45.52 87.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.356 168.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.62 78.43 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -176.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.84 ' HG2' HG23 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -67.08 -33.52 75.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.248 167.124 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . 0.521 ' HB2' ' HA ' ' B' ' 35' ' ' MET . 3.2 m-20 -72.41 -54.5 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.432 -171.836 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.826 HG23 ' O ' ' B' ' 63' ' ' ALA . 51.8 mt -60.83 -35.53 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.382 -174.797 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.704 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.89 -57.77 11.24 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.167 -173.008 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.456 ' HA ' ' CG2' ' B' ' 44' ' ' ILE . 43.2 p -66.18 -14.61 62.15 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.76 176.796 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.531 ' HG3' ' HB3' ' B' ' 68' ' ' LYS . 0.0 OUTLIER -87.56 -35.5 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.974 179.501 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' B' ' 46' ' ' LEU . . . -77.36 -12.03 59.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.286 170.322 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.79 HD11 ' N ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -85.57 -61.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.56 -172.508 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HA ' ' HG3' ' B' ' 48' ' ' ARG . 2.2 mptm? -60.6 -17.57 47.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.573 172.083 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.784 HD22 ' OD1' ' B' ' 59' ' ' ASP . 0.8 OUTLIER -61.63 -27.73 68.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.233 167.895 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.714 ' O ' ' HB3' ' B' ' 50' ' ' ALA . . . -73.55 -44.34 57.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.33 179.712 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.505 ' HB2' ' NE ' ' B' ' 52' ' ' ARG . 0.0 OUTLIER -81.07 -31.28 34.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.346 -177.906 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . 0.482 ' N ' ' HD2' ' B' ' 48' ' ' ARG . 6.2 t60 -60.98 -36.64 79.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.264 168.674 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' B' ' 47' ' ' ALA . . . -60.99 -52.83 63.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.152 165.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.87 28.37 0.74 Allowed Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.533 -173.825 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.505 ' NE ' ' HB2' ' B' ' 48' ' ' ARG . 6.1 mpt_? 65.11 96.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.139 -0.53 . . . . 0.0 110.521 169.371 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -152.36 -73.24 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.433 -177.019 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.465 HG22 ' O ' ' B' ' 55' ' ' ILE . 90.5 m -165.14 148.26 8.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.298 -173.731 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.465 ' O ' HG22 ' B' ' 54' ' ' THR . 31.8 mt -94.25 147.82 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.42 168.282 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.61 -174.61 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.4 -169.602 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.4 77.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.217 -168.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.69 ' O ' HD22 ' B' ' 62' ' ' LEU . 2.0 tm-20 -93.97 23.49 4.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.076 -179.81 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.784 ' OD1' HD22 ' B' ' 46' ' ' LEU . 0.8 OUTLIER -117.8 -17.26 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.511 166.664 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.612 ' O ' HG23 ' B' ' 64' ' ' VAL . 32.9 mm -92.27 -59.92 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.292 -175.58 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.645 ' HG2' HD11 ' A' ' 31' ' ' ILE . 71.2 mt-10 -60.48 -10.44 4.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.228 168.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.69 HD22 ' O ' ' B' ' 58' ' ' GLU . 0.8 OUTLIER -100.47 -14.94 18.07 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.876 177.952 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.826 ' O ' HG23 ' B' ' 39' ' ' ILE . . . -102.22 5.85 40.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.553 165.184 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.999 HG11 HG12 ' A' ' 31' ' ' ILE . 55.7 t -113.83 -84.5 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.572 -177.576 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' NH1' ' B' ' 65' ' ' ARG . 0.4 OUTLIER -60.8 -22.36 64.07 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.187 -178.73 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . 0.465 ' HD2' ' CG ' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -82.18 -46.7 13.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.944 160.504 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.17 31.71 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.335 -163.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.554 ' HD3' ' HG ' ' B' ' 46' ' ' LEU . 4.1 tptt 62.85 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.583 178.683 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.465 ' CG ' ' HD2' ' B' ' 66' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.598 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.354 166.483 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 121.067 0.461 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 15.5 mm-40 58.45 172.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.704 170.228 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.908 ' HB2' HD11 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -98.64 104.35 23.96 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.514 -175.908 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 2' ' ' GLU . 8.1 Cg_exo -50.45 156.19 4.36 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.503 2.135 . . . . 0.0 113.537 168.056 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 pp -87.69 62.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.38 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' A' ' 7' ' ' PRO . . . -153.25 -57.42 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.753 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.696 -177.388 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 6' ' ' ALA . 9.8 Cg_endo -59.35 -41.37 59.18 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.548 2.165 . . . . 0.0 113.657 170.654 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.908 HD11 ' HB2' ' A' ' 3' ' ' LEU . 27.9 mt -61.41 -23.67 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.43 170.913 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.8 -57.54 18.3 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -167.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -20.92 64.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.402 -170.507 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.856 HG22 HD13 ' A' ' 12' ' ' ILE . 28.0 mt -61.65 -49.75 83.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.183 167.115 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.867 HD12 ' HB2' ' B' ' 40' ' ' ALA . 1.8 mm -96.61 45.47 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.549 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 -35.13 0.1 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.779 173.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -60.37 -31.47 70.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 113.411 -1.722 . . . . 0.0 109.929 170.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.43 -53.04 62.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.502 170.103 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.88 33.09 0.52 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.552 -169.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.981 ' HB2' HD11 ' B' ' 44' ' ' ILE . . . -82.83 138.46 33.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -90.82 -50.34 5.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.001 -170.6 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.83 171.25 15.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.412 -168.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.797 ' CG1' ' HB3' ' A' ' 24' ' ' ALA . 17.1 m -115.24 -173.5 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.273 167.295 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.734 ' HA ' HG21 ' B' ' 54' ' ' THR . 54.0 p -90.33 -65.38 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.125 175.248 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -141.52 -34.75 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.71 161.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 47.7 m-20 -107.76 -106.15 0.34 Allowed 'General case' 0 C--O 1.253 1.277 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.657 165.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.797 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . 88.98 -56.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.026 1.331 . . . . 0.0 109.695 -168.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.504 ' NH1' ' HB ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.11 -21.45 46.61 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 113.545 -1.661 . . . . 0.0 110.647 -179.067 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -64.07 -43.26 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.806 173.618 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.637 HG22 ' CD1' ' A' ' 31' ' ' ILE . 51.2 m -60.66 -46.05 91.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.205 172.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.788 HD13 HG23 ' B' ' 60' ' ' ILE . 2.1 tp -60.82 -33.89 73.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.269 173.445 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.91 -26.25 62.24 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.295 -1.321 . . . . 0.0 110.384 175.279 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.98 28.87 2.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.528 176.373 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.977 HD13 HG21 ' B' ' 64' ' ' VAL . 66.8 mt -145.15 -64.54 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.109 -170.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -60.06 -38.64 83.43 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.69 177.21 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.587 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 5.0 tm-20 -86.35 -23.57 26.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.101 -169.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -91.57 19.26 6.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 173.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpp -126.21 -32.4 2.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.11 164.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.678 ' HA2' HD11 ' B' ' 32' ' ' LEU . . . -60.9 -40.9 98.98 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.695 -179.739 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.38 -18.77 65.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.481 -179.599 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' CE2' ' A' ' 67' ' ' PHE . 33.0 m-20 -101.73 -18.85 15.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.369 -167.476 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.645 ' CG2' HG23 ' A' ' 64' ' ' VAL . 14.9 mt -80.75 -24.83 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.377 171.422 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' B' ' 12' ' ' ILE . . . -72.85 -70.04 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.396 -166.916 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.49 ' HA ' ' HB ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -60.74 -10.0 4.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.503 -176.753 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 67' ' ' PHE . 54.2 mm-40 -88.13 -47.66 8.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.216 177.094 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 46' ' ' LEU . . . -62.45 -27.17 68.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.187 170.355 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.836 HD11 ' HB2' ' B' ' 17' ' ' ALA . 97.9 mt -77.95 -52.1 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.18 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -26.69 68.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.494 174.33 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 43' ' ' ALA . 4.6 mt -62.27 -40.5 96.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.319 176.533 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.711 ' HB2' ' CD1' ' A' ' 55' ' ' ILE . . . -61.21 -25.56 67.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.272 -167.756 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -103.95 -25.72 12.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.35 -176.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -64.33 -37.8 88.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.339 169.473 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.2 -44.33 97.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.334 168.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.83 18.95 14.01 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 169.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptt-85 179.18 -167.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.274 170.339 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.75 137.08 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.562 170.013 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' B' ' 21' ' ' SER . 86.6 m -60.82 171.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.386 167.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.711 ' CD1' ' HB2' ' A' ' 47' ' ' ALA . 18.8 mm -60.6 136.9 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.481 175.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.866 ' CA ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -159.97 -178.27 6.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.366 -167.092 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.01 -18.68 61.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.245 -171.057 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -93.34 -17.79 23.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.057 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 m-20 -78.23 -43.54 28.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.373 168.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.809 HG23 HD22 ' B' ' 28' ' ' LEU . 37.7 mm -72.22 -57.64 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.404 -170.371 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -67.77 -40.4 84.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.074 -166.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -37.47 82.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.442 170.049 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 59' ' ' ASP . . . -61.56 -16.41 47.65 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.438 -175.752 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.645 HG23 ' CG2' ' A' ' 39' ' ' ILE 0.256 0.4 OUTLIER -104.57 -50.39 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.042 -160.582 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -93.69 23.8 4.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.526 -178.077 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.5 ttt-85 -122.05 -55.71 1.87 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.481 -176.74 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 38' ' ' ASP . 1.5 p90 -61.26 -46.88 88.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.3 -163.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.98 158.26 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.415 -168.451 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.556 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.393 -169.331 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 121.162 0.506 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.88 161.0 40.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.968 -173.594 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.785 ' CD2' HD11 ' A' ' 11' ' ' ILE . 4.0 mt -74.05 138.56 75.91 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.799 -168.091 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -58.96 157.15 30.15 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.357 2.038 . . . . 0.0 113.221 164.703 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 5' ' ' ILE . . . . . 0.404 ' CG2' HD13 ' B' ' 26' ' ' ILE . 49.6 pt -93.02 23.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.519 178.7 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' B' ' 7' ' ' PRO . . . -90.87 -57.81 0.25 Allowed Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.763 170.063 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 7' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' B' ' 6' ' ' ALA . 9.2 Cg_endo -60.7 -54.62 1.87 Allowed 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.532 2.155 . . . . 0.0 113.57 173.325 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.725 HD11 HD12 ' B' ' 3' ' ' LEU . 28.7 mt -60.5 -13.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.498 169.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.41 -61.49 1.98 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -175.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.496 ' HA ' ' HB2' ' B' ' 13' ' ' LYS . 0.0 OUTLIER -93.82 17.06 12.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.593 -167.13 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.594 HD11 ' CD2' ' A' ' 3' ' ' LEU . 29.0 mt -96.73 -49.62 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.004 162.79 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.742 HD13 ' HB2' ' A' ' 40' ' ' ALA . 5.1 mm -68.04 -38.28 79.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.211 178.557 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.496 ' HB2' ' HA ' ' B' ' 10' ' ' ARG . 7.8 mttt -61.57 -35.25 77.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.355 174.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -62.54 -34.02 76.09 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.862 -177.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ILE . . . -59.26 -52.39 65.85 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.433 169.385 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.79 15.82 0.3 Allowed Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.221 179.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.836 ' HB2' HD11 ' A' ' 44' ' ' ILE . . . -62.83 125.72 24.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.219 164.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.36 -53.96 2.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.039 -167.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.549 ' O ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -130.55 93.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.412 171.653 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 55' ' ' ILE . 27.8 t -67.94 166.0 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.282 168.367 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 21' ' ' SER . . . . . 0.622 ' HB2' ' HB ' ' A' ' 54' ' ' THR . 26.5 t -102.32 -166.44 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.388 170.39 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.31 167.36 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.284 166.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 70.65 -61.31 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.498 171.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.866 ' HB2' ' CA ' ' A' ' 56' ' ' LYS . . . -61.88 -47.07 86.65 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.388 -167.212 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -60.83 -12.11 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.601 178.99 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.691 ' O ' ' HB3' ' B' ' 29' ' ' ALA . 16.9 mm -114.03 -15.88 9.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.645 -175.906 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.834 ' O ' HD12 ' B' ' 31' ' ' ILE . 41.4 m -73.77 -33.82 64.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.436 -171.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.809 HD22 HG23 ' A' ' 60' ' ' ILE . 2.7 mm? -62.71 -21.76 66.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.407 168.399 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 26' ' ' ILE . . . -79.07 -12.79 60.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.382 175.032 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 4.6 mttm -95.75 -29.1 14.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.493 172.229 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 31' ' ' ILE . . . . . 0.834 HD12 ' O ' ' B' ' 27' ' ' THR . 2.9 mp -78.73 -79.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.184 170.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.001 HD23 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -59.91 -12.89 8.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.649 -161.918 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' B' ' 3' ' ' LEU . 0.0 OUTLIER -93.39 -31.52 14.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.102 178.212 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' B' ' 30' ' ' LYS . 1.5 mt-10 -72.25 -29.74 64.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.148 169.022 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 19.2 mtt -99.45 36.24 1.8 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.278 172.78 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.644 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -144.94 -40.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 170.658 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -43.48 98.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.179 165.527 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 38' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -62.82 -38.81 92.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.438 -171.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.653 HG21 ' CD1' ' A' ' 28' ' ' LEU . 9.8 mt -70.6 -37.86 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.331 -175.583 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' A' ' 12' ' ' ILE . . . -60.77 -64.39 0.97 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.355 -168.767 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.463 ' HA ' ' HB ' ' B' ' 44' ' ' ILE . 1.2 t -61.69 -11.21 10.88 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.419 -176.588 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 42' ' ' GLU . . . . . 0.754 ' C ' HD12 ' B' ' 46' ' ' LEU . 0.2 OUTLIER -88.03 -51.9 5.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.183 174.408 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.661 ' O ' HD12 ' B' ' 55' ' ' ILE . . . -60.79 -9.63 4.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.364 171.23 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 17' ' ' ALA . 57.9 mt -99.11 -54.37 6.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.127 179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -23.67 62.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.343 -177.658 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.928 HD22 HD23 ' B' ' 62' ' ' LEU . 12.1 mt -60.71 -48.36 82.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.373 170.791 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.9 -60.32 3.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.371 171.303 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -20.64 62.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.365 -169.612 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 49' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -61.5 -44.9 96.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.363 169.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.15 -51.7 59.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 169.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 29.6 5.37 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 169.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.62 -171.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.3 169.854 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 44.4 mttp 64.34 163.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.439 -178.056 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.734 HG21 ' HA ' ' A' ' 21' ' ' SER . 6.1 t -88.52 -167.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.382 -169.399 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.661 HD12 ' O ' ' B' ' 43' ' ' ALA . 10.6 mm -100.63 142.6 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.327 173.146 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.528 ' HE2' ' H ' ' B' ' 57' ' ' ALA . 1.9 tmtt? -160.56 172.52 17.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.312 -165.132 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.528 ' H ' ' HE2' ' B' ' 56' ' ' LYS . . . -61.72 -33.23 73.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.369 -168.444 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' HD3' ' B' ' 56' ' ' LYS . 1.8 pt-20 -83.62 15.7 3.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.203 177.705 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' B' ' 62' ' ' LEU . 0.3 OUTLIER -130.65 -20.79 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.54 167.303 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 60' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 28' ' ' LEU . 10.1 mm -79.49 -50.44 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 61' ' ' GLU . . . . . 0.496 ' HA ' ' HB ' ' B' ' 64' ' ' VAL . 20.4 mt-10 -61.31 -39.46 90.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.027 166.212 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.928 HD23 HD22 ' B' ' 46' ' ' LEU . 0.3 OUTLIER -62.22 -32.2 72.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.508 178.351 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.577 ' HB2' ' N ' ' B' ' 43' ' ' ALA . . . -81.03 -35.68 31.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.207 175.054 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.977 HG21 HD13 ' A' ' 31' ' ' ILE . 19.9 t -62.39 -79.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.637 175.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -58.99 -12.73 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.664 -164.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -60.42 -26.0 66.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.512 171.501 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 67' ' ' PHE . . . . . 0.543 ' CZ ' ' HG3' ' B' ' 42' ' ' GLU . 17.4 m-85 -88.01 -50.41 6.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.409 -175.404 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -134.27 119.34 18.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.39 -172.315 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.24 0.587 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.306 170.661 . . . . . . . . 1 1 . 1 stop_ save_